id	sid	tid	token	lemma	pos
ihlr-18967	1	1	microsoft	microsoft	PROPN
ihlr-18967	1	2	word	word	NOUN
ihlr-18967	1	3	1	1	NUM
ihlr-18967	1	4	-	-	PUNCT
ihlr-18967	1	5	volume	volume	NOUN
ihlr-18967	1	6	xii	xii	NOUN
ihlr-18967	1	7	masthead.docx	masthead.docx	NOUN
ihlr-18967	1	8	supporting	support	VERB
ihlr-18967	1	9	the	the	DET
ihlr-18967	1	10	rationale	rationale	NOUN
ihlr-18967	1	11	behind	behind	ADP
ihlr-18967	1	12	the	the	DET
ihlr-18967	1	13	hatchwaxman	hatchwaxman	PROPN
ihlr-18967	1	14	act	act	PROPN
ihlr-18967	1	15	and	and	CCONJ
ihlr-18967	1	16	patent	patent	NOUN
ihlr-18967	1	17	law	law	NOUN
ihlr-18967	1	18	:	:	PUNCT
ihlr-18967	1	19	how	how	SCONJ
ihlr-18967	1	20	reverse	reverse	ADJ
ihlr-18967	1	21	payment	payment	NOUN
ihlr-18967	1	22	settlements	settlement	NOUN
ihlr-18967	1	23	under	under	ADP
ihlr-18967	1	24	ftc	ftc	PROPN
ihlr-18967	1	25	v.	v.	ADP
ihlr-18967	1	26	actavis	actavis	PROPN
ihlr-18967	1	27	,	,	PUNCT
ihlr-18967	1	28	inc	inc	PROPN
ihlr-18967	1	29	.	.	PROPN
ihlr-18967	1	30	can	can	AUX
ihlr-18967	1	31	be	be	AUX
ihlr-18967	1	32	procompetitive	procompetitive	ADJ
ihlr-18967	1	33	andrew	andrew	PROPN
ihlr-18967	1	34	e.	e.	PROPN
ihlr-18967	1	35	podgorny	podgorny	PROPN
ihlr-18967	1	36	*	*	PUNCT
ihlr-18967	1	37	i.	i.	NOUN
ihlr-18967	1	38	introduction	introduction	NOUN
ihlr-18967	1	39	..................................................................	..................................................................	PUNCT
ihlr-18967	1	40	424	424	NUM
ihlr-18967	1	41	a.	a.	NOUN
ihlr-18967	1	42	the	the	DET
ihlr-18967	1	43	issue	issue	NOUN
ihlr-18967	1	44	.....................................................................	.....................................................................	PUNCT
ihlr-18967	1	45	426	426	NUM
ihlr-18967	1	46	b.	b.	PROPN
ihlr-18967	1	47	roadmap	roadmap	PROPN
ihlr-18967	1	48	.....................................................................	.....................................................................	PUNCT
ihlr-18967	1	49	428	428	NUM
ihlr-18967	1	50	ii	ii	NOUN
ihlr-18967	1	51	.	.	PUNCT
ihlr-18967	1	52	background	background	NOUN
ihlr-18967	1	53	information	information	NOUN
ihlr-18967	1	54	...........................................	...........................................	PUNCT
ihlr-18967	1	55	428	428	NUM
ihlr-18967	1	56	a.	a.	NOUN
ihlr-18967	1	57	pre	pre	VERB
ihlr-18967	1	58	-	-	ADJ
ihlr-18967	1	59	hatch	hatch	ADJ
ihlr-18967	1	60	-	-	PUNCT
ihlr-18967	1	61	waxman	waxman	NOUN
ihlr-18967	1	62	act	act	NOUN
ihlr-18967	1	63	.............................................	.............................................	PUNCT
ihlr-18967	1	64	428	428	NUM
ihlr-18967	1	65	b.	b.	X
ihlr-18967	1	66	the	the	DET
ihlr-18967	1	67	hatch	hatch	PROPN
ihlr-18967	1	68	-	-	PUNCT
ihlr-18967	1	69	waxman	waxman	PROPN
ihlr-18967	1	70	act	act	PROPN
ihlr-18967	1	71	:	:	PUNCT
ihlr-18967	1	72	a	a	DET
ihlr-18967	1	73	compromise	compromise	NOUN
ihlr-18967	1	74	for	for	ADP
ihlr-18967	1	75	pioneer	pioneer	NOUN
ihlr-18967	1	76	and	and	CCONJ
ihlr-18967	1	77	generic	generic	ADJ
ihlr-18967	1	78	manufacturers	manufacturer	NOUN
ihlr-18967	1	79	......................................	......................................	PUNCT
ihlr-18967	1	80	430	430	NUM
ihlr-18967	1	81	c.	c.	NOUN
ihlr-18967	1	82	the	the	DET
ihlr-18967	1	83	hatch	hatch	PROPN
ihlr-18967	1	84	-	-	PUNCT
ihlr-18967	1	85	waxman	waxman	PROPN
ihlr-18967	1	86	act	act	NOUN
ihlr-18967	1	87	and	and	CCONJ
ihlr-18967	1	88	reverse	reverse	VERB
ihlr-18967	1	89	payment	payment	NOUN
ihlr-18967	1	90	settlements	settlement	NOUN
ihlr-18967	1	91	................................................................	................................................................	PUNCT
ihlr-18967	2	1	432	432	NUM
ihlr-18967	2	2	d.	d.	PROPN
ihlr-18967	2	3	alternative	alternative	PROPN
ihlr-18967	2	4	methods	method	NOUN
ihlr-18967	2	5	to	to	PART
ihlr-18967	2	6	analyze	analyze	VERB
ihlr-18967	2	7	reverse	reverse	ADJ
ihlr-18967	2	8	payment	payment	NOUN
ihlr-18967	2	9	settlements	settlement	NOUN
ihlr-18967	2	10	................................................................	................................................................	PUNCT
ihlr-18967	3	1	434	434	NUM
ihlr-18967	3	2	1	1	NUM
ihlr-18967	3	3	.	.	PUNCT
ihlr-18967	4	1	the	the	DET
ihlr-18967	4	2	third	third	ADJ
ihlr-18967	4	3	circuit	circuit	NOUN
ihlr-18967	4	4	:	:	PUNCT
ihlr-18967	4	5	the	the	DET
ihlr-18967	4	6	quick	quick	ADJ
ihlr-18967	4	7	look	look	NOUN
ihlr-18967	4	8	rule	rule	NOUN
ihlr-18967	4	9	of	of	ADP
ihlr-18967	4	10	reason	reason	NOUN
ihlr-18967	4	11	...	...	PUNCT
ihlr-18967	4	12	436	436	NUM
ihlr-18967	4	13	2	2	NUM
ihlr-18967	4	14	.	.	PUNCT
ihlr-18967	5	1	the	the	DET
ihlr-18967	5	2	eleventh	eleventh	ADJ
ihlr-18967	5	3	circuit	circuit	NOUN
ihlr-18967	5	4	:	:	PUNCT
ihlr-18967	5	5	scope	scope	NOUN
ihlr-18967	5	6	of	of	ADP
ihlr-18967	5	7	patent	patent	NOUN
ihlr-18967	5	8	test	test	NOUN
ihlr-18967	5	9	.............	.............	PUNCT
ihlr-18967	6	1	436	436	NUM
ihlr-18967	6	2	e.	e.	PROPN
ihlr-18967	6	3	the	the	DET
ihlr-18967	6	4	circuit	circuit	NOUN
ihlr-18967	6	5	split	split	VERB
ihlr-18967	6	6	and	and	CCONJ
ihlr-18967	6	7	supreme	supreme	PROPN
ihlr-18967	6	8	court	court	NOUN
ihlr-18967	6	9	decision	decision	NOUN
ihlr-18967	6	10	........	........	PUNCT
ihlr-18967	7	1	437	437	NUM
ihlr-18967	7	2	1	1	NUM
ihlr-18967	7	3	.	.	PUNCT
ihlr-18967	8	1	in	in	ADP
ihlr-18967	8	2	re	re	NOUN
ihlr-18967	8	3	k	k	X
ihlr-18967	8	4	-	-	ADJ
ihlr-18967	8	5	dur	dur	ADJ
ihlr-18967	8	6	antitrust	antitrust	ADJ
ihlr-18967	8	7	litigation	litigation	NOUN
ihlr-18967	8	8	..............................	..............................	PUNCT
ihlr-18967	8	9	437	437	NUM
ihlr-18967	8	10	2	2	NUM
ihlr-18967	8	11	.	.	PUNCT
ihlr-18967	8	12	ftc	ftc	PROPN
ihlr-18967	8	13	v.	v.	PROPN
ihlr-18967	8	14	watson	watson	PROPN
ihlr-18967	8	15	pharmaceuticals	pharmaceuticals	PROPN
ihlr-18967	8	16	inc	inc	PROPN
ihlr-18967	8	17	.	.	PROPN
ihlr-18967	8	18	.......................	.......................	PUNCT
ihlr-18967	9	1	439	439	NUM
ihlr-18967	9	2	3	3	NUM
ihlr-18967	9	3	.	.	PUNCT
ihlr-18967	9	4	ftc	ftc	PROPN
ihlr-18967	9	5	v.	v.	ADP
ihlr-18967	9	6	actavis	actavis	PROPN
ihlr-18967	9	7	,	,	PUNCT
ihlr-18967	9	8	inc	inc	PROPN
ihlr-18967	9	9	.	.	PROPN
ihlr-18967	9	10	...................................................	...................................................	PROPN
ihlr-18967	10	1	440	440	NUM
ihlr-18967	10	2	f.	f.	NOUN
ihlr-18967	10	3	what	what	PRON
ihlr-18967	10	4	is	be	AUX
ihlr-18967	10	5	the	the	DET
ihlr-18967	10	6	rule	rule	NOUN
ihlr-18967	10	7	of	of	ADP
ihlr-18967	10	8	reason	reason	NOUN
ihlr-18967	10	9	?	?	PUNCT
ihlr-18967	11	1	.......................................	.......................................	PUNCT
ihlr-18967	12	1	442	442	NUM
ihlr-18967	12	2	g.	g.	PROPN
ihlr-18967	12	3	congress	congress	PROPN
ihlr-18967	12	4	addresses	address	NOUN
ihlr-18967	12	5	reverse	reverse	VERB
ihlr-18967	12	6	payment	payment	NOUN
ihlr-18967	12	7	settlements	settlement	NOUN
ihlr-18967	12	8	...	...	PUNCT
ihlr-18967	12	9	443	443	NUM
ihlr-18967	12	10	iii	iii	NOUN
ihlr-18967	12	11	.	.	PUNCT
ihlr-18967	13	1	analysis	analysis	NOUN
ihlr-18967	13	2	:	:	PUNCT
ihlr-18967	13	3	the	the	DET
ihlr-18967	13	4	residual	residual	ADJ
ihlr-18967	13	5	effect	effect	NOUN
ihlr-18967	13	6	of	of	ADP
ihlr-18967	13	7	actavis	actavis	NOUN
ihlr-18967	13	8	and	and	CCONJ
ihlr-18967	13	9	importance	importance	NOUN
ihlr-18967	13	10	of	of	ADP
ihlr-18967	13	11	crafting	craft	VERB
ihlr-18967	13	12	pro	pro	ADJ
ihlr-18967	13	13	-	-	ADJ
ihlr-18967	13	14	competitive	competitive	ADJ
ihlr-18967	13	15	settlements	settlement	NOUN
ihlr-18967	13	16	.................................................................	.................................................................	PUNCT
ihlr-18967	13	17	444	444	NUM
ihlr-18967	13	18	a.	a.	NOUN
ihlr-18967	13	19	impact	impact	NOUN
ihlr-18967	13	20	of	of	ADP
ihlr-18967	13	21	using	use	VERB
ihlr-18967	13	22	rule	rule	NOUN
ihlr-18967	13	23	of	of	ADP
ihlr-18967	13	24	reason	reason	NOUN
ihlr-18967	13	25	analysis	analysis	NOUN
ihlr-18967	13	26	..................	..................	PUNCT
ihlr-18967	13	27	444	444	NUM
ihlr-18967	13	28	1	1	NUM
ihlr-18967	13	29	.	.	PUNCT
ihlr-18967	14	1	effect	effect	NOUN
ihlr-18967	14	2	of	of	ADP
ihlr-18967	14	3	antitrust	antitrust	ADJ
ihlr-18967	14	4	laws	law	NOUN
ihlr-18967	14	5	:	:	PUNCT
ihlr-18967	14	6	how	how	SCONJ
ihlr-18967	14	7	consumers	consumer	NOUN
ihlr-18967	14	8	benefit	benefit	VERB
ihlr-18967	14	9	..	..	PUNCT
ihlr-18967	14	10	444	444	NUM
ihlr-18967	14	11	2	2	NUM
ihlr-18967	14	12	.	.	PUNCT
ihlr-18967	14	13	effect	effect	NOUN
ihlr-18967	14	14	of	of	ADP
ihlr-18967	14	15	antitrust	antitrust	ADJ
ihlr-18967	14	16	laws	law	NOUN
ihlr-18967	14	17	:	:	PUNCT
ihlr-18967	14	18	different	different	ADJ
ihlr-18967	14	19	affect	affect	VERB
ihlr-18967	14	20	on	on	ADP
ihlr-18967	14	21	drug	drug	NOUN
ihlr-18967	14	22	manufacturers	manufacturer	NOUN
ihlr-18967	14	23	...............................................................	...............................................................	PUNCT
ihlr-18967	15	1	449	449	NUM
ihlr-18967	15	2	b.	b.	NOUN
ihlr-18967	15	3	complying	comply	VERB
ihlr-18967	15	4	with	with	ADP
ihlr-18967	15	5	the	the	DET
ihlr-18967	15	6	actavis	actavis	ADJ
ihlr-18967	15	7	framework	framework	NOUN
ihlr-18967	15	8	:	:	PUNCT
ihlr-18967	15	9	crafting	craft	VERB
ihlr-18967	15	10	procompetitive	procompetitive	ADJ
ihlr-18967	15	11	reverse	reverse	ADJ
ihlr-18967	15	12	payment	payment	NOUN
ihlr-18967	15	13	settlements	settlement	NOUN
ihlr-18967	15	14	........	........	PUNCT
ihlr-18967	16	1	452	452	NUM
ihlr-18967	16	2	*	*	PUNCT
ihlr-18967	16	3	j.d	j.d	PROPN
ihlr-18967	16	4	.	.	PROPN
ihlr-18967	16	5	candidate	candidate	NOUN
ihlr-18967	16	6	,	,	PUNCT
ihlr-18967	16	7	2015	2015	NUM
ihlr-18967	16	8	,	,	PUNCT
ihlr-18967	16	9	indiana	indiana	PROPN
ihlr-18967	16	10	university	university	PROPN
ihlr-18967	16	11	robert	robert	PROPN
ihlr-18967	16	12	h.	h.	PROPN
ihlr-18967	16	13	mckinney	mckinney	PROPN
ihlr-18967	16	14	school	school	PROPN
ihlr-18967	16	15	of	of	ADP
ihlr-18967	16	16	law	law	NOUN
ihlr-18967	16	17	;	;	PUNCT
ihlr-18967	16	18	b.s	b.s	PROPN
ihlr-18967	16	19	.	.	PROPN
ihlr-18967	16	20	,	,	PUNCT
ihlr-18967	16	21	2011	2011	NUM
ihlr-18967	16	22	,	,	PUNCT
ihlr-18967	16	23	indiana	indiana	PROPN
ihlr-18967	16	24	university	university	PROPN
ihlr-18967	16	25	-	-	PUNCT
ihlr-18967	16	26	bloomington	bloomington	PROPN
ihlr-18967	16	27	.	.	PUNCT
ihlr-18967	17	1	http://dx.doi.org/10.18060/18967	http://dx.doi.org/10.18060/18967	PROPN
ihlr-18967	17	2	424	424	NUM
ihlr-18967	17	3	indiana	indiana	PROPN
ihlr-18967	17	4	health	health	PROPN
ihlr-18967	17	5	law	law	PROPN
ihlr-18967	17	6	review	review	NOUN
ihlr-18967	17	7	vol	vol	NOUN
ihlr-18967	17	8	.	.	PUNCT
ihlr-18967	18	1	12:1	12:1	NUM
ihlr-18967	18	2	1	1	NUM
ihlr-18967	18	3	.	.	PUNCT
ihlr-18967	19	1	what	what	DET
ihlr-18967	19	2	type	type	NOUN
ihlr-18967	19	3	of	of	ADP
ihlr-18967	19	4	payments	payment	NOUN
ihlr-18967	19	5	implicate	implicate	VERB
ihlr-18967	19	6	the	the	DET
ihlr-18967	19	7	actavis	actavis	ADJ
ihlr-18967	19	8	analysis	analysis	NOUN
ihlr-18967	19	9	.........................................................................	.........................................................................	PUNCT
ihlr-18967	19	10	453	453	NUM
ihlr-18967	19	11	2	2	NUM
ihlr-18967	19	12	.	.	PUNCT
ihlr-18967	19	13	market	market	NOUN
ihlr-18967	19	14	power	power	NOUN
ihlr-18967	19	15	............................................................	............................................................	PUNCT
ihlr-18967	19	16	454	454	NUM
ihlr-18967	19	17	3	3	NUM
ihlr-18967	19	18	.	.	PUNCT
ihlr-18967	19	19	relevant	relevant	ADJ
ihlr-18967	19	20	market	market	NOUN
ihlr-18967	19	21	........................................................	........................................................	PUNCT
ihlr-18967	20	1	455	455	NUM
ihlr-18967	20	2	4	4	NUM
ihlr-18967	20	3	.	.	PUNCT
ihlr-18967	20	4	redeeming	redeem	VERB
ihlr-18967	20	5	virtues	virtue	NOUN
ihlr-18967	20	6	....................................................	....................................................	PUNCT
ihlr-18967	21	1	456	456	NUM
ihlr-18967	21	2	5	5	NUM
ihlr-18967	21	3	.	.	NOUN
ihlr-18967	21	4	size	size	NOUN
ihlr-18967	21	5	of	of	ADP
ihlr-18967	21	6	monetary	monetary	ADJ
ihlr-18967	21	7	payments	payment	NOUN
ihlr-18967	21	8	......................................	......................................	PUNCT
ihlr-18967	22	1	458	458	NUM
ihlr-18967	22	2	6	6	NUM
ihlr-18967	22	3	.	.	PUNCT
ihlr-18967	22	4	time	time	NOUN
ihlr-18967	22	5	frame	frame	NOUN
ihlr-18967	22	6	for	for	ADP
ihlr-18967	22	7	generic	generic	ADJ
ihlr-18967	22	8	entry	entry	NOUN
ihlr-18967	22	9	.................................	.................................	PUNCT
ihlr-18967	23	1	461	461	NUM
ihlr-18967	23	2	7	7	NUM
ihlr-18967	23	3	.	.	PUNCT
ihlr-18967	23	4	strength	strength	NOUN
ihlr-18967	23	5	of	of	ADP
ihlr-18967	23	6	patent	patent	NOUN
ihlr-18967	23	7	.....................................................	.....................................................	PUNCT
ihlr-18967	24	1	462	462	NUM
ihlr-18967	24	2	8	8	NUM
ihlr-18967	24	3	.	.	PUNCT
ihlr-18967	24	4	venue	venue	NOUN
ihlr-18967	24	5	.........................................................................	.........................................................................	PUNCT
ihlr-18967	25	1	463	463	NUM
ihlr-18967	25	2	9	9	NUM
ihlr-18967	25	3	.	.	PUNCT
ihlr-18967	25	4	ability	ability	NOUN
ihlr-18967	25	5	to	to	PART
ihlr-18967	25	6	explain	explain	VERB
ihlr-18967	25	7	......................................................	......................................................	PUNCT
ihlr-18967	25	8	464	464	NUM
ihlr-18967	25	9	iv	iv	NOUN
ihlr-18967	25	10	.	.	PUNCT
ihlr-18967	25	11	policy	policy	NOUN
ihlr-18967	25	12	recommendation	recommendation	NOUN
ihlr-18967	25	13	:	:	PUNCT
ihlr-18967	25	14	how	how	SCONJ
ihlr-18967	25	15	reverse	reverse	ADJ
ihlr-18967	25	16	payment	payment	NOUN
ihlr-18967	25	17	settlements	settlement	NOUN
ihlr-18967	25	18	support	support	VERB
ihlr-18967	25	19	the	the	DET
ihlr-18967	25	20	intent	intent	NOUN
ihlr-18967	25	21	of	of	ADP
ihlr-18967	25	22	patent	patent	NOUN
ihlr-18967	25	23	law	law	NOUN
ihlr-18967	25	24	and	and	CCONJ
ihlr-18967	25	25	the	the	DET
ihlr-18967	25	26	hatch	hatch	NOUN
ihlr-18967	25	27	-	-	PUNCT
ihlr-18967	25	28	waxman	waxman	PROPN
ihlr-18967	25	29	act	act	NOUN
ihlr-18967	25	30	..............................................	..............................................	PUNCT
ihlr-18967	25	31	464	464	NUM
ihlr-18967	26	1	v.	v.	ADP
ihlr-18967	26	2	conclusion	conclusion	NOUN
ihlr-18967	26	3	....................................................................	....................................................................	PUNCT
ihlr-18967	26	4	468	468	NUM
ihlr-18967	26	5	i.	i.	PROPN
ihlr-18967	26	6	introduction	introduction	PROPN
ihlr-18967	26	7	john	john	PROPN
ihlr-18967	26	8	’s	’s	PROPN
ihlr-18967	26	9	family	family	NOUN
ihlr-18967	26	10	has	have	AUX
ihlr-18967	26	11	come	come	VERB
ihlr-18967	26	12	to	to	PART
ihlr-18967	26	13	visit	visit	VERB
ihlr-18967	26	14	him	he	PRON
ihlr-18967	26	15	at	at	ADP
ihlr-18967	26	16	the	the	DET
ihlr-18967	26	17	nursing	nursing	NOUN
ihlr-18967	26	18	home	home	NOUN
ihlr-18967	26	19	.	.	PUNCT
ihlr-18967	27	1	his	his	PRON
ihlr-18967	27	2	grandchildren	grandchild	NOUN
ihlr-18967	27	3	,	,	PUNCT
ihlr-18967	27	4	bursting	burst	VERB
ihlr-18967	27	5	with	with	ADP
ihlr-18967	27	6	excitement	excitement	NOUN
ihlr-18967	27	7	,	,	PUNCT
ihlr-18967	27	8	come	come	VERB
ihlr-18967	27	9	running	run	VERB
ihlr-18967	27	10	into	into	ADP
ihlr-18967	27	11	the	the	DET
ihlr-18967	27	12	room	room	NOUN
ihlr-18967	27	13	and	and	CCONJ
ihlr-18967	27	14	jump	jump	VERB
ihlr-18967	27	15	up	up	ADP
ihlr-18967	27	16	to	to	PART
ihlr-18967	27	17	hug	hug	VERB
ihlr-18967	27	18	their	their	PRON
ihlr-18967	27	19	grandfather	grandfather	NOUN
ihlr-18967	27	20	,	,	PUNCT
ihlr-18967	27	21	only	only	ADV
ihlr-18967	27	22	to	to	PART
ihlr-18967	27	23	be	be	AUX
ihlr-18967	27	24	greeted	greet	VERB
ihlr-18967	27	25	with	with	ADP
ihlr-18967	27	26	,	,	PUNCT
ihlr-18967	27	27	“	"	PUNCT
ihlr-18967	27	28	who	who	PRON
ihlr-18967	27	29	might	might	AUX
ihlr-18967	27	30	you	you	PRON
ihlr-18967	27	31	be	be	AUX
ihlr-18967	27	32	?	?	PUNCT
ihlr-18967	27	33	”	"	PUNCT
ihlr-18967	28	1	john	john	PROPN
ihlr-18967	28	2	suffers	suffer	VERB
ihlr-18967	28	3	from	from	ADP
ihlr-18967	28	4	alzheimer	alzheimer	PROPN
ihlr-18967	28	5	’s	’s	PART
ihlr-18967	28	6	disease	disease	NOUN
ihlr-18967	28	7	,	,	PUNCT
ihlr-18967	28	8	which	which	PRON
ihlr-18967	28	9	causes	cause	VERB
ihlr-18967	28	10	him	he	PRON
ihlr-18967	28	11	memory	memory	NOUN
ihlr-18967	28	12	loss	loss	NOUN
ihlr-18967	28	13	and	and	CCONJ
ihlr-18967	28	14	also	also	ADV
ihlr-18967	28	15	affects	affect	VERB
ihlr-18967	28	16	his	his	PRON
ihlr-18967	28	17	intellectual	intellectual	ADJ
ihlr-18967	28	18	abilities	ability	NOUN
ihlr-18967	28	19	used	use	VERB
ihlr-18967	28	20	in	in	ADP
ihlr-18967	28	21	daily	daily	PROPN
ihlr-18967	28	22	life.1	life.1	PROPN
ihlr-18967	28	23	alzheimer	alzheimer	PROPN
ihlr-18967	28	24	’s	’s	PART
ihlr-18967	28	25	disease	disease	NOUN
ihlr-18967	28	26	is	be	AUX
ihlr-18967	28	27	one	one	NUM
ihlr-18967	28	28	of	of	ADP
ihlr-18967	28	29	many	many	ADJ
ihlr-18967	28	30	known	know	VERB
ihlr-18967	28	31	ailments	ailment	NOUN
ihlr-18967	28	32	that	that	PRON
ihlr-18967	28	33	has	have	AUX
ihlr-18967	28	34	continued	continue	VERB
ihlr-18967	28	35	to	to	PART
ihlr-18967	28	36	perplex	perplex	VERB
ihlr-18967	28	37	scientists	scientist	NOUN
ihlr-18967	28	38	for	for	ADP
ihlr-18967	28	39	over	over	ADP
ihlr-18967	28	40	a	a	PRON
ihlr-18967	28	41	century	century	NOUN
ihlr-18967	28	42	and	and	CCONJ
ihlr-18967	28	43	,	,	PUNCT
ihlr-18967	28	44	to	to	ADP
ihlr-18967	28	45	this	this	DET
ihlr-18967	28	46	day	day	NOUN
ihlr-18967	28	47	,	,	PUNCT
ihlr-18967	28	48	has	have	VERB
ihlr-18967	28	49	no	no	DET
ihlr-18967	28	50	cure	cure	NOUN
ihlr-18967	28	51	.	.	PUNCT
ihlr-18967	29	1	abc	abc	PROPN
ihlr-18967	29	2	corporation	corporation	PROPN
ihlr-18967	29	3	(	(	PUNCT
ihlr-18967	29	4	“	"	PUNCT
ihlr-18967	29	5	abc	abc	PROPN
ihlr-18967	29	6	”	"	PUNCT
ihlr-18967	29	7	)	)	PUNCT
ihlr-18967	29	8	is	be	AUX
ihlr-18967	29	9	attempting	attempt	VERB
ihlr-18967	29	10	to	to	PART
ihlr-18967	29	11	develop	develop	VERB
ihlr-18967	29	12	a	a	DET
ihlr-18967	29	13	new	new	ADJ
ihlr-18967	29	14	drug	drug	NOUN
ihlr-18967	29	15	that	that	PRON
ihlr-18967	29	16	will	will	AUX
ihlr-18967	29	17	revolutionize	revolutionize	VERB
ihlr-18967	29	18	medical	medical	ADJ
ihlr-18967	29	19	treatment	treatment	NOUN
ihlr-18967	29	20	for	for	ADP
ihlr-18967	29	21	people	people	NOUN
ihlr-18967	29	22	suffering	suffer	VERB
ihlr-18967	29	23	from	from	ADP
ihlr-18967	29	24	alzheimer	alzheimer	PROPN
ihlr-18967	29	25	’s	’s	PART
ihlr-18967	29	26	disease	disease	NOUN
ihlr-18967	29	27	.	.	PUNCT
ihlr-18967	30	1	abc	abc	PROPN
ihlr-18967	30	2	’s	’s	PART
ihlr-18967	30	3	main	main	ADJ
ihlr-18967	30	4	business	business	NOUN
ihlr-18967	30	5	includes	include	VERB
ihlr-18967	30	6	research	research	NOUN
ihlr-18967	30	7	,	,	PUNCT
ihlr-18967	30	8	development	development	NOUN
ihlr-18967	30	9	,	,	PUNCT
ihlr-18967	30	10	and	and	CCONJ
ihlr-18967	30	11	marketing	marketing	NOUN
ihlr-18967	30	12	of	of	ADP
ihlr-18967	30	13	new	new	ADJ
ihlr-18967	30	14	pharmaceutical	pharmaceutical	ADJ
ihlr-18967	30	15	drugs	drug	NOUN
ihlr-18967	30	16	.	.	PUNCT
ihlr-18967	31	1	recently	recently	ADV
ihlr-18967	31	2	,	,	PUNCT
ihlr-18967	31	3	due	due	ADJ
ihlr-18967	31	4	in	in	ADP
ihlr-18967	31	5	large	large	ADJ
ihlr-18967	31	6	part	part	NOUN
ihlr-18967	31	7	to	to	ADP
ihlr-18967	31	8	complex	complex	ADJ
ihlr-18967	31	9	research	research	NOUN
ihlr-18967	31	10	and	and	CCONJ
ihlr-18967	31	11	numerous	numerous	ADJ
ihlr-18967	31	12	clinical	clinical	ADJ
ihlr-18967	31	13	trials	trial	NOUN
ihlr-18967	31	14	,	,	PUNCT
ihlr-18967	31	15	abc	abc	PROPN
ihlr-18967	31	16	has	have	AUX
ihlr-18967	31	17	poured	pour	VERB
ihlr-18967	31	18	millions	million	NOUN
ihlr-18967	31	19	of	of	ADP
ihlr-18967	31	20	dollars	dollar	NOUN
ihlr-18967	31	21	and	and	CCONJ
ihlr-18967	31	22	years	year	NOUN
ihlr-18967	31	23	of	of	ADP
ihlr-18967	31	24	research	research	NOUN
ihlr-18967	31	25	into	into	ADP
ihlr-18967	31	26	drug	drug	NOUN
ihlr-18967	31	27	23	23	NUM
ihlr-18967	31	28	.	.	PUNCT
ihlr-18967	32	1	dr	dr	PROPN
ihlr-18967	32	2	.	.	PROPN
ihlr-18967	32	3	white	white	PROPN
ihlr-18967	32	4	,	,	PUNCT
ihlr-18967	32	5	the	the	DET
ihlr-18967	32	6	lead	lead	ADJ
ihlr-18967	32	7	scientist	scientist	NOUN
ihlr-18967	32	8	for	for	ADP
ihlr-18967	32	9	drug	drug	NOUN
ihlr-18967	32	10	23	23	NUM
ihlr-18967	32	11	,	,	PUNCT
ihlr-18967	32	12	claims	claim	VERB
ihlr-18967	32	13	that	that	SCONJ
ihlr-18967	32	14	if	if	SCONJ
ihlr-18967	32	15	1	1	NUM
ihlr-18967	32	16	see	see	VERB
ihlr-18967	32	17	alzheimer	alzheimer	PROPN
ihlr-18967	32	18	’s	’s	PART
ihlr-18967	32	19	ass’n	ass’n	NOUN
ihlr-18967	32	20	,	,	PUNCT
ihlr-18967	32	21	what	what	PRON
ihlr-18967	32	22	is	be	AUX
ihlr-18967	32	23	alzheimer	alzheimer	NOUN
ihlr-18967	32	24	’s	’s	PART
ihlr-18967	32	25	?	?	PUNCT
ihlr-18967	32	26	,	,	PUNCT
ihlr-18967	32	27	alz.org	alz.org	PROPN
ihlr-18967	32	28	,	,	PUNCT
ihlr-18967	32	29	https://www.alz.org/alzheimers_disease_what_is_alzheimers.asp	https://www.alz.org/alzheimers_disease_what_is_alzheimers.asp	NOUN
ihlr-18967	32	30	(	(	PUNCT
ihlr-18967	32	31	last	last	ADV
ihlr-18967	32	32	visited	visit	VERB
ihlr-18967	32	33	mar	mar	PROPN
ihlr-18967	32	34	.	.	PROPN
ihlr-18967	32	35	8	8	NUM
ihlr-18967	32	36	,	,	PUNCT
ihlr-18967	32	37	2014	2014	NUM
ihlr-18967	32	38	)	)	PUNCT
ihlr-18967	32	39	.	.	PUNCT
ihlr-18967	33	1	2015	2015	NUM
ihlr-18967	33	2	rationale	rationale	NOUN
ihlr-18967	33	3	behind	behind	ADP
ihlr-18967	33	4	hatch	hatch	NOUN
ihlr-18967	33	5	-	-	PUNCT
ihlr-18967	33	6	waxman	waxman	PROPN
ihlr-18967	33	7	act	act	PROPN
ihlr-18967	33	8	and	and	CCONJ
ihlr-18967	33	9	patent	patent	NOUN
ihlr-18967	33	10	law	law	NOUN
ihlr-18967	33	11	425	425	NUM
ihlr-18967	33	12	abc	abc	PROPN
ihlr-18967	33	13	is	be	AUX
ihlr-18967	33	14	successful	successful	ADJ
ihlr-18967	33	15	in	in	ADP
ihlr-18967	33	16	its	its	PRON
ihlr-18967	33	17	development	development	NOUN
ihlr-18967	33	18	of	of	ADP
ihlr-18967	33	19	drug	drug	NOUN
ihlr-18967	33	20	23	23	NUM
ihlr-18967	33	21	,	,	PUNCT
ihlr-18967	33	22	its	its	PRON
ihlr-18967	33	23	scientists	scientist	NOUN
ihlr-18967	33	24	will	will	AUX
ihlr-18967	33	25	have	have	AUX
ihlr-18967	33	26	developed	develop	VERB
ihlr-18967	33	27	a	a	DET
ihlr-18967	33	28	cure	cure	NOUN
ihlr-18967	33	29	for	for	ADP
ihlr-18967	33	30	alzheimer	alzheimer	PROPN
ihlr-18967	33	31	’s	’s	PART
ihlr-18967	33	32	disease	disease	NOUN
ihlr-18967	33	33	.	.	PUNCT
ihlr-18967	34	1	while	while	SCONJ
ihlr-18967	34	2	abc	abc	PROPN
ihlr-18967	34	3	is	be	AUX
ihlr-18967	34	4	taking	take	VERB
ihlr-18967	34	5	a	a	DET
ihlr-18967	34	6	huge	huge	ADJ
ihlr-18967	34	7	risk	risk	NOUN
ihlr-18967	34	8	by	by	ADP
ihlr-18967	34	9	expending	expend	VERB
ihlr-18967	34	10	a	a	DET
ihlr-18967	34	11	large	large	ADJ
ihlr-18967	34	12	amount	amount	NOUN
ihlr-18967	34	13	of	of	ADP
ihlr-18967	34	14	resources	resource	NOUN
ihlr-18967	34	15	into	into	ADP
ihlr-18967	34	16	a	a	DET
ihlr-18967	34	17	drug	drug	NOUN
ihlr-18967	34	18	that	that	PRON
ihlr-18967	34	19	may	may	AUX
ihlr-18967	34	20	or	or	CCONJ
ihlr-18967	34	21	may	may	AUX
ihlr-18967	34	22	not	not	PART
ihlr-18967	34	23	pay	pay	VERB
ihlr-18967	34	24	any	any	DET
ihlr-18967	34	25	dividends	dividend	NOUN
ihlr-18967	34	26	,	,	PUNCT
ihlr-18967	34	27	that	that	DET
ihlr-18967	34	28	risk	risk	NOUN
ihlr-18967	34	29	is	be	AUX
ihlr-18967	34	30	worthwhile	worthwhile	ADJ
ihlr-18967	34	31	because	because	SCONJ
ihlr-18967	34	32	of	of	ADP
ihlr-18967	34	33	the	the	DET
ihlr-18967	34	34	potential	potential	ADJ
ihlr-18967	34	35	benefit	benefit	NOUN
ihlr-18967	34	36	to	to	ADP
ihlr-18967	34	37	society	society	NOUN
ihlr-18967	34	38	and	and	CCONJ
ihlr-18967	34	39	the	the	DET
ihlr-18967	34	40	financial	financial	ADJ
ihlr-18967	34	41	windfall	windfall	NOUN
ihlr-18967	34	42	abc	abc	PROPN
ihlr-18967	34	43	will	will	AUX
ihlr-18967	34	44	gain	gain	VERB
ihlr-18967	34	45	from	from	ADP
ihlr-18967	34	46	the	the	DET
ihlr-18967	34	47	right	right	NOUN
ihlr-18967	34	48	to	to	PART
ihlr-18967	34	49	legally	legally	ADV
ihlr-18967	34	50	sell	sell	VERB
ihlr-18967	34	51	the	the	DET
ihlr-18967	34	52	drug	drug	NOUN
ihlr-18967	34	53	at	at	ADP
ihlr-18967	34	54	a	a	DET
ihlr-18967	34	55	monopolistic	monopolistic	ADJ
ihlr-18967	34	56	price2	price2	NOUN
ihlr-18967	34	57	by	by	ADP
ihlr-18967	34	58	virtue	virtue	NOUN
ihlr-18967	34	59	of	of	ADP
ihlr-18967	34	60	obtaining	obtain	VERB
ihlr-18967	34	61	a	a	DET
ihlr-18967	34	62	patent	patent	NOUN
ihlr-18967	34	63	.	.	PUNCT
ihlr-18967	35	1	after	after	ADP
ihlr-18967	35	2	years	year	NOUN
ihlr-18967	35	3	of	of	ADP
ihlr-18967	35	4	painstaking	painstaking	ADJ
ihlr-18967	35	5	effort	effort	NOUN
ihlr-18967	35	6	and	and	CCONJ
ihlr-18967	35	7	near	near	ADP
ihlr-18967	35	8	bankruptcy	bankruptcy	NOUN
ihlr-18967	35	9	for	for	ADP
ihlr-18967	35	10	abc	abc	PROPN
ihlr-18967	35	11	,	,	PUNCT
ihlr-18967	35	12	drug	drug	NOUN
ihlr-18967	35	13	23	23	NUM
ihlr-18967	35	14	has	have	AUX
ihlr-18967	35	15	come	come	VERB
ihlr-18967	35	16	to	to	ADP
ihlr-18967	35	17	fruition	fruition	NOUN
ihlr-18967	35	18	.	.	PUNCT
ihlr-18967	36	1	drug	drug	NOUN
ihlr-18967	36	2	23	23	NUM
ihlr-18967	36	3	has	have	AUX
ihlr-18967	36	4	accomplished	accomplish	VERB
ihlr-18967	36	5	exactly	exactly	ADV
ihlr-18967	36	6	what	what	PRON
ihlr-18967	36	7	it	it	PRON
ihlr-18967	36	8	set	set	VERB
ihlr-18967	36	9	out	out	ADP
ihlr-18967	36	10	to	to	PART
ihlr-18967	36	11	do	do	VERB
ihlr-18967	36	12	,	,	PUNCT
ihlr-18967	36	13	cure	cure	NOUN
ihlr-18967	36	14	alzheimer	alzheimer	PROPN
ihlr-18967	36	15	’s	’s	PART
ihlr-18967	36	16	disease	disease	NOUN
ihlr-18967	36	17	.	.	PUNCT
ihlr-18967	37	1	wanting	want	VERB
ihlr-18967	37	2	to	to	PART
ihlr-18967	37	3	sell	sell	VERB
ihlr-18967	37	4	its	its	PRON
ihlr-18967	37	5	product	product	NOUN
ihlr-18967	37	6	,	,	PUNCT
ihlr-18967	37	7	abc	abc	PROPN
ihlr-18967	37	8	,	,	PUNCT
ihlr-18967	37	9	the	the	DET
ihlr-18967	37	10	pioneer	pioneer	NOUN
ihlr-18967	37	11	manufacturer	manufacturer	NOUN
ihlr-18967	37	12	,	,	PUNCT
ihlr-18967	37	13	files	file	VERB
ihlr-18967	37	14	a	a	DET
ihlr-18967	37	15	new	new	ADJ
ihlr-18967	37	16	drug	drug	NOUN
ihlr-18967	37	17	application3	application3	PROPN
ihlr-18967	37	18	(	(	PUNCT
ihlr-18967	37	19	“	"	PUNCT
ihlr-18967	37	20	nda	nda	PROPN
ihlr-18967	37	21	”	"	PUNCT
ihlr-18967	37	22	)	)	PUNCT
ihlr-18967	37	23	with	with	ADP
ihlr-18967	37	24	the	the	DET
ihlr-18967	37	25	food	food	NOUN
ihlr-18967	37	26	and	and	CCONJ
ihlr-18967	37	27	drug	drug	PROPN
ihlr-18967	37	28	administration	administration	NOUN
ihlr-18967	37	29	(	(	PUNCT
ihlr-18967	37	30	“	"	PUNCT
ihlr-18967	37	31	fda	fda	PROPN
ihlr-18967	37	32	”	"	PUNCT
ihlr-18967	37	33	)	)	PUNCT
ihlr-18967	37	34	.	.	PUNCT
ihlr-18967	38	1	thereafter	thereafter	ADV
ihlr-18967	38	2	,	,	PUNCT
ihlr-18967	38	3	abc	abc	PROPN
ihlr-18967	38	4	receives	receive	VERB
ihlr-18967	38	5	approval	approval	NOUN
ihlr-18967	38	6	from	from	ADP
ihlr-18967	38	7	the	the	DET
ihlr-18967	38	8	fda	fda	PROPN
ihlr-18967	38	9	and	and	CCONJ
ihlr-18967	38	10	begins	begin	VERB
ihlr-18967	38	11	marketing	market	VERB
ihlr-18967	38	12	drug	drug	NOUN
ihlr-18967	38	13	23	23	NUM
ihlr-18967	38	14	.	.	PUNCT
ihlr-18967	39	1	abc	abc	PROPN
ihlr-18967	39	2	’s	’s	PART
ihlr-18967	39	3	stock	stock	NOUN
ihlr-18967	39	4	price	price	NOUN
ihlr-18967	39	5	skyrockets	skyrocket	NOUN
ihlr-18967	39	6	,	,	PUNCT
ihlr-18967	39	7	mostly	mostly	ADV
ihlr-18967	39	8	due	due	ADP
ihlr-18967	39	9	to	to	ADP
ihlr-18967	39	10	a	a	DET
ihlr-18967	39	11	large	large	ADJ
ihlr-18967	39	12	uptick	uptick	NOUN
ihlr-18967	39	13	in	in	ADP
ihlr-18967	39	14	revenue	revenue	NOUN
ihlr-18967	39	15	and	and	CCONJ
ihlr-18967	39	16	profit	profit	NOUN
ihlr-18967	39	17	resulting	result	VERB
ihlr-18967	39	18	from	from	ADP
ihlr-18967	39	19	drug	drug	NOUN
ihlr-18967	39	20	23	23	NUM
ihlr-18967	39	21	being	be	AUX
ihlr-18967	39	22	sold	sell	VERB
ihlr-18967	39	23	at	at	ADP
ihlr-18967	39	24	a	a	DET
ihlr-18967	39	25	monopolistic	monopolistic	ADJ
ihlr-18967	39	26	price	price	NOUN
ihlr-18967	39	27	.	.	PUNCT
ihlr-18967	40	1	a	a	DET
ihlr-18967	40	2	few	few	ADJ
ihlr-18967	40	3	years	year	NOUN
ihlr-18967	40	4	down	down	ADP
ihlr-18967	40	5	the	the	DET
ihlr-18967	40	6	line	line	NOUN
ihlr-18967	40	7	,	,	PUNCT
ihlr-18967	40	8	xyz	xyz	PROPN
ihlr-18967	40	9	corporation	corporation	NOUN
ihlr-18967	40	10	(	(	PUNCT
ihlr-18967	40	11	“	"	PUNCT
ihlr-18967	40	12	xyz	xyz	NOUN
ihlr-18967	40	13	”	"	PUNCT
ihlr-18967	40	14	)	)	PUNCT
ihlr-18967	40	15	plans	plan	VERB
ihlr-18967	40	16	to	to	PART
ihlr-18967	40	17	bring	bring	VERB
ihlr-18967	40	18	drug	drug	NOUN
ihlr-18967	40	19	70	70	NUM
ihlr-18967	40	20	to	to	ADP
ihlr-18967	40	21	the	the	DET
ihlr-18967	40	22	market	market	NOUN
ihlr-18967	40	23	,	,	PUNCT
ihlr-18967	40	24	a	a	DET
ihlr-18967	40	25	drug	drug	NOUN
ihlr-18967	40	26	equivalent	equivalent	ADJ
ihlr-18967	40	27	to	to	ADP
ihlr-18967	40	28	abc	abc	PROPN
ihlr-18967	40	29	’s	’s	PART
ihlr-18967	40	30	drug	drug	PROPN
ihlr-18967	40	31	23	23	NUM
ihlr-18967	40	32	.	.	PUNCT
ihlr-18967	41	1	xyz	xyz	PROPN
ihlr-18967	41	2	does	do	AUX
ihlr-18967	41	3	not	not	PART
ihlr-18967	41	4	develop	develop	VERB
ihlr-18967	41	5	new	new	ADJ
ihlr-18967	41	6	drugs	drug	NOUN
ihlr-18967	41	7	like	like	ADP
ihlr-18967	41	8	abc	abc	PROPN
ihlr-18967	41	9	;	;	PUNCT
ihlr-18967	41	10	instead	instead	ADV
ihlr-18967	41	11	,	,	PUNCT
ihlr-18967	41	12	xyz	xyz	PROPN
ihlr-18967	41	13	focuses	focus	VERB
ihlr-18967	41	14	its	its	PRON
ihlr-18967	41	15	business	business	NOUN
ihlr-18967	41	16	on	on	ADP
ihlr-18967	41	17	bringing	bring	VERB
ihlr-18967	41	18	generic	generic	ADJ
ihlr-18967	41	19	equivalents	equivalent	NOUN
ihlr-18967	41	20	to	to	ADP
ihlr-18967	41	21	the	the	DET
ihlr-18967	41	22	market	market	NOUN
ihlr-18967	41	23	.	.	PUNCT
ihlr-18967	42	1	in	in	ADP
ihlr-18967	42	2	order	order	NOUN
ihlr-18967	42	3	to	to	PART
ihlr-18967	42	4	be	be	AUX
ihlr-18967	42	5	able	able	ADJ
ihlr-18967	42	6	to	to	PART
ihlr-18967	42	7	sell	sell	VERB
ihlr-18967	42	8	drug	drug	NOUN
ihlr-18967	42	9	70	70	NUM
ihlr-18967	42	10	,	,	PUNCT
ihlr-18967	42	11	xyz	xyz	PROPN
ihlr-18967	42	12	,	,	PUNCT
ihlr-18967	42	13	the	the	DET
ihlr-18967	42	14	generic	generic	ADJ
ihlr-18967	42	15	manufacturer	manufacturer	NOUN
ihlr-18967	42	16	,	,	PUNCT
ihlr-18967	42	17	files	file	VERB
ihlr-18967	42	18	an	an	DET
ihlr-18967	42	19	abbreviated	abbreviate	VERB
ihlr-18967	42	20	new	new	ADJ
ihlr-18967	42	21	drug	drug	NOUN
ihlr-18967	42	22	application4	application4	NOUN
ihlr-18967	42	23	(	(	PUNCT
ihlr-18967	42	24	“	"	PUNCT
ihlr-18967	42	25	anda	anda	PROPN
ihlr-18967	42	26	”	"	PUNCT
ihlr-18967	42	27	)	)	PUNCT
ihlr-18967	42	28	with	with	ADP
ihlr-18967	42	29	the	the	DET
ihlr-18967	42	30	fda	fda	PROPN
ihlr-18967	42	31	certifying	certify	VERB
ihlr-18967	42	32	that	that	SCONJ
ihlr-18967	42	33	abc	abc	PROPN
ihlr-18967	42	34	’s	’s	PART
ihlr-18967	42	35	patent	patent	NOUN
ihlr-18967	42	36	is	be	AUX
ihlr-18967	42	37	either	either	CCONJ
ihlr-18967	42	38	invalid	invalid	ADJ
ihlr-18967	42	39	or	or	CCONJ
ihlr-18967	42	40	will	will	AUX
ihlr-18967	42	41	not	not	PART
ihlr-18967	42	42	be	be	AUX
ihlr-18967	42	43	infringed	infringe	VERB
ihlr-18967	42	44	by	by	ADP
ihlr-18967	42	45	xyz.5	xyz.5	PROPN
ihlr-18967	42	46	this	this	DET
ihlr-18967	42	47	process	process	NOUN
ihlr-18967	42	48	of	of	ADP
ihlr-18967	42	49	certification	certification	NOUN
ihlr-18967	42	50	is	be	AUX
ihlr-18967	42	51	necessary	necessary	ADJ
ihlr-18967	42	52	to	to	PART
ihlr-18967	42	53	show	show	VERB
ihlr-18967	42	54	that	that	SCONJ
ihlr-18967	42	55	xyz	xyz	PROPN
ihlr-18967	42	56	will	will	AUX
ihlr-18967	42	57	not	not	PART
ihlr-18967	42	58	infringe	infringe	VERB
ihlr-18967	42	59	the	the	DET
ihlr-18967	42	60	patent	patent	NOUN
ihlr-18967	42	61	granted	grant	VERB
ihlr-18967	42	62	to	to	ADP
ihlr-18967	42	63	abc.6	abc.6	PROPN
ihlr-18967	42	64	as	as	ADP
ihlr-18967	42	65	a	a	DET
ihlr-18967	42	66	result	result	NOUN
ihlr-18967	42	67	of	of	ADP
ihlr-18967	42	68	xyz	xyz	PROPN
ihlr-18967	42	69	’s	’s	PART
ihlr-18967	42	70	anda	anda	PROPN
ihlr-18967	42	71	filing	filing	PROPN
ihlr-18967	42	72	,	,	PUNCT
ihlr-18967	42	73	litigation	litigation	NOUN
ihlr-18967	42	74	ensues	ensue	NOUN
ihlr-18967	42	75	.	.	PUNCT
ihlr-18967	43	1	abc	abc	PROPN
ihlr-18967	43	2	files	file	VERB
ihlr-18967	43	3	suit	suit	NOUN
ihlr-18967	43	4	against	against	ADP
ihlr-18967	43	5	xyz	xyz	PROPN
ihlr-18967	43	6	alleging	allege	VERB
ihlr-18967	43	7	drug	drug	NOUN
ihlr-18967	43	8	70	70	NUM
ihlr-18967	43	9	will	will	AUX
ihlr-18967	43	10	infringe	infringe	VERB
ihlr-18967	43	11	its	its	PRON
ihlr-18967	43	12	patent	patent	NOUN
ihlr-18967	43	13	covering	cover	VERB
ihlr-18967	43	14	drug	drug	NOUN
ihlr-18967	43	15	23	23	NUM
ihlr-18967	43	16	.	.	PUNCT
ihlr-18967	44	1	realizing	realize	VERB
ihlr-18967	44	2	that	that	SCONJ
ihlr-18967	44	3	it	it	PRON
ihlr-18967	44	4	is	be	AUX
ihlr-18967	44	5	in	in	ADP
ihlr-18967	44	6	neither	neither	DET
ihlr-18967	44	7	company	company	NOUN
ihlr-18967	44	8	’s	’s	PART
ihlr-18967	44	9	2	2	NUM
ihlr-18967	44	10	a	a	DET
ihlr-18967	44	11	patent	patent	NOUN
ihlr-18967	44	12	grants	grant	VERB
ihlr-18967	44	13	the	the	DET
ihlr-18967	44	14	patentee	patentee	NOUN
ihlr-18967	44	15	monopolistic	monopolistic	ADJ
ihlr-18967	44	16	control	control	NOUN
ihlr-18967	44	17	in	in	ADP
ihlr-18967	44	18	a	a	DET
ihlr-18967	44	19	given	give	VERB
ihlr-18967	44	20	market	market	NOUN
ihlr-18967	44	21	.	.	PUNCT
ihlr-18967	45	1	times	time	NOUN
ihlr-18967	45	2	-	-	PUNCT
ihlr-18967	45	3	picayune	picayune	PROPN
ihlr-18967	45	4	pub	pub	NOUN
ihlr-18967	45	5	.	.	PUNCT
ihlr-18967	46	1	co.	co.	PROPN
ihlr-18967	47	1	v.	v.	ADP
ihlr-18967	47	2	united	united	PROPN
ihlr-18967	47	3	states	states	PROPN
ihlr-18967	47	4	,	,	PUNCT
ihlr-18967	47	5	345	345	NUM
ihlr-18967	47	6	u.s	u.s	PROPN
ihlr-18967	47	7	.	.	PROPN
ihlr-18967	47	8	594	594	NUM
ihlr-18967	47	9	,	,	PUNCT
ihlr-18967	47	10	608	608	NUM
ihlr-18967	47	11	(	(	PUNCT
ihlr-18967	47	12	1953	1953	NUM
ihlr-18967	47	13	)	)	PUNCT
ihlr-18967	47	14	.	.	PUNCT
ihlr-18967	48	1	however	however	ADV
ihlr-18967	48	2	,	,	PUNCT
ihlr-18967	48	3	control	control	NOUN
ihlr-18967	48	4	granted	grant	VERB
ihlr-18967	48	5	by	by	ADP
ihlr-18967	48	6	a	a	DET
ihlr-18967	48	7	patent	patent	NOUN
ihlr-18967	48	8	is	be	AUX
ihlr-18967	48	9	limited	limit	VERB
ihlr-18967	48	10	to	to	ADP
ihlr-18967	48	11	“	"	PUNCT
ihlr-18967	48	12	the	the	DET
ihlr-18967	48	13	literal	literal	ADJ
ihlr-18967	48	14	scope	scope	NOUN
ihlr-18967	48	15	of	of	ADP
ihlr-18967	48	16	the	the	DET
ihlr-18967	48	17	patent	patent	NOUN
ihlr-18967	48	18	claims	claim	VERB
ihlr-18967	48	19	.	.	PUNCT
ihlr-18967	48	20	”	"	PUNCT
ihlr-18967	49	1	dawson	dawson	PROPN
ihlr-18967	49	2	chem	chem	PROPN
ihlr-18967	49	3	.	.	PUNCT
ihlr-18967	50	1	co.	co.	PROPN
ihlr-18967	51	1	v.	v.	ADP
ihlr-18967	51	2	rohm	rohm	PROPN
ihlr-18967	51	3	and	and	CCONJ
ihlr-18967	51	4	haas	haas	PROPN
ihlr-18967	51	5	co.	co.	PROPN
ihlr-18967	51	6	,	,	PUNCT
ihlr-18967	51	7	448	448	NUM
ihlr-18967	51	8	u.s	u.s	PROPN
ihlr-18967	51	9	.	.	PROPN
ihlr-18967	51	10	176	176	NUM
ihlr-18967	51	11	,	,	PUNCT
ihlr-18967	51	12	221	221	NUM
ihlr-18967	51	13	(	(	PUNCT
ihlr-18967	51	14	1980	1980	NUM
ihlr-18967	51	15	)	)	PUNCT
ihlr-18967	51	16	.	.	PUNCT
ihlr-18967	52	1	therefore	therefore	ADV
ihlr-18967	52	2	,	,	PUNCT
ihlr-18967	52	3	as	as	ADV
ihlr-18967	52	4	long	long	ADV
ihlr-18967	52	5	as	as	SCONJ
ihlr-18967	52	6	the	the	DET
ihlr-18967	52	7	patentee	patentee	NOUN
ihlr-18967	52	8	is	be	AUX
ihlr-18967	52	9	within	within	ADP
ihlr-18967	52	10	the	the	DET
ihlr-18967	52	11	scope	scope	NOUN
ihlr-18967	52	12	of	of	ADP
ihlr-18967	52	13	the	the	DET
ihlr-18967	52	14	patent	patent	NOUN
ihlr-18967	52	15	,	,	PUNCT
ihlr-18967	52	16	they	they	PRON
ihlr-18967	52	17	can	can	AUX
ihlr-18967	52	18	legally	legally	ADV
ihlr-18967	52	19	charge	charge	VERB
ihlr-18967	52	20	a	a	DET
ihlr-18967	52	21	monopolistic	monopolistic	ADJ
ihlr-18967	52	22	price	price	NOUN
ihlr-18967	52	23	.	.	PUNCT
ihlr-18967	53	1	3	3	NUM
ihlr-18967	53	2	see	see	VERB
ihlr-18967	53	3	discussion	discussion	NOUN
ihlr-18967	53	4	infra	infra	NOUN
ihlr-18967	53	5	section	section	NOUN
ihlr-18967	53	6	ii.c	ii.c	VERB
ihlr-18967	53	7	.	.	PUNCT
ihlr-18967	54	1	4	4	NUM
ihlr-18967	54	2	see	see	VERB
ihlr-18967	54	3	discussion	discussion	NOUN
ihlr-18967	54	4	infra	infra	NOUN
ihlr-18967	54	5	section	section	NOUN
ihlr-18967	54	6	ii.c	ii.c	VERB
ihlr-18967	54	7	.	.	PUNCT
ihlr-18967	55	1	5	5	NUM
ihlr-18967	55	2	see	see	VERB
ihlr-18967	55	3	21	21	NUM
ihlr-18967	55	4	u.s.c	u.s.c	ADJ
ihlr-18967	55	5	.	.	PUNCT
ihlr-18967	56	1	§	§	PROPN
ihlr-18967	56	2	355(j)(2)(a)(vii)(iv	355(j)(2)(a)(vii)(iv	NUM
ihlr-18967	56	3	)	)	PUNCT
ihlr-18967	56	4	(	(	PUNCT
ihlr-18967	56	5	2015	2015	NUM
ihlr-18967	56	6	)	)	PUNCT
ihlr-18967	56	7	(	(	PUNCT
ihlr-18967	56	8	paragraph	paragraph	NOUN
ihlr-18967	56	9	iv	iv	NUM
ihlr-18967	56	10	route	route	NOUN
ihlr-18967	56	11	)	)	PUNCT
ihlr-18967	56	12	.	.	PUNCT
ihlr-18967	57	1	6	6	NUM
ihlr-18967	57	2	21	21	NUM
ihlr-18967	57	3	u.s.c	u.s.c	NOUN
ihlr-18967	57	4	.	.	PUNCT
ihlr-18967	58	1	§	§	PROPN
ihlr-18967	58	2	355(j)(2)(a)(vii	355(j)(2)(a)(vii	PROPN
ihlr-18967	58	3	)	)	PUNCT
ihlr-18967	58	4	(	(	PUNCT
ihlr-18967	58	5	2015	2015	NUM
ihlr-18967	58	6	)	)	PUNCT
ihlr-18967	58	7	.	.	PUNCT
ihlr-18967	59	1	426	426	NUM
ihlr-18967	59	2	indiana	indiana	PROPN
ihlr-18967	59	3	health	health	PROPN
ihlr-18967	59	4	law	law	PROPN
ihlr-18967	59	5	review	review	NOUN
ihlr-18967	59	6	vol	vol	NOUN
ihlr-18967	59	7	.	.	PUNCT
ihlr-18967	60	1	12:1	12:1	NUM
ihlr-18967	60	2	best	good	ADJ
ihlr-18967	60	3	interest	interest	NOUN
ihlr-18967	60	4	to	to	PART
ihlr-18967	60	5	be	be	AUX
ihlr-18967	60	6	involved	involve	VERB
ihlr-18967	60	7	in	in	ADP
ihlr-18967	60	8	a	a	DET
ihlr-18967	60	9	prolonged	prolonged	ADJ
ihlr-18967	60	10	legal	legal	ADJ
ihlr-18967	60	11	battle	battle	NOUN
ihlr-18967	60	12	,	,	PUNCT
ihlr-18967	60	13	abc	abc	PROPN
ihlr-18967	60	14	and	and	CCONJ
ihlr-18967	60	15	xyz	xyz	PROPN
ihlr-18967	60	16	amicably	amicably	ADV
ihlr-18967	60	17	settle	settle	VERB
ihlr-18967	60	18	before	before	SCONJ
ihlr-18967	60	19	trial	trial	NOUN
ihlr-18967	60	20	begins	begin	VERB
ihlr-18967	60	21	.	.	PUNCT
ihlr-18967	61	1	the	the	DET
ihlr-18967	61	2	relevant	relevant	ADJ
ihlr-18967	61	3	terms	term	NOUN
ihlr-18967	61	4	of	of	ADP
ihlr-18967	61	5	the	the	DET
ihlr-18967	61	6	settlement	settlement	NOUN
ihlr-18967	61	7	agreement	agreement	NOUN
ihlr-18967	61	8	are	be	AUX
ihlr-18967	61	9	as	as	SCONJ
ihlr-18967	61	10	follows	follow	VERB
ihlr-18967	61	11	:	:	PUNCT
ihlr-18967	61	12	1	1	X
ihlr-18967	61	13	.	.	X
ihlr-18967	61	14	abc	abc	PROPN
ihlr-18967	61	15	voluntarily	voluntarily	ADV
ihlr-18967	61	16	agrees	agree	VERB
ihlr-18967	61	17	to	to	PART
ihlr-18967	61	18	dismiss	dismiss	VERB
ihlr-18967	61	19	the	the	DET
ihlr-18967	61	20	patent	patent	NOUN
ihlr-18967	61	21	infringement	infringement	NOUN
ihlr-18967	61	22	suit	suit	NOUN
ihlr-18967	61	23	against	against	ADP
ihlr-18967	61	24	xyz	xyz	PROPN
ihlr-18967	61	25	.	.	PUNCT
ihlr-18967	62	1	2	2	X
ihlr-18967	62	2	.	.	X
ihlr-18967	62	3	abc	abc	PROPN
ihlr-18967	62	4	shall	shall	AUX
ihlr-18967	62	5	pay	pay	VERB
ihlr-18967	62	6	xyz	xyz	NOUN
ihlr-18967	62	7	the	the	DET
ihlr-18967	62	8	sum	sum	NOUN
ihlr-18967	62	9	of	of	ADP
ihlr-18967	62	10	$	$	SYM
ihlr-18967	62	11	10,000,000.00	10,000,000.00	NUM
ihlr-18967	62	12	per	per	ADP
ihlr-18967	62	13	year	year	NOUN
ihlr-18967	62	14	for	for	ADP
ihlr-18967	62	15	the	the	DET
ihlr-18967	62	16	remaining	remain	VERB
ihlr-18967	62	17	term	term	NOUN
ihlr-18967	62	18	of	of	ADP
ihlr-18967	62	19	the	the	DET
ihlr-18967	62	20	patent7	patent7	NOUN
ihlr-18967	62	21	on	on	ADP
ihlr-18967	62	22	drug	drug	NOUN
ihlr-18967	62	23	23	23	NUM
ihlr-18967	62	24	.	.	PUNCT
ihlr-18967	63	1	3	3	X
ihlr-18967	63	2	.	.	X
ihlr-18967	64	1	as	as	ADP
ihlr-18967	64	2	consideration	consideration	NOUN
ihlr-18967	64	3	,	,	PUNCT
ihlr-18967	64	4	xyz	xyz	PROPN
ihlr-18967	64	5	will	will	AUX
ihlr-18967	64	6	refrain	refrain	VERB
ihlr-18967	64	7	from	from	ADP
ihlr-18967	64	8	bringing	bring	VERB
ihlr-18967	64	9	to	to	ADP
ihlr-18967	64	10	market	market	NOUN
ihlr-18967	64	11	drug	drug	NOUN
ihlr-18967	64	12	70	70	NUM
ihlr-18967	64	13	until	until	SCONJ
ihlr-18967	64	14	the	the	DET
ihlr-18967	64	15	patent	patent	NOUN
ihlr-18967	64	16	on	on	ADP
ihlr-18967	64	17	drug	drug	NOUN
ihlr-18967	64	18	23	23	NUM
ihlr-18967	64	19	has	have	AUX
ihlr-18967	64	20	expired	expire	VERB
ihlr-18967	64	21	.	.	PUNCT
ihlr-18967	65	1	4	4	X
ihlr-18967	65	2	.	.	X
ihlr-18967	65	3	xyz	xyz	NOUN
ihlr-18967	65	4	will	will	AUX
ihlr-18967	65	5	provide	provide	VERB
ihlr-18967	65	6	marketing	marketing	NOUN
ihlr-18967	65	7	services	service	NOUN
ihlr-18967	65	8	in	in	ADP
ihlr-18967	65	9	regards	regard	NOUN
ihlr-18967	65	10	to	to	ADP
ihlr-18967	65	11	abc	abc	PROPN
ihlr-18967	65	12	’s	’s	PART
ihlr-18967	65	13	drug	drug	PROPN
ihlr-18967	65	14	23	23	NUM
ihlr-18967	65	15	.	.	PUNCT
ihlr-18967	66	1	said	say	VERB
ihlr-18967	66	2	marketing	marketing	NOUN
ihlr-18967	66	3	services	service	NOUN
ihlr-18967	66	4	will	will	AUX
ihlr-18967	66	5	be	be	AUX
ihlr-18967	66	6	comprised	comprise	VERB
ihlr-18967	66	7	of	of	ADP
ihlr-18967	66	8	promoting	promote	VERB
ihlr-18967	66	9	abc	abc	PROPN
ihlr-18967	66	10	’s	’s	PART
ihlr-18967	66	11	drug	drug	NOUN
ihlr-18967	66	12	23	23	NUM
ihlr-18967	66	13	to	to	ADP
ihlr-18967	66	14	physicians	physician	NOUN
ihlr-18967	66	15	.	.	PUNCT
ihlr-18967	67	1	this	this	DET
ihlr-18967	67	2	type	type	NOUN
ihlr-18967	67	3	of	of	ADP
ihlr-18967	67	4	settlement	settlement	NOUN
ihlr-18967	67	5	agreement	agreement	NOUN
ihlr-18967	67	6	is	be	AUX
ihlr-18967	67	7	known	know	VERB
ihlr-18967	67	8	as	as	ADP
ihlr-18967	67	9	a	a	DET
ihlr-18967	67	10	reverse	reverse	ADJ
ihlr-18967	67	11	payment	payment	NOUN
ihlr-18967	67	12	settlement	settlement	NOUN
ihlr-18967	67	13	.	.	PUNCT
ihlr-18967	68	1	the	the	DET
ihlr-18967	68	2	name	name	NOUN
ihlr-18967	68	3	derives	derive	VERB
ihlr-18967	68	4	from	from	ADP
ihlr-18967	68	5	a	a	DET
ihlr-18967	68	6	defendant	defendant	NOUN
ihlr-18967	68	7	in	in	ADP
ihlr-18967	68	8	a	a	DET
ihlr-18967	68	9	patent	patent	NOUN
ihlr-18967	68	10	infringement	infringement	NOUN
ihlr-18967	68	11	suit	suit	NOUN
ihlr-18967	68	12	receiving	receive	VERB
ihlr-18967	68	13	something	something	PRON
ihlr-18967	68	14	of	of	ADP
ihlr-18967	68	15	value	value	NOUN
ihlr-18967	68	16	,	,	PUNCT
ihlr-18967	68	17	as	as	SCONJ
ihlr-18967	68	18	compared	compare	VERB
ihlr-18967	68	19	to	to	ADP
ihlr-18967	68	20	a	a	DET
ihlr-18967	68	21	normal	normal	ADJ
ihlr-18967	68	22	lawsuit	lawsuit	NOUN
ihlr-18967	68	23	where	where	SCONJ
ihlr-18967	68	24	the	the	DET
ihlr-18967	68	25	plaintiff	plaintiff	NOUN
ihlr-18967	68	26	would	would	AUX
ihlr-18967	68	27	receive	receive	VERB
ihlr-18967	68	28	something	something	PRON
ihlr-18967	68	29	of	of	ADP
ihlr-18967	68	30	value	value	NOUN
ihlr-18967	68	31	.	.	PUNCT
ihlr-18967	69	1	in	in	ADP
ihlr-18967	69	2	the	the	DET
ihlr-18967	69	3	example	example	NOUN
ihlr-18967	69	4	above	above	ADV
ihlr-18967	69	5	,	,	PUNCT
ihlr-18967	69	6	abc	abc	PROPN
ihlr-18967	69	7	brought	bring	VERB
ihlr-18967	69	8	the	the	DET
ihlr-18967	69	9	infringement	infringement	NOUN
ihlr-18967	69	10	suit	suit	NOUN
ihlr-18967	69	11	against	against	ADP
ihlr-18967	69	12	xyz	xyz	PROPN
ihlr-18967	69	13	,	,	PUNCT
ihlr-18967	69	14	but	but	CCONJ
ihlr-18967	69	15	in	in	ADP
ihlr-18967	69	16	the	the	DET
ihlr-18967	69	17	end	end	NOUN
ihlr-18967	69	18	,	,	PUNCT
ihlr-18967	69	19	xyz	xyz	PROPN
ihlr-18967	69	20	was	be	AUX
ihlr-18967	69	21	the	the	DET
ihlr-18967	69	22	one	one	NUM
ihlr-18967	69	23	who	who	PRON
ihlr-18967	69	24	received	receive	VERB
ihlr-18967	69	25	a	a	DET
ihlr-18967	69	26	monetary	monetary	ADJ
ihlr-18967	69	27	payment	payment	NOUN
ihlr-18967	69	28	.	.	PUNCT
ihlr-18967	70	1	a.	a.	NOUN
ihlr-18967	71	1	the	the	DET
ihlr-18967	71	2	issue	issue	NOUN
ihlr-18967	71	3	a	a	DET
ihlr-18967	71	4	large	large	ADJ
ihlr-18967	71	5	contributing	contribute	VERB
ihlr-18967	71	6	factor	factor	NOUN
ihlr-18967	71	7	to	to	ADP
ihlr-18967	71	8	the	the	DET
ihlr-18967	71	9	growing	grow	VERB
ihlr-18967	71	10	cost	cost	NOUN
ihlr-18967	71	11	of	of	ADP
ihlr-18967	71	12	health	health	NOUN
ihlr-18967	71	13	care	care	NOUN
ihlr-18967	71	14	in	in	ADP
ihlr-18967	71	15	the	the	DET
ihlr-18967	71	16	united	united	PROPN
ihlr-18967	71	17	states	states	PROPN
ihlr-18967	71	18	involves	involve	VERB
ihlr-18967	71	19	the	the	DET
ihlr-18967	71	20	rising	rise	VERB
ihlr-18967	71	21	cost	cost	NOUN
ihlr-18967	71	22	of	of	ADP
ihlr-18967	71	23	prescription	prescription	NOUN
ihlr-18967	71	24	drugs.8	drugs.8	PROPN
ihlr-18967	71	25	critics	critic	NOUN
ihlr-18967	71	26	argue	argue	VERB
ihlr-18967	71	27	that	that	SCONJ
ihlr-18967	71	28	reverse	reverse	VERB
ihlr-18967	71	29	payment	payment	NOUN
ihlr-18967	71	30	settlements	settlement	NOUN
ihlr-18967	71	31	increase	increase	VERB
ihlr-18967	71	32	the	the	DET
ihlr-18967	71	33	cost	cost	NOUN
ihlr-18967	71	34	of	of	ADP
ihlr-18967	71	35	drugs	drug	NOUN
ihlr-18967	71	36	by	by	ADP
ihlr-18967	71	37	delaying	delay	VERB
ihlr-18967	71	38	generic	generic	ADJ
ihlr-18967	71	39	drug	drug	NOUN
ihlr-18967	71	40	entry	entry	NOUN
ihlr-18967	71	41	into	into	ADP
ihlr-18967	71	42	the	the	DET
ihlr-18967	71	43	market.9	market.9	NOUN
ihlr-18967	71	44	also	also	ADV
ihlr-18967	71	45	,	,	PUNCT
ihlr-18967	71	46	some	some	PRON
ihlr-18967	71	47	have	have	AUX
ihlr-18967	71	48	criticized	criticize	VERB
ihlr-18967	71	49	reverse	reverse	ADJ
ihlr-18967	71	50	payment	payment	NOUN
ihlr-18967	71	51	settlements	settlement	NOUN
ihlr-18967	71	52	as	as	ADP
ihlr-18967	71	53	anticompetitive.10	anticompetitive.10	ADJ
ihlr-18967	71	54	on	on	ADP
ihlr-18967	71	55	the	the	DET
ihlr-18967	71	56	other	other	ADJ
ihlr-18967	71	57	hand	hand	NOUN
ihlr-18967	71	58	,	,	PUNCT
ihlr-18967	71	59	it	it	PRON
ihlr-18967	71	60	can	can	AUX
ihlr-18967	71	61	be	be	AUX
ihlr-18967	71	62	argued	argue	VERB
ihlr-18967	71	63	that	that	SCONJ
ihlr-18967	71	64	reverse	reverse	ADJ
ihlr-18967	71	65	payment	payment	NOUN
ihlr-18967	71	66	settlements	settlement	NOUN
ihlr-18967	71	67	are	be	AUX
ihlr-18967	71	68	necessary	necessary	ADJ
ihlr-18967	71	69	to	to	PART
ihlr-18967	71	70	protect	protect	VERB
ihlr-18967	71	71	patents	patent	NOUN
ihlr-18967	71	72	which	which	PRON
ihlr-18967	71	73	provide	provide	VERB
ihlr-18967	71	74	7	7	NUM
ihlr-18967	71	75	see	see	NOUN
ihlr-18967	71	76	infra	infra	NOUN
ihlr-18967	71	77	note	note	VERB
ihlr-18967	71	78	35	35	NUM
ihlr-18967	71	79	.	.	NOUN
ihlr-18967	71	80	8	8	NUM
ihlr-18967	71	81	see	see	VERB
ihlr-18967	71	82	u.s	u.s	PROPN
ihlr-18967	71	83	.	.	PROPN
ihlr-18967	71	84	census	census	PROPN
ihlr-18967	71	85	bureau	bureau	PROPN
ihlr-18967	71	86	,	,	PUNCT
ihlr-18967	71	87	statistical	statistical	ADJ
ihlr-18967	71	88	abstract	abstract	NOUN
ihlr-18967	71	89	of	of	ADP
ihlr-18967	71	90	the	the	DET
ihlr-18967	71	91	united	united	PROPN
ihlr-18967	71	92	states	states	PROPN
ihlr-18967	71	93	:	:	PUNCT
ihlr-18967	71	94	national	national	ADJ
ihlr-18967	71	95	health	health	NOUN
ihlr-18967	71	96	expenditures	expenditure	NOUN
ihlr-18967	71	97	(	(	PUNCT
ihlr-18967	71	98	2012	2012	NUM
ihlr-18967	71	99	)	)	PUNCT
ihlr-18967	71	100	(	(	PUNCT
ihlr-18967	71	101	showing	show	VERB
ihlr-18967	71	102	total	total	ADJ
ihlr-18967	71	103	national	national	ADJ
ihlr-18967	71	104	health	health	PROPN
ihlr-18967	71	105	care	care	NOUN
ihlr-18967	71	106	expenditures	expenditure	NOUN
ihlr-18967	71	107	increased	increase	VERB
ihlr-18967	71	108	from	from	ADP
ihlr-18967	71	109	$	$	SYM
ihlr-18967	71	110	1,286,800,000,000	1,286,800,000,000	NUM
ihlr-18967	71	111	in	in	ADP
ihlr-18967	71	112	1999	1999	NUM
ihlr-18967	71	113	to	to	ADP
ihlr-18967	71	114	$	$	SYM
ihlr-18967	71	115	2,486,300,000,000	2,486,300,000,000	NUM
ihlr-18967	71	116	in	in	ADP
ihlr-18967	71	117	2009	2009	NUM
ihlr-18967	71	118	)	)	PUNCT
ihlr-18967	72	1	[	[	X
ihlr-18967	72	2	hereinafter	hereinafter	NOUN
ihlr-18967	72	3	2012	2012	NUM
ihlr-18967	72	4	census	census	NOUN
ihlr-18967	72	5	]	]	PUNCT
ihlr-18967	72	6	.	.	PUNCT
ihlr-18967	73	1	9	9	NUM
ihlr-18967	73	2	pay	pay	VERB
ihlr-18967	73	3	-	-	PUNCT
ihlr-18967	73	4	for	for	ADP
ihlr-18967	73	5	-	-	PUNCT
ihlr-18967	73	6	delay	delay	NOUN
ihlr-18967	73	7	:	:	PUNCT
ihlr-18967	73	8	how	how	SCONJ
ihlr-18967	73	9	drug	drug	NOUN
ihlr-18967	73	10	company	company	NOUN
ihlr-18967	73	11	pay	pay	NOUN
ihlr-18967	73	12	-	-	PUNCT
ihlr-18967	73	13	offs	off	NOUN
ihlr-18967	73	14	cost	cost	NOUN
ihlr-18967	73	15	consumers	consumer	NOUN
ihlr-18967	73	16	billions	billion	NOUN
ihlr-18967	73	17	,	,	PUNCT
ihlr-18967	73	18	fed	fed	PROPN
ihlr-18967	73	19	.	.	PUNCT
ihlr-18967	74	1	trade	trade	PROPN
ihlr-18967	74	2	commission	commission	PROPN
ihlr-18967	74	3	(	(	PUNCT
ihlr-18967	74	4	2010	2010	NUM
ihlr-18967	74	5	)	)	PUNCT
ihlr-18967	74	6	,	,	PUNCT
ihlr-18967	74	7	http://www.ftc.gov/	http://www.ftc.gov/	NOUN
ihlr-18967	74	8	sites	site	NOUN
ihlr-18967	74	9	/	/	SYM
ihlr-18967	74	10	default	default	NOUN
ihlr-18967	74	11	/	/	SYM
ihlr-18967	74	12	files	file	NOUN
ihlr-18967	74	13	/	/	SYM
ihlr-18967	74	14	documents	document	NOUN
ihlr-18967	74	15	/	/	SYM
ihlr-18967	74	16	reports	report	NOUN
ihlr-18967	74	17	/	/	SYM
ihlr-18967	74	18	pay	pay	NOUN
ihlr-18967	74	19	-	-	PUNCT
ihlr-18967	74	20	delay	delay	NOUN
ihlr-18967	74	21	-	-	PUNCT
ihlr-18967	74	22	how	how	ADV
ihlr-18967	74	23	-	-	PUNCT
ihlr-18967	74	24	drug	drug	NOUN
ihlr-18967	74	25	-	-	PUNCT
ihlr-18967	74	26	company	company	NOUN
ihlr-18967	74	27	-	-	PUNCT
ihlr-18967	74	28	payoffs	payoff	NOUN
ihlr-18967	74	29	-	-	PUNCT
ihlr-18967	74	30	cost	cost	NOUN
ihlr-18967	74	31	-	-	PUNCT
ihlr-18967	74	32	consumers	consumer	NOUN
ihlr-18967	74	33	-	-	PUNCT
ihlr-18967	74	34	billions	billion	NOUN
ihlr-18967	74	35	-	-	PUNCT
ihlr-18967	74	36	federal	federal	ADJ
ihlr-18967	74	37	-	-	PUNCT
ihlr-18967	74	38	trade	trade	NOUN
ihlr-18967	74	39	-	-	PUNCT
ihlr-18967	74	40	commission	commission	NOUN
ihlr-18967	74	41	-	-	PUNCT
ihlr-18967	74	42	staffstudy/100112payfordelayrpt.pdf	staffstudy/100112payfordelayrpt.pdf	NOUN
ihlr-18967	75	1	[	[	X
ihlr-18967	75	2	hereinafter	hereinafter	NOUN
ihlr-18967	75	3	pay	pay	VERB
ihlr-18967	75	4	-	-	PUNCT
ihlr-18967	75	5	for	for	ADP
ihlr-18967	75	6	-	-	PUNCT
ihlr-18967	75	7	delay	delay	NOUN
ihlr-18967	75	8	]	]	PUNCT
ihlr-18967	75	9	.	.	PUNCT
ihlr-18967	76	1	10	10	NUM
ihlr-18967	77	1	i	i	PRON
ihlr-18967	77	2	d.	d.	PROPN
ihlr-18967	77	3	2015	2015	NUM
ihlr-18967	77	4	rationale	rationale	NOUN
ihlr-18967	77	5	behind	behind	ADP
ihlr-18967	77	6	hatch	hatch	NOUN
ihlr-18967	77	7	-	-	PUNCT
ihlr-18967	77	8	waxman	waxman	PROPN
ihlr-18967	77	9	act	act	PROPN
ihlr-18967	77	10	and	and	CCONJ
ihlr-18967	77	11	patent	patent	NOUN
ihlr-18967	77	12	law	law	NOUN
ihlr-18967	77	13	427	427	NUM
ihlr-18967	77	14	incentives11	incentives11	NOUN
ihlr-18967	77	15	to	to	PART
ihlr-18967	77	16	drug	drug	NOUN
ihlr-18967	77	17	manufacturers	manufacturer	NOUN
ihlr-18967	77	18	to	to	PART
ihlr-18967	77	19	take	take	VERB
ihlr-18967	77	20	the	the	DET
ihlr-18967	77	21	risks	risk	NOUN
ihlr-18967	77	22	associated	associate	VERB
ihlr-18967	77	23	with	with	ADP
ihlr-18967	77	24	developing	develop	VERB
ihlr-18967	77	25	new	new	ADJ
ihlr-18967	77	26	drugs.12	drugs.12	NOUN
ihlr-18967	77	27	in	in	ADP
ihlr-18967	77	28	recent	recent	ADJ
ihlr-18967	77	29	years	year	NOUN
ihlr-18967	77	30	,	,	PUNCT
ihlr-18967	77	31	the	the	DET
ihlr-18967	77	32	federal	federal	PROPN
ihlr-18967	77	33	trade	trade	PROPN
ihlr-18967	77	34	commission	commission	PROPN
ihlr-18967	77	35	(	(	PUNCT
ihlr-18967	77	36	“	"	PUNCT
ihlr-18967	77	37	ftc	ftc	PROPN
ihlr-18967	77	38	”	"	PUNCT
ihlr-18967	77	39	)	)	PUNCT
ihlr-18967	77	40	has	have	AUX
ihlr-18967	77	41	brought	bring	VERB
ihlr-18967	77	42	numerous	numerous	ADJ
ihlr-18967	77	43	lawsuits	lawsuit	NOUN
ihlr-18967	77	44	in	in	ADP
ihlr-18967	77	45	an	an	DET
ihlr-18967	77	46	attempt	attempt	NOUN
ihlr-18967	77	47	to	to	PART
ihlr-18967	77	48	have	have	AUX
ihlr-18967	77	49	a	a	DET
ihlr-18967	77	50	court	court	NOUN
ihlr-18967	77	51	hold	hold	VERB
ihlr-18967	77	52	reverse	reverse	ADJ
ihlr-18967	77	53	payment	payment	NOUN
ihlr-18967	77	54	settlements	settlement	NOUN
ihlr-18967	77	55	illegal	illegal	ADJ
ihlr-18967	77	56	due	due	ADP
ihlr-18967	77	57	to	to	ADP
ihlr-18967	77	58	their	their	PRON
ihlr-18967	77	59	anticompetitive	anticompetitive	ADJ
ihlr-18967	77	60	effect.13	effect.13	NOUN
ihlr-18967	77	61	in	in	ADP
ihlr-18967	77	62	late	late	ADJ
ihlr-18967	77	63	2012	2012	NUM
ihlr-18967	77	64	,	,	PUNCT
ihlr-18967	77	65	the	the	DET
ihlr-18967	77	66	supreme	supreme	PROPN
ihlr-18967	77	67	court	court	PROPN
ihlr-18967	77	68	granted	grant	VERB
ihlr-18967	77	69	certiorari	certiorari	NOUN
ihlr-18967	77	70	in	in	ADP
ihlr-18967	77	71	order	order	NOUN
ihlr-18967	77	72	to	to	PART
ihlr-18967	77	73	resolve	resolve	VERB
ihlr-18967	77	74	a	a	DET
ihlr-18967	77	75	circuit	circuit	NOUN
ihlr-18967	77	76	split	split	NOUN
ihlr-18967	77	77	regarding	regard	VERB
ihlr-18967	77	78	the	the	DET
ihlr-18967	77	79	proper	proper	ADJ
ihlr-18967	77	80	analysis	analysis	NOUN
ihlr-18967	77	81	for	for	ADP
ihlr-18967	77	82	determining	determine	VERB
ihlr-18967	77	83	whether	whether	SCONJ
ihlr-18967	77	84	a	a	DET
ihlr-18967	77	85	reverse	reverse	ADJ
ihlr-18967	77	86	payment	payment	NOUN
ihlr-18967	77	87	settlement	settlement	NOUN
ihlr-18967	77	88	is	be	AUX
ihlr-18967	77	89	anticompetitive.14	anticompetitive.14	SCONJ
ihlr-18967	77	90	the	the	DET
ihlr-18967	77	91	current	current	ADJ
ihlr-18967	77	92	issue	issue	NOUN
ihlr-18967	77	93	arises	arise	VERB
ihlr-18967	77	94	as	as	SCONJ
ihlr-18967	77	95	the	the	DET
ihlr-18967	77	96	court	court	NOUN
ihlr-18967	77	97	took	take	VERB
ihlr-18967	77	98	a	a	DET
ihlr-18967	77	99	middle	middle	ADJ
ihlr-18967	77	100	ground	ground	NOUN
ihlr-18967	77	101	by	by	ADP
ihlr-18967	77	102	holding	hold	VERB
ihlr-18967	77	103	that	that	SCONJ
ihlr-18967	77	104	the	the	DET
ihlr-18967	77	105	rule	rule	NOUN
ihlr-18967	77	106	of	of	ADP
ihlr-18967	77	107	reason,15	reason,15	PROPN
ihlr-18967	77	108	a	a	DET
ihlr-18967	77	109	standard	standard	NOUN
ihlr-18967	77	110	borrowed	borrow	VERB
ihlr-18967	77	111	from	from	ADP
ihlr-18967	77	112	antitrust	antitrust	ADJ
ihlr-18967	77	113	law	law	NOUN
ihlr-18967	77	114	,	,	PUNCT
ihlr-18967	77	115	was	be	AUX
ihlr-18967	77	116	applicable	applicable	ADJ
ihlr-18967	77	117	to	to	PART
ihlr-18967	77	118	reverse	reverse	VERB
ihlr-18967	77	119	payment	payment	NOUN
ihlr-18967	77	120	settlements	settlement	NOUN
ihlr-18967	77	121	.	.	PUNCT
ihlr-18967	78	1	in	in	ADP
ihlr-18967	78	2	addition	addition	NOUN
ihlr-18967	78	3	,	,	PUNCT
ihlr-18967	78	4	congressional	congressional	ADJ
ihlr-18967	78	5	action16	action16	NOUN
ihlr-18967	78	6	on	on	ADP
ihlr-18967	78	7	the	the	DET
ihlr-18967	78	8	horizon	horizon	NOUN
ihlr-18967	78	9	potentially	potentially	ADV
ihlr-18967	78	10	conflicts	conflict	VERB
ihlr-18967	78	11	with	with	ADP
ihlr-18967	78	12	the	the	DET
ihlr-18967	78	13	court	court	NOUN
ihlr-18967	78	14	’s	’s	PART
ihlr-18967	78	15	opinion	opinion	NOUN
ihlr-18967	78	16	.	.	PUNCT
ihlr-18967	79	1	given	give	VERB
ihlr-18967	79	2	that	that	SCONJ
ihlr-18967	79	3	actavis	actavis	PROPN
ihlr-18967	79	4	was	be	AUX
ihlr-18967	79	5	handed	hand	VERB
ihlr-18967	79	6	down	down	ADP
ihlr-18967	79	7	june	june	PROPN
ihlr-18967	79	8	17	17	NUM
ihlr-18967	79	9	,	,	PUNCT
ihlr-18967	79	10	2013	2013	NUM
ihlr-18967	79	11	,	,	PUNCT
ihlr-18967	79	12	its	its	PRON
ihlr-18967	79	13	impact	impact	NOUN
ihlr-18967	79	14	is	be	AUX
ihlr-18967	79	15	still	still	ADV
ihlr-18967	79	16	not	not	PART
ihlr-18967	79	17	fully	fully	ADV
ihlr-18967	79	18	realized	realize	VERB
ihlr-18967	79	19	.	.	PUNCT
ihlr-18967	80	1	however	however	ADV
ihlr-18967	80	2	,	,	PUNCT
ihlr-18967	80	3	as	as	SCONJ
ihlr-18967	80	4	will	will	AUX
ihlr-18967	80	5	be	be	AUX
ihlr-18967	80	6	demonstrated	demonstrate	VERB
ihlr-18967	80	7	in	in	ADP
ihlr-18967	80	8	this	this	DET
ihlr-18967	80	9	note	note	NOUN
ihlr-18967	80	10	,	,	PUNCT
ihlr-18967	80	11	although	although	SCONJ
ihlr-18967	80	12	the	the	DET
ihlr-18967	80	13	court	court	NOUN
ihlr-18967	80	14	has	have	AUX
ihlr-18967	80	15	provided	provide	VERB
ihlr-18967	80	16	little	little	ADJ
ihlr-18967	80	17	guidance	guidance	NOUN
ihlr-18967	80	18	for	for	ADP
ihlr-18967	80	19	drug	drug	NOUN
ihlr-18967	80	20	manufacturers	manufacturer	NOUN
ihlr-18967	80	21	,	,	PUNCT
ihlr-18967	80	22	district	district	NOUN
ihlr-18967	80	23	courts	court	NOUN
ihlr-18967	80	24	,	,	PUNCT
ihlr-18967	80	25	and	and	CCONJ
ihlr-18967	80	26	the	the	DET
ihlr-18967	80	27	ftc	ftc	PROPN
ihlr-18967	80	28	,	,	PUNCT
ihlr-18967	80	29	the	the	DET
ihlr-18967	80	30	rule	rule	NOUN
ihlr-18967	80	31	of	of	ADP
ihlr-18967	80	32	reason	reason	NOUN
ihlr-18967	80	33	is	be	AUX
ihlr-18967	80	34	a	a	DET
ihlr-18967	80	35	sound	sound	ADJ
ihlr-18967	80	36	choice	choice	NOUN
ihlr-18967	80	37	as	as	SCONJ
ihlr-18967	80	38	it	it	PRON
ihlr-18967	80	39	resonates	resonate	VERB
ihlr-18967	80	40	with	with	ADP
ihlr-18967	80	41	fundamental	fundamental	ADJ
ihlr-18967	80	42	and	and	CCONJ
ihlr-18967	80	43	important	important	ADJ
ihlr-18967	80	44	rationales	rationale	NOUN
ihlr-18967	80	45	behind	behind	ADP
ihlr-18967	80	46	patent	patent	NOUN
ihlr-18967	80	47	law	law	NOUN
ihlr-18967	80	48	and	and	CCONJ
ihlr-18967	80	49	the	the	DET
ihlr-18967	80	50	hatch	hatch	NOUN
ihlr-18967	80	51	-	-	PUNCT
ihlr-18967	80	52	waxman	waxman	PROPN
ihlr-18967	80	53	act	act	PROPN
ihlr-18967	80	54	.	.	PUNCT
ihlr-18967	81	1	11	11	NUM
ihlr-18967	81	2	see	see	VERB
ihlr-18967	81	3	rebecca	rebecca	PROPN
ihlr-18967	81	4	s.	s.	PROPN
ihlr-18967	81	5	eisenberg	eisenberg	PROPN
ihlr-18967	81	6	,	,	PUNCT
ihlr-18967	81	7	patents	patent	NOUN
ihlr-18967	81	8	and	and	CCONJ
ihlr-18967	81	9	the	the	DET
ihlr-18967	81	10	progress	progress	NOUN
ihlr-18967	81	11	of	of	ADP
ihlr-18967	81	12	science	science	NOUN
ihlr-18967	81	13	:	:	PUNCT
ihlr-18967	81	14	exclusive	exclusive	ADJ
ihlr-18967	81	15	rights	right	NOUN
ihlr-18967	81	16	and	and	CCONJ
ihlr-18967	81	17	experimental	experimental	ADJ
ihlr-18967	81	18	use	use	NOUN
ihlr-18967	81	19	,	,	PUNCT
ihlr-18967	81	20	56	56	NUM
ihlr-18967	81	21	u.	u.	NOUN
ihlr-18967	81	22	chi	chi	PROPN
ihlr-18967	81	23	.	.	PUNCT
ihlr-18967	82	1	l.	l.	PROPN
ihlr-18967	82	2	rev	rev	PROPN
ihlr-18967	82	3	.	.	PROPN
ihlr-18967	82	4	1017	1017	NUM
ihlr-18967	82	5	,	,	PUNCT
ihlr-18967	82	6	102437	102437	NUM
ihlr-18967	82	7	(	(	PUNCT
ihlr-18967	82	8	1989	1989	NUM
ihlr-18967	82	9	)	)	PUNCT
ihlr-18967	82	10	(	(	PUNCT
ihlr-18967	82	11	discussing	discuss	VERB
ihlr-18967	82	12	theories	theory	NOUN
ihlr-18967	82	13	of	of	ADP
ihlr-18967	82	14	justification	justification	NOUN
ihlr-18967	82	15	for	for	ADP
ihlr-18967	82	16	monopolies	monopoly	NOUN
ihlr-18967	82	17	created	create	VERB
ihlr-18967	82	18	by	by	ADP
ihlr-18967	82	19	patents	patent	NOUN
ihlr-18967	82	20	)	)	PUNCT
ihlr-18967	82	21	.	.	PUNCT
ihlr-18967	83	1	12	12	NUM
ihlr-18967	83	2	matthew	matthew	PROPN
ihlr-18967	83	3	herper	herper	PROPN
ihlr-18967	83	4	,	,	PUNCT
ihlr-18967	83	5	the	the	DET
ihlr-18967	83	6	truly	truly	ADV
ihlr-18967	83	7	staggering	staggering	ADJ
ihlr-18967	83	8	cost	cost	NOUN
ihlr-18967	83	9	of	of	ADP
ihlr-18967	83	10	inventing	invent	VERB
ihlr-18967	83	11	new	new	ADJ
ihlr-18967	83	12	drugs	drug	NOUN
ihlr-18967	83	13	,	,	PUNCT
ihlr-18967	83	14	forbes	forbes	X
ihlr-18967	83	15	(	(	PUNCT
ihlr-18967	83	16	feb	feb	PROPN
ihlr-18967	83	17	.	.	PROPN
ihlr-18967	83	18	10	10	NUM
ihlr-18967	83	19	,	,	PUNCT
ihlr-18967	83	20	2012	2012	NUM
ihlr-18967	83	21	,	,	PUNCT
ihlr-18967	83	22	7:41	7:41	NUM
ihlr-18967	83	23	am	am	NOUN
ihlr-18967	83	24	)	)	PUNCT
ihlr-18967	83	25	,	,	PUNCT
ihlr-18967	83	26	http://www.forbes.com/	http://www.forbes.com/	ADJ
ihlr-18967	83	27	sites	site	NOUN
ihlr-18967	83	28	/	/	SYM
ihlr-18967	83	29	matthewherper/2012/02/10	matthewherper/2012/02/10	VERB
ihlr-18967	83	30	/	/	SYM
ihlr-18967	83	31	the	the	DET
ihlr-18967	83	32	-	-	PUNCT
ihlr-18967	83	33	truly	truly	ADV
ihlr-18967	83	34	-	-	PUNCT
ihlr-18967	83	35	staggering	staggering	ADJ
ihlr-18967	83	36	-	-	PUNCT
ihlr-18967	83	37	cost	cost	NOUN
ihlr-18967	83	38	-	-	PUNCT
ihlr-18967	83	39	of	of	ADP
ihlr-18967	83	40	-	-	PUNCT
ihlr-18967	83	41	inventingnew	inventingnew	NOUN
ihlr-18967	83	42	-	-	PUNCT
ihlr-18967	83	43	drugs/.	drugs/.	NOUN
ihlr-18967	83	44	the	the	DET
ihlr-18967	83	45	author	author	NOUN
ihlr-18967	83	46	notes	note	VERB
ihlr-18967	83	47	the	the	DET
ihlr-18967	83	48	cost	cost	NOUN
ihlr-18967	83	49	of	of	ADP
ihlr-18967	83	50	research	research	NOUN
ihlr-18967	83	51	and	and	CCONJ
ihlr-18967	83	52	development	development	NOUN
ihlr-18967	83	53	,	,	PUNCT
ihlr-18967	83	54	while	while	SCONJ
ihlr-18967	83	55	it	it	PRON
ihlr-18967	83	56	varies	vary	VERB
ihlr-18967	83	57	manufacturer	manufacturer	NOUN
ihlr-18967	83	58	to	to	PART
ihlr-18967	83	59	manufacture	manufacture	VERB
ihlr-18967	83	60	,	,	PUNCT
ihlr-18967	83	61	is	be	AUX
ihlr-18967	83	62	astronomical	astronomical	ADJ
ihlr-18967	83	63	.	.	PUNCT
ihlr-18967	84	1	in	in	ADP
ihlr-18967	84	2	2011	2011	NUM
ihlr-18967	84	3	,	,	PUNCT
ihlr-18967	84	4	on	on	ADP
ihlr-18967	84	5	average	average	ADJ
ihlr-18967	84	6	,	,	PUNCT
ihlr-18967	84	7	astrazeneca	astrazeneca	PROPN
ihlr-18967	84	8	spent	spend	VERB
ihlr-18967	84	9	$	$	SYM
ihlr-18967	84	10	11.79	11.79	NUM
ihlr-18967	84	11	billion	billion	NUM
ihlr-18967	84	12	,	,	PUNCT
ihlr-18967	84	13	roche	roche	PROPN
ihlr-18967	84	14	spent	spend	VERB
ihlr-18967	84	15	$	$	SYM
ihlr-18967	84	16	7.8	7.8	NUM
ihlr-18967	84	17	billion	billion	NUM
ihlr-18967	84	18	,	,	PUNCT
ihlr-18967	84	19	pfizer	pfizer	NOUN
ihlr-18967	84	20	spent	spend	VERB
ihlr-18967	84	21	$	$	SYM
ihlr-18967	84	22	7.72	7.72	NUM
ihlr-18967	84	23	billion	billion	NUM
ihlr-18967	84	24	,	,	PUNCT
ihlr-18967	84	25	and	and	CCONJ
ihlr-18967	84	26	eli	eli	PROPN
ihlr-18967	84	27	lilly	lilly	PROPN
ihlr-18967	84	28	spent	spend	VERB
ihlr-18967	84	29	$	$	SYM
ihlr-18967	84	30	4.57	4.57	NUM
ihlr-18967	84	31	billion	billion	NUM
ihlr-18967	84	32	on	on	ADP
ihlr-18967	84	33	research	research	NOUN
ihlr-18967	84	34	and	and	CCONJ
ihlr-18967	84	35	development	development	NOUN
ihlr-18967	84	36	per	per	ADP
ihlr-18967	84	37	drug	drug	NOUN
ihlr-18967	84	38	.	.	PUNCT
ihlr-18967	85	1	13	13	NUM
ihlr-18967	85	2	e.g.	e.g.	X
ihlr-18967	85	3	,	,	PUNCT
ihlr-18967	85	4	ftc	ftc	PROPN
ihlr-18967	85	5	v.	v.	PROPN
ihlr-18967	85	6	watson	watson	PROPN
ihlr-18967	85	7	pharms	pharms	PROPN
ihlr-18967	85	8	.	.	PUNCT
ihlr-18967	85	9	,	,	PUNCT
ihlr-18967	85	10	inc	inc	PROPN
ihlr-18967	85	11	.	.	PROPN
ihlr-18967	85	12	,	,	PUNCT
ihlr-18967	85	13	677	677	NUM
ihlr-18967	85	14	f.3d	f.3d	NUM
ihlr-18967	85	15	1298	1298	NUM
ihlr-18967	85	16	(	(	PUNCT
ihlr-18967	85	17	11th	11th	ADJ
ihlr-18967	85	18	cir	cir	NOUN
ihlr-18967	85	19	.	.	PROPN
ihlr-18967	85	20	2012	2012	NUM
ihlr-18967	85	21	)	)	PUNCT
ihlr-18967	85	22	,	,	PUNCT
ihlr-18967	85	23	rev’d	rev’d	NOUN
ihlr-18967	85	24	sub	sub	PROPN
ihlr-18967	85	25	nom	nom	PROPN
ihlr-18967	85	26	.	.	PROPN
ihlr-18967	85	27	ftc	ftc	PROPN
ihlr-18967	85	28	v.	v.	ADP
ihlr-18967	85	29	actavis	actavis	PROPN
ihlr-18967	85	30	,	,	PUNCT
ihlr-18967	85	31	inc	inc	PROPN
ihlr-18967	85	32	.	.	PROPN
ihlr-18967	85	33	,	,	PUNCT
ihlr-18967	85	34	133	133	NUM
ihlr-18967	85	35	s.	s.	PROPN
ihlr-18967	85	36	ct	ct	PROPN
ihlr-18967	85	37	.	.	PROPN
ihlr-18967	85	38	2223	2223	NUM
ihlr-18967	85	39	(	(	PUNCT
ihlr-18967	85	40	2013	2013	NUM
ihlr-18967	85	41	)	)	PUNCT
ihlr-18967	85	42	;	;	PUNCT
ihlr-18967	85	43	scheringplough	scheringplough	PROPN
ihlr-18967	85	44	corp	corp	PROPN
ihlr-18967	85	45	.	.	PROPN
ihlr-18967	85	46	v.	v.	PROPN
ihlr-18967	85	47	f.t.c	f.t.c	PROPN
ihlr-18967	85	48	.	.	PROPN
ihlr-18967	85	49	,	,	PUNCT
ihlr-18967	85	50	402	402	NUM
ihlr-18967	85	51	f.3d	f.3d	NUM
ihlr-18967	85	52	1056	1056	NUM
ihlr-18967	85	53	(	(	PUNCT
ihlr-18967	85	54	11th	11th	ADJ
ihlr-18967	85	55	cir	cir	NOUN
ihlr-18967	85	56	.	.	PROPN
ihlr-18967	85	57	2005	2005	NUM
ihlr-18967	85	58	)	)	PUNCT
ihlr-18967	85	59	.	.	PUNCT
ihlr-18967	86	1	14	14	NUM
ihlr-18967	86	2	watson	watson	PROPN
ihlr-18967	86	3	pharms	pharm	NOUN
ihlr-18967	86	4	.	.	PUNCT
ihlr-18967	86	5	,	,	PUNCT
ihlr-18967	86	6	677	677	NUM
ihlr-18967	86	7	f.3d	f.3d	NUM
ihlr-18967	86	8	1298	1298	NUM
ihlr-18967	86	9	,	,	PUNCT
ihlr-18967	86	10	cert	cert	NOUN
ihlr-18967	86	11	.	.	PUNCT
ihlr-18967	87	1	granted	grant	VERB
ihlr-18967	87	2	,	,	PUNCT
ihlr-18967	87	3	81	81	NUM
ihlr-18967	87	4	u.s.l.w	u.s.l.w	PROPN
ihlr-18967	87	5	.	.	PROPN
ihlr-18967	87	6	3216	3216	NUM
ihlr-18967	87	7	(	(	PUNCT
ihlr-18967	87	8	u.s	u.s	PROPN
ihlr-18967	87	9	.	.	PROPN
ihlr-18967	87	10	dec	dec	PROPN
ihlr-18967	87	11	.	.	PROPN
ihlr-18967	87	12	7	7	NUM
ihlr-18967	87	13	,	,	PUNCT
ihlr-18967	87	14	2012	2012	NUM
ihlr-18967	87	15	)	)	PUNCT
ihlr-18967	87	16	(	(	PUNCT
ihlr-18967	87	17	no	no	INTJ
ihlr-18967	87	18	.	.	NOUN
ihlr-18967	88	1	12	12	NUM
ihlr-18967	88	2	-	-	SYM
ihlr-18967	88	3	416	416	NUM
ihlr-18967	88	4	)	)	PUNCT
ihlr-18967	88	5	.	.	PUNCT
ihlr-18967	89	1	15	15	NUM
ihlr-18967	89	2	actavis	actavi	NOUN
ihlr-18967	89	3	,	,	PUNCT
ihlr-18967	89	4	133	133	NUM
ihlr-18967	89	5	s.	s.	PROPN
ihlr-18967	89	6	ct	ct	PROPN
ihlr-18967	89	7	.	.	PUNCT
ihlr-18967	90	1	at	at	ADP
ihlr-18967	90	2	2237	2237	NUM
ihlr-18967	90	3	.	.	PUNCT
ihlr-18967	91	1	16	16	NUM
ihlr-18967	91	2	see	see	VERB
ihlr-18967	91	3	preserve	preserve	VERB
ihlr-18967	91	4	access	access	NOUN
ihlr-18967	91	5	to	to	ADP
ihlr-18967	91	6	affordable	affordable	ADJ
ihlr-18967	91	7	generics	generic	NOUN
ihlr-18967	91	8	act	act	PROPN
ihlr-18967	91	9	,	,	PUNCT
ihlr-18967	91	10	s.	s.	PROPN
ihlr-18967	91	11	214	214	NUM
ihlr-18967	91	12	,	,	PUNCT
ihlr-18967	91	13	113th	113th	PROPN
ihlr-18967	91	14	cong	cong	NOUN
ihlr-18967	91	15	.	.	PUNCT
ihlr-18967	92	1	(	(	PUNCT
ihlr-18967	92	2	2013	2013	NUM
ihlr-18967	92	3	)	)	PUNCT
ihlr-18967	92	4	(	(	PUNCT
ihlr-18967	92	5	introduced	introduce	VERB
ihlr-18967	92	6	to	to	ADP
ihlr-18967	92	7	the	the	DET
ihlr-18967	92	8	senate	senate	PROPN
ihlr-18967	92	9	on	on	ADP
ihlr-18967	92	10	feb	feb	PROPN
ihlr-18967	92	11	.	.	PROPN
ihlr-18967	92	12	4	4	NUM
ihlr-18967	92	13	,	,	PUNCT
ihlr-18967	92	14	2013	2013	NUM
ihlr-18967	92	15	and	and	CCONJ
ihlr-18967	92	16	held	hold	VERB
ihlr-18967	92	17	hearings	hearing	NOUN
ihlr-18967	92	18	on	on	ADP
ihlr-18967	92	19	july	july	PROPN
ihlr-18967	92	20	23	23	NUM
ihlr-18967	92	21	,	,	PUNCT
ihlr-18967	92	22	2013	2013	NUM
ihlr-18967	92	23	)	)	PUNCT
ihlr-18967	92	24	(	(	PUNCT
ihlr-18967	92	25	establishing	establish	VERB
ihlr-18967	92	26	a	a	DET
ihlr-18967	92	27	presumption	presumption	NOUN
ihlr-18967	92	28	that	that	SCONJ
ihlr-18967	92	29	reverse	reverse	ADJ
ihlr-18967	92	30	payment	payment	NOUN
ihlr-18967	92	31	settlements	settlement	NOUN
ihlr-18967	92	32	are	be	AUX
ihlr-18967	92	33	anticompetitive	anticompetitive	ADJ
ihlr-18967	92	34	)	)	PUNCT
ihlr-18967	92	35	.	.	PUNCT
ihlr-18967	93	1	http://dx.doi.org/10.2307/1599761	http://dx.doi.org/10.2307/1599761	VERB
ihlr-18967	93	2	428	428	NUM
ihlr-18967	93	3	indiana	indiana	PROPN
ihlr-18967	93	4	health	health	PROPN
ihlr-18967	93	5	law	law	PROPN
ihlr-18967	93	6	review	review	NOUN
ihlr-18967	93	7	vol	vol	NOUN
ihlr-18967	93	8	.	.	PUNCT
ihlr-18967	94	1	12:1	12:1	NUM
ihlr-18967	94	2	b.	b.	PROPN
ihlr-18967	94	3	roadmap	roadmap	PROPN
ihlr-18967	94	4	the	the	DET
ihlr-18967	94	5	court	court	NOUN
ihlr-18967	94	6	’s	’s	PART
ihlr-18967	94	7	application	application	NOUN
ihlr-18967	94	8	of	of	ADP
ihlr-18967	94	9	rule	rule	NOUN
ihlr-18967	94	10	of	of	ADP
ihlr-18967	94	11	reason	reason	NOUN
ihlr-18967	94	12	analysis	analysis	NOUN
ihlr-18967	94	13	was	be	AUX
ihlr-18967	94	14	correct	correct	ADJ
ihlr-18967	94	15	and	and	CCONJ
ihlr-18967	94	16	should	should	AUX
ihlr-18967	94	17	not	not	PART
ihlr-18967	94	18	be	be	AUX
ihlr-18967	94	19	changed	change	VERB
ihlr-18967	94	20	by	by	ADP
ihlr-18967	94	21	congress.17	congress.17	PROPN
ihlr-18967	94	22	the	the	DET
ihlr-18967	94	23	court	court	NOUN
ihlr-18967	94	24	’s	’s	PART
ihlr-18967	94	25	opinion	opinion	NOUN
ihlr-18967	94	26	did	do	AUX
ihlr-18967	94	27	not	not	PART
ihlr-18967	94	28	prohibit	prohibit	VERB
ihlr-18967	94	29	reverse	reverse	ADJ
ihlr-18967	94	30	payment	payment	NOUN
ihlr-18967	94	31	settlements	settlement	NOUN
ihlr-18967	94	32	per	per	ADP
ihlr-18967	94	33	se	se	X
ihlr-18967	94	34	and	and	CCONJ
ihlr-18967	94	35	in	in	ADP
ihlr-18967	94	36	doing	do	VERB
ihlr-18967	94	37	so	so	ADV
ihlr-18967	94	38	the	the	DET
ihlr-18967	94	39	court	court	NOUN
ihlr-18967	94	40	outlined	outline	VERB
ihlr-18967	94	41	a	a	DET
ihlr-18967	94	42	brief	brief	ADJ
ihlr-18967	94	43	framework	framework	NOUN
ihlr-18967	94	44	for	for	ADP
ihlr-18967	94	45	analyzing	analyze	VERB
ihlr-18967	94	46	reverse	reverse	ADJ
ihlr-18967	94	47	payment	payment	NOUN
ihlr-18967	94	48	settlements	settlement	NOUN
ihlr-18967	94	49	under	under	ADP
ihlr-18967	94	50	the	the	DET
ihlr-18967	94	51	rule	rule	NOUN
ihlr-18967	94	52	of	of	ADP
ihlr-18967	94	53	reason	reason	NOUN
ihlr-18967	94	54	.	.	PUNCT
ihlr-18967	95	1	this	this	DET
ihlr-18967	95	2	note	note	NOUN
ihlr-18967	95	3	addresses	address	VERB
ihlr-18967	95	4	the	the	DET
ihlr-18967	95	5	impact	impact	NOUN
ihlr-18967	95	6	of	of	ADP
ihlr-18967	95	7	using	use	VERB
ihlr-18967	95	8	the	the	DET
ihlr-18967	95	9	rule	rule	NOUN
ihlr-18967	95	10	of	of	ADP
ihlr-18967	95	11	reason	reason	NOUN
ihlr-18967	95	12	,	,	PUNCT
ihlr-18967	95	13	what	what	DET
ihlr-18967	95	14	courts	court	NOUN
ihlr-18967	95	15	will	will	AUX
ihlr-18967	95	16	look	look	VERB
ihlr-18967	95	17	at	at	ADP
ihlr-18967	95	18	,	,	PUNCT
ihlr-18967	95	19	under	under	ADP
ihlr-18967	95	20	actavis	actavis	NOUN
ihlr-18967	95	21	,	,	PUNCT
ihlr-18967	95	22	to	to	PART
ihlr-18967	95	23	determine	determine	VERB
ihlr-18967	95	24	if	if	SCONJ
ihlr-18967	95	25	a	a	DET
ihlr-18967	95	26	reverse	reverse	ADJ
ihlr-18967	95	27	payment	payment	NOUN
ihlr-18967	95	28	settlement	settlement	NOUN
ihlr-18967	95	29	is	be	AUX
ihlr-18967	95	30	pro	pro	ADJ
ihlr-18967	95	31	-	-	ADJ
ihlr-18967	95	32	competitive	competitive	ADJ
ihlr-18967	95	33	,	,	PUNCT
ihlr-18967	95	34	and	and	CCONJ
ihlr-18967	95	35	why	why	SCONJ
ihlr-18967	95	36	the	the	DET
ihlr-18967	95	37	rule	rule	NOUN
ihlr-18967	95	38	of	of	ADP
ihlr-18967	95	39	reason	reason	NOUN
ihlr-18967	95	40	was	be	AUX
ihlr-18967	95	41	the	the	DET
ihlr-18967	95	42	correct	correct	ADJ
ihlr-18967	95	43	choice	choice	NOUN
ihlr-18967	95	44	for	for	ADP
ihlr-18967	95	45	analysis	analysis	NOUN
ihlr-18967	95	46	.	.	PUNCT
ihlr-18967	96	1	in	in	ADP
ihlr-18967	96	2	order	order	NOUN
ihlr-18967	96	3	to	to	PART
ihlr-18967	96	4	facilitate	facilitate	VERB
ihlr-18967	96	5	a	a	DET
ihlr-18967	96	6	better	well	ADJ
ihlr-18967	96	7	understanding	understanding	NOUN
ihlr-18967	96	8	of	of	ADP
ihlr-18967	96	9	reverse	reverse	ADJ
ihlr-18967	96	10	payment	payment	NOUN
ihlr-18967	96	11	settlements	settlement	NOUN
ihlr-18967	96	12	and	and	CCONJ
ihlr-18967	96	13	recent	recent	ADJ
ihlr-18967	96	14	common	common	ADJ
ihlr-18967	96	15	law	law	NOUN
ihlr-18967	96	16	,	,	PUNCT
ihlr-18967	96	17	section	section	NOUN
ihlr-18967	96	18	ii	ii	PROPN
ihlr-18967	96	19	begins	begin	VERB
ihlr-18967	96	20	by	by	ADP
ihlr-18967	96	21	providing	provide	VERB
ihlr-18967	96	22	background	background	NOUN
ihlr-18967	96	23	information	information	NOUN
ihlr-18967	96	24	about	about	ADP
ihlr-18967	96	25	the	the	DET
ihlr-18967	96	26	hatch	hatch	NOUN
ihlr-18967	96	27	-	-	PUNCT
ihlr-18967	96	28	waxman	waxman	PROPN
ihlr-18967	96	29	act	act	NOUN
ihlr-18967	96	30	and	and	CCONJ
ihlr-18967	96	31	its	its	PRON
ihlr-18967	96	32	application	application	NOUN
ihlr-18967	96	33	to	to	PART
ihlr-18967	96	34	reverse	reverse	VERB
ihlr-18967	96	35	payment	payment	NOUN
ihlr-18967	96	36	settlements	settlement	NOUN
ihlr-18967	96	37	.	.	PUNCT
ihlr-18967	97	1	additionally	additionally	ADV
ihlr-18967	97	2	,	,	PUNCT
ihlr-18967	97	3	section	section	NOUN
ihlr-18967	97	4	ii	ii	NOUN
ihlr-18967	97	5	provides	provide	VERB
ihlr-18967	97	6	information	information	NOUN
ihlr-18967	97	7	on	on	ADP
ihlr-18967	97	8	the	the	DET
ihlr-18967	97	9	existing	exist	VERB
ihlr-18967	97	10	state	state	NOUN
ihlr-18967	97	11	of	of	ADP
ihlr-18967	97	12	common	common	ADJ
ihlr-18967	97	13	law	law	NOUN
ihlr-18967	97	14	pre	pre	ADJ
ihlr-18967	97	15	-	-	NOUN
ihlr-18967	97	16	actavis	actavis	ADJ
ihlr-18967	97	17	,	,	PUNCT
ihlr-18967	97	18	a	a	DET
ihlr-18967	97	19	brief	brief	ADJ
ihlr-18967	97	20	overview	overview	NOUN
ihlr-18967	97	21	of	of	ADP
ihlr-18967	97	22	the	the	DET
ihlr-18967	97	23	rule	rule	NOUN
ihlr-18967	97	24	of	of	ADP
ihlr-18967	97	25	reason	reason	NOUN
ihlr-18967	97	26	,	,	PUNCT
ihlr-18967	97	27	and	and	CCONJ
ihlr-18967	97	28	an	an	DET
ihlr-18967	97	29	overview	overview	NOUN
ihlr-18967	97	30	of	of	ADP
ihlr-18967	97	31	recent	recent	ADJ
ihlr-18967	97	32	congressional	congressional	ADJ
ihlr-18967	97	33	action	action	NOUN
ihlr-18967	97	34	.	.	PUNCT
ihlr-18967	98	1	section	section	NOUN
ihlr-18967	98	2	iii	iii	PROPN
ihlr-18967	98	3	discusses	discuss	VERB
ihlr-18967	98	4	how	how	SCONJ
ihlr-18967	98	5	actavis	actavis	ADJ
ihlr-18967	98	6	will	will	AUX
ihlr-18967	98	7	benefit	benefit	VERB
ihlr-18967	98	8	consumers	consumer	NOUN
ihlr-18967	98	9	and	and	CCONJ
ihlr-18967	98	10	may	may	AUX
ihlr-18967	98	11	cause	cause	VERB
ihlr-18967	98	12	a	a	DET
ihlr-18967	98	13	slight	slight	ADJ
ihlr-18967	98	14	burden	burden	NOUN
ihlr-18967	98	15	for	for	ADP
ihlr-18967	98	16	manufactures	manufacture	NOUN
ihlr-18967	98	17	.	.	PUNCT
ihlr-18967	99	1	next	next	ADV
ihlr-18967	99	2	,	,	PUNCT
ihlr-18967	99	3	section	section	NOUN
ihlr-18967	99	4	iii	iii	NOUN
ihlr-18967	99	5	provides	provide	VERB
ihlr-18967	99	6	a	a	DET
ihlr-18967	99	7	solution	solution	NOUN
ihlr-18967	99	8	for	for	ADP
ihlr-18967	99	9	crafting	craft	VERB
ihlr-18967	99	10	a	a	DET
ihlr-18967	99	11	pro	pro	ADJ
ihlr-18967	99	12	-	-	ADJ
ihlr-18967	99	13	competitive	competitive	ADJ
ihlr-18967	99	14	reverse	reverse	ADJ
ihlr-18967	99	15	payment	payment	NOUN
ihlr-18967	99	16	settlement	settlement	NOUN
ihlr-18967	99	17	under	under	ADP
ihlr-18967	99	18	actavis	actavis	PROPN
ihlr-18967	99	19	.	.	PUNCT
ihlr-18967	100	1	finally	finally	ADV
ihlr-18967	100	2	,	,	PUNCT
ihlr-18967	100	3	section	section	NOUN
ihlr-18967	100	4	iv	iv	NUM
ihlr-18967	100	5	discusses	discuss	VERB
ihlr-18967	100	6	a	a	DET
ihlr-18967	100	7	policy	policy	NOUN
ihlr-18967	100	8	recommendation	recommendation	NOUN
ihlr-18967	100	9	concerning	concern	VERB
ihlr-18967	100	10	potential	potential	ADJ
ihlr-18967	100	11	congressional	congressional	ADJ
ihlr-18967	100	12	action	action	NOUN
ihlr-18967	100	13	in	in	ADP
ihlr-18967	100	14	regards	regard	NOUN
ihlr-18967	100	15	to	to	PART
ihlr-18967	100	16	reverse	reverse	VERB
ihlr-18967	100	17	payment	payment	NOUN
ihlr-18967	100	18	settlements	settlement	NOUN
ihlr-18967	100	19	.	.	PUNCT
ihlr-18967	101	1	ii	ii	PROPN
ihlr-18967	101	2	.	.	PUNCT
ihlr-18967	102	1	background	background	PROPN
ihlr-18967	102	2	information	information	PROPN
ihlr-18967	102	3	a.	a.	NOUN
ihlr-18967	102	4	pre	pre	PROPN
ihlr-18967	102	5	-	-	ADJ
ihlr-18967	102	6	hatch	hatch	ADJ
ihlr-18967	102	7	-	-	PUNCT
ihlr-18967	102	8	waxman	waxman	PROPN
ihlr-18967	102	9	act	act	NOUN
ihlr-18967	102	10	on	on	ADP
ihlr-18967	102	11	june	june	PROPN
ihlr-18967	102	12	25	25	NUM
ihlr-18967	102	13	,	,	PUNCT
ihlr-18967	102	14	1938	1938	NUM
ihlr-18967	102	15	the	the	DET
ihlr-18967	102	16	federal	federal	ADJ
ihlr-18967	102	17	food	food	NOUN
ihlr-18967	102	18	,	,	PUNCT
ihlr-18967	102	19	drug	drug	NOUN
ihlr-18967	102	20	,	,	PUNCT
ihlr-18967	102	21	and	and	CCONJ
ihlr-18967	102	22	cosmetics	cosmetic	NOUN
ihlr-18967	102	23	act	act	NOUN
ihlr-18967	102	24	(	(	PUNCT
ihlr-18967	102	25	“	"	PUNCT
ihlr-18967	102	26	fdca	fdca	NOUN
ihlr-18967	102	27	”	"	PUNCT
ihlr-18967	102	28	)	)	PUNCT
ihlr-18967	102	29	was	be	AUX
ihlr-18967	102	30	signed	sign	VERB
ihlr-18967	102	31	into	into	ADP
ihlr-18967	102	32	law.18	law.18	PROPN
ihlr-18967	102	33	the	the	DET
ihlr-18967	102	34	fdca	fdca	NOUN
ihlr-18967	102	35	,	,	PUNCT
ihlr-18967	102	36	for	for	ADP
ihlr-18967	102	37	the	the	DET
ihlr-18967	102	38	first	first	ADJ
ihlr-18967	102	39	17	17	NUM
ihlr-18967	102	40	contra	contra	PROPN
ihlr-18967	102	41	brianna	brianna	PROPN
ihlr-18967	102	42	ford	ford	PROPN
ihlr-18967	102	43	,	,	PUNCT
ihlr-18967	102	44	using	use	VERB
ihlr-18967	102	45	reverse	reverse	ADJ
ihlr-18967	102	46	payment	payment	NOUN
ihlr-18967	102	47	agreements	agreement	NOUN
ihlr-18967	102	48	as	as	ADP
ihlr-18967	102	49	an	an	DET
ihlr-18967	102	50	effective	effective	ADJ
ihlr-18967	102	51	way	way	NOUN
ihlr-18967	102	52	to	to	PART
ihlr-18967	102	53	maintain	maintain	VERB
ihlr-18967	102	54	a	a	DET
ihlr-18967	102	55	patent	patent	NOUN
ihlr-18967	102	56	monopoly	monopoly	NOUN
ihlr-18967	102	57	in	in	ADP
ihlr-18967	102	58	the	the	DET
ihlr-18967	102	59	pharmaceutical	pharmaceutical	NOUN
ihlr-18967	102	60	industry	industry	NOUN
ihlr-18967	102	61	,	,	PUNCT
ihlr-18967	102	62	21	21	NUM
ihlr-18967	102	63	am	am	NOUN
ihlr-18967	102	64	.	.	PUNCT
ihlr-18967	103	1	u.	u.	PROPN
ihlr-18967	103	2	j.	j.	PROPN
ihlr-18967	103	3	gender	gender	PROPN
ihlr-18967	103	4	soc	soc	PROPN
ihlr-18967	103	5	.	.	PUNCT
ihlr-18967	104	1	pol’y	pol’y	NOUN
ihlr-18967	104	2	&	&	CCONJ
ihlr-18967	104	3	l.	l.	PROPN
ihlr-18967	104	4	919	919	NUM
ihlr-18967	104	5	,	,	PUNCT
ihlr-18967	104	6	949	949	NUM
ihlr-18967	104	7	(	(	PUNCT
ihlr-18967	104	8	2013	2013	NUM
ihlr-18967	104	9	)	)	PUNCT
ihlr-18967	105	1	(	(	PUNCT
ihlr-18967	105	2	arguing	argue	VERB
ihlr-18967	105	3	for	for	SCONJ
ihlr-18967	105	4	congress	congress	PROPN
ihlr-18967	105	5	to	to	PART
ihlr-18967	105	6	ban	ban	VERB
ihlr-18967	105	7	reverse	reverse	ADJ
ihlr-18967	105	8	payment	payment	NOUN
ihlr-18967	105	9	settlements	settlement	NOUN
ihlr-18967	105	10	)	)	PUNCT
ihlr-18967	105	11	.	.	PUNCT
ihlr-18967	106	1	18	18	NUM
ihlr-18967	106	2	federal	federal	ADJ
ihlr-18967	106	3	food	food	NOUN
ihlr-18967	106	4	,	,	PUNCT
ihlr-18967	106	5	drug	drug	NOUN
ihlr-18967	106	6	,	,	PUNCT
ihlr-18967	106	7	and	and	CCONJ
ihlr-18967	106	8	cosmetics	cosmetic	NOUN
ihlr-18967	106	9	act	act	PROPN
ihlr-18967	106	10	,	,	PUNCT
ihlr-18967	106	11	pub	pub	NOUN
ihlr-18967	106	12	.	.	PUNCT
ihlr-18967	107	1	l.	l.	PROPN
ihlr-18967	107	2	no	no	INTJ
ihlr-18967	107	3	.	.	PROPN
ihlr-18967	108	1	75	75	NUM
ihlr-18967	108	2	-	-	SYM
ihlr-18967	108	3	717	717	NUM
ihlr-18967	108	4	,	,	PUNCT
ihlr-18967	108	5	52	52	NUM
ihlr-18967	108	6	stat	stat	NOUN
ihlr-18967	108	7	.	.	PUNCT
ihlr-18967	109	1	1040	1040	NUM
ihlr-18967	109	2	(	(	PUNCT
ihlr-18967	109	3	1938	1938	NUM
ihlr-18967	109	4	)	)	PUNCT
ihlr-18967	109	5	(	(	PUNCT
ihlr-18967	109	6	codified	codify	VERB
ihlr-18967	109	7	as	as	SCONJ
ihlr-18967	109	8	amended	amend	VERB
ihlr-18967	109	9	at	at	ADP
ihlr-18967	109	10	21	21	NUM
ihlr-18967	109	11	u.s.c	u.s.c	ADJ
ihlr-18967	109	12	.	.	PUNCT
ihlr-18967	110	1	§	§	PROPN
ihlr-18967	110	2	§	§	PROPN
ihlr-18967	110	3	301	301	NUM
ihlr-18967	110	4	-	-	PUNCT
ihlr-18967	110	5	399f	399f	NOUN
ihlr-18967	110	6	(	(	PUNCT
ihlr-18967	110	7	2015	2015	NUM
ihlr-18967	110	8	)	)	PUNCT
ihlr-18967	110	9	)	)	PUNCT
ihlr-18967	110	10	.	.	PUNCT
ihlr-18967	111	1	2015	2015	NUM
ihlr-18967	111	2	rationale	rationale	NOUN
ihlr-18967	111	3	behind	behind	ADP
ihlr-18967	111	4	hatch	hatch	NOUN
ihlr-18967	111	5	-	-	PUNCT
ihlr-18967	111	6	waxman	waxman	PROPN
ihlr-18967	111	7	act	act	PROPN
ihlr-18967	111	8	and	and	CCONJ
ihlr-18967	111	9	patent	patent	NOUN
ihlr-18967	111	10	law	law	NOUN
ihlr-18967	111	11	429	429	NUM
ihlr-18967	111	12	time	time	NOUN
ihlr-18967	111	13	,	,	PUNCT
ihlr-18967	111	14	empowered	empower	VERB
ihlr-18967	111	15	the	the	DET
ihlr-18967	111	16	fda	fda	PROPN
ihlr-18967	111	17	to	to	PART
ihlr-18967	111	18	review	review	VERB
ihlr-18967	111	19	the	the	DET
ihlr-18967	111	20	safety	safety	NOUN
ihlr-18967	111	21	of	of	ADP
ihlr-18967	111	22	new	new	ADJ
ihlr-18967	111	23	drugs.19	drugs.19	NOUN
ihlr-18967	111	24	before	before	ADP
ihlr-18967	111	25	1962	1962	NUM
ihlr-18967	111	26	,	,	PUNCT
ihlr-18967	111	27	drugs	drug	NOUN
ihlr-18967	111	28	were	be	AUX
ihlr-18967	111	29	only	only	ADV
ihlr-18967	111	30	approved	approve	VERB
ihlr-18967	111	31	for	for	ADP
ihlr-18967	111	32	safety	safety	NOUN
ihlr-18967	111	33	without	without	ADP
ihlr-18967	111	34	any	any	DET
ihlr-18967	111	35	form	form	NOUN
ihlr-18967	111	36	of	of	ADP
ihlr-18967	111	37	an	an	DET
ihlr-18967	111	38	efficacy	efficacy	NOUN
ihlr-18967	111	39	requirement.20	requirement.20	NOUN
ihlr-18967	111	40	this	this	PRON
ihlr-18967	111	41	would	would	AUX
ihlr-18967	111	42	mean	mean	VERB
ihlr-18967	111	43	that	that	SCONJ
ihlr-18967	111	44	in	in	ADP
ihlr-18967	111	45	the	the	DET
ihlr-18967	111	46	earlier	early	ADJ
ihlr-18967	111	47	example	example	NOUN
ihlr-18967	111	48	,	,	PUNCT
ihlr-18967	111	49	drug	drug	NOUN
ihlr-18967	111	50	23	23	NUM
ihlr-18967	111	51	developed	develop	VERB
ihlr-18967	111	52	by	by	ADP
ihlr-18967	111	53	abc	abc	PROPN
ihlr-18967	111	54	before	before	ADP
ihlr-18967	111	55	1962	1962	NUM
ihlr-18967	111	56	,	,	PUNCT
ihlr-18967	111	57	would	would	AUX
ihlr-18967	111	58	be	be	AUX
ihlr-18967	111	59	approvable	approvable	ADJ
ihlr-18967	111	60	without	without	ADP
ihlr-18967	111	61	proof	proof	NOUN
ihlr-18967	111	62	of	of	ADP
ihlr-18967	111	63	improving	improve	VERB
ihlr-18967	111	64	a	a	DET
ihlr-18967	111	65	consumer	consumer	NOUN
ihlr-18967	111	66	’s	’s	PART
ihlr-18967	111	67	memory	memory	NOUN
ihlr-18967	111	68	or	or	CCONJ
ihlr-18967	111	69	other	other	ADJ
ihlr-18967	111	70	intellectual	intellectual	ADJ
ihlr-18967	111	71	abilities	ability	NOUN
ihlr-18967	111	72	.	.	PUNCT
ihlr-18967	112	1	in	in	ADP
ihlr-18967	112	2	1962	1962	NUM
ihlr-18967	112	3	,	,	PUNCT
ihlr-18967	112	4	an	an	DET
ihlr-18967	112	5	amendment	amendment	NOUN
ihlr-18967	112	6	to	to	PART
ihlr-18967	112	7	fdca	fdca	VERB
ihlr-18967	112	8	added	add	VERB
ihlr-18967	112	9	“	"	PUNCT
ihlr-18967	112	10	a	a	DET
ihlr-18967	112	11	proofof	proofof	ADJ
ihlr-18967	112	12	-	-	PUNCT
ihlr-18967	112	13	efficacy	efficacy	NOUN
ihlr-18967	112	14	requirement	requirement	NOUN
ihlr-18967	112	15	[	[	X
ihlr-18967	112	16	for	for	ADP
ihlr-18967	112	17	]	]	PUNCT
ihlr-18967	112	18	new	new	ADJ
ihlr-18967	112	19	drug	drug	NOUN
ihlr-18967	112	20	approval[s].”21	approval[s].”21	PUNCT
ihlr-18967	112	21	subsequently	subsequently	ADV
ihlr-18967	112	22	,	,	PUNCT
ihlr-18967	112	23	after	after	ADP
ihlr-18967	112	24	1962	1962	NUM
ihlr-18967	112	25	,	,	PUNCT
ihlr-18967	112	26	a	a	DET
ihlr-18967	112	27	manufacturer	manufacturer	NOUN
ihlr-18967	112	28	was	be	AUX
ihlr-18967	112	29	required	require	VERB
ihlr-18967	112	30	to	to	PART
ihlr-18967	112	31	“	"	PUNCT
ihlr-18967	112	32	demonstrate	demonstrate	VERB
ihlr-18967	112	33	not	not	PART
ihlr-18967	112	34	only	only	ADV
ihlr-18967	112	35	the	the	DET
ihlr-18967	112	36	safety	safety	NOUN
ihlr-18967	112	37	of	of	ADP
ihlr-18967	112	38	the	the	DET
ihlr-18967	112	39	drug	drug	NOUN
ihlr-18967	112	40	,	,	PUNCT
ihlr-18967	112	41	but	but	CCONJ
ihlr-18967	112	42	that	that	SCONJ
ihlr-18967	112	43	it	it	PRON
ihlr-18967	112	44	was	be	AUX
ihlr-18967	112	45	effective	effective	ADJ
ihlr-18967	112	46	for	for	ADP
ihlr-18967	112	47	its	its	PRON
ihlr-18967	112	48	intended	intended	ADJ
ihlr-18967	112	49	use	use	NOUN
ihlr-18967	112	50	.	.	PUNCT
ihlr-18967	113	1	”22	”22	PROPN
ihlr-18967	113	2	after	after	ADP
ihlr-18967	113	3	1962	1962	NUM
ihlr-18967	113	4	,	,	PUNCT
ihlr-18967	113	5	generic	generic	ADJ
ihlr-18967	113	6	drugs	drug	NOUN
ihlr-18967	113	7	generally	generally	ADV
ihlr-18967	113	8	entered	enter	VERB
ihlr-18967	113	9	the	the	DET
ihlr-18967	113	10	market	market	NOUN
ihlr-18967	113	11	through	through	ADP
ihlr-18967	113	12	an	an	DET
ihlr-18967	113	13	abbreviated	abbreviate	VERB
ihlr-18967	113	14	approval	approval	NOUN
ihlr-18967	113	15	process23	process23	NOUN
ihlr-18967	113	16	or	or	CCONJ
ihlr-18967	113	17	through	through	ADP
ihlr-18967	113	18	“	"	PUNCT
ihlr-18967	113	19	paper”24	paper”24	ADJ
ihlr-18967	113	20	new	new	ADJ
ihlr-18967	113	21	drug	drug	NOUN
ihlr-18967	113	22	applications.25	applications.25	NOUN
ihlr-18967	113	23	however	however	ADV
ihlr-18967	113	24	,	,	PUNCT
ihlr-18967	113	25	neither	neither	CCONJ
ihlr-18967	113	26	the	the	DET
ihlr-18967	113	27	abbreviated	abbreviate	VERB
ihlr-18967	113	28	approval	approval	NOUN
ihlr-18967	113	29	process	process	NOUN
ihlr-18967	113	30	nor	nor	CCONJ
ihlr-18967	113	31	the	the	DET
ihlr-18967	113	32	“	"	PUNCT
ihlr-18967	113	33	paper	paper	NOUN
ihlr-18967	113	34	”	"	PUNCT
ihlr-18967	113	35	new	new	ADJ
ihlr-18967	113	36	drug	drug	NOUN
ihlr-18967	113	37	application	application	NOUN
ihlr-18967	113	38	had	have	VERB
ihlr-18967	113	39	a	a	DET
ihlr-18967	113	40	large	large	ADJ
ihlr-18967	113	41	effect	effect	NOUN
ihlr-18967	113	42	on	on	ADP
ihlr-18967	113	43	generic	generic	ADJ
ihlr-18967	113	44	drugs	drug	NOUN
ihlr-18967	113	45	entering	enter	VERB
ihlr-18967	113	46	the	the	DET
ihlr-18967	113	47	market	market	NOUN
ihlr-18967	113	48	.	.	PUNCT
ihlr-18967	114	1	the	the	DET
ihlr-18967	114	2	abbreviated	abbreviate	VERB
ihlr-18967	114	3	approval	approval	NOUN
ihlr-18967	114	4	process	process	NOUN
ihlr-18967	114	5	had	have	VERB
ihlr-18967	114	6	a	a	DET
ihlr-18967	114	7	minimal	minimal	ADJ
ihlr-18967	114	8	effect	effect	NOUN
ihlr-18967	114	9	,	,	PUNCT
ihlr-18967	114	10	because	because	SCONJ
ihlr-18967	114	11	it	it	PRON
ihlr-18967	114	12	only	only	ADV
ihlr-18967	114	13	applied	apply	VERB
ihlr-18967	114	14	to	to	ADP
ihlr-18967	114	15	drugs	drug	NOUN
ihlr-18967	114	16	approved	approve	VERB
ihlr-18967	114	17	prior	prior	ADV
ihlr-18967	114	18	to	to	ADP
ihlr-18967	114	19	1962.26	1962.26	NUM
ihlr-18967	114	20	also	also	ADV
ihlr-18967	114	21	,	,	PUNCT
ihlr-18967	114	22	the	the	DET
ihlr-18967	114	23	paper	paper	NOUN
ihlr-18967	114	24	-	-	PUNCT
ihlr-18967	114	25	nda	nda	PROPN
ihlr-18967	114	26	had	have	VERB
ihlr-18967	114	27	little	little	ADJ
ihlr-18967	114	28	effect	effect	NOUN
ihlr-18967	114	29	because	because	SCONJ
ihlr-18967	114	30	of	of	ADP
ihlr-18967	114	31	the	the	DET
ihlr-18967	114	32	lack	lack	NOUN
ihlr-18967	114	33	of	of	ADP
ihlr-18967	114	34	publically	publically	ADV
ihlr-18967	114	35	available	available	ADJ
ihlr-18967	114	36	information	information	NOUN
ihlr-18967	114	37	on	on	ADP
ihlr-18967	114	38	safety	safety	NOUN
ihlr-18967	114	39	and	and	CCONJ
ihlr-18967	114	40	19	19	NUM
ihlr-18967	114	41	elizabeth	elizabeth	PROPN
ihlr-18967	114	42	stotland	stotland	PROPN
ihlr-18967	114	43	weiswasser	weiswasser	PROPN
ihlr-18967	114	44	&	&	CCONJ
ihlr-18967	114	45	scott	scott	PROPN
ihlr-18967	114	46	d.	d.	PROPN
ihlr-18967	114	47	danzis	danzis	PROPN
ihlr-18967	114	48	,	,	PUNCT
ihlr-18967	114	49	the	the	DET
ihlr-18967	114	50	hatchwaxman	hatchwaxman	ADJ
ihlr-18967	114	51	act	act	NOUN
ihlr-18967	114	52	:	:	PUNCT
ihlr-18967	114	53	history	history	NOUN
ihlr-18967	114	54	,	,	PUNCT
ihlr-18967	114	55	structure	structure	NOUN
ihlr-18967	114	56	,	,	PUNCT
ihlr-18967	114	57	and	and	CCONJ
ihlr-18967	114	58	legacy	legacy	NOUN
ihlr-18967	114	59	,	,	PUNCT
ihlr-18967	114	60	71	71	NUM
ihlr-18967	114	61	antitrust	antitrust	ADJ
ihlr-18967	114	62	l.j	l.j	NOUN
ihlr-18967	114	63	.	.	PROPN
ihlr-18967	114	64	585	585	NUM
ihlr-18967	114	65	,	,	PUNCT
ihlr-18967	114	66	587	587	NUM
ihlr-18967	114	67	(	(	PUNCT
ihlr-18967	114	68	2003	2003	NUM
ihlr-18967	114	69	)	)	PUNCT
ihlr-18967	114	70	.	.	PUNCT
ihlr-18967	115	1	20	20	NUM
ihlr-18967	115	2	gerald	gerald	PROPN
ihlr-18967	115	3	j.	j.	PROPN
ihlr-18967	115	4	mossinghoff	mossinghoff	PROPN
ihlr-18967	115	5	,	,	PUNCT
ihlr-18967	115	6	overview	overview	NOUN
ihlr-18967	115	7	of	of	ADP
ihlr-18967	115	8	the	the	DET
ihlr-18967	115	9	hatch	hatch	NOUN
ihlr-18967	115	10	-	-	PUNCT
ihlr-18967	115	11	waxman	waxman	PROPN
ihlr-18967	115	12	act	act	NOUN
ihlr-18967	115	13	and	and	CCONJ
ihlr-18967	115	14	its	its	PRON
ihlr-18967	115	15	impact	impact	NOUN
ihlr-18967	115	16	on	on	ADP
ihlr-18967	115	17	the	the	DET
ihlr-18967	115	18	drug	drug	NOUN
ihlr-18967	115	19	development	development	NOUN
ihlr-18967	115	20	process	process	NOUN
ihlr-18967	115	21	,	,	PUNCT
ihlr-18967	115	22	54	54	NUM
ihlr-18967	115	23	food	food	NOUN
ihlr-18967	115	24	&	&	CCONJ
ihlr-18967	115	25	drug	drug	PROPN
ihlr-18967	115	26	l.j	l.j	PROPN
ihlr-18967	115	27	.	.	PROPN
ihlr-18967	115	28	187	187	NUM
ihlr-18967	115	29	,	,	PUNCT
ihlr-18967	115	30	187	187	NUM
ihlr-18967	115	31	(	(	PUNCT
ihlr-18967	115	32	1999	1999	NUM
ihlr-18967	115	33	)	)	PUNCT
ihlr-18967	115	34	.	.	PUNCT
ihlr-18967	116	1	21	21	NUM
ihlr-18967	117	1	i	i	PRON
ihlr-18967	117	2	d.	d.	PROPN
ihlr-18967	117	3	(	(	PUNCT
ihlr-18967	117	4	discussing	discuss	VERB
ihlr-18967	117	5	the	the	DET
ihlr-18967	117	6	thalidomide	thalidomide	ADJ
ihlr-18967	117	7	problem	problem	NOUN
ihlr-18967	117	8	in	in	ADP
ihlr-18967	117	9	infants	infant	NOUN
ihlr-18967	117	10	led	lead	VERB
ihlr-18967	117	11	to	to	ADP
ihlr-18967	117	12	adding	add	VERB
ihlr-18967	117	13	a	a	DET
ihlr-18967	117	14	proof	proof	NOUN
ihlr-18967	117	15	-	-	PUNCT
ihlr-18967	117	16	of	of	ADP
ihlr-18967	117	17	-	-	PUNCT
ihlr-18967	117	18	efficacy	efficacy	NOUN
ihlr-18967	117	19	requirement	requirement	NOUN
ihlr-18967	117	20	)	)	PUNCT
ihlr-18967	117	21	;	;	PUNCT
ihlr-18967	117	22	see	see	VERB
ihlr-18967	117	23	also	also	ADV
ihlr-18967	117	24	russell	russell	PROPN
ihlr-18967	117	25	mokhiber	mokhiber	PROPN
ihlr-18967	117	26	,	,	PUNCT
ihlr-18967	117	27	the	the	DET
ihlr-18967	117	28	tragic	tragic	ADJ
ihlr-18967	117	29	children	child	NOUN
ihlr-18967	117	30	of	of	ADP
ihlr-18967	117	31	thalidomide	thalidomide	NOUN
ihlr-18967	117	32	,	,	PUNCT
ihlr-18967	117	33	8	8	NUM
ihlr-18967	117	34	multinational	multinational	ADJ
ihlr-18967	117	35	monitor	monitor	NOUN
ihlr-18967	117	36	4	4	NUM
ihlr-18967	117	37	,	,	PUNCT
ihlr-18967	117	38	4	4	NUM
ihlr-18967	117	39	(	(	PUNCT
ihlr-18967	117	40	1987	1987	NUM
ihlr-18967	117	41	)	)	PUNCT
ihlr-18967	117	42	(	(	PUNCT
ihlr-18967	117	43	discussing	discuss	VERB
ihlr-18967	117	44	how	how	SCONJ
ihlr-18967	117	45	pregnant	pregnant	ADJ
ihlr-18967	117	46	mothers	mother	NOUN
ihlr-18967	117	47	in	in	ADP
ihlr-18967	117	48	the	the	DET
ihlr-18967	117	49	1950s	1950	NOUN
ihlr-18967	117	50	and	and	CCONJ
ihlr-18967	117	51	early	early	ADJ
ihlr-18967	117	52	1960s	1960	NOUN
ihlr-18967	117	53	took	take	VERB
ihlr-18967	117	54	the	the	DET
ihlr-18967	117	55	drug	drug	NOUN
ihlr-18967	117	56	thalidomide	thalidomide	NOUN
ihlr-18967	117	57	which	which	PRON
ihlr-18967	117	58	caused	cause	VERB
ihlr-18967	117	59	deformities	deformity	NOUN
ihlr-18967	117	60	in	in	ADP
ihlr-18967	117	61	babies	baby	NOUN
ihlr-18967	117	62	)	)	PUNCT
ihlr-18967	117	63	.	.	PUNCT
ihlr-18967	118	1	22	22	NUM
ihlr-18967	118	2	weiswasser	weiswasser	NOUN
ihlr-18967	118	3	&	&	CCONJ
ihlr-18967	118	4	danzis	danzi	NOUN
ihlr-18967	118	5	,	,	PUNCT
ihlr-18967	118	6	supra	supra	PROPN
ihlr-18967	118	7	note	note	NOUN
ihlr-18967	118	8	19	19	NUM
ihlr-18967	118	9	,	,	PUNCT
ihlr-18967	118	10	at	at	ADP
ihlr-18967	118	11	588	588	NUM
ihlr-18967	118	12	.	.	X
ihlr-18967	118	13	23	23	NUM
ihlr-18967	119	1	i	i	PRON
ihlr-18967	119	2	d.	d.	PROPN
ihlr-18967	119	3	(	(	PUNCT
ihlr-18967	119	4	discussing	discuss	VERB
ihlr-18967	119	5	how	how	SCONJ
ihlr-18967	119	6	this	this	DET
ihlr-18967	119	7	process	process	NOUN
ihlr-18967	119	8	only	only	ADV
ihlr-18967	119	9	applied	apply	VERB
ihlr-18967	119	10	to	to	ADP
ihlr-18967	119	11	drugs	drug	NOUN
ihlr-18967	119	12	which	which	PRON
ihlr-18967	119	13	were	be	AUX
ihlr-18967	119	14	approved	approve	VERB
ihlr-18967	119	15	prior	prior	ADV
ihlr-18967	119	16	to	to	ADP
ihlr-18967	119	17	1962	1962	NUM
ihlr-18967	119	18	and	and	CCONJ
ihlr-18967	119	19	reviewed	review	VERB
ihlr-18967	119	20	through	through	ADP
ihlr-18967	119	21	the	the	DET
ihlr-18967	119	22	drug	drug	NOUN
ihlr-18967	119	23	efficacy	efficacy	NOUN
ihlr-18967	119	24	study	study	NOUN
ihlr-18967	119	25	implementation	implementation	NOUN
ihlr-18967	119	26	)	)	PUNCT
ihlr-18967	119	27	.	.	PUNCT
ihlr-18967	120	1	24	24	NUM
ihlr-18967	120	2	see	see	VERB
ihlr-18967	120	3	mossinghoff	mossinghoff	NOUN
ihlr-18967	120	4	,	,	PUNCT
ihlr-18967	120	5	supra	supra	PROPN
ihlr-18967	120	6	note	note	NOUN
ihlr-18967	120	7	20	20	NUM
ihlr-18967	120	8	(	(	PUNCT
ihlr-18967	120	9	discussing	discuss	VERB
ihlr-18967	120	10	how	how	SCONJ
ihlr-18967	120	11	the	the	DET
ihlr-18967	120	12	term	term	NOUN
ihlr-18967	120	13	paper	paper	NOUN
ihlr-18967	120	14	arose	arise	VERB
ihlr-18967	120	15	because	because	SCONJ
ihlr-18967	120	16	only	only	ADV
ihlr-18967	120	17	published	publish	VERB
ihlr-18967	120	18	scientific	scientific	ADJ
ihlr-18967	120	19	or	or	CCONJ
ihlr-18967	120	20	medical	medical	ADJ
ihlr-18967	120	21	literature	literature	NOUN
ihlr-18967	120	22	was	be	AUX
ihlr-18967	120	23	used	use	VERB
ihlr-18967	120	24	to	to	PART
ihlr-18967	120	25	approve	approve	VERB
ihlr-18967	120	26	the	the	DET
ihlr-18967	120	27	nda	nda	NOUN
ihlr-18967	120	28	)	)	PUNCT
ihlr-18967	120	29	.	.	PUNCT
ihlr-18967	121	1	25	25	NUM
ihlr-18967	121	2	weiswasser	weiswasser	NOUN
ihlr-18967	121	3	&	&	CCONJ
ihlr-18967	121	4	danzis	danzi	NOUN
ihlr-18967	121	5	,	,	PUNCT
ihlr-18967	121	6	supra	supra	PROPN
ihlr-18967	121	7	note	note	NOUN
ihlr-18967	121	8	19	19	NUM
ihlr-18967	121	9	,	,	PUNCT
ihlr-18967	121	10	at	at	ADP
ihlr-18967	121	11	589	589	NUM
ihlr-18967	121	12	(	(	PUNCT
ihlr-18967	121	13	explaining	explain	VERB
ihlr-18967	121	14	how	how	SCONJ
ihlr-18967	121	15	drugs	drug	NOUN
ihlr-18967	121	16	were	be	AUX
ihlr-18967	121	17	approved	approve	VERB
ihlr-18967	121	18	based	base	VERB
ihlr-18967	121	19	on	on	ADP
ihlr-18967	121	20	publically	publically	ADV
ihlr-18967	121	21	available	available	ADJ
ihlr-18967	121	22	data	datum	NOUN
ihlr-18967	121	23	declaring	declare	VERB
ihlr-18967	121	24	the	the	DET
ihlr-18967	121	25	drug	drug	NOUN
ihlr-18967	121	26	’s	’s	PART
ihlr-18967	121	27	safety	safety	NOUN
ihlr-18967	121	28	and	and	CCONJ
ihlr-18967	121	29	effectiveness	effectiveness	NOUN
ihlr-18967	121	30	)	)	PUNCT
ihlr-18967	121	31	.	.	PUNCT
ihlr-18967	122	1	26	26	NUM
ihlr-18967	123	1	i	i	PRON
ihlr-18967	123	2	d.	d.	PROPN
ihlr-18967	123	3	430	430	NUM
ihlr-18967	123	4	indiana	indiana	PROPN
ihlr-18967	123	5	health	health	PROPN
ihlr-18967	123	6	law	law	PROPN
ihlr-18967	123	7	review	review	NOUN
ihlr-18967	123	8	vol	vol	NOUN
ihlr-18967	123	9	.	.	PUNCT
ihlr-18967	124	1	12:1	12:1	NUM
ihlr-18967	124	2	effectiveness	effectiveness	NOUN
ihlr-18967	124	3	for	for	ADP
ihlr-18967	124	4	drugs.27	drugs.27	PROPN
ihlr-18967	124	5	this	this	PRON
ihlr-18967	124	6	resulted	result	VERB
ihlr-18967	124	7	in	in	ADP
ihlr-18967	124	8	congressional	congressional	ADJ
ihlr-18967	124	9	testimony	testimony	NOUN
ihlr-18967	124	10	in	in	ADP
ihlr-18967	124	11	1984	1984	NUM
ihlr-18967	124	12	stating	state	VERB
ihlr-18967	124	13	“	"	PUNCT
ihlr-18967	124	14	there	there	PRON
ihlr-18967	124	15	were	be	VERB
ihlr-18967	124	16	150	150	NUM
ihlr-18967	124	17	drugs	drug	NOUN
ihlr-18967	124	18	that	that	PRON
ihlr-18967	124	19	were	be	AUX
ihlr-18967	124	20	off	off	ADP
ihlr-18967	124	21	-	-	PUNCT
ihlr-18967	124	22	patent	patent	NOUN
ihlr-18967	124	23	,	,	PUNCT
ihlr-18967	124	24	but	but	CCONJ
ihlr-18967	124	25	for	for	ADP
ihlr-18967	124	26	which	which	PRON
ihlr-18967	124	27	there	there	PRON
ihlr-18967	124	28	were	be	VERB
ihlr-18967	124	29	no	no	DET
ihlr-18967	124	30	generics	generic	NOUN
ihlr-18967	124	31	because	because	SCONJ
ihlr-18967	124	32	generic	generic	ADJ
ihlr-18967	124	33	companies	company	NOUN
ihlr-18967	124	34	simply	simply	ADV
ihlr-18967	124	35	would	would	AUX
ihlr-18967	124	36	not	not	PART
ihlr-18967	124	37	spend	spend	VERB
ihlr-18967	124	38	the	the	DET
ihlr-18967	124	39	time	time	NOUN
ihlr-18967	124	40	and	and	CCONJ
ihlr-18967	124	41	money	money	NOUN
ihlr-18967	124	42	doing	do	VERB
ihlr-18967	124	43	the	the	DET
ihlr-18967	124	44	clinical	clinical	ADJ
ihlr-18967	124	45	trial[s	trial[s	NOUN
ihlr-18967	124	46	]	]	PUNCT
ihlr-18967	124	47	to	to	PART
ihlr-18967	124	48	get	get	VERB
ihlr-18967	124	49	to	to	ADP
ihlr-18967	124	50	market	market	NOUN
ihlr-18967	124	51	,	,	PUNCT
ihlr-18967	124	52	and	and	CCONJ
ihlr-18967	124	53	that	that	SCONJ
ihlr-18967	124	54	there	there	PRON
ihlr-18967	124	55	were	be	VERB
ihlr-18967	124	56	only	only	ADV
ihlr-18967	124	57	fifteen	fifteen	NUM
ihlr-18967	124	58	‘	'	PUNCT
ihlr-18967	124	59	paper	paper	NOUN
ihlr-18967	124	60	ndas	nda	NOUN
ihlr-18967	124	61	,	,	PUNCT
ihlr-18967	124	62	’	'	PUNCT
ihlr-18967	124	63	for	for	ADP
ihlr-18967	124	64	post-1962	post-1962	NOUN
ihlr-18967	124	65	generics	generic	NOUN
ihlr-18967	124	66	.	.	PUNCT
ihlr-18967	124	67	”28	”28	NOUN
ihlr-18967	124	68	b.	b.	PROPN
ihlr-18967	125	1	the	the	DET
ihlr-18967	125	2	hatch	hatch	PROPN
ihlr-18967	125	3	-	-	PUNCT
ihlr-18967	125	4	waxman	waxman	PROPN
ihlr-18967	125	5	act	act	PROPN
ihlr-18967	125	6	:	:	PUNCT
ihlr-18967	125	7	a	a	DET
ihlr-18967	125	8	compromise	compromise	NOUN
ihlr-18967	125	9	for	for	ADP
ihlr-18967	125	10	pioneer	pioneer	NOUN
ihlr-18967	125	11	and	and	CCONJ
ihlr-18967	125	12	generic	generic	ADJ
ihlr-18967	125	13	manufacturers	manufacturer	NOUN
ihlr-18967	125	14	the	the	DET
ihlr-18967	125	15	drug	drug	NOUN
ihlr-18967	125	16	price	price	NOUN
ihlr-18967	125	17	competition	competition	NOUN
ihlr-18967	125	18	and	and	CCONJ
ihlr-18967	125	19	patent	patent	NOUN
ihlr-18967	125	20	term	term	NOUN
ihlr-18967	125	21	restoration	restoration	NOUN
ihlr-18967	125	22	act	act	NOUN
ihlr-18967	125	23	of	of	ADP
ihlr-18967	125	24	1984	1984	NUM
ihlr-18967	125	25	,	,	PUNCT
ihlr-18967	125	26	commonly	commonly	ADV
ihlr-18967	125	27	known	know	VERB
ihlr-18967	125	28	as	as	ADP
ihlr-18967	125	29	the	the	DET
ihlr-18967	125	30	hatchwaxman	hatchwaxman	PROPN
ihlr-18967	125	31	act	act	PROPN
ihlr-18967	125	32	,	,	PUNCT
ihlr-18967	125	33	was	be	AUX
ihlr-18967	125	34	enacted	enact	VERB
ihlr-18967	125	35	to	to	PART
ihlr-18967	125	36	revise	revise	VERB
ihlr-18967	125	37	the	the	DET
ihlr-18967	125	38	procedures	procedure	NOUN
ihlr-18967	125	39	for	for	ADP
ihlr-18967	125	40	filing	file	VERB
ihlr-18967	125	41	a	a	DET
ihlr-18967	125	42	nda	nda	NOUN
ihlr-18967	125	43	under	under	ADP
ihlr-18967	125	44	the	the	DET
ihlr-18967	125	45	fdca.29	fdca.29	NOUN
ihlr-18967	125	46	the	the	DET
ihlr-18967	125	47	hatch	hatch	NOUN
ihlr-18967	125	48	-	-	PUNCT
ihlr-18967	125	49	waxman	waxman	PROPN
ihlr-18967	125	50	act	act	PROPN
ihlr-18967	125	51	attempts	attempt	VERB
ihlr-18967	125	52	to	to	PART
ihlr-18967	125	53	“	"	PUNCT
ihlr-18967	125	54	strike	strike	VERB
ihlr-18967	125	55	a	a	DET
ihlr-18967	125	56	balance	balance	NOUN
ihlr-18967	125	57	between	between	ADP
ihlr-18967	125	58	two	two	NUM
ihlr-18967	125	59	competing	compete	VERB
ihlr-18967	125	60	policy	policy	NOUN
ihlr-18967	125	61	interests	interest	NOUN
ihlr-18967	125	62	:	:	PUNCT
ihlr-18967	125	63	(	(	PUNCT
ihlr-18967	125	64	1	1	X
ihlr-18967	125	65	)	)	PUNCT
ihlr-18967	125	66	inducing	induce	VERB
ihlr-18967	125	67	pioneering	pioneer	VERB
ihlr-18967	125	68	research	research	NOUN
ihlr-18967	125	69	and	and	CCONJ
ihlr-18967	125	70	development	development	NOUN
ihlr-18967	125	71	of	of	ADP
ihlr-18967	125	72	new	new	ADJ
ihlr-18967	125	73	drugs	drug	NOUN
ihlr-18967	125	74	and	and	CCONJ
ihlr-18967	125	75	(	(	PUNCT
ihlr-18967	125	76	2	2	X
ihlr-18967	125	77	)	)	PUNCT
ihlr-18967	125	78	enabling	enable	VERB
ihlr-18967	125	79	competitors	competitor	NOUN
ihlr-18967	125	80	to	to	PART
ihlr-18967	125	81	bring	bring	VERB
ihlr-18967	125	82	low	low	ADJ
ihlr-18967	125	83	-	-	PUNCT
ihlr-18967	125	84	cost	cost	NOUN
ihlr-18967	125	85	,	,	PUNCT
ihlr-18967	125	86	generic	generic	ADJ
ihlr-18967	125	87	copies	copy	NOUN
ihlr-18967	125	88	of	of	ADP
ihlr-18967	125	89	those	those	DET
ihlr-18967	125	90	drugs	drug	NOUN
ihlr-18967	125	91	to	to	ADP
ihlr-18967	125	92	market	market	NOUN
ihlr-18967	125	93	.	.	PUNCT
ihlr-18967	126	1	”30	”30	VERB
ihlr-18967	126	2	furthermore	furthermore	ADV
ihlr-18967	126	3	,	,	PUNCT
ihlr-18967	126	4	in	in	ADP
ihlr-18967	126	5	bringing	bring	VERB
ihlr-18967	126	6	low	low	ADJ
ihlr-18967	126	7	-	-	PUNCT
ihlr-18967	126	8	cost	cost	NOUN
ihlr-18967	126	9	drugs	drug	NOUN
ihlr-18967	126	10	to	to	ADP
ihlr-18967	126	11	the	the	DET
ihlr-18967	126	12	market	market	NOUN
ihlr-18967	126	13	,	,	PUNCT
ihlr-18967	126	14	it	it	PRON
ihlr-18967	126	15	will	will	AUX
ihlr-18967	126	16	allow	allow	VERB
ihlr-18967	126	17	access	access	NOUN
ihlr-18967	126	18	to	to	ADP
ihlr-18967	126	19	certain	certain	ADJ
ihlr-18967	126	20	drugs	drug	NOUN
ihlr-18967	126	21	for	for	ADP
ihlr-18967	126	22	consumers	consumer	NOUN
ihlr-18967	126	23	who	who	PRON
ihlr-18967	126	24	might	might	AUX
ihlr-18967	126	25	not	not	PART
ihlr-18967	126	26	otherwise	otherwise	ADV
ihlr-18967	126	27	be	be	AUX
ihlr-18967	126	28	able	able	ADJ
ihlr-18967	126	29	to	to	PART
ihlr-18967	126	30	obtain	obtain	VERB
ihlr-18967	126	31	them	they	PRON
ihlr-18967	126	32	.	.	PUNCT
ihlr-18967	127	1	public	public	ADJ
ihlr-18967	127	2	policy	policy	NOUN
ihlr-18967	127	3	support	support	NOUN
ihlr-18967	127	4	for	for	ADP
ihlr-18967	127	5	generic	generic	ADJ
ihlr-18967	127	6	drugs	drug	NOUN
ihlr-18967	127	7	often	often	ADV
ihlr-18967	127	8	conflicts	conflict	VERB
ihlr-18967	127	9	with	with	ADP
ihlr-18967	127	10	patent	patent	NOUN
ihlr-18967	127	11	law	law	NOUN
ihlr-18967	127	12	’s	’s	PART
ihlr-18967	127	13	justifications	justification	NOUN
ihlr-18967	127	14	for	for	ADP
ihlr-18967	127	15	granting	grant	VERB
ihlr-18967	127	16	monopolistic	monopolistic	ADJ
ihlr-18967	127	17	power	power	NOUN
ihlr-18967	127	18	to	to	ADP
ihlr-18967	127	19	the	the	DET
ihlr-18967	127	20	patentee.31	patentee.31	NOUN
ihlr-18967	127	21	in	in	ADP
ihlr-18967	127	22	order	order	NOUN
ihlr-18967	127	23	to	to	PART
ihlr-18967	127	24	induce	induce	VERB
ihlr-18967	127	25	pioneer	pioneer	NOUN
ihlr-18967	127	26	research	research	NOUN
ihlr-18967	127	27	and	and	CCONJ
ihlr-18967	127	28	development	development	NOUN
ihlr-18967	127	29	,	,	PUNCT
ihlr-18967	127	30	congress	congress	PROPN
ihlr-18967	127	31	desired	desire	VERB
ihlr-18967	127	32	for	for	SCONJ
ihlr-18967	127	33	pioneer	pioneer	NOUN
ihlr-18967	127	34	manufacturers	manufacturer	NOUN
ihlr-18967	127	35	to	to	PART
ihlr-18967	127	36	receive	receive	VERB
ihlr-18967	127	37	a	a	DET
ihlr-18967	127	38	patent	patent	NOUN
ihlr-18967	127	39	term	term	NOUN
ihlr-18967	127	40	extension.32	extension.32	VERB
ihlr-18967	127	41	as	as	SCONJ
ihlr-18967	127	42	the	the	DET
ihlr-18967	127	43	house	house	NOUN
ihlr-18967	127	44	reported	report	VERB
ihlr-18967	127	45	in	in	ADP
ihlr-18967	127	46	1984	1984	NUM
ihlr-18967	127	47	,	,	PUNCT
ihlr-18967	127	48	pharmaceutical	pharmaceutical	ADJ
ihlr-18967	127	49	manufacturers	manufacturer	NOUN
ihlr-18967	127	50	27	27	NUM
ihlr-18967	128	1	i	i	PROPN
ihlr-18967	128	2	d.	d.	PROPN
ihlr-18967	128	3	28	28	NUM
ihlr-18967	128	4	mossinghoff	mossinghoff	PROPN
ihlr-18967	128	5	,	,	PUNCT
ihlr-18967	128	6	supra	supra	PROPN
ihlr-18967	128	7	note	note	NOUN
ihlr-18967	128	8	20	20	NUM
ihlr-18967	128	9	(	(	PUNCT
ihlr-18967	128	10	citing	cite	VERB
ihlr-18967	128	11	h.r	h.r	PROPN
ihlr-18967	128	12	.	.	PROPN
ihlr-18967	128	13	rep	rep	PROPN
ihlr-18967	128	14	.	.	PROPN
ihlr-18967	129	1	no	no	INTJ
ihlr-18967	129	2	.	.	NOUN
ihlr-18967	130	1	98	98	NUM
ihlr-18967	130	2	-	-	SYM
ihlr-18967	130	3	857	857	NUM
ihlr-18967	130	4	,	,	PUNCT
ihlr-18967	130	5	pt	pt	X
ihlr-18967	130	6	.	.	PROPN
ihlr-18967	130	7	1	1	NUM
ihlr-18967	130	8	(	(	PUNCT
ihlr-18967	130	9	1984	1984	NUM
ihlr-18967	130	10	)	)	PUNCT
ihlr-18967	130	11	.	.	PUNCT
ihlr-18967	131	1	29	29	NUM
ihlr-18967	131	2	drug	drug	NOUN
ihlr-18967	131	3	price	price	NOUN
ihlr-18967	131	4	competition	competition	NOUN
ihlr-18967	131	5	and	and	CCONJ
ihlr-18967	131	6	patent	patent	NOUN
ihlr-18967	131	7	term	term	NOUN
ihlr-18967	131	8	restoration	restoration	NOUN
ihlr-18967	131	9	act	act	NOUN
ihlr-18967	131	10	of	of	ADP
ihlr-18967	131	11	1984	1984	NUM
ihlr-18967	131	12	,	,	PUNCT
ihlr-18967	131	13	pub	pub	NOUN
ihlr-18967	131	14	.	.	PUNCT
ihlr-18967	132	1	l.	l.	PROPN
ihlr-18967	132	2	no	no	INTJ
ihlr-18967	132	3	.	.	PROPN
ihlr-18967	133	1	98	98	NUM
ihlr-18967	133	2	-	-	SYM
ihlr-18967	133	3	417	417	NUM
ihlr-18967	133	4	,	,	PUNCT
ihlr-18967	133	5	98	98	NUM
ihlr-18967	133	6	stat	stat	NOUN
ihlr-18967	133	7	.	.	PUNCT
ihlr-18967	134	1	1585	1585	NUM
ihlr-18967	134	2	(	(	PUNCT
ihlr-18967	134	3	1984	1984	NUM
ihlr-18967	134	4	)	)	PUNCT
ihlr-18967	134	5	.	.	PUNCT
ihlr-18967	135	1	30	30	NUM
ihlr-18967	135	2	caraco	caraco	PROPN
ihlr-18967	135	3	pharm	pharm	NOUN
ihlr-18967	135	4	.	.	PUNCT
ihlr-18967	136	1	labs	labs	PROPN
ihlr-18967	136	2	.	.	PUNCT
ihlr-18967	136	3	,	,	PUNCT
ihlr-18967	136	4	ltd	ltd	PROPN
ihlr-18967	136	5	.	.	PROPN
ihlr-18967	136	6	v.	v.	ADP
ihlr-18967	136	7	forest	forest	PROPN
ihlr-18967	136	8	labs	labs	PROPN
ihlr-18967	136	9	.	.	PUNCT
ihlr-18967	136	10	,	,	PUNCT
ihlr-18967	136	11	inc	inc	PROPN
ihlr-18967	136	12	.	.	PROPN
ihlr-18967	136	13	527	527	NUM
ihlr-18967	136	14	f.3d	f.3d	NUM
ihlr-18967	136	15	1278	1278	NUM
ihlr-18967	136	16	,	,	PUNCT
ihlr-18967	136	17	1282	1282	NUM
ihlr-18967	136	18	(	(	PUNCT
ihlr-18967	136	19	fed	fed	PROPN
ihlr-18967	136	20	.	.	PUNCT
ihlr-18967	136	21	cir	cir	PROPN
ihlr-18967	136	22	.	.	PROPN
ihlr-18967	136	23	2008	2008	NUM
ihlr-18967	136	24	)	)	PUNCT
ihlr-18967	137	1	(	(	PUNCT
ihlr-18967	137	2	quoting	quote	VERB
ihlr-18967	137	3	andrx	andrx	NOUN
ihlr-18967	137	4	pharms	pharm	NOUN
ihlr-18967	137	5	.	.	PUNCT
ihlr-18967	137	6	,	,	PUNCT
ihlr-18967	137	7	inc	inc	PROPN
ihlr-18967	137	8	.	.	PROPN
ihlr-18967	137	9	v.	v.	PROPN
ihlr-18967	137	10	biovail	biovail	PROPN
ihlr-18967	137	11	corp	corp	PROPN
ihlr-18967	137	12	.	.	PROPN
ihlr-18967	137	13	,	,	PUNCT
ihlr-18967	137	14	276	276	NUM
ihlr-18967	137	15	f.3d	f.3d	NUM
ihlr-18967	137	16	1368	1368	NUM
ihlr-18967	137	17	,	,	PUNCT
ihlr-18967	137	18	1371	1371	NUM
ihlr-18967	138	1	(	(	PUNCT
ihlr-18967	138	2	fed	fed	PROPN
ihlr-18967	138	3	.	.	PUNCT
ihlr-18967	138	4	cir	cir	PROPN
ihlr-18967	138	5	.	.	PROPN
ihlr-18967	138	6	2002	2002	NUM
ihlr-18967	138	7	)	)	PUNCT
ihlr-18967	138	8	)	)	PUNCT
ihlr-18967	138	9	.	.	PUNCT
ihlr-18967	139	1	31	31	NUM
ihlr-18967	139	2	eisenberg	eisenberg	PROPN
ihlr-18967	139	3	,	,	PUNCT
ihlr-18967	139	4	supra	supra	PROPN
ihlr-18967	139	5	note	note	PROPN
ihlr-18967	139	6	11	11	NUM
ihlr-18967	139	7	.	.	PUNCT
ihlr-18967	140	1	generally	generally	ADV
ihlr-18967	140	2	,	,	PUNCT
ihlr-18967	140	3	public	public	ADJ
ihlr-18967	140	4	policy	policy	NOUN
ihlr-18967	140	5	in	in	ADP
ihlr-18967	140	6	favor	favor	NOUN
ihlr-18967	140	7	of	of	ADP
ihlr-18967	140	8	bringing	bring	VERB
ihlr-18967	140	9	lower	low	ADJ
ihlr-18967	140	10	cost	cost	NOUN
ihlr-18967	140	11	drugs	drug	NOUN
ihlr-18967	140	12	in	in	ADP
ihlr-18967	140	13	a	a	DET
ihlr-18967	140	14	more	more	ADV
ihlr-18967	140	15	timely	timely	ADJ
ihlr-18967	140	16	fashion	fashion	NOUN
ihlr-18967	140	17	to	to	ADP
ihlr-18967	140	18	market	market	NOUN
ihlr-18967	140	19	is	be	AUX
ihlr-18967	140	20	the	the	DET
ihlr-18967	140	21	hallmark	hallmark	NOUN
ihlr-18967	140	22	behind	behind	ADP
ihlr-18967	140	23	generic	generic	ADJ
ihlr-18967	140	24	drugs	drug	NOUN
ihlr-18967	140	25	.	.	PUNCT
ihlr-18967	141	1	i	i	PRON
ihlr-18967	141	2	d.	d.	PROPN
ihlr-18967	141	3	meanwhile	meanwhile	ADV
ihlr-18967	141	4	,	,	PUNCT
ihlr-18967	141	5	the	the	DET
ihlr-18967	141	6	justification	justification	NOUN
ihlr-18967	141	7	for	for	ADP
ihlr-18967	141	8	a	a	DET
ihlr-18967	141	9	monopoly	monopoly	NOUN
ihlr-18967	141	10	created	create	VERB
ihlr-18967	141	11	by	by	ADP
ihlr-18967	141	12	a	a	DET
ihlr-18967	141	13	patent	patent	NOUN
ihlr-18967	141	14	can	can	AUX
ihlr-18967	141	15	be	be	AUX
ihlr-18967	141	16	seen	see	VERB
ihlr-18967	141	17	as	as	ADP
ihlr-18967	141	18	an	an	DET
ihlr-18967	141	19	“	"	PUNCT
ihlr-18967	141	20	incentive	incentive	NOUN
ihlr-18967	141	21	to	to	PART
ihlr-18967	141	22	invent	invent	VERB
ihlr-18967	141	23	,	,	PUNCT
ihlr-18967	141	24	”	"	PUNCT
ihlr-18967	141	25	“	"	PUNCT
ihlr-18967	141	26	incentive	incentive	NOUN
ihlr-18967	141	27	to	to	PART
ihlr-18967	141	28	disclose	disclose	VERB
ihlr-18967	141	29	,	,	PUNCT
ihlr-18967	141	30	”	"	PUNCT
ihlr-18967	141	31	and	and	CCONJ
ihlr-18967	141	32	an	an	DET
ihlr-18967	141	33	incentive	incentive	NOUN
ihlr-18967	141	34	to	to	PART
ihlr-18967	141	35	“	"	PUNCT
ihlr-18967	141	36	invest	invest	VERB
ihlr-18967	141	37	in	in	ADP
ihlr-18967	141	38	innovation	innovation	NOUN
ihlr-18967	141	39	.	.	PUNCT
ihlr-18967	141	40	”	"	PUNCT
ihlr-18967	142	1	i	i	PRON
ihlr-18967	142	2	d.	d.	PROPN
ihlr-18967	142	3	32	32	NUM
ihlr-18967	143	1	h.r	h.r	PROPN
ihlr-18967	143	2	.	.	PROPN
ihlr-18967	143	3	rep	rep	PROPN
ihlr-18967	143	4	.	.	PROPN
ihlr-18967	143	5	no	no	INTJ
ihlr-18967	143	6	.	.	NOUN
ihlr-18967	144	1	98	98	NUM
ihlr-18967	144	2	-	-	SYM
ihlr-18967	144	3	857	857	NUM
ihlr-18967	144	4	,	,	PUNCT
ihlr-18967	144	5	at	at	ADP
ihlr-18967	144	6	15	15	NUM
ihlr-18967	144	7	(	(	PUNCT
ihlr-18967	144	8	1984	1984	NUM
ihlr-18967	144	9	)	)	PUNCT
ihlr-18967	144	10	.	.	PUNCT
ihlr-18967	145	1	2015	2015	NUM
ihlr-18967	145	2	rationale	rationale	NOUN
ihlr-18967	145	3	behind	behind	ADP
ihlr-18967	145	4	hatch	hatch	NOUN
ihlr-18967	145	5	-	-	PUNCT
ihlr-18967	145	6	waxman	waxman	PROPN
ihlr-18967	145	7	act	act	PROPN
ihlr-18967	145	8	and	and	CCONJ
ihlr-18967	145	9	patent	patent	NOUN
ihlr-18967	145	10	law	law	NOUN
ihlr-18967	145	11	431	431	NUM
ihlr-18967	145	12	testified	testify	VERB
ihlr-18967	145	13	that	that	SCONJ
ihlr-18967	145	14	“	"	PUNCT
ihlr-18967	145	15	the	the	DET
ihlr-18967	145	16	average	average	ADJ
ihlr-18967	145	17	effective	effective	ADJ
ihlr-18967	145	18	patent	patent	NOUN
ihlr-18967	145	19	term	term	NOUN
ihlr-18967	145	20	of	of	ADP
ihlr-18967	145	21	drugs	drug	NOUN
ihlr-18967	145	22	has	have	VERB
ihlr-18967	145	23	declined”33	declined”33	PROPN
ihlr-18967	145	24	as	as	ADP
ihlr-18967	145	25	a	a	DET
ihlr-18967	145	26	result	result	NOUN
ihlr-18967	145	27	of	of	ADP
ihlr-18967	145	28	government	government	NOUN
ihlr-18967	145	29	review.34	review.34	PROPN
ihlr-18967	145	30	congress	congress	PROPN
ihlr-18967	145	31	attempted	attempt	VERB
ihlr-18967	145	32	to	to	PART
ihlr-18967	145	33	return	return	VERB
ihlr-18967	145	34	this	this	DET
ihlr-18967	145	35	lost	lose	VERB
ihlr-18967	145	36	time	time	NOUN
ihlr-18967	145	37	through	through	ADP
ihlr-18967	145	38	a	a	DET
ihlr-18967	145	39	“	"	PUNCT
ihlr-18967	145	40	restoration	restoration	NOUN
ihlr-18967	145	41	of	of	ADP
ihlr-18967	145	42	some	some	PRON
ihlr-18967	145	43	of	of	ADP
ihlr-18967	145	44	the	the	DET
ihlr-18967	145	45	time	time	NOUN
ihlr-18967	145	46	lost	lose	VERB
ihlr-18967	145	47	on	on	ADP
ihlr-18967	145	48	patent	patent	NOUN
ihlr-18967	145	49	life	life	NOUN
ihlr-18967	145	50	while	while	SCONJ
ihlr-18967	145	51	the	the	DET
ihlr-18967	145	52	product	product	NOUN
ihlr-18967	145	53	is	be	AUX
ihlr-18967	145	54	awaiting	await	VERB
ihlr-18967	145	55	pre	pre	ADJ
ihlr-18967	145	56	-	-	ADJ
ihlr-18967	145	57	market	market	ADJ
ihlr-18967	145	58	approval	approval	NOUN
ihlr-18967	145	59	.	.	PUNCT
ihlr-18967	146	1	”35	”35	NOUN
ihlr-18967	146	2	this	this	DET
ihlr-18967	146	3	restored	restore	VERB
ihlr-18967	146	4	patent	patent	NOUN
ihlr-18967	146	5	life	life	NOUN
ihlr-18967	146	6	is	be	AUX
ihlr-18967	146	7	“	"	PUNCT
ihlr-18967	146	8	equal	equal	ADJ
ihlr-18967	146	9	to	to	ADP
ihlr-18967	146	10	the	the	DET
ihlr-18967	146	11	regulatory	regulatory	ADJ
ihlr-18967	146	12	review	review	NOUN
ihlr-18967	146	13	period	period	NOUN
ihlr-18967	146	14	for	for	ADP
ihlr-18967	146	15	the	the	DET
ihlr-18967	146	16	approved	approve	VERB
ihlr-18967	146	17	product	product	NOUN
ihlr-18967	146	18	which	which	DET
ihlr-18967	146	19	period	period	NOUN
ihlr-18967	146	20	occurs	occur	VERB
ihlr-18967	146	21	after	after	ADP
ihlr-18967	146	22	the	the	DET
ihlr-18967	146	23	date	date	NOUN
ihlr-18967	146	24	the	the	DET
ihlr-18967	146	25	patent	patent	NOUN
ihlr-18967	146	26	is	be	AUX
ihlr-18967	146	27	issued	issue	VERB
ihlr-18967	146	28	.	.	PUNCT
ihlr-18967	147	1	”36	”36	VERB
ihlr-18967	147	2	this	this	DET
ihlr-18967	147	3	period	period	NOUN
ihlr-18967	147	4	is	be	AUX
ihlr-18967	147	5	subject	subject	ADJ
ihlr-18967	147	6	to	to	ADP
ihlr-18967	147	7	a	a	DET
ihlr-18967	147	8	number	number	NOUN
ihlr-18967	147	9	of	of	ADP
ihlr-18967	147	10	limitations	limitation	NOUN
ihlr-18967	147	11	,	,	PUNCT
ihlr-18967	147	12	but	but	CCONJ
ihlr-18967	147	13	as	as	ADP
ihlr-18967	147	14	a	a	DET
ihlr-18967	147	15	general	general	ADJ
ihlr-18967	147	16	matter	matter	NOUN
ihlr-18967	147	17	is	be	AUX
ihlr-18967	147	18	one	one	NUM
ihlr-18967	147	19	-	-	PUNCT
ihlr-18967	147	20	half	half	NOUN
ihlr-18967	147	21	the	the	DET
ihlr-18967	147	22	length	length	NOUN
ihlr-18967	147	23	of	of	ADP
ihlr-18967	147	24	time	time	NOUN
ihlr-18967	147	25	between	between	ADP
ihlr-18967	147	26	the	the	DET
ihlr-18967	147	27	effective	effective	ADJ
ihlr-18967	147	28	date	date	NOUN
ihlr-18967	147	29	of	of	ADP
ihlr-18967	147	30	the	the	DET
ihlr-18967	147	31	investigational	investigational	ADJ
ihlr-18967	147	32	new	new	ADJ
ihlr-18967	147	33	drug	drug	NOUN
ihlr-18967	147	34	application	application	NOUN
ihlr-18967	147	35	(	(	PUNCT
ihlr-18967	147	36	ind)–an	ind)–an	ADJ
ihlr-18967	147	37	application	application	NOUN
ihlr-18967	147	38	allowing	allow	VERB
ihlr-18967	147	39	a	a	DET
ihlr-18967	147	40	drug	drug	NOUN
ihlr-18967	147	41	sponsor	sponsor	NOUN
ihlr-18967	147	42	to	to	PART
ihlr-18967	147	43	advance	advance	VERB
ihlr-18967	147	44	from	from	ADP
ihlr-18967	147	45	preclinical	preclinical	ADJ
ihlr-18967	147	46	to	to	ADP
ihlr-18967	147	47	clinical	clinical	ADJ
ihlr-18967	147	48	trials	trial	NOUN
ihlr-18967	147	49	–	–	PUNCT
ihlr-18967	147	50	and	and	CCONJ
ihlr-18967	147	51	submission	submission	NOUN
ihlr-18967	147	52	of	of	ADP
ihlr-18967	147	53	the	the	DET
ihlr-18967	147	54	nda	nda	NOUN
ihlr-18967	147	55	,	,	PUNCT
ihlr-18967	147	56	plus	plus	CCONJ
ihlr-18967	147	57	the	the	DET
ihlr-18967	147	58	length	length	NOUN
ihlr-18967	147	59	of	of	ADP
ihlr-18967	147	60	time	time	NOUN
ihlr-18967	147	61	between	between	ADP
ihlr-18967	147	62	filing	filing	NOUN
ihlr-18967	147	63	and	and	CCONJ
ihlr-18967	147	64	approval	approval	NOUN
ihlr-18967	147	65	of	of	ADP
ihlr-18967	147	66	the	the	DET
ihlr-18967	147	67	nda	nda	PROPN
ihlr-18967	147	68	,	,	PUNCT
ihlr-18967	147	69	up	up	ADP
ihlr-18967	147	70	to	to	ADP
ihlr-18967	147	71	a	a	DET
ihlr-18967	147	72	total	total	NOUN
ihlr-18967	147	73	of	of	ADP
ihlr-18967	147	74	five	five	NUM
ihlr-18967	147	75	years.37	years.37	NOUN
ihlr-18967	147	76	lastly	lastly	ADV
ihlr-18967	147	77	,	,	PUNCT
ihlr-18967	147	78	the	the	DET
ihlr-18967	147	79	term	term	NOUN
ihlr-18967	147	80	of	of	ADP
ihlr-18967	147	81	the	the	DET
ihlr-18967	147	82	patent	patent	NOUN
ihlr-18967	147	83	after	after	ADP
ihlr-18967	147	84	the	the	DET
ihlr-18967	147	85	date	date	NOUN
ihlr-18967	147	86	of	of	ADP
ihlr-18967	147	87	approval	approval	NOUN
ihlr-18967	147	88	plus	plus	CCONJ
ihlr-18967	147	89	the	the	DET
ihlr-18967	147	90	period	period	NOUN
ihlr-18967	147	91	of	of	ADP
ihlr-18967	147	92	extension	extension	NOUN
ihlr-18967	147	93	will	will	AUX
ihlr-18967	147	94	be	be	AUX
ihlr-18967	147	95	adjusted	adjust	VERB
ihlr-18967	147	96	so	so	SCONJ
ihlr-18967	147	97	it	it	PRON
ihlr-18967	147	98	does	do	AUX
ihlr-18967	147	99	not	not	PART
ihlr-18967	147	100	exceed	exceed	VERB
ihlr-18967	147	101	fourteen	fourteen	NUM
ihlr-18967	147	102	years	year	NOUN
ihlr-18967	147	103	from	from	ADP
ihlr-18967	147	104	the	the	DET
ihlr-18967	147	105	date	date	NOUN
ihlr-18967	147	106	of	of	ADP
ihlr-18967	147	107	approval.38	approval.38	NOUN
ihlr-18967	147	108	these	these	DET
ihlr-18967	147	109	adjustments	adjustment	NOUN
ihlr-18967	147	110	satisfy	satisfy	VERB
ihlr-18967	147	111	congress	congress	PROPN
ihlr-18967	147	112	’	'	PUNCT
ihlr-18967	147	113	intent	intent	NOUN
ihlr-18967	147	114	to	to	PART
ihlr-18967	147	115	return	return	VERB
ihlr-18967	147	116	lost	lose	VERB
ihlr-18967	147	117	time	time	NOUN
ihlr-18967	147	118	while	while	SCONJ
ihlr-18967	147	119	the	the	DET
ihlr-18967	147	120	drug	drug	NOUN
ihlr-18967	147	121	is	be	AUX
ihlr-18967	147	122	being	be	AUX
ihlr-18967	147	123	approved	approve	VERB
ihlr-18967	147	124	.	.	PUNCT
ihlr-18967	148	1	in	in	ADP
ihlr-18967	148	2	order	order	NOUN
ihlr-18967	148	3	to	to	PART
ihlr-18967	148	4	improve	improve	VERB
ihlr-18967	148	5	the	the	DET
ihlr-18967	148	6	amount	amount	NOUN
ihlr-18967	148	7	of	of	ADP
ihlr-18967	148	8	generic	generic	ADJ
ihlr-18967	148	9	equivalents	equivalent	NOUN
ihlr-18967	148	10	on	on	ADP
ihlr-18967	148	11	the	the	DET
ihlr-18967	148	12	market	market	NOUN
ihlr-18967	148	13	,	,	PUNCT
ihlr-18967	148	14	the	the	DET
ihlr-18967	148	15	act	act	NOUN
ihlr-18967	148	16	“	"	PUNCT
ihlr-18967	148	17	relax[es	relax[es	PROPN
ihlr-18967	148	18	]	]	PUNCT
ihlr-18967	148	19	the	the	DET
ihlr-18967	148	20	testing	testing	NOUN
ihlr-18967	148	21	requirements	requirement	NOUN
ihlr-18967	148	22	imposed	impose	VERB
ihlr-18967	148	23	on	on	ADP
ihlr-18967	148	24	generic	generic	ADJ
ihlr-18967	148	25	manufacturers	manufacturer	NOUN
ihlr-18967	148	26	and	and	CCONJ
ihlr-18967	148	27	allow[s	allow[s	PROPN
ihlr-18967	148	28	]	]	PUNCT
ihlr-18967	148	29	them	they	PRON
ihlr-18967	148	30	to	to	PART
ihlr-18967	148	31	piggyback	piggyback	VERB
ihlr-18967	148	32	on	on	ADP
ihlr-18967	148	33	data	datum	NOUN
ihlr-18967	148	34	developed	develop	VERB
ihlr-18967	148	35	by	by	ADP
ihlr-18967	148	36	the	the	DET
ihlr-18967	148	37	pioneer	pioneer	NOUN
ihlr-18967	149	1	[	[	X
ihlr-18967	149	2	manufacturer].”39	manufacturer].”39	VERB
ihlr-18967	149	3	specifically	specifically	ADV
ihlr-18967	149	4	,	,	PUNCT
ihlr-18967	149	5	the	the	DET
ihlr-18967	149	6	new	new	ADJ
ihlr-18967	149	7	procedure	procedure	NOUN
ihlr-18967	149	8	for	for	ADP
ihlr-18967	149	9	an	an	DET
ihlr-18967	149	10	anda	anda	PROPN
ihlr-18967	149	11	allows	allow	VERB
ihlr-18967	149	12	“	"	PUNCT
ihlr-18967	149	13	generic	generic	ADJ
ihlr-18967	149	14	copies	copy	NOUN
ihlr-18967	149	15	of	of	ADP
ihlr-18967	149	16	any	any	DET
ihlr-18967	149	17	drugs	drug	NOUN
ihlr-18967	149	18	[	[	X
ihlr-18967	149	19	to	to	PART
ihlr-18967	149	20	]	]	PUNCT
ihlr-18967	149	21	be	be	AUX
ihlr-18967	149	22	approved	approve	VERB
ihlr-18967	149	23	if	if	SCONJ
ihlr-18967	149	24	the	the	DET
ihlr-18967	149	25	generic	generic	ADJ
ihlr-18967	149	26	is	be	AUX
ihlr-18967	149	27	the	the	DET
ihlr-18967	149	28	same	same	ADJ
ihlr-18967	149	29	as	as	ADP
ihlr-18967	149	30	the	the	DET
ihlr-18967	149	31	original	original	ADJ
ihlr-18967	149	32	drug	drug	NOUN
ihlr-18967	149	33	or	or	CCONJ
ihlr-18967	149	34	so	so	ADV
ihlr-18967	149	35	similar	similar	ADJ
ihlr-18967	149	36	33	33	NUM
ihlr-18967	149	37	i	i	PROPN
ihlr-18967	149	38	d.	d.	NOUN
ihlr-18967	149	39	at	at	ADP
ihlr-18967	149	40	17	17	NUM
ihlr-18967	149	41	-	-	SYM
ihlr-18967	149	42	18	18	NUM
ihlr-18967	149	43	34	34	NUM
ihlr-18967	149	44	fact	fact	NOUN
ihlr-18967	149	45	sheet	sheet	NOUN
ihlr-18967	149	46	:	:	PUNCT
ihlr-18967	149	47	new	new	ADJ
ihlr-18967	149	48	drug	drug	NOUN
ihlr-18967	149	49	development	development	NOUN
ihlr-18967	149	50	process	process	NOUN
ihlr-18967	149	51	,	,	PUNCT
ihlr-18967	149	52	cal	cal	PROPN
ihlr-18967	149	53	.	.	PUNCT
ihlr-18967	150	1	biomedical	biomedical	ADJ
ihlr-18967	150	2	res	re	NOUN
ihlr-18967	150	3	.	.	PUNCT
ihlr-18967	151	1	ass’n	ass’n	PROPN
ihlr-18967	151	2	,	,	PUNCT
ihlr-18967	151	3	http://ca-biomed.org/pdf/media-kit/fact-sheets/	http://ca-biomed.org/pdf/media-kit/fact-sheets/	PROPN
ihlr-18967	151	4	cbradrugdevelop.pdf	cbradrugdevelop.pdf	PROPN
ihlr-18967	151	5	(	(	PUNCT
ihlr-18967	151	6	last	last	ADV
ihlr-18967	151	7	visited	visit	VERB
ihlr-18967	151	8	sept	sept	PROPN
ihlr-18967	151	9	.	.	PROPN
ihlr-18967	151	10	8	8	NUM
ihlr-18967	151	11	,	,	PUNCT
ihlr-18967	151	12	2014	2014	NUM
ihlr-18967	151	13	)	)	PUNCT
ihlr-18967	151	14	.	.	PUNCT
ihlr-18967	152	1	patent	patent	NOUN
ihlr-18967	152	2	terms	term	NOUN
ihlr-18967	152	3	are	be	AUX
ihlr-18967	152	4	for	for	ADP
ihlr-18967	152	5	twenty	twenty	NUM
ihlr-18967	152	6	years	year	NOUN
ihlr-18967	152	7	beginning	begin	VERB
ihlr-18967	152	8	on	on	ADP
ihlr-18967	152	9	the	the	DET
ihlr-18967	152	10	date	date	NOUN
ihlr-18967	152	11	the	the	DET
ihlr-18967	152	12	patent	patent	NOUN
ihlr-18967	152	13	is	be	AUX
ihlr-18967	152	14	issued	issue	VERB
ihlr-18967	152	15	.	.	PUNCT
ihlr-18967	153	1	35	35	NUM
ihlr-18967	153	2	u.s.c	u.s.c	NOUN
ihlr-18967	153	3	.	.	PUNCT
ihlr-18967	154	1	§	§	NOUN
ihlr-18967	154	2	154(a)(2	154(a)(2	NOUN
ihlr-18967	154	3	)	)	PUNCT
ihlr-18967	154	4	.	.	PUNCT
ihlr-18967	155	1	i	i	PRON
ihlr-18967	155	2	d.	d.	PROPN
ihlr-18967	155	3	however	however	ADV
ihlr-18967	155	4	,	,	PUNCT
ihlr-18967	155	5	the	the	DET
ihlr-18967	155	6	effective	effective	ADJ
ihlr-18967	155	7	patent	patent	NOUN
ihlr-18967	155	8	term	term	NOUN
ihlr-18967	155	9	must	must	AUX
ihlr-18967	155	10	be	be	AUX
ihlr-18967	155	11	viewed	view	VERB
ihlr-18967	155	12	based	base	VERB
ihlr-18967	155	13	on	on	ADP
ihlr-18967	155	14	the	the	DET
ihlr-18967	155	15	time	time	NOUN
ihlr-18967	155	16	in	in	ADP
ihlr-18967	155	17	which	which	PRON
ihlr-18967	155	18	a	a	DET
ihlr-18967	155	19	drug	drug	NOUN
ihlr-18967	155	20	is	be	AUX
ihlr-18967	155	21	available	available	ADJ
ihlr-18967	155	22	for	for	ADP
ihlr-18967	155	23	purchase	purchase	NOUN
ihlr-18967	155	24	by	by	ADP
ihlr-18967	155	25	consumers	consumer	NOUN
ihlr-18967	155	26	.	.	PUNCT
ihlr-18967	156	1	i	i	PRON
ihlr-18967	156	2	d.	d.	PROPN
ihlr-18967	156	3	on	on	ADP
ihlr-18967	156	4	average	average	ADJ
ihlr-18967	156	5	,	,	PUNCT
ihlr-18967	156	6	it	it	PRON
ihlr-18967	156	7	takes	take	VERB
ihlr-18967	156	8	“	"	PUNCT
ihlr-18967	156	9	12	12	NUM
ihlr-18967	156	10	years	year	NOUN
ihlr-18967	156	11	for	for	SCONJ
ihlr-18967	156	12	a	a	DET
ihlr-18967	156	13	drug	drug	NOUN
ihlr-18967	156	14	to	to	PART
ihlr-18967	156	15	travel	travel	VERB
ihlr-18967	156	16	from	from	ADP
ihlr-18967	156	17	the	the	DET
ihlr-18967	156	18	research	research	NOUN
ihlr-18967	156	19	lab	lab	NOUN
ihlr-18967	156	20	to	to	ADP
ihlr-18967	156	21	the	the	DET
ihlr-18967	156	22	[	[	X
ihlr-18967	156	23	consumer	consumer	NOUN
ihlr-18967	156	24	]	]	X
ihlr-18967	156	25	.	.	PUNCT
ihlr-18967	156	26	”	"	PUNCT
ihlr-18967	157	1	i	i	PRON
ihlr-18967	157	2	d.	d.	PROPN
ihlr-18967	157	3	subsequently	subsequently	ADV
ihlr-18967	157	4	,	,	PUNCT
ihlr-18967	157	5	on	on	ADP
ihlr-18967	157	6	average	average	ADJ
ihlr-18967	157	7	,	,	PUNCT
ihlr-18967	157	8	a	a	DET
ihlr-18967	157	9	new	new	ADJ
ihlr-18967	157	10	drug	drug	NOUN
ihlr-18967	157	11	only	only	ADV
ihlr-18967	157	12	has	have	VERB
ihlr-18967	157	13	an	an	DET
ihlr-18967	157	14	effective	effective	ADJ
ihlr-18967	157	15	patent	patent	NOUN
ihlr-18967	157	16	term	term	NOUN
ihlr-18967	157	17	of	of	ADP
ihlr-18967	157	18	8	8	NUM
ihlr-18967	157	19	years	year	NOUN
ihlr-18967	157	20	.	.	PUNCT
ihlr-18967	158	1	35	35	NUM
ihlr-18967	158	2	h.r	h.r	PROPN
ihlr-18967	158	3	.	.	PROPN
ihlr-18967	158	4	rep	rep	PROPN
ihlr-18967	158	5	.	.	PROPN
ihlr-18967	158	6	no	no	INTJ
ihlr-18967	158	7	.	.	NOUN
ihlr-18967	159	1	98	98	NUM
ihlr-18967	159	2	-	-	SYM
ihlr-18967	159	3	857	857	NUM
ihlr-18967	159	4	,	,	PUNCT
ihlr-18967	159	5	at	at	ADP
ihlr-18967	159	6	15	15	NUM
ihlr-18967	159	7	(	(	PUNCT
ihlr-18967	159	8	1984	1984	NUM
ihlr-18967	159	9	)	)	PUNCT
ihlr-18967	159	10	.	.	PUNCT
ihlr-18967	160	1	36	36	NUM
ihlr-18967	160	2	35	35	NUM
ihlr-18967	160	3	u.s.c	u.s.c	NOUN
ihlr-18967	160	4	.	.	PUNCT
ihlr-18967	161	1	§	§	NOUN
ihlr-18967	161	2	156(c	156(c	NOUN
ihlr-18967	161	3	)	)	PUNCT
ihlr-18967	161	4	(	(	PUNCT
ihlr-18967	161	5	2015	2015	NUM
ihlr-18967	161	6	)	)	PUNCT
ihlr-18967	161	7	.	.	PUNCT
ihlr-18967	162	1	37	37	NUM
ihlr-18967	162	2	weiswasser	weiswasser	NOUN
ihlr-18967	162	3	&	&	CCONJ
ihlr-18967	162	4	danzis	danzi	NOUN
ihlr-18967	162	5	,	,	PUNCT
ihlr-18967	162	6	supra	supra	PROPN
ihlr-18967	162	7	note	note	NOUN
ihlr-18967	162	8	19	19	NUM
ihlr-18967	162	9	,	,	PUNCT
ihlr-18967	162	10	at	at	ADP
ihlr-18967	162	11	591	591	NUM
ihlr-18967	162	12	.	.	PUNCT
ihlr-18967	163	1	38	38	NUM
ihlr-18967	163	2	35	35	NUM
ihlr-18967	163	3	u.s.c	u.s.c	NOUN
ihlr-18967	163	4	.	.	PUNCT
ihlr-18967	164	1	§	§	NOUN
ihlr-18967	164	2	156(c)(3	156(c)(3	NOUN
ihlr-18967	164	3	)	)	PUNCT
ihlr-18967	164	4	(	(	PUNCT
ihlr-18967	164	5	2015	2015	NUM
ihlr-18967	164	6	)	)	PUNCT
ihlr-18967	164	7	.	.	PUNCT
ihlr-18967	165	1	39	39	NUM
ihlr-18967	165	2	weiswasser	weiswasser	NOUN
ihlr-18967	165	3	&	&	CCONJ
ihlr-18967	165	4	danzis	danzi	NOUN
ihlr-18967	165	5	,	,	PUNCT
ihlr-18967	165	6	supra	supra	PROPN
ihlr-18967	165	7	note	note	NOUN
ihlr-18967	165	8	19	19	NUM
ihlr-18967	165	9	,	,	PUNCT
ihlr-18967	165	10	at	at	ADP
ihlr-18967	165	11	590	590	NUM
ihlr-18967	165	12	.	.	PUNCT
ihlr-18967	166	1	432	432	NUM
ihlr-18967	166	2	indiana	indiana	PROPN
ihlr-18967	166	3	health	health	PROPN
ihlr-18967	166	4	law	law	PROPN
ihlr-18967	166	5	review	review	NOUN
ihlr-18967	166	6	vol	vol	NOUN
ihlr-18967	166	7	.	.	PUNCT
ihlr-18967	167	1	12:1	12:1	NUM
ihlr-18967	167	2	that	that	SCONJ
ihlr-18967	167	3	fda	fda	PROPN
ihlr-18967	167	4	has	have	AUX
ihlr-18967	167	5	determined	determine	VERB
ihlr-18967	167	6	the	the	DET
ihlr-18967	167	7	differences	difference	NOUN
ihlr-18967	167	8	do	do	AUX
ihlr-18967	167	9	not	not	PART
ihlr-18967	167	10	require	require	VERB
ihlr-18967	167	11	safety	safety	NOUN
ihlr-18967	167	12	and	and	CCONJ
ihlr-18967	167	13	effectiveness	effectiveness	NOUN
ihlr-18967	167	14	testing	testing	NOUN
ihlr-18967	167	15	.	.	PUNCT
ihlr-18967	168	1	”40	”40	PROPN
ihlr-18967	168	2	c.	c.	PROPN
ihlr-18967	168	3	the	the	DET
ihlr-18967	168	4	hatch	hatch	PROPN
ihlr-18967	168	5	-	-	PUNCT
ihlr-18967	168	6	waxman	waxman	PROPN
ihlr-18967	168	7	act	act	NOUN
ihlr-18967	168	8	and	and	CCONJ
ihlr-18967	168	9	reverse	reverse	VERB
ihlr-18967	168	10	payment	payment	NOUN
ihlr-18967	168	11	settlements	settlement	NOUN
ihlr-18967	168	12	reverse	reverse	VERB
ihlr-18967	168	13	payment	payment	NOUN
ihlr-18967	168	14	settlements	settlement	NOUN
ihlr-18967	168	15	are	be	AUX
ihlr-18967	168	16	“	"	PUNCT
ihlr-18967	168	17	[	[	PUNCT
ihlr-18967	168	18	p]ayments	p]ayment	NOUN
ihlr-18967	168	19	pursuant	pursuant	ADJ
ihlr-18967	168	20	to	to	ADP
ihlr-18967	168	21	the	the	DET
ihlr-18967	168	22	settlement	settlement	NOUN
ihlr-18967	168	23	of	of	ADP
ihlr-18967	168	24	a	a	DET
ihlr-18967	168	25	patent	patent	NOUN
ihlr-18967	169	1	[	[	X
ihlr-18967	169	2	infringement	infringement	NOUN
ihlr-18967	169	3	]	]	PUNCT
ihlr-18967	169	4	suit	suit	NOUN
ihlr-18967	169	5	[	[	PUNCT
ihlr-18967	169	6	which	which	PRON
ihlr-18967	169	7	flow	flow	NOUN
ihlr-18967	169	8	from	from	ADP
ihlr-18967	169	9	the	the	DET
ihlr-18967	169	10	patent	patent	NOUN
ihlr-18967	169	11	holder	holder	NOUN
ihlr-18967	169	12	to	to	ADP
ihlr-18967	169	13	the	the	DET
ihlr-18967	169	14	alleged	allege	VERB
ihlr-18967	169	15	infringer	infringer	NOUN
ihlr-18967	169	16	]	]	PUNCT
ihlr-18967	169	17	.	.	PUNCT
ihlr-18967	169	18	.	.	PUNCT
ihlr-18967	169	19	.	.	PUNCT
ihlr-18967	170	1	by	by	ADP
ihlr-18967	170	2	contrast	contrast	NOUN
ihlr-18967	170	3	,	,	PUNCT
ihlr-18967	170	4	‘	'	PUNCT
ihlr-18967	170	5	[	[	X
ihlr-18967	170	6	t]ypically	t]ypically	ADV
ihlr-18967	170	7	,	,	PUNCT
ihlr-18967	170	8	in	in	ADP
ihlr-18967	170	9	patent	patent	NOUN
ihlr-18967	170	10	infringement	infringement	NOUN
ihlr-18967	170	11	cases	case	VERB
ihlr-18967	170	12	the	the	DET
ihlr-18967	170	13	payment	payment	NOUN
ihlr-18967	170	14	flows	flow	VERB
ihlr-18967	170	15	from	from	ADP
ihlr-18967	170	16	the	the	DET
ihlr-18967	170	17	alleged	alleged	ADJ
ihlr-18967	170	18	infringer	infringer	NOUN
ihlr-18967	170	19	to	to	ADP
ihlr-18967	170	20	the	the	DET
ihlr-18967	170	21	patent	patent	NOUN
ihlr-18967	170	22	holder	holder	NOUN
ihlr-18967	170	23	.	.	PUNCT
ihlr-18967	170	24	’”41	’”41	X
ihlr-18967	171	1	in	in	ADP
ihlr-18967	171	2	the	the	DET
ihlr-18967	171	3	context	context	NOUN
ihlr-18967	171	4	of	of	ADP
ihlr-18967	171	5	reverse	reverse	ADJ
ihlr-18967	171	6	payment	payment	NOUN
ihlr-18967	171	7	settlements	settlement	NOUN
ihlr-18967	171	8	,	,	PUNCT
ihlr-18967	171	9	there	there	PRON
ihlr-18967	171	10	are	be	VERB
ihlr-18967	171	11	four	four	NUM
ihlr-18967	171	12	key	key	ADJ
ihlr-18967	171	13	features	feature	NOUN
ihlr-18967	171	14	of	of	ADP
ihlr-18967	171	15	the	the	DET
ihlr-18967	171	16	hatch	hatch	NOUN
ihlr-18967	171	17	-	-	PUNCT
ihlr-18967	171	18	waxman	waxman	NOUN
ihlr-18967	171	19	act.42	act.42	NOUN
ihlr-18967	171	20	first	first	ADV
ihlr-18967	171	21	,	,	PUNCT
ihlr-18967	171	22	a	a	DET
ihlr-18967	171	23	drug	drug	NOUN
ihlr-18967	171	24	manufacturer	manufacturer	NOUN
ihlr-18967	171	25	who	who	PRON
ihlr-18967	171	26	develops	develop	VERB
ihlr-18967	171	27	a	a	DET
ihlr-18967	171	28	new	new	ADJ
ihlr-18967	171	29	prescription	prescription	NOUN
ihlr-18967	171	30	drug	drug	NOUN
ihlr-18967	171	31	must	must	AUX
ihlr-18967	171	32	file	file	VERB
ihlr-18967	171	33	a	a	DET
ihlr-18967	171	34	nda	nda	NOUN
ihlr-18967	171	35	with	with	ADP
ihlr-18967	171	36	the	the	DET
ihlr-18967	171	37	fda.43	fda.43	NOUN
ihlr-18967	171	38	after	after	ADP
ihlr-18967	171	39	receiving	receive	VERB
ihlr-18967	171	40	approval	approval	NOUN
ihlr-18967	171	41	,	,	PUNCT
ihlr-18967	171	42	a	a	DET
ihlr-18967	171	43	drug	drug	NOUN
ihlr-18967	171	44	manufacturer	manufacturer	NOUN
ihlr-18967	171	45	will	will	AUX
ihlr-18967	171	46	generally	generally	ADV
ihlr-18967	171	47	file	file	VERB
ihlr-18967	171	48	a	a	DET
ihlr-18967	171	49	patent	patent	NOUN
ihlr-18967	171	50	application	application	NOUN
ihlr-18967	171	51	with	with	ADP
ihlr-18967	171	52	the	the	DET
ihlr-18967	171	53	patent	patent	NOUN
ihlr-18967	171	54	and	and	CCONJ
ihlr-18967	171	55	trademark	trademark	NOUN
ihlr-18967	171	56	officer.44	officer.44	NOUN
ihlr-18967	171	57	40	40	NUM
ihlr-18967	171	58	h.r	h.r	PROPN
ihlr-18967	171	59	.	.	PROPN
ihlr-18967	171	60	rep	rep	PROPN
ihlr-18967	171	61	.	.	PROPN
ihlr-18967	172	1	no	no	INTJ
ihlr-18967	172	2	.	.	NOUN
ihlr-18967	173	1	98	98	NUM
ihlr-18967	173	2	-	-	SYM
ihlr-18967	173	3	857	857	NUM
ihlr-18967	173	4	,	,	PUNCT
ihlr-18967	173	5	at	at	ADP
ihlr-18967	173	6	14	14	NUM
ihlr-18967	173	7	-	-	SYM
ihlr-18967	173	8	15	15	NUM
ihlr-18967	173	9	(	(	PUNCT
ihlr-18967	173	10	1984	1984	NUM
ihlr-18967	173	11	)	)	PUNCT
ihlr-18967	173	12	(	(	PUNCT
ihlr-18967	173	13	explaining	explain	VERB
ihlr-18967	173	14	how	how	SCONJ
ihlr-18967	173	15	the	the	DET
ihlr-18967	173	16	new	new	ADJ
ihlr-18967	173	17	anda	anda	PROPN
ihlr-18967	173	18	process	process	NOUN
ihlr-18967	173	19	provides	provide	VERB
ihlr-18967	173	20	for	for	ADP
ihlr-18967	173	21	“	"	PUNCT
ihlr-18967	173	22	piggybacking	piggyback	VERB
ihlr-18967	173	23	”	"	PUNCT
ihlr-18967	173	24	off	off	ADP
ihlr-18967	173	25	of	of	ADP
ihlr-18967	173	26	new	new	ADJ
ihlr-18967	173	27	pioneer	pioneer	NOUN
ihlr-18967	173	28	drugs	drug	NOUN
ihlr-18967	173	29	that	that	PRON
ihlr-18967	173	30	are	be	AUX
ihlr-18967	173	31	submitted	submit	VERB
ihlr-18967	173	32	after	after	ADP
ihlr-18967	173	33	1962	1962	NUM
ihlr-18967	173	34	)	)	PUNCT
ihlr-18967	173	35	.	.	PUNCT
ihlr-18967	174	1	41	41	NUM
ihlr-18967	174	2	in	in	ADP
ihlr-18967	174	3	re	re	ADP
ihlr-18967	174	4	tamoxifen	tamoxifen	NOUN
ihlr-18967	174	5	citrate	citrate	NOUN
ihlr-18967	174	6	antitrust	antitrust	ADJ
ihlr-18967	174	7	litig	litig	NOUN
ihlr-18967	174	8	.	.	PUNCT
ihlr-18967	175	1	,	,	PUNCT
ihlr-18967	175	2	466	466	NUM
ihlr-18967	175	3	f.3d	f.3d	NUM
ihlr-18967	175	4	187	187	NUM
ihlr-18967	175	5	,	,	PUNCT
ihlr-18967	175	6	205	205	NUM
ihlr-18967	175	7	(	(	PUNCT
ihlr-18967	175	8	2d	2d	NUM
ihlr-18967	175	9	cir	cir	NOUN
ihlr-18967	175	10	.	.	PROPN
ihlr-18967	175	11	2005	2005	NUM
ihlr-18967	175	12	)	)	PUNCT
ihlr-18967	175	13	(	(	PUNCT
ihlr-18967	175	14	quoting	quote	VERB
ihlr-18967	175	15	david	david	PROPN
ihlr-18967	175	16	a.	a.	PROPN
ihlr-18967	175	17	balto	balto	PROPN
ihlr-18967	175	18	,	,	PUNCT
ihlr-18967	175	19	pharmaceutical	pharmaceutical	NOUN
ihlr-18967	175	20	patent	patent	NOUN
ihlr-18967	175	21	settlements	settlement	NOUN
ihlr-18967	175	22	:	:	PUNCT
ihlr-18967	175	23	the	the	DET
ihlr-18967	175	24	antitrust	antitrust	ADJ
ihlr-18967	175	25	risks	risk	NOUN
ihlr-18967	175	26	,	,	PUNCT
ihlr-18967	175	27	55	55	NUM
ihlr-18967	175	28	food	food	NOUN
ihlr-18967	175	29	&	&	CCONJ
ihlr-18967	175	30	drug	drug	PROPN
ihlr-18967	175	31	l.j	l.j	PROPN
ihlr-18967	175	32	.	.	PROPN
ihlr-18967	175	33	321	321	NUM
ihlr-18967	175	34	,	,	PUNCT
ihlr-18967	175	35	335	335	NUM
ihlr-18967	175	36	(	(	PUNCT
ihlr-18967	175	37	2000	2000	NUM
ihlr-18967	175	38	)	)	PUNCT
ihlr-18967	175	39	)	)	PUNCT
ihlr-18967	175	40	,	,	PUNCT
ihlr-18967	175	41	abrogated	abrogate	VERB
ihlr-18967	175	42	by	by	ADP
ihlr-18967	175	43	f.t.c	f.t.c	NOUN
ihlr-18967	175	44	.	.	PUNCT
ihlr-18967	176	1	v.	v.	ADP
ihlr-18967	176	2	actavis	actavis	PROPN
ihlr-18967	176	3	,	,	PUNCT
ihlr-18967	176	4	inc	inc	PROPN
ihlr-18967	176	5	.	.	PROPN
ihlr-18967	176	6	,	,	PUNCT
ihlr-18967	176	7	133	133	NUM
ihlr-18967	176	8	s.	s.	PROPN
ihlr-18967	176	9	ct	ct	PROPN
ihlr-18967	176	10	.	.	PROPN
ihlr-18967	176	11	2223	2223	NUM
ihlr-18967	176	12	(	(	PUNCT
ihlr-18967	176	13	2013	2013	NUM
ihlr-18967	176	14	)	)	PUNCT
ihlr-18967	176	15	.	.	PUNCT
ihlr-18967	177	1	42	42	NUM
ihlr-18967	177	2	actavis	actavi	NOUN
ihlr-18967	177	3	,	,	PUNCT
ihlr-18967	177	4	133	133	NUM
ihlr-18967	177	5	s.	s.	PROPN
ihlr-18967	177	6	ct	ct	PROPN
ihlr-18967	177	7	.	.	PUNCT
ihlr-18967	178	1	at	at	ADP
ihlr-18967	178	2	2227	2227	NUM
ihlr-18967	178	3	.	.	PUNCT
ihlr-18967	179	1	43	43	NUM
ihlr-18967	179	2	21	21	NUM
ihlr-18967	179	3	u.s.c	u.s.c	NOUN
ihlr-18967	179	4	.	.	PUNCT
ihlr-18967	180	1	§	§	PROPN
ihlr-18967	180	2	355(b)(1	355(b)(1	NOUN
ihlr-18967	180	3	)	)	PUNCT
ihlr-18967	180	4	(	(	PUNCT
ihlr-18967	180	5	2015	2015	NUM
ihlr-18967	180	6	)	)	PUNCT
ihlr-18967	180	7	(	(	PUNCT
ihlr-18967	180	8	requiring	require	VERB
ihlr-18967	180	9	the	the	DET
ihlr-18967	180	10	following	following	NOUN
ihlr-18967	180	11	for	for	ADP
ihlr-18967	180	12	a	a	DET
ihlr-18967	180	13	nda	nda	NOUN
ihlr-18967	180	14	:	:	PUNCT
ihlr-18967	180	15	safety	safety	NOUN
ihlr-18967	180	16	and	and	CCONJ
ihlr-18967	180	17	effectiveness	effectiveness	NOUN
ihlr-18967	180	18	reports	report	NOUN
ihlr-18967	180	19	;	;	PUNCT
ihlr-18967	180	20	components	component	NOUN
ihlr-18967	180	21	of	of	ADP
ihlr-18967	180	22	the	the	DET
ihlr-18967	180	23	drug	drug	NOUN
ihlr-18967	180	24	;	;	PUNCT
ihlr-18967	180	25	composition	composition	NOUN
ihlr-18967	180	26	of	of	ADP
ihlr-18967	180	27	the	the	DET
ihlr-18967	180	28	drug	drug	NOUN
ihlr-18967	180	29	;	;	PUNCT
ihlr-18967	180	30	“	"	PUNCT
ihlr-18967	180	31	description	description	NOUN
ihlr-18967	180	32	of	of	ADP
ihlr-18967	180	33	methods	method	NOUN
ihlr-18967	180	34	used	use	VERB
ihlr-18967	180	35	in	in	ADP
ihlr-18967	180	36	,	,	PUNCT
ihlr-18967	180	37	facilities	facility	NOUN
ihlr-18967	180	38	and	and	CCONJ
ihlr-18967	180	39	controls	control	NOUN
ihlr-18967	180	40	used	use	VERB
ihlr-18967	180	41	for	for	ADP
ihlr-18967	180	42	,	,	PUNCT
ihlr-18967	180	43	the	the	DET
ihlr-18967	180	44	manufacture	manufacture	NOUN
ihlr-18967	180	45	,	,	PUNCT
ihlr-18967	180	46	processing	processing	NOUN
ihlr-18967	180	47	and	and	CCONJ
ihlr-18967	180	48	packing	packing	NOUN
ihlr-18967	180	49	of	of	ADP
ihlr-18967	180	50	drug	drug	NOUN
ihlr-18967	180	51	”	"	PUNCT
ihlr-18967	180	52	;	;	PUNCT
ihlr-18967	180	53	samples	sample	NOUN
ihlr-18967	180	54	and	and	CCONJ
ihlr-18967	180	55	articles	article	NOUN
ihlr-18967	180	56	of	of	ADP
ihlr-18967	180	57	components	component	NOUN
ihlr-18967	180	58	as	as	SCONJ
ihlr-18967	180	59	required	require	VERB
ihlr-18967	180	60	by	by	ADP
ihlr-18967	180	61	the	the	DET
ihlr-18967	180	62	secretary	secretary	NOUN
ihlr-18967	180	63	;	;	PUNCT
ihlr-18967	180	64	“	"	PUNCT
ihlr-18967	180	65	specimens	specimen	NOUN
ihlr-18967	180	66	of	of	ADP
ihlr-18967	180	67	the	the	DET
ihlr-18967	180	68	labeling	labeling	NOUN
ihlr-18967	180	69	proposed	propose	VERB
ihlr-18967	180	70	”	"	PUNCT
ihlr-18967	180	71	;	;	PUNCT
ihlr-18967	180	72	“	"	PUNCT
ihlr-18967	180	73	any	any	DET
ihlr-18967	180	74	assessments	assessment	NOUN
ihlr-18967	180	75	required	require	VERB
ihlr-18967	180	76	under	under	ADP
ihlr-18967	180	77	section	section	NOUN
ihlr-18967	180	78	355(c	355(c	PROPN
ihlr-18967	180	79	)	)	PUNCT
ihlr-18967	180	80	”	"	PUNCT
ihlr-18967	180	81	;	;	PUNCT
ihlr-18967	180	82	and	and	CCONJ
ihlr-18967	180	83	“	"	PUNCT
ihlr-18967	180	84	[	[	X
ihlr-18967	180	85	t]he	t]he	ADV
ihlr-18967	180	86	applicant	applicant	ADJ
ihlr-18967	180	87	shall	shall	AUX
ihlr-18967	180	88	file	file	VERB
ihlr-18967	180	89	with	with	ADP
ihlr-18967	180	90	the	the	DET
ihlr-18967	180	91	application	application	NOUN
ihlr-18967	180	92	the	the	DET
ihlr-18967	180	93	patent	patent	NOUN
ihlr-18967	180	94	number	number	NOUN
ihlr-18967	180	95	and	and	CCONJ
ihlr-18967	180	96	the	the	DET
ihlr-18967	180	97	expiration	expiration	NOUN
ihlr-18967	180	98	date	date	NOUN
ihlr-18967	180	99	of	of	ADP
ihlr-18967	180	100	any	any	DET
ihlr-18967	180	101	patent	patent	NOUN
ihlr-18967	180	102	which	which	PRON
ihlr-18967	180	103	claims	claim	VERB
ihlr-18967	180	104	the	the	DET
ihlr-18967	180	105	drug	drug	NOUN
ihlr-18967	180	106	for	for	ADP
ihlr-18967	180	107	which	which	PRON
ihlr-18967	180	108	the	the	DET
ihlr-18967	180	109	applicant	applicant	NOUN
ihlr-18967	180	110	submitted	submit	VERB
ihlr-18967	180	111	the	the	DET
ihlr-18967	180	112	application	application	NOUN
ihlr-18967	180	113	or	or	CCONJ
ihlr-18967	180	114	which	which	PRON
ihlr-18967	180	115	claims	claim	VERB
ihlr-18967	180	116	a	a	DET
ihlr-18967	180	117	method	method	NOUN
ihlr-18967	180	118	of	of	ADP
ihlr-18967	180	119	using	use	VERB
ihlr-18967	180	120	such	such	ADJ
ihlr-18967	180	121	drug	drug	NOUN
ihlr-18967	180	122	and	and	CCONJ
ihlr-18967	180	123	with	with	ADP
ihlr-18967	180	124	respect	respect	NOUN
ihlr-18967	180	125	to	to	ADP
ihlr-18967	180	126	which	which	PRON
ihlr-18967	180	127	a	a	DET
ihlr-18967	180	128	claim	claim	NOUN
ihlr-18967	180	129	of	of	ADP
ihlr-18967	180	130	patent	patent	NOUN
ihlr-18967	180	131	infringement	infringement	NOUN
ihlr-18967	180	132	could	could	AUX
ihlr-18967	180	133	reasonably	reasonably	ADV
ihlr-18967	180	134	be	be	AUX
ihlr-18967	180	135	asserted	assert	VERB
ihlr-18967	180	136	if	if	SCONJ
ihlr-18967	180	137	a	a	DET
ihlr-18967	180	138	person	person	NOUN
ihlr-18967	180	139	not	not	PART
ihlr-18967	180	140	licensed	license	VERB
ihlr-18967	180	141	by	by	ADP
ihlr-18967	180	142	the	the	DET
ihlr-18967	180	143	owner	owner	NOUN
ihlr-18967	180	144	engaged	engage	VERB
ihlr-18967	180	145	in	in	ADP
ihlr-18967	180	146	the	the	DET
ihlr-18967	180	147	manufacture	manufacture	NOUN
ihlr-18967	180	148	,	,	PUNCT
ihlr-18967	180	149	use	use	NOUN
ihlr-18967	180	150	,	,	PUNCT
ihlr-18967	180	151	or	or	CCONJ
ihlr-18967	180	152	sale	sale	NOUN
ihlr-18967	180	153	of	of	ADP
ihlr-18967	180	154	the	the	DET
ihlr-18967	180	155	drug	drug	NOUN
ihlr-18967	180	156	”	"	PUNCT
ihlr-18967	180	157	)	)	PUNCT
ihlr-18967	180	158	.	.	PUNCT
ihlr-18967	181	1	44	44	NUM
ihlr-18967	181	2	obtaining	obtain	VERB
ihlr-18967	181	3	a	a	DET
ihlr-18967	181	4	patent	patent	NOUN
ihlr-18967	181	5	is	be	AUX
ihlr-18967	181	6	desirable	desirable	ADJ
ihlr-18967	181	7	because	because	SCONJ
ihlr-18967	181	8	it	it	PRON
ihlr-18967	181	9	can	can	AUX
ihlr-18967	181	10	be	be	AUX
ihlr-18967	181	11	used	use	VERB
ihlr-18967	181	12	to	to	PART
ihlr-18967	181	13	“	"	PUNCT
ihlr-18967	181	14	invoke	invoke	VERB
ihlr-18967	181	15	the	the	DET
ihlr-18967	181	16	state	state	NOUN
ihlr-18967	181	17	’s	’s	PART
ihlr-18967	181	18	power	power	NOUN
ihlr-18967	181	19	to	to	PART
ihlr-18967	181	20	prevent	prevent	VERB
ihlr-18967	181	21	others	other	NOUN
ihlr-18967	181	22	from	from	ADP
ihlr-18967	181	23	utilizing	utilize	VERB
ihlr-18967	181	24	[	[	PUNCT
ihlr-18967	181	25	one	one	NUM
ihlr-18967	181	26	’s	’s	PART
ihlr-18967	181	27	]	]	PUNCT
ihlr-18967	181	28	discovery	discovery	NOUN
ihlr-18967	181	29	without	without	ADP
ihlr-18967	181	30	[	[	X
ihlr-18967	181	31	their	their	PRON
ihlr-18967	181	32	]	]	X
ihlr-18967	181	33	consent	consent	NOUN
ihlr-18967	181	34	.	.	PUNCT
ihlr-18967	181	35	”	"	PUNCT
ihlr-18967	182	1	united	united	PROPN
ihlr-18967	182	2	states	states	PROPN
ihlr-18967	182	3	v.	v.	ADP
ihlr-18967	182	4	westinghouse	westinghouse	PROPN
ihlr-18967	182	5	elec	elec	PROPN
ihlr-18967	182	6	.	.	PROPN
ihlr-18967	182	7	corp	corp	PROPN
ihlr-18967	182	8	.	.	PROPN
ihlr-18967	182	9	,	,	PUNCT
ihlr-18967	182	10	648	648	NUM
ihlr-18967	182	11	f.2d	f.2d	ADP
ihlr-18967	182	12	642	642	NUM
ihlr-18967	182	13	,	,	PUNCT
ihlr-18967	182	14	647	647	NUM
ihlr-18967	182	15	(	(	PUNCT
ihlr-18967	182	16	9th	9th	ADJ
ihlr-18967	182	17	cir	cir	NOUN
ihlr-18967	182	18	.	.	PUNCT
ihlr-18967	182	19	1981	1981	NUM
ihlr-18967	182	20	)	)	PUNCT
ihlr-18967	182	21	.	.	PUNCT
ihlr-18967	183	1	in	in	ADP
ihlr-18967	183	2	the	the	DET
ihlr-18967	183	3	united	united	PROPN
ihlr-18967	183	4	states	states	PROPN
ihlr-18967	183	5	,	,	PUNCT
ihlr-18967	183	6	patents	patent	NOUN
ihlr-18967	183	7	are	be	AUX
ihlr-18967	183	8	issued	issue	VERB
ihlr-18967	183	9	by	by	ADP
ihlr-18967	183	10	the	the	DET
ihlr-18967	183	11	united	united	PROPN
ihlr-18967	183	12	states	states	PROPN
ihlr-18967	183	13	patent	patent	PROPN
ihlr-18967	183	14	and	and	CCONJ
ihlr-18967	183	15	trademark	trademark	NOUN
ihlr-18967	183	16	office	office	NOUN
ihlr-18967	183	17	.	.	PUNCT
ihlr-18967	184	1	general	general	ADJ
ihlr-18967	184	2	information	information	NOUN
ihlr-18967	184	3	concerning	concern	VERB
ihlr-18967	184	4	patents	patent	NOUN
ihlr-18967	184	5	,	,	PUNCT
ihlr-18967	184	6	uspto.gov	uspto.gov	ADP
ihlr-18967	184	7	,	,	PUNCT
ihlr-18967	184	8	http://www.uspto.gov/	http://www.uspto.gov/	ADP
ihlr-18967	184	9	patents	patent	NOUN
ihlr-18967	184	10	/	/	SYM
ihlr-18967	184	11	resources	resource	NOUN
ihlr-18967	184	12	/	/	SYM
ihlr-18967	184	13	general_info_concerning_patents.jsp#heading-1	general_info_concerning_patents.jsp#heading-1	NOUN
ihlr-18967	184	14	(	(	PUNCT
ihlr-18967	184	15	last	last	ADJ
ihlr-18967	184	16	2015	2015	NUM
ihlr-18967	184	17	rationale	rationale	NOUN
ihlr-18967	184	18	behind	behind	ADP
ihlr-18967	184	19	hatch	hatch	NOUN
ihlr-18967	184	20	-	-	PUNCT
ihlr-18967	184	21	waxman	waxman	PROPN
ihlr-18967	184	22	act	act	PROPN
ihlr-18967	184	23	and	and	CCONJ
ihlr-18967	184	24	patent	patent	NOUN
ihlr-18967	184	25	law	law	NOUN
ihlr-18967	184	26	433	433	NUM
ihlr-18967	184	27	thereafter	thereafter	ADV
ihlr-18967	184	28	,	,	PUNCT
ihlr-18967	184	29	the	the	DET
ihlr-18967	184	30	fda	fda	PROPN
ihlr-18967	184	31	lists	list	VERB
ihlr-18967	184	32	patents	patent	NOUN
ihlr-18967	184	33	from	from	ADP
ihlr-18967	184	34	ndas	ndas	PROPN
ihlr-18967	184	35	in	in	ADP
ihlr-18967	184	36	the	the	DET
ihlr-18967	184	37	publication	publication	NOUN
ihlr-18967	184	38	“	"	PUNCT
ihlr-18967	184	39	approved	approve	VERB
ihlr-18967	184	40	drug	drug	NOUN
ihlr-18967	184	41	products	product	NOUN
ihlr-18967	184	42	with	with	ADP
ihlr-18967	184	43	therapeutic	therapeutic	ADJ
ihlr-18967	184	44	equivalence	equivalence	NOUN
ihlr-18967	184	45	evaluations	evaluation	NOUN
ihlr-18967	184	46	.	.	PUNCT
ihlr-18967	185	1	”45	”45	PROPN
ihlr-18967	185	2	frequently	frequently	ADV
ihlr-18967	185	3	,	,	PUNCT
ihlr-18967	185	4	this	this	DET
ihlr-18967	185	5	publication	publication	NOUN
ihlr-18967	185	6	is	be	AUX
ihlr-18967	185	7	referred	refer	VERB
ihlr-18967	185	8	to	to	ADP
ihlr-18967	185	9	as	as	ADP
ihlr-18967	185	10	“	"	PUNCT
ihlr-18967	185	11	the	the	DET
ihlr-18967	185	12	orange	orange	PROPN
ihlr-18967	185	13	book	book	NOUN
ihlr-18967	185	14	.	.	PUNCT
ihlr-18967	186	1	”46	”46	VERB
ihlr-18967	186	2	second	second	ADV
ihlr-18967	186	3	,	,	PUNCT
ihlr-18967	186	4	after	after	SCONJ
ihlr-18967	186	5	the	the	DET
ihlr-18967	186	6	fda	fda	PROPN
ihlr-18967	186	7	has	have	AUX
ihlr-18967	186	8	approved	approve	VERB
ihlr-18967	186	9	a	a	DET
ihlr-18967	186	10	pioneer	pioneer	NOUN
ihlr-18967	186	11	drug	drug	NOUN
ihlr-18967	186	12	,	,	PUNCT
ihlr-18967	186	13	a	a	DET
ihlr-18967	186	14	generic	generic	ADJ
ihlr-18967	186	15	manufacturer	manufacturer	NOUN
ihlr-18967	186	16	can	can	AUX
ihlr-18967	186	17	file	file	VERB
ihlr-18967	186	18	an	an	DET
ihlr-18967	186	19	anda.47	anda.47	NOUN
ihlr-18967	186	20	using	use	VERB
ihlr-18967	186	21	an	an	DET
ihlr-18967	186	22	anda	anda	PROPN
ihlr-18967	186	23	allows	allow	VERB
ihlr-18967	186	24	the	the	DET
ihlr-18967	186	25	generic	generic	ADJ
ihlr-18967	186	26	manufacturer	manufacturer	NOUN
ihlr-18967	186	27	to	to	PART
ihlr-18967	186	28	piggyback	piggyback	VERB
ihlr-18967	186	29	off	off	ADP
ihlr-18967	186	30	the	the	DET
ihlr-18967	186	31	pioneer	pioneer	NOUN
ihlr-18967	186	32	manufacturer	manufacturer	NOUN
ihlr-18967	186	33	and	and	CCONJ
ihlr-18967	186	34	avoid	avoid	VERB
ihlr-18967	186	35	duplicate	duplicate	NOUN
ihlr-18967	186	36	testing.48	testing.48	PROPN
ihlr-18967	186	37	however	however	ADV
ihlr-18967	186	38	,	,	PUNCT
ihlr-18967	186	39	if	if	SCONJ
ihlr-18967	186	40	the	the	DET
ihlr-18967	186	41	pioneer	pioneer	NOUN
ihlr-18967	186	42	drug	drug	NOUN
ihlr-18967	186	43	includes	include	VERB
ihlr-18967	186	44	a	a	DET
ihlr-18967	186	45	new	new	ADJ
ihlr-18967	186	46	active	active	ADJ
ihlr-18967	186	47	updated	update	VERB
ihlr-18967	186	48	oct	oct	PROPN
ihlr-18967	186	49	.	.	PROPN
ihlr-18967	186	50	2014	2014	NUM
ihlr-18967	186	51	)	)	PUNCT
ihlr-18967	186	52	.	.	PUNCT
ihlr-18967	187	1	generally	generally	ADV
ihlr-18967	187	2	,	,	PUNCT
ihlr-18967	187	3	there	there	PRON
ihlr-18967	187	4	are	be	VERB
ihlr-18967	187	5	three	three	NUM
ihlr-18967	187	6	types	type	NOUN
ihlr-18967	187	7	:	:	PUNCT
ihlr-18967	187	8	utility	utility	NOUN
ihlr-18967	187	9	patents	patent	NOUN
ihlr-18967	187	10	(	(	PUNCT
ihlr-18967	187	11	the	the	DET
ihlr-18967	187	12	general	general	ADJ
ihlr-18967	187	13	“	"	PUNCT
ihlr-18967	187	14	all	all	DET
ihlr-18967	187	15	purpose	purpose	NOUN
ihlr-18967	187	16	”	"	PUNCT
ihlr-18967	187	17	patent	patent	NOUN
ihlr-18967	187	18	)	)	PUNCT
ihlr-18967	187	19	,	,	PUNCT
ihlr-18967	187	20	design	design	NOUN
ihlr-18967	187	21	patents	patent	NOUN
ihlr-18967	187	22	(	(	PUNCT
ihlr-18967	187	23	article	article	NOUN
ihlr-18967	187	24	of	of	ADP
ihlr-18967	187	25	manufacture	manufacture	NOUN
ihlr-18967	187	26	)	)	PUNCT
ihlr-18967	187	27	,	,	PUNCT
ihlr-18967	187	28	and	and	CCONJ
ihlr-18967	187	29	plant	plant	NOUN
ihlr-18967	187	30	patents	patent	NOUN
ihlr-18967	187	31	(	(	PUNCT
ihlr-18967	187	32	new	new	ADJ
ihlr-18967	187	33	plant	plant	NOUN
ihlr-18967	187	34	variety	variety	NOUN
ihlr-18967	187	35	)	)	PUNCT
ihlr-18967	187	36	.	.	PUNCT
ihlr-18967	188	1	patents	patent	NOUN
ihlr-18967	188	2	,	,	PUNCT
ihlr-18967	188	3	uspto.gov	uspto.gov	ADP
ihlr-18967	188	4	,	,	PUNCT
ihlr-18967	188	5	http://www.uspto.gov/patents/	http://www.uspto.gov/patents/	PROPN
ihlr-18967	188	6	(	(	PUNCT
ihlr-18967	188	7	last	last	ADV
ihlr-18967	188	8	visited	visit	VERB
ihlr-18967	188	9	mar	mar	PROPN
ihlr-18967	188	10	.	.	PROPN
ihlr-18967	188	11	8	8	NUM
ihlr-18967	188	12	,	,	PUNCT
ihlr-18967	188	13	2014	2014	NUM
ihlr-18967	188	14	)	)	PUNCT
ihlr-18967	188	15	.	.	PUNCT
ihlr-18967	189	1	obtaining	obtain	VERB
ihlr-18967	189	2	a	a	DET
ihlr-18967	189	3	patent	patent	NOUN
ihlr-18967	189	4	involves	involve	VERB
ihlr-18967	189	5	many	many	ADJ
ihlr-18967	189	6	steps	step	NOUN
ihlr-18967	189	7	,	,	PUNCT
ihlr-18967	189	8	such	such	ADJ
ihlr-18967	189	9	as	as	ADP
ihlr-18967	189	10	:	:	PUNCT
ihlr-18967	189	11	determining	determine	VERB
ihlr-18967	189	12	patentability	patentability	NOUN
ihlr-18967	189	13	,	,	PUNCT
ihlr-18967	189	14	filing	filing	NOUN
ihlr-18967	189	15	strategy	strategy	NOUN
ihlr-18967	189	16	,	,	PUNCT
ihlr-18967	189	17	domestic	domestic	ADJ
ihlr-18967	189	18	v.	v.	ADP
ihlr-18967	189	19	international	international	ADJ
ihlr-18967	189	20	protection	protection	NOUN
ihlr-18967	189	21	and	and	CCONJ
ihlr-18967	189	22	examination	examination	NOUN
ihlr-18967	189	23	.	.	PUNCT
ihlr-18967	190	1	see	see	VERB
ihlr-18967	190	2	generally	generally	ADV
ihlr-18967	190	3	process	process	NOUN
ihlr-18967	190	4	for	for	ADP
ihlr-18967	190	5	obtaining	obtain	VERB
ihlr-18967	190	6	a	a	DET
ihlr-18967	190	7	utility	utility	NOUN
ihlr-18967	190	8	patent	patent	NOUN
ihlr-18967	190	9	,	,	PUNCT
ihlr-18967	190	10	uspto.gov	uspto.gov	PROPN
ihlr-18967	190	11	,	,	PUNCT
ihlr-18967	190	12	http://www.uspto.gov/patents/process/index.jsp?utm_source=feedburner	http://www.uspto.gov/patents/process/index.jsp?utm_source=feedburner	PROPN
ihlr-18967	190	13	&	&	CCONJ
ihlr-18967	190	14	utm_medium	utm_medium	NOUN
ihlr-18967	190	15	=	=	SYM
ihlr-18967	190	16	twitter&utm_campaign	twitter&utm_campaign	PROPN
ihlr-18967	190	17	=	=	ADJ
ihlr-18967	190	18	feed%3a+hackernewsyc+(hac	feed%3a+hackernewsyc+(hac	NOUN
ihlr-18967	190	19	ker+news+yc	ker+news+yc	PROPN
ihlr-18967	190	20	)	)	PUNCT
ihlr-18967	190	21	(	(	PUNCT
ihlr-18967	190	22	last	last	ADV
ihlr-18967	190	23	visited	visit	VERB
ihlr-18967	190	24	mar	mar	PROPN
ihlr-18967	190	25	.	.	PROPN
ihlr-18967	190	26	8	8	NUM
ihlr-18967	190	27	,	,	PUNCT
ihlr-18967	190	28	2014	2014	NUM
ihlr-18967	190	29	)	)	PUNCT
ihlr-18967	190	30	.	.	PUNCT
ihlr-18967	191	1	lastly	lastly	ADV
ihlr-18967	191	2	,	,	PUNCT
ihlr-18967	191	3	the	the	DET
ihlr-18967	191	4	term	term	NOUN
ihlr-18967	191	5	of	of	ADP
ihlr-18967	191	6	a	a	DET
ihlr-18967	191	7	patent	patent	NOUN
ihlr-18967	191	8	begins	begin	VERB
ihlr-18967	191	9	when	when	SCONJ
ihlr-18967	191	10	the	the	DET
ihlr-18967	191	11	patent	patent	NOUN
ihlr-18967	191	12	is	be	AUX
ihlr-18967	191	13	issued	issue	VERB
ihlr-18967	191	14	and	and	CCONJ
ihlr-18967	191	15	ends	end	VERB
ihlr-18967	191	16	“	"	PUNCT
ihlr-18967	191	17	20	20	NUM
ihlr-18967	191	18	years	year	NOUN
ihlr-18967	191	19	from	from	ADP
ihlr-18967	191	20	the	the	DET
ihlr-18967	191	21	date	date	NOUN
ihlr-18967	191	22	on	on	ADP
ihlr-18967	191	23	which	which	PRON
ihlr-18967	191	24	the	the	DET
ihlr-18967	191	25	application	application	NOUN
ihlr-18967	191	26	for	for	ADP
ihlr-18967	191	27	the	the	DET
ihlr-18967	191	28	patent	patent	NOUN
ihlr-18967	191	29	was	be	AUX
ihlr-18967	191	30	filed	file	VERB
ihlr-18967	191	31	,	,	PUNCT
ihlr-18967	191	32	”	"	PUNCT
ihlr-18967	191	33	unless	unless	SCONJ
ihlr-18967	191	34	“	"	PUNCT
ihlr-18967	191	35	the	the	DET
ihlr-18967	191	36	application	application	NOUN
ihlr-18967	191	37	contain	contain	VERB
ihlr-18967	191	38	a	a	DET
ihlr-18967	191	39	specific	specific	ADJ
ihlr-18967	191	40	reference	reference	NOUN
ihlr-18967	191	41	to	to	ADP
ihlr-18967	191	42	an	an	DET
ihlr-18967	191	43	earlier	early	ADV
ihlr-18967	191	44	filed	file	VERB
ihlr-18967	191	45	application	application	NOUN
ihlr-18967	191	46	.	.	PUNCT
ihlr-18967	191	47	.	.	PUNCT
ihlr-18967	191	48	.	.	PUNCT
ihlr-18967	192	1	[	[	X
ihlr-18967	192	2	then	then	ADV
ihlr-18967	192	3	]	]	PUNCT
ihlr-18967	192	4	from	from	ADP
ihlr-18967	192	5	the	the	DET
ihlr-18967	192	6	date	date	NOUN
ihlr-18967	192	7	on	on	ADP
ihlr-18967	192	8	which	which	PRON
ihlr-18967	192	9	the	the	DET
ihlr-18967	192	10	earliest	early	ADJ
ihlr-18967	192	11	such	such	ADJ
ihlr-18967	192	12	application	application	NOUN
ihlr-18967	192	13	was	be	AUX
ihlr-18967	192	14	filed	file	VERB
ihlr-18967	192	15	.	.	PUNCT
ihlr-18967	192	16	”	"	PUNCT
ihlr-18967	193	1	35	35	NUM
ihlr-18967	193	2	u.s.c	u.s.c	NOUN
ihlr-18967	193	3	.	.	PUNCT
ihlr-18967	194	1	§	§	PROPN
ihlr-18967	194	2	154(a)(2	154(a)(2	NUM
ihlr-18967	194	3	)	)	PUNCT
ihlr-18967	194	4	(	(	PUNCT
ihlr-18967	194	5	2015	2015	NUM
ihlr-18967	194	6	)	)	PUNCT
ihlr-18967	194	7	.	.	PUNCT
ihlr-18967	195	1	45	45	NUM
ihlr-18967	195	2	caraco	caraco	PROPN
ihlr-18967	195	3	pharm	pharm	NOUN
ihlr-18967	195	4	.	.	PUNCT
ihlr-18967	196	1	labs	labs	PROPN
ihlr-18967	196	2	.	.	PUNCT
ihlr-18967	196	3	,	,	PUNCT
ihlr-18967	196	4	ltd	ltd	PROPN
ihlr-18967	196	5	.	.	PROPN
ihlr-18967	196	6	v.	v.	ADP
ihlr-18967	196	7	forest	forest	PROPN
ihlr-18967	196	8	labs	labs	PROPN
ihlr-18967	196	9	.	.	PUNCT
ihlr-18967	196	10	,	,	PUNCT
ihlr-18967	196	11	inc	inc	PROPN
ihlr-18967	196	12	.	.	PROPN
ihlr-18967	196	13	527	527	NUM
ihlr-18967	196	14	f.3d	f.3d	NUM
ihlr-18967	196	15	1278	1278	NUM
ihlr-18967	196	16	,	,	PUNCT
ihlr-18967	196	17	1282	1282	NUM
ihlr-18967	196	18	(	(	PUNCT
ihlr-18967	196	19	fed	fed	PROPN
ihlr-18967	196	20	.	.	PUNCT
ihlr-18967	196	21	cir	cir	PROPN
ihlr-18967	196	22	.	.	PROPN
ihlr-18967	196	23	2008	2008	NUM
ihlr-18967	196	24	)	)	PUNCT
ihlr-18967	196	25	.	.	PUNCT
ihlr-18967	197	1	46	46	NUM
ihlr-18967	198	1	i	i	PROPN
ihlr-18967	198	2	d.	d.	PROPN
ihlr-18967	198	3	;	;	PUNCT
ihlr-18967	198	4	see	see	AUX
ihlr-18967	198	5	also	also	ADV
ihlr-18967	198	6	approved	approve	VERB
ihlr-18967	198	7	drug	drug	NOUN
ihlr-18967	198	8	products	product	NOUN
ihlr-18967	198	9	with	with	ADP
ihlr-18967	198	10	therapeutic	therapeutic	ADJ
ihlr-18967	198	11	equivalence	equivalence	NOUN
ihlr-18967	198	12	evaluations	evaluation	NOUN
ihlr-18967	198	13	(	(	PUNCT
ihlr-18967	198	14	orange	orange	NOUN
ihlr-18967	198	15	book	book	NOUN
ihlr-18967	198	16	)	)	PUNCT
ihlr-18967	198	17	,	,	PUNCT
ihlr-18967	198	18	u.s	u.s	PROPN
ihlr-18967	198	19	.	.	PROPN
ihlr-18967	198	20	food	food	PROPN
ihlr-18967	198	21	&	&	CCONJ
ihlr-18967	198	22	drug	drug	PROPN
ihlr-18967	198	23	admin	admin	PROPN
ihlr-18967	198	24	.	.	PROPN
ihlr-18967	198	25	,	,	PUNCT
ihlr-18967	198	26	http://www.fda.gov/drugs/informationondrugs/ucm129662.htm	http://www.fda.gov/drugs/informationondrugs/ucm129662.htm	PROPN
ihlr-18967	198	27	(	(	PUNCT
ihlr-18967	198	28	last	last	ADJ
ihlr-18967	198	29	visited	visit	VERB
ihlr-18967	198	30	mar	mar	PROPN
ihlr-18967	198	31	.	.	PROPN
ihlr-18967	198	32	8	8	NUM
ihlr-18967	198	33	,	,	PUNCT
ihlr-18967	198	34	2014	2014	NUM
ihlr-18967	198	35	)	)	PUNCT
ihlr-18967	198	36	.	.	PUNCT
ihlr-18967	199	1	47	47	NUM
ihlr-18967	199	2	21	21	NUM
ihlr-18967	199	3	u.s.c	u.s.c	NOUN
ihlr-18967	199	4	.	.	PUNCT
ihlr-18967	200	1	§	§	PROPN
ihlr-18967	200	2	355(j	355(j	PROPN
ihlr-18967	200	3	)	)	PUNCT
ihlr-18967	200	4	(	(	PUNCT
ihlr-18967	200	5	2015	2015	NUM
ihlr-18967	200	6	)	)	PUNCT
ihlr-18967	200	7	.	.	PUNCT
ihlr-18967	201	1	48	48	NUM
ihlr-18967	201	2	for	for	ADP
ihlr-18967	201	3	example	example	NOUN
ihlr-18967	201	4	,	,	PUNCT
ihlr-18967	201	5	in	in	ADP
ihlr-18967	201	6	2011	2011	NUM
ihlr-18967	201	7	,	,	PUNCT
ihlr-18967	201	8	the	the	DET
ihlr-18967	201	9	branded	brand	VERB
ihlr-18967	201	10	cholesterol	cholesterol	NOUN
ihlr-18967	201	11	-	-	PUNCT
ihlr-18967	201	12	lowering	lower	VERB
ihlr-18967	201	13	drug	drug	NOUN
ihlr-18967	201	14	lipitor	lipitor	NOUN
ihlr-18967	201	15	came	come	VERB
ihlr-18967	201	16	off	off	ADP
ihlr-18967	201	17	patent	patent	NOUN
ihlr-18967	201	18	and	and	CCONJ
ihlr-18967	201	19	generic	generic	ADJ
ihlr-18967	201	20	versions	version	NOUN
ihlr-18967	201	21	were	be	AUX
ihlr-18967	201	22	available	available	ADJ
ihlr-18967	201	23	under	under	ADP
ihlr-18967	201	24	the	the	DET
ihlr-18967	201	25	name	name	NOUN
ihlr-18967	201	26	atorvastatin	atorvastatin	NOUN
ihlr-18967	201	27	.	.	PUNCT
ihlr-18967	202	1	daniel	daniel	PROPN
ihlr-18967	202	2	j.	j.	PROPN
ihlr-18967	202	3	denoon	denoon	PROPN
ihlr-18967	202	4	,	,	PUNCT
ihlr-18967	202	5	lipitor	lipitor	NOUN
ihlr-18967	202	6	goes	go	VERB
ihlr-18967	202	7	generic	generic	ADJ
ihlr-18967	202	8	:	:	PUNCT
ihlr-18967	202	9	what	what	PRON
ihlr-18967	202	10	it	it	PRON
ihlr-18967	202	11	means	mean	VERB
ihlr-18967	202	12	for	for	ADP
ihlr-18967	202	13	you	you	PRON
ihlr-18967	202	14	,	,	PUNCT
ihlr-18967	202	15	webmd	webmd	PROPN
ihlr-18967	202	16	(	(	PUNCT
ihlr-18967	202	17	nov	nov	PROPN
ihlr-18967	202	18	.	.	PROPN
ihlr-18967	202	19	29	29	NUM
ihlr-18967	202	20	,	,	PUNCT
ihlr-18967	202	21	2011	2011	NUM
ihlr-18967	202	22	)	)	PUNCT
ihlr-18967	202	23	,	,	PUNCT
ihlr-18967	202	24	http://www.webmd.com/cholesterolmanagement/news/20111129/faq-generic-lipitor	http://www.webmd.com/cholesterolmanagement/news/20111129/faq-generic-lipitor	PROPN
ihlr-18967	202	25	.	.	PUNCT
ihlr-18967	203	1	in	in	ADP
ihlr-18967	203	2	a	a	DET
ihlr-18967	203	3	letter	letter	NOUN
ihlr-18967	203	4	from	from	ADP
ihlr-18967	203	5	keith	keith	PROPN
ihlr-18967	203	6	webber	webber	PROPN
ihlr-18967	203	7	,	,	PUNCT
ihlr-18967	203	8	deputy	deputy	NOUN
ihlr-18967	203	9	director	director	NOUN
ihlr-18967	203	10	for	for	ADP
ihlr-18967	203	11	the	the	DET
ihlr-18967	203	12	office	office	NOUN
ihlr-18967	203	13	of	of	ADP
ihlr-18967	203	14	pharmaceutical	pharmaceutical	NOUN
ihlr-18967	203	15	science	science	NOUN
ihlr-18967	203	16	,	,	PUNCT
ihlr-18967	203	17	to	to	ADP
ihlr-18967	203	18	ranbaxy	ranbaxy	PROPN
ihlr-18967	203	19	laboratories	laboratory	NOUN
ihlr-18967	203	20	,	,	PUNCT
ihlr-18967	203	21	generic	generic	ADJ
ihlr-18967	203	22	lipitor	lipitor	NOUN
ihlr-18967	203	23	manufacturer	manufacturer	NOUN
ihlr-18967	203	24	,	,	PUNCT
ihlr-18967	203	25	webber	webber	PROPN
ihlr-18967	203	26	notes	note	VERB
ihlr-18967	203	27	how	how	SCONJ
ihlr-18967	203	28	ranbaxy	ranbaxy	PROPN
ihlr-18967	203	29	’s	’s	PART
ihlr-18967	203	30	anda	anda	PROPN
ihlr-18967	203	31	for	for	ADP
ihlr-18967	203	32	their	their	PRON
ihlr-18967	203	33	atorvastatin	atorvastatin	NOUN
ihlr-18967	203	34	tablets	tablet	NOUN
ihlr-18967	203	35	are	be	AUX
ihlr-18967	203	36	approved	approve	VERB
ihlr-18967	203	37	as	as	SCONJ
ihlr-18967	203	38	they	they	PRON
ihlr-18967	203	39	were	be	AUX
ihlr-18967	203	40	found	find	VERB
ihlr-18967	203	41	“	"	PUNCT
ihlr-18967	203	42	to	to	PART
ihlr-18967	203	43	be	be	AUX
ihlr-18967	203	44	bioequivalent	bioequivalent	NOUN
ihlr-18967	203	45	and	and	CCONJ
ihlr-18967	203	46	,	,	PUNCT
ihlr-18967	203	47	therefore	therefore	ADV
ihlr-18967	203	48	,	,	PUNCT
ihlr-18967	203	49	therapeutically	therapeutically	ADV
ihlr-18967	203	50	equivalent	equivalent	ADJ
ihlr-18967	203	51	”	"	PUNCT
ihlr-18967	203	52	to	to	ADP
ihlr-18967	203	53	lipitor	lipitor	NOUN
ihlr-18967	203	54	tablets	tablet	NOUN
ihlr-18967	203	55	.	.	PUNCT
ihlr-18967	204	1	letter	letter	NOUN
ihlr-18967	204	2	from	from	ADP
ihlr-18967	204	3	keith	keith	PROPN
ihlr-18967	204	4	webber	webber	PROPN
ihlr-18967	204	5	,	,	PUNCT
ihlr-18967	204	6	deputy	deputy	NOUN
ihlr-18967	204	7	director	director	NOUN
ihlr-18967	204	8	,	,	PUNCT
ihlr-18967	204	9	office	office	NOUN
ihlr-18967	204	10	of	of	ADP
ihlr-18967	204	11	pharmaceutical	pharmaceutical	NOUN
ihlr-18967	204	12	science	science	NOUN
ihlr-18967	204	13	,	,	PUNCT
ihlr-18967	204	14	to	to	PART
ihlr-18967	204	15	scott	scott	PROPN
ihlr-18967	204	16	d.	d.	PROPN
ihlr-18967	204	17	tomsky	tomsky	PROPN
ihlr-18967	204	18	,	,	PUNCT
ihlr-18967	204	19	senior	senior	ADJ
ihlr-18967	204	20	manage	manage	NOUN
ihlr-18967	204	21	,	,	PUNCT
ihlr-18967	204	22	regulatory	regulatory	ADJ
ihlr-18967	204	23	affairs	affair	NOUN
ihlr-18967	204	24	(	(	PUNCT
ihlr-18967	204	25	2011	2011	NUM
ihlr-18967	204	26	)	)	PUNCT
ihlr-18967	204	27	(	(	PUNCT
ihlr-18967	204	28	on	on	ADP
ihlr-18967	204	29	file	file	NOUN
ihlr-18967	204	30	with	with	ADP
ihlr-18967	204	31	author	author	NOUN
ihlr-18967	204	32	)	)	PUNCT
ihlr-18967	204	33	,	,	PUNCT
ihlr-18967	204	34	available	available	ADJ
ihlr-18967	204	35	at	at	ADP
ihlr-18967	204	36	http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2011/076477orig	http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2011/076477orig	PROPN
ihlr-18967	204	37	1s000ltr.pdf	1s000ltr.pdf	PROPN
ihlr-18967	204	38	.	.	PUNCT
ihlr-18967	205	1	434	434	NUM
ihlr-18967	205	2	indiana	indiana	PROPN
ihlr-18967	205	3	health	health	PROPN
ihlr-18967	205	4	law	law	PROPN
ihlr-18967	205	5	review	review	NOUN
ihlr-18967	205	6	vol	vol	NOUN
ihlr-18967	205	7	.	.	PUNCT
ihlr-18967	206	1	12:1	12:1	NUM
ihlr-18967	206	2	ingredient	ingredient	NOUN
ihlr-18967	206	3	,	,	PUNCT
ihlr-18967	206	4	which	which	PRON
ihlr-18967	206	5	has	have	AUX
ihlr-18967	206	6	not	not	PART
ihlr-18967	206	7	been	be	AUX
ihlr-18967	206	8	previously	previously	ADV
ihlr-18967	206	9	approved	approve	VERB
ihlr-18967	206	10	in	in	ADP
ihlr-18967	206	11	any	any	DET
ihlr-18967	206	12	other	other	ADJ
ihlr-18967	206	13	application	application	NOUN
ihlr-18967	206	14	,	,	PUNCT
ihlr-18967	206	15	an	an	DET
ihlr-18967	206	16	anda	anda	PROPN
ihlr-18967	206	17	can	can	AUX
ihlr-18967	206	18	not	not	PART
ihlr-18967	206	19	be	be	AUX
ihlr-18967	206	20	filed	file	VERB
ihlr-18967	206	21	until	until	ADP
ihlr-18967	206	22	“	"	PUNCT
ihlr-18967	206	23	the	the	DET
ihlr-18967	206	24	expiration	expiration	NOUN
ihlr-18967	206	25	of	of	ADP
ihlr-18967	206	26	four	four	NUM
ihlr-18967	206	27	years	year	NOUN
ihlr-18967	206	28	from	from	ADP
ihlr-18967	206	29	the	the	DET
ihlr-18967	206	30	date	date	NOUN
ihlr-18967	206	31	of	of	ADP
ihlr-18967	206	32	the	the	DET
ihlr-18967	206	33	approval	approval	NOUN
ihlr-18967	206	34	.	.	PUNCT
ihlr-18967	207	1	”49	”49	PROPN
ihlr-18967	207	2	third	third	ADJ
ihlr-18967	207	3	,	,	PUNCT
ihlr-18967	207	4	in	in	ADP
ihlr-18967	207	5	order	order	NOUN
ihlr-18967	207	6	to	to	PART
ihlr-18967	207	7	avoid	avoid	VERB
ihlr-18967	207	8	patent	patent	NOUN
ihlr-18967	207	9	infringement	infringement	NOUN
ihlr-18967	207	10	,	,	PUNCT
ihlr-18967	207	11	the	the	DET
ihlr-18967	207	12	generic	generic	ADJ
ihlr-18967	207	13	manufacture	manufacture	NOUN
ihlr-18967	207	14	must	must	AUX
ihlr-18967	207	15	provide	provide	VERB
ihlr-18967	207	16	a	a	DET
ihlr-18967	207	17	certification	certification	NOUN
ihlr-18967	207	18	that	that	SCONJ
ihlr-18967	207	19	the	the	DET
ihlr-18967	207	20	generic	generic	ADJ
ihlr-18967	207	21	drug	drug	NOUN
ihlr-18967	207	22	will	will	AUX
ihlr-18967	207	23	not	not	PART
ihlr-18967	207	24	infringe	infringe	VERB
ihlr-18967	207	25	the	the	DET
ihlr-18967	207	26	patent	patent	NOUN
ihlr-18967	207	27	of	of	ADP
ihlr-18967	207	28	the	the	DET
ihlr-18967	207	29	pioneer	pioneer	NOUN
ihlr-18967	207	30	drug.50	drug.50	PROPN
ihlr-18967	207	31	the	the	DET
ihlr-18967	207	32	generic	generic	ADJ
ihlr-18967	207	33	manufacturer	manufacturer	NOUN
ihlr-18967	207	34	can	can	AUX
ihlr-18967	207	35	certify	certify	VERB
ihlr-18967	207	36	(	(	PUNCT
ihlr-18967	207	37	1	1	X
ihlr-18967	207	38	)	)	PUNCT
ihlr-18967	207	39	“	"	PUNCT
ihlr-18967	207	40	that	that	SCONJ
ihlr-18967	207	41	such	such	ADJ
ihlr-18967	207	42	patent	patent	NOUN
ihlr-18967	207	43	information	information	NOUN
ihlr-18967	207	44	has	have	AUX
ihlr-18967	207	45	not	not	PART
ihlr-18967	207	46	been	be	AUX
ihlr-18967	207	47	filed	file	VERB
ihlr-18967	207	48	;	;	PUNCT
ihlr-18967	207	49	”	"	PUNCT
ihlr-18967	207	50	(	(	PUNCT
ihlr-18967	207	51	2	2	X
ihlr-18967	207	52	)	)	PUNCT
ihlr-18967	207	53	that	that	SCONJ
ihlr-18967	207	54	such	such	ADJ
ihlr-18967	207	55	patent	patent	NOUN
ihlr-18967	207	56	has	have	AUX
ihlr-18967	207	57	expired	expire	VERB
ihlr-18967	207	58	;	;	PUNCT
ihlr-18967	207	59	”	"	PUNCT
ihlr-18967	207	60	(	(	PUNCT
ihlr-18967	207	61	3	3	X
ihlr-18967	207	62	)	)	PUNCT
ihlr-18967	207	63	“	"	PUNCT
ihlr-18967	207	64	the	the	DET
ihlr-18967	207	65	date	date	NOUN
ihlr-18967	207	66	on	on	ADP
ihlr-18967	207	67	which	which	PRON
ihlr-18967	207	68	such	such	ADJ
ihlr-18967	207	69	patent	patent	NOUN
ihlr-18967	207	70	will	will	AUX
ihlr-18967	207	71	expire	expire	VERB
ihlr-18967	207	72	;	;	PUNCT
ihlr-18967	207	73	”	"	PUNCT
ihlr-18967	207	74	or	or	CCONJ
ihlr-18967	207	75	(	(	PUNCT
ihlr-18967	207	76	4	4	NUM
ihlr-18967	207	77	)	)	PUNCT
ihlr-18967	207	78	“	"	PUNCT
ihlr-18967	207	79	that	that	SCONJ
ihlr-18967	207	80	such	such	ADJ
ihlr-18967	207	81	patent	patent	NOUN
ihlr-18967	207	82	is	be	AUX
ihlr-18967	207	83	invalid	invalid	ADJ
ihlr-18967	207	84	or	or	CCONJ
ihlr-18967	207	85	will	will	AUX
ihlr-18967	207	86	not	not	PART
ihlr-18967	207	87	be	be	AUX
ihlr-18967	207	88	infringed	infringe	VERB
ihlr-18967	207	89	by	by	ADP
ihlr-18967	207	90	the	the	DET
ihlr-18967	207	91	manufacture	manufacture	NOUN
ihlr-18967	207	92	,	,	PUNCT
ihlr-18967	207	93	use	use	NOUN
ihlr-18967	207	94	,	,	PUNCT
ihlr-18967	207	95	or	or	CCONJ
ihlr-18967	207	96	sale	sale	NOUN
ihlr-18967	207	97	of	of	ADP
ihlr-18967	207	98	the	the	DET
ihlr-18967	207	99	new	new	ADJ
ihlr-18967	207	100	drug	drug	NOUN
ihlr-18967	207	101	for	for	ADP
ihlr-18967	207	102	which	which	PRON
ihlr-18967	207	103	the	the	DET
ihlr-18967	207	104	application	application	NOUN
ihlr-18967	207	105	is	be	AUX
ihlr-18967	207	106	submitted	submit	VERB
ihlr-18967	207	107	.	.	PUNCT
ihlr-18967	208	1	”51	”51	PROPN
ihlr-18967	208	2	the	the	DET
ihlr-18967	208	3	fourth	fourth	ADJ
ihlr-18967	208	4	option	option	NOUN
ihlr-18967	208	5	,	,	PUNCT
ihlr-18967	208	6	known	know	VERB
ihlr-18967	208	7	as	as	ADP
ihlr-18967	208	8	the	the	DET
ihlr-18967	208	9	paragraph	paragraph	NOUN
ihlr-18967	208	10	iv	iv	NUM
ihlr-18967	208	11	route	route	NOUN
ihlr-18967	208	12	,	,	PUNCT
ihlr-18967	208	13	is	be	AUX
ihlr-18967	208	14	enticing	entice	VERB
ihlr-18967	208	15	to	to	ADP
ihlr-18967	208	16	generic	generic	ADJ
ihlr-18967	208	17	manufacturers	manufacturer	NOUN
ihlr-18967	208	18	as	as	SCONJ
ihlr-18967	208	19	it	it	PRON
ihlr-18967	208	20	will	will	AUX
ihlr-18967	208	21	often	often	ADV
ihlr-18967	208	22	allow	allow	VERB
ihlr-18967	208	23	generic	generic	ADJ
ihlr-18967	208	24	manufacturers	manufacturer	NOUN
ihlr-18967	208	25	to	to	PART
ihlr-18967	208	26	bring	bring	VERB
ihlr-18967	208	27	its	its	PRON
ihlr-18967	208	28	product	product	NOUN
ihlr-18967	208	29	to	to	ADP
ihlr-18967	208	30	the	the	DET
ihlr-18967	208	31	market	market	NOUN
ihlr-18967	208	32	sooner	soon	ADV
ihlr-18967	208	33	than	than	ADP
ihlr-18967	208	34	under	under	ADP
ihlr-18967	208	35	the	the	DET
ihlr-18967	208	36	other	other	ADJ
ihlr-18967	208	37	three	three	NUM
ihlr-18967	208	38	routes	route	NOUN
ihlr-18967	208	39	.	.	PUNCT
ihlr-18967	209	1	in	in	ADP
ihlr-18967	209	2	order	order	NOUN
ihlr-18967	209	3	to	to	PART
ihlr-18967	209	4	provide	provide	VERB
ihlr-18967	209	5	some	some	DET
ihlr-18967	209	6	protection	protection	NOUN
ihlr-18967	209	7	,	,	PUNCT
ihlr-18967	209	8	under	under	ADP
ihlr-18967	209	9	the	the	DET
ihlr-18967	209	10	paragraph	paragraph	NOUN
ihlr-18967	209	11	iv	iv	NUM
ihlr-18967	209	12	route	route	NOUN
ihlr-18967	209	13	a	a	DET
ihlr-18967	209	14	pioneer	pioneer	NOUN
ihlr-18967	209	15	manufacturer	manufacturer	NOUN
ihlr-18967	209	16	has	have	VERB
ihlr-18967	209	17	45	45	NUM
ihlr-18967	209	18	days	day	NOUN
ihlr-18967	209	19	to	to	PART
ihlr-18967	209	20	bring	bring	VERB
ihlr-18967	209	21	an	an	DET
ihlr-18967	209	22	infringement	infringement	NOUN
ihlr-18967	209	23	suit.52	suit.52	PROPN
ihlr-18967	209	24	fourth	fourth	ADV
ihlr-18967	209	25	,	,	PUNCT
ihlr-18967	209	26	a	a	DET
ihlr-18967	209	27	generic	generic	ADJ
ihlr-18967	209	28	manufacturer	manufacturer	NOUN
ihlr-18967	209	29	who	who	PRON
ihlr-18967	209	30	is	be	AUX
ihlr-18967	209	31	first	first	ADJ
ihlr-18967	209	32	to	to	PART
ihlr-18967	209	33	file	file	VERB
ihlr-18967	209	34	an	an	DET
ihlr-18967	209	35	anda	anda	NOUN
ihlr-18967	209	36	under	under	ADP
ihlr-18967	209	37	the	the	DET
ihlr-18967	209	38	paragraph	paragraph	NOUN
ihlr-18967	209	39	iv	iv	NUM
ihlr-18967	209	40	route	route	NOUN
ihlr-18967	209	41	is	be	AUX
ihlr-18967	209	42	entitled	entitle	VERB
ihlr-18967	209	43	to	to	ADP
ihlr-18967	209	44	an	an	DET
ihlr-18967	209	45	exclusivity	exclusivity	NOUN
ihlr-18967	209	46	period	period	NOUN
ihlr-18967	209	47	of	of	ADP
ihlr-18967	209	48	180	180	NUM
ihlr-18967	209	49	days	day	NOUN
ihlr-18967	209	50	after	after	ADP
ihlr-18967	209	51	the	the	DET
ihlr-18967	209	52	date	date	NOUN
ihlr-18967	209	53	of	of	ADP
ihlr-18967	209	54	the	the	DET
ihlr-18967	209	55	first	first	ADJ
ihlr-18967	209	56	commercial	commercial	ADJ
ihlr-18967	209	57	marketing	marketing	NOUN
ihlr-18967	209	58	of	of	ADP
ihlr-18967	209	59	the	the	DET
ihlr-18967	209	60	drug.53	drug.53	PROPN
ihlr-18967	209	61	d.	d.	PROPN
ihlr-18967	209	62	alternative	alternative	ADJ
ihlr-18967	209	63	methods	method	NOUN
ihlr-18967	209	64	to	to	PART
ihlr-18967	209	65	analyze	analyze	VERB
ihlr-18967	209	66	reverse	reverse	ADJ
ihlr-18967	209	67	payment	payment	NOUN
ihlr-18967	209	68	settlements	settlement	NOUN
ihlr-18967	209	69	generic	generic	ADJ
ihlr-18967	209	70	manufacturers	manufacturer	NOUN
ihlr-18967	209	71	frequently	frequently	ADV
ihlr-18967	209	72	certify	certify	VERB
ihlr-18967	209	73	under	under	ADP
ihlr-18967	209	74	the	the	DET
ihlr-18967	209	75	paragraph	paragraph	NOUN
ihlr-18967	209	76	iv	iv	NUM
ihlr-18967	209	77	route	route	NOUN
ihlr-18967	209	78	.	.	PUNCT
ihlr-18967	210	1	in	in	ADP
ihlr-18967	210	2	order	order	NOUN
ihlr-18967	210	3	to	to	PART
ihlr-18967	210	4	counter	counter	VERB
ihlr-18967	210	5	this	this	DET
ihlr-18967	210	6	certification	certification	NOUN
ihlr-18967	210	7	,	,	PUNCT
ihlr-18967	210	8	the	the	DET
ihlr-18967	210	9	pioneer	pioneer	NOUN
ihlr-18967	210	10	manufacturer	manufacturer	NOUN
ihlr-18967	210	11	will	will	AUX
ihlr-18967	210	12	bring	bring	VERB
ihlr-18967	210	13	suit	suit	NOUN
ihlr-18967	210	14	against	against	ADP
ihlr-18967	210	15	the	the	DET
ihlr-18967	210	16	generic	generic	ADJ
ihlr-18967	210	17	manufacture	manufacture	NOUN
ihlr-18967	210	18	alleging	allege	VERB
ihlr-18967	210	19	patent	patent	NOUN
ihlr-18967	210	20	infringement	infringement	NOUN
ihlr-18967	210	21	.	.	PUNCT
ihlr-18967	211	1	in	in	ADP
ihlr-18967	211	2	the	the	DET
ihlr-18967	211	3	context	context	NOUN
ihlr-18967	211	4	of	of	ADP
ihlr-18967	211	5	this	this	DET
ihlr-18967	211	6	note	note	NOUN
ihlr-18967	211	7	,	,	PUNCT
ihlr-18967	211	8	these	these	DET
ihlr-18967	211	9	suits	suit	NOUN
ihlr-18967	211	10	are	be	AUX
ihlr-18967	211	11	resolved	resolve	VERB
ihlr-18967	211	12	through	through	ADP
ihlr-18967	211	13	a	a	DET
ihlr-18967	211	14	reverse	reverse	ADJ
ihlr-18967	211	15	payment	payment	NOUN
ihlr-18967	211	16	settlement	settlement	NOUN
ihlr-18967	211	17	instead	instead	ADV
ihlr-18967	211	18	of	of	ADP
ihlr-18967	211	19	litigating	litigate	VERB
ihlr-18967	211	20	the	the	DET
ihlr-18967	211	21	infringement	infringement	NOUN
ihlr-18967	211	22	suit	suit	NOUN
ihlr-18967	211	23	in	in	ADP
ihlr-18967	211	24	a	a	DET
ihlr-18967	211	25	court	court	NOUN
ihlr-18967	211	26	of	of	ADP
ihlr-18967	211	27	law	law	NOUN
ihlr-18967	211	28	.	.	PUNCT
ihlr-18967	212	1	while	while	SCONJ
ihlr-18967	212	2	settlements	settlement	NOUN
ihlr-18967	212	3	are	be	AUX
ihlr-18967	212	4	generally	generally	ADV
ihlr-18967	212	5	49	49	NUM
ihlr-18967	212	6	21	21	NUM
ihlr-18967	212	7	u.s.c	u.s.c	NOUN
ihlr-18967	212	8	.	.	PUNCT
ihlr-18967	213	1	§	§	PROPN
ihlr-18967	213	2	355(j)(5)(f)(ii	355(j)(5)(f)(ii	NUM
ihlr-18967	213	3	)	)	PUNCT
ihlr-18967	213	4	(	(	PUNCT
ihlr-18967	213	5	2015	2015	NUM
ihlr-18967	213	6	)	)	PUNCT
ihlr-18967	213	7	.	.	PUNCT
ihlr-18967	214	1	50	50	NUM
ihlr-18967	215	1	i	i	PRON
ihlr-18967	215	2	d.	d.	PROPN
ihlr-18967	215	3	§	§	PROPN
ihlr-18967	215	4	355(j)(2)(a)(vii	355(j)(2)(a)(vii	PROPN
ihlr-18967	215	5	)	)	PUNCT
ihlr-18967	215	6	.	.	PUNCT
ihlr-18967	216	1	51	51	NUM
ihlr-18967	217	1	i	i	PRON
ihlr-18967	217	2	d.	d.	PROPN
ihlr-18967	217	3	§	§	PROPN
ihlr-18967	217	4	355(j)(2)(a)(vii)(i)-(iv	355(j)(2)(a)(vii)(i)-(iv	PROPN
ihlr-18967	217	5	)	)	PUNCT
ihlr-18967	217	6	.	.	PUNCT
ihlr-18967	218	1	52	52	NUM
ihlr-18967	219	1	i	i	PRON
ihlr-18967	219	2	d.	d.	PROPN
ihlr-18967	219	3	§	§	PROPN
ihlr-18967	219	4	355(j)(5)(b)(iii	355(j)(5)(b)(iii	PROPN
ihlr-18967	219	5	)	)	PUNCT
ihlr-18967	219	6	(	(	PUNCT
ihlr-18967	220	1	stating	state	VERB
ihlr-18967	220	2	further	far	ADV
ihlr-18967	220	3	that	that	SCONJ
ihlr-18967	220	4	if	if	SCONJ
ihlr-18967	220	5	an	an	DET
ihlr-18967	220	6	infringement	infringement	NOUN
ihlr-18967	220	7	suit	suit	NOUN
ihlr-18967	220	8	is	be	AUX
ihlr-18967	220	9	brought	bring	VERB
ihlr-18967	220	10	,	,	PUNCT
ihlr-18967	220	11	the	the	DET
ihlr-18967	220	12	fda	fda	PROPN
ihlr-18967	220	13	must	must	AUX
ihlr-18967	220	14	withhold	withhold	VERB
ihlr-18967	220	15	approval	approval	NOUN
ihlr-18967	220	16	of	of	ADP
ihlr-18967	220	17	the	the	DET
ihlr-18967	220	18	generic	generic	ADJ
ihlr-18967	220	19	drug	drug	NOUN
ihlr-18967	220	20	for	for	ADP
ihlr-18967	220	21	a	a	DET
ihlr-18967	220	22	period	period	NOUN
ihlr-18967	220	23	of	of	ADP
ihlr-18967	220	24	30	30	NUM
ihlr-18967	220	25	months	month	NOUN
ihlr-18967	220	26	)	)	PUNCT
ihlr-18967	220	27	.	.	PUNCT
ihlr-18967	221	1	53	53	NUM
ihlr-18967	222	1	i	i	PROPN
ihlr-18967	222	2	d.	d.	PROPN
ihlr-18967	222	3	§	§	PROPN
ihlr-18967	222	4	355(j)(5)(b)(iv)(i	355(j)(5)(b)(iv)(i	NUM
ihlr-18967	222	5	)	)	PUNCT
ihlr-18967	222	6	.	.	PUNCT
ihlr-18967	223	1	2015	2015	NUM
ihlr-18967	223	2	rationale	rationale	NOUN
ihlr-18967	223	3	behind	behind	ADP
ihlr-18967	223	4	hatch	hatch	NOUN
ihlr-18967	223	5	-	-	PUNCT
ihlr-18967	223	6	waxman	waxman	PROPN
ihlr-18967	223	7	act	act	PROPN
ihlr-18967	223	8	and	and	CCONJ
ihlr-18967	223	9	patent	patent	NOUN
ihlr-18967	223	10	law	law	NOUN
ihlr-18967	223	11	435	435	NUM
ihlr-18967	223	12	favored	favor	VERB
ihlr-18967	223	13	,	,	PUNCT
ihlr-18967	223	14	the	the	DET
ihlr-18967	223	15	ftc	ftc	PROPN
ihlr-18967	223	16	has	have	VERB
ihlr-18967	223	17	issue	issue	NOUN
ihlr-18967	223	18	with	with	ADP
ihlr-18967	223	19	these	these	DET
ihlr-18967	223	20	reverse	reverse	ADJ
ihlr-18967	223	21	payment	payment	NOUN
ihlr-18967	223	22	settlements	settlement	NOUN
ihlr-18967	223	23	because	because	SCONJ
ihlr-18967	223	24	,	,	PUNCT
ihlr-18967	223	25	in	in	ADP
ihlr-18967	223	26	its	its	PRON
ihlr-18967	223	27	eyes	eye	NOUN
ihlr-18967	223	28	,	,	PUNCT
ihlr-18967	223	29	they	they	PRON
ihlr-18967	223	30	are	be	AUX
ihlr-18967	223	31	anticompetitive.54	anticompetitive.54	ADJ
ihlr-18967	223	32	before	before	ADP
ihlr-18967	223	33	actavis	actavis	NOUN
ihlr-18967	223	34	,	,	PUNCT
ihlr-18967	223	35	federal	federal	ADJ
ihlr-18967	223	36	courts	court	NOUN
ihlr-18967	223	37	were	be	AUX
ihlr-18967	223	38	split	split	VERB
ihlr-18967	223	39	on	on	ADP
ihlr-18967	223	40	whether	whether	SCONJ
ihlr-18967	223	41	antitrust	antitrust	ADJ
ihlr-18967	223	42	or	or	CCONJ
ihlr-18967	223	43	patent	patent	NOUN
ihlr-18967	223	44	law	law	NOUN
ihlr-18967	223	45	applied	apply	VERB
ihlr-18967	223	46	to	to	PART
ihlr-18967	223	47	reverse	reverse	VERB
ihlr-18967	223	48	payment	payment	NOUN
ihlr-18967	223	49	settlements	settlement	NOUN
ihlr-18967	223	50	under	under	ADP
ihlr-18967	223	51	the	the	DET
ihlr-18967	223	52	hatch	hatch	NOUN
ihlr-18967	223	53	-	-	PUNCT
ihlr-18967	223	54	waxman	waxman	NOUN
ihlr-18967	223	55	act.55	act.55	PROPN
ihlr-18967	223	56	however	however	ADV
ihlr-18967	223	57	,	,	PUNCT
ihlr-18967	223	58	initially	initially	ADV
ihlr-18967	223	59	,	,	PUNCT
ihlr-18967	223	60	due	due	ADP
ihlr-18967	223	61	to	to	ADP
ihlr-18967	223	62	binding	binding	ADJ
ihlr-18967	223	63	and	and	CCONJ
ihlr-18967	223	64	favorable	favorable	ADJ
ihlr-18967	223	65	precedent	precedent	NOUN
ihlr-18967	223	66	in	in	ADP
ihlr-18967	223	67	the	the	DET
ihlr-18967	223	68	eleventh	eleventh	ADJ
ihlr-18967	223	69	circuit	circuit	NOUN
ihlr-18967	223	70	,	,	PUNCT
ihlr-18967	223	71	pharmaceutical	pharmaceutical	ADJ
ihlr-18967	223	72	manufacturers	manufacturer	NOUN
ihlr-18967	223	73	would	would	AUX
ihlr-18967	223	74	generally	generally	ADV
ihlr-18967	223	75	appeal	appeal	VERB
ihlr-18967	223	76	ftc	ftc	PROPN
ihlr-18967	223	77	final	final	ADJ
ihlr-18967	223	78	orders	order	NOUN
ihlr-18967	223	79	in	in	ADP
ihlr-18967	223	80	its	its	PRON
ihlr-18967	223	81	jurisdiction.56	jurisdiction.56	NOUN
ihlr-18967	223	82	this	this	PRON
ihlr-18967	223	83	allowed	allow	VERB
ihlr-18967	223	84	pharmaceutical	pharmaceutical	ADJ
ihlr-18967	223	85	manufacturers	manufacturer	NOUN
ihlr-18967	223	86	to	to	PART
ihlr-18967	223	87	prevent	prevent	VERB
ihlr-18967	223	88	another	another	DET
ihlr-18967	223	89	circuit	circuit	NOUN
ihlr-18967	223	90	from	from	ADP
ihlr-18967	223	91	creating	create	VERB
ihlr-18967	223	92	a	a	DET
ihlr-18967	223	93	circuit	circuit	NOUN
ihlr-18967	223	94	split	split	NOUN
ihlr-18967	223	95	,	,	PUNCT
ihlr-18967	223	96	and	and	CCONJ
ihlr-18967	223	97	in	in	ADP
ihlr-18967	223	98	turn	turn	NOUN
ihlr-18967	223	99	make	make	VERB
ihlr-18967	223	100	the	the	DET
ihlr-18967	223	101	issue	issue	NOUN
ihlr-18967	223	102	appealable	appealable	ADJ
ihlr-18967	223	103	to	to	ADP
ihlr-18967	223	104	the	the	DET
ihlr-18967	223	105	supreme	supreme	PROPN
ihlr-18967	223	106	court.57	court.57	PROPN
ihlr-18967	223	107	eventually	eventually	ADV
ihlr-18967	223	108	,	,	PUNCT
ihlr-18967	223	109	a	a	DET
ihlr-18967	223	110	group	group	NOUN
ihlr-18967	223	111	of	of	ADP
ihlr-18967	223	112	wholesalers	wholesaler	NOUN
ihlr-18967	223	113	and	and	CCONJ
ihlr-18967	223	114	retailers	retailer	NOUN
ihlr-18967	223	115	brought	bring	VERB
ihlr-18967	223	116	a	a	DET
ihlr-18967	223	117	suit	suit	NOUN
ihlr-18967	223	118	involving	involve	VERB
ihlr-18967	223	119	reverse	reverse	ADJ
ihlr-18967	223	120	payment	payment	NOUN
ihlr-18967	223	121	settlements	settlement	NOUN
ihlr-18967	223	122	in	in	ADP
ihlr-18967	223	123	the	the	DET
ihlr-18967	223	124	third	third	ADJ
ihlr-18967	223	125	circuit.58	circuit.58	NOUN
ihlr-18967	223	126	subsequently	subsequently	ADV
ihlr-18967	223	127	,	,	PUNCT
ihlr-18967	223	128	the	the	DET
ihlr-18967	223	129	third	third	ADJ
ihlr-18967	223	130	circuit	circuit	NOUN
ihlr-18967	223	131	’s	’s	PART
ihlr-18967	223	132	decision	decision	NOUN
ihlr-18967	223	133	in	in	ADP
ihlr-18967	223	134	in	in	ADP
ihlr-18967	223	135	re	re	PROPN
ihlr-18967	223	136	54	54	NUM
ihlr-18967	223	137	see	see	VERB
ihlr-18967	223	138	pay	pay	NOUN
ihlr-18967	223	139	-	-	PUNCT
ihlr-18967	223	140	for	for	ADP
ihlr-18967	223	141	-	-	PUNCT
ihlr-18967	223	142	delay	delay	NOUN
ihlr-18967	223	143	,	,	PUNCT
ihlr-18967	223	144	supra	supra	NOUN
ihlr-18967	223	145	note	note	NOUN
ihlr-18967	223	146	9	9	NUM
ihlr-18967	223	147	(	(	PUNCT
ihlr-18967	223	148	explaining	explain	VERB
ihlr-18967	223	149	how	how	SCONJ
ihlr-18967	223	150	reverse	reverse	ADJ
ihlr-18967	223	151	payment	payment	NOUN
ihlr-18967	223	152	settlements	settlement	NOUN
ihlr-18967	223	153	“	"	PUNCT
ihlr-18967	223	154	have	have	AUX
ihlr-18967	223	155	significantly	significantly	ADV
ihlr-18967	223	156	postponed	postpone	VERB
ihlr-18967	223	157	substantial	substantial	ADJ
ihlr-18967	223	158	consumer	consumer	NOUN
ihlr-18967	223	159	savings	saving	NOUN
ihlr-18967	223	160	from	from	ADP
ihlr-18967	223	161	lower	low	ADJ
ihlr-18967	223	162	generic	generic	ADJ
ihlr-18967	223	163	prices	price	NOUN
ihlr-18967	223	164	”	"	PUNCT
ihlr-18967	223	165	)	)	PUNCT
ihlr-18967	223	166	.	.	PUNCT
ihlr-18967	224	1	55	55	NUM
ihlr-18967	224	2	compare	compare	VERB
ihlr-18967	224	3	in	in	ADP
ihlr-18967	224	4	re	re	ADP
ihlr-18967	224	5	ciprofloxacin	ciprofloxacin	PROPN
ihlr-18967	224	6	hydrochloride	hydrochloride	ADJ
ihlr-18967	224	7	antitrust	antitrust	ADJ
ihlr-18967	224	8	litig	litig	NOUN
ihlr-18967	224	9	.	.	PUNCT
ihlr-18967	224	10	,	,	PUNCT
ihlr-18967	224	11	544	544	NUM
ihlr-18967	224	12	f.3d	f.3d	NUM
ihlr-18967	224	13	1323	1323	NUM
ihlr-18967	224	14	,	,	PUNCT
ihlr-18967	224	15	1336	1336	NUM
ihlr-18967	224	16	(	(	PUNCT
ihlr-18967	224	17	fed	fed	PROPN
ihlr-18967	224	18	.	.	PUNCT
ihlr-18967	224	19	cir	cir	PROPN
ihlr-18967	224	20	.	.	PROPN
ihlr-18967	224	21	2008	2008	NUM
ihlr-18967	224	22	)	)	PUNCT
ihlr-18967	225	1	(	(	PUNCT
ihlr-18967	225	2	inquiry	inquiry	NOUN
ihlr-18967	225	3	is	be	AUX
ihlr-18967	225	4	whether	whether	SCONJ
ihlr-18967	225	5	the	the	DET
ihlr-18967	225	6	agreement	agreement	NOUN
ihlr-18967	225	7	exceeded	exceed	VERB
ihlr-18967	225	8	the	the	DET
ihlr-18967	225	9	exclusionary	exclusionary	ADJ
ihlr-18967	225	10	zone	zone	NOUN
ihlr-18967	225	11	of	of	ADP
ihlr-18967	225	12	the	the	DET
ihlr-18967	225	13	patent	patent	NOUN
ihlr-18967	225	14	)	)	PUNCT
ihlr-18967	225	15	,	,	PUNCT
ihlr-18967	225	16	abrogated	abrogate	VERB
ihlr-18967	225	17	by	by	ADP
ihlr-18967	225	18	ftc	ftc	PROPN
ihlr-18967	225	19	v.	v.	ADP
ihlr-18967	225	20	actavis	actavis	PROPN
ihlr-18967	225	21	,	,	PUNCT
ihlr-18967	225	22	inc	inc	PROPN
ihlr-18967	225	23	.	.	PROPN
ihlr-18967	225	24	,	,	PUNCT
ihlr-18967	225	25	133	133	NUM
ihlr-18967	225	26	s.	s.	PROPN
ihlr-18967	225	27	ct	ct	PROPN
ihlr-18967	225	28	.	.	PROPN
ihlr-18967	225	29	2223	2223	NUM
ihlr-18967	225	30	(	(	PUNCT
ihlr-18967	225	31	2013	2013	NUM
ihlr-18967	225	32	)	)	PUNCT
ihlr-18967	225	33	;	;	PUNCT
ihlr-18967	225	34	in	in	ADP
ihlr-18967	225	35	re	re	ADP
ihlr-18967	225	36	tamoxifen	tamoxifen	NOUN
ihlr-18967	225	37	citrate	citrate	NOUN
ihlr-18967	225	38	antitrust	antitrust	ADJ
ihlr-18967	225	39	litig	litig	NOUN
ihlr-18967	225	40	.	.	PUNCT
ihlr-18967	226	1	,	,	PUNCT
ihlr-18967	226	2	466	466	NUM
ihlr-18967	226	3	f.3d	f.3d	NUM
ihlr-18967	226	4	187	187	NUM
ihlr-18967	226	5	,	,	PUNCT
ihlr-18967	226	6	212	212	NUM
ihlr-18967	226	7	-	-	SYM
ihlr-18967	226	8	13	13	NUM
ihlr-18967	226	9	(	(	PUNCT
ihlr-18967	226	10	2d	2d	NUM
ihlr-18967	226	11	cir	cir	NOUN
ihlr-18967	226	12	.	.	PUNCT
ihlr-18967	226	13	2006	2006	NUM
ihlr-18967	226	14	)	)	PUNCT
ihlr-18967	226	15	(	(	PUNCT
ihlr-18967	226	16	immune	immune	ADJ
ihlr-18967	226	17	from	from	ADP
ihlr-18967	226	18	antitrust	antitrust	ADJ
ihlr-18967	226	19	attack	attack	NOUN
ihlr-18967	226	20	as	as	ADV
ihlr-18967	226	21	long	long	ADV
ihlr-18967	226	22	as	as	SCONJ
ihlr-18967	226	23	settlement	settlement	NOUN
ihlr-18967	226	24	does	do	AUX
ihlr-18967	226	25	not	not	PART
ihlr-18967	226	26	exceed	exceed	VERB
ihlr-18967	226	27	scope	scope	NOUN
ihlr-18967	226	28	of	of	ADP
ihlr-18967	226	29	patent	patent	NOUN
ihlr-18967	226	30	)	)	PUNCT
ihlr-18967	226	31	,	,	PUNCT
ihlr-18967	226	32	abrogated	abrogate	VERB
ihlr-18967	226	33	by	by	ADP
ihlr-18967	226	34	actavis	actavis	PROPN
ihlr-18967	226	35	,	,	PUNCT
ihlr-18967	226	36	133	133	NUM
ihlr-18967	226	37	s.	s.	PROPN
ihlr-18967	226	38	ct	ct	PROPN
ihlr-18967	226	39	.	.	PROPN
ihlr-18967	226	40	2223	2223	NUM
ihlr-18967	226	41	;	;	PUNCT
ihlr-18967	226	42	valley	valley	NOUN
ihlr-18967	226	43	drug	drug	PROPN
ihlr-18967	226	44	co.	co.	PROPN
ihlr-18967	226	45	v.	v.	ADP
ihlr-18967	226	46	geneva	geneva	PROPN
ihlr-18967	226	47	pharms	pharms	PROPN
ihlr-18967	226	48	.	.	PUNCT
ihlr-18967	226	49	,	,	PUNCT
ihlr-18967	226	50	inc	inc	PROPN
ihlr-18967	226	51	.	.	PROPN
ihlr-18967	226	52	,	,	PUNCT
ihlr-18967	226	53	344	344	NUM
ihlr-18967	226	54	f.3d	f.3d	NUM
ihlr-18967	226	55	1294	1294	NUM
ihlr-18967	226	56	,	,	PUNCT
ihlr-18967	226	57	1311	1311	NUM
ihlr-18967	226	58	(	(	PUNCT
ihlr-18967	226	59	11th	11th	ADJ
ihlr-18967	226	60	cir	cir	NOUN
ihlr-18967	226	61	.	.	PROPN
ihlr-18967	226	62	2003	2003	NUM
ihlr-18967	226	63	)	)	PUNCT
ihlr-18967	226	64	(	(	PUNCT
ihlr-18967	226	65	a	a	DET
ihlr-18967	226	66	reverse	reverse	ADJ
ihlr-18967	226	67	payment	payment	NOUN
ihlr-18967	226	68	settlement	settlement	NOUN
ihlr-18967	226	69	does	do	AUX
ihlr-18967	226	70	not	not	PART
ihlr-18967	226	71	demonstrate	demonstrate	VERB
ihlr-18967	226	72	a	a	DET
ihlr-18967	226	73	settlement	settlement	NOUN
ihlr-18967	226	74	is	be	AUX
ihlr-18967	226	75	anticompetitive	anticompetitive	ADJ
ihlr-18967	226	76	)	)	PUNCT
ihlr-18967	226	77	,	,	PUNCT
ihlr-18967	226	78	with	with	ADP
ihlr-18967	226	79	in	in	ADP
ihlr-18967	226	80	re	re	NOUN
ihlr-18967	226	81	k	k	ADJ
ihlr-18967	226	82	-	-	ADJ
ihlr-18967	226	83	dur	dur	ADJ
ihlr-18967	226	84	antitrust	antitrust	ADJ
ihlr-18967	226	85	litig	litig	NOUN
ihlr-18967	226	86	.	.	PUNCT
ihlr-18967	227	1	,	,	PUNCT
ihlr-18967	227	2	686	686	NUM
ihlr-18967	227	3	f.	f.	NOUN
ihlr-18967	227	4	3d	3d	PROPN
ihlr-18967	227	5	197	197	NUM
ihlr-18967	227	6	,	,	PUNCT
ihlr-18967	227	7	218	218	NUM
ihlr-18967	227	8	(	(	PUNCT
ihlr-18967	227	9	3d	3d	PROPN
ihlr-18967	227	10	cir	cir	NOUN
ihlr-18967	227	11	.	.	PROPN
ihlr-18967	227	12	2012	2012	NUM
ihlr-18967	227	13	)	)	PUNCT
ihlr-18967	227	14	(	(	PUNCT
ihlr-18967	227	15	presumably	presumably	ADV
ihlr-18967	227	16	an	an	DET
ihlr-18967	227	17	unreasonable	unreasonable	ADJ
ihlr-18967	227	18	restraint	restraint	NOUN
ihlr-18967	227	19	on	on	ADP
ihlr-18967	227	20	trade	trade	NOUN
ihlr-18967	227	21	)	)	PUNCT
ihlr-18967	227	22	,	,	PUNCT
ihlr-18967	227	23	vacated	vacate	VERB
ihlr-18967	227	24	,	,	PUNCT
ihlr-18967	227	25	actavis	actavi	NOUN
ihlr-18967	227	26	,	,	PUNCT
ihlr-18967	227	27	133	133	NUM
ihlr-18967	227	28	s.	s.	PROPN
ihlr-18967	227	29	ct	ct	PROPN
ihlr-18967	227	30	.	.	PROPN
ihlr-18967	227	31	2223	2223	NUM
ihlr-18967	227	32	,	,	PUNCT
ihlr-18967	227	33	and	and	CCONJ
ihlr-18967	227	34	in	in	ADP
ihlr-18967	227	35	re	re	PROPN
ihlr-18967	227	36	cardizem	cardizem	PROPN
ihlr-18967	227	37	cd	cd	PROPN
ihlr-18967	227	38	antitrust	antitrust	ADJ
ihlr-18967	227	39	litig	litig	NOUN
ihlr-18967	227	40	.	.	PUNCT
ihlr-18967	227	41	,	,	PUNCT
ihlr-18967	227	42	332	332	NUM
ihlr-18967	227	43	f.3d	f.3d	NUM
ihlr-18967	227	44	896	896	NUM
ihlr-18967	227	45	,	,	PUNCT
ihlr-18967	227	46	908	908	NUM
ihlr-18967	227	47	(	(	PUNCT
ihlr-18967	227	48	6th	6th	ADJ
ihlr-18967	227	49	cir	cir	NOUN
ihlr-18967	227	50	.	.	PROPN
ihlr-18967	227	51	2003	2003	NUM
ihlr-18967	227	52	)	)	PUNCT
ihlr-18967	228	1	(	(	PUNCT
ihlr-18967	228	2	reverse	reverse	VERB
ihlr-18967	228	3	payment	payment	NOUN
ihlr-18967	228	4	delaying	delay	VERB
ihlr-18967	228	5	180	180	NUM
ihlr-18967	228	6	day	day	NOUN
ihlr-18967	228	7	exclusivity	exclusivity	NOUN
ihlr-18967	228	8	period	period	NOUN
ihlr-18967	228	9	was	be	AUX
ihlr-18967	228	10	a	a	DET
ihlr-18967	228	11	horizontal	horizontal	ADJ
ihlr-18967	228	12	restraint	restraint	NOUN
ihlr-18967	228	13	of	of	ADP
ihlr-18967	228	14	trade	trade	NOUN
ihlr-18967	228	15	,	,	PUNCT
ihlr-18967	228	16	which	which	PRON
ihlr-18967	228	17	are	be	AUX
ihlr-18967	228	18	deemed	deem	VERB
ihlr-18967	228	19	per	per	ADP
ihlr-18967	228	20	se	se	X
ihlr-18967	228	21	illegal	illegal	ADJ
ihlr-18967	228	22	restraints	restraint	NOUN
ihlr-18967	228	23	on	on	ADP
ihlr-18967	228	24	trade	trade	NOUN
ihlr-18967	228	25	)	)	PUNCT
ihlr-18967	228	26	;	;	PUNCT
ihlr-18967	228	27	andrx	andrx	NOUN
ihlr-18967	228	28	pharms	pharm	NOUN
ihlr-18967	228	29	.	.	PUNCT
ihlr-18967	228	30	,	,	PUNCT
ihlr-18967	228	31	inc	inc	PROPN
ihlr-18967	228	32	.	.	PROPN
ihlr-18967	228	33	v.	v.	PROPN
ihlr-18967	228	34	biovail	biovail	PROPN
ihlr-18967	228	35	corp	corp	PROPN
ihlr-18967	228	36	.	.	PROPN
ihlr-18967	228	37	int’l	int’l	NUM
ihlr-18967	228	38	,	,	PUNCT
ihlr-18967	228	39	256	256	NUM
ihlr-18967	228	40	f.3d	f.3d	NUM
ihlr-18967	228	41	799	799	NUM
ihlr-18967	228	42	,	,	PUNCT
ihlr-18967	228	43	813	813	NUM
ihlr-18967	228	44	(	(	PUNCT
ihlr-18967	228	45	d.c	d.c	PROPN
ihlr-18967	228	46	.	.	PROPN
ihlr-18967	228	47	cir	cir	PROPN
ihlr-18967	228	48	.	.	PROPN
ihlr-18967	228	49	2001	2001	NUM
ihlr-18967	228	50	)	)	PUNCT
ihlr-18967	228	51	(	(	PUNCT
ihlr-18967	228	52	agreement	agreement	NOUN
ihlr-18967	228	53	to	to	PART
ihlr-18967	228	54	maintain	maintain	VERB
ihlr-18967	228	55	the	the	DET
ihlr-18967	228	56	status	status	NOUN
ihlr-18967	228	57	quo	quo	NOUN
ihlr-18967	228	58	until	until	ADP
ihlr-18967	228	59	end	end	NOUN
ihlr-18967	228	60	of	of	ADP
ihlr-18967	228	61	infringement	infringement	NOUN
ihlr-18967	228	62	suit	suit	NOUN
ihlr-18967	228	63	“	"	PUNCT
ihlr-18967	228	64	harms	harm	VERB
ihlr-18967	228	65	consumers	consumer	NOUN
ihlr-18967	228	66	by	by	ADP
ihlr-18967	228	67	slowing	slow	VERB
ihlr-18967	228	68	the	the	DET
ihlr-18967	228	69	introduction	introduction	NOUN
ihlr-18967	228	70	of	of	ADP
ihlr-18967	228	71	lower	low	ADJ
ihlr-18967	228	72	priced	price	VERB
ihlr-18967	228	73	products	product	NOUN
ihlr-18967	228	74	into	into	ADP
ihlr-18967	228	75	the	the	DET
ihlr-18967	228	76	market	market	NOUN
ihlr-18967	228	77	”	"	PUNCT
ihlr-18967	228	78	)	)	PUNCT
ihlr-18967	228	79	.	.	PUNCT
ihlr-18967	229	1	56	56	NUM
ihlr-18967	229	2	see	see	VERB
ihlr-18967	229	3	15	15	NUM
ihlr-18967	229	4	u.s.c	u.s.c	ADJ
ihlr-18967	229	5	.	.	PUNCT
ihlr-18967	230	1	§	§	PROPN
ihlr-18967	230	2	45(c	45(c	NUM
ihlr-18967	230	3	)	)	PUNCT
ihlr-18967	230	4	(	(	PUNCT
ihlr-18967	230	5	2015	2015	NUM
ihlr-18967	230	6	)	)	PUNCT
ihlr-18967	230	7	(	(	PUNCT
ihlr-18967	230	8	“	"	PUNCT
ihlr-18967	230	9	any	any	DET
ihlr-18967	230	10	person	person	NOUN
ihlr-18967	230	11	,	,	PUNCT
ihlr-18967	230	12	partnership	partnership	NOUN
ihlr-18967	230	13	,	,	PUNCT
ihlr-18967	230	14	or	or	CCONJ
ihlr-18967	230	15	corporation	corporation	NOUN
ihlr-18967	230	16	required	require	VERB
ihlr-18967	230	17	by	by	ADP
ihlr-18967	230	18	an	an	DET
ihlr-18967	230	19	order	order	NOUN
ihlr-18967	230	20	of	of	ADP
ihlr-18967	230	21	the	the	DET
ihlr-18967	230	22	[	[	X
ihlr-18967	230	23	ftc	ftc	X
ihlr-18967	230	24	]	]	PUNCT
ihlr-18967	230	25	to	to	PART
ihlr-18967	230	26	cease	cease	VERB
ihlr-18967	230	27	and	and	CCONJ
ihlr-18967	230	28	desist	desist	VERB
ihlr-18967	230	29	from	from	ADP
ihlr-18967	230	30	using	use	VERB
ihlr-18967	230	31	any	any	DET
ihlr-18967	230	32	method	method	NOUN
ihlr-18967	230	33	of	of	ADP
ihlr-18967	230	34	competition	competition	NOUN
ihlr-18967	230	35	or	or	CCONJ
ihlr-18967	230	36	act	act	NOUN
ihlr-18967	230	37	or	or	CCONJ
ihlr-18967	230	38	practice	practice	NOUN
ihlr-18967	230	39	may	may	AUX
ihlr-18967	230	40	obtain	obtain	VERB
ihlr-18967	230	41	a	a	DET
ihlr-18967	230	42	review	review	NOUN
ihlr-18967	230	43	of	of	ADP
ihlr-18967	230	44	such	such	ADJ
ihlr-18967	230	45	order	order	NOUN
ihlr-18967	230	46	in	in	ADP
ihlr-18967	230	47	the	the	DET
ihlr-18967	230	48	court	court	NOUN
ihlr-18967	230	49	of	of	ADP
ihlr-18967	230	50	appeals	appeals	PROPN
ihlr-18967	230	51	of	of	ADP
ihlr-18967	230	52	the	the	DET
ihlr-18967	230	53	united	united	PROPN
ihlr-18967	230	54	states	states	PROPN
ihlr-18967	230	55	,	,	PUNCT
ihlr-18967	230	56	within	within	ADP
ihlr-18967	230	57	any	any	DET
ihlr-18967	230	58	circuit	circuit	NOUN
ihlr-18967	230	59	where	where	SCONJ
ihlr-18967	230	60	the	the	DET
ihlr-18967	230	61	method	method	NOUN
ihlr-18967	230	62	of	of	ADP
ihlr-18967	230	63	competition	competition	NOUN
ihlr-18967	230	64	or	or	CCONJ
ihlr-18967	230	65	the	the	DET
ihlr-18967	230	66	act	act	NOUN
ihlr-18967	230	67	or	or	CCONJ
ihlr-18967	230	68	practice	practice	NOUN
ihlr-18967	230	69	in	in	ADP
ihlr-18967	230	70	question	question	NOUN
ihlr-18967	230	71	was	be	AUX
ihlr-18967	230	72	used	use	VERB
ihlr-18967	230	73	or	or	CCONJ
ihlr-18967	230	74	where	where	SCONJ
ihlr-18967	230	75	such	such	ADJ
ihlr-18967	230	76	person	person	NOUN
ihlr-18967	230	77	,	,	PUNCT
ihlr-18967	230	78	partnership	partnership	NOUN
ihlr-18967	230	79	,	,	PUNCT
ihlr-18967	230	80	or	or	CCONJ
ihlr-18967	230	81	corporation	corporation	NOUN
ihlr-18967	230	82	resides	reside	VERB
ihlr-18967	230	83	or	or	CCONJ
ihlr-18967	230	84	carries	carry	VERB
ihlr-18967	230	85	on	on	ADP
ihlr-18967	230	86	business	business	NOUN
ihlr-18967	230	87	.	.	PUNCT
ihlr-18967	230	88	.	.	PUNCT
ihlr-18967	230	89	.	.	PUNCT
ihlr-18967	230	90	.	.	PUNCT
ihlr-18967	230	91	”	"	PUNCT
ihlr-18967	231	1	)	)	PUNCT
ihlr-18967	231	2	(	(	PUNCT
ihlr-18967	231	3	emphasis	emphasis	NOUN
ihlr-18967	231	4	added	add	VERB
ihlr-18967	231	5	)	)	PUNCT
ihlr-18967	231	6	.	.	PUNCT
ihlr-18967	232	1	57	57	NUM
ihlr-18967	232	2	see	see	NOUN
ihlr-18967	232	3	sup	sup	NOUN
ihlr-18967	232	4	.	.	PUNCT
ihlr-18967	233	1	ct	ct	PROPN
ihlr-18967	233	2	.	.	PUNCT
ihlr-18967	234	1	r.	r.	PROPN
ihlr-18967	234	2	10	10	NUM
ihlr-18967	234	3	.	.	PUNCT
ihlr-18967	234	4	58	58	NUM
ihlr-18967	234	5	in	in	ADP
ihlr-18967	234	6	re	re	PROPN
ihlr-18967	234	7	k	k	X
ihlr-18967	234	8	-	-	PUNCT
ihlr-18967	234	9	dur	dur	PROPN
ihlr-18967	234	10	,	,	PUNCT
ihlr-18967	234	11	686	686	NUM
ihlr-18967	234	12	f.3d	f.3d	NUM
ihlr-18967	234	13	at	at	ADP
ihlr-18967	234	14	207	207	NUM
ihlr-18967	234	15	.	.	PUNCT
ihlr-18967	235	1	436	436	NUM
ihlr-18967	235	2	indiana	indiana	PROPN
ihlr-18967	235	3	health	health	PROPN
ihlr-18967	235	4	law	law	PROPN
ihlr-18967	235	5	review	review	NOUN
ihlr-18967	235	6	vol	vol	NOUN
ihlr-18967	235	7	.	.	PUNCT
ihlr-18967	236	1	12:1	12:1	NUM
ihlr-18967	236	2	k	k	ADJ
ihlr-18967	236	3	-	-	PUNCT
ihlr-18967	236	4	dur	dur	PROPN
ihlr-18967	236	5	antitrust	antitrust	ADJ
ihlr-18967	236	6	litigation	litigation	NOUN
ihlr-18967	236	7	created	create	VERB
ihlr-18967	236	8	a	a	DET
ihlr-18967	236	9	circuit	circuit	NOUN
ihlr-18967	236	10	split	split	VERB
ihlr-18967	236	11	with	with	ADP
ihlr-18967	236	12	the	the	DET
ihlr-18967	236	13	eleventh	eleventh	ADJ
ihlr-18967	236	14	circuit	circuit	NOUN
ihlr-18967	236	15	’s	’s	PART
ihlr-18967	236	16	decision	decision	NOUN
ihlr-18967	236	17	in	in	ADP
ihlr-18967	236	18	ftc	ftc	PROPN
ihlr-18967	236	19	v.	v.	PROPN
ihlr-18967	236	20	watson	watson	PROPN
ihlr-18967	236	21	pharmaceuticals	pharmaceutical	NOUN
ihlr-18967	236	22	.	.	PUNCT
ihlr-18967	237	1	1	1	X
ihlr-18967	237	2	.	.	X
ihlr-18967	237	3	the	the	DET
ihlr-18967	237	4	third	third	ADJ
ihlr-18967	237	5	circuit	circuit	NOUN
ihlr-18967	237	6	:	:	PUNCT
ihlr-18967	237	7	the	the	DET
ihlr-18967	237	8	quick	quick	ADJ
ihlr-18967	237	9	look	look	NOUN
ihlr-18967	237	10	rule	rule	NOUN
ihlr-18967	237	11	of	of	ADP
ihlr-18967	237	12	reason	reason	NOUN
ihlr-18967	237	13	test	test	NOUN
ihlr-18967	237	14	the	the	DET
ihlr-18967	237	15	third	third	ADJ
ihlr-18967	237	16	circuit	circuit	NOUN
ihlr-18967	237	17	applied	apply	VERB
ihlr-18967	237	18	a	a	DET
ihlr-18967	237	19	“	"	PUNCT
ihlr-18967	237	20	quick	quick	ADJ
ihlr-18967	237	21	look	look	NOUN
ihlr-18967	237	22	”	"	PUNCT
ihlr-18967	237	23	rule	rule	NOUN
ihlr-18967	237	24	of	of	ADP
ihlr-18967	237	25	reason	reason	NOUN
ihlr-18967	237	26	analysis.59	analysis.59	VERB
ihlr-18967	237	27	in	in	ADP
ihlr-18967	237	28	doing	do	VERB
ihlr-18967	237	29	so	so	ADV
ihlr-18967	237	30	,	,	PUNCT
ihlr-18967	237	31	the	the	DET
ihlr-18967	237	32	third	third	ADJ
ihlr-18967	237	33	circuit	circuit	NOUN
ihlr-18967	237	34	held	hold	VERB
ihlr-18967	237	35	that	that	SCONJ
ihlr-18967	237	36	reverse	reverse	ADJ
ihlr-18967	237	37	payment	payment	NOUN
ihlr-18967	237	38	settlements	settlement	NOUN
ihlr-18967	237	39	were	be	AUX
ihlr-18967	237	40	“	"	PUNCT
ihlr-18967	237	41	prima	prima	NOUN
ihlr-18967	237	42	facie	facie	NOUN
ihlr-18967	237	43	evidence	evidence	NOUN
ihlr-18967	237	44	of	of	ADP
ihlr-18967	237	45	an	an	DET
ihlr-18967	237	46	unreasonable	unreasonable	ADJ
ihlr-18967	237	47	restraint	restraint	NOUN
ihlr-18967	237	48	of	of	ADP
ihlr-18967	237	49	trade	trade	NOUN
ihlr-18967	237	50	.	.	PUNCT
ihlr-18967	237	51	.	.	PUNCT
ihlr-18967	237	52	.	.	PUNCT
ihlr-18967	238	1	.”60	.”60	PROPN
ihlr-18967	239	1	this	this	DET
ihlr-18967	239	2	presumption	presumption	NOUN
ihlr-18967	239	3	can	can	AUX
ihlr-18967	239	4	be	be	AUX
ihlr-18967	239	5	“	"	PUNCT
ihlr-18967	239	6	rebutted	rebut	VERB
ihlr-18967	239	7	by	by	ADP
ihlr-18967	239	8	showing	show	VERB
ihlr-18967	239	9	that	that	SCONJ
ihlr-18967	239	10	the	the	DET
ihlr-18967	239	11	payment	payment	NOUN
ihlr-18967	239	12	(	(	PUNCT
ihlr-18967	239	13	1	1	NUM
ihlr-18967	239	14	)	)	PUNCT
ihlr-18967	239	15	was	be	AUX
ihlr-18967	239	16	for	for	ADP
ihlr-18967	239	17	a	a	DET
ihlr-18967	239	18	purpose	purpose	NOUN
ihlr-18967	239	19	other	other	ADJ
ihlr-18967	239	20	than	than	ADP
ihlr-18967	239	21	delayed	delay	VERB
ihlr-18967	239	22	entry	entry	NOUN
ihlr-18967	239	23	or	or	CCONJ
ihlr-18967	239	24	(	(	PUNCT
ihlr-18967	239	25	2	2	NUM
ihlr-18967	239	26	)	)	PUNCT
ihlr-18967	239	27	offers	offer	VERB
ihlr-18967	239	28	some	some	DET
ihlr-18967	239	29	procompetitive	procompetitive	ADJ
ihlr-18967	239	30	benefit	benefit	NOUN
ihlr-18967	239	31	.	.	PUNCT
ihlr-18967	240	1	”61	”61	NOUN
ihlr-18967	240	2	based	base	VERB
ihlr-18967	240	3	on	on	ADP
ihlr-18967	240	4	the	the	DET
ihlr-18967	240	5	presumption	presumption	NOUN
ihlr-18967	240	6	of	of	ADP
ihlr-18967	240	7	anticompetitive	anticompetitive	ADJ
ihlr-18967	240	8	harm	harm	NOUN
ihlr-18967	240	9	,	,	PUNCT
ihlr-18967	240	10	the	the	DET
ihlr-18967	240	11	majority	majority	NOUN
ihlr-18967	240	12	,	,	PUNCT
ihlr-18967	240	13	if	if	SCONJ
ihlr-18967	240	14	not	not	PART
ihlr-18967	240	15	all	all	PRON
ihlr-18967	240	16	,	,	PUNCT
ihlr-18967	240	17	reverse	reverse	ADJ
ihlr-18967	240	18	payment	payment	NOUN
ihlr-18967	240	19	settlements	settlement	NOUN
ihlr-18967	240	20	would	would	AUX
ihlr-18967	240	21	be	be	AUX
ihlr-18967	240	22	struck	strike	VERB
ihlr-18967	240	23	down	down	ADP
ihlr-18967	240	24	and	and	CCONJ
ihlr-18967	240	25	as	as	ADP
ihlr-18967	240	26	a	a	DET
ihlr-18967	240	27	result	result	NOUN
ihlr-18967	240	28	contradict	contradict	VERB
ihlr-18967	240	29	incentives	incentive	NOUN
ihlr-18967	240	30	provided	provide	VERB
ihlr-18967	240	31	by	by	ADP
ihlr-18967	240	32	patent	patent	NOUN
ihlr-18967	240	33	law	law	NOUN
ihlr-18967	240	34	.	.	PUNCT
ihlr-18967	241	1	2	2	X
ihlr-18967	241	2	.	.	X
ihlr-18967	241	3	the	the	DET
ihlr-18967	241	4	eleventh	eleventh	ADJ
ihlr-18967	241	5	circuit	circuit	NOUN
ihlr-18967	241	6	:	:	PUNCT
ihlr-18967	241	7	scope	scope	NOUN
ihlr-18967	241	8	of	of	ADP
ihlr-18967	241	9	patent	patent	NOUN
ihlr-18967	241	10	test	test	NOUN
ihlr-18967	241	11	conversely	conversely	ADV
ihlr-18967	241	12	,	,	PUNCT
ihlr-18967	241	13	the	the	DET
ihlr-18967	241	14	eleventh	eleventh	ADJ
ihlr-18967	241	15	circuit	circuit	NOUN
ihlr-18967	241	16	applied	apply	VERB
ihlr-18967	241	17	a	a	DET
ihlr-18967	241	18	scope	scope	NOUN
ihlr-18967	241	19	of	of	ADP
ihlr-18967	241	20	patent	patent	NOUN
ihlr-18967	241	21	test.62	test.62	VERB
ihlr-18967	241	22	the	the	DET
ihlr-18967	241	23	eleventh	eleventh	ADJ
ihlr-18967	241	24	circuit	circuit	NOUN
ihlr-18967	241	25	holds	hold	VERB
ihlr-18967	241	26	that	that	SCONJ
ihlr-18967	241	27	“	"	PUNCT
ihlr-18967	241	28	absent	absent	ADJ
ihlr-18967	241	29	sham	sham	ADJ
ihlr-18967	241	30	litigation	litigation	NOUN
ihlr-18967	241	31	or	or	CCONJ
ihlr-18967	241	32	fraud	fraud	NOUN
ihlr-18967	241	33	in	in	ADP
ihlr-18967	241	34	obtaining	obtain	VERB
ihlr-18967	241	35	the	the	DET
ihlr-18967	241	36	patent	patent	NOUN
ihlr-18967	241	37	,	,	PUNCT
ihlr-18967	241	38	a	a	DET
ihlr-18967	241	39	reverse	reverse	ADJ
ihlr-18967	241	40	payment	payment	NOUN
ihlr-18967	241	41	settlement	settlement	NOUN
ihlr-18967	241	42	is	be	AUX
ihlr-18967	241	43	immune	immune	ADJ
ihlr-18967	241	44	from	from	ADP
ihlr-18967	241	45	antitrust	antitrust	ADJ
ihlr-18967	241	46	attack	attack	NOUN
ihlr-18967	241	47	so	so	ADV
ihlr-18967	241	48	long	long	ADV
ihlr-18967	241	49	as	as	SCONJ
ihlr-18967	241	50	its	its	PRON
ihlr-18967	241	51	anticompetitive	anticompetitive	ADJ
ihlr-18967	241	52	effects	effect	NOUN
ihlr-18967	241	53	fall	fall	VERB
ihlr-18967	241	54	within	within	ADP
ihlr-18967	241	55	the	the	DET
ihlr-18967	241	56	scope	scope	NOUN
ihlr-18967	241	57	of	of	ADP
ihlr-18967	241	58	the	the	DET
ihlr-18967	241	59	exclusionary	exclusionary	ADJ
ihlr-18967	241	60	potential	potential	NOUN
ihlr-18967	241	61	of	of	ADP
ihlr-18967	241	62	the	the	DET
ihlr-18967	241	63	patent	patent	NOUN
ihlr-18967	241	64	.	.	PUNCT
ihlr-18967	242	1	”63	”63	NOUN
ihlr-18967	243	1	the	the	DET
ihlr-18967	243	2	key	key	NOUN
ihlr-18967	243	3	is	be	AUX
ihlr-18967	243	4	the	the	DET
ihlr-18967	243	5	potential	potential	ADJ
ihlr-18967	243	6	exclusionary	exclusionary	ADJ
ihlr-18967	243	7	power	power	NOUN
ihlr-18967	243	8	of	of	ADP
ihlr-18967	243	9	a	a	DET
ihlr-18967	243	10	patent	patent	NOUN
ihlr-18967	243	11	,	,	PUNCT
ihlr-18967	243	12	not	not	PART
ihlr-18967	243	13	the	the	DET
ihlr-18967	243	14	actual	actual	ADJ
ihlr-18967	243	15	power	power	NOUN
ihlr-18967	243	16	.	.	PUNCT
ihlr-18967	244	1	for	for	ADP
ihlr-18967	244	2	example	example	NOUN
ihlr-18967	244	3	,	,	PUNCT
ihlr-18967	244	4	a	a	DET
ihlr-18967	244	5	patent	patent	NOUN
ihlr-18967	244	6	issued	issue	VERB
ihlr-18967	244	7	for	for	ADP
ihlr-18967	244	8	a	a	DET
ihlr-18967	244	9	drug	drug	NOUN
ihlr-18967	244	10	has	have	VERB
ihlr-18967	244	11	the	the	DET
ihlr-18967	244	12	potential	potential	ADJ
ihlr-18967	244	13	exclusionary	exclusionary	ADJ
ihlr-18967	244	14	power	power	NOUN
ihlr-18967	244	15	to	to	PART
ihlr-18967	244	16	exclude	exclude	VERB
ihlr-18967	244	17	all	all	DET
ihlr-18967	244	18	similar	similar	ADJ
ihlr-18967	244	19	drugs	drug	NOUN
ihlr-18967	244	20	.	.	PUNCT
ihlr-18967	245	1	however	however	ADV
ihlr-18967	245	2	,	,	PUNCT
ihlr-18967	245	3	at	at	ADP
ihlr-18967	245	4	the	the	DET
ihlr-18967	245	5	same	same	ADJ
ihlr-18967	245	6	time	time	NOUN
ihlr-18967	245	7	,	,	PUNCT
ihlr-18967	245	8	said	say	VERB
ihlr-18967	245	9	patent	patent	NOUN
ihlr-18967	245	10	may	may	AUX
ihlr-18967	245	11	not	not	PART
ihlr-18967	245	12	have	have	VERB
ihlr-18967	245	13	any	any	DET
ihlr-18967	245	14	59	59	NUM
ihlr-18967	245	15	i	i	PRON
ihlr-18967	245	16	d.	d.	PROPN
ihlr-18967	245	17	at	at	ADP
ihlr-18967	245	18	218	218	NUM
ihlr-18967	245	19	.	.	PUNCT
ihlr-18967	246	1	60	60	NUM
ihlr-18967	247	1	i	i	PRON
ihlr-18967	247	2	d.	d.	PROPN
ihlr-18967	247	3	61	61	NUM
ihlr-18967	247	4	i	i	PRON
ihlr-18967	247	5	d.	d.	PROPN
ihlr-18967	247	6	(	(	PUNCT
ihlr-18967	247	7	stating	state	VERB
ihlr-18967	247	8	that	that	SCONJ
ihlr-18967	247	9	a	a	DET
ihlr-18967	247	10	procompetitive	procompetitive	ADJ
ihlr-18967	247	11	benefit	benefit	NOUN
ihlr-18967	247	12	may	may	AUX
ihlr-18967	247	13	be	be	AUX
ihlr-18967	247	14	“	"	PUNCT
ihlr-18967	247	15	a	a	DET
ihlr-18967	247	16	modest	modest	ADJ
ihlr-18967	247	17	cash	cash	NOUN
ihlr-18967	247	18	payment	payment	NOUN
ihlr-18967	247	19	that	that	PRON
ihlr-18967	247	20	enables	enable	VERB
ihlr-18967	247	21	a	a	DET
ihlr-18967	247	22	cash	cash	NOUN
ihlr-18967	247	23	-	-	PUNCT
ihlr-18967	247	24	starved	starve	VERB
ihlr-18967	247	25	generic	generic	ADJ
ihlr-18967	247	26	manufacture	manufacture	NOUN
ihlr-18967	247	27	to	to	PART
ihlr-18967	247	28	avoid	avoid	VERB
ihlr-18967	247	29	bankruptcy	bankruptcy	NOUN
ihlr-18967	247	30	and	and	CCONJ
ihlr-18967	247	31	begin	begin	VERB
ihlr-18967	247	32	marketing	market	VERB
ihlr-18967	247	33	a	a	DET
ihlr-18967	247	34	generic	generic	ADJ
ihlr-18967	247	35	drug	drug	NOUN
ihlr-18967	247	36	”	"	PUNCT
ihlr-18967	247	37	)	)	PUNCT
ihlr-18967	247	38	.	.	PUNCT
ihlr-18967	248	1	62	62	NUM
ihlr-18967	248	2	see	see	VERB
ihlr-18967	248	3	also	also	ADV
ihlr-18967	248	4	in	in	ADP
ihlr-18967	248	5	re	re	ADP
ihlr-18967	248	6	ciprofloxacin	ciprofloxacin	PROPN
ihlr-18967	248	7	hydrochloride	hydrochloride	ADJ
ihlr-18967	248	8	antitrust	antitrust	ADJ
ihlr-18967	248	9	litig	litig	NOUN
ihlr-18967	248	10	.	.	PUNCT
ihlr-18967	248	11	,	,	PUNCT
ihlr-18967	248	12	544	544	NUM
ihlr-18967	248	13	f.3d	f.3d	NUM
ihlr-18967	248	14	1323	1323	NUM
ihlr-18967	248	15	,	,	PUNCT
ihlr-18967	248	16	1336	1336	NUM
ihlr-18967	248	17	(	(	PUNCT
ihlr-18967	248	18	fed	fed	PROPN
ihlr-18967	248	19	.	.	PUNCT
ihlr-18967	248	20	cir	cir	PROPN
ihlr-18967	248	21	.	.	PROPN
ihlr-18967	248	22	2008	2008	NUM
ihlr-18967	248	23	)	)	PUNCT
ihlr-18967	248	24	,	,	PUNCT
ihlr-18967	248	25	abrogated	abrogate	VERB
ihlr-18967	248	26	by	by	ADP
ihlr-18967	248	27	f.t.c	f.t.c	NOUN
ihlr-18967	248	28	.	.	PUNCT
ihlr-18967	249	1	v.	v.	ADP
ihlr-18967	249	2	actavis	actavis	PROPN
ihlr-18967	249	3	,	,	PUNCT
ihlr-18967	249	4	inc	inc	PROPN
ihlr-18967	249	5	.	.	PROPN
ihlr-18967	249	6	,	,	PUNCT
ihlr-18967	249	7	133	133	NUM
ihlr-18967	249	8	s.	s.	PROPN
ihlr-18967	249	9	ct	ct	PROPN
ihlr-18967	249	10	.	.	PROPN
ihlr-18967	249	11	2223	2223	NUM
ihlr-18967	249	12	(	(	PUNCT
ihlr-18967	249	13	2013	2013	NUM
ihlr-18967	249	14	)	)	PUNCT
ihlr-18967	249	15	;	;	PUNCT
ihlr-18967	249	16	in	in	ADP
ihlr-18967	249	17	re	re	ADP
ihlr-18967	249	18	tamoxifen	tamoxifen	NOUN
ihlr-18967	249	19	citrate	citrate	NOUN
ihlr-18967	249	20	antitrust	antitrust	ADJ
ihlr-18967	249	21	litig	litig	NOUN
ihlr-18967	249	22	.	.	PUNCT
ihlr-18967	250	1	,	,	PUNCT
ihlr-18967	250	2	466	466	NUM
ihlr-18967	250	3	f.3d	f.3d	NUM
ihlr-18967	250	4	187	187	NUM
ihlr-18967	250	5	,	,	PUNCT
ihlr-18967	250	6	212	212	NUM
ihlr-18967	250	7	-	-	SYM
ihlr-18967	250	8	13	13	NUM
ihlr-18967	250	9	(	(	PUNCT
ihlr-18967	250	10	2d	2d	NUM
ihlr-18967	250	11	cir	cir	NOUN
ihlr-18967	250	12	.	.	PUNCT
ihlr-18967	250	13	2006	2006	NUM
ihlr-18967	250	14	)	)	PUNCT
ihlr-18967	250	15	,	,	PUNCT
ihlr-18967	250	16	abrogated	abrogate	VERB
ihlr-18967	250	17	by	by	ADP
ihlr-18967	250	18	actavis	actavis	PROPN
ihlr-18967	250	19	,	,	PUNCT
ihlr-18967	250	20	133	133	NUM
ihlr-18967	250	21	s.	s.	PROPN
ihlr-18967	250	22	ct	ct	PROPN
ihlr-18967	250	23	.	.	PROPN
ihlr-18967	250	24	2223	2223	NUM
ihlr-18967	250	25	.	.	PUNCT
ihlr-18967	251	1	63	63	NUM
ihlr-18967	251	2	ftc	ftc	PROPN
ihlr-18967	251	3	v.	v.	PROPN
ihlr-18967	251	4	watson	watson	PROPN
ihlr-18967	251	5	pharms	pharms	PROPN
ihlr-18967	251	6	.	.	PUNCT
ihlr-18967	251	7	inc	inc	PROPN
ihlr-18967	251	8	.	.	PROPN
ihlr-18967	251	9	,	,	PUNCT
ihlr-18967	251	10	677	677	NUM
ihlr-18967	251	11	f.3d	f.3d	NUM
ihlr-18967	251	12	1298	1298	NUM
ihlr-18967	251	13	,	,	PUNCT
ihlr-18967	251	14	1312	1312	NUM
ihlr-18967	251	15	(	(	PUNCT
ihlr-18967	251	16	11th	11th	ADJ
ihlr-18967	251	17	cir	cir	NOUN
ihlr-18967	251	18	.	.	PROPN
ihlr-18967	251	19	2012	2012	NUM
ihlr-18967	251	20	)	)	PUNCT
ihlr-18967	251	21	,	,	PUNCT
ihlr-18967	251	22	rev’d	rev’d	NOUN
ihlr-18967	251	23	sub	sub	PROPN
ihlr-18967	251	24	nom	nom	PROPN
ihlr-18967	251	25	.	.	PUNCT
ihlr-18967	251	26	actavis	actavis	PROPN
ihlr-18967	251	27	,	,	PUNCT
ihlr-18967	251	28	133	133	NUM
ihlr-18967	251	29	s.	s.	PROPN
ihlr-18967	251	30	ct	ct	PROPN
ihlr-18967	251	31	.	.	PROPN
ihlr-18967	251	32	2223	2223	NUM
ihlr-18967	251	33	.	.	PUNCT
ihlr-18967	252	1	2015	2015	NUM
ihlr-18967	252	2	rationale	rationale	NOUN
ihlr-18967	252	3	behind	behind	ADP
ihlr-18967	252	4	hatch	hatch	NOUN
ihlr-18967	252	5	-	-	PUNCT
ihlr-18967	252	6	waxman	waxman	PROPN
ihlr-18967	252	7	act	act	PROPN
ihlr-18967	252	8	and	and	CCONJ
ihlr-18967	252	9	patent	patent	NOUN
ihlr-18967	252	10	law	law	NOUN
ihlr-18967	252	11	437	437	NUM
ihlr-18967	252	12	actual	actual	ADJ
ihlr-18967	252	13	power	power	NOUN
ihlr-18967	252	14	if	if	SCONJ
ihlr-18967	252	15	a	a	DET
ihlr-18967	252	16	court	court	NOUN
ihlr-18967	252	17	invalidates	invalidate	VERB
ihlr-18967	252	18	the	the	DET
ihlr-18967	252	19	patent	patent	NOUN
ihlr-18967	252	20	.	.	PUNCT
ihlr-18967	253	1	consequently	consequently	ADV
ihlr-18967	253	2	,	,	PUNCT
ihlr-18967	253	3	“	"	PUNCT
ihlr-18967	253	4	actual	actual	ADJ
ihlr-18967	253	5	power	power	NOUN
ihlr-18967	253	6	”	"	PUNCT
ihlr-18967	253	7	takes	take	VERB
ihlr-18967	253	8	into	into	ADP
ihlr-18967	253	9	account	account	NOUN
ihlr-18967	253	10	the	the	DET
ihlr-18967	253	11	validity	validity	NOUN
ihlr-18967	253	12	of	of	ADP
ihlr-18967	253	13	the	the	DET
ihlr-18967	253	14	patent	patent	NOUN
ihlr-18967	253	15	while	while	SCONJ
ihlr-18967	253	16	“	"	PUNCT
ihlr-18967	253	17	potential	potential	ADJ
ihlr-18967	253	18	exclusionary	exclusionary	ADJ
ihlr-18967	253	19	power	power	NOUN
ihlr-18967	253	20	”	"	PUNCT
ihlr-18967	253	21	assumes	assume	VERB
ihlr-18967	253	22	validity	validity	NOUN
ihlr-18967	253	23	.	.	PUNCT
ihlr-18967	254	1	this	this	PRON
ihlr-18967	254	2	leads	lead	VERB
ihlr-18967	254	3	to	to	ADP
ihlr-18967	254	4	the	the	DET
ihlr-18967	254	5	conclusion	conclusion	NOUN
ihlr-18967	254	6	that	that	SCONJ
ihlr-18967	254	7	“	"	PUNCT
ihlr-18967	254	8	a	a	DET
ihlr-18967	254	9	court	court	NOUN
ihlr-18967	254	10	judgment	judgment	NOUN
ihlr-18967	254	11	about	about	ADP
ihlr-18967	254	12	a	a	DET
ihlr-18967	254	13	patent	patent	NOUN
ihlr-18967	254	14	’s	’s	PART
ihlr-18967	254	15	actual	actual	ADJ
ihlr-18967	254	16	exclusionary	exclusionary	ADJ
ihlr-18967	254	17	power	power	NOUN
ihlr-18967	254	18	,	,	PUNCT
ihlr-18967	254	19	unless	unless	SCONJ
ihlr-18967	254	20	that	that	DET
ihlr-18967	254	21	judgment	judgment	NOUN
ihlr-18967	254	22	comes	come	VERB
ihlr-18967	254	23	before	before	ADP
ihlr-18967	254	24	settlement	settlement	NOUN
ihlr-18967	254	25	,	,	PUNCT
ihlr-18967	254	26	does	do	AUX
ihlr-18967	254	27	not	not	PART
ihlr-18967	254	28	count	count	VERB
ihlr-18967	254	29	.	.	PUNCT
ihlr-18967	255	1	”64	”64	VERB
ihlr-18967	255	2	the	the	DET
ihlr-18967	255	3	general	general	ADJ
ihlr-18967	255	4	policy	policy	NOUN
ihlr-18967	255	5	rationale	rationale	NOUN
ihlr-18967	255	6	behind	behind	ADP
ihlr-18967	255	7	the	the	DET
ihlr-18967	255	8	scope	scope	NOUN
ihlr-18967	255	9	of	of	ADP
ihlr-18967	255	10	patent	patent	NOUN
ihlr-18967	255	11	test	test	NOUN
ihlr-18967	255	12	is	be	AUX
ihlr-18967	255	13	one	one	NUM
ihlr-18967	255	14	of	of	ADP
ihlr-18967	255	15	favoring	favor	VERB
ihlr-18967	255	16	settlement.65	settlement.65	ADP
ihlr-18967	255	17	the	the	DET
ihlr-18967	255	18	eleventh	eleventh	ADJ
ihlr-18967	255	19	circuit	circuit	NOUN
ihlr-18967	255	20	has	have	AUX
ihlr-18967	255	21	specifically	specifically	ADV
ihlr-18967	255	22	noted	note	VERB
ihlr-18967	255	23	the	the	DET
ihlr-18967	255	24	high	high	ADJ
ihlr-18967	255	25	stakes	stake	NOUN
ihlr-18967	255	26	nature	nature	NOUN
ihlr-18967	255	27	of	of	ADP
ihlr-18967	255	28	patent	patent	NOUN
ihlr-18967	255	29	litigation	litigation	NOUN
ihlr-18967	255	30	and	and	CCONJ
ihlr-18967	255	31	that	that	SCONJ
ihlr-18967	255	32	“	"	PUNCT
ihlr-18967	255	33	parties	party	NOUN
ihlr-18967	255	34	settle	settle	VERB
ihlr-18967	255	35	to	to	PART
ihlr-18967	255	36	cap	cap	VERB
ihlr-18967	255	37	the	the	DET
ihlr-18967	255	38	cost	cost	NOUN
ihlr-18967	255	39	of	of	ADP
ihlr-18967	255	40	litigation	litigation	NOUN
ihlr-18967	255	41	and	and	CCONJ
ihlr-18967	255	42	to	to	PART
ihlr-18967	255	43	avoid	avoid	VERB
ihlr-18967	255	44	the	the	DET
ihlr-18967	255	45	chance	chance	NOUN
ihlr-18967	255	46	of	of	ADP
ihlr-18967	255	47	losing	lose	VERB
ihlr-18967	255	48	.	.	PUNCT
ihlr-18967	256	1	”66	”66	PROPN
ihlr-18967	256	2	e.	e.	PROPN
ihlr-18967	257	1	the	the	DET
ihlr-18967	257	2	circuit	circuit	NOUN
ihlr-18967	257	3	split	split	VERB
ihlr-18967	257	4	and	and	CCONJ
ihlr-18967	257	5	supreme	supreme	PROPN
ihlr-18967	257	6	court	court	PROPN
ihlr-18967	257	7	decision	decision	NOUN
ihlr-18967	257	8	1	1	NUM
ihlr-18967	257	9	.	.	PUNCT
ihlr-18967	258	1	in	in	ADP
ihlr-18967	258	2	re	re	NOUN
ihlr-18967	258	3	k	k	X
ihlr-18967	258	4	-	-	ADJ
ihlr-18967	258	5	dur	dur	ADJ
ihlr-18967	258	6	antitrust	antitrust	ADJ
ihlr-18967	258	7	litigation67	litigation67	NOUN
ihlr-18967	258	8	schering	schering	NOUN
ihlr-18967	258	9	-	-	PUNCT
ihlr-18967	258	10	plough	plough	NOUN
ihlr-18967	258	11	corporation	corporation	NOUN
ihlr-18967	258	12	(	(	PUNCT
ihlr-18967	258	13	“	"	PUNCT
ihlr-18967	258	14	schering	schering	NOUN
ihlr-18967	258	15	”	"	PUNCT
ihlr-18967	258	16	)	)	PUNCT
ihlr-18967	258	17	obtained	obtain	VERB
ihlr-18967	258	18	the	the	DET
ihlr-18967	258	19	‘	'	PUNCT
ihlr-18967	258	20	743	743	NUM
ihlr-18967	258	21	patent	patent	NOUN
ihlr-18967	258	22	on	on	ADP
ihlr-18967	258	23	september	september	PROPN
ihlr-18967	258	24	5	5	NUM
ihlr-18967	258	25	,	,	PUNCT
ihlr-18967	258	26	1989	1989	NUM
ihlr-18967	258	27	for	for	ADP
ihlr-18967	258	28	its	its	PRON
ihlr-18967	258	29	drug	drug	NOUN
ihlr-18967	258	30	k	k	NOUN
ihlr-18967	258	31	-	-	ADJ
ihlr-18967	258	32	dur.68	dur.68	ADJ
ihlr-18967	258	33	thereafter	thereafter	ADV
ihlr-18967	258	34	,	,	PUNCT
ihlr-18967	258	35	two	two	NUM
ihlr-18967	258	36	generic	generic	ADJ
ihlr-18967	258	37	manufacturers	manufacturer	NOUN
ihlr-18967	258	38	,	,	PUNCT
ihlr-18967	258	39	upsher	upsher	NOUN
ihlr-18967	258	40	and	and	CCONJ
ihlr-18967	258	41	esi	esi	PROPN
ihlr-18967	258	42	,	,	PUNCT
ihlr-18967	258	43	filed	file	VERB
ihlr-18967	258	44	an	an	DET
ihlr-18967	258	45	anda	anda	NOUN
ihlr-18967	258	46	,	,	PUNCT
ihlr-18967	258	47	with	with	ADP
ihlr-18967	258	48	a	a	DET
ihlr-18967	258	49	paragraph	paragraph	NOUN
ihlr-18967	258	50	iv	iv	NUM
ihlr-18967	258	51	certification	certification	NOUN
ihlr-18967	258	52	alleging	allege	VERB
ihlr-18967	258	53	that	that	SCONJ
ihlr-18967	258	54	it	it	PRON
ihlr-18967	258	55	would	would	AUX
ihlr-18967	258	56	not	not	PART
ihlr-18967	258	57	infringe	infringe	VERB
ihlr-18967	258	58	schering	schering	NOUN
ihlr-18967	258	59	’s	’s	PART
ihlr-18967	258	60	‘	'	PUNCT
ihlr-18967	258	61	743	743	NUM
ihlr-18967	258	62	patent.69	patent.69	NOUN
ihlr-18967	258	63	as	as	ADP
ihlr-18967	258	64	a	a	DET
ihlr-18967	258	65	result	result	NOUN
ihlr-18967	258	66	,	,	PUNCT
ihlr-18967	258	67	schering	schering	NOUN
ihlr-18967	258	68	brought	bring	VERB
ihlr-18967	258	69	a	a	DET
ihlr-18967	258	70	patent	patent	NOUN
ihlr-18967	258	71	infringement	infringement	NOUN
ihlr-18967	258	72	suit.70	suit.70	ADJ
ihlr-18967	258	73	schering	schering	NOUN
ihlr-18967	258	74	settled	settle	VERB
ihlr-18967	258	75	with	with	ADP
ihlr-18967	258	76	both	both	CCONJ
ihlr-18967	258	77	generic	generic	ADJ
ihlr-18967	258	78	manufactures	manufacture	NOUN
ihlr-18967	258	79	before	before	SCONJ
ihlr-18967	258	80	a	a	DET
ihlr-18967	258	81	trial	trial	NOUN
ihlr-18967	258	82	occurred.71	occurred.71	VERB
ihlr-18967	258	83	first	first	ADV
ihlr-18967	258	84	,	,	PUNCT
ihlr-18967	258	85	schering	schering	NOUN
ihlr-18967	258	86	’s	’s	PART
ihlr-18967	258	87	settlement	settlement	NOUN
ihlr-18967	258	88	with	with	ADP
ihlr-18967	258	89	upsher	upsher	PROPN
ihlr-18967	258	90	provided	provide	VERB
ihlr-18967	258	91	that	that	PRON
ihlr-18967	258	92	:	:	PUNCT
ihlr-18967	258	93	(	(	PUNCT
ihlr-18967	258	94	a	a	X
ihlr-18967	258	95	)	)	PUNCT
ihlr-18967	258	96	upsher	upsher	NOUN
ihlr-18967	258	97	would	would	AUX
ihlr-18967	258	98	refrain	refrain	VERB
ihlr-18967	258	99	from	from	ADP
ihlr-18967	258	100	marketing	market	VERB
ihlr-18967	258	101	its	its	PRON
ihlr-18967	258	102	generic	generic	ADJ
ihlr-18967	258	103	product	product	NOUN
ihlr-18967	258	104	until	until	ADP
ihlr-18967	258	105	september	september	PROPN
ihlr-18967	258	106	1	1	NUM
ihlr-18967	258	107	,	,	PUNCT
ihlr-18967	258	108	2001	2001	NUM
ihlr-18967	258	109	,	,	PUNCT
ihlr-18967	258	110	when	when	SCONJ
ihlr-18967	258	111	it	it	PRON
ihlr-18967	258	112	would	would	AUX
ihlr-18967	258	113	receive	receive	VERB
ihlr-18967	258	114	a	a	DET
ihlr-18967	258	115	non	non	ADJ
ihlr-18967	258	116	-	-	ADJ
ihlr-18967	258	117	royalty	royalty	ADJ
ihlr-18967	258	118	non	non	ADJ
ihlr-18967	258	119	-	-	ADJ
ihlr-18967	258	120	exclusive	exclusive	ADJ
ihlr-18967	258	121	license	license	NOUN
ihlr-18967	258	122	under	under	ADP
ihlr-18967	258	123	the	the	DET
ihlr-18967	258	124	‘	'	PUNCT
ihlr-18967	258	125	743	743	NUM
ihlr-18967	258	126	patent	patent	NOUN
ihlr-18967	258	127	;	;	PUNCT
ihlr-18967	258	128	(	(	PUNCT
ihlr-18967	258	129	b	b	X
ihlr-18967	258	130	)	)	PUNCT
ihlr-18967	258	131	upsher	upsher	NOUN
ihlr-18967	258	132	would	would	AUX
ihlr-18967	258	133	grant	grant	VERB
ihlr-18967	258	134	schering	schere	VERB
ihlr-18967	258	135	various	various	ADJ
ihlr-18967	258	136	licenses	license	NOUN
ihlr-18967	258	137	for	for	ADP
ihlr-18967	258	138	products	product	NOUN
ihlr-18967	258	139	which	which	PRON
ihlr-18967	258	140	upsher	upsher	NOUN
ihlr-18967	258	141	developed	develop	VERB
ihlr-18967	258	142	;	;	PUNCT
ihlr-18967	258	143	and	and	CCONJ
ihlr-18967	258	144	(	(	PUNCT
ihlr-18967	258	145	c	c	X
ihlr-18967	258	146	)	)	PUNCT
ihlr-18967	258	147	schering	schering	NOUN
ihlr-18967	258	148	was	be	AUX
ihlr-18967	258	149	to	to	ADP
ihlr-18967	258	150	64	64	NUM
ihlr-18967	258	151	i	i	PRON
ihlr-18967	258	152	d.	d.	NOUN
ihlr-18967	258	153	at	at	ADP
ihlr-18967	258	154	1308	1308	NUM
ihlr-18967	258	155	(	(	PUNCT
ihlr-18967	258	156	quoting	quote	VERB
ihlr-18967	258	157	valley	valley	NOUN
ihlr-18967	258	158	drug	drug	PROPN
ihlr-18967	258	159	co.	co.	PROPN
ihlr-18967	258	160	v.	v.	ADP
ihlr-18967	258	161	geneva	geneva	PROPN
ihlr-18967	258	162	pharms	pharms	PROPN
ihlr-18967	258	163	.	.	PUNCT
ihlr-18967	258	164	,	,	PUNCT
ihlr-18967	258	165	inc	inc	PROPN
ihlr-18967	258	166	.	.	PROPN
ihlr-18967	258	167	,	,	PUNCT
ihlr-18967	258	168	344	344	NUM
ihlr-18967	258	169	f.3d	f.3d	NUM
ihlr-18967	258	170	1294	1294	NUM
ihlr-18967	258	171	,	,	PUNCT
ihlr-18967	258	172	1311	1311	NUM
ihlr-18967	258	173	(	(	PUNCT
ihlr-18967	258	174	11th	11th	ADJ
ihlr-18967	258	175	cir	cir	NOUN
ihlr-18967	258	176	.	.	PROPN
ihlr-18967	258	177	2003	2003	NUM
ihlr-18967	258	178	)	)	PUNCT
ihlr-18967	258	179	)	)	PUNCT
ihlr-18967	258	180	.	.	PUNCT
ihlr-18967	259	1	65	65	NUM
ihlr-18967	259	2	see	see	VERB
ihlr-18967	259	3	i	i	PRON
ihlr-18967	259	4	d.	d.	PROPN
ihlr-18967	259	5	at	at	ADP
ihlr-18967	259	6	1313	1313	NUM
ihlr-18967	259	7	.	.	PUNCT
ihlr-18967	260	1	66	66	NUM
ihlr-18967	261	1	i	i	PRON
ihlr-18967	261	2	d.	d.	PROPN
ihlr-18967	261	3	(	(	PUNCT
ihlr-18967	261	4	comparing	compare	VERB
ihlr-18967	261	5	a	a	DET
ihlr-18967	261	6	party	party	NOUN
ihlr-18967	261	7	who	who	PRON
ihlr-18967	261	8	is	be	AUX
ihlr-18967	261	9	likely	likely	ADJ
ihlr-18967	261	10	to	to	PART
ihlr-18967	261	11	win	win	VERB
ihlr-18967	261	12	patent	patent	NOUN
ihlr-18967	261	13	litigation	litigation	NOUN
ihlr-18967	261	14	to	to	ADP
ihlr-18967	261	15	a	a	DET
ihlr-18967	261	16	person	person	NOUN
ihlr-18967	261	17	who	who	PRON
ihlr-18967	261	18	is	be	AUX
ihlr-18967	261	19	likely	likely	ADJ
ihlr-18967	261	20	to	to	PART
ihlr-18967	261	21	win	win	VERB
ihlr-18967	261	22	a	a	DET
ihlr-18967	261	23	game	game	NOUN
ihlr-18967	261	24	of	of	ADP
ihlr-18967	261	25	russian	russian	ADJ
ihlr-18967	261	26	roulette	roulette	NOUN
ihlr-18967	261	27	,	,	PUNCT
ihlr-18967	261	28	but	but	CCONJ
ihlr-18967	261	29	still	still	ADV
ihlr-18967	261	30	not	not	PART
ihlr-18967	261	31	willing	willing	ADJ
ihlr-18967	261	32	to	to	PART
ihlr-18967	261	33	take	take	VERB
ihlr-18967	261	34	the	the	DET
ihlr-18967	261	35	chance	chance	NOUN
ihlr-18967	261	36	)	)	PUNCT
ihlr-18967	261	37	.	.	PUNCT
ihlr-18967	262	1	67	67	NUM
ihlr-18967	262	2	in	in	ADP
ihlr-18967	262	3	re	re	PROPN
ihlr-18967	262	4	k	k	X
ihlr-18967	262	5	-	-	ADJ
ihlr-18967	262	6	dur	dur	ADJ
ihlr-18967	262	7	antitrust	antitrust	ADJ
ihlr-18967	262	8	litig	litig	NOUN
ihlr-18967	262	9	.	.	PUNCT
ihlr-18967	263	1	,	,	PUNCT
ihlr-18967	263	2	686	686	NUM
ihlr-18967	263	3	f.	f.	NOUN
ihlr-18967	263	4	3d	3d	NUM
ihlr-18967	263	5	197	197	NUM
ihlr-18967	263	6	(	(	PUNCT
ihlr-18967	263	7	3d	3d	NUM
ihlr-18967	263	8	cir	cir	NOUN
ihlr-18967	263	9	.	.	PROPN
ihlr-18967	263	10	2012	2012	NUM
ihlr-18967	263	11	)	)	PUNCT
ihlr-18967	263	12	,	,	PUNCT
ihlr-18967	263	13	vacated	vacate	VERB
ihlr-18967	263	14	,	,	PUNCT
ihlr-18967	263	15	actavis	actavi	NOUN
ihlr-18967	263	16	,	,	PUNCT
ihlr-18967	263	17	133	133	NUM
ihlr-18967	263	18	s.	s.	PROPN
ihlr-18967	263	19	ct	ct	PROPN
ihlr-18967	263	20	.	.	PROPN
ihlr-18967	263	21	2223	2223	NUM
ihlr-18967	263	22	.	.	PUNCT
ihlr-18967	264	1	68	68	NUM
ihlr-18967	265	1	i	i	PRON
ihlr-18967	265	2	d.	d.	PROPN
ihlr-18967	265	3	at	at	ADP
ihlr-18967	265	4	205	205	NUM
ihlr-18967	265	5	.	.	PUNCT
ihlr-18967	266	1	69	69	NUM
ihlr-18967	267	1	i	i	PRON
ihlr-18967	267	2	d.	d.	PROPN
ihlr-18967	267	3	at	at	ADP
ihlr-18967	267	4	205	205	NUM
ihlr-18967	267	5	-	-	SYM
ihlr-18967	267	6	06	06	NUM
ihlr-18967	267	7	70	70	NUM
ihlr-18967	268	1	i	i	PRON
ihlr-18967	268	2	d.	d.	PROPN
ihlr-18967	268	3	71	71	NUM
ihlr-18967	269	1	i	i	PRON
ihlr-18967	269	2	d.	d.	PROPN
ihlr-18967	269	3	438	438	NUM
ihlr-18967	269	4	indiana	indiana	PROPN
ihlr-18967	269	5	health	health	PROPN
ihlr-18967	269	6	law	law	PROPN
ihlr-18967	269	7	review	review	NOUN
ihlr-18967	269	8	vol	vol	NOUN
ihlr-18967	269	9	.	.	PUNCT
ihlr-18967	270	1	12:1	12:1	NUM
ihlr-18967	270	2	pay	pay	VERB
ihlr-18967	270	3	upsher	upsher	NOUN
ihlr-18967	270	4	$	$	SYM
ihlr-18967	270	5	60,000,000	60,000,000	NUM
ihlr-18967	270	6	over	over	ADP
ihlr-18967	270	7	three	three	NUM
ihlr-18967	270	8	years	year	NOUN
ihlr-18967	270	9	and	and	CCONJ
ihlr-18967	270	10	other	other	ADJ
ihlr-18967	270	11	amounts	amount	NOUN
ihlr-18967	270	12	based	base	VERB
ihlr-18967	270	13	on	on	ADP
ihlr-18967	270	14	the	the	DET
ihlr-18967	270	15	sales	sale	NOUN
ihlr-18967	270	16	of	of	ADP
ihlr-18967	270	17	the	the	DET
ihlr-18967	270	18	products	product	NOUN
ihlr-18967	270	19	licensed	license	VERB
ihlr-18967	270	20	to	to	PART
ihlr-18967	270	21	schering.72	schering.72	VERB
ihlr-18967	270	22	second	second	ADJ
ihlr-18967	270	23	,	,	PUNCT
ihlr-18967	270	24	schering	schering	NOUN
ihlr-18967	270	25	’s	’s	PART
ihlr-18967	270	26	settlement	settlement	NOUN
ihlr-18967	270	27	with	with	ADP
ihlr-18967	270	28	esi	esi	PROPN
ihlr-18967	270	29	provided	provide	VERB
ihlr-18967	270	30	that	that	SCONJ
ihlr-18967	270	31	:	:	PUNCT
ihlr-18967	270	32	(	(	PUNCT
ihlr-18967	270	33	a	a	X
ihlr-18967	270	34	)	)	PUNCT
ihlr-18967	270	35	esi	esi	NOUN
ihlr-18967	270	36	would	would	AUX
ihlr-18967	270	37	receive	receive	VERB
ihlr-18967	270	38	a	a	DET
ihlr-18967	270	39	royalty	royalty	NOUN
ihlr-18967	270	40	-	-	PUNCT
ihlr-18967	270	41	free	free	ADJ
ihlr-18967	270	42	license	license	NOUN
ihlr-18967	270	43	under	under	ADP
ihlr-18967	270	44	the	the	DET
ihlr-18967	270	45	‘	'	PUNCT
ihlr-18967	270	46	743	743	NUM
ihlr-18967	270	47	patent	patent	NOUN
ihlr-18967	270	48	beginning	begin	VERB
ihlr-18967	270	49	on	on	ADP
ihlr-18967	270	50	january	january	PROPN
ihlr-18967	270	51	1	1	NUM
ihlr-18967	270	52	,	,	PUNCT
ihlr-18967	270	53	2004	2004	NUM
ihlr-18967	270	54	;	;	PUNCT
ihlr-18967	270	55	(	(	PUNCT
ihlr-18967	270	56	b	b	X
ihlr-18967	270	57	)	)	PUNCT
ihlr-18967	270	58	schering	schering	NOUN
ihlr-18967	270	59	paid	pay	VERB
ihlr-18967	270	60	esi	esi	PROPN
ihlr-18967	270	61	$	$	SYM
ihlr-18967	270	62	5,000,000	5,000,000	NUM
ihlr-18967	270	63	up	up	ADP
ihlr-18967	270	64	front	front	NOUN
ihlr-18967	270	65	;	;	PUNCT
ihlr-18967	270	66	and	and	CCONJ
ihlr-18967	270	67	(	(	PUNCT
ihlr-18967	270	68	c	c	X
ihlr-18967	270	69	)	)	PUNCT
ihlr-18967	270	70	schering	schering	NOUN
ihlr-18967	270	71	would	would	AUX
ihlr-18967	270	72	pay	pay	VERB
ihlr-18967	270	73	esi	esi	PROPN
ihlr-18967	270	74	additional	additional	ADJ
ihlr-18967	270	75	compensation	compensation	NOUN
ihlr-18967	270	76	based	base	VERB
ihlr-18967	270	77	on	on	ADP
ihlr-18967	270	78	when	when	SCONJ
ihlr-18967	270	79	esi	esi	PROPN
ihlr-18967	270	80	’s	’s	PROPN
ihlr-18967	270	81	anda	anda	PROPN
ihlr-18967	270	82	was	be	AUX
ihlr-18967	270	83	approved	approve	VERB
ihlr-18967	270	84	by	by	ADP
ihlr-18967	270	85	the	the	DET
ihlr-18967	270	86	fda.73	fda.73	PROPN
ihlr-18967	270	87	the	the	DET
ihlr-18967	270	88	ftc	ftc	PROPN
ihlr-18967	270	89	filed	file	VERB
ihlr-18967	270	90	a	a	DET
ihlr-18967	270	91	complaint	complaint	NOUN
ihlr-18967	270	92	against	against	ADP
ihlr-18967	270	93	schering	schering	NOUN
ihlr-18967	270	94	,	,	PUNCT
ihlr-18967	270	95	upsher	upsher	PROPN
ihlr-18967	270	96	,	,	PUNCT
ihlr-18967	270	97	and	and	CCONJ
ihlr-18967	270	98	esi	esi	PROPN
ihlr-18967	270	99	alleging	allege	VERB
ihlr-18967	270	100	the	the	DET
ihlr-18967	270	101	settlements	settlement	NOUN
ihlr-18967	270	102	unreasonably	unreasonably	ADV
ihlr-18967	270	103	restrained	restrained	ADJ
ihlr-18967	270	104	commerce.74	commerce.74	NOUN
ihlr-18967	270	105	in	in	ADP
ihlr-18967	270	106	addition	addition	NOUN
ihlr-18967	270	107	,	,	PUNCT
ihlr-18967	270	108	forty	forty	NUM
ihlr-18967	270	109	-	-	PUNCT
ihlr-18967	270	110	four	four	NUM
ihlr-18967	270	111	wholesalers	wholesaler	NOUN
ihlr-18967	270	112	and	and	CCONJ
ihlr-18967	270	113	retailers	retailer	NOUN
ihlr-18967	270	114	who	who	PRON
ihlr-18967	270	115	purchased	purchase	VERB
ihlr-18967	270	116	k	k	PROPN
ihlr-18967	270	117	-	-	PUNCT
ihlr-18967	270	118	dur	dur	PROPN
ihlr-18967	270	119	from	from	ADP
ihlr-18967	270	120	schering	schering	NOUN
ihlr-18967	270	121	brought	bring	VERB
ihlr-18967	270	122	suit	suit	NOUN
ihlr-18967	270	123	and	and	CCONJ
ihlr-18967	270	124	were	be	AUX
ihlr-18967	270	125	certified	certify	VERB
ihlr-18967	270	126	as	as	ADP
ihlr-18967	270	127	a	a	DET
ihlr-18967	270	128	class	class	NOUN
ihlr-18967	270	129	of	of	ADP
ihlr-18967	270	130	plaintiffs.75	plaintiffs.75	PROPN
ihlr-18967	270	131	the	the	DET
ihlr-18967	270	132	district	district	NOUN
ihlr-18967	270	133	court	court	NOUN
ihlr-18967	270	134	adopted	adopt	VERB
ihlr-18967	270	135	the	the	DET
ihlr-18967	270	136	report	report	NOUN
ihlr-18967	270	137	and	and	CCONJ
ihlr-18967	270	138	recommendation	recommendation	NOUN
ihlr-18967	270	139	of	of	ADP
ihlr-18967	270	140	a	a	DET
ihlr-18967	270	141	special	special	ADJ
ihlr-18967	270	142	master	master	NOUN
ihlr-18967	270	143	which	which	PRON
ihlr-18967	270	144	applied	apply	VERB
ihlr-18967	270	145	the	the	DET
ihlr-18967	270	146	scope	scope	NOUN
ihlr-18967	270	147	of	of	ADP
ihlr-18967	270	148	patent	patent	NOUN
ihlr-18967	270	149	test	test	NOUN
ihlr-18967	270	150	(	(	PUNCT
ihlr-18967	270	151	a	a	DET
ihlr-18967	270	152	reverse	reverse	ADJ
ihlr-18967	270	153	payment	payment	NOUN
ihlr-18967	270	154	settlement	settlement	NOUN
ihlr-18967	270	155	is	be	AUX
ihlr-18967	270	156	valid	valid	ADJ
ihlr-18967	270	157	as	as	ADV
ihlr-18967	270	158	long	long	ADV
ihlr-18967	270	159	as	as	SCONJ
ihlr-18967	270	160	it	it	PRON
ihlr-18967	270	161	falls	fall	VERB
ihlr-18967	270	162	within	within	ADP
ihlr-18967	270	163	the	the	DET
ihlr-18967	270	164	potential	potential	ADJ
ihlr-18967	270	165	exclusionary	exclusionary	ADJ
ihlr-18967	270	166	effect	effect	NOUN
ihlr-18967	270	167	of	of	ADP
ihlr-18967	270	168	the	the	DET
ihlr-18967	270	169	patent	patent	NOUN
ihlr-18967	270	170	)	)	PUNCT
ihlr-18967	270	171	and	and	CCONJ
ihlr-18967	270	172	held	hold	VERB
ihlr-18967	270	173	that	that	SCONJ
ihlr-18967	270	174	the	the	DET
ihlr-18967	270	175	settlements	settlement	NOUN
ihlr-18967	270	176	did	do	AUX
ihlr-18967	270	177	not	not	PART
ihlr-18967	270	178	exceed	exceed	VERB
ihlr-18967	270	179	the	the	DET
ihlr-18967	270	180	scope	scope	NOUN
ihlr-18967	270	181	of	of	ADP
ihlr-18967	270	182	schering	schering	NOUN
ihlr-18967	270	183	’s	’s	PART
ihlr-18967	270	184	‘	'	PUNCT
ihlr-18967	270	185	743	743	NUM
ihlr-18967	270	186	patent.76	patent.76	PROPN
ihlr-18967	270	187	on	on	ADP
ihlr-18967	270	188	appeal	appeal	NOUN
ihlr-18967	270	189	,	,	PUNCT
ihlr-18967	270	190	the	the	DET
ihlr-18967	270	191	third	third	ADJ
ihlr-18967	270	192	circuit	circuit	NOUN
ihlr-18967	270	193	rejected	reject	VERB
ihlr-18967	270	194	the	the	DET
ihlr-18967	270	195	scope	scope	NOUN
ihlr-18967	270	196	of	of	ADP
ihlr-18967	270	197	patent	patent	NOUN
ihlr-18967	270	198	test.77	test.77	NOUN
ihlr-18967	270	199	the	the	DET
ihlr-18967	270	200	court	court	NOUN
ihlr-18967	270	201	instructed	instruct	VERB
ihlr-18967	270	202	“	"	PUNCT
ihlr-18967	270	203	the	the	DET
ihlr-18967	270	204	district	district	NOUN
ihlr-18967	270	205	court	court	NOUN
ihlr-18967	270	206	to	to	PART
ihlr-18967	270	207	apply	apply	VERB
ihlr-18967	270	208	a	a	DET
ihlr-18967	270	209	quick	quick	ADJ
ihlr-18967	270	210	look	look	NOUN
ihlr-18967	270	211	rule	rule	NOUN
ihlr-18967	270	212	of	of	ADP
ihlr-18967	270	213	reason	reason	NOUN
ihlr-18967	270	214	analysis	analysis	NOUN
ihlr-18967	270	215	based	base	VERB
ihlr-18967	270	216	on	on	ADP
ihlr-18967	270	217	the	the	DET
ihlr-18967	270	218	economic	economic	ADJ
ihlr-18967	270	219	realities	reality	NOUN
ihlr-18967	270	220	of	of	ADP
ihlr-18967	270	221	the	the	DET
ihlr-18967	270	222	reverse	reverse	ADJ
ihlr-18967	270	223	payment	payment	NOUN
ihlr-18967	270	224	settlement	settlement	NOUN
ihlr-18967	270	225	rather	rather	ADV
ihlr-18967	270	226	than	than	ADP
ihlr-18967	270	227	the	the	DET
ihlr-18967	270	228	labels	label	NOUN
ihlr-18967	270	229	applied	apply	VERB
ihlr-18967	270	230	by	by	ADP
ihlr-18967	270	231	the	the	DET
ihlr-18967	270	232	settling	settle	VERB
ihlr-18967	270	233	parties	party	NOUN
ihlr-18967	270	234	.	.	PUNCT
ihlr-18967	271	1	”78	”78	ADV
ihlr-18967	271	2	“	"	PUNCT
ihlr-18967	271	3	[	[	X
ihlr-18967	271	4	a	a	X
ihlr-18967	271	5	]	]	X
ihlr-18967	271	6	generic	generic	ADJ
ihlr-18967	271	7	patent	patent	NOUN
ihlr-18967	271	8	challenger	challenger	NOUN
ihlr-18967	271	9	who	who	PRON
ihlr-18967	271	10	agrees	agree	VERB
ihlr-18967	271	11	to	to	PART
ihlr-18967	271	12	delay	delay	VERB
ihlr-18967	271	13	entry	entry	NOUN
ihlr-18967	271	14	into	into	ADP
ihlr-18967	271	15	the	the	DET
ihlr-18967	271	16	market	market	NOUN
ihlr-18967	271	17	[	[	X
ihlr-18967	271	18	is	be	AUX
ihlr-18967	271	19	]	]	PUNCT
ihlr-18967	271	20	prima	prima	NOUN
ihlr-18967	271	21	facie	facie	NOUN
ihlr-18967	271	22	evidence	evidence	NOUN
ihlr-18967	271	23	of	of	ADP
ihlr-18967	271	24	an	an	DET
ihlr-18967	271	25	unreasonable	unreasonable	ADJ
ihlr-18967	271	26	restraint	restraint	NOUN
ihlr-18967	271	27	of	of	ADP
ihlr-18967	271	28	trade	trade	NOUN
ihlr-18967	271	29	,	,	PUNCT
ihlr-18967	271	30	which	which	PRON
ihlr-18967	271	31	[	[	X
ihlr-18967	271	32	can	can	AUX
ihlr-18967	271	33	]	]	AUX
ihlr-18967	271	34	be	be	AUX
ihlr-18967	271	35	rebutted	rebut	VERB
ihlr-18967	271	36	by	by	ADP
ihlr-18967	271	37	showing	show	VERB
ihlr-18967	271	38	that	that	SCONJ
ihlr-18967	271	39	the	the	DET
ihlr-18967	271	40	payment	payment	NOUN
ihlr-18967	271	41	72	72	NUM
ihlr-18967	271	42	i	i	PRON
ihlr-18967	271	43	d.	d.	PROPN
ihlr-18967	271	44	at	at	ADP
ihlr-18967	271	45	205	205	NUM
ihlr-18967	271	46	.	.	PUNCT
ihlr-18967	272	1	73	73	NUM
ihlr-18967	273	1	i	i	PRON
ihlr-18967	273	2	d.	d.	PROPN
ihlr-18967	273	3	at	at	ADP
ihlr-18967	273	4	206	206	NUM
ihlr-18967	273	5	.	.	PUNCT
ihlr-18967	274	1	74	74	NUM
ihlr-18967	275	1	i	i	PRON
ihlr-18967	275	2	d.	d.	VERB
ihlr-18967	275	3	at	at	ADP
ihlr-18967	275	4	206	206	NUM
ihlr-18967	275	5	-	-	SYM
ihlr-18967	275	6	07	07	NUM
ihlr-18967	275	7	.	.	PUNCT
ihlr-18967	276	1	however	however	ADV
ihlr-18967	276	2	,	,	PUNCT
ihlr-18967	276	3	the	the	DET
ihlr-18967	276	4	ftc	ftc	PROPN
ihlr-18967	276	5	’s	’s	PART
ihlr-18967	276	6	suit	suit	NOUN
ihlr-18967	276	7	is	be	AUX
ihlr-18967	276	8	not	not	PART
ihlr-18967	276	9	part	part	NOUN
ihlr-18967	276	10	of	of	ADP
ihlr-18967	276	11	this	this	DET
ihlr-18967	276	12	appeal	appeal	NOUN
ihlr-18967	276	13	.	.	PUNCT
ihlr-18967	277	1	after	after	SCONJ
ihlr-18967	277	2	an	an	DET
ihlr-18967	277	3	administrative	administrative	ADJ
ihlr-18967	277	4	law	law	NOUN
ihlr-18967	277	5	judge	judge	NOUN
ihlr-18967	277	6	dismissed	dismiss	VERB
ihlr-18967	277	7	the	the	DET
ihlr-18967	277	8	ftc	ftc	PROPN
ihlr-18967	277	9	’s	’s	PART
ihlr-18967	277	10	complaint	complaint	NOUN
ihlr-18967	277	11	,	,	PUNCT
ihlr-18967	277	12	the	the	DET
ihlr-18967	277	13	ftc	ftc	PROPN
ihlr-18967	277	14	issued	issue	VERB
ihlr-18967	277	15	a	a	DET
ihlr-18967	277	16	final	final	ADJ
ihlr-18967	277	17	order	order	NOUN
ihlr-18967	277	18	that	that	SCONJ
ihlr-18967	277	19	the	the	DET
ihlr-18967	277	20	settlements	settlement	NOUN
ihlr-18967	277	21	were	be	AUX
ihlr-18967	277	22	unreasonable	unreasonable	ADJ
ihlr-18967	277	23	restraints	restraint	NOUN
ihlr-18967	277	24	on	on	ADP
ihlr-18967	277	25	commerce	commerce	NOUN
ihlr-18967	277	26	.	.	PUNCT
ihlr-18967	278	1	i	i	PRON
ihlr-18967	278	2	d.	d.	PROPN
ihlr-18967	278	3	at	at	ADP
ihlr-18967	278	4	207	207	NUM
ihlr-18967	278	5	;	;	PUNCT
ihlr-18967	278	6	in	in	ADP
ihlr-18967	278	7	re	re	VERB
ihlr-18967	278	8	schering	schering	NOUN
ihlr-18967	278	9	-	-	PUNCT
ihlr-18967	278	10	plough	plough	PROPN
ihlr-18967	278	11	corp	corp	PROPN
ihlr-18967	278	12	.	.	PROPN
ihlr-18967	278	13	,	,	PUNCT
ihlr-18967	278	14	final	final	ADJ
ihlr-18967	278	15	order	order	NOUN
ihlr-18967	278	16	,	,	PUNCT
ihlr-18967	278	17	136	136	NUM
ihlr-18967	278	18	f.t.c	f.t.c	NOUN
ihlr-18967	278	19	.	.	PROPN
ihlr-18967	278	20	956	956	NUM
ihlr-18967	278	21	,	,	PUNCT
ihlr-18967	278	22	1052	1052	NUM
ihlr-18967	278	23	(	(	PUNCT
ihlr-18967	278	24	2003	2003	NUM
ihlr-18967	278	25	)	)	PUNCT
ihlr-18967	278	26	.	.	PUNCT
ihlr-18967	279	1	subsequently	subsequently	ADV
ihlr-18967	279	2	,	,	PUNCT
ihlr-18967	279	3	schering	schering	NOUN
ihlr-18967	279	4	appealed	appeal	VERB
ihlr-18967	279	5	the	the	DET
ihlr-18967	279	6	ftc	ftc	PROPN
ihlr-18967	279	7	’s	’s	PART
ihlr-18967	279	8	final	final	ADJ
ihlr-18967	279	9	order	order	NOUN
ihlr-18967	279	10	to	to	ADP
ihlr-18967	279	11	the	the	DET
ihlr-18967	279	12	eleventh	eleventh	ADJ
ihlr-18967	279	13	circuit	circuit	NOUN
ihlr-18967	279	14	which	which	PRON
ihlr-18967	279	15	reversed	reverse	VERB
ihlr-18967	279	16	under	under	ADP
ihlr-18967	279	17	the	the	DET
ihlr-18967	279	18	scope	scope	NOUN
ihlr-18967	279	19	of	of	ADP
ihlr-18967	279	20	patent	patent	NOUN
ihlr-18967	279	21	test	test	NOUN
ihlr-18967	279	22	.	.	PUNCT
ihlr-18967	280	1	schering	schering	NOUN
ihlr-18967	280	2	-	-	PUNCT
ihlr-18967	280	3	plough	plough	PROPN
ihlr-18967	280	4	corp	corp	PROPN
ihlr-18967	280	5	.	.	PROPN
ihlr-18967	280	6	v.	v.	PROPN
ihlr-18967	280	7	ftc	ftc	PROPN
ihlr-18967	280	8	,	,	PUNCT
ihlr-18967	280	9	402	402	NUM
ihlr-18967	280	10	f.3d	f.3d	NUM
ihlr-18967	280	11	1056	1056	NUM
ihlr-18967	280	12	,	,	PUNCT
ihlr-18967	280	13	1058	1058	NUM
ihlr-18967	280	14	(	(	PUNCT
ihlr-18967	280	15	11th	11th	ADJ
ihlr-18967	280	16	cir	cir	NOUN
ihlr-18967	280	17	.	.	PROPN
ihlr-18967	280	18	2005	2005	NUM
ihlr-18967	280	19	)	)	PUNCT
ihlr-18967	280	20	.	.	PUNCT
ihlr-18967	281	1	75	75	NUM
ihlr-18967	281	2	in	in	ADP
ihlr-18967	281	3	re	re	ADJ
ihlr-18967	281	4	k	k	X
ihlr-18967	281	5	-	-	PUNCT
ihlr-18967	281	6	dur	dur	PROPN
ihlr-18967	281	7	,	,	PUNCT
ihlr-18967	281	8	686	686	NUM
ihlr-18967	281	9	f.3d	f.3d	NUM
ihlr-18967	281	10	at	at	ADP
ihlr-18967	281	11	208	208	NUM
ihlr-18967	281	12	.	.	PUNCT
ihlr-18967	282	1	76	76	NUM
ihlr-18967	283	1	i	i	PRON
ihlr-18967	283	2	d.	d.	PROPN
ihlr-18967	283	3	77	77	NUM
ihlr-18967	284	1	i	i	PRON
ihlr-18967	284	2	d.	d.	PROPN
ihlr-18967	284	3	at	at	ADP
ihlr-18967	284	4	214	214	NUM
ihlr-18967	284	5	.	.	PUNCT
ihlr-18967	285	1	78	78	NUM
ihlr-18967	286	1	i	i	PRON
ihlr-18967	286	2	d.	d.	NOUN
ihlr-18967	286	3	at	at	ADP
ihlr-18967	286	4	218	218	NUM
ihlr-18967	286	5	.	.	PUNCT
ihlr-18967	287	1	2015	2015	NUM
ihlr-18967	287	2	rationale	rationale	NOUN
ihlr-18967	287	3	behind	behind	ADP
ihlr-18967	287	4	hatch	hatch	NOUN
ihlr-18967	287	5	-	-	PUNCT
ihlr-18967	287	6	waxman	waxman	PROPN
ihlr-18967	287	7	act	act	PROPN
ihlr-18967	287	8	and	and	CCONJ
ihlr-18967	287	9	patent	patent	NOUN
ihlr-18967	287	10	law	law	NOUN
ihlr-18967	287	11	439	439	NUM
ihlr-18967	287	12	(	(	PUNCT
ihlr-18967	287	13	1	1	NUM
ihlr-18967	287	14	)	)	PUNCT
ihlr-18967	287	15	was	be	AUX
ihlr-18967	287	16	for	for	ADP
ihlr-18967	287	17	a	a	DET
ihlr-18967	287	18	purpose	purpose	NOUN
ihlr-18967	287	19	other	other	ADJ
ihlr-18967	287	20	than	than	ADP
ihlr-18967	287	21	delayed	delay	VERB
ihlr-18967	287	22	entry	entry	NOUN
ihlr-18967	287	23	or	or	CCONJ
ihlr-18967	287	24	(	(	PUNCT
ihlr-18967	287	25	2	2	NUM
ihlr-18967	287	26	)	)	PUNCT
ihlr-18967	287	27	offers	offer	VERB
ihlr-18967	287	28	some	some	DET
ihlr-18967	287	29	pro	pro	ADJ
ihlr-18967	287	30	-	-	ADJ
ihlr-18967	287	31	competitive	competitive	ADJ
ihlr-18967	287	32	benefit	benefit	NOUN
ihlr-18967	287	33	.	.	PUNCT
ihlr-18967	288	1	”79	”79	PROPN
ihlr-18967	288	2	2	2	NUM
ihlr-18967	288	3	.	.	X
ihlr-18967	289	1	ftc	ftc	PROPN
ihlr-18967	289	2	v.	v.	PROPN
ihlr-18967	289	3	watson	watson	PROPN
ihlr-18967	289	4	pharmaceuticals	pharmaceuticals	PROPN
ihlr-18967	289	5	inc.80	inc.80	PROPN
ihlr-18967	289	6	in	in	ADP
ihlr-18967	289	7	2000	2000	NUM
ihlr-18967	289	8	,	,	PUNCT
ihlr-18967	289	9	the	the	DET
ihlr-18967	289	10	fda	fda	PROPN
ihlr-18967	289	11	approved	approve	VERB
ihlr-18967	289	12	an	an	DET
ihlr-18967	289	13	nda	nda	NOUN
ihlr-18967	289	14	for	for	ADP
ihlr-18967	289	15	solvay	solvay	NOUN
ihlr-18967	289	16	pharmaceuticals	pharmaceuticals	PROPN
ihlr-18967	289	17	(	(	PUNCT
ihlr-18967	289	18	“	"	PUNCT
ihlr-18967	289	19	solvay	solvay	NOUN
ihlr-18967	289	20	”	"	PUNCT
ihlr-18967	289	21	)	)	PUNCT
ihlr-18967	289	22	for	for	ADP
ihlr-18967	289	23	its	its	PRON
ihlr-18967	289	24	drug	drug	NOUN
ihlr-18967	289	25	androgel.81	androgel.81	ADJ
ihlr-18967	289	26	in	in	ADP
ihlr-18967	289	27	2003	2003	NUM
ihlr-18967	289	28	,	,	PUNCT
ihlr-18967	289	29	under	under	ADP
ihlr-18967	289	30	paragraph	paragraph	NOUN
ihlr-18967	289	31	iv	iv	NUM
ihlr-18967	289	32	certification	certification	NOUN
ihlr-18967	289	33	,	,	PUNCT
ihlr-18967	289	34	watson	watson	PROPN
ihlr-18967	289	35	pharmaceuticals	pharmaceuticals	PROPN
ihlr-18967	289	36	,	,	PUNCT
ihlr-18967	289	37	inc	inc	PROPN
ihlr-18967	289	38	.	.	PROPN
ihlr-18967	290	1	(	(	PUNCT
ihlr-18967	290	2	now	now	ADV
ihlr-18967	290	3	actavis)82	actavis)82	ADJ
ihlr-18967	290	4	(	(	PUNCT
ihlr-18967	290	5	“	"	PUNCT
ihlr-18967	290	6	watson	watson	NOUN
ihlr-18967	290	7	”	"	PUNCT
ihlr-18967	290	8	)	)	PUNCT
ihlr-18967	290	9	filed	file	VERB
ihlr-18967	290	10	an	an	DET
ihlr-18967	290	11	anda	anda	NOUN
ihlr-18967	290	12	for	for	ADP
ihlr-18967	290	13	a	a	DET
ihlr-18967	290	14	generic	generic	ADJ
ihlr-18967	290	15	version	version	NOUN
ihlr-18967	290	16	of	of	ADP
ihlr-18967	290	17	androgel.83	androgel.83	PROPN
ihlr-18967	290	18	further	far	ADV
ihlr-18967	290	19	,	,	PUNCT
ihlr-18967	290	20	after	after	SCONJ
ihlr-18967	290	21	watson	watson	PROPN
ihlr-18967	290	22	filed	file	VERB
ihlr-18967	290	23	their	their	PRON
ihlr-18967	290	24	anda	anda	NOUN
ihlr-18967	290	25	,	,	PUNCT
ihlr-18967	290	26	paddock	paddock	NOUN
ihlr-18967	290	27	laboratories	laboratory	NOUN
ihlr-18967	290	28	(	(	PUNCT
ihlr-18967	290	29	“	"	PUNCT
ihlr-18967	290	30	paddock	paddock	NOUN
ihlr-18967	290	31	”	"	PUNCT
ihlr-18967	290	32	)	)	PUNCT
ihlr-18967	290	33	also	also	ADV
ihlr-18967	290	34	filed	file	VERB
ihlr-18967	290	35	an	an	DET
ihlr-18967	290	36	anda	anda	PROPN
ihlr-18967	290	37	under	under	ADP
ihlr-18967	290	38	paragraph	paragraph	NOUN
ihlr-18967	290	39	iv	iv	NUM
ihlr-18967	290	40	certification.84	certification.84	NOUN
ihlr-18967	290	41	not	not	PART
ihlr-18967	290	42	filing	file	VERB
ihlr-18967	290	43	a	a	DET
ihlr-18967	290	44	separate	separate	ADJ
ihlr-18967	290	45	anda	anda	NOUN
ihlr-18967	290	46	,	,	PUNCT
ihlr-18967	290	47	par	par	NOUN
ihlr-18967	290	48	pharmaceutical	pharmaceutical	NOUN
ihlr-18967	290	49	(	(	PUNCT
ihlr-18967	290	50	“	"	PUNCT
ihlr-18967	290	51	par	par	NOUN
ihlr-18967	290	52	”	"	PUNCT
ihlr-18967	290	53	)	)	PUNCT
ihlr-18967	290	54	joined	join	VERB
ihlr-18967	290	55	paddock	paddock	NOUN
ihlr-18967	290	56	on	on	ADP
ihlr-18967	290	57	the	the	DET
ihlr-18967	290	58	patent	patent	NOUN
ihlr-18967	290	59	litigation	litigation	NOUN
ihlr-18967	290	60	in	in	ADP
ihlr-18967	290	61	exchange	exchange	NOUN
ihlr-18967	290	62	for	for	ADP
ihlr-18967	290	63	potential	potential	ADJ
ihlr-18967	290	64	profit	profit	NOUN
ihlr-18967	290	65	from	from	ADP
ihlr-18967	290	66	paddock	paddock	NOUN
ihlr-18967	290	67	’s	’s	PART
ihlr-18967	290	68	generic	generic	ADJ
ihlr-18967	290	69	drug.85	drug.85	NOUN
ihlr-18967	290	70	as	as	ADP
ihlr-18967	290	71	a	a	DET
ihlr-18967	290	72	result	result	NOUN
ihlr-18967	290	73	of	of	ADP
ihlr-18967	290	74	paragraph	paragraph	NOUN
ihlr-18967	290	75	iv	iv	NUM
ihlr-18967	290	76	certification	certification	NOUN
ihlr-18967	290	77	filed	file	VERB
ihlr-18967	290	78	by	by	ADP
ihlr-18967	290	79	watson	watson	PROPN
ihlr-18967	290	80	and	and	CCONJ
ihlr-18967	290	81	paddock	paddock	NOUN
ihlr-18967	290	82	,	,	PUNCT
ihlr-18967	290	83	solvay	solvay	NOUN
ihlr-18967	290	84	filed	file	VERB
ihlr-18967	290	85	suit	suit	NOUN
ihlr-18967	290	86	for	for	ADP
ihlr-18967	290	87	patent	patent	NOUN
ihlr-18967	290	88	infringement	infringement	NOUN
ihlr-18967	290	89	within	within	ADP
ihlr-18967	290	90	the	the	DET
ihlr-18967	290	91	appropriate	appropriate	ADJ
ihlr-18967	290	92	forty	forty	NUM
ihlr-18967	290	93	-	-	PUNCT
ihlr-18967	290	94	five	five	NUM
ihlr-18967	290	95	day	day	NOUN
ihlr-18967	290	96	window.86	window.86	NOUN
ihlr-18967	290	97	litigation	litigation	NOUN
ihlr-18967	290	98	ensued	ensue	VERB
ihlr-18967	290	99	until	until	ADP
ihlr-18967	290	100	2006	2006	NUM
ihlr-18967	290	101	when	when	SCONJ
ihlr-18967	290	102	all	all	DET
ihlr-18967	290	103	parties	party	NOUN
ihlr-18967	290	104	settled	settle	VERB
ihlr-18967	290	105	and	and	CCONJ
ihlr-18967	290	106	entered	enter	VERB
ihlr-18967	290	107	into	into	ADP
ihlr-18967	290	108	the	the	DET
ihlr-18967	290	109	following	follow	VERB
ihlr-18967	290	110	reverse	reverse	ADJ
ihlr-18967	290	111	payment	payment	NOUN
ihlr-18967	290	112	settlement	settlement	NOUN
ihlr-18967	290	113	agreements.87	agreements.87	PROPN
ihlr-18967	290	114	first	first	ADV
ihlr-18967	290	115	,	,	PUNCT
ihlr-18967	290	116	solvay	solvay	PROPN
ihlr-18967	290	117	’s	’s	PART
ihlr-18967	290	118	settlement	settlement	NOUN
ihlr-18967	290	119	with	with	ADP
ihlr-18967	290	120	watson	watson	PROPN
ihlr-18967	290	121	provided	provide	VERB
ihlr-18967	290	122	the	the	DET
ihlr-18967	290	123	following	following	NOUN
ihlr-18967	290	124	:	:	PUNCT
ihlr-18967	290	125	(	(	PUNCT
ihlr-18967	290	126	a	a	X
ihlr-18967	290	127	)	)	PUNCT
ihlr-18967	290	128	watson	watson	NOUN
ihlr-18967	290	129	would	would	AUX
ihlr-18967	290	130	not	not	PART
ihlr-18967	290	131	bring	bring	VERB
ihlr-18967	290	132	its	its	PRON
ihlr-18967	290	133	generic	generic	NOUN
ihlr-18967	290	134	to	to	ADP
ihlr-18967	290	135	market	market	NOUN
ihlr-18967	290	136	until	until	ADP
ihlr-18967	290	137	august	august	PROPN
ihlr-18967	290	138	31	31	NUM
ihlr-18967	290	139	,	,	PUNCT
ihlr-18967	290	140	2015	2015	NUM
ihlr-18967	290	141	,	,	PUNCT
ihlr-18967	290	142	sixty	sixty	NUM
ihlr-18967	290	143	-	-	PUNCT
ihlr-18967	290	144	five	five	NUM
ihlr-18967	290	145	months	month	NOUN
ihlr-18967	290	146	before	before	SCONJ
ihlr-18967	290	147	solvay	solvay	PROPN
ihlr-18967	290	148	’s	’s	PART
ihlr-18967	290	149	patent	patent	NOUN
ihlr-18967	290	150	expired	expire	VERB
ihlr-18967	290	151	;	;	PUNCT
ihlr-18967	290	152	(	(	PUNCT
ihlr-18967	290	153	b	b	X
ihlr-18967	290	154	)	)	PUNCT
ihlr-18967	290	155	watson	watson	NOUN
ihlr-18967	290	156	would	would	AUX
ihlr-18967	290	157	promote	promote	VERB
ihlr-18967	290	158	androgel	androgel	NOUN
ihlr-18967	290	159	to	to	ADP
ihlr-18967	290	160	urologists	urologist	NOUN
ihlr-18967	290	161	;	;	PUNCT
ihlr-18967	290	162	and	and	CCONJ
ihlr-18967	290	163	(	(	PUNCT
ihlr-18967	290	164	c	c	X
ihlr-18967	290	165	)	)	PUNCT
ihlr-18967	290	166	solvay	solvay	NOUN
ihlr-18967	290	167	would	would	AUX
ihlr-18967	290	168	share	share	VERB
ihlr-18967	290	169	with	with	ADP
ihlr-18967	290	170	watson	watson	PROPN
ihlr-18967	290	171	an	an	DET
ihlr-18967	290	172	estimated	estimate	VERB
ihlr-18967	290	173	profit	profit	NOUN
ihlr-18967	290	174	of	of	ADP
ihlr-18967	290	175	$	$	SYM
ihlr-18967	290	176	19-$30	19-$30	NUM
ihlr-18967	290	177	million	million	NUM
ihlr-18967	290	178	annually	annually	ADV
ihlr-18967	290	179	for	for	ADP
ihlr-18967	290	180	nine	nine	NUM
ihlr-18967	290	181	years.88	years.88	NOUN
ihlr-18967	290	182	second	second	ADJ
ihlr-18967	290	183	,	,	PUNCT
ihlr-18967	290	184	solvay	solvay	NOUN
ihlr-18967	290	185	’s	’s	PART
ihlr-18967	290	186	settlement	settlement	NOUN
ihlr-18967	290	187	with	with	ADP
ihlr-18967	290	188	paddock	paddock	NOUN
ihlr-18967	290	189	and	and	CCONJ
ihlr-18967	290	190	par	par	NOUN
ihlr-18967	290	191	79	79	NUM
ihlr-18967	291	1	i	i	PRON
ihlr-18967	291	2	d.	d.	PROPN
ihlr-18967	291	3	80	80	NUM
ihlr-18967	291	4	ftc	ftc	PROPN
ihlr-18967	291	5	v.	v.	PROPN
ihlr-18967	291	6	watson	watson	PROPN
ihlr-18967	291	7	pharms	pharms	PROPN
ihlr-18967	291	8	.	.	PUNCT
ihlr-18967	291	9	inc	inc	PROPN
ihlr-18967	291	10	.	.	PROPN
ihlr-18967	291	11	,	,	PUNCT
ihlr-18967	291	12	677	677	NUM
ihlr-18967	291	13	f.3d	f.3d	NUM
ihlr-18967	291	14	1298	1298	NUM
ihlr-18967	291	15	(	(	PUNCT
ihlr-18967	291	16	11th	11th	ADJ
ihlr-18967	291	17	cir	cir	NOUN
ihlr-18967	291	18	.	.	PROPN
ihlr-18967	291	19	2012	2012	NUM
ihlr-18967	291	20	)	)	PUNCT
ihlr-18967	291	21	,	,	PUNCT
ihlr-18967	291	22	rev’d	rev’d	NOUN
ihlr-18967	291	23	sub	sub	PROPN
ihlr-18967	291	24	nom	nom	PROPN
ihlr-18967	291	25	.	.	PROPN
ihlr-18967	291	26	f.t.c	f.t.c	PROPN
ihlr-18967	291	27	.	.	PUNCT
ihlr-18967	292	1	v.	v.	ADP
ihlr-18967	292	2	actavis	actavis	PROPN
ihlr-18967	292	3	,	,	PUNCT
ihlr-18967	292	4	inc	inc	PROPN
ihlr-18967	292	5	.	.	PROPN
ihlr-18967	292	6	,	,	PUNCT
ihlr-18967	292	7	133	133	NUM
ihlr-18967	292	8	s.	s.	PROPN
ihlr-18967	292	9	ct	ct	PROPN
ihlr-18967	292	10	.	.	PROPN
ihlr-18967	292	11	2223	2223	NUM
ihlr-18967	292	12	(	(	PUNCT
ihlr-18967	292	13	2013	2013	NUM
ihlr-18967	292	14	)	)	PUNCT
ihlr-18967	292	15	.	.	PUNCT
ihlr-18967	293	1	81	81	NUM
ihlr-18967	294	1	i	i	PRON
ihlr-18967	294	2	d.	d.	PROPN
ihlr-18967	294	3	at	at	ADP
ihlr-18967	294	4	1304	1304	NUM
ihlr-18967	294	5	.	.	PUNCT
ihlr-18967	295	1	82	82	NUM
ihlr-18967	295	2	press	press	NOUN
ihlr-18967	295	3	release	release	NOUN
ihlr-18967	295	4	,	,	PUNCT
ihlr-18967	295	5	actavis	actavis	PROPN
ihlr-18967	295	6	,	,	PUNCT
ihlr-18967	295	7	inc	inc	PROPN
ihlr-18967	295	8	.	.	PROPN
ihlr-18967	295	9	,	,	PUNCT
ihlr-18967	295	10	watson	watson	PROPN
ihlr-18967	295	11	announces	announce	VERB
ihlr-18967	295	12	new	new	ADJ
ihlr-18967	295	13	name	name	NOUN
ihlr-18967	295	14	-	-	PUNCT
ihlr-18967	295	15	actavis	actavis	NOUN
ihlr-18967	295	16	--	--	PUNCT
ihlr-18967	295	17	for	for	ADP
ihlr-18967	295	18	global	global	ADJ
ihlr-18967	295	19	operations	operation	NOUN
ihlr-18967	295	20	(	(	PUNCT
ihlr-18967	295	21	oct	oct	PROPN
ihlr-18967	295	22	.	.	PROPN
ihlr-18967	295	23	31	31	NUM
ihlr-18967	295	24	,	,	PUNCT
ihlr-18967	295	25	2012	2012	NUM
ihlr-18967	295	26	)	)	PUNCT
ihlr-18967	295	27	(	(	PUNCT
ihlr-18967	295	28	on	on	ADP
ihlr-18967	295	29	file	file	NOUN
ihlr-18967	295	30	with	with	ADP
ihlr-18967	295	31	author	author	NOUN
ihlr-18967	295	32	)	)	PUNCT
ihlr-18967	295	33	,	,	PUNCT
ihlr-18967	295	34	available	available	ADJ
ihlr-18967	295	35	at	at	ADP
ihlr-18967	295	36	http://phx.corporate-ir.net/phoenix.zhtml?c=65778&p=irolnewsarticle&id=1752588&highlight=.	http://phx.corporate-ir.net/phoenix.zhtml?c=65778&p=irolnewsarticle&id=1752588&highlight=.	DET
ihlr-18967	295	37	83	83	NUM
ihlr-18967	295	38	watson	watson	NOUN
ihlr-18967	295	39	pharms	pharm	NOUN
ihlr-18967	295	40	.	.	PUNCT
ihlr-18967	296	1	,	,	PUNCT
ihlr-18967	296	2	677	677	NUM
ihlr-18967	296	3	f.3d	f.3d	NUM
ihlr-18967	296	4	at	at	ADP
ihlr-18967	296	5	1304	1304	NUM
ihlr-18967	296	6	.	.	PUNCT
ihlr-18967	297	1	84	84	NUM
ihlr-18967	298	1	i	i	PRON
ihlr-18967	298	2	d.	d.	PROPN
ihlr-18967	298	3	85	85	NUM
ihlr-18967	299	1	i	i	PRON
ihlr-18967	299	2	d.	d.	PROPN
ihlr-18967	299	3	86	86	NUM
ihlr-18967	300	1	i	i	PRON
ihlr-18967	300	2	d.	d.	PROPN
ihlr-18967	300	3	87	87	NUM
ihlr-18967	301	1	i	i	PRON
ihlr-18967	301	2	d.	d.	PROPN
ihlr-18967	301	3	at	at	ADP
ihlr-18967	301	4	1304	1304	NUM
ihlr-18967	301	5	-	-	SYM
ihlr-18967	301	6	05	05	NUM
ihlr-18967	301	7	.	.	PROPN
ihlr-18967	301	8	88	88	NUM
ihlr-18967	302	1	i	i	PRON
ihlr-18967	302	2	d.	d.	NOUN
ihlr-18967	302	3	at	at	ADP
ihlr-18967	302	4	1305	1305	NUM
ihlr-18967	302	5	.	.	PUNCT
ihlr-18967	303	1	440	440	NUM
ihlr-18967	303	2	indiana	indiana	PROPN
ihlr-18967	303	3	health	health	PROPN
ihlr-18967	303	4	law	law	PROPN
ihlr-18967	303	5	review	review	NOUN
ihlr-18967	303	6	vol	vol	NOUN
ihlr-18967	303	7	.	.	PUNCT
ihlr-18967	304	1	12:1	12:1	NUM
ihlr-18967	304	2	provided	provide	VERB
ihlr-18967	304	3	for	for	ADP
ihlr-18967	304	4	:	:	PUNCT
ihlr-18967	304	5	(	(	PUNCT
ihlr-18967	304	6	a	a	X
ihlr-18967	304	7	)	)	PUNCT
ihlr-18967	304	8	paddock	paddock	NOUN
ihlr-18967	304	9	/	/	SYM
ihlr-18967	304	10	par	par	NOUN
ihlr-18967	304	11	would	would	AUX
ihlr-18967	304	12	not	not	PART
ihlr-18967	304	13	bring	bring	VERB
ihlr-18967	304	14	its	its	PRON
ihlr-18967	304	15	generic	generic	NOUN
ihlr-18967	304	16	to	to	ADP
ihlr-18967	304	17	market	market	NOUN
ihlr-18967	304	18	until	until	ADP
ihlr-18967	304	19	august	august	PROPN
ihlr-18967	304	20	31	31	NUM
ihlr-18967	304	21	,	,	PUNCT
ihlr-18967	304	22	2015	2015	NUM
ihlr-18967	304	23	;	;	PUNCT
ihlr-18967	304	24	(	(	PUNCT
ihlr-18967	304	25	b	b	X
ihlr-18967	304	26	)	)	PUNCT
ihlr-18967	304	27	par	par	NOUN
ihlr-18967	304	28	would	would	AUX
ihlr-18967	304	29	promote	promote	VERB
ihlr-18967	304	30	androgel	androgel	NOUN
ihlr-18967	304	31	to	to	ADP
ihlr-18967	304	32	primary	primary	ADJ
ihlr-18967	304	33	care	care	NOUN
ihlr-18967	304	34	doctors	doctor	NOUN
ihlr-18967	304	35	;	;	PUNCT
ihlr-18967	304	36	(	(	PUNCT
ihlr-18967	304	37	c	c	X
ihlr-18967	304	38	)	)	PUNCT
ihlr-18967	304	39	par	par	NOUN
ihlr-18967	304	40	was	be	AUX
ihlr-18967	304	41	to	to	PART
ihlr-18967	304	42	serve	serve	VERB
ihlr-18967	304	43	as	as	ADP
ihlr-18967	304	44	a	a	DET
ihlr-18967	304	45	backup	backup	ADJ
ihlr-18967	304	46	manufacturer	manufacturer	NOUN
ihlr-18967	304	47	;	;	PUNCT
ihlr-18967	304	48	and	and	CCONJ
ihlr-18967	304	49	(	(	PUNCT
ihlr-18967	304	50	d	d	NOUN
ihlr-18967	304	51	)	)	PUNCT
ihlr-18967	304	52	paddock	paddock	NOUN
ihlr-18967	304	53	/	/	SYM
ihlr-18967	304	54	par	par	NOUN
ihlr-18967	304	55	would	would	AUX
ihlr-18967	304	56	receive	receive	VERB
ihlr-18967	304	57	$	$	SYM
ihlr-18967	304	58	10	10	NUM
ihlr-18967	304	59	million	million	NUM
ihlr-18967	304	60	per	per	ADP
ihlr-18967	304	61	year	year	NOUN
ihlr-18967	304	62	for	for	ADP
ihlr-18967	304	63	six	six	NUM
ihlr-18967	304	64	years	year	NOUN
ihlr-18967	304	65	and	and	CCONJ
ihlr-18967	304	66	$	$	SYM
ihlr-18967	304	67	2	2	NUM
ihlr-18967	304	68	million	million	NUM
ihlr-18967	304	69	per	per	ADP
ihlr-18967	304	70	year	year	NOUN
ihlr-18967	304	71	for	for	ADP
ihlr-18967	304	72	the	the	DET
ihlr-18967	304	73	backup	backup	ADJ
ihlr-18967	304	74	manufacturer	manufacturer	NOUN
ihlr-18967	304	75	deal.89	deal.89	NOUN
ihlr-18967	304	76	after	after	ADP
ihlr-18967	304	77	reporting	report	VERB
ihlr-18967	304	78	the	the	DET
ihlr-18967	304	79	settlement	settlement	NOUN
ihlr-18967	304	80	,	,	PUNCT
ihlr-18967	304	81	the	the	DET
ihlr-18967	304	82	ftc	ftc	PROPN
ihlr-18967	304	83	filed	file	VERB
ihlr-18967	304	84	an	an	DET
ihlr-18967	304	85	antitrust	antitrust	ADJ
ihlr-18967	304	86	lawsuit	lawsuit	NOUN
ihlr-18967	304	87	against	against	ADP
ihlr-18967	304	88	the	the	DET
ihlr-18967	304	89	four	four	NUM
ihlr-18967	304	90	companies.90	companies.90	NOUN
ihlr-18967	304	91	while	while	SCONJ
ihlr-18967	304	92	solvay	solvay	PROPN
ihlr-18967	304	93	,	,	PUNCT
ihlr-18967	304	94	watson	watson	PROPN
ihlr-18967	304	95	,	,	PUNCT
ihlr-18967	304	96	paddock	paddock	NOUN
ihlr-18967	304	97	,	,	PUNCT
ihlr-18967	304	98	and	and	CCONJ
ihlr-18967	304	99	par	par	NOUN
ihlr-18967	304	100	contended	contend	VERB
ihlr-18967	304	101	the	the	DET
ihlr-18967	304	102	payments	payment	NOUN
ihlr-18967	304	103	of	of	ADP
ihlr-18967	304	104	compensation	compensation	NOUN
ihlr-18967	304	105	were	be	AUX
ihlr-18967	304	106	for	for	ADP
ihlr-18967	304	107	services	service	NOUN
ihlr-18967	304	108	provided	provide	VERB
ihlr-18967	304	109	by	by	ADP
ihlr-18967	304	110	the	the	DET
ihlr-18967	304	111	generic	generic	ADJ
ihlr-18967	304	112	manufacturers	manufacturer	NOUN
ihlr-18967	304	113	,	,	PUNCT
ihlr-18967	304	114	the	the	DET
ihlr-18967	304	115	ftc	ftc	PROPN
ihlr-18967	304	116	alleged	allege	VERB
ihlr-18967	304	117	that	that	SCONJ
ihlr-18967	304	118	the	the	DET
ihlr-18967	304	119	agreements	agreement	NOUN
ihlr-18967	304	120	were	be	AUX
ihlr-18967	304	121	just	just	ADV
ihlr-18967	304	122	to	to	PART
ihlr-18967	304	123	keep	keep	VERB
ihlr-18967	304	124	generic	generic	ADJ
ihlr-18967	304	125	androgel	androgel	NOUN
ihlr-18967	304	126	off	off	ADP
ihlr-18967	304	127	the	the	DET
ihlr-18967	304	128	market.91	market.91	NOUN
ihlr-18967	304	129	applying	apply	VERB
ihlr-18967	304	130	the	the	DET
ihlr-18967	304	131	scope	scope	NOUN
ihlr-18967	304	132	of	of	ADP
ihlr-18967	304	133	patent	patent	NOUN
ihlr-18967	304	134	test	test	NOUN
ihlr-18967	304	135	,	,	PUNCT
ihlr-18967	304	136	the	the	DET
ihlr-18967	304	137	district	district	NOUN
ihlr-18967	304	138	court	court	NOUN
ihlr-18967	304	139	dismissed	dismiss	VERB
ihlr-18967	304	140	the	the	DET
ihlr-18967	304	141	ftc	ftc	PROPN
ihlr-18967	304	142	’s	’s	PART
ihlr-18967	304	143	complaint	complaint	NOUN
ihlr-18967	304	144	because	because	SCONJ
ihlr-18967	304	145	it	it	PRON
ihlr-18967	304	146	did	do	AUX
ihlr-18967	304	147	not	not	PART
ihlr-18967	304	148	allege	allege	VERB
ihlr-18967	304	149	that	that	SCONJ
ihlr-18967	304	150	the	the	DET
ihlr-18967	304	151	settlement	settlement	NOUN
ihlr-18967	304	152	exceeded	exceed	VERB
ihlr-18967	304	153	the	the	DET
ihlr-18967	304	154	scope	scope	NOUN
ihlr-18967	304	155	of	of	ADP
ihlr-18967	304	156	solvay	solvay	PROPN
ihlr-18967	304	157	’s	’s	PART
ihlr-18967	304	158	patent.92	patent.92	NOUN
ihlr-18967	304	159	on	on	ADP
ihlr-18967	304	160	appeal	appeal	NOUN
ihlr-18967	304	161	,	,	PUNCT
ihlr-18967	304	162	the	the	DET
ihlr-18967	304	163	eleventh	eleventh	ADJ
ihlr-18967	304	164	circuit	circuit	NOUN
ihlr-18967	304	165	affirmed.93	affirmed.93	NOUN
ihlr-18967	304	166	in	in	ADP
ihlr-18967	304	167	doing	do	VERB
ihlr-18967	304	168	so	so	ADV
ihlr-18967	304	169	,	,	PUNCT
ihlr-18967	304	170	the	the	DET
ihlr-18967	304	171	eleven	eleven	NUM
ihlr-18967	304	172	circuit	circuit	NOUN
ihlr-18967	304	173	reaffirmed	reaffirm	VERB
ihlr-18967	304	174	its	its	PRON
ihlr-18967	304	175	holding	holding	NOUN
ihlr-18967	304	176	in	in	ADP
ihlr-18967	304	177	valley	valley	NOUN
ihlr-18967	304	178	drug	drug	NOUN
ihlr-18967	304	179	that	that	PRON
ihlr-18967	304	180	“	"	PUNCT
ihlr-18967	304	181	reverse	reverse	ADJ
ihlr-18967	304	182	payment	payment	NOUN
ihlr-18967	304	183	settlements	settlement	NOUN
ihlr-18967	304	184	are	be	AUX
ihlr-18967	304	185	immune	immune	ADJ
ihlr-18967	304	186	from	from	ADP
ihlr-18967	304	187	antitrust	antitrust	ADJ
ihlr-18967	304	188	liability	liability	NOUN
ihlr-18967	304	189	if	if	SCONJ
ihlr-18967	304	190	the	the	DET
ihlr-18967	304	191	anticompetitive	anticompetitive	ADJ
ihlr-18967	304	192	effects	effect	NOUN
ihlr-18967	304	193	of	of	ADP
ihlr-18967	304	194	their	their	PRON
ihlr-18967	304	195	settlement	settlement	NOUN
ihlr-18967	304	196	fall	fall	NOUN
ihlr-18967	304	197	‘	'	PUNCT
ihlr-18967	304	198	within	within	ADP
ihlr-18967	304	199	the	the	DET
ihlr-18967	304	200	scope	scope	NOUN
ihlr-18967	304	201	of	of	ADP
ihlr-18967	304	202	the	the	DET
ihlr-18967	304	203	exclusionary	exclusionary	ADJ
ihlr-18967	304	204	potential	potential	NOUN
ihlr-18967	304	205	of	of	ADP
ihlr-18967	304	206	the	the	DET
ihlr-18967	304	207	patent	patent	NOUN
ihlr-18967	304	208	.	.	PUNCT
ihlr-18967	304	209	’”94	’”94	PROPN
ihlr-18967	305	1	3	3	NUM
ihlr-18967	305	2	.	.	X
ihlr-18967	305	3	ftc	ftc	PROPN
ihlr-18967	305	4	v.	v.	ADP
ihlr-18967	305	5	actavis	actavis	PROPN
ihlr-18967	305	6	,	,	PUNCT
ihlr-18967	305	7	inc.95	inc.95	NOUN
ihlr-18967	305	8	after	after	ADP
ihlr-18967	305	9	ftc	ftc	PROPN
ihlr-18967	305	10	v.	v.	PROPN
ihlr-18967	305	11	watson	watson	PROPN
ihlr-18967	305	12	pharmaceuticals	pharmaceuticals	PROPN
ihlr-18967	305	13	inc	inc	PROPN
ihlr-18967	305	14	.	.	PROPN
ihlr-18967	305	15	was	be	AUX
ihlr-18967	305	16	decided	decide	VERB
ihlr-18967	305	17	,	,	PUNCT
ihlr-18967	305	18	the	the	DET
ihlr-18967	305	19	supreme	supreme	PROPN
ihlr-18967	305	20	court	court	PROPN
ihlr-18967	305	21	of	of	ADP
ihlr-18967	305	22	the	the	DET
ihlr-18967	305	23	united	united	PROPN
ihlr-18967	305	24	states	states	PROPN
ihlr-18967	305	25	granted	grant	VERB
ihlr-18967	305	26	certiorari	certiorari	NOUN
ihlr-18967	305	27	due	due	ADP
ihlr-18967	305	28	to	to	ADP
ihlr-18967	305	29	the	the	DET
ihlr-18967	305	30	circuit	circuit	NOUN
ihlr-18967	305	31	split	split	VERB
ihlr-18967	305	32	between	between	ADP
ihlr-18967	305	33	the	the	DET
ihlr-18967	305	34	third	third	ADJ
ihlr-18967	305	35	and	and	CCONJ
ihlr-18967	305	36	eleventh	eleventh	ADJ
ihlr-18967	305	37	circuit	circuit	NOUN
ihlr-18967	305	38	.	.	PUNCT
ihlr-18967	306	1	the	the	DET
ihlr-18967	306	2	court	court	NOUN
ihlr-18967	306	3	rejected	reject	VERB
ihlr-18967	306	4	the	the	DET
ihlr-18967	306	5	eleventh	eleventh	ADJ
ihlr-18967	306	6	circuit	circuit	NOUN
ihlr-18967	306	7	’s	’s	PART
ihlr-18967	306	8	application	application	NOUN
ihlr-18967	306	9	of	of	ADP
ihlr-18967	306	10	the	the	DET
ihlr-18967	306	11	scope	scope	NOUN
ihlr-18967	306	12	of	of	ADP
ihlr-18967	306	13	patent	patent	NOUN
ihlr-18967	306	14	test.96	test.96	PROPN
ihlr-18967	306	15	in	in	ADP
ihlr-18967	306	16	doing	do	VERB
ihlr-18967	306	17	so	so	ADV
ihlr-18967	306	18	,	,	PUNCT
ihlr-18967	306	19	the	the	DET
ihlr-18967	306	20	court	court	NOUN
ihlr-18967	306	21	held	hold	VERB
ihlr-18967	306	22	that	that	SCONJ
ihlr-18967	306	23	the	the	DET
ihlr-18967	306	24	ftc	ftc	PROPN
ihlr-18967	306	25	should	should	AUX
ihlr-18967	306	26	have	have	VERB
ihlr-18967	306	27	the	the	DET
ihlr-18967	306	28	opportunity	opportunity	NOUN
ihlr-18967	306	29	to	to	PART
ihlr-18967	306	30	prove	prove	VERB
ihlr-18967	306	31	its	its	PRON
ihlr-18967	306	32	antitrust	antitrust	ADJ
ihlr-18967	306	33	claim	claim	NOUN
ihlr-18967	306	34	under	under	ADP
ihlr-18967	306	35	the	the	DET
ihlr-18967	306	36	rule	rule	NOUN
ihlr-18967	306	37	of	of	ADP
ihlr-18967	306	38	reason.97	reason.97	NOUN
ihlr-18967	306	39	89	89	NUM
ihlr-18967	307	1	i	i	PRON
ihlr-18967	307	2	d.	d.	PROPN
ihlr-18967	307	3	90	90	NUM
ihlr-18967	308	1	i	i	PRON
ihlr-18967	308	2	d.	d.	PROPN
ihlr-18967	308	3	91	91	NUM
ihlr-18967	309	1	i	i	PRON
ihlr-18967	309	2	d.	d.	PROPN
ihlr-18967	309	3	92	92	NUM
ihlr-18967	310	1	i	i	PRON
ihlr-18967	310	2	d.	d.	PROPN
ihlr-18967	310	3	at	at	ADP
ihlr-18967	310	4	1306	1306	NUM
ihlr-18967	310	5	.	.	PUNCT
ihlr-18967	311	1	93	93	NUM
ihlr-18967	312	1	i	i	PRON
ihlr-18967	312	2	d.	d.	PROPN
ihlr-18967	312	3	at	at	ADP
ihlr-18967	312	4	1315	1315	NUM
ihlr-18967	312	5	.	.	PUNCT
ihlr-18967	313	1	94	94	NUM
ihlr-18967	314	1	i	i	PRON
ihlr-18967	314	2	d.	d.	PROPN
ihlr-18967	314	3	at	at	ADP
ihlr-18967	314	4	1309	1309	NUM
ihlr-18967	314	5	(	(	PUNCT
ihlr-18967	314	6	quoting	quote	VERB
ihlr-18967	314	7	valley	valley	NOUN
ihlr-18967	314	8	drug	drug	PROPN
ihlr-18967	314	9	co.	co.	PROPN
ihlr-18967	314	10	v.	v.	ADP
ihlr-18967	314	11	geneva	geneva	PROPN
ihlr-18967	314	12	pharms	pharms	PROPN
ihlr-18967	314	13	.	.	PUNCT
ihlr-18967	314	14	,	,	PUNCT
ihlr-18967	314	15	inc	inc	PROPN
ihlr-18967	314	16	.	.	PROPN
ihlr-18967	314	17	,	,	PUNCT
ihlr-18967	314	18	344	344	NUM
ihlr-18967	314	19	f.3d	f.3d	NUM
ihlr-18967	314	20	1294	1294	NUM
ihlr-18967	314	21	,	,	PUNCT
ihlr-18967	314	22	1311	1311	NUM
ihlr-18967	314	23	(	(	PUNCT
ihlr-18967	314	24	11th	11th	ADJ
ihlr-18967	314	25	cir	cir	NOUN
ihlr-18967	314	26	.	.	PROPN
ihlr-18967	314	27	2003	2003	NUM
ihlr-18967	314	28	)	)	PUNCT
ihlr-18967	314	29	)	)	PUNCT
ihlr-18967	314	30	.	.	PUNCT
ihlr-18967	315	1	95	95	NUM
ihlr-18967	315	2	ftc	ftc	PROPN
ihlr-18967	315	3	v.	v.	ADP
ihlr-18967	315	4	actavis	actavis	PROPN
ihlr-18967	315	5	,	,	PUNCT
ihlr-18967	315	6	inc	inc	PROPN
ihlr-18967	315	7	.	.	PROPN
ihlr-18967	315	8	,	,	PUNCT
ihlr-18967	315	9	133	133	NUM
ihlr-18967	315	10	s.	s.	PROPN
ihlr-18967	315	11	ct	ct	PROPN
ihlr-18967	315	12	.	.	PROPN
ihlr-18967	315	13	2223	2223	NUM
ihlr-18967	315	14	(	(	PUNCT
ihlr-18967	315	15	2013	2013	NUM
ihlr-18967	315	16	)	)	PUNCT
ihlr-18967	315	17	.	.	PUNCT
ihlr-18967	316	1	96	96	NUM
ihlr-18967	317	1	i	i	PRON
ihlr-18967	317	2	d.	d.	PROPN
ihlr-18967	317	3	at	at	ADP
ihlr-18967	317	4	2231	2231	NUM
ihlr-18967	317	5	.	.	PUNCT
ihlr-18967	318	1	97	97	NUM
ihlr-18967	319	1	i	i	PRON
ihlr-18967	319	2	d.	d.	PROPN
ihlr-18967	319	3	at	at	ADP
ihlr-18967	319	4	2234	2234	NUM
ihlr-18967	319	5	.	.	PUNCT
ihlr-18967	320	1	2015	2015	NUM
ihlr-18967	320	2	rationale	rationale	NOUN
ihlr-18967	320	3	behind	behind	ADP
ihlr-18967	320	4	hatch	hatch	NOUN
ihlr-18967	320	5	-	-	PUNCT
ihlr-18967	320	6	waxman	waxman	PROPN
ihlr-18967	320	7	act	act	PROPN
ihlr-18967	320	8	and	and	CCONJ
ihlr-18967	320	9	patent	patent	NOUN
ihlr-18967	320	10	law	law	NOUN
ihlr-18967	320	11	441	441	NUM
ihlr-18967	320	12	the	the	DET
ihlr-18967	320	13	court	court	NOUN
ihlr-18967	320	14	set	set	VERB
ihlr-18967	320	15	out	out	ADP
ihlr-18967	320	16	a	a	DET
ihlr-18967	320	17	list	list	NOUN
ihlr-18967	320	18	of	of	ADP
ihlr-18967	320	19	five	five	NUM
ihlr-18967	320	20	considerations	consideration	NOUN
ihlr-18967	320	21	for	for	ADP
ihlr-18967	320	22	lower	low	ADJ
ihlr-18967	320	23	courts	court	NOUN
ihlr-18967	320	24	to	to	PART
ihlr-18967	320	25	look	look	VERB
ihlr-18967	320	26	at	at	ADP
ihlr-18967	320	27	when	when	SCONJ
ihlr-18967	320	28	analyzing	analyze	VERB
ihlr-18967	320	29	a	a	DET
ihlr-18967	320	30	reverse	reverse	ADJ
ihlr-18967	320	31	payment	payment	NOUN
ihlr-18967	320	32	settlement	settlement	NOUN
ihlr-18967	320	33	.	.	PUNCT
ihlr-18967	321	1	first	first	ADV
ihlr-18967	321	2	,	,	PUNCT
ihlr-18967	321	3	“	"	PUNCT
ihlr-18967	321	4	the	the	DET
ihlr-18967	321	5	specific	specific	ADJ
ihlr-18967	321	6	restraint	restraint	NOUN
ihlr-18967	321	7	at	at	ADP
ihlr-18967	321	8	issue	issue	NOUN
ihlr-18967	321	9	has	have	VERB
ihlr-18967	321	10	the	the	DET
ihlr-18967	321	11	potential	potential	NOUN
ihlr-18967	321	12	for	for	ADP
ihlr-18967	321	13	genuine	genuine	ADJ
ihlr-18967	321	14	adverse	adverse	ADJ
ihlr-18967	321	15	effects	effect	NOUN
ihlr-18967	321	16	on	on	ADP
ihlr-18967	321	17	competition	competition	NOUN
ihlr-18967	321	18	.	.	PUNCT
ihlr-18967	322	1	”98	”98	PROPN
ihlr-18967	323	1	second	second	ADV
ihlr-18967	323	2	,	,	PUNCT
ihlr-18967	323	3	“	"	PUNCT
ihlr-18967	323	4	these	these	DET
ihlr-18967	323	5	anticompetitive	anticompetitive	ADJ
ihlr-18967	323	6	consequences	consequence	NOUN
ihlr-18967	323	7	will	will	AUX
ihlr-18967	323	8	at	at	ADP
ihlr-18967	323	9	least	least	ADJ
ihlr-18967	323	10	sometimes	sometimes	ADV
ihlr-18967	323	11	prove	prove	VERB
ihlr-18967	323	12	unjustified	unjustified	ADJ
ihlr-18967	323	13	.	.	PUNCT
ihlr-18967	324	1	”99	”99	PROPN
ihlr-18967	324	2	third	third	PROPN
ihlr-18967	324	3	,	,	PUNCT
ihlr-18967	324	4	“	"	PUNCT
ihlr-18967	324	5	where	where	SCONJ
ihlr-18967	324	6	a	a	DET
ihlr-18967	324	7	reverse	reverse	ADJ
ihlr-18967	324	8	payment	payment	NOUN
ihlr-18967	324	9	threatens	threaten	VERB
ihlr-18967	324	10	to	to	PART
ihlr-18967	324	11	work	work	VERB
ihlr-18967	324	12	unjustified	unjustified	ADJ
ihlr-18967	324	13	anticompetitive	anticompetitive	ADJ
ihlr-18967	324	14	harm	harm	NOUN
ihlr-18967	324	15	,	,	PUNCT
ihlr-18967	324	16	the	the	DET
ihlr-18967	324	17	patentee	patentee	NOUN
ihlr-18967	324	18	likely	likely	ADV
ihlr-18967	324	19	possesses	possess	VERB
ihlr-18967	324	20	the	the	DET
ihlr-18967	324	21	power	power	NOUN
ihlr-18967	324	22	to	to	PART
ihlr-18967	324	23	bring	bring	VERB
ihlr-18967	324	24	that	that	DET
ihlr-18967	324	25	harm	harm	NOUN
ihlr-18967	324	26	about	about	ADP
ihlr-18967	324	27	in	in	ADP
ihlr-18967	324	28	practice	practice	NOUN
ihlr-18967	324	29	.	.	PUNCT
ihlr-18967	325	1	”100	”100	PUNCT
ihlr-18967	325	2	fourth	fourth	ADJ
ihlr-18967	325	3	,	,	PUNCT
ihlr-18967	325	4	“	"	PUNCT
ihlr-18967	325	5	an	an	DET
ihlr-18967	325	6	antitrust	antitrust	ADJ
ihlr-18967	325	7	action	action	NOUN
ihlr-18967	325	8	is	be	AUX
ihlr-18967	325	9	likely	likely	ADJ
ihlr-18967	325	10	to	to	PART
ihlr-18967	325	11	prove	prove	VERB
ihlr-18967	325	12	more	more	ADV
ihlr-18967	325	13	feasible	feasible	ADJ
ihlr-18967	325	14	administratively	administratively	ADV
ihlr-18967	325	15	than	than	SCONJ
ihlr-18967	325	16	the	the	DET
ihlr-18967	325	17	eleventh	eleventh	ADJ
ihlr-18967	325	18	circuit	circuit	NOUN
ihlr-18967	325	19	believed	believe	VERB
ihlr-18967	325	20	.	.	PUNCT
ihlr-18967	326	1	”101	”101	PRON
ihlr-18967	326	2	fifth	fifth	ADJ
ihlr-18967	326	3	,	,	PUNCT
ihlr-18967	326	4	“	"	PUNCT
ihlr-18967	326	5	the	the	DET
ihlr-18967	326	6	fact	fact	NOUN
ihlr-18967	326	7	that	that	SCONJ
ihlr-18967	326	8	a	a	DET
ihlr-18967	326	9	large	large	ADJ
ihlr-18967	326	10	,	,	PUNCT
ihlr-18967	326	11	unjustified	unjustified	ADJ
ihlr-18967	326	12	reverse	reverse	ADJ
ihlr-18967	326	13	payment	payment	NOUN
ihlr-18967	326	14	risks	risk	NOUN
ihlr-18967	326	15	antitrust	antitrust	ADJ
ihlr-18967	326	16	liability	liability	NOUN
ihlr-18967	326	17	does	do	AUX
ihlr-18967	326	18	not	not	PART
ihlr-18967	326	19	prevent	prevent	VERB
ihlr-18967	326	20	litigating	litigating	NOUN
ihlr-18967	326	21	parties	party	NOUN
ihlr-18967	326	22	from	from	ADP
ihlr-18967	326	23	settling	settle	VERB
ihlr-18967	326	24	their	their	PRON
ihlr-18967	326	25	lawsuit	lawsuit	NOUN
ihlr-18967	326	26	.	.	PUNCT
ihlr-18967	327	1	”102	”102	PUNCT
ihlr-18967	328	1	further	far	ADV
ihlr-18967	328	2	,	,	PUNCT
ihlr-18967	328	3	the	the	DET
ihlr-18967	328	4	court	court	NOUN
ihlr-18967	328	5	rejected	reject	VERB
ihlr-18967	328	6	the	the	DET
ihlr-18967	328	7	ftc	ftc	PROPN
ihlr-18967	328	8	’s	’s	PART
ihlr-18967	328	9	argument	argument	NOUN
ihlr-18967	328	10	and	and	CCONJ
ihlr-18967	328	11	third	third	ADJ
ihlr-18967	328	12	circuit	circuit	NOUN
ihlr-18967	328	13	’s	’s	PART
ihlr-18967	328	14	application	application	NOUN
ihlr-18967	328	15	of	of	ADP
ihlr-18967	328	16	a	a	DET
ihlr-18967	328	17	quick	quick	ADJ
ihlr-18967	328	18	look	look	NOUN
ihlr-18967	328	19	approach.103	approach.103	PUNCT
ihlr-18967	328	20	the	the	DET
ihlr-18967	328	21	court	court	NOUN
ihlr-18967	328	22	reasoned	reason	VERB
ihlr-18967	328	23	that	that	SCONJ
ihlr-18967	328	24	reverse	reverse	ADJ
ihlr-18967	328	25	payment	payment	NOUN
ihlr-18967	328	26	settlements	settlement	NOUN
ihlr-18967	328	27	are	be	AUX
ihlr-18967	328	28	complex	complex	ADJ
ihlr-18967	328	29	and	and	CCONJ
ihlr-18967	328	30	may	may	AUX
ihlr-18967	328	31	not	not	PART
ihlr-18967	328	32	be	be	AUX
ihlr-18967	328	33	understood	understand	VERB
ihlr-18967	328	34	by	by	ADP
ihlr-18967	328	35	“	"	PUNCT
ihlr-18967	328	36	an	an	DET
ihlr-18967	328	37	observer	observer	NOUN
ihlr-18967	328	38	with	with	ADP
ihlr-18967	328	39	.	.	PUNCT
ihlr-18967	328	40	.	.	PUNCT
ihlr-18967	328	41	.	.	PUNCT
ihlr-18967	329	1	[	[	X
ihlr-18967	329	2	a	a	X
ihlr-18967	329	3	]	]	X
ihlr-18967	329	4	rudimentary	rudimentary	ADJ
ihlr-18967	329	5	understanding	understanding	NOUN
ihlr-18967	329	6	of	of	ADP
ihlr-18967	329	7	economics”104	economics”104	NOUN
ihlr-18967	330	1	because	because	SCONJ
ihlr-18967	330	2	“	"	PUNCT
ihlr-18967	330	3	a	a	DET
ihlr-18967	330	4	reverse	reverse	ADJ
ihlr-18967	330	5	payment	payment	NOUN
ihlr-18967	330	6	bringing	bring	VERB
ihlr-18967	330	7	about	about	ADP
ihlr-18967	330	8	anticompetitive	anticompetitive	ADJ
ihlr-18967	330	9	effects	effect	NOUN
ihlr-18967	330	10	[	[	X
ihlr-18967	330	11	(	(	PUNCT
ihlr-18967	330	12	a	a	NOUN
ihlr-18967	330	13	)	)	PUNCT
ihlr-18967	330	14	]	]	PUNCT
ihlr-18967	330	15	depends	depend	VERB
ihlr-18967	330	16	upon	upon	SCONJ
ihlr-18967	330	17	its	its	PRON
ihlr-18967	330	18	size	size	NOUN
ihlr-18967	330	19	,	,	PUNCT
ihlr-18967	330	20	[	[	X
ihlr-18967	330	21	(	(	PUNCT
ihlr-18967	330	22	b	b	NOUN
ihlr-18967	330	23	)	)	PUNCT
ihlr-18967	330	24	]	]	PUNCT
ihlr-18967	330	25	its	its	PRON
ihlr-18967	330	26	scale	scale	NOUN
ihlr-18967	330	27	in	in	ADP
ihlr-18967	330	28	relation	relation	NOUN
ihlr-18967	330	29	to	to	ADP
ihlr-18967	330	30	the	the	DET
ihlr-18967	330	31	payor	payor	NOUN
ihlr-18967	330	32	’s	’s	PART
ihlr-18967	330	33	anticipated	anticipate	VERB
ihlr-18967	330	34	future	future	ADJ
ihlr-18967	330	35	litigation	litigation	NOUN
ihlr-18967	330	36	costs	cost	NOUN
ihlr-18967	330	37	,	,	PUNCT
ihlr-18967	330	38	[	[	X
ihlr-18967	330	39	(	(	PUNCT
ihlr-18967	330	40	c	c	NOUN
ihlr-18967	330	41	)	)	PUNCT
ihlr-18967	330	42	]	]	PUNCT
ihlr-18967	331	1	its	its	PRON
ihlr-18967	331	2	independence	independence	NOUN
ihlr-18967	331	3	from	from	ADP
ihlr-18967	331	4	other	other	ADJ
ihlr-18967	331	5	services	service	NOUN
ihlr-18967	331	6	for	for	ADP
ihlr-18967	331	7	which	which	PRON
ihlr-18967	331	8	it	it	PRON
ihlr-18967	331	9	might	might	AUX
ihlr-18967	331	10	represent	represent	VERB
ihlr-18967	331	11	payment	payment	NOUN
ihlr-18967	331	12	,	,	PUNCT
ihlr-18967	331	13	and	and	CCONJ
ihlr-18967	331	14	[	[	X
ihlr-18967	331	15	(	(	PUNCT
ihlr-18967	331	16	d	d	NOUN
ihlr-18967	331	17	)	)	PUNCT
ihlr-18967	331	18	]	]	PUNCT
ihlr-18967	331	19	the	the	DET
ihlr-18967	331	20	lack	lack	NOUN
ihlr-18967	331	21	of	of	ADP
ihlr-18967	331	22	any	any	DET
ihlr-18967	331	23	other	other	ADJ
ihlr-18967	331	24	convincing	convincing	ADJ
ihlr-18967	331	25	justification	justification	NOUN
ihlr-18967	331	26	.	.	PUNCT
ihlr-18967	332	1	”105	”105	ADJ
ihlr-18967	332	2	in	in	ADP
ihlr-18967	332	3	dissent	dissent	NOUN
ihlr-18967	332	4	,	,	PUNCT
ihlr-18967	332	5	chief	chief	ADJ
ihlr-18967	332	6	justice	justice	NOUN
ihlr-18967	332	7	roberts	roberts	PROPN
ihlr-18967	332	8	,	,	PUNCT
ihlr-18967	332	9	along	along	ADP
ihlr-18967	332	10	with	with	ADP
ihlr-18967	332	11	justices	justice	NOUN
ihlr-18967	332	12	scalia	scalia	PROPN
ihlr-18967	332	13	and	and	CCONJ
ihlr-18967	332	14	thomas	thomas	PROPN
ihlr-18967	332	15	,	,	PUNCT
ihlr-18967	332	16	argued	argue	VERB
ihlr-18967	332	17	that	that	SCONJ
ihlr-18967	332	18	the	the	DET
ihlr-18967	332	19	scope	scope	NOUN
ihlr-18967	332	20	of	of	ADP
ihlr-18967	332	21	patent	patent	NOUN
ihlr-18967	332	22	analysis	analysis	NOUN
ihlr-18967	332	23	should	should	AUX
ihlr-18967	332	24	govern.106	govern.106	VERB
ihlr-18967	332	25	the	the	DET
ihlr-18967	332	26	dissent	dissent	NOUN
ihlr-18967	332	27	recognized	recognize	VERB
ihlr-18967	332	28	the	the	DET
ihlr-18967	332	29	long	long	ADV
ihlr-18967	332	30	-	-	PUNCT
ihlr-18967	332	31	lived	live	VERB
ihlr-18967	332	32	principle	principle	NOUN
ihlr-18967	332	33	that	that	SCONJ
ihlr-18967	332	34	a	a	DET
ihlr-18967	332	35	patent	patent	NOUN
ihlr-18967	332	36	is	be	AUX
ihlr-18967	332	37	an	an	DET
ihlr-18967	332	38	exception	exception	NOUN
ihlr-18967	332	39	to	to	ADP
ihlr-18967	332	40	antitrust	antitrust	ADJ
ihlr-18967	332	41	law	law	NOUN
ihlr-18967	332	42	and	and	CCONJ
ihlr-18967	332	43	grants	grant	VERB
ihlr-18967	332	44	monopolistic	monopolistic	ADJ
ihlr-18967	332	45	powers	power	NOUN
ihlr-18967	332	46	to	to	ADP
ihlr-18967	332	47	the	the	DET
ihlr-18967	332	48	holder.107	holder.107	PROPN
ihlr-18967	332	49	moreover	moreover	ADV
ihlr-18967	332	50	,	,	PUNCT
ihlr-18967	332	51	the	the	DET
ihlr-18967	332	52	dissent	dissent	NOUN
ihlr-18967	332	53	argued	argue	VERB
ihlr-18967	332	54	that	that	SCONJ
ihlr-18967	332	55	it	it	PRON
ihlr-18967	332	56	has	have	AUX
ihlr-18967	332	57	been	be	AUX
ihlr-18967	332	58	“	"	PUNCT
ihlr-18967	332	59	long	long	ADV
ihlr-18967	332	60	recognized	recognize	VERB
ihlr-18967	332	61	that	that	SCONJ
ihlr-18967	332	62	a	a	DET
ihlr-18967	332	63	patent	patent	NOUN
ihlr-18967	332	64	holder	holder	NOUN
ihlr-18967	332	65	is	be	AUX
ihlr-18967	332	66	entitled	entitle	VERB
ihlr-18967	332	67	to	to	PART
ihlr-18967	332	68	license	license	VERB
ihlr-18967	332	69	a	a	DET
ihlr-18967	332	70	competitor	competitor	NOUN
ihlr-18967	332	71	to	to	PART
ihlr-18967	332	72	sell	sell	VERB
ihlr-18967	332	73	its	its	PRON
ihlr-18967	332	74	product	product	NOUN
ihlr-18967	332	75	on	on	ADP
ihlr-18967	332	76	the	the	DET
ihlr-18967	332	77	condition	condition	NOUN
ihlr-18967	332	78	that	that	SCONJ
ihlr-18967	332	79	the	the	DET
ihlr-18967	332	80	competitor	competitor	NOUN
ihlr-18967	332	81	charge	charge	VERB
ihlr-18967	332	82	a	a	DET
ihlr-18967	332	83	98	98	NUM
ihlr-18967	332	84	i	i	PRON
ihlr-18967	332	85	d.	d.	PROPN
ihlr-18967	332	86	99	99	NUM
ihlr-18967	333	1	i	i	PRON
ihlr-18967	333	2	d.	d.	PROPN
ihlr-18967	333	3	at	at	ADP
ihlr-18967	333	4	2235	2235	NUM
ihlr-18967	333	5	-	-	SYM
ihlr-18967	333	6	36	36	NUM
ihlr-18967	333	7	.	.	NOUN
ihlr-18967	333	8	100	100	NUM
ihlr-18967	334	1	i	i	PRON
ihlr-18967	334	2	d.	d.	PROPN
ihlr-18967	334	3	at	at	ADP
ihlr-18967	334	4	2236	2236	NUM
ihlr-18967	334	5	.	.	PUNCT
ihlr-18967	335	1	101	101	NUM
ihlr-18967	336	1	i	i	PRON
ihlr-18967	336	2	d.	d.	PROPN
ihlr-18967	336	3	102	102	NUM
ihlr-18967	337	1	i	i	PRON
ihlr-18967	337	2	d.	d.	PROPN
ihlr-18967	337	3	at	at	ADP
ihlr-18967	337	4	2237	2237	NUM
ihlr-18967	337	5	.	.	PUNCT
ihlr-18967	338	1	103	103	NUM
ihlr-18967	339	1	i	i	PRON
ihlr-18967	339	2	d.	d.	PROPN
ihlr-18967	339	3	104	104	NUM
ihlr-18967	340	1	i	i	PRON
ihlr-18967	340	2	d.	d.	PROPN
ihlr-18967	340	3	105	105	NUM
ihlr-18967	341	1	i	i	PRON
ihlr-18967	341	2	d.	d.	PROPN
ihlr-18967	341	3	106	106	NUM
ihlr-18967	342	1	i	i	PRON
ihlr-18967	342	2	d.	d.	PROPN
ihlr-18967	342	3	at	at	ADP
ihlr-18967	342	4	2238	2238	NUM
ihlr-18967	342	5	(	(	PUNCT
ihlr-18967	342	6	roberts	roberts	PROPN
ihlr-18967	342	7	,	,	PUNCT
ihlr-18967	342	8	c.j	c.j	PROPN
ihlr-18967	342	9	.	.	PROPN
ihlr-18967	342	10	,	,	PUNCT
ihlr-18967	342	11	dissenting	dissent	VERB
ihlr-18967	342	12	)	)	PUNCT
ihlr-18967	342	13	.	.	PUNCT
ihlr-18967	343	1	107	107	NUM
ihlr-18967	344	1	i	i	PRON
ihlr-18967	344	2	d.	d.	PROPN
ihlr-18967	344	3	442	442	NUM
ihlr-18967	344	4	indiana	indiana	PROPN
ihlr-18967	344	5	health	health	PROPN
ihlr-18967	344	6	law	law	PROPN
ihlr-18967	344	7	review	review	NOUN
ihlr-18967	344	8	vol	vol	NOUN
ihlr-18967	344	9	.	.	PUNCT
ihlr-18967	345	1	12:1	12:1	NUM
ihlr-18967	345	2	certain	certain	ADJ
ihlr-18967	345	3	,	,	PUNCT
ihlr-18967	345	4	fixed	fixed	ADJ
ihlr-18967	345	5	price	price	NOUN
ihlr-18967	345	6	”	"	PUNCT
ihlr-18967	345	7	and	and	CCONJ
ihlr-18967	345	8	there	there	PRON
ihlr-18967	345	9	is	be	VERB
ihlr-18967	345	10	no	no	DET
ihlr-18967	345	11	violation	violation	NOUN
ihlr-18967	345	12	of	of	ADP
ihlr-18967	345	13	antitrust	antitrust	ADJ
ihlr-18967	345	14	law	law	NOUN
ihlr-18967	345	15	“	"	PUNCT
ihlr-18967	345	16	for	for	SCONJ
ihlr-18967	345	17	a	a	DET
ihlr-18967	345	18	competitor	competitor	NOUN
ihlr-18967	345	19	to	to	PART
ihlr-18967	345	20	refrain	refrain	VERB
ihlr-18967	345	21	from	from	ADP
ihlr-18967	345	22	challenging	challenge	VERB
ihlr-18967	345	23	a	a	DET
ihlr-18967	345	24	patent	patent	NOUN
ihlr-18967	345	25	.	.	PUNCT
ihlr-18967	345	26	”108	”108	NOUN
ihlr-18967	346	1	the	the	DET
ihlr-18967	346	2	dissent	dissent	NOUN
ihlr-18967	346	3	went	go	VERB
ihlr-18967	346	4	as	as	ADV
ihlr-18967	346	5	far	far	ADV
ihlr-18967	346	6	as	as	ADP
ihlr-18967	346	7	saying	say	VERB
ihlr-18967	346	8	that	that	SCONJ
ihlr-18967	346	9	the	the	DET
ihlr-18967	346	10	majorities	majority	NOUN
ihlr-18967	346	11	’	'	PUNCT
ihlr-18967	346	12	approach	approach	NOUN
ihlr-18967	346	13	will	will	AUX
ihlr-18967	346	14	ironically	ironically	ADV
ihlr-18967	346	15	“	"	PUNCT
ihlr-18967	346	16	discourage	discourage	VERB
ihlr-18967	346	17	generics	generic	NOUN
ihlr-18967	346	18	from	from	ADP
ihlr-18967	346	19	challenging	challenge	VERB
ihlr-18967	346	20	pharmaceutical	pharmaceutical	ADJ
ihlr-18967	346	21	patents	patent	NOUN
ihlr-18967	346	22	”	"	PUNCT
ihlr-18967	346	23	because	because	SCONJ
ihlr-18967	346	24	of	of	ADP
ihlr-18967	346	25	the	the	DET
ihlr-18967	346	26	cost	cost	NOUN
ihlr-18967	346	27	,	,	PUNCT
ihlr-18967	346	28	time	time	NOUN
ihlr-18967	346	29	,	,	PUNCT
ihlr-18967	346	30	and	and	CCONJ
ihlr-18967	346	31	uncertainty	uncertainty	NOUN
ihlr-18967	346	32	of	of	ADP
ihlr-18967	346	33	patent	patent	NOUN
ihlr-18967	346	34	litigation.109	litigation.109	VERB
ihlr-18967	346	35	subsequently	subsequently	ADV
ihlr-18967	346	36	,	,	PUNCT
ihlr-18967	346	37	the	the	DET
ihlr-18967	346	38	dissent	dissent	NOUN
ihlr-18967	346	39	held	hold	VERB
ihlr-18967	346	40	there	there	PRON
ihlr-18967	346	41	can	can	AUX
ihlr-18967	346	42	be	be	AUX
ihlr-18967	346	43	no	no	DET
ihlr-18967	346	44	violation	violation	NOUN
ihlr-18967	346	45	of	of	ADP
ihlr-18967	346	46	antitrust	antitrust	ADJ
ihlr-18967	346	47	laws	law	NOUN
ihlr-18967	346	48	when	when	SCONJ
ihlr-18967	346	49	the	the	DET
ihlr-18967	346	50	patent	patent	NOUN
ihlr-18967	346	51	holder	holder	NOUN
ihlr-18967	346	52	is	be	AUX
ihlr-18967	346	53	acting	act	VERB
ihlr-18967	346	54	within	within	ADP
ihlr-18967	346	55	the	the	DET
ihlr-18967	346	56	scope	scope	NOUN
ihlr-18967	346	57	of	of	ADP
ihlr-18967	346	58	their	their	PRON
ihlr-18967	346	59	patent.110	patent.110	PROPN
ihlr-18967	346	60	f.	f.	PROPN
ihlr-18967	346	61	what	what	PRON
ihlr-18967	346	62	is	be	AUX
ihlr-18967	346	63	the	the	DET
ihlr-18967	346	64	rule	rule	NOUN
ihlr-18967	346	65	of	of	ADP
ihlr-18967	346	66	reason	reason	NOUN
ihlr-18967	346	67	?	?	PUNCT
ihlr-18967	347	1	section	section	NOUN
ihlr-18967	347	2	1	1	NUM
ihlr-18967	347	3	of	of	ADP
ihlr-18967	347	4	the	the	DET
ihlr-18967	347	5	sherman	sherman	PROPN
ihlr-18967	347	6	act	act	PROPN
ihlr-18967	347	7	states	state	NOUN
ihlr-18967	347	8	:	:	PUNCT
ihlr-18967	347	9	“	"	PUNCT
ihlr-18967	347	10	[	[	X
ihlr-18967	347	11	e]very	e]very	ADP
ihlr-18967	347	12	contract	contract	NOUN
ihlr-18967	347	13	,	,	PUNCT
ihlr-18967	347	14	combination	combination	NOUN
ihlr-18967	347	15	in	in	ADP
ihlr-18967	347	16	the	the	DET
ihlr-18967	347	17	form	form	NOUN
ihlr-18967	347	18	of	of	ADP
ihlr-18967	347	19	trust	trust	NOUN
ihlr-18967	347	20	or	or	CCONJ
ihlr-18967	347	21	otherwise	otherwise	ADV
ihlr-18967	347	22	,	,	PUNCT
ihlr-18967	347	23	or	or	CCONJ
ihlr-18967	347	24	conspiracy	conspiracy	NOUN
ihlr-18967	347	25	,	,	PUNCT
ihlr-18967	347	26	in	in	ADP
ihlr-18967	347	27	restraint	restraint	NOUN
ihlr-18967	347	28	of	of	ADP
ihlr-18967	347	29	trade	trade	NOUN
ihlr-18967	347	30	or	or	CCONJ
ihlr-18967	347	31	commerce	commerce	NOUN
ihlr-18967	347	32	among	among	ADP
ihlr-18967	347	33	the	the	DET
ihlr-18967	347	34	several	several	ADJ
ihlr-18967	347	35	states	state	NOUN
ihlr-18967	347	36	,	,	PUNCT
ihlr-18967	347	37	or	or	CCONJ
ihlr-18967	347	38	with	with	ADP
ihlr-18967	347	39	foreign	foreign	ADJ
ihlr-18967	347	40	nations	nation	NOUN
ihlr-18967	347	41	,	,	PUNCT
ihlr-18967	347	42	is	be	AUX
ihlr-18967	347	43	declared	declare	VERB
ihlr-18967	347	44	to	to	PART
ihlr-18967	347	45	be	be	AUX
ihlr-18967	347	46	illegal	illegal	ADJ
ihlr-18967	347	47	.	.	PUNCT
ihlr-18967	347	48	”111	”111	NOUN
ihlr-18967	347	49	in	in	ADP
ihlr-18967	347	50	determining	determine	VERB
ihlr-18967	347	51	whether	whether	SCONJ
ihlr-18967	347	52	there	there	PRON
ihlr-18967	347	53	is	be	VERB
ihlr-18967	347	54	a	a	DET
ihlr-18967	347	55	restraint	restraint	NOUN
ihlr-18967	347	56	on	on	ADP
ihlr-18967	347	57	trade	trade	NOUN
ihlr-18967	347	58	in	in	ADP
ihlr-18967	347	59	violation	violation	NOUN
ihlr-18967	347	60	of	of	ADP
ihlr-18967	347	61	section	section	NOUN
ihlr-18967	347	62	1	1	NUM
ihlr-18967	347	63	,	,	PUNCT
ihlr-18967	347	64	courts	court	NOUN
ihlr-18967	347	65	apply	apply	VERB
ihlr-18967	347	66	the	the	DET
ihlr-18967	347	67	rule	rule	NOUN
ihlr-18967	347	68	of	of	ADP
ihlr-18967	347	69	reason.112	reason.112	NOUN
ihlr-18967	347	70	what	what	PRON
ihlr-18967	347	71	is	be	AUX
ihlr-18967	347	72	more	more	ADJ
ihlr-18967	347	73	,	,	PUNCT
ihlr-18967	347	74	the	the	DET
ihlr-18967	347	75	supreme	supreme	PROPN
ihlr-18967	347	76	court	court	PROPN
ihlr-18967	347	77	has	have	AUX
ihlr-18967	347	78	interpreted	interpret	VERB
ihlr-18967	347	79	this	this	DET
ihlr-18967	347	80	statute	statute	NOUN
ihlr-18967	347	81	as	as	ADP
ihlr-18967	347	82	only	only	ADV
ihlr-18967	347	83	prohibiting	prohibit	VERB
ihlr-18967	347	84	unreasonable	unreasonable	ADJ
ihlr-18967	347	85	restraints	restraint	NOUN
ihlr-18967	347	86	of	of	ADP
ihlr-18967	347	87	trade.113	trade.113	NOUN
ihlr-18967	347	88	“	"	PUNCT
ihlr-18967	347	89	under	under	ADP
ihlr-18967	347	90	this	this	DET
ihlr-18967	347	91	rule	rule	NOUN
ihlr-18967	347	92	,	,	PUNCT
ihlr-18967	347	93	the	the	DET
ihlr-18967	347	94	factfinder	factfinder	NOUN
ihlr-18967	347	95	weighs	weigh	VERB
ihlr-18967	347	96	all	all	PRON
ihlr-18967	347	97	of	of	ADP
ihlr-18967	347	98	the	the	DET
ihlr-18967	347	99	circumstances	circumstance	NOUN
ihlr-18967	347	100	of	of	ADP
ihlr-18967	347	101	a	a	DET
ihlr-18967	347	102	case	case	NOUN
ihlr-18967	347	103	in	in	ADP
ihlr-18967	347	104	deciding	decide	VERB
ihlr-18967	347	105	whether	whether	SCONJ
ihlr-18967	347	106	a	a	DET
ihlr-18967	347	107	restrictive	restrictive	ADJ
ihlr-18967	347	108	practice	practice	NOUN
ihlr-18967	347	109	should	should	AUX
ihlr-18967	347	110	be	be	AUX
ihlr-18967	347	111	prohibited	prohibit	VERB
ihlr-18967	347	112	as	as	ADP
ihlr-18967	347	113	imposing	impose	VERB
ihlr-18967	347	114	an	an	DET
ihlr-18967	347	115	unreasonable	unreasonable	ADJ
ihlr-18967	347	116	restraint	restraint	NOUN
ihlr-18967	347	117	on	on	ADP
ihlr-18967	347	118	competition	competition	NOUN
ihlr-18967	347	119	.	.	PUNCT
ihlr-18967	347	120	”114	”114	PUNCT
ihlr-18967	348	1	this	this	DET
ihlr-18967	348	2	inquiry	inquiry	NOUN
ihlr-18967	348	3	is	be	AUX
ihlr-18967	348	4	generally	generally	ADV
ihlr-18967	348	5	viewed	view	VERB
ihlr-18967	348	6	by	by	ADP
ihlr-18967	348	7	courts	court	NOUN
ihlr-18967	348	8	in	in	ADP
ihlr-18967	348	9	terms	term	NOUN
ihlr-18967	348	10	of	of	ADP
ihlr-18967	348	11	shifting	shift	VERB
ihlr-18967	348	12	the	the	DET
ihlr-18967	348	13	burden	burden	NOUN
ihlr-18967	348	14	of	of	ADP
ihlr-18967	348	15	proof.115	proof.115	PROPN
ihlr-18967	348	16	first	first	ADV
ihlr-18967	348	17	,	,	PUNCT
ihlr-18967	348	18	“	"	PUNCT
ihlr-18967	348	19	the	the	DET
ihlr-18967	348	20	plaintiff	plaintiff	NOUN
ihlr-18967	348	21	carries	carry	VERB
ihlr-18967	348	22	the	the	DET
ihlr-18967	348	23	burden	burden	NOUN
ihlr-18967	348	24	of	of	ADP
ihlr-18967	348	25	showing	show	VERB
ihlr-18967	348	26	that	that	SCONJ
ihlr-18967	348	27	an	an	DET
ihlr-18967	348	28	agreement	agreement	NOUN
ihlr-18967	348	29	or	or	CCONJ
ihlr-18967	348	30	contract	contract	NOUN
ihlr-18967	348	31	has	have	VERB
ihlr-18967	348	32	an	an	DET
ihlr-18967	348	33	anticompetitive	anticompetitive	ADJ
ihlr-18967	348	34	effect	effect	NOUN
ihlr-18967	348	35	on	on	ADP
ihlr-18967	348	36	a	a	DET
ihlr-18967	348	37	given	give	VERB
ihlr-18967	348	38	market	market	NOUN
ihlr-18967	348	39	within	within	ADP
ihlr-18967	348	40	a	a	DET
ihlr-18967	348	41	geographic	geographic	ADJ
ihlr-18967	348	42	area	area	NOUN
ihlr-18967	348	43	.	.	PUNCT
ihlr-18967	349	1	”116	”116	PUNCT
ihlr-18967	350	1	second	second	ADJ
ihlr-18967	350	2	,	,	PUNCT
ihlr-18967	350	3	“	"	PUNCT
ihlr-18967	350	4	[	[	X
ihlr-18967	350	5	i]f	i]f	ADP
ihlr-18967	350	6	the	the	DET
ihlr-18967	350	7	108	108	NUM
ihlr-18967	350	8	i	i	PRON
ihlr-18967	350	9	d.	d.	PROPN
ihlr-18967	350	10	at	at	ADP
ihlr-18967	350	11	2239	2239	NUM
ihlr-18967	350	12	.	.	PUNCT
ihlr-18967	351	1	109	109	NUM
ihlr-18967	351	2	i	i	PROPN
ihlr-18967	351	3	d.	d.	PROPN
ihlr-18967	351	4	at	at	ADP
ihlr-18967	351	5	2247	2247	NUM
ihlr-18967	351	6	.	.	PUNCT
ihlr-18967	352	1	110	110	NUM
ihlr-18967	352	2	i	i	PRON
ihlr-18967	352	3	d.	d.	PROPN
ihlr-18967	352	4	at	at	ADP
ihlr-18967	352	5	2239	2239	NUM
ihlr-18967	352	6	.	.	PUNCT
ihlr-18967	352	7	111	111	NUM
ihlr-18967	352	8	15	15	NUM
ihlr-18967	352	9	u.s.c	u.s.c	NOUN
ihlr-18967	352	10	.	.	PUNCT
ihlr-18967	353	1	§	§	PROPN
ihlr-18967	353	2	1	1	NUM
ihlr-18967	353	3	(	(	PUNCT
ihlr-18967	353	4	2015	2015	NUM
ihlr-18967	353	5	)	)	PUNCT
ihlr-18967	353	6	.	.	PUNCT
ihlr-18967	354	1	112	112	NUM
ihlr-18967	354	2	leegin	leegin	NOUN
ihlr-18967	354	3	creative	creative	ADJ
ihlr-18967	354	4	leather	leather	NOUN
ihlr-18967	354	5	prods	prod	NOUN
ihlr-18967	354	6	.	.	PUNCT
ihlr-18967	354	7	,	,	PUNCT
ihlr-18967	354	8	inc	inc	PROPN
ihlr-18967	354	9	.	.	PROPN
ihlr-18967	355	1	v.	v.	PROPN
ihlr-18967	355	2	psks	psks	PROPN
ihlr-18967	355	3	,	,	PUNCT
ihlr-18967	355	4	inc	inc	PROPN
ihlr-18967	355	5	.	.	PROPN
ihlr-18967	355	6	,	,	PUNCT
ihlr-18967	355	7	551	551	NUM
ihlr-18967	355	8	u.s	u.s	PROPN
ihlr-18967	355	9	.	.	PROPN
ihlr-18967	355	10	877	877	NUM
ihlr-18967	355	11	,	,	PUNCT
ihlr-18967	355	12	885	885	NUM
ihlr-18967	355	13	(	(	PUNCT
ihlr-18967	355	14	2007	2007	NUM
ihlr-18967	355	15	)	)	PUNCT
ihlr-18967	355	16	.	.	PUNCT
ihlr-18967	356	1	113	113	NUM
ihlr-18967	356	2	nat’l	nat’l	NOUN
ihlr-18967	356	3	collegiate	collegiate	VERB
ihlr-18967	356	4	athletic	athletic	ADJ
ihlr-18967	356	5	ass’n	ass’n	NOUN
ihlr-18967	356	6	v.	v.	ADP
ihlr-18967	356	7	bd	bd	PROPN
ihlr-18967	356	8	.	.	PROPN
ihlr-18967	356	9	of	of	ADP
ihlr-18967	356	10	regents	regent	NOUN
ihlr-18967	356	11	of	of	ADP
ihlr-18967	356	12	univ	univ	PROPN
ihlr-18967	356	13	.	.	PROPN
ihlr-18967	356	14	of	of	ADP
ihlr-18967	356	15	okla	okla	PROPN
ihlr-18967	356	16	.	.	PUNCT
ihlr-18967	356	17	,	,	PUNCT
ihlr-18967	356	18	468	468	NUM
ihlr-18967	356	19	u.s	u.s	PROPN
ihlr-18967	356	20	.	.	PROPN
ihlr-18967	356	21	85	85	NUM
ihlr-18967	356	22	,	,	PUNCT
ihlr-18967	356	23	98	98	NUM
ihlr-18967	356	24	(	(	PUNCT
ihlr-18967	356	25	1984	1984	NUM
ihlr-18967	356	26	)	)	PUNCT
ihlr-18967	356	27	.	.	PUNCT
ihlr-18967	357	1	114	114	NUM
ihlr-18967	357	2	leegin	leegin	NOUN
ihlr-18967	357	3	creative	creative	ADJ
ihlr-18967	357	4	leather	leather	NOUN
ihlr-18967	357	5	products	product	NOUN
ihlr-18967	357	6	,	,	PUNCT
ihlr-18967	357	7	551	551	NUM
ihlr-18967	357	8	u.s	u.s	PROPN
ihlr-18967	357	9	.	.	PROPN
ihlr-18967	357	10	at	at	ADP
ihlr-18967	357	11	885	885	NUM
ihlr-18967	357	12	(	(	PUNCT
ihlr-18967	357	13	quoting	quote	VERB
ihlr-18967	357	14	cont’l	cont’l	PROPN
ihlr-18967	357	15	t.v	t.v	PROPN
ihlr-18967	357	16	.	.	PROPN
ihlr-18967	357	17	,	,	PUNCT
ihlr-18967	357	18	inc	inc	PROPN
ihlr-18967	357	19	.	.	PROPN
ihlr-18967	357	20	v.	v.	PROPN
ihlr-18967	357	21	gte	gte	PROPN
ihlr-18967	357	22	sylvania	sylvania	PROPN
ihlr-18967	357	23	inc	inc	PROPN
ihlr-18967	357	24	.	.	PROPN
ihlr-18967	357	25	,	,	PUNCT
ihlr-18967	357	26	433	433	NUM
ihlr-18967	357	27	u.s	u.s	PROPN
ihlr-18967	357	28	.	.	PROPN
ihlr-18967	357	29	36	36	NUM
ihlr-18967	357	30	,	,	PUNCT
ihlr-18967	357	31	49	49	NUM
ihlr-18967	357	32	(	(	PUNCT
ihlr-18967	357	33	1977	1977	NUM
ihlr-18967	357	34	)	)	PUNCT
ihlr-18967	357	35	)	)	PUNCT
ihlr-18967	357	36	.	.	PUNCT
ihlr-18967	358	1	115	115	NUM
ihlr-18967	358	2	william	william	PROPN
ihlr-18967	358	3	holmes	holmes	PROPN
ihlr-18967	358	4	&	&	CCONJ
ihlr-18967	358	5	melissa	melissa	PROPN
ihlr-18967	358	6	mangiaracina	mangiaracina	PROPN
ihlr-18967	358	7	,	,	PUNCT
ihlr-18967	358	8	antitrsut	antitrsut	PROPN
ihlr-18967	358	9	law	law	PROPN
ihlr-18967	358	10	handbook	handbook	NOUN
ihlr-18967	358	11	§	§	PROPN
ihlr-18967	358	12	2:10	2:10	NUM
ihlr-18967	358	13	(	(	PUNCT
ihlr-18967	358	14	2013	2013	NUM
ihlr-18967	358	15	)	)	PUNCT
ihlr-18967	358	16	.	.	PUNCT
ihlr-18967	359	1	116	116	NUM
ihlr-18967	360	1	agnew	agnew	PROPN
ihlr-18967	360	2	v.	v.	PROPN
ihlr-18967	360	3	nat’l	nat’l	PROPN
ihlr-18967	360	4	collegiate	collegiate	VERB
ihlr-18967	360	5	athletic	athletic	ADJ
ihlr-18967	360	6	ass’n	ass’n	NOUN
ihlr-18967	360	7	,	,	PUNCT
ihlr-18967	360	8	683	683	NUM
ihlr-18967	360	9	f.3d	f.3d	NUM
ihlr-18967	360	10	328	328	NUM
ihlr-18967	360	11	,	,	PUNCT
ihlr-18967	360	12	335	335	NUM
ihlr-18967	360	13	(	(	PUNCT
ihlr-18967	360	14	7th	7th	ADJ
ihlr-18967	360	15	cir	cir	NOUN
ihlr-18967	360	16	.	.	PROPN
ihlr-18967	360	17	2012	2012	NUM
ihlr-18967	360	18	)	)	PUNCT
ihlr-18967	361	1	(	(	PUNCT
ihlr-18967	361	2	citing	cite	VERB
ihlr-18967	361	3	reifert	reifert	PROPN
ihlr-18967	361	4	v.	v.	PROPN
ihlr-18967	361	5	s.	s.	PROPN
ihlr-18967	361	6	cent	cent	PROPN
ihlr-18967	361	7	.	.	PUNCT
ihlr-18967	362	1	wis	wis	PROPN
ihlr-18967	362	2	.	.	PUNCT
ihlr-18967	363	1	mls	mls	PROPN
ihlr-18967	363	2	corp	corp	PROPN
ihlr-18967	363	3	.	.	PROPN
ihlr-18967	363	4	,	,	PUNCT
ihlr-18967	363	5	450	450	NUM
ihlr-18967	363	6	f.3d	f.3d	NUM
ihlr-18967	363	7	312	312	NUM
ihlr-18967	363	8	,	,	PUNCT
ihlr-18967	363	9	321	321	NUM
ihlr-18967	363	10	2015	2015	NUM
ihlr-18967	363	11	rationale	rationale	NOUN
ihlr-18967	363	12	behind	behind	ADP
ihlr-18967	363	13	hatch	hatch	NOUN
ihlr-18967	363	14	-	-	PUNCT
ihlr-18967	363	15	waxman	waxman	PROPN
ihlr-18967	363	16	act	act	PROPN
ihlr-18967	363	17	and	and	CCONJ
ihlr-18967	363	18	patent	patent	NOUN
ihlr-18967	363	19	law	law	NOUN
ihlr-18967	363	20	443	443	NUM
ihlr-18967	363	21	plaintiff	plaintiff	NOUN
ihlr-18967	363	22	meets	meet	VERB
ihlr-18967	363	23	his	his	PRON
ihlr-18967	363	24	burden	burden	NOUN
ihlr-18967	363	25	,	,	PUNCT
ihlr-18967	363	26	the	the	DET
ihlr-18967	363	27	defendant	defendant	NOUN
ihlr-18967	363	28	can	can	AUX
ihlr-18967	363	29	show	show	VERB
ihlr-18967	363	30	that	that	SCONJ
ihlr-18967	363	31	the	the	DET
ihlr-18967	363	32	restraint	restraint	NOUN
ihlr-18967	363	33	in	in	ADP
ihlr-18967	363	34	question	question	NOUN
ihlr-18967	363	35	actually	actually	ADV
ihlr-18967	363	36	has	have	VERB
ihlr-18967	363	37	a	a	DET
ihlr-18967	363	38	procompetitive	procompetitive	ADJ
ihlr-18967	363	39	effect	effect	NOUN
ihlr-18967	363	40	on	on	ADP
ihlr-18967	363	41	balance	balance	NOUN
ihlr-18967	363	42	.	.	PUNCT
ihlr-18967	363	43	”117	”117	VERB
ihlr-18967	364	1	third	third	ADV
ihlr-18967	364	2	,	,	PUNCT
ihlr-18967	364	3	“	"	PUNCT
ihlr-18967	364	4	the	the	DET
ihlr-18967	364	5	plaintiff	plaintiff	NOUN
ihlr-18967	364	6	can	can	AUX
ihlr-18967	364	7	dispute	dispute	VERB
ihlr-18967	364	8	[	[	PRON
ihlr-18967	364	9	the	the	DET
ihlr-18967	364	10	defendant	defendant	NOUN
ihlr-18967	364	11	’s	’s	PART
ihlr-18967	364	12	]	]	PUNCT
ihlr-18967	364	13	claim	claim	NOUN
ihlr-18967	364	14	or	or	CCONJ
ihlr-18967	364	15	show	show	VERB
ihlr-18967	364	16	that	that	SCONJ
ihlr-18967	364	17	the	the	DET
ihlr-18967	364	18	restraint	restraint	NOUN
ihlr-18967	364	19	in	in	ADP
ihlr-18967	364	20	question	question	NOUN
ihlr-18967	364	21	is	be	AUX
ihlr-18967	364	22	not	not	PART
ihlr-18967	364	23	reasonably	reasonably	ADV
ihlr-18967	364	24	necessary	necessary	ADJ
ihlr-18967	364	25	to	to	PART
ihlr-18967	364	26	achieve	achieve	VERB
ihlr-18967	364	27	the	the	DET
ihlr-18967	364	28	procompetitive	procompetitive	ADJ
ihlr-18967	364	29	objective	objective	NOUN
ihlr-18967	364	30	.	.	PUNCT
ihlr-18967	365	1	”118	”118	VERB
ihlr-18967	366	1	lastly	lastly	ADV
ihlr-18967	366	2	,	,	PUNCT
ihlr-18967	366	3	some	some	DET
ihlr-18967	366	4	courts	court	NOUN
ihlr-18967	366	5	recognize	recognize	VERB
ihlr-18967	366	6	that	that	SCONJ
ihlr-18967	366	7	when	when	SCONJ
ihlr-18967	366	8	there	there	PRON
ihlr-18967	366	9	are	be	VERB
ihlr-18967	366	10	restraints	restraint	NOUN
ihlr-18967	366	11	and	and	CCONJ
ihlr-18967	366	12	procompetitive	procompetitive	ADJ
ihlr-18967	366	13	effects	effect	NOUN
ihlr-18967	366	14	,	,	PUNCT
ihlr-18967	366	15	a	a	DET
ihlr-18967	366	16	court	court	NOUN
ihlr-18967	366	17	must	must	AUX
ihlr-18967	366	18	balance	balance	VERB
ihlr-18967	366	19	the	the	DET
ihlr-18967	366	20	effects.119	effects.119	PROPN
ihlr-18967	366	21	however	however	ADV
ihlr-18967	366	22	,	,	PUNCT
ihlr-18967	366	23	one	one	NUM
ihlr-18967	366	24	author	author	NOUN
ihlr-18967	366	25	argues	argue	VERB
ihlr-18967	366	26	that	that	SCONJ
ihlr-18967	366	27	balancing	balancing	NOUN
ihlr-18967	366	28	is	be	AUX
ihlr-18967	366	29	a	a	DET
ihlr-18967	366	30	myth	myth	NOUN
ihlr-18967	366	31	because	because	SCONJ
ihlr-18967	366	32	“	"	PUNCT
ihlr-18967	366	33	[	[	X
ihlr-18967	366	34	m]ost	m]ost	NOUN
ihlr-18967	366	35	cases	case	NOUN
ihlr-18967	366	36	are	be	AUX
ihlr-18967	366	37	resolved	resolve	VERB
ihlr-18967	366	38	based	base	VERB
ihlr-18967	366	39	on	on	ADP
ihlr-18967	366	40	the	the	DET
ihlr-18967	366	41	weight	weight	NOUN
ihlr-18967	366	42	of	of	ADP
ihlr-18967	366	43	the	the	DET
ihlr-18967	366	44	evidence	evidence	NOUN
ihlr-18967	366	45	and	and	CCONJ
ihlr-18967	366	46	the	the	DET
ihlr-18967	366	47	presence	presence	NOUN
ihlr-18967	366	48	or	or	CCONJ
ihlr-18967	366	49	absence	absence	NOUN
ihlr-18967	366	50	of	of	ADP
ihlr-18967	366	51	evidence	evidence	NOUN
ihlr-18967	366	52	of	of	ADP
ihlr-18967	366	53	competitive	competitive	ADJ
ihlr-18967	366	54	effects	effect	NOUN
ihlr-18967	366	55	or	or	CCONJ
ihlr-18967	366	56	evident	evident	ADJ
ihlr-18967	366	57	and	and	CCONJ
ihlr-18967	366	58	substantial	substantial	ADJ
ihlr-18967	366	59	efficiencies	efficiency	NOUN
ihlr-18967	366	60	.	.	PUNCT
ihlr-18967	366	61	”120	”120	PROPN
ihlr-18967	366	62	g.	g.	PROPN
ihlr-18967	366	63	congress	congress	PROPN
ihlr-18967	366	64	addresses	address	NOUN
ihlr-18967	366	65	reverse	reverse	VERB
ihlr-18967	366	66	payment	payment	NOUN
ihlr-18967	366	67	settlements	settlement	NOUN
ihlr-18967	366	68	in	in	ADP
ihlr-18967	366	69	2013	2013	NUM
ihlr-18967	366	70	,	,	PUNCT
ihlr-18967	366	71	senator	senator	PROPN
ihlr-18967	366	72	amy	amy	PROPN
ihlr-18967	366	73	klobuchar	klobuchar	PROPN
ihlr-18967	366	74	introduced	introduce	VERB
ihlr-18967	366	75	the	the	DET
ihlr-18967	366	76	preserve	preserve	NOUN
ihlr-18967	366	77	access	access	NOUN
ihlr-18967	366	78	to	to	ADP
ihlr-18967	366	79	affordable	affordable	ADJ
ihlr-18967	366	80	generics	generic	NOUN
ihlr-18967	366	81	act	act	NOUN
ihlr-18967	366	82	(	(	PUNCT
ihlr-18967	366	83	“	"	PUNCT
ihlr-18967	366	84	paaga”).121	paaga”).121	VERB
ihlr-18967	366	85	the	the	DET
ihlr-18967	366	86	intent	intent	NOUN
ihlr-18967	366	87	of	of	ADP
ihlr-18967	366	88	paaga	paaga	NOUN
ihlr-18967	366	89	is	be	AUX
ihlr-18967	366	90	“	"	PUNCT
ihlr-18967	366	91	[	[	X
ihlr-18967	366	92	t]o	t]o	NOUN
ihlr-18967	366	93	prohibit	prohibit	VERB
ihlr-18967	366	94	brand	brand	NOUN
ihlr-18967	366	95	name	name	NOUN
ihlr-18967	366	96	drug	drug	NOUN
ihlr-18967	366	97	companies	company	NOUN
ihlr-18967	366	98	from	from	ADP
ihlr-18967	366	99	compensating	compensate	VERB
ihlr-18967	366	100	generic	generic	ADJ
ihlr-18967	366	101	drug	drug	NOUN
ihlr-18967	366	102	companies	company	NOUN
ihlr-18967	366	103	to	to	PART
ihlr-18967	366	104	delay	delay	VERB
ihlr-18967	366	105	the	the	DET
ihlr-18967	366	106	entry	entry	NOUN
ihlr-18967	366	107	of	of	ADP
ihlr-18967	366	108	a	a	DET
ihlr-18967	366	109	generic	generic	ADJ
ihlr-18967	366	110	drug	drug	NOUN
ihlr-18967	366	111	into	into	ADP
ihlr-18967	366	112	the	the	DET
ihlr-18967	366	113	market	market	NOUN
ihlr-18967	366	114	.	.	PUNCT
ihlr-18967	367	1	”122	”122	PUNCT
ihlr-18967	368	1	furthermore	furthermore	ADV
ihlr-18967	368	2	,	,	PUNCT
ihlr-18967	368	3	paaga	paaga	NOUN
ihlr-18967	368	4	includes	include	VERB
ihlr-18967	368	5	a	a	DET
ihlr-18967	368	6	strong	strong	ADJ
ihlr-18967	368	7	presumption	presumption	NOUN
ihlr-18967	368	8	that	that	SCONJ
ihlr-18967	368	9	a	a	DET
ihlr-18967	368	10	reverse	reverse	ADJ
ihlr-18967	368	11	payment	payment	NOUN
ihlr-18967	368	12	settlement	settlement	NOUN
ihlr-18967	368	13	is	be	AUX
ihlr-18967	368	14	anticompetitive	anticompetitive	ADJ
ihlr-18967	368	15	when	when	SCONJ
ihlr-18967	368	16	the	the	DET
ihlr-18967	368	17	generic	generic	ADJ
ihlr-18967	368	18	manufacturer	manufacturer	NOUN
ihlr-18967	368	19	“	"	PUNCT
ihlr-18967	368	20	receives	receive	VERB
ihlr-18967	368	21	anything	anything	PRON
ihlr-18967	368	22	of	of	ADP
ihlr-18967	368	23	value	value	NOUN
ihlr-18967	368	24	”	"	PUNCT
ihlr-18967	368	25	or	or	CCONJ
ihlr-18967	368	26	when	when	SCONJ
ihlr-18967	368	27	the	the	DET
ihlr-18967	368	28	generic	generic	ADJ
ihlr-18967	368	29	manufacturer	manufacturer	NOUN
ihlr-18967	368	30	“	"	PUNCT
ihlr-18967	368	31	agrees	agree	VERB
ihlr-18967	368	32	to	to	PART
ihlr-18967	368	33	limit	limit	VERB
ihlr-18967	368	34	or	or	CCONJ
ihlr-18967	368	35	forego	forego	ADJ
ihlr-18967	368	36	(	(	PUNCT
ihlr-18967	368	37	7th	7th	ADJ
ihlr-18967	368	38	cir	cir	NOUN
ihlr-18967	368	39	.	.	PUNCT
ihlr-18967	368	40	2006	2006	NUM
ihlr-18967	368	41	)	)	PUNCT
ihlr-18967	368	42	)	)	PUNCT
ihlr-18967	368	43	.	.	PUNCT
ihlr-18967	369	1	see	see	VERB
ihlr-18967	369	2	also	also	ADV
ihlr-18967	369	3	major	major	ADJ
ihlr-18967	369	4	league	league	NOUN
ihlr-18967	369	5	baseball	baseball	NOUN
ihlr-18967	369	6	props	prop	NOUN
ihlr-18967	369	7	.	.	PUNCT
ihlr-18967	369	8	,	,	PUNCT
ihlr-18967	369	9	inc	inc	PROPN
ihlr-18967	369	10	.	.	PROPN
ihlr-18967	370	1	v.	v.	PROPN
ihlr-18967	370	2	salvino	salvino	PROPN
ihlr-18967	370	3	,	,	PUNCT
ihlr-18967	370	4	inc	inc	PROPN
ihlr-18967	370	5	.	.	PROPN
ihlr-18967	370	6	542	542	NUM
ihlr-18967	370	7	f.3d	f.3d	NUM
ihlr-18967	370	8	290	290	NUM
ihlr-18967	370	9	,	,	PUNCT
ihlr-18967	370	10	317	317	NUM
ihlr-18967	370	11	(	(	PUNCT
ihlr-18967	370	12	2d	2d	NUM
ihlr-18967	370	13	cir	cir	NOUN
ihlr-18967	370	14	.	.	PROPN
ihlr-18967	370	15	2008	2008	NUM
ihlr-18967	370	16	)	)	PUNCT
ihlr-18967	370	17	;	;	PUNCT
ihlr-18967	370	18	law	law	NOUN
ihlr-18967	370	19	v.	v.	CCONJ
ihlr-18967	370	20	nat’l	nat’l	NOUN
ihlr-18967	370	21	collegiate	collegiate	VERB
ihlr-18967	370	22	athletic	athletic	ADJ
ihlr-18967	370	23	ass’n	ass’n	NOUN
ihlr-18967	370	24	,	,	PUNCT
ihlr-18967	370	25	134	134	NUM
ihlr-18967	370	26	f.3d	f.3d	NUM
ihlr-18967	370	27	1010	1010	NUM
ihlr-18967	370	28	,	,	PUNCT
ihlr-18967	370	29	1019	1019	NUM
ihlr-18967	370	30	(	(	PUNCT
ihlr-18967	370	31	10th	10th	ADJ
ihlr-18967	370	32	cir	cir	NOUN
ihlr-18967	370	33	.	.	PUNCT
ihlr-18967	370	34	1998	1998	NUM
ihlr-18967	370	35	)	)	PUNCT
ihlr-18967	370	36	.	.	PUNCT
ihlr-18967	371	1	117	117	NUM
ihlr-18967	371	2	agnew	agnew	PROPN
ihlr-18967	371	3	,	,	PUNCT
ihlr-18967	371	4	683	683	NUM
ihlr-18967	371	5	f.3d	f.3d	NUM
ihlr-18967	371	6	at	at	ADP
ihlr-18967	371	7	335	335	NUM
ihlr-18967	371	8	-	-	SYM
ihlr-18967	371	9	36	36	NUM
ihlr-18967	371	10	.	.	PUNCT
ihlr-18967	372	1	see	see	VERB
ihlr-18967	372	2	also	also	ADV
ihlr-18967	372	3	major	major	ADJ
ihlr-18967	372	4	league	league	NOUN
ihlr-18967	372	5	baseball	baseball	NOUN
ihlr-18967	372	6	props	prop	NOUN
ihlr-18967	372	7	.	.	PUNCT
ihlr-18967	373	1	,	,	PUNCT
ihlr-18967	373	2	542	542	NUM
ihlr-18967	373	3	f.3d	f.3d	NUM
ihlr-18967	373	4	at	at	ADP
ihlr-18967	373	5	317	317	NUM
ihlr-18967	373	6	;	;	PUNCT
ihlr-18967	373	7	law	law	NOUN
ihlr-18967	373	8	,	,	PUNCT
ihlr-18967	373	9	134	134	NUM
ihlr-18967	373	10	f.3d	f.3d	NUM
ihlr-18967	373	11	at	at	ADP
ihlr-18967	373	12	1019	1019	NUM
ihlr-18967	373	13	.	.	PUNCT
ihlr-18967	374	1	118	118	NUM
ihlr-18967	374	2	agnew	agnew	PROPN
ihlr-18967	374	3	,	,	PUNCT
ihlr-18967	374	4	683	683	NUM
ihlr-18967	374	5	f.3d	f.3d	NUM
ihlr-18967	374	6	at	at	ADP
ihlr-18967	374	7	336	336	NUM
ihlr-18967	374	8	.	.	PUNCT
ihlr-18967	375	1	see	see	VERB
ihlr-18967	375	2	also	also	ADV
ihlr-18967	375	3	major	major	ADJ
ihlr-18967	375	4	league	league	NOUN
ihlr-18967	375	5	baseball	baseball	NOUN
ihlr-18967	375	6	props	prop	NOUN
ihlr-18967	375	7	.	.	PUNCT
ihlr-18967	376	1	,	,	PUNCT
ihlr-18967	376	2	542	542	NUM
ihlr-18967	376	3	f.3d	f.3d	NUM
ihlr-18967	376	4	at	at	ADP
ihlr-18967	376	5	317	317	NUM
ihlr-18967	376	6	;	;	PUNCT
ihlr-18967	376	7	law	law	NOUN
ihlr-18967	376	8	,	,	PUNCT
ihlr-18967	376	9	134	134	NUM
ihlr-18967	376	10	f.3d	f.3d	NUM
ihlr-18967	376	11	at	at	ADP
ihlr-18967	376	12	1019	1019	NUM
ihlr-18967	376	13	.	.	PUNCT
ihlr-18967	377	1	119	119	NUM
ihlr-18967	377	2	stop	stop	VERB
ihlr-18967	377	3	&	&	CCONJ
ihlr-18967	377	4	shop	shop	PROPN
ihlr-18967	377	5	supermarket	supermarket	PROPN
ihlr-18967	377	6	co.	co.	PROPN
ihlr-18967	377	7	v.	v.	ADP
ihlr-18967	377	8	blue	blue	PROPN
ihlr-18967	377	9	cross	cross	PROPN
ihlr-18967	377	10	&	&	CCONJ
ihlr-18967	377	11	blue	blue	ADJ
ihlr-18967	377	12	shield	shield	NOUN
ihlr-18967	377	13	of	of	ADP
ihlr-18967	377	14	r.i	r.i	PROPN
ihlr-18967	377	15	.	.	PROPN
ihlr-18967	377	16	,	,	PUNCT
ihlr-18967	377	17	373	373	NUM
ihlr-18967	377	18	f.3d	f.3d	NUM
ihlr-18967	377	19	57	57	NUM
ihlr-18967	377	20	,	,	PUNCT
ihlr-18967	377	21	61	61	NUM
ihlr-18967	377	22	(	(	PUNCT
ihlr-18967	377	23	1st	1st	ADJ
ihlr-18967	377	24	cir	cir	NOUN
ihlr-18967	377	25	.	.	PUNCT
ihlr-18967	377	26	2004	2004	NUM
ihlr-18967	377	27	)	)	PUNCT
ihlr-18967	377	28	;	;	PUNCT
ihlr-18967	377	29	america	america	PROPN
ihlr-18967	377	30	ad	ad	PROPN
ihlr-18967	377	31	mgmt	mgmt	PROPN
ihlr-18967	377	32	.	.	PROPN
ihlr-18967	377	33	,	,	PUNCT
ihlr-18967	377	34	inc	inc	PROPN
ihlr-18967	377	35	.	.	PROPN
ihlr-18967	377	36	v.	v.	PROPN
ihlr-18967	377	37	gte	gte	PROPN
ihlr-18967	377	38	corp	corp	PROPN
ihlr-18967	377	39	.	.	PROPN
ihlr-18967	377	40	,	,	PUNCT
ihlr-18967	377	41	92	92	NUM
ihlr-18967	377	42	f.3d	f.3d	NUM
ihlr-18967	377	43	781	781	NUM
ihlr-18967	377	44	,	,	PUNCT
ihlr-18967	377	45	789	789	NUM
ihlr-18967	377	46	(	(	PUNCT
ihlr-18967	377	47	9th	9th	ADJ
ihlr-18967	377	48	cir	cir	NOUN
ihlr-18967	377	49	.	.	PUNCT
ihlr-18967	377	50	1996	1996	NUM
ihlr-18967	377	51	)	)	PUNCT
ihlr-18967	377	52	.	.	PUNCT
ihlr-18967	378	1	120	120	NUM
ihlr-18967	378	2	andrew	andrew	PROPN
ihlr-18967	378	3	i.	i.	PROPN
ihlr-18967	378	4	gavil	gavil	NOUN
ihlr-18967	378	5	,	,	PUNCT
ihlr-18967	378	6	moving	move	VERB
ihlr-18967	378	7	beyond	beyond	ADP
ihlr-18967	378	8	caricature	caricature	NOUN
ihlr-18967	378	9	and	and	CCONJ
ihlr-18967	378	10	characterization	characterization	NOUN
ihlr-18967	378	11	:	:	PUNCT
ihlr-18967	378	12	the	the	DET
ihlr-18967	378	13	modern	modern	ADJ
ihlr-18967	378	14	rule	rule	NOUN
ihlr-18967	378	15	of	of	ADP
ihlr-18967	378	16	reason	reason	NOUN
ihlr-18967	378	17	in	in	ADP
ihlr-18967	378	18	practice	practice	NOUN
ihlr-18967	378	19	,	,	PUNCT
ihlr-18967	378	20	85	85	NUM
ihlr-18967	378	21	s.	s.	PROPN
ihlr-18967	378	22	cal	cal	PROPN
ihlr-18967	378	23	.	.	PUNCT
ihlr-18967	379	1	l.	l.	PROPN
ihlr-18967	379	2	rev	rev	PROPN
ihlr-18967	379	3	.	.	PROPN
ihlr-18967	379	4	733	733	NUM
ihlr-18967	379	5	,	,	PUNCT
ihlr-18967	379	6	761	761	NUM
ihlr-18967	379	7	(	(	PUNCT
ihlr-18967	379	8	2012	2012	NUM
ihlr-18967	379	9	)	)	PUNCT
ihlr-18967	379	10	.	.	PUNCT
ihlr-18967	380	1	121	121	NUM
ihlr-18967	380	2	preserve	preserve	NOUN
ihlr-18967	380	3	access	access	NOUN
ihlr-18967	380	4	to	to	ADP
ihlr-18967	380	5	affordable	affordable	ADJ
ihlr-18967	380	6	generics	generic	NOUN
ihlr-18967	380	7	act	act	PROPN
ihlr-18967	380	8	,	,	PUNCT
ihlr-18967	380	9	s.	s.	PROPN
ihlr-18967	380	10	214	214	NUM
ihlr-18967	380	11	,	,	PUNCT
ihlr-18967	380	12	113th	113th	PROPN
ihlr-18967	380	13	cong	cong	NOUN
ihlr-18967	380	14	.	.	PUNCT
ihlr-18967	381	1	(	(	PUNCT
ihlr-18967	381	2	2013	2013	NUM
ihlr-18967	381	3	)	)	PUNCT
ihlr-18967	381	4	.	.	PUNCT
ihlr-18967	382	1	122	122	NUM
ihlr-18967	383	1	i	i	PRON
ihlr-18967	383	2	d.	d.	PROPN
ihlr-18967	383	3	444	444	NUM
ihlr-18967	383	4	indiana	indiana	PROPN
ihlr-18967	383	5	health	health	PROPN
ihlr-18967	383	6	law	law	PROPN
ihlr-18967	383	7	review	review	NOUN
ihlr-18967	383	8	vol	vol	NOUN
ihlr-18967	383	9	.	.	PUNCT
ihlr-18967	384	1	12:1	12:1	NUM
ihlr-18967	384	2	research	research	NOUN
ihlr-18967	384	3	,	,	PUNCT
ihlr-18967	384	4	development	development	NOUN
ihlr-18967	384	5	,	,	PUNCT
ihlr-18967	384	6	manufacturing	manufacturing	NOUN
ihlr-18967	384	7	,	,	PUNCT
ihlr-18967	384	8	marketing	marketing	NOUN
ihlr-18967	384	9	,	,	PUNCT
ihlr-18967	384	10	or	or	CCONJ
ihlr-18967	384	11	sales	sale	NOUN
ihlr-18967	384	12	of	of	ADP
ihlr-18967	384	13	the	the	DET
ihlr-18967	384	14	[	[	X
ihlr-18967	384	15	generic	generic	ADJ
ihlr-18967	384	16	]	]	PUNCT
ihlr-18967	384	17	product	product	NOUN
ihlr-18967	384	18	for	for	ADP
ihlr-18967	384	19	any	any	DET
ihlr-18967	384	20	period	period	NOUN
ihlr-18967	384	21	of	of	ADP
ihlr-18967	384	22	time	time	NOUN
ihlr-18967	384	23	.	.	PUNCT
ihlr-18967	385	1	”123	”123	NUM
ihlr-18967	386	1	iii	iii	NOUN
ihlr-18967	386	2	.	.	PUNCT
ihlr-18967	387	1	analysis	analysis	NOUN
ihlr-18967	387	2	:	:	PUNCT
ihlr-18967	387	3	the	the	DET
ihlr-18967	387	4	residual	residual	ADJ
ihlr-18967	387	5	effect	effect	NOUN
ihlr-18967	387	6	of	of	ADP
ihlr-18967	387	7	actavis	actavis	NOUN
ihlr-18967	387	8	and	and	CCONJ
ihlr-18967	387	9	importance	importance	NOUN
ihlr-18967	387	10	of	of	ADP
ihlr-18967	387	11	crafting	craft	VERB
ihlr-18967	387	12	pro	pro	ADJ
ihlr-18967	387	13	-	-	ADJ
ihlr-18967	387	14	competitive	competitive	ADJ
ihlr-18967	387	15	settlements	settlement	NOUN
ihlr-18967	387	16	a.	a.	NOUN
ihlr-18967	387	17	impact	impact	NOUN
ihlr-18967	387	18	of	of	ADP
ihlr-18967	387	19	using	use	VERB
ihlr-18967	387	20	rule	rule	NOUN
ihlr-18967	387	21	of	of	ADP
ihlr-18967	387	22	reason	reason	NOUN
ihlr-18967	387	23	analysis	analysis	NOUN
ihlr-18967	387	24	the	the	DET
ihlr-18967	387	25	rule	rule	NOUN
ihlr-18967	387	26	of	of	ADP
ihlr-18967	387	27	reason	reason	NOUN
ihlr-18967	387	28	appropriately	appropriately	ADV
ihlr-18967	387	29	strikes	strike	VERB
ihlr-18967	387	30	a	a	DET
ihlr-18967	387	31	balance	balance	NOUN
ihlr-18967	387	32	between	between	ADP
ihlr-18967	387	33	and	and	CCONJ
ihlr-18967	387	34	supports	support	VERB
ihlr-18967	387	35	the	the	DET
ihlr-18967	387	36	policy	policy	NOUN
ihlr-18967	387	37	rationale	rationale	NOUN
ihlr-18967	387	38	behind	behind	ADP
ihlr-18967	387	39	the	the	DET
ihlr-18967	387	40	hatch	hatch	NOUN
ihlr-18967	387	41	-	-	PUNCT
ihlr-18967	387	42	waxman	waxman	PROPN
ihlr-18967	387	43	act	act	PROPN
ihlr-18967	387	44	and	and	CCONJ
ihlr-18967	387	45	patent	patent	NOUN
ihlr-18967	387	46	law	law	NOUN
ihlr-18967	387	47	.	.	PUNCT
ihlr-18967	388	1	first	first	ADV
ihlr-18967	388	2	,	,	PUNCT
ihlr-18967	388	3	rule	rule	NOUN
ihlr-18967	388	4	of	of	ADP
ihlr-18967	388	5	reason	reason	NOUN
ihlr-18967	388	6	analysis	analysis	NOUN
ihlr-18967	388	7	directly	directly	ADV
ihlr-18967	388	8	supports	support	VERB
ihlr-18967	388	9	one	one	NUM
ihlr-18967	388	10	of	of	ADP
ihlr-18967	388	11	the	the	DET
ihlr-18967	388	12	intentions	intention	NOUN
ihlr-18967	388	13	behind	behind	ADP
ihlr-18967	388	14	the	the	DET
ihlr-18967	388	15	hatch	hatch	PROPN
ihlr-18967	388	16	-	-	PUNCT
ihlr-18967	388	17	waxman	waxman	PROPN
ihlr-18967	388	18	act	act	PROPN
ihlr-18967	388	19	:	:	PUNCT
ihlr-18967	388	20	having	have	VERB
ihlr-18967	388	21	more	more	ADJ
ihlr-18967	388	22	generic	generic	ADJ
ihlr-18967	388	23	drugs	drug	NOUN
ihlr-18967	388	24	available	available	ADJ
ihlr-18967	388	25	for	for	ADP
ihlr-18967	388	26	consumers.124	consumers.124	NOUN
ihlr-18967	388	27	second	second	ADJ
ihlr-18967	388	28	,	,	PUNCT
ihlr-18967	388	29	patent	patent	NOUN
ihlr-18967	388	30	law	law	NOUN
ihlr-18967	388	31	protection	protection	NOUN
ihlr-18967	388	32	will	will	AUX
ihlr-18967	388	33	still	still	ADV
ihlr-18967	388	34	be	be	AUX
ihlr-18967	388	35	available	available	ADJ
ihlr-18967	388	36	for	for	ADP
ihlr-18967	388	37	pioneer	pioneer	NOUN
ihlr-18967	388	38	manufacturers	manufacturer	NOUN
ihlr-18967	388	39	,	,	PUNCT
ihlr-18967	388	40	thus	thus	ADV
ihlr-18967	388	41	,	,	PUNCT
ihlr-18967	388	42	supporting	support	VERB
ihlr-18967	388	43	patent	patent	NOUN
ihlr-18967	388	44	law	law	NOUN
ihlr-18967	388	45	and	and	CCONJ
ihlr-18967	388	46	another	another	DET
ihlr-18967	388	47	rationale	rationale	NOUN
ihlr-18967	388	48	behind	behind	ADP
ihlr-18967	388	49	the	the	DET
ihlr-18967	388	50	hatchwaxman	hatchwaxman	PROPN
ihlr-18967	388	51	act	act	PROPN
ihlr-18967	388	52	:	:	PUNCT
ihlr-18967	388	53	developing	develop	VERB
ihlr-18967	388	54	new	new	ADJ
ihlr-18967	388	55	drugs.125	drugs.125	NOUN
ihlr-18967	388	56	finally	finally	ADV
ihlr-18967	388	57	,	,	PUNCT
ihlr-18967	388	58	by	by	ADP
ihlr-18967	388	59	applying	apply	VERB
ihlr-18967	388	60	rule	rule	NOUN
ihlr-18967	388	61	of	of	ADP
ihlr-18967	388	62	reason	reason	NOUN
ihlr-18967	388	63	analysis	analysis	NOUN
ihlr-18967	388	64	to	to	PART
ihlr-18967	388	65	reverse	reverse	VERB
ihlr-18967	388	66	payment	payment	NOUN
ihlr-18967	388	67	settlements	settlement	NOUN
ihlr-18967	388	68	,	,	PUNCT
ihlr-18967	388	69	consumers	consumer	NOUN
ihlr-18967	388	70	and	and	CCONJ
ihlr-18967	388	71	manufactures	manufacture	NOUN
ihlr-18967	388	72	are	be	AUX
ihlr-18967	388	73	likely	likely	ADJ
ihlr-18967	388	74	to	to	PART
ihlr-18967	388	75	be	be	AUX
ihlr-18967	388	76	affected	affect	VERB
ihlr-18967	388	77	differently	differently	ADV
ihlr-18967	388	78	,	,	PUNCT
ihlr-18967	388	79	with	with	ADP
ihlr-18967	388	80	the	the	DET
ihlr-18967	388	81	former	former	ADJ
ihlr-18967	388	82	benefiting	benefiting	NOUN
ihlr-18967	388	83	and	and	CCONJ
ihlr-18967	388	84	the	the	DET
ihlr-18967	388	85	latter	latter	ADJ
ihlr-18967	388	86	burdening	burdening	NOUN
ihlr-18967	388	87	.	.	PUNCT
ihlr-18967	389	1	1	1	X
ihlr-18967	389	2	.	.	X
ihlr-18967	389	3	effect	effect	NOUN
ihlr-18967	389	4	of	of	ADP
ihlr-18967	389	5	antitrust	antitrust	ADJ
ihlr-18967	389	6	laws	law	NOUN
ihlr-18967	389	7	:	:	PUNCT
ihlr-18967	389	8	how	how	SCONJ
ihlr-18967	389	9	consumers	consumer	NOUN
ihlr-18967	389	10	benefit	benefit	VERB
ihlr-18967	389	11	a	a	DET
ihlr-18967	389	12	2010	2010	NUM
ihlr-18967	389	13	analysis	analysis	NOUN
ihlr-18967	389	14	by	by	ADP
ihlr-18967	389	15	the	the	DET
ihlr-18967	389	16	ftc	ftc	PROPN
ihlr-18967	389	17	found	find	VERB
ihlr-18967	389	18	that	that	SCONJ
ihlr-18967	389	19	reverse	reverse	VERB
ihlr-18967	389	20	payment	payment	NOUN
ihlr-18967	389	21	settlements	settlement	NOUN
ihlr-18967	389	22	cost	cost	VERB
ihlr-18967	389	23	consumers	consumer	NOUN
ihlr-18967	389	24	$	$	SYM
ihlr-18967	389	25	3.5	3.5	NUM
ihlr-18967	389	26	billion	billion	NUM
ihlr-18967	389	27	annually.126	annually.126	NOUN
ihlr-18967	389	28	meanwhile	meanwhile	ADV
ihlr-18967	389	29	,	,	PUNCT
ihlr-18967	389	30	the	the	DET
ihlr-18967	389	31	goal	goal	NOUN
ihlr-18967	389	32	of	of	ADP
ihlr-18967	389	33	antitrust	antitrust	ADJ
ihlr-18967	389	34	law	law	NOUN
ihlr-18967	389	35	is	be	AUX
ihlr-18967	389	36	to	to	PART
ihlr-18967	389	37	benefit	benefit	VERB
ihlr-18967	389	38	consumers	consumer	NOUN
ihlr-18967	389	39	by	by	ADP
ihlr-18967	389	40	promoting	promote	VERB
ihlr-18967	389	41	competition	competition	NOUN
ihlr-18967	389	42	in	in	ADP
ihlr-18967	389	43	the	the	DET
ihlr-18967	389	44	marketplace.127	marketplace.127	NOUN
ihlr-18967	389	45	by	by	ADP
ihlr-18967	389	46	providing	provide	VERB
ihlr-18967	389	47	greater	great	ADJ
ihlr-18967	389	48	competition	competition	NOUN
ihlr-18967	389	49	(	(	PUNCT
ihlr-18967	389	50	supply	supply	NOUN
ihlr-18967	389	51	)	)	PUNCT
ihlr-18967	389	52	,	,	PUNCT
ihlr-18967	389	53	more	more	ADJ
ihlr-18967	389	54	suppliers	supplier	NOUN
ihlr-18967	389	55	will	will	AUX
ihlr-18967	389	56	be	be	AUX
ihlr-18967	389	57	forced	force	VERB
ihlr-18967	389	58	to	to	PART
ihlr-18967	389	59	fight	fight	VERB
ihlr-18967	389	60	over	over	ADP
ihlr-18967	389	61	a	a	DET
ihlr-18967	389	62	finite	finite	ADJ
ihlr-18967	389	63	number	number	NOUN
ihlr-18967	389	64	of	of	ADP
ihlr-18967	389	65	consumers	consumer	NOUN
ihlr-18967	389	66	which	which	PRON
ihlr-18967	389	67	can	can	AUX
ihlr-18967	389	68	result	result	VERB
ihlr-18967	389	69	in	in	ADP
ihlr-18967	389	70	the	the	DET
ihlr-18967	389	71	supplier	supplier	NOUN
ihlr-18967	389	72	lowering	lowering	NOUN
ihlr-18967	389	73	costs	cost	NOUN
ihlr-18967	389	74	or	or	CCONJ
ihlr-18967	389	75	developing	develop	VERB
ihlr-18967	389	76	a	a	DET
ihlr-18967	389	77	superior	superior	ADJ
ihlr-18967	389	78	product	product	NOUN
ihlr-18967	389	79	in	in	ADP
ihlr-18967	389	80	order	order	NOUN
ihlr-18967	389	81	to	to	PART
ihlr-18967	389	82	attract	attract	VERB
ihlr-18967	389	83	consumers	consumer	NOUN
ihlr-18967	389	84	.	.	PUNCT
ihlr-18967	390	1	therefore	therefore	ADV
ihlr-18967	390	2	,	,	PUNCT
ihlr-18967	390	3	by	by	ADP
ihlr-18967	390	4	applying	apply	VERB
ihlr-18967	390	5	antitrust	antitrust	ADJ
ihlr-18967	390	6	analysis	analysis	NOUN
ihlr-18967	390	7	to	to	PART
ihlr-18967	390	8	reverse	reverse	VERB
ihlr-18967	390	9	payment	payment	NOUN
ihlr-18967	390	10	settlements	settlement	NOUN
ihlr-18967	390	11	,	,	PUNCT
ihlr-18967	390	12	consumers	consumer	NOUN
ihlr-18967	390	13	are	be	AUX
ihlr-18967	390	14	likely	likely	ADJ
ihlr-18967	390	15	to	to	PART
ihlr-18967	390	16	benefit	benefit	VERB
ihlr-18967	390	17	from	from	ADP
ihlr-18967	390	18	more	more	ADJ
ihlr-18967	390	19	123	123	NUM
ihlr-18967	390	20	i	i	PRON
ihlr-18967	390	21	d.	d.	PROPN
ihlr-18967	390	22	at	at	ADP
ihlr-18967	390	23	§	§	PROPN
ihlr-18967	390	24	28(a)(2	28(a)(2	NUM
ihlr-18967	390	25	)	)	PUNCT
ihlr-18967	390	26	.	.	PUNCT
ihlr-18967	391	1	124	124	NUM
ihlr-18967	391	2	caraco	caraco	PROPN
ihlr-18967	391	3	pharm	pharm	NOUN
ihlr-18967	391	4	.	.	PUNCT
ihlr-18967	392	1	labs	labs	PROPN
ihlr-18967	392	2	.	.	PUNCT
ihlr-18967	392	3	,	,	PUNCT
ihlr-18967	392	4	ltd	ltd	PROPN
ihlr-18967	392	5	.	.	PROPN
ihlr-18967	392	6	v.	v.	ADP
ihlr-18967	392	7	forest	forest	PROPN
ihlr-18967	392	8	labs	labs	PROPN
ihlr-18967	392	9	.	.	PUNCT
ihlr-18967	392	10	,	,	PUNCT
ihlr-18967	392	11	inc	inc	PROPN
ihlr-18967	392	12	.	.	PROPN
ihlr-18967	392	13	527	527	NUM
ihlr-18967	392	14	f.3d	f.3d	NUM
ihlr-18967	392	15	1278	1278	NUM
ihlr-18967	392	16	,	,	PUNCT
ihlr-18967	392	17	1282	1282	NUM
ihlr-18967	392	18	(	(	PUNCT
ihlr-18967	392	19	fed	fed	PROPN
ihlr-18967	392	20	.	.	PUNCT
ihlr-18967	392	21	cir	cir	PROPN
ihlr-18967	392	22	.	.	PROPN
ihlr-18967	392	23	2008	2008	NUM
ihlr-18967	392	24	)	)	PUNCT
ihlr-18967	392	25	.	.	PUNCT
ihlr-18967	393	1	125	125	NUM
ihlr-18967	393	2	i	i	NOUN
ihlr-18967	393	3	d.	d.	NOUN
ihlr-18967	393	4	126	126	NUM
ihlr-18967	393	5	pay	pay	NOUN
ihlr-18967	393	6	-	-	PUNCT
ihlr-18967	393	7	for	for	ADP
ihlr-18967	393	8	-	-	PUNCT
ihlr-18967	393	9	delay	delay	NOUN
ihlr-18967	393	10	,	,	PUNCT
ihlr-18967	393	11	supra	supra	NOUN
ihlr-18967	393	12	note	note	NOUN
ihlr-18967	393	13	9	9	NUM
ihlr-18967	393	14	.	.	X
ihlr-18967	393	15	127	127	NUM
ihlr-18967	393	16	58	58	NUM
ihlr-18967	393	17	c.j.s	c.j.s	NOUN
ihlr-18967	393	18	monopolies	monopoly	NOUN
ihlr-18967	393	19	§	§	PROPN
ihlr-18967	393	20	7	7	NUM
ihlr-18967	393	21	(	(	PUNCT
ihlr-18967	393	22	2014	2014	NUM
ihlr-18967	393	23	)	)	PUNCT
ihlr-18967	393	24	.	.	PUNCT
ihlr-18967	394	1	2015	2015	NUM
ihlr-18967	394	2	rationale	rationale	NOUN
ihlr-18967	394	3	behind	behind	ADP
ihlr-18967	394	4	hatch	hatch	NOUN
ihlr-18967	394	5	-	-	PUNCT
ihlr-18967	394	6	waxman	waxman	PROPN
ihlr-18967	394	7	act	act	PROPN
ihlr-18967	394	8	and	and	CCONJ
ihlr-18967	394	9	patent	patent	NOUN
ihlr-18967	394	10	law	law	NOUN
ihlr-18967	394	11	445	445	NUM
ihlr-18967	394	12	drugs	drug	NOUN
ihlr-18967	394	13	being	be	AUX
ihlr-18967	394	14	introduced	introduce	VERB
ihlr-18967	394	15	into	into	ADP
ihlr-18967	394	16	the	the	DET
ihlr-18967	394	17	market	market	NOUN
ihlr-18967	394	18	,	,	PUNCT
ihlr-18967	394	19	an	an	DET
ihlr-18967	394	20	effect	effect	NOUN
ihlr-18967	394	21	supported	support	VERB
ihlr-18967	394	22	by	by	ADP
ihlr-18967	394	23	the	the	DET
ihlr-18967	394	24	hatch	hatch	PROPN
ihlr-18967	394	25	-	-	PUNCT
ihlr-18967	394	26	waxman	waxman	PROPN
ihlr-18967	394	27	act	act	PROPN
ihlr-18967	394	28	.	.	PUNCT
ihlr-18967	395	1	first	first	ADV
ihlr-18967	395	2	,	,	PUNCT
ihlr-18967	395	3	applying	apply	VERB
ihlr-18967	395	4	the	the	DET
ihlr-18967	395	5	rule	rule	NOUN
ihlr-18967	395	6	of	of	ADP
ihlr-18967	395	7	reason	reason	NOUN
ihlr-18967	395	8	will	will	AUX
ihlr-18967	395	9	increase	increase	VERB
ihlr-18967	395	10	market	market	NOUN
ihlr-18967	395	11	competition	competition	NOUN
ihlr-18967	395	12	by	by	ADP
ihlr-18967	395	13	forcing	force	VERB
ihlr-18967	395	14	generic	generic	ADJ
ihlr-18967	395	15	companies	company	NOUN
ihlr-18967	395	16	to	to	PART
ihlr-18967	395	17	enter	enter	VERB
ihlr-18967	395	18	the	the	DET
ihlr-18967	395	19	market	market	NOUN
ihlr-18967	395	20	sooner.128	sooner.128	NOUN
ihlr-18967	395	21	many	many	ADJ
ihlr-18967	395	22	,	,	PUNCT
ihlr-18967	395	23	if	if	SCONJ
ihlr-18967	395	24	not	not	PART
ihlr-18967	395	25	all	all	PRON
ihlr-18967	395	26	,	,	PUNCT
ihlr-18967	395	27	reverse	reverse	VERB
ihlr-18967	395	28	payment	payment	NOUN
ihlr-18967	395	29	settlements	settlement	NOUN
ihlr-18967	395	30	,	,	PUNCT
ihlr-18967	395	31	as	as	ADP
ihlr-18967	395	32	part	part	NOUN
ihlr-18967	395	33	of	of	ADP
ihlr-18967	395	34	the	the	DET
ihlr-18967	395	35	agreement	agreement	NOUN
ihlr-18967	395	36	,	,	PUNCT
ihlr-18967	395	37	require	require	VERB
ihlr-18967	395	38	generic	generic	ADJ
ihlr-18967	395	39	manufactures	manufacture	NOUN
ihlr-18967	395	40	to	to	PART
ihlr-18967	395	41	delay	delay	VERB
ihlr-18967	395	42	marketing	marketing	NOUN
ihlr-18967	395	43	of	of	ADP
ihlr-18967	395	44	its	its	PRON
ihlr-18967	395	45	drug.129	drug.129	PROPN
ihlr-18967	395	46	as	as	ADP
ihlr-18967	395	47	a	a	DET
ihlr-18967	395	48	result	result	NOUN
ihlr-18967	395	49	of	of	ADP
ihlr-18967	395	50	actavis	actavis	NOUN
ihlr-18967	395	51	,	,	PUNCT
ihlr-18967	395	52	reverse	reverse	ADJ
ihlr-18967	395	53	payment	payment	NOUN
ihlr-18967	395	54	settlement	settlement	NOUN
ihlr-18967	395	55	will	will	AUX
ihlr-18967	395	56	not	not	PART
ihlr-18967	395	57	be	be	AUX
ihlr-18967	395	58	able	able	ADJ
ihlr-18967	395	59	to	to	PART
ihlr-18967	395	60	focus	focus	VERB
ihlr-18967	395	61	on	on	ADP
ihlr-18967	395	62	delaying	delay	VERB
ihlr-18967	395	63	a	a	DET
ihlr-18967	395	64	generic	generic	ADJ
ihlr-18967	395	65	drug	drug	NOUN
ihlr-18967	395	66	as	as	ADP
ihlr-18967	395	67	consideration	consideration	NOUN
ihlr-18967	395	68	for	for	ADP
ihlr-18967	395	69	a	a	DET
ihlr-18967	395	70	monetary	monetary	ADJ
ihlr-18967	395	71	payment	payment	NOUN
ihlr-18967	395	72	by	by	ADP
ihlr-18967	395	73	the	the	DET
ihlr-18967	395	74	pioneer	pioneer	NOUN
ihlr-18967	395	75	manufacturer	manufacturer	NOUN
ihlr-18967	395	76	.	.	PUNCT
ihlr-18967	396	1	in	in	ADP
ihlr-18967	396	2	actavis	actavis	PROPN
ihlr-18967	396	3	,	,	PUNCT
ihlr-18967	396	4	the	the	DET
ihlr-18967	396	5	court	court	NOUN
ihlr-18967	396	6	made	make	VERB
ihlr-18967	396	7	it	it	PRON
ihlr-18967	396	8	clear	clear	ADJ
ihlr-18967	396	9	that	that	SCONJ
ihlr-18967	396	10	most	most	ADJ
ihlr-18967	396	11	delays	delay	NOUN
ihlr-18967	396	12	will	will	AUX
ihlr-18967	396	13	not	not	PART
ihlr-18967	396	14	be	be	AUX
ihlr-18967	396	15	tolerated.130	tolerated.130	ADJ
ihlr-18967	396	16	by	by	ADP
ihlr-18967	396	17	not	not	PART
ihlr-18967	396	18	including	include	VERB
ihlr-18967	396	19	delays	delay	NOUN
ihlr-18967	396	20	,	,	PUNCT
ihlr-18967	396	21	more	more	ADJ
ihlr-18967	396	22	generic	generic	ADJ
ihlr-18967	396	23	drugs	drug	NOUN
ihlr-18967	396	24	will	will	AUX
ihlr-18967	396	25	enter	enter	VERB
ihlr-18967	396	26	the	the	DET
ihlr-18967	396	27	market	market	NOUN
ihlr-18967	396	28	in	in	ADP
ihlr-18967	396	29	a	a	DET
ihlr-18967	396	30	quicker	quick	ADJ
ihlr-18967	396	31	time	time	NOUN
ihlr-18967	396	32	frame	frame	NOUN
ihlr-18967	396	33	.	.	PUNCT
ihlr-18967	397	1	this	this	PRON
ihlr-18967	397	2	shows	show	VERB
ihlr-18967	397	3	how	how	SCONJ
ihlr-18967	397	4	the	the	DET
ihlr-18967	397	5	rule	rule	NOUN
ihlr-18967	397	6	of	of	ADP
ihlr-18967	397	7	reason	reason	NOUN
ihlr-18967	397	8	supports	support	VERB
ihlr-18967	397	9	the	the	DET
ihlr-18967	397	10	intention	intention	NOUN
ihlr-18967	397	11	behind	behind	ADP
ihlr-18967	397	12	the	the	DET
ihlr-18967	397	13	hatch	hatch	NOUN
ihlr-18967	397	14	-	-	PUNCT
ihlr-18967	397	15	waxman	waxman	PROPN
ihlr-18967	397	16	act	act	NOUN
ihlr-18967	397	17	to	to	PART
ihlr-18967	397	18	have	have	VERB
ihlr-18967	397	19	more	more	ADJ
ihlr-18967	397	20	generic	generic	ADJ
ihlr-18967	397	21	drugs	drug	NOUN
ihlr-18967	397	22	on	on	ADP
ihlr-18967	397	23	the	the	DET
ihlr-18967	397	24	market.131	market.131	NOUN
ihlr-18967	397	25	therefore	therefore	ADV
ihlr-18967	397	26	,	,	PUNCT
ihlr-18967	397	27	more	more	ADV
ihlr-18967	397	28	generic	generic	ADJ
ihlr-18967	397	29	drugs	drug	NOUN
ihlr-18967	397	30	will	will	AUX
ihlr-18967	397	31	be	be	AUX
ihlr-18967	397	32	able	able	ADJ
ihlr-18967	397	33	to	to	PART
ihlr-18967	397	34	enter	enter	VERB
ihlr-18967	397	35	the	the	DET
ihlr-18967	397	36	markets	market	NOUN
ihlr-18967	397	37	sooner	soon	ADV
ihlr-18967	397	38	,	,	PUNCT
ihlr-18967	397	39	which	which	PRON
ihlr-18967	397	40	will	will	AUX
ihlr-18967	397	41	result	result	VERB
ihlr-18967	397	42	in	in	ADP
ihlr-18967	397	43	more	more	ADJ
ihlr-18967	397	44	competition	competition	NOUN
ihlr-18967	397	45	between	between	ADP
ihlr-18967	397	46	drug	drug	NOUN
ihlr-18967	397	47	manufacturers	manufacturer	NOUN
ihlr-18967	397	48	.	.	PUNCT
ihlr-18967	398	1	on	on	ADP
ihlr-18967	398	2	the	the	DET
ihlr-18967	398	3	other	other	ADJ
ihlr-18967	398	4	hand	hand	NOUN
ihlr-18967	398	5	,	,	PUNCT
ihlr-18967	398	6	as	as	SCONJ
ihlr-18967	398	7	chief	chief	PROPN
ihlr-18967	398	8	justice	justice	NOUN
ihlr-18967	398	9	roberts	roberts	PROPN
ihlr-18967	398	10	argued	argue	VERB
ihlr-18967	398	11	in	in	ADP
ihlr-18967	398	12	actavis	actavis	PROPN
ihlr-18967	398	13	,	,	PUNCT
ihlr-18967	398	14	generic	generic	ADJ
ihlr-18967	398	15	manufacturers	manufacturer	NOUN
ihlr-18967	398	16	may	may	AUX
ihlr-18967	398	17	challenge	challenge	VERB
ihlr-18967	398	18	pioneer	pioneer	NOUN
ihlr-18967	398	19	manufacturer	manufacturer	NOUN
ihlr-18967	398	20	’s	’s	PART
ihlr-18967	398	21	patents	patent	NOUN
ihlr-18967	398	22	less	less	ADJ
ihlr-18967	398	23	often.132	often.132	NOUN
ihlr-18967	398	24	generally	generally	ADV
ihlr-18967	398	25	,	,	PUNCT
ihlr-18967	398	26	patent	patent	NOUN
ihlr-18967	398	27	litigation	litigation	NOUN
ihlr-18967	398	28	is	be	AUX
ihlr-18967	398	29	expensive	expensive	ADJ
ihlr-18967	398	30	and	and	CCONJ
ihlr-18967	398	31	time	time	NOUN
ihlr-18967	398	32	consuming	consume	VERB
ihlr-18967	398	33	.	.	PUNCT
ihlr-18967	399	1	generic	generic	ADJ
ihlr-18967	399	2	manufacturers	manufacturer	NOUN
ihlr-18967	399	3	will	will	AUX
ihlr-18967	399	4	need	need	VERB
ihlr-18967	399	5	to	to	PART
ihlr-18967	399	6	weigh	weigh	VERB
ihlr-18967	399	7	the	the	DET
ihlr-18967	399	8	costs	cost	NOUN
ihlr-18967	399	9	and	and	CCONJ
ihlr-18967	399	10	benefits	benefit	NOUN
ihlr-18967	399	11	of	of	ADP
ihlr-18967	399	12	bringing	bring	VERB
ihlr-18967	399	13	a	a	DET
ihlr-18967	399	14	lawsuit	lawsuit	NOUN
ihlr-18967	399	15	,	,	PUNCT
ihlr-18967	399	16	and	and	CCONJ
ihlr-18967	399	17	there	there	PRON
ihlr-18967	399	18	may	may	AUX
ihlr-18967	399	19	be	be	AUX
ihlr-18967	399	20	times	time	NOUN
ihlr-18967	399	21	where	where	SCONJ
ihlr-18967	399	22	a	a	DET
ihlr-18967	399	23	generic	generic	ADJ
ihlr-18967	399	24	manufacturer	manufacturer	NOUN
ihlr-18967	399	25	chooses	choose	VERB
ihlr-18967	399	26	not	not	PART
ihlr-18967	399	27	to	to	PART
ihlr-18967	399	28	bring	bring	VERB
ihlr-18967	399	29	lawsuit	lawsuit	NOUN
ihlr-18967	399	30	when	when	SCONJ
ihlr-18967	399	31	it	it	PRON
ihlr-18967	399	32	would	would	AUX
ihlr-18967	399	33	have	have	VERB
ihlr-18967	399	34	pre	pre	ADJ
ihlr-18967	399	35	-	-	ADJ
ihlr-18967	399	36	actavis	actavis	ADJ
ihlr-18967	399	37	.	.	PUNCT
ihlr-18967	400	1	moreover	moreover	ADV
ihlr-18967	400	2	,	,	PUNCT
ihlr-18967	400	3	generic	generic	ADJ
ihlr-18967	400	4	manufacturers	manufacturer	NOUN
ihlr-18967	400	5	may	may	AUX
ihlr-18967	400	6	128	128	NUM
ihlr-18967	400	7	angela	angela	PROPN
ihlr-18967	400	8	maas	maas	PROPN
ihlr-18967	400	9	,	,	PUNCT
ihlr-18967	400	10	supreme	supreme	PROPN
ihlr-18967	400	11	court	court	PROPN
ihlr-18967	400	12	punts	punt	NOUN
ihlr-18967	400	13	on	on	ADP
ihlr-18967	400	14	pay	pay	NOUN
ihlr-18967	400	15	-	-	PUNCT
ihlr-18967	400	16	for	for	ADP
ihlr-18967	400	17	-	-	PUNCT
ihlr-18967	400	18	delay	delay	NOUN
ihlr-18967	400	19	,	,	PUNCT
ihlr-18967	400	20	prompting	prompt	VERB
ihlr-18967	400	21	disagreement	disagreement	NOUN
ihlr-18967	400	22	over	over	ADP
ihlr-18967	400	23	impact	impact	NOUN
ihlr-18967	400	24	,	,	PUNCT
ihlr-18967	400	25	ais	ais	PROPN
ihlr-18967	400	26	health	health	PROPN
ihlr-18967	400	27	(	(	PUNCT
ihlr-18967	400	28	june	june	PROPN
ihlr-18967	400	29	21	21	NUM
ihlr-18967	400	30	,	,	PUNCT
ihlr-18967	400	31	2013	2013	NUM
ihlr-18967	400	32	)	)	PUNCT
ihlr-18967	400	33	,	,	PUNCT
ihlr-18967	400	34	http://aishealth.com/archive/ndbn062113-02	http://aishealth.com/archive/ndbn062113-02	PROPN
ihlr-18967	400	35	.	.	PUNCT
ihlr-18967	401	1	129	129	NUM
ihlr-18967	401	2	ark	ark	PROPN
ihlr-18967	401	3	.	.	PUNCT
ihlr-18967	402	1	carpenters	carpenter	NOUN
ihlr-18967	402	2	health	health	NOUN
ihlr-18967	402	3	and	and	CCONJ
ihlr-18967	402	4	welfare	welfare	NOUN
ihlr-18967	402	5	fund	fund	PROPN
ihlr-18967	402	6	v.	v.	PROPN
ihlr-18967	402	7	bayer	bayer	PROPN
ihlr-18967	402	8	ag	ag	PROPN
ihlr-18967	402	9	,	,	PUNCT
ihlr-18967	402	10	604	604	NUM
ihlr-18967	402	11	f.3d	f.3d	NUM
ihlr-18967	402	12	98	98	NUM
ihlr-18967	402	13	,	,	PUNCT
ihlr-18967	402	14	102	102	NUM
ihlr-18967	402	15	(	(	PUNCT
ihlr-18967	402	16	2d	2d	NUM
ihlr-18967	402	17	cir	cir	NOUN
ihlr-18967	402	18	.	.	PUNCT
ihlr-18967	402	19	2010	2010	NUM
ihlr-18967	402	20	)	)	PUNCT
ihlr-18967	402	21	(	(	PUNCT
ihlr-18967	402	22	delay	delay	NOUN
ihlr-18967	402	23	until	until	SCONJ
ihlr-18967	402	24	patent	patent	NOUN
ihlr-18967	402	25	expired	expire	VERB
ihlr-18967	402	26	)	)	PUNCT
ihlr-18967	402	27	;	;	PUNCT
ihlr-18967	402	28	schering	schering	NOUN
ihlr-18967	402	29	-	-	PUNCT
ihlr-18967	402	30	plough	plough	PROPN
ihlr-18967	402	31	corp	corp	PROPN
ihlr-18967	402	32	.	.	PROPN
ihlr-18967	402	33	v.	v.	PROPN
ihlr-18967	402	34	f.t.c	f.t.c	PROPN
ihlr-18967	402	35	.	.	PROPN
ihlr-18967	402	36	402	402	NUM
ihlr-18967	402	37	f.3d	f.3d	NUM
ihlr-18967	402	38	1056	1056	NUM
ihlr-18967	402	39	,	,	PUNCT
ihlr-18967	402	40	1060	1060	NUM
ihlr-18967	402	41	(	(	PUNCT
ihlr-18967	402	42	11th	11th	ADJ
ihlr-18967	402	43	cir	cir	NOUN
ihlr-18967	402	44	.	.	PROPN
ihlr-18967	402	45	2005	2005	NUM
ihlr-18967	402	46	)	)	PUNCT
ihlr-18967	402	47	(	(	PUNCT
ihlr-18967	402	48	delay	delay	VERB
ihlr-18967	402	49	until	until	SCONJ
ihlr-18967	402	50	three	three	NUM
ihlr-18967	402	51	years	year	NOUN
ihlr-18967	402	52	before	before	SCONJ
ihlr-18967	402	53	patent	patent	NOUN
ihlr-18967	402	54	expired	expire	VERB
ihlr-18967	402	55	)	)	PUNCT
ihlr-18967	402	56	;	;	PUNCT
ihlr-18967	402	57	valley	valley	NOUN
ihlr-18967	402	58	drug	drug	PROPN
ihlr-18967	402	59	co.	co.	PROPN
ihlr-18967	402	60	v.	v.	ADP
ihlr-18967	402	61	geneva	geneva	PROPN
ihlr-18967	402	62	pharms	pharms	PROPN
ihlr-18967	402	63	.	.	PUNCT
ihlr-18967	402	64	,	,	PUNCT
ihlr-18967	402	65	inc	inc	PROPN
ihlr-18967	402	66	.	.	PROPN
ihlr-18967	402	67	344	344	NUM
ihlr-18967	402	68	f.3d	f.3d	NUM
ihlr-18967	402	69	1294	1294	NUM
ihlr-18967	402	70	,	,	PUNCT
ihlr-18967	402	71	1300	1300	NUM
ihlr-18967	402	72	(	(	PUNCT
ihlr-18967	402	73	11th	11th	ADJ
ihlr-18967	402	74	cir	cir	NOUN
ihlr-18967	402	75	.	.	PROPN
ihlr-18967	402	76	2003	2003	NUM
ihlr-18967	402	77	)	)	PUNCT
ihlr-18967	402	78	(	(	PUNCT
ihlr-18967	402	79	delay	delay	VERB
ihlr-18967	402	80	until	until	ADP
ihlr-18967	402	81	another	another	DET
ihlr-18967	402	82	generic	generic	ADJ
ihlr-18967	402	83	entered	enter	VERB
ihlr-18967	402	84	market	market	NOUN
ihlr-18967	402	85	or	or	CCONJ
ihlr-18967	402	86	patent	patent	NOUN
ihlr-18967	402	87	expired	expire	VERB
ihlr-18967	402	88	)	)	PUNCT
ihlr-18967	402	89	;	;	PUNCT
ihlr-18967	402	90	la	la	X
ihlr-18967	402	91	.	.	PUNCT
ihlr-18967	402	92	wholesale	wholesale	PROPN
ihlr-18967	402	93	drug	drug	PROPN
ihlr-18967	402	94	co.	co.	PROPN
ihlr-18967	402	95	,	,	PUNCT
ihlr-18967	402	96	inc	inc	PROPN
ihlr-18967	402	97	.	.	PROPN
ihlr-18967	402	98	v.	v.	PROPN
ihlr-18967	402	99	shire	shire	PROPN
ihlr-18967	402	100	llc	llc	PROPN
ihlr-18967	402	101	,	,	PUNCT
ihlr-18967	402	102	929	929	NUM
ihlr-18967	402	103	f.supp.2d	f.supp.2d	NUM
ihlr-18967	402	104	256	256	NUM
ihlr-18967	402	105	,	,	PUNCT
ihlr-18967	402	106	258	258	NUM
ihlr-18967	402	107	(	(	PUNCT
ihlr-18967	402	108	s.d.n.y	s.d.n.y	PROPN
ihlr-18967	402	109	.	.	PROPN
ihlr-18967	402	110	2013	2013	NUM
ihlr-18967	402	111	)	)	PUNCT
ihlr-18967	402	112	(	(	PUNCT
ihlr-18967	402	113	three	three	NUM
ihlr-18967	402	114	year	year	NOUN
ihlr-18967	402	115	delay	delay	NOUN
ihlr-18967	402	116	)	)	PUNCT
ihlr-18967	402	117	.	.	PUNCT
ihlr-18967	403	1	130	130	NUM
ihlr-18967	403	2	ftc	ftc	PROPN
ihlr-18967	403	3	v.	v.	ADP
ihlr-18967	403	4	actavis	actavis	PROPN
ihlr-18967	403	5	,	,	PUNCT
ihlr-18967	403	6	inc	inc	PROPN
ihlr-18967	403	7	.	.	PROPN
ihlr-18967	403	8	133	133	NUM
ihlr-18967	403	9	s.	s.	PROPN
ihlr-18967	403	10	ct	ct	PROPN
ihlr-18967	403	11	.	.	PROPN
ihlr-18967	403	12	2223	2223	NUM
ihlr-18967	403	13	,	,	PUNCT
ihlr-18967	403	14	2234	2234	NUM
ihlr-18967	403	15	(	(	PUNCT
ihlr-18967	403	16	2013	2013	NUM
ihlr-18967	403	17	)	)	PUNCT
ihlr-18967	403	18	.	.	PUNCT
ihlr-18967	404	1	131	131	NUM
ihlr-18967	404	2	see	see	VERB
ihlr-18967	404	3	i	i	PROPN
ihlr-18967	404	4	d.	d.	PROPN
ihlr-18967	404	5	(	(	PUNCT
ihlr-18967	404	6	citing	cite	VERB
ihlr-18967	404	7	148	148	NUM
ihlr-18967	404	8	cong	cong	NOUN
ihlr-18967	404	9	.	.	PUNCT
ihlr-18967	405	1	rec	rec	PROPN
ihlr-18967	405	2	.	.	PROPN
ihlr-18967	405	3	14437	14437	NUM
ihlr-18967	405	4	(	(	PUNCT
ihlr-18967	405	5	2002	2002	NUM
ihlr-18967	405	6	)	)	PUNCT
ihlr-18967	405	7	(	(	PUNCT
ihlr-18967	405	8	remarks	remark	NOUN
ihlr-18967	405	9	of	of	ADP
ihlr-18967	405	10	sen	sen	PROPN
ihlr-18967	405	11	.	.	PROPN
ihlr-18967	405	12	hatch	hatch	PROPN
ihlr-18967	405	13	)	)	PUNCT
ihlr-18967	405	14	(	(	PUNCT
ihlr-18967	405	15	“	"	PUNCT
ihlr-18967	405	16	it	it	PRON
ihlr-18967	405	17	was	be	AUX
ihlr-18967	405	18	and	and	CCONJ
ihlr-18967	405	19	is	be	AUX
ihlr-18967	405	20	very	very	ADV
ihlr-18967	405	21	clear	clear	ADJ
ihlr-18967	405	22	that	that	SCONJ
ihlr-18967	405	23	the	the	DET
ihlr-18967	405	24	[	[	X
ihlr-18967	405	25	hatch	hatch	NOUN
ihlr-18967	405	26	–	–	PUNCT
ihlr-18967	405	27	waxman	waxman	PROPN
ihlr-18967	405	28	act	act	PROPN
ihlr-18967	405	29	]	]	PUNCT
ihlr-18967	405	30	was	be	AUX
ihlr-18967	405	31	not	not	PART
ihlr-18967	405	32	designed	design	VERB
ihlr-18967	405	33	to	to	PART
ihlr-18967	405	34	allow	allow	VERB
ihlr-18967	405	35	deals	deal	NOUN
ihlr-18967	405	36	between	between	ADP
ihlr-18967	405	37	brand	brand	NOUN
ihlr-18967	405	38	and	and	CCONJ
ihlr-18967	405	39	generic	generic	ADJ
ihlr-18967	405	40	companies	company	NOUN
ihlr-18967	405	41	to	to	PART
ihlr-18967	405	42	delay	delay	VERB
ihlr-18967	405	43	competition	competition	NOUN
ihlr-18967	405	44	.	.	PUNCT
ihlr-18967	405	45	”	"	PUNCT
ihlr-18967	405	46	)	)	PUNCT
ihlr-18967	405	47	)	)	PUNCT
ihlr-18967	405	48	.	.	PUNCT
ihlr-18967	406	1	132	132	NUM
ihlr-18967	406	2	i	i	PRON
ihlr-18967	406	3	d.	d.	PROPN
ihlr-18967	406	4	at	at	ADP
ihlr-18967	406	5	2247	2247	NUM
ihlr-18967	406	6	(	(	PUNCT
ihlr-18967	406	7	roberts	roberts	PROPN
ihlr-18967	406	8	,	,	PUNCT
ihlr-18967	406	9	c.j	c.j	PROPN
ihlr-18967	406	10	.	.	PROPN
ihlr-18967	406	11	,	,	PUNCT
ihlr-18967	406	12	dissenting	dissent	VERB
ihlr-18967	406	13	)	)	PUNCT
ihlr-18967	406	14	.	.	PUNCT
ihlr-18967	407	1	446	446	NUM
ihlr-18967	407	2	indiana	indiana	PROPN
ihlr-18967	407	3	health	health	PROPN
ihlr-18967	407	4	law	law	PROPN
ihlr-18967	407	5	review	review	NOUN
ihlr-18967	407	6	vol	vol	NOUN
ihlr-18967	407	7	.	.	PUNCT
ihlr-18967	408	1	12:1	12:1	NUM
ihlr-18967	408	2	not	not	PART
ihlr-18967	408	3	want	want	VERB
ihlr-18967	408	4	to	to	PART
ihlr-18967	408	5	spend	spend	VERB
ihlr-18967	408	6	money	money	NOUN
ihlr-18967	408	7	and	and	CCONJ
ihlr-18967	408	8	invest	invest	VERB
ihlr-18967	408	9	the	the	DET
ihlr-18967	408	10	necessary	necessary	ADJ
ihlr-18967	408	11	time	time	NOUN
ihlr-18967	408	12	when	when	SCONJ
ihlr-18967	408	13	there	there	PRON
ihlr-18967	408	14	is	be	VERB
ihlr-18967	408	15	a	a	DET
ihlr-18967	408	16	level	level	NOUN
ihlr-18967	408	17	of	of	ADP
ihlr-18967	408	18	uncertainty	uncertainty	NOUN
ihlr-18967	408	19	surrounding	surround	VERB
ihlr-18967	408	20	the	the	DET
ihlr-18967	408	21	validity	validity	NOUN
ihlr-18967	408	22	of	of	ADP
ihlr-18967	408	23	a	a	DET
ihlr-18967	408	24	patent	patent	NOUN
ihlr-18967	408	25	.	.	PUNCT
ihlr-18967	409	1	as	as	ADP
ihlr-18967	409	2	a	a	DET
ihlr-18967	409	3	result	result	NOUN
ihlr-18967	409	4	,	,	PUNCT
ihlr-18967	409	5	actavis	actavis	PROPN
ihlr-18967	409	6	may	may	AUX
ihlr-18967	409	7	not	not	PART
ihlr-18967	409	8	effectuate	effectuate	VERB
ihlr-18967	409	9	the	the	DET
ihlr-18967	409	10	intent	intent	NOUN
ihlr-18967	409	11	of	of	ADP
ihlr-18967	409	12	hatch	hatch	NOUN
ihlr-18967	409	13	-	-	PUNCT
ihlr-18967	409	14	waxman	waxman	NOUN
ihlr-18967	409	15	to	to	PART
ihlr-18967	409	16	increase	increase	VERB
ihlr-18967	409	17	the	the	DET
ihlr-18967	409	18	amount	amount	NOUN
ihlr-18967	409	19	of	of	ADP
ihlr-18967	409	20	generic	generic	ADJ
ihlr-18967	409	21	drugs	drug	NOUN
ihlr-18967	409	22	in	in	ADP
ihlr-18967	409	23	a	a	DET
ihlr-18967	409	24	market	market	NOUN
ihlr-18967	409	25	.	.	PUNCT
ihlr-18967	410	1	second	second	ADJ
ihlr-18967	410	2	,	,	PUNCT
ihlr-18967	410	3	consumers	consumer	NOUN
ihlr-18967	410	4	will	will	AUX
ihlr-18967	410	5	receive	receive	VERB
ihlr-18967	410	6	lower	low	ADJ
ihlr-18967	410	7	-	-	PUNCT
ihlr-18967	410	8	cost	cost	NOUN
ihlr-18967	410	9	drugs	drug	NOUN
ihlr-18967	410	10	marketed	market	VERB
ihlr-18967	410	11	in	in	ADP
ihlr-18967	410	12	a	a	DET
ihlr-18967	410	13	more	more	ADV
ihlr-18967	410	14	timely	timely	ADJ
ihlr-18967	410	15	fashion.133	fashion.133	ADJ
ihlr-18967	410	16	part	part	NOUN
ihlr-18967	410	17	of	of	ADP
ihlr-18967	410	18	the	the	DET
ihlr-18967	410	19	growing	grow	VERB
ihlr-18967	410	20	cost	cost	NOUN
ihlr-18967	410	21	of	of	ADP
ihlr-18967	410	22	healthcare	healthcare	NOUN
ihlr-18967	410	23	involves	involve	VERB
ihlr-18967	410	24	the	the	DET
ihlr-18967	410	25	rising	rise	VERB
ihlr-18967	410	26	cost	cost	NOUN
ihlr-18967	410	27	of	of	ADP
ihlr-18967	410	28	prescription	prescription	NOUN
ihlr-18967	410	29	drugs	drug	NOUN
ihlr-18967	410	30	.	.	PUNCT
ihlr-18967	411	1	from	from	ADP
ihlr-18967	411	2	2005	2005	NUM
ihlr-18967	411	3	until	until	ADP
ihlr-18967	411	4	2009	2009	NUM
ihlr-18967	411	5	,	,	PUNCT
ihlr-18967	411	6	the	the	DET
ihlr-18967	411	7	cost	cost	NOUN
ihlr-18967	411	8	of	of	ADP
ihlr-18967	411	9	prescription	prescription	NOUN
ihlr-18967	411	10	drugs	drug	NOUN
ihlr-18967	411	11	has	have	AUX
ihlr-18967	411	12	risen	rise	VERB
ihlr-18967	411	13	from	from	ADP
ihlr-18967	411	14	$	$	SYM
ihlr-18967	411	15	201.7	201.7	NUM
ihlr-18967	411	16	billion	billion	NUM
ihlr-18967	411	17	to	to	PART
ihlr-18967	411	18	$	$	SYM
ihlr-18967	411	19	249.9	249.9	NUM
ihlr-18967	411	20	billion	billion	NUM
ihlr-18967	411	21	per	per	ADP
ihlr-18967	411	22	year.134	year.134	PROPN
ihlr-18967	411	23	the	the	DET
ihlr-18967	411	24	fda	fda	PROPN
ihlr-18967	411	25	has	have	AUX
ihlr-18967	411	26	reported	report	VERB
ihlr-18967	411	27	,	,	PUNCT
ihlr-18967	411	28	on	on	ADP
ihlr-18967	411	29	average	average	ADJ
ihlr-18967	411	30	,	,	PUNCT
ihlr-18967	411	31	generic	generic	ADJ
ihlr-18967	411	32	drugs	drug	NOUN
ihlr-18967	411	33	cost	cost	VERB
ihlr-18967	411	34	8085	8085	NUM
ihlr-18967	411	35	%	%	NOUN
ihlr-18967	411	36	less	less	ADJ
ihlr-18967	411	37	than	than	ADP
ihlr-18967	411	38	brand	brand	NOUN
ihlr-18967	411	39	name	name	NOUN
ihlr-18967	411	40	drugs.135	drugs.135	NOUN
ihlr-18967	411	41	it	it	PRON
ihlr-18967	411	42	is	be	AUX
ihlr-18967	411	43	estimated	estimate	VERB
ihlr-18967	411	44	that	that	SCONJ
ihlr-18967	411	45	generic	generic	ADJ
ihlr-18967	411	46	drugs	drug	NOUN
ihlr-18967	411	47	saved	save	VERB
ihlr-18967	411	48	consumers	consumer	NOUN
ihlr-18967	411	49	$	$	SYM
ihlr-18967	411	50	700	700	NUM
ihlr-18967	411	51	billion	billion	NUM
ihlr-18967	411	52	from	from	ADP
ihlr-18967	411	53	1999	1999	NUM
ihlr-18967	411	54	until	until	SCONJ
ihlr-18967	411	55	2008.136	2008.136	ADV
ihlr-18967	411	56	further	far	ADV
ihlr-18967	411	57	,	,	PUNCT
ihlr-18967	411	58	some	some	PRON
ihlr-18967	411	59	estimations	estimation	VERB
ihlr-18967	411	60	state	state	NOUN
ihlr-18967	411	61	that	that	PRON
ihlr-18967	411	62	reverse	reverse	VERB
ihlr-18967	411	63	payment	payment	NOUN
ihlr-18967	411	64	settlements	settlement	NOUN
ihlr-18967	411	65	cost	cost	VERB
ihlr-18967	411	66	consumers	consumer	NOUN
ihlr-18967	411	67	approximately	approximately	ADV
ihlr-18967	411	68	$	$	SYM
ihlr-18967	411	69	3.5	3.5	NUM
ihlr-18967	411	70	billion	billion	NUM
ihlr-18967	411	71	per	per	ADP
ihlr-18967	411	72	year.137	year.137	NOUN
ihlr-18967	411	73	under	under	ADP
ihlr-18967	411	74	actavis	actavis	PROPN
ihlr-18967	411	75	,	,	PUNCT
ihlr-18967	411	76	generic	generic	ADJ
ihlr-18967	411	77	manufacturers	manufacturer	NOUN
ihlr-18967	411	78	will	will	AUX
ihlr-18967	411	79	be	be	AUX
ihlr-18967	411	80	able	able	ADJ
ihlr-18967	411	81	to	to	PART
ihlr-18967	411	82	introduce	introduce	VERB
ihlr-18967	411	83	more	more	ADJ
ihlr-18967	411	84	generic	generic	ADJ
ihlr-18967	411	85	drugs	drug	NOUN
ihlr-18967	411	86	into	into	ADP
ihlr-18967	411	87	the	the	DET
ihlr-18967	411	88	market	market	NOUN
ihlr-18967	411	89	in	in	ADP
ihlr-18967	411	90	a	a	DET
ihlr-18967	411	91	more	more	ADV
ihlr-18967	411	92	consumer	consumer	NOUN
ihlr-18967	411	93	friendly	friendly	ADJ
ihlr-18967	411	94	time	time	NOUN
ihlr-18967	411	95	.	.	PUNCT
ihlr-18967	412	1	generic	generic	ADJ
ihlr-18967	412	2	drugs	drug	NOUN
ihlr-18967	412	3	will	will	AUX
ihlr-18967	412	4	be	be	AUX
ihlr-18967	412	5	marketed	market	VERB
ihlr-18967	412	6	sooner	soon	ADV
ihlr-18967	412	7	as	as	ADP
ihlr-18967	412	8	a	a	DET
ihlr-18967	412	9	result	result	NOUN
ihlr-18967	412	10	of	of	ADP
ihlr-18967	412	11	actavis	actavis	NOUN
ihlr-18967	412	12	because	because	SCONJ
ihlr-18967	412	13	settlement	settlement	NOUN
ihlr-18967	412	14	agreements	agreement	NOUN
ihlr-18967	412	15	between	between	ADP
ihlr-18967	412	16	pioneer	pioneer	NOUN
ihlr-18967	412	17	and	and	CCONJ
ihlr-18967	412	18	generic	generic	ADJ
ihlr-18967	412	19	manufacturers	manufacturer	NOUN
ihlr-18967	412	20	will	will	AUX
ihlr-18967	412	21	likely	likely	ADV
ihlr-18967	412	22	not	not	PART
ihlr-18967	412	23	include	include	VERB
ihlr-18967	412	24	delays	delay	NOUN
ihlr-18967	412	25	or	or	CCONJ
ihlr-18967	412	26	will	will	AUX
ihlr-18967	412	27	include	include	VERB
ihlr-18967	412	28	delays	delay	NOUN
ihlr-18967	412	29	that	that	PRON
ihlr-18967	412	30	are	be	AUX
ihlr-18967	412	31	substantially	substantially	ADV
ihlr-18967	412	32	less	less	ADJ
ihlr-18967	412	33	than	than	ADP
ihlr-18967	412	34	pre	pre	ADJ
ihlr-18967	412	35	-	-	ADJ
ihlr-18967	412	36	actavis	actavis	ADJ
ihlr-18967	412	37	settlements	settlement	NOUN
ihlr-18967	412	38	.	.	PUNCT
ihlr-18967	413	1	more	more	ADJ
ihlr-18967	413	2	generic	generic	ADJ
ihlr-18967	413	3	drugs	drug	NOUN
ihlr-18967	413	4	in	in	ADP
ihlr-18967	413	5	the	the	DET
ihlr-18967	413	6	market	market	NOUN
ihlr-18967	413	7	will	will	AUX
ihlr-18967	413	8	translate	translate	VERB
ihlr-18967	413	9	into	into	ADP
ihlr-18967	413	10	more	more	ADJ
ihlr-18967	413	11	generic	generic	ADJ
ihlr-18967	413	12	drugs	drug	NOUN
ihlr-18967	413	13	being	be	AUX
ihlr-18967	413	14	available	available	ADJ
ihlr-18967	413	15	for	for	ADP
ihlr-18967	413	16	consumers	consumer	NOUN
ihlr-18967	413	17	at	at	ADP
ihlr-18967	413	18	a	a	DET
ihlr-18967	413	19	lower	low	ADJ
ihlr-18967	413	20	cost	cost	NOUN
ihlr-18967	413	21	,	,	PUNCT
ihlr-18967	413	22	a	a	DET
ihlr-18967	413	23	result	result	NOUN
ihlr-18967	413	24	of	of	ADP
ihlr-18967	413	25	basic	basic	ADJ
ihlr-18967	413	26	economic	economic	ADJ
ihlr-18967	413	27	principles	principle	NOUN
ihlr-18967	413	28	of	of	ADP
ihlr-18967	413	29	supply	supply	NOUN
ihlr-18967	413	30	and	and	CCONJ
ihlr-18967	413	31	demand	demand	NOUN
ihlr-18967	413	32	.	.	PUNCT
ihlr-18967	414	1	consequently	consequently	ADV
ihlr-18967	414	2	,	,	PUNCT
ihlr-18967	414	3	the	the	DET
ihlr-18967	414	4	rule	rule	NOUN
ihlr-18967	414	5	of	of	ADP
ihlr-18967	414	6	reason	reason	NOUN
ihlr-18967	414	7	furthers	further	VERB
ihlr-18967	414	8	the	the	DET
ihlr-18967	414	9	intent	intent	NOUN
ihlr-18967	414	10	of	of	ADP
ihlr-18967	414	11	the	the	DET
ihlr-18967	414	12	hatch	hatch	NOUN
ihlr-18967	414	13	-	-	PUNCT
ihlr-18967	414	14	waxman	waxman	PROPN
ihlr-18967	414	15	act	act	NOUN
ihlr-18967	414	16	to	to	PART
ihlr-18967	414	17	lower	lower	VERB
ihlr-18967	414	18	the	the	DET
ihlr-18967	414	19	cost	cost	NOUN
ihlr-18967	414	20	of	of	ADP
ihlr-18967	414	21	drugs	drug	NOUN
ihlr-18967	414	22	for	for	ADP
ihlr-18967	414	23	consumer	consumer	NOUN
ihlr-18967	414	24	.	.	PUNCT
ihlr-18967	415	1	133	133	NUM
ihlr-18967	415	2	aaron	aaron	PROPN
ihlr-18967	415	3	kesselheim	kesselheim	PROPN
ihlr-18967	415	4	&	&	CCONJ
ihlr-18967	415	5	nathan	nathan	PROPN
ihlr-18967	415	6	shiu	shiu	PROPN
ihlr-18967	415	7	,	,	PUNCT
ihlr-18967	415	8	ftc	ftc	PROPN
ihlr-18967	415	9	v.	v.	ADP
ihlr-18967	415	10	actavis	actavis	PROPN
ihlr-18967	415	11	:	:	PUNCT
ihlr-18967	415	12	the	the	DET
ihlr-18967	415	13	supreme	supreme	PROPN
ihlr-18967	415	14	court	court	PROPN
ihlr-18967	415	15	issues	issue	VERB
ihlr-18967	415	16	a	a	DET
ihlr-18967	415	17	reversal	reversal	NOUN
ihlr-18967	415	18	on	on	ADP
ihlr-18967	415	19	reverse	reverse	ADJ
ihlr-18967	415	20	payments	payment	NOUN
ihlr-18967	415	21	,	,	PUNCT
ihlr-18967	415	22	health	health	NOUN
ihlr-18967	415	23	affairs	affair	NOUN
ihlr-18967	415	24	blog	blog	NOUN
ihlr-18967	415	25	(	(	PUNCT
ihlr-18967	415	26	june	june	PROPN
ihlr-18967	415	27	21	21	NUM
ihlr-18967	415	28	,	,	PUNCT
ihlr-18967	415	29	2013	2013	NUM
ihlr-18967	415	30	)	)	PUNCT
ihlr-18967	415	31	,	,	PUNCT
ihlr-18967	415	32	http://healthaffairs.org/blog/2013/06/21/ftc-v-actavisthe-supreme-court-issues-a-reversal-on-reverse-payments/.	http://healthaffairs.org/blog/2013/06/21/ftc-v-actavisthe-supreme-court-issues-a-reversal-on-reverse-payments/.	NOUN
ihlr-18967	415	33	134	134	NUM
ihlr-18967	415	34	2012	2012	NUM
ihlr-18967	415	35	census	census	NOUN
ihlr-18967	415	36	,	,	PUNCT
ihlr-18967	415	37	supra	supra	PROPN
ihlr-18967	415	38	note	note	NOUN
ihlr-18967	415	39	8	8	NUM
ihlr-18967	415	40	.	.	NOUN
ihlr-18967	415	41	135	135	NUM
ihlr-18967	415	42	facts	fact	NOUN
ihlr-18967	415	43	about	about	ADP
ihlr-18967	415	44	generic	generic	ADJ
ihlr-18967	415	45	drugs	drug	NOUN
ihlr-18967	415	46	,	,	PUNCT
ihlr-18967	415	47	u.s	u.s	PROPN
ihlr-18967	415	48	.	.	PROPN
ihlr-18967	415	49	food	food	PROPN
ihlr-18967	415	50	&	&	CCONJ
ihlr-18967	415	51	drug	drug	PROPN
ihlr-18967	415	52	administration	administration	PROPN
ihlr-18967	415	53	,	,	PUNCT
ihlr-18967	415	54	http://www.fda.gov/drugs/resourcesforyou/consumers/buyingusingmedici	http://www.fda.gov/drugs/resourcesforyou/consumers/buyingusingmedici	PROPN
ihlr-18967	415	55	nesafely	nesafely	ADV
ihlr-18967	415	56	/	/	SYM
ihlr-18967	415	57	understandinggenericdrugs	understandinggenericdrug	NOUN
ihlr-18967	415	58	/	/	SYM
ihlr-18967	415	59	ucm167991.htm	ucm167991.htm	PROPN
ihlr-18967	415	60	(	(	PUNCT
ihlr-18967	415	61	last	last	ADJ
ihlr-18967	415	62	visited	visit	VERB
ihlr-18967	415	63	sept	sept	PROPN
ihlr-18967	415	64	.	.	PROPN
ihlr-18967	415	65	17	17	NUM
ihlr-18967	415	66	,	,	PUNCT
ihlr-18967	415	67	2014	2014	NUM
ihlr-18967	415	68	)	)	PUNCT
ihlr-18967	415	69	.	.	PUNCT
ihlr-18967	416	1	136	136	NUM
ihlr-18967	416	2	scott	scott	PROPN
ihlr-18967	416	3	hemphill	hemphill	PROPN
ihlr-18967	416	4	&	&	CCONJ
ihlr-18967	416	5	bhaven	bhaven	VERB
ihlr-18967	416	6	n.	n.	PROPN
ihlr-18967	416	7	sampat	sampat	NOUN
ihlr-18967	416	8	,	,	PUNCT
ihlr-18967	416	9	when	when	SCONJ
ihlr-18967	416	10	do	do	VERB
ihlr-18967	416	11	generics	generics	NOUN
ihlr-18967	416	12	challenge	challenge	NOUN
ihlr-18967	416	13	drug	drug	NOUN
ihlr-18967	416	14	patents	patent	NOUN
ihlr-18967	416	15	?	?	PUNCT
ihlr-18967	416	16	,	,	PUNCT
ihlr-18967	416	17	8	8	NUM
ihlr-18967	416	18	j.	j.	PROPN
ihlr-18967	416	19	empirical	empirical	ADJ
ihlr-18967	416	20	legal	legal	ADJ
ihlr-18967	416	21	stud	stud	NOUN
ihlr-18967	416	22	.	.	PUNCT
ihlr-18967	417	1	613	613	NUM
ihlr-18967	417	2	,	,	PUNCT
ihlr-18967	417	3	614	614	NUM
ihlr-18967	417	4	(	(	PUNCT
ihlr-18967	417	5	2011	2011	NUM
ihlr-18967	417	6	)	)	PUNCT
ihlr-18967	417	7	.	.	PUNCT
ihlr-18967	418	1	137	137	NUM
ihlr-18967	418	2	ftc	ftc	PROPN
ihlr-18967	418	3	v.	v.	PROPN
ihlr-18967	418	4	watson	watson	PROPN
ihlr-18967	418	5	pharms	pharms	PROPN
ihlr-18967	418	6	.	.	PUNCT
ihlr-18967	418	7	,	,	PUNCT
ihlr-18967	418	8	inc	inc	PROPN
ihlr-18967	418	9	.	.	PROPN
ihlr-18967	418	10	677	677	NUM
ihlr-18967	418	11	f.3d	f.3d	NUM
ihlr-18967	418	12	1298	1298	NUM
ihlr-18967	418	13	,	,	PUNCT
ihlr-18967	418	14	1302	1302	NUM
ihlr-18967	418	15	(	(	PUNCT
ihlr-18967	418	16	11th	11th	ADJ
ihlr-18967	418	17	cir	cir	NOUN
ihlr-18967	418	18	.	.	PROPN
ihlr-18967	418	19	2012	2012	NUM
ihlr-18967	418	20	)	)	PUNCT
ihlr-18967	418	21	.	.	PUNCT
ihlr-18967	419	1	http://dx.doi.org/10.1111/j.1740-1461.2011.01235.x	http://dx.doi.org/10.1111/j.1740-1461.2011.01235.x	VERB
ihlr-18967	419	2	2015	2015	NUM
ihlr-18967	419	3	rationale	rationale	NOUN
ihlr-18967	419	4	behind	behind	ADP
ihlr-18967	419	5	hatch	hatch	NOUN
ihlr-18967	419	6	-	-	PUNCT
ihlr-18967	419	7	waxman	waxman	PROPN
ihlr-18967	419	8	act	act	PROPN
ihlr-18967	419	9	and	and	CCONJ
ihlr-18967	419	10	patent	patent	NOUN
ihlr-18967	419	11	law	law	NOUN
ihlr-18967	419	12	447	447	NUM
ihlr-18967	419	13	alternatively	alternatively	ADV
ihlr-18967	419	14	,	,	PUNCT
ihlr-18967	419	15	it	it	PRON
ihlr-18967	419	16	is	be	AUX
ihlr-18967	419	17	a	a	DET
ihlr-18967	419	18	possibility	possibility	NOUN
ihlr-18967	419	19	that	that	SCONJ
ihlr-18967	419	20	pioneer	pioneer	NOUN
ihlr-18967	419	21	manufacturers	manufacturer	NOUN
ihlr-18967	419	22	may	may	AUX
ihlr-18967	419	23	pass	pass	VERB
ihlr-18967	419	24	on	on	ADP
ihlr-18967	419	25	any	any	DET
ihlr-18967	419	26	lost	lose	VERB
ihlr-18967	419	27	profits	profit	NOUN
ihlr-18967	419	28	to	to	ADP
ihlr-18967	419	29	consumers	consumer	NOUN
ihlr-18967	419	30	.	.	PUNCT
ihlr-18967	420	1	pioneer	pioneer	NOUN
ihlr-18967	420	2	manufacturers	manufacturer	NOUN
ihlr-18967	420	3	whose	whose	DET
ihlr-18967	420	4	patent	patent	NOUN
ihlr-18967	420	5	term	term	NOUN
ihlr-18967	420	6	is	be	AUX
ihlr-18967	420	7	undercut	undercut	ADJ
ihlr-18967	420	8	are	be	AUX
ihlr-18967	420	9	at	at	ADP
ihlr-18967	420	10	risk	risk	NOUN
ihlr-18967	420	11	of	of	ADP
ihlr-18967	420	12	losing	lose	VERB
ihlr-18967	420	13	a	a	DET
ihlr-18967	420	14	substantial	substantial	ADJ
ihlr-18967	420	15	amount	amount	NOUN
ihlr-18967	420	16	of	of	ADP
ihlr-18967	420	17	revenue	revenue	NOUN
ihlr-18967	420	18	.	.	PUNCT
ihlr-18967	421	1	in	in	ADP
ihlr-18967	421	2	order	order	NOUN
ihlr-18967	421	3	to	to	PART
ihlr-18967	421	4	counter	counter	VERB
ihlr-18967	421	5	this	this	PRON
ihlr-18967	421	6	,	,	PUNCT
ihlr-18967	421	7	pioneer	pioneer	NOUN
ihlr-18967	421	8	manufacturers	manufacturer	NOUN
ihlr-18967	421	9	may	may	AUX
ihlr-18967	421	10	charge	charge	VERB
ihlr-18967	421	11	a	a	DET
ihlr-18967	421	12	higher	high	ADJ
ihlr-18967	421	13	price	price	NOUN
ihlr-18967	421	14	during	during	ADP
ihlr-18967	421	15	its	its	PRON
ihlr-18967	421	16	initial	initial	ADJ
ihlr-18967	421	17	selling	selling	NOUN
ihlr-18967	421	18	period	period	NOUN
ihlr-18967	421	19	(	(	PUNCT
ihlr-18967	421	20	when	when	SCONJ
ihlr-18967	421	21	the	the	DET
ihlr-18967	421	22	patent	patent	NOUN
ihlr-18967	421	23	still	still	ADV
ihlr-18967	421	24	protects	protect	VERB
ihlr-18967	421	25	its	its	PRON
ihlr-18967	421	26	ability	ability	NOUN
ihlr-18967	421	27	to	to	PART
ihlr-18967	421	28	charge	charge	VERB
ihlr-18967	421	29	monopolistic	monopolistic	ADJ
ihlr-18967	421	30	prices	price	NOUN
ihlr-18967	421	31	)	)	PUNCT
ihlr-18967	421	32	.	.	PUNCT
ihlr-18967	422	1	regardless	regardless	ADV
ihlr-18967	422	2	,	,	PUNCT
ihlr-18967	422	3	consumers	consumer	NOUN
ihlr-18967	422	4	may	may	AUX
ihlr-18967	422	5	benefit	benefit	VERB
ihlr-18967	422	6	because	because	SCONJ
ihlr-18967	422	7	the	the	DET
ihlr-18967	422	8	costs	cost	NOUN
ihlr-18967	422	9	passed	pass	VERB
ihlr-18967	422	10	on	on	ADP
ihlr-18967	422	11	may	may	AUX
ihlr-18967	422	12	not	not	PART
ihlr-18967	422	13	rise	rise	VERB
ihlr-18967	422	14	to	to	ADP
ihlr-18967	422	15	the	the	DET
ihlr-18967	422	16	billions	billion	NOUN
ihlr-18967	422	17	of	of	ADP
ihlr-18967	422	18	extra	extra	ADJ
ihlr-18967	422	19	dollars	dollar	NOUN
ihlr-18967	422	20	consumers	consumer	NOUN
ihlr-18967	422	21	spend	spend	VERB
ihlr-18967	422	22	on	on	ADP
ihlr-18967	422	23	branded	brand	VERB
ihlr-18967	422	24	drugs	drug	NOUN
ihlr-18967	422	25	due	due	ADJ
ihlr-18967	422	26	to	to	ADP
ihlr-18967	422	27	monopolistic	monopolistic	ADJ
ihlr-18967	422	28	prices.138	prices.138	PROPN
ihlr-18967	422	29	third	third	NOUN
ihlr-18967	422	30	,	,	PUNCT
ihlr-18967	422	31	consumers	consumer	NOUN
ihlr-18967	422	32	may	may	AUX
ihlr-18967	422	33	improve	improve	VERB
ihlr-18967	422	34	their	their	PRON
ihlr-18967	422	35	health	health	NOUN
ihlr-18967	422	36	outcomes	outcome	NOUN
ihlr-18967	422	37	as	as	ADP
ihlr-18967	422	38	a	a	DET
ihlr-18967	422	39	result	result	NOUN
ihlr-18967	422	40	of	of	ADP
ihlr-18967	422	41	pioneer	pioneer	NOUN
ihlr-18967	422	42	manufacturers	manufacturer	NOUN
ihlr-18967	422	43	developing	develop	VERB
ihlr-18967	422	44	more	more	ADV
ihlr-18967	422	45	new	new	ADJ
ihlr-18967	422	46	active	active	ADJ
ihlr-18967	422	47	ingredient	ingredient	NOUN
ihlr-18967	422	48	drugs	drug	NOUN
ihlr-18967	422	49	.	.	PUNCT
ihlr-18967	423	1	as	as	ADP
ihlr-18967	423	2	a	a	DET
ihlr-18967	423	3	result	result	NOUN
ihlr-18967	423	4	of	of	ADP
ihlr-18967	423	5	actavis	actavis	NOUN
ihlr-18967	423	6	,	,	PUNCT
ihlr-18967	423	7	pioneer	pioneer	NOUN
ihlr-18967	423	8	drug	drug	NOUN
ihlr-18967	423	9	manufacturers	manufacturer	NOUN
ihlr-18967	423	10	may	may	AUX
ihlr-18967	423	11	allocate	allocate	VERB
ihlr-18967	423	12	more	more	ADJ
ihlr-18967	423	13	resources	resource	NOUN
ihlr-18967	423	14	into	into	ADP
ihlr-18967	423	15	developing	develop	VERB
ihlr-18967	423	16	new	new	ADJ
ihlr-18967	423	17	active	active	ADJ
ihlr-18967	423	18	ingredients	ingredient	NOUN
ihlr-18967	423	19	as	as	SCONJ
ihlr-18967	423	20	opposed	oppose	VERB
ihlr-18967	423	21	to	to	ADP
ihlr-18967	423	22	updating	update	VERB
ihlr-18967	423	23	formulas	formula	NOUN
ihlr-18967	423	24	of	of	ADP
ihlr-18967	423	25	old	old	ADJ
ihlr-18967	423	26	products.139	products.139	ADJ
ihlr-18967	423	27	as	as	ADP
ihlr-18967	423	28	one	one	NUM
ihlr-18967	423	29	empirical	empirical	ADJ
ihlr-18967	423	30	study	study	NOUN
ihlr-18967	423	31	,	,	PUNCT
ihlr-18967	423	32	analyzing	analyze	VERB
ihlr-18967	423	33	what	what	DET
ihlr-18967	423	34	type	type	NOUN
ihlr-18967	423	35	of	of	ADP
ihlr-18967	423	36	drug	drug	NOUN
ihlr-18967	423	37	patents	patent	NOUN
ihlr-18967	423	38	get	get	AUX
ihlr-18967	423	39	challenged	challenge	VERB
ihlr-18967	423	40	most	most	ADV
ihlr-18967	423	41	frequently	frequently	ADV
ihlr-18967	423	42	under	under	ADP
ihlr-18967	423	43	the	the	DET
ihlr-18967	423	44	paragraph	paragraph	NOUN
ihlr-18967	423	45	iv	iv	NUM
ihlr-18967	423	46	route	route	NOUN
ihlr-18967	423	47	,	,	PUNCT
ihlr-18967	423	48	suggests	suggest	VERB
ihlr-18967	423	49	,	,	PUNCT
ihlr-18967	423	50	generic	generic	ADJ
ihlr-18967	423	51	companies	company	NOUN
ihlr-18967	423	52	more	more	ADV
ihlr-18967	423	53	often	often	ADV
ihlr-18967	423	54	challenge	challenge	VERB
ihlr-18967	423	55	pioneer	pioneer	NOUN
ihlr-18967	423	56	drugs	drug	NOUN
ihlr-18967	423	57	using	use	VERB
ihlr-18967	423	58	a	a	DET
ihlr-18967	423	59	new	new	ADJ
ihlr-18967	423	60	formulation	formulation	NOUN
ihlr-18967	423	61	as	as	SCONJ
ihlr-18967	423	62	compared	compare	VERB
ihlr-18967	423	63	to	to	ADP
ihlr-18967	423	64	pioneer	pioneer	NOUN
ihlr-18967	423	65	drugs	drug	NOUN
ihlr-18967	423	66	containing	contain	VERB
ihlr-18967	423	67	a	a	DET
ihlr-18967	423	68	new	new	ADJ
ihlr-18967	423	69	active	active	ADJ
ihlr-18967	423	70	ingredient.140	ingredient.140	NOUN
ihlr-18967	423	71	by	by	ADP
ihlr-18967	423	72	focusing	focus	VERB
ihlr-18967	423	73	on	on	ADP
ihlr-18967	423	74	new	new	ADJ
ihlr-18967	423	75	active	active	ADJ
ihlr-18967	423	76	ingredients	ingredient	NOUN
ihlr-18967	423	77	,	,	PUNCT
ihlr-18967	423	78	there	there	PRON
ihlr-18967	423	79	is	be	VERB
ihlr-18967	423	80	a	a	DET
ihlr-18967	423	81	lower	low	ADJ
ihlr-18967	423	82	risk	risk	NOUN
ihlr-18967	423	83	of	of	ADP
ihlr-18967	423	84	patent	patent	NOUN
ihlr-18967	423	85	litigation	litigation	NOUN
ihlr-18967	423	86	because	because	SCONJ
ihlr-18967	423	87	a	a	DET
ihlr-18967	423	88	generic	generic	ADJ
ihlr-18967	423	89	company	company	NOUN
ihlr-18967	423	90	is	be	AUX
ihlr-18967	423	91	less	less	ADV
ihlr-18967	423	92	likely	likely	ADJ
ihlr-18967	423	93	to	to	PART
ihlr-18967	423	94	challenge	challenge	VERB
ihlr-18967	423	95	the	the	DET
ihlr-18967	423	96	patent	patent	NOUN
ihlr-18967	423	97	’s	’s	PART
ihlr-18967	423	98	validity	validity	NOUN
ihlr-18967	423	99	.	.	PUNCT
ihlr-18967	424	1	while	while	SCONJ
ihlr-18967	424	2	new	new	ADJ
ihlr-18967	424	3	active	active	ADJ
ihlr-18967	424	4	ingredient	ingredient	NOUN
ihlr-18967	424	5	drugs	drug	NOUN
ihlr-18967	424	6	may	may	AUX
ihlr-18967	424	7	be	be	AUX
ihlr-18967	424	8	less	less	ADV
ihlr-18967	424	9	likely	likely	ADJ
ihlr-18967	424	10	to	to	PART
ihlr-18967	424	11	be	be	AUX
ihlr-18967	424	12	challenged	challenge	VERB
ihlr-18967	424	13	,	,	PUNCT
ihlr-18967	424	14	it	it	PRON
ihlr-18967	424	15	would	would	AUX
ihlr-18967	424	16	be	be	AUX
ihlr-18967	424	17	unwise	unwise	ADJ
ihlr-18967	424	18	to	to	PART
ihlr-18967	424	19	expect	expect	VERB
ihlr-18967	424	20	a	a	DET
ihlr-18967	424	21	huge	huge	ADJ
ihlr-18967	424	22	shift	shift	NOUN
ihlr-18967	424	23	in	in	ADP
ihlr-18967	424	24	development	development	NOUN
ihlr-18967	424	25	of	of	ADP
ihlr-18967	424	26	new	new	ADJ
ihlr-18967	424	27	active	active	ADJ
ihlr-18967	424	28	ingredient	ingredient	NOUN
ihlr-18967	424	29	drugs	drug	NOUN
ihlr-18967	424	30	as	as	SCONJ
ihlr-18967	424	31	they	they	PRON
ihlr-18967	424	32	are	be	AUX
ihlr-18967	424	33	138	138	NUM
ihlr-18967	424	34	see	see	NOUN
ihlr-18967	424	35	pay	pay	NOUN
ihlr-18967	424	36	-	-	PUNCT
ihlr-18967	424	37	for	for	ADP
ihlr-18967	424	38	-	-	PUNCT
ihlr-18967	424	39	delay	delay	NOUN
ihlr-18967	424	40	,	,	PUNCT
ihlr-18967	424	41	supra	supra	NOUN
ihlr-18967	424	42	note	note	NOUN
ihlr-18967	424	43	9	9	NUM
ihlr-18967	424	44	(	(	PUNCT
ihlr-18967	424	45	explaining	explain	VERB
ihlr-18967	424	46	that	that	SCONJ
ihlr-18967	424	47	a	a	DET
ihlr-18967	424	48	brand	brand	NOUN
ihlr-18967	424	49	name	name	NOUN
ihlr-18967	424	50	drug	drug	NOUN
ihlr-18967	424	51	cost	cost	VERB
ihlr-18967	424	52	$	$	SYM
ihlr-18967	424	53	300	300	NUM
ihlr-18967	424	54	/	/	SYM
ihlr-18967	424	55	month	month	NOUN
ihlr-18967	424	56	while	while	SCONJ
ihlr-18967	424	57	the	the	DET
ihlr-18967	424	58	generic	generic	ADJ
ihlr-18967	424	59	equivalent	equivalent	NOUN
ihlr-18967	424	60	costs	cost	VERB
ihlr-18967	424	61	$	$	SYM
ihlr-18967	424	62	30	30	NUM
ihlr-18967	424	63	/	/	SYM
ihlr-18967	424	64	month	month	NOUN
ihlr-18967	424	65	)	)	PUNCT
ihlr-18967	424	66	.	.	PUNCT
ihlr-18967	425	1	139	139	NUM
ihlr-18967	425	2	kesselheim	kesselheim	NOUN
ihlr-18967	425	3	&	&	CCONJ
ihlr-18967	425	4	shiu	shiu	PROPN
ihlr-18967	425	5	,	,	PUNCT
ihlr-18967	425	6	supra	supra	PROPN
ihlr-18967	425	7	note	note	PROPN
ihlr-18967	425	8	133	133	NUM
ihlr-18967	425	9	.	.	PUNCT
ihlr-18967	426	1	140	140	NUM
ihlr-18967	426	2	hemphill	hemphill	PROPN
ihlr-18967	426	3	&	&	CCONJ
ihlr-18967	426	4	sampat	sampat	PROPN
ihlr-18967	426	5	,	,	PUNCT
ihlr-18967	426	6	supra	supra	PROPN
ihlr-18967	426	7	note	note	NOUN
ihlr-18967	426	8	136	136	NUM
ihlr-18967	426	9	,	,	PUNCT
ihlr-18967	426	10	at	at	ADP
ihlr-18967	426	11	643	643	NUM
ihlr-18967	426	12	.	.	PUNCT
ihlr-18967	426	13	analyzing	analyze	VERB
ihlr-18967	426	14	paragraph	paragraph	NOUN
ihlr-18967	426	15	iv	iv	NUM
ihlr-18967	426	16	challenges	challenge	NOUN
ihlr-18967	426	17	under	under	ADP
ihlr-18967	426	18	the	the	DET
ihlr-18967	426	19	hatch	hatch	NOUN
ihlr-18967	426	20	-	-	PUNCT
ihlr-18967	426	21	waxman	waxman	PROPN
ihlr-18967	426	22	act	act	PROPN
ihlr-18967	426	23	,	,	PUNCT
ihlr-18967	426	24	as	as	ADP
ihlr-18967	426	25	a	a	DET
ihlr-18967	426	26	sample	sample	NOUN
ihlr-18967	426	27	size	size	NOUN
ihlr-18967	426	28	,	,	PUNCT
ihlr-18967	426	29	the	the	DET
ihlr-18967	426	30	researchers	researcher	NOUN
ihlr-18967	426	31	looked	look	VERB
ihlr-18967	426	32	at	at	ADP
ihlr-18967	426	33	drugs	drug	NOUN
ihlr-18967	426	34	that	that	PRON
ihlr-18967	426	35	were	be	AUX
ihlr-18967	426	36	first	first	ADV
ihlr-18967	426	37	eligible	eligible	ADJ
ihlr-18967	426	38	for	for	ADP
ihlr-18967	426	39	challenge	challenge	NOUN
ihlr-18967	426	40	in	in	ADP
ihlr-18967	426	41	2000	2000	NUM
ihlr-18967	426	42	-	-	SYM
ihlr-18967	426	43	2008	2008	NUM
ihlr-18967	426	44	.	.	PUNCT
ihlr-18967	427	1	i	i	PRON
ihlr-18967	427	2	d.	d.	PROPN
ihlr-18967	427	3	in	in	ADP
ihlr-18967	427	4	their	their	PRON
ihlr-18967	427	5	findings	finding	NOUN
ihlr-18967	427	6	,	,	PUNCT
ihlr-18967	427	7	they	they	PRON
ihlr-18967	427	8	found	find	VERB
ihlr-18967	427	9	a	a	DET
ihlr-18967	427	10	strong	strong	ADJ
ihlr-18967	427	11	association	association	NOUN
ihlr-18967	427	12	between	between	ADP
ihlr-18967	427	13	patent	patent	NOUN
ihlr-18967	427	14	portfolios	portfolio	NOUN
ihlr-18967	427	15	and	and	CCONJ
ihlr-18967	427	16	generic	generic	ADJ
ihlr-18967	427	17	challenges	challenge	NOUN
ihlr-18967	427	18	.	.	PUNCT
ihlr-18967	428	1	i	i	PRON
ihlr-18967	428	2	d.	d.	PROPN
ihlr-18967	428	3	specifically	specifically	ADV
ihlr-18967	428	4	,	,	PUNCT
ihlr-18967	428	5	non	non	ADJ
ihlr-18967	428	6	-	-	ADJ
ihlr-18967	428	7	active	active	ADJ
ihlr-18967	428	8	ingredient	ingredient	NOUN
ihlr-18967	428	9	patents	patent	NOUN
ihlr-18967	428	10	are	be	AUX
ihlr-18967	428	11	challenged	challenge	VERB
ihlr-18967	428	12	more	more	ADV
ihlr-18967	428	13	frequently	frequently	ADV
ihlr-18967	428	14	.	.	PUNCT
ihlr-18967	429	1	i	i	PRON
ihlr-18967	429	2	d.	d.	PROPN
ihlr-18967	429	3	further	far	ADV
ihlr-18967	429	4	,	,	PUNCT
ihlr-18967	429	5	patent	patent	NOUN
ihlr-18967	429	6	portfolios	portfolio	NOUN
ihlr-18967	429	7	with	with	ADP
ihlr-18967	429	8	low	low	ADJ
ihlr-18967	429	9	-	-	PUNCT
ihlr-18967	429	10	quality	quality	NOUN
ihlr-18967	429	11	patents	patent	NOUN
ihlr-18967	429	12	,	,	PUNCT
ihlr-18967	429	13	extra	extra	ADJ
ihlr-18967	429	14	nominal	nominal	ADJ
ihlr-18967	429	15	patents	patent	NOUN
ihlr-18967	429	16	and	and	CCONJ
ihlr-18967	429	17	late	late	ADV
ihlr-18967	429	18	filed	file	VERB
ihlr-18967	429	19	patents	patent	NOUN
ihlr-18967	429	20	are	be	AUX
ihlr-18967	429	21	much	much	ADV
ihlr-18967	429	22	more	more	ADV
ihlr-18967	429	23	likely	likely	ADJ
ihlr-18967	429	24	to	to	PART
ihlr-18967	429	25	draw	draw	VERB
ihlr-18967	429	26	a	a	DET
ihlr-18967	429	27	paragraph	paragraph	NOUN
ihlr-18967	429	28	iv	iv	NUM
ihlr-18967	429	29	challenge	challenge	NOUN
ihlr-18967	429	30	.	.	PUNCT
ihlr-18967	430	1	i	i	PRON
ihlr-18967	430	2	d.	d.	PROPN
ihlr-18967	430	3	the	the	DET
ihlr-18967	430	4	authors	author	NOUN
ihlr-18967	430	5	rejected	reject	VERB
ihlr-18967	430	6	the	the	DET
ihlr-18967	430	7	hypothesis	hypothesis	NOUN
ihlr-18967	430	8	that	that	SCONJ
ihlr-18967	430	9	the	the	DET
ihlr-18967	430	10	composition	composition	NOUN
ihlr-18967	430	11	of	of	ADP
ihlr-18967	430	12	a	a	DET
ihlr-18967	430	13	drug	drug	NOUN
ihlr-18967	430	14	’s	’s	PART
ihlr-18967	430	15	patent	patent	NOUN
ihlr-18967	430	16	portfolio	portfolio	NOUN
ihlr-18967	430	17	is	be	AUX
ihlr-18967	430	18	not	not	PART
ihlr-18967	430	19	correlated	correlate	VERB
ihlr-18967	430	20	to	to	PART
ihlr-18967	430	21	paragraph	paragraph	VERB
ihlr-18967	430	22	iv	iv	NUM
ihlr-18967	430	23	challenges	challenge	NOUN
ihlr-18967	430	24	.	.	PUNCT
ihlr-18967	431	1	i	i	PRON
ihlr-18967	431	2	d.	d.	PROPN
ihlr-18967	431	3	subsequently	subsequently	ADV
ihlr-18967	431	4	,	,	PUNCT
ihlr-18967	431	5	as	as	SCONJ
ihlr-18967	431	6	opposed	oppose	VERB
ihlr-18967	431	7	to	to	ADP
ihlr-18967	431	8	the	the	DET
ihlr-18967	431	9	conventional	conventional	ADJ
ihlr-18967	431	10	wisdom	wisdom	NOUN
ihlr-18967	431	11	that	that	SCONJ
ihlr-18967	431	12	challenges	challenge	NOUN
ihlr-18967	431	13	are	be	AUX
ihlr-18967	431	14	only	only	ADV
ihlr-18967	431	15	about	about	ADP
ihlr-18967	431	16	sales	sale	NOUN
ihlr-18967	431	17	,	,	PUNCT
ihlr-18967	431	18	patent	patent	NOUN
ihlr-18967	431	19	portfolio	portfolio	NOUN
ihlr-18967	431	20	characteristics	characteristic	NOUN
ihlr-18967	431	21	may	may	AUX
ihlr-18967	431	22	have	have	VERB
ihlr-18967	431	23	a	a	DET
ihlr-18967	431	24	significant	significant	ADJ
ihlr-18967	431	25	effect	effect	NOUN
ihlr-18967	431	26	.	.	PUNCT
ihlr-18967	432	1	i	i	PRON
ihlr-18967	432	2	d.	d.	PROPN
ihlr-18967	432	3	448	448	NUM
ihlr-18967	432	4	indiana	indiana	PROPN
ihlr-18967	432	5	health	health	PROPN
ihlr-18967	432	6	law	law	PROPN
ihlr-18967	432	7	review	review	NOUN
ihlr-18967	432	8	vol	vol	NOUN
ihlr-18967	432	9	.	.	PUNCT
ihlr-18967	433	1	12:1	12:1	NUM
ihlr-18967	433	2	extremely	extremely	ADV
ihlr-18967	433	3	costly	costly	ADJ
ihlr-18967	433	4	and	and	CCONJ
ihlr-18967	433	5	still	still	ADV
ihlr-18967	433	6	subject	subject	ADJ
ihlr-18967	433	7	to	to	ADP
ihlr-18967	433	8	patent	patent	NOUN
ihlr-18967	433	9	challenges	challenge	NOUN
ihlr-18967	433	10	.	.	PUNCT
ihlr-18967	434	1	with	with	ADP
ihlr-18967	434	2	all	all	PRON
ihlr-18967	434	3	that	that	PRON
ihlr-18967	434	4	is	be	AUX
ihlr-18967	434	5	considered	consider	VERB
ihlr-18967	434	6	,	,	PUNCT
ihlr-18967	434	7	pioneer	pioneer	NOUN
ihlr-18967	434	8	drug	drug	NOUN
ihlr-18967	434	9	manufacturers	manufacturer	NOUN
ihlr-18967	434	10	who	who	PRON
ihlr-18967	434	11	input	input	VERB
ihlr-18967	434	12	more	more	ADJ
ihlr-18967	434	13	resources	resource	NOUN
ihlr-18967	434	14	into	into	ADP
ihlr-18967	434	15	new	new	ADJ
ihlr-18967	434	16	active	active	ADJ
ihlr-18967	434	17	ingredients	ingredient	NOUN
ihlr-18967	434	18	will	will	AUX
ihlr-18967	434	19	likely	likely	ADV
ihlr-18967	434	20	have	have	VERB
ihlr-18967	434	21	an	an	DET
ihlr-18967	434	22	increased	increase	VERB
ihlr-18967	434	23	chance	chance	NOUN
ihlr-18967	434	24	,	,	PUNCT
ihlr-18967	434	25	albeit	albeit	SCONJ
ihlr-18967	434	26	a	a	DET
ihlr-18967	434	27	small	small	ADJ
ihlr-18967	434	28	increase	increase	NOUN
ihlr-18967	434	29	,	,	PUNCT
ihlr-18967	434	30	of	of	ADP
ihlr-18967	434	31	avoiding	avoid	VERB
ihlr-18967	434	32	patent	patent	NOUN
ihlr-18967	434	33	litigation	litigation	NOUN
ihlr-18967	434	34	while	while	SCONJ
ihlr-18967	434	35	also	also	ADV
ihlr-18967	434	36	providing	provide	VERB
ihlr-18967	434	37	socially	socially	ADV
ihlr-18967	434	38	valuable	valuable	ADJ
ihlr-18967	434	39	research	research	NOUN
ihlr-18967	434	40	and	and	CCONJ
ihlr-18967	434	41	development.141	development.141	VERB
ihlr-18967	434	42	accordingly	accordingly	ADV
ihlr-18967	434	43	,	,	PUNCT
ihlr-18967	434	44	the	the	DET
ihlr-18967	434	45	policy	policy	NOUN
ihlr-18967	434	46	interests	interest	NOUN
ihlr-18967	434	47	of	of	ADP
ihlr-18967	434	48	the	the	DET
ihlr-18967	434	49	hatch	hatch	NOUN
ihlr-18967	434	50	-	-	PUNCT
ihlr-18967	434	51	waxman	waxman	PROPN
ihlr-18967	434	52	act	act	PROPN
ihlr-18967	434	53	and	and	CCONJ
ihlr-18967	434	54	patent	patent	NOUN
ihlr-18967	434	55	law	law	NOUN
ihlr-18967	434	56	are	be	AUX
ihlr-18967	434	57	supported	support	VERB
ihlr-18967	434	58	as	as	SCONJ
ihlr-18967	434	59	new	new	ADJ
ihlr-18967	434	60	research	research	NOUN
ihlr-18967	434	61	will	will	AUX
ihlr-18967	434	62	be	be	AUX
ihlr-18967	434	63	completed	complete	VERB
ihlr-18967	434	64	,	,	PUNCT
ihlr-18967	434	65	resulting	result	VERB
ihlr-18967	434	66	in	in	ADP
ihlr-18967	434	67	new	new	ADJ
ihlr-18967	434	68	drug	drug	NOUN
ihlr-18967	434	69	development	development	NOUN
ihlr-18967	434	70	.	.	PUNCT
ihlr-18967	435	1	however	however	ADV
ihlr-18967	435	2	,	,	PUNCT
ihlr-18967	435	3	developing	develop	VERB
ihlr-18967	435	4	new	new	ADJ
ihlr-18967	435	5	active	active	ADJ
ihlr-18967	435	6	ingredient	ingredient	NOUN
ihlr-18967	435	7	drugs	drug	NOUN
ihlr-18967	435	8	may	may	AUX
ihlr-18967	435	9	not	not	PART
ihlr-18967	435	10	be	be	AUX
ihlr-18967	435	11	a	a	DET
ihlr-18967	435	12	realistic	realistic	ADJ
ihlr-18967	435	13	business	business	NOUN
ihlr-18967	435	14	model	model	NOUN
ihlr-18967	435	15	for	for	ADP
ihlr-18967	435	16	all	all	DET
ihlr-18967	435	17	pioneer	pioneer	NOUN
ihlr-18967	435	18	manufactures	manufacture	NOUN
ihlr-18967	435	19	.	.	PUNCT
ihlr-18967	436	1	new	new	ADJ
ihlr-18967	436	2	drug	drug	NOUN
ihlr-18967	436	3	development	development	NOUN
ihlr-18967	436	4	takes	take	VERB
ihlr-18967	436	5	on	on	ADP
ihlr-18967	436	6	average	average	ADJ
ihlr-18967	436	7	ten	ten	NUM
ihlr-18967	436	8	to	to	ADP
ihlr-18967	436	9	fifteen	fifteen	NUM
ihlr-18967	436	10	years	year	NOUN
ihlr-18967	436	11	and	and	CCONJ
ihlr-18967	436	12	costs	cost	NOUN
ihlr-18967	436	13	,	,	PUNCT
ihlr-18967	436	14	on	on	ADP
ihlr-18967	436	15	average	average	ADJ
ihlr-18967	436	16	,	,	PUNCT
ihlr-18967	436	17	over	over	ADP
ihlr-18967	436	18	$	$	SYM
ihlr-18967	436	19	1.3	1.3	NUM
ihlr-18967	436	20	billion.142	billion.142	NOUN
ihlr-18967	436	21	also	also	ADV
ihlr-18967	436	22	,	,	PUNCT
ihlr-18967	436	23	not	not	PART
ihlr-18967	436	24	all	all	DET
ihlr-18967	436	25	new	new	ADJ
ihlr-18967	436	26	drugs	drug	NOUN
ihlr-18967	436	27	are	be	AUX
ihlr-18967	436	28	approved	approve	VERB
ihlr-18967	436	29	by	by	ADP
ihlr-18967	436	30	the	the	DET
ihlr-18967	436	31	fda	fda	PROPN
ihlr-18967	436	32	nor	nor	CCONJ
ihlr-18967	436	33	are	be	AUX
ihlr-18967	436	34	all	all	PRON
ihlr-18967	436	35	expenditures	expenditure	NOUN
ihlr-18967	436	36	for	for	ADP
ihlr-18967	436	37	research	research	NOUN
ihlr-18967	436	38	and	and	CCONJ
ihlr-18967	436	39	development	development	NOUN
ihlr-18967	436	40	recouped.143	recouped.143	NOUN
ihlr-18967	436	41	this	this	DET
ihlr-18967	436	42	disincentive	disincentive	ADJ
ihlr-18967	436	43	for	for	ADP
ihlr-18967	436	44	developing	develop	VERB
ihlr-18967	436	45	new	new	ADJ
ihlr-18967	436	46	drugs	drug	NOUN
ihlr-18967	436	47	can	can	AUX
ihlr-18967	436	48	be	be	AUX
ihlr-18967	436	49	alleviated	alleviate	VERB
ihlr-18967	436	50	,	,	PUNCT
ihlr-18967	436	51	in	in	ADP
ihlr-18967	436	52	part	part	NOUN
ihlr-18967	436	53	,	,	PUNCT
ihlr-18967	436	54	through	through	ADP
ihlr-18967	436	55	patents	patent	NOUN
ihlr-18967	436	56	.	.	PUNCT
ihlr-18967	437	1	“	"	PUNCT
ihlr-18967	437	2	strong	strong	ADJ
ihlr-18967	437	3	protection	protection	NOUN
ihlr-18967	437	4	of	of	ADP
ihlr-18967	437	5	intellectual	intellectual	ADJ
ihlr-18967	437	6	property	property	NOUN
ihlr-18967	437	7	rights	right	NOUN
ihlr-18967	437	8	,	,	PUNCT
ihlr-18967	437	9	and	and	CCONJ
ihlr-18967	437	10	the	the	DET
ihlr-18967	437	11	accompanying	accompanying	ADJ
ihlr-18967	437	12	rewards	reward	NOUN
ihlr-18967	437	13	,	,	PUNCT
ihlr-18967	437	14	provides	provide	VERB
ihlr-18967	437	15	an	an	DET
ihlr-18967	437	16	incentive	incentive	NOUN
ihlr-18967	437	17	for	for	SCONJ
ihlr-18967	437	18	pharmaceutical	pharmaceutical	ADJ
ihlr-18967	437	19	companies	company	NOUN
ihlr-18967	437	20	to	to	PART
ihlr-18967	437	21	make	make	VERB
ihlr-18967	437	22	such	such	DET
ihlr-18967	437	23	a	a	DET
ihlr-18967	437	24	large	large	ADJ
ihlr-18967	437	25	,	,	PUNCT
ihlr-18967	437	26	high	high	ADJ
ihlr-18967	437	27	-	-	PUNCT
ihlr-18967	437	28	risk	risk	NOUN
ihlr-18967	437	29	investment	investment	NOUN
ihlr-18967	437	30	.	.	PUNCT
ihlr-18967	438	1	”144	”144	PUNCT
ihlr-18967	439	1	one	one	NUM
ihlr-18967	439	2	solution	solution	NOUN
ihlr-18967	439	3	to	to	ADP
ihlr-18967	439	4	the	the	DET
ihlr-18967	439	5	disincentive	disincentive	NOUN
ihlr-18967	439	6	created	create	VERB
ihlr-18967	439	7	by	by	ADP
ihlr-18967	439	8	cost	cost	NOUN
ihlr-18967	439	9	may	may	AUX
ihlr-18967	439	10	be	be	AUX
ihlr-18967	439	11	for	for	SCONJ
ihlr-18967	439	12	congress	congress	PROPN
ihlr-18967	439	13	to	to	PART
ihlr-18967	439	14	provide	provide	VERB
ihlr-18967	439	15	greater	great	ADJ
ihlr-18967	439	16	incentives	incentive	NOUN
ihlr-18967	439	17	for	for	ADP
ihlr-18967	439	18	developing	develop	VERB
ihlr-18967	439	19	new	new	ADJ
ihlr-18967	439	20	active	active	ADJ
ihlr-18967	439	21	ingredient	ingredient	NOUN
ihlr-18967	439	22	drugs	drug	NOUN
ihlr-18967	439	23	by	by	ADP
ihlr-18967	439	24	providing	provide	VERB
ihlr-18967	439	25	them	they	PRON
ihlr-18967	439	26	with	with	ADP
ihlr-18967	439	27	a	a	DET
ihlr-18967	439	28	longer	long	ADJ
ihlr-18967	439	29	patent	patent	NOUN
ihlr-18967	439	30	term	term	NOUN
ihlr-18967	439	31	or	or	CCONJ
ihlr-18967	439	32	make	make	VERB
ihlr-18967	439	33	it	it	PRON
ihlr-18967	439	34	harder	hard	ADJ
ihlr-18967	439	35	for	for	SCONJ
ihlr-18967	439	36	generic	generic	ADJ
ihlr-18967	439	37	manufacturers	manufacturer	NOUN
ihlr-18967	439	38	to	to	PART
ihlr-18967	439	39	challenge	challenge	VERB
ihlr-18967	439	40	patents	patent	NOUN
ihlr-18967	439	41	based	base	VERB
ihlr-18967	439	42	on	on	ADP
ihlr-18967	439	43	new	new	ADJ
ihlr-18967	439	44	active	active	ADJ
ihlr-18967	439	45	ingredients	ingredient	NOUN
ihlr-18967	439	46	.	.	PUNCT
ihlr-18967	440	1	141	141	NUM
ihlr-18967	440	2	see	see	VERB
ihlr-18967	440	3	i	i	PRON
ihlr-18967	440	4	d.	d.	PROPN
ihlr-18967	440	5	at	at	ADP
ihlr-18967	440	6	644	644	NUM
ihlr-18967	440	7	(	(	PUNCT
ihlr-18967	440	8	suggesting	suggest	VERB
ihlr-18967	440	9	that	that	SCONJ
ihlr-18967	440	10	paragraph	paragraph	NOUN
ihlr-18967	440	11	iv	iv	NUM
ihlr-18967	440	12	challenges	challenge	NOUN
ihlr-18967	440	13	target	target	VERB
ihlr-18967	440	14	drugs	drug	NOUN
ihlr-18967	440	15	with	with	ADP
ihlr-18967	440	16	weak	weak	ADJ
ihlr-18967	440	17	late	late	ADV
ihlr-18967	440	18	-	-	PUNCT
ihlr-18967	440	19	expiring	expire	VERB
ihlr-18967	440	20	patents	patent	NOUN
ihlr-18967	440	21	and	and	CCONJ
ihlr-18967	440	22	because	because	SCONJ
ihlr-18967	440	23	weak	weak	ADJ
ihlr-18967	440	24	late	late	ADV
ihlr-18967	440	25	-	-	PUNCT
ihlr-18967	440	26	expiring	expire	VERB
ihlr-18967	440	27	patents	patent	NOUN
ihlr-18967	440	28	are	be	AUX
ihlr-18967	440	29	assumed	assume	VERB
ihlr-18967	440	30	to	to	PART
ihlr-18967	440	31	be	be	AUX
ihlr-18967	440	32	less	less	ADV
ihlr-18967	440	33	related	related	ADJ
ihlr-18967	440	34	to	to	ADP
ihlr-18967	440	35	socially	socially	ADV
ihlr-18967	440	36	valuable	valuable	ADJ
ihlr-18967	440	37	research	research	NOUN
ihlr-18967	440	38	and	and	CCONJ
ihlr-18967	440	39	development	development	NOUN
ihlr-18967	440	40	,	,	PUNCT
ihlr-18967	440	41	challenges	challenge	NOUN
ihlr-18967	440	42	may	may	AUX
ihlr-18967	440	43	be	be	AUX
ihlr-18967	440	44	an	an	DET
ihlr-18967	440	45	important	important	ADJ
ihlr-18967	440	46	means	mean	NOUN
ihlr-18967	440	47	to	to	PART
ihlr-18967	440	48	curtail	curtail	VERB
ihlr-18967	440	49	patents	patent	NOUN
ihlr-18967	440	50	that	that	PRON
ihlr-18967	440	51	have	have	VERB
ihlr-18967	440	52	high	high	ADJ
ihlr-18967	440	53	social	social	ADJ
ihlr-18967	440	54	costs	cost	NOUN
ihlr-18967	440	55	which	which	PRON
ihlr-18967	440	56	stem	stem	VERB
ihlr-18967	440	57	from	from	ADP
ihlr-18967	440	58	sustaining	sustain	VERB
ihlr-18967	440	59	high	high	ADJ
ihlr-18967	440	60	prices	price	NOUN
ihlr-18967	440	61	for	for	ADP
ihlr-18967	440	62	consumers	consumer	NOUN
ihlr-18967	440	63	)	)	PUNCT
ihlr-18967	440	64	.	.	PUNCT
ihlr-18967	441	1	142	142	NUM
ihlr-18967	441	2	bret	bret	PROPN
ihlr-18967	441	3	dickey	dickey	PROPN
ihlr-18967	441	4	et	et	PROPN
ihlr-18967	441	5	al	al	PROPN
ihlr-18967	441	6	.	.	PROPN
ihlr-18967	441	7	,	,	PUNCT
ihlr-18967	441	8	an	an	DET
ihlr-18967	441	9	economic	economic	ADJ
ihlr-18967	441	10	assessment	assessment	NOUN
ihlr-18967	441	11	of	of	ADP
ihlr-18967	441	12	patent	patent	NOUN
ihlr-18967	441	13	settlements	settlement	NOUN
ihlr-18967	441	14	in	in	ADP
ihlr-18967	441	15	the	the	DET
ihlr-18967	441	16	pharmaceutical	pharmaceutical	NOUN
ihlr-18967	441	17	industry	industry	NOUN
ihlr-18967	441	18	,	,	PUNCT
ihlr-18967	441	19	19	19	NUM
ihlr-18967	441	20	annals	annal	VERB
ihlr-18967	441	21	health	health	PROPN
ihlr-18967	441	22	l.	l.	PROPN
ihlr-18967	441	23	367	367	NUM
ihlr-18967	441	24	,	,	PUNCT
ihlr-18967	441	25	369	369	NUM
ihlr-18967	441	26	(	(	PUNCT
ihlr-18967	441	27	2010	2010	NUM
ihlr-18967	441	28	)	)	PUNCT
ihlr-18967	441	29	.	.	PUNCT
ihlr-18967	442	1	143	143	NUM
ihlr-18967	443	1	i	i	PRON
ihlr-18967	443	2	d.	d.	PROPN
ihlr-18967	443	3	144	144	NUM
ihlr-18967	444	1	i	i	PROPN
ihlr-18967	444	2	d.	d.	PROPN
ihlr-18967	444	3	2015	2015	NUM
ihlr-18967	444	4	rationale	rationale	NOUN
ihlr-18967	444	5	behind	behind	ADP
ihlr-18967	444	6	hatch	hatch	NOUN
ihlr-18967	444	7	-	-	PUNCT
ihlr-18967	444	8	waxman	waxman	PROPN
ihlr-18967	444	9	act	act	PROPN
ihlr-18967	444	10	and	and	CCONJ
ihlr-18967	444	11	patent	patent	NOUN
ihlr-18967	444	12	law	law	NOUN
ihlr-18967	444	13	449	449	NUM
ihlr-18967	444	14	2	2	NUM
ihlr-18967	444	15	.	.	PUNCT
ihlr-18967	445	1	effect	effect	NOUN
ihlr-18967	445	2	of	of	ADP
ihlr-18967	445	3	antitrust	antitrust	ADJ
ihlr-18967	445	4	laws	law	NOUN
ihlr-18967	445	5	:	:	PUNCT
ihlr-18967	445	6	different	different	ADJ
ihlr-18967	445	7	affect	affect	VERB
ihlr-18967	445	8	on	on	ADP
ihlr-18967	445	9	drug	drug	NOUN
ihlr-18967	445	10	manufacturers	manufacturer	NOUN
ihlr-18967	445	11	since	since	SCONJ
ihlr-18967	445	12	the	the	DET
ihlr-18967	445	13	advent	advent	NOUN
ihlr-18967	445	14	of	of	ADP
ihlr-18967	445	15	reverse	reverse	ADJ
ihlr-18967	445	16	payment	payment	NOUN
ihlr-18967	445	17	settlements	settlement	NOUN
ihlr-18967	445	18	,	,	PUNCT
ihlr-18967	445	19	courts	court	NOUN
ihlr-18967	445	20	analyzing	analyze	VERB
ihlr-18967	445	21	these	these	DET
ihlr-18967	445	22	settlements	settlement	NOUN
ihlr-18967	445	23	under	under	ADP
ihlr-18967	445	24	the	the	DET
ihlr-18967	445	25	scope	scope	NOUN
ihlr-18967	445	26	of	of	ADP
ihlr-18967	445	27	patent	patent	NOUN
ihlr-18967	445	28	test	test	NOUN
ihlr-18967	445	29	provided	provide	VERB
ihlr-18967	445	30	manufacturers	manufacturer	NOUN
ihlr-18967	445	31	with	with	ADP
ihlr-18967	445	32	“	"	PUNCT
ihlr-18967	445	33	a	a	DET
ihlr-18967	445	34	safety	safety	NOUN
ihlr-18967	445	35	net	net	NOUN
ihlr-18967	445	36	.	.	PUNCT
ihlr-18967	445	37	”	"	PUNCT
ihlr-18967	446	1	the	the	DET
ihlr-18967	446	2	scope	scope	NOUN
ihlr-18967	446	3	of	of	ADP
ihlr-18967	446	4	patent	patent	NOUN
ihlr-18967	446	5	test	test	NOUN
ihlr-18967	446	6	provided	provide	VERB
ihlr-18967	446	7	manufacturers	manufacturer	NOUN
ihlr-18967	446	8	with	with	ADP
ihlr-18967	446	9	an	an	DET
ihlr-18967	446	10	“	"	PUNCT
ihlr-18967	446	11	almost	almost	ADV
ihlr-18967	446	12	unrebuttable	unrebuttable	ADJ
ihlr-18967	446	13	presumption	presumption	NOUN
ihlr-18967	446	14	of	of	ADP
ihlr-18967	446	15	patent	patent	NOUN
ihlr-18967	446	16	validity	validity	NOUN
ihlr-18967	446	17	.	.	PUNCT
ihlr-18967	446	18	”145	”145	NOUN
ihlr-18967	446	19	any	any	DET
ihlr-18967	446	20	act	act	NOUN
ihlr-18967	446	21	of	of	ADP
ihlr-18967	446	22	congress	congress	PROPN
ihlr-18967	446	23	creating	create	VERB
ihlr-18967	446	24	a	a	DET
ihlr-18967	446	25	presumption	presumption	NOUN
ihlr-18967	446	26	against	against	ADP
ihlr-18967	446	27	reverse	reverse	ADJ
ihlr-18967	446	28	payment	payment	NOUN
ihlr-18967	446	29	settlements146	settlements146	PROPN
ihlr-18967	446	30	will	will	AUX
ihlr-18967	446	31	create	create	VERB
ihlr-18967	446	32	unwarranted	unwarranted	ADJ
ihlr-18967	446	33	burdens	burden	NOUN
ihlr-18967	446	34	for	for	ADP
ihlr-18967	446	35	drug	drug	NOUN
ihlr-18967	446	36	manufacturers	manufacturer	NOUN
ihlr-18967	446	37	to	to	ADP
ihlr-18967	446	38	a	a	DET
ihlr-18967	446	39	much	much	ADV
ihlr-18967	446	40	stronger	strong	ADJ
ihlr-18967	446	41	degree	degree	NOUN
ihlr-18967	446	42	than	than	ADP
ihlr-18967	446	43	the	the	DET
ihlr-18967	446	44	rule	rule	NOUN
ihlr-18967	446	45	of	of	ADP
ihlr-18967	446	46	reason	reason	NOUN
ihlr-18967	446	47	.	.	PUNCT
ihlr-18967	447	1	in	in	ADP
ihlr-18967	447	2	retreating	retreat	VERB
ihlr-18967	447	3	from	from	ADP
ihlr-18967	447	4	a	a	DET
ihlr-18967	447	5	presumption	presumption	NOUN
ihlr-18967	447	6	of	of	ADP
ihlr-18967	447	7	patent	patent	NOUN
ihlr-18967	447	8	validity	validity	NOUN
ihlr-18967	447	9	under	under	ADP
ihlr-18967	447	10	the	the	DET
ihlr-18967	447	11	scope	scope	NOUN
ihlr-18967	447	12	of	of	ADP
ihlr-18967	447	13	patent	patent	NOUN
ihlr-18967	447	14	test	test	NOUN
ihlr-18967	447	15	,	,	PUNCT
ihlr-18967	447	16	drug	drug	NOUN
ihlr-18967	447	17	manufacturers	manufacturer	NOUN
ihlr-18967	447	18	,	,	PUNCT
ihlr-18967	447	19	under	under	ADP
ihlr-18967	447	20	the	the	DET
ihlr-18967	447	21	rule	rule	NOUN
ihlr-18967	447	22	of	of	ADP
ihlr-18967	447	23	reason	reason	NOUN
ihlr-18967	447	24	analysis	analysis	NOUN
ihlr-18967	447	25	,	,	PUNCT
ihlr-18967	447	26	will	will	AUX
ihlr-18967	447	27	be	be	AUX
ihlr-18967	447	28	burdened	burden	VERB
ihlr-18967	447	29	,	,	PUNCT
ihlr-18967	447	30	but	but	CCONJ
ihlr-18967	447	31	in	in	ADP
ihlr-18967	447	32	a	a	DET
ihlr-18967	447	33	manageable	manageable	ADJ
ihlr-18967	447	34	way	way	NOUN
ihlr-18967	447	35	.	.	PUNCT
ihlr-18967	448	1	subsequently	subsequently	ADV
ihlr-18967	448	2	,	,	PUNCT
ihlr-18967	448	3	burdens	burden	NOUN
ihlr-18967	448	4	placed	place	VERB
ihlr-18967	448	5	on	on	ADP
ihlr-18967	448	6	drug	drug	NOUN
ihlr-18967	448	7	manufacturers	manufacturer	NOUN
ihlr-18967	448	8	will	will	AUX
ihlr-18967	448	9	adversely	adversely	ADV
ihlr-18967	448	10	affect	affect	VERB
ihlr-18967	448	11	the	the	DET
ihlr-18967	448	12	intentions	intention	NOUN
ihlr-18967	448	13	behind	behind	ADP
ihlr-18967	448	14	the	the	DET
ihlr-18967	448	15	hatch	hatch	NOUN
ihlr-18967	448	16	-	-	PUNCT
ihlr-18967	448	17	waxman	waxman	PROPN
ihlr-18967	448	18	act	act	PROPN
ihlr-18967	448	19	and	and	CCONJ
ihlr-18967	448	20	patent	patent	NOUN
ihlr-18967	448	21	law	law	NOUN
ihlr-18967	448	22	to	to	PART
ihlr-18967	448	23	stimulate	stimulate	VERB
ihlr-18967	448	24	innovative	innovative	ADJ
ihlr-18967	448	25	research	research	NOUN
ihlr-18967	448	26	and	and	CCONJ
ihlr-18967	448	27	development	development	NOUN
ihlr-18967	448	28	.	.	PUNCT
ihlr-18967	449	1	first	first	ADV
ihlr-18967	449	2	,	,	PUNCT
ihlr-18967	449	3	due	due	ADP
ihlr-18967	449	4	to	to	ADP
ihlr-18967	449	5	ambiguity	ambiguity	NOUN
ihlr-18967	449	6	created	create	VERB
ihlr-18967	449	7	by	by	ADP
ihlr-18967	449	8	actavis	actavi	NOUN
ihlr-18967	449	9	,	,	PUNCT
ihlr-18967	449	10	parties	party	NOUN
ihlr-18967	449	11	in	in	ADP
ihlr-18967	449	12	a	a	DET
ihlr-18967	449	13	patent	patent	NOUN
ihlr-18967	449	14	infringement	infringement	NOUN
ihlr-18967	449	15	suit	suit	NOUN
ihlr-18967	449	16	will	will	AUX
ihlr-18967	449	17	be	be	AUX
ihlr-18967	449	18	less	less	ADV
ihlr-18967	449	19	likely	likely	ADJ
ihlr-18967	449	20	to	to	PART
ihlr-18967	449	21	settle	settle	VERB
ihlr-18967	449	22	and	and	CCONJ
ihlr-18967	449	23	more	more	ADV
ihlr-18967	449	24	likely	likely	ADJ
ihlr-18967	449	25	to	to	PART
ihlr-18967	449	26	litigate	litigate	VERB
ihlr-18967	449	27	.	.	PUNCT
ihlr-18967	450	1	further	far	ADV
ihlr-18967	450	2	,	,	PUNCT
ihlr-18967	450	3	any	any	DET
ihlr-18967	450	4	presumption	presumption	NOUN
ihlr-18967	450	5	against	against	ADP
ihlr-18967	450	6	reverse	reverse	ADJ
ihlr-18967	450	7	payment	payment	NOUN
ihlr-18967	450	8	settlements	settlement	NOUN
ihlr-18967	450	9	enacted	enact	VERB
ihlr-18967	450	10	by	by	ADP
ihlr-18967	450	11	congress	congress	PROPN
ihlr-18967	450	12	will	will	AUX
ihlr-18967	450	13	further	far	ADV
ihlr-18967	450	14	deter	deter	VERB
ihlr-18967	450	15	manufacturers	manufacturer	NOUN
ihlr-18967	450	16	from	from	ADP
ihlr-18967	450	17	considering	consider	VERB
ihlr-18967	450	18	settlement	settlement	NOUN
ihlr-18967	450	19	.	.	PUNCT
ihlr-18967	451	1	fewer	few	ADJ
ihlr-18967	451	2	settlements	settlement	NOUN
ihlr-18967	451	3	equate	equate	VERB
ihlr-18967	451	4	to	to	ADP
ihlr-18967	451	5	patent	patent	NOUN
ihlr-18967	451	6	infringement	infringement	NOUN
ihlr-18967	451	7	suits	suit	NOUN
ihlr-18967	451	8	becoming	become	VERB
ihlr-18967	451	9	more	more	ADV
ihlr-18967	451	10	expensive	expensive	ADJ
ihlr-18967	451	11	for	for	ADP
ihlr-18967	451	12	both	both	CCONJ
ihlr-18967	451	13	pioneer	pioneer	NOUN
ihlr-18967	451	14	and	and	CCONJ
ihlr-18967	451	15	generic	generic	ADJ
ihlr-18967	451	16	manufacturers	manufacturer	NOUN
ihlr-18967	451	17	.	.	PUNCT
ihlr-18967	452	1	increases	increase	NOUN
ihlr-18967	452	2	in	in	ADP
ihlr-18967	452	3	litigation	litigation	NOUN
ihlr-18967	452	4	costs	cost	NOUN
ihlr-18967	452	5	can	can	AUX
ihlr-18967	452	6	arise	arise	VERB
ihlr-18967	452	7	out	out	ADP
ihlr-18967	452	8	of	of	ADP
ihlr-18967	452	9	“	"	PUNCT
ihlr-18967	452	10	(	(	PUNCT
ihlr-18967	452	11	1	1	NUM
ihlr-18967	452	12	)	)	PUNCT
ihlr-18967	452	13	direct	direct	ADJ
ihlr-18967	452	14	litigation	litigation	NOUN
ihlr-18967	452	15	costs	cost	NOUN
ihlr-18967	452	16	,	,	PUNCT
ihlr-18967	452	17	(	(	PUNCT
ihlr-18967	452	18	2	2	X
ihlr-18967	452	19	)	)	PUNCT
ihlr-18967	452	20	indirect	indirect	ADJ
ihlr-18967	452	21	costs	cost	NOUN
ihlr-18967	452	22	,	,	PUNCT
ihlr-18967	452	23	such	such	ADJ
ihlr-18967	452	24	as	as	ADP
ihlr-18967	452	25	requiring	require	VERB
ihlr-18967	452	26	the	the	DET
ihlr-18967	452	27	attention	attention	NOUN
ihlr-18967	452	28	of	of	ADP
ihlr-18967	452	29	company	company	NOUN
ihlr-18967	452	30	executives	executive	NOUN
ihlr-18967	452	31	,	,	PUNCT
ihlr-18967	452	32	distracting	distract	VERB
ihlr-18967	452	33	them	they	PRON
ihlr-18967	452	34	from	from	ADP
ihlr-18967	452	35	the	the	DET
ihlr-18967	452	36	operation	operation	NOUN
ihlr-18967	452	37	of	of	ADP
ihlr-18967	452	38	the	the	DET
ihlr-18967	452	39	business	business	NOUN
ihlr-18967	452	40	,	,	PUNCT
ihlr-18967	452	41	and	and	CCONJ
ihlr-18967	452	42	(	(	PUNCT
ihlr-18967	452	43	3	3	X
ihlr-18967	452	44	)	)	PUNCT
ihlr-18967	452	45	costs	cost	NOUN
ihlr-18967	452	46	due	due	ADJ
ihlr-18967	452	47	to	to	ADP
ihlr-18967	452	48	the	the	DET
ihlr-18967	452	49	uncertainty	uncertainty	NOUN
ihlr-18967	452	50	of	of	ADP
ihlr-18967	452	51	litigation	litigation	NOUN
ihlr-18967	452	52	outcomes	outcome	NOUN
ihlr-18967	452	53	.	.	PUNCT
ihlr-18967	453	1	”147	”147	PROPN
ihlr-18967	453	2	also	also	ADV
ihlr-18967	453	3	,	,	PUNCT
ihlr-18967	453	4	applying	apply	VERB
ihlr-18967	453	5	the	the	DET
ihlr-18967	453	6	rule	rule	NOUN
ihlr-18967	453	7	of	of	ADP
ihlr-18967	453	8	reason	reason	NOUN
ihlr-18967	453	9	analysis	analysis	NOUN
ihlr-18967	453	10	will	will	AUX
ihlr-18967	453	11	lead	lead	VERB
ihlr-18967	453	12	to	to	ADP
ihlr-18967	453	13	more	more	ADV
ihlr-18967	453	14	expansive	expansive	ADJ
ihlr-18967	453	15	discovery148	discovery148	PROPN
ihlr-18967	453	16	which	which	PRON
ihlr-18967	453	17	will	will	AUX
ihlr-18967	453	18	lengthen	lengthen	VERB
ihlr-18967	453	19	lawsuit	lawsuit	NOUN
ihlr-18967	453	20	duration	duration	NOUN
ihlr-18967	453	21	and	and	CCONJ
ihlr-18967	453	22	145	145	NUM
ihlr-18967	453	23	in	in	ADP
ihlr-18967	453	24	re	re	NOUN
ihlr-18967	453	25	k	k	X
ihlr-18967	453	26	-	-	ADJ
ihlr-18967	453	27	dur	dur	ADJ
ihlr-18967	453	28	antitrust	antitrust	ADJ
ihlr-18967	453	29	litig	litig	NOUN
ihlr-18967	453	30	.	.	PUNCT
ihlr-18967	454	1	,	,	PUNCT
ihlr-18967	454	2	686	686	NUM
ihlr-18967	454	3	f.3d	f.3d	NUM
ihlr-18967	454	4	197	197	NUM
ihlr-18967	454	5	,	,	PUNCT
ihlr-18967	454	6	214	214	NUM
ihlr-18967	454	7	(	(	PUNCT
ihlr-18967	454	8	3d	3d	PROPN
ihlr-18967	454	9	cir	cir	NOUN
ihlr-18967	454	10	.	.	PROPN
ihlr-18967	454	11	2012	2012	NUM
ihlr-18967	454	12	)	)	PUNCT
ihlr-18967	454	13	.	.	PUNCT
ihlr-18967	455	1	146	146	NUM
ihlr-18967	455	2	see	see	VERB
ihlr-18967	455	3	preserve	preserve	VERB
ihlr-18967	455	4	access	access	NOUN
ihlr-18967	455	5	to	to	ADP
ihlr-18967	455	6	affordable	affordable	ADJ
ihlr-18967	455	7	generics	generic	NOUN
ihlr-18967	455	8	act	act	PROPN
ihlr-18967	455	9	,	,	PUNCT
ihlr-18967	455	10	s.	s.	PROPN
ihlr-18967	455	11	214	214	NUM
ihlr-18967	455	12	,	,	PUNCT
ihlr-18967	455	13	113th	113th	PROPN
ihlr-18967	455	14	cong	cong	NOUN
ihlr-18967	455	15	.	.	PUNCT
ihlr-18967	456	1	§	§	PROPN
ihlr-18967	456	2	28(a)(2	28(a)(2	NUM
ihlr-18967	456	3	)	)	PUNCT
ihlr-18967	456	4	(	(	PUNCT
ihlr-18967	456	5	2013	2013	NUM
ihlr-18967	456	6	)	)	PUNCT
ihlr-18967	456	7	(	(	PUNCT
ihlr-18967	456	8	establishing	establish	VERB
ihlr-18967	456	9	a	a	DET
ihlr-18967	456	10	presumption	presumption	NOUN
ihlr-18967	456	11	that	that	SCONJ
ihlr-18967	456	12	reverse	reverse	ADJ
ihlr-18967	456	13	payment	payment	NOUN
ihlr-18967	456	14	settlements	settlement	NOUN
ihlr-18967	456	15	are	be	AUX
ihlr-18967	456	16	anticompetitive	anticompetitive	ADJ
ihlr-18967	456	17	)	)	PUNCT
ihlr-18967	456	18	.	.	PUNCT
ihlr-18967	457	1	147	147	NUM
ihlr-18967	457	2	dickey	dickey	PROPN
ihlr-18967	457	3	,	,	PUNCT
ihlr-18967	457	4	supra	supra	PROPN
ihlr-18967	457	5	note	note	PROPN
ihlr-18967	457	6	142	142	NUM
ihlr-18967	457	7	,	,	PUNCT
ihlr-18967	457	8	at	at	ADP
ihlr-18967	457	9	375	375	NUM
ihlr-18967	457	10	.	.	NOUN
ihlr-18967	457	11	148	148	NUM
ihlr-18967	457	12	cal	cal	NOUN
ihlr-18967	457	13	.	.	PUNCT
ihlr-18967	458	1	dental	dental	ADJ
ihlr-18967	458	2	ass’n	ass’n	PROPN
ihlr-18967	458	3	v.	v.	ADP
ihlr-18967	458	4	ftc	ftc	PROPN
ihlr-18967	458	5	,	,	PUNCT
ihlr-18967	458	6	526	526	NUM
ihlr-18967	458	7	u.s	u.s	PROPN
ihlr-18967	458	8	.	.	PROPN
ihlr-18967	458	9	756	756	NUM
ihlr-18967	458	10	,	,	PUNCT
ihlr-18967	458	11	759	759	NUM
ihlr-18967	458	12	(	(	PUNCT
ihlr-18967	458	13	1999	1999	NUM
ihlr-18967	458	14	)	)	PUNCT
ihlr-18967	458	15	(	(	PUNCT
ihlr-18967	458	16	explaining	explain	VERB
ihlr-18967	458	17	how	how	SCONJ
ihlr-18967	458	18	rule	rule	NOUN
ihlr-18967	458	19	of	of	ADP
ihlr-18967	458	20	reason	reason	NOUN
ihlr-18967	458	21	analysis	analysis	NOUN
ihlr-18967	458	22	“	"	PUNCT
ihlr-18967	458	23	demands	demand	VERB
ihlr-18967	458	24	a	a	DET
ihlr-18967	458	25	more	more	ADV
ihlr-18967	458	26	thorough	thorough	ADJ
ihlr-18967	458	27	enquiry	enquiry	NOUN
ihlr-18967	458	28	”	"	PUNCT
ihlr-18967	458	29	than	than	ADP
ihlr-18967	458	30	a	a	DET
ihlr-18967	458	31	“	"	PUNCT
ihlr-18967	458	32	quick	quick	ADJ
ihlr-18967	458	33	-	-	PUNCT
ihlr-18967	458	34	look	look	NOUN
ihlr-18967	458	35	”	"	PUNCT
ihlr-18967	458	36	analysis	analysis	NOUN
ihlr-18967	458	37	)	)	PUNCT
ihlr-18967	458	38	.	.	PUNCT
ihlr-18967	459	1	450	450	NUM
ihlr-18967	459	2	indiana	indiana	PROPN
ihlr-18967	459	3	health	health	PROPN
ihlr-18967	459	4	law	law	PROPN
ihlr-18967	459	5	review	review	NOUN
ihlr-18967	459	6	vol	vol	NOUN
ihlr-18967	459	7	.	.	PUNCT
ihlr-18967	460	1	12:1	12:1	NUM
ihlr-18967	460	2	thereby	thereby	ADV
ihlr-18967	460	3	increase	increase	VERB
ihlr-18967	460	4	the	the	DET
ihlr-18967	460	5	cost	cost	NOUN
ihlr-18967	460	6	of	of	ADP
ihlr-18967	460	7	litigation.149	litigation.149	NOUN
ihlr-18967	460	8	although	although	SCONJ
ihlr-18967	460	9	,	,	PUNCT
ihlr-18967	460	10	while	while	SCONJ
ihlr-18967	460	11	the	the	DET
ihlr-18967	460	12	court	court	NOUN
ihlr-18967	460	13	stated	state	VERB
ihlr-18967	460	14	that	that	SCONJ
ihlr-18967	460	15	it	it	PRON
ihlr-18967	460	16	was	be	AUX
ihlr-18967	460	17	not	not	PART
ihlr-18967	460	18	establishing	establish	VERB
ihlr-18967	460	19	a	a	DET
ihlr-18967	460	20	quick	quick	ADJ
ihlr-18967	460	21	-	-	PUNCT
ihlr-18967	460	22	look	look	NOUN
ihlr-18967	460	23	analysis,150	analysis,150	NOUN
ihlr-18967	460	24	the	the	DET
ihlr-18967	460	25	court	court	NOUN
ihlr-18967	460	26	’s	’s	PART
ihlr-18967	460	27	emphasis	emphasis	NOUN
ihlr-18967	460	28	on	on	ADP
ihlr-18967	460	29	the	the	DET
ihlr-18967	460	30	“	"	PUNCT
ihlr-18967	460	31	size	size	NOUN
ihlr-18967	460	32	of	of	ADP
ihlr-18967	460	33	payment”151	payment”151	NOUN
ihlr-18967	460	34	implies	imply	VERB
ihlr-18967	460	35	there	there	PRON
ihlr-18967	460	36	is	be	VERB
ihlr-18967	460	37	an	an	DET
ihlr-18967	460	38	element	element	NOUN
ihlr-18967	460	39	of	of	ADP
ihlr-18967	460	40	quick	quick	ADJ
ihlr-18967	460	41	-	-	PUNCT
ihlr-18967	460	42	look	look	NOUN
ihlr-18967	460	43	analysis	analysis	NOUN
ihlr-18967	460	44	which	which	PRON
ihlr-18967	460	45	the	the	DET
ihlr-18967	460	46	court	court	NOUN
ihlr-18967	460	47	has	have	AUX
ihlr-18967	460	48	subtly	subtly	ADV
ihlr-18967	460	49	approved	approve	VERB
ihlr-18967	460	50	.	.	PUNCT
ihlr-18967	461	1	as	as	ADP
ihlr-18967	461	2	a	a	DET
ihlr-18967	461	3	result	result	NOUN
ihlr-18967	461	4	,	,	PUNCT
ihlr-18967	461	5	it	it	PRON
ihlr-18967	461	6	is	be	AUX
ihlr-18967	461	7	unlikely	unlikely	ADJ
ihlr-18967	461	8	that	that	SCONJ
ihlr-18967	461	9	all	all	DET
ihlr-18967	461	10	litigation	litigation	NOUN
ihlr-18967	461	11	will	will	AUX
ihlr-18967	461	12	be	be	AUX
ihlr-18967	461	13	lengthy	lengthy	ADJ
ihlr-18967	461	14	.	.	PUNCT
ihlr-18967	462	1	as	as	SCONJ
ihlr-18967	462	2	the	the	DET
ihlr-18967	462	3	court	court	NOUN
ihlr-18967	462	4	suggests	suggest	VERB
ihlr-18967	462	5	,	,	PUNCT
ihlr-18967	462	6	it	it	PRON
ihlr-18967	462	7	is	be	AUX
ihlr-18967	462	8	not	not	PART
ihlr-18967	462	9	always	always	ADV
ihlr-18967	462	10	necessary	necessary	ADJ
ihlr-18967	462	11	to	to	PART
ihlr-18967	462	12	litigate	litigate	VERB
ihlr-18967	462	13	patent	patent	NOUN
ihlr-18967	462	14	validity	validity	NOUN
ihlr-18967	462	15	in	in	ADP
ihlr-18967	462	16	order	order	NOUN
ihlr-18967	462	17	to	to	PART
ihlr-18967	462	18	determine	determine	VERB
ihlr-18967	462	19	if	if	SCONJ
ihlr-18967	462	20	the	the	DET
ihlr-18967	462	21	settlement	settlement	NOUN
ihlr-18967	462	22	is	be	AUX
ihlr-18967	462	23	anticompetitive.152	anticompetitive.152	ADJ
ihlr-18967	462	24	increased	increase	VERB
ihlr-18967	462	25	cost	cost	NOUN
ihlr-18967	462	26	of	of	ADP
ihlr-18967	462	27	litigation	litigation	NOUN
ihlr-18967	462	28	may	may	AUX
ihlr-18967	462	29	also	also	ADV
ihlr-18967	462	30	result	result	VERB
ihlr-18967	462	31	in	in	ADP
ihlr-18967	462	32	generic	generic	ADJ
ihlr-18967	462	33	manufacturers	manufacturer	NOUN
ihlr-18967	462	34	challenging	challenge	VERB
ihlr-18967	462	35	fewer	few	ADJ
ihlr-18967	462	36	patents	patent	NOUN
ihlr-18967	462	37	.	.	PUNCT
ihlr-18967	463	1	generic	generic	ADJ
ihlr-18967	463	2	manufacturers	manufacturer	NOUN
ihlr-18967	463	3	may	may	AUX
ihlr-18967	463	4	be	be	AUX
ihlr-18967	463	5	reluctant	reluctant	ADJ
ihlr-18967	463	6	to	to	PART
ihlr-18967	463	7	challenge	challenge	VERB
ihlr-18967	463	8	a	a	DET
ihlr-18967	463	9	patent	patent	NOUN
ihlr-18967	463	10	as	as	SCONJ
ihlr-18967	463	11	generic	generic	ADJ
ihlr-18967	463	12	manufacturers	manufacturer	NOUN
ihlr-18967	463	13	have	have	AUX
ihlr-18967	463	14	historically	historically	ADV
ihlr-18967	463	15	lost	lose	VERB
ihlr-18967	463	16	more	more	ADV
ihlr-18967	463	17	often	often	ADV
ihlr-18967	463	18	than	than	ADP
ihlr-18967	463	19	not	not	PART
ihlr-18967	463	20	when	when	SCONJ
ihlr-18967	463	21	patent	patent	NOUN
ihlr-18967	463	22	litigation	litigation	NOUN
ihlr-18967	463	23	proceeds	proceed	VERB
ihlr-18967	463	24	to	to	ADP
ihlr-18967	463	25	a	a	DET
ihlr-18967	463	26	judgment.153	judgment.153	VERB
ihlr-18967	463	27	as	as	ADP
ihlr-18967	463	28	chief	chief	ADJ
ihlr-18967	463	29	justice	justice	NOUN
ihlr-18967	463	30	roberts	roberts	PROPN
ihlr-18967	463	31	argued	argue	VERB
ihlr-18967	463	32	in	in	ADP
ihlr-18967	463	33	dissent	dissent	NOUN
ihlr-18967	463	34	,	,	PUNCT
ihlr-18967	463	35	the	the	DET
ihlr-18967	463	36	majority	majority	NOUN
ihlr-18967	463	37	’s	’s	PART
ihlr-18967	463	38	opinion	opinion	NOUN
ihlr-18967	463	39	may	may	AUX
ihlr-18967	463	40	discourage	discourage	VERB
ihlr-18967	463	41	generic	generic	ADJ
ihlr-18967	463	42	manufacturers	manufacturer	NOUN
ihlr-18967	463	43	from	from	ADP
ihlr-18967	463	44	certifying	certify	VERB
ihlr-18967	463	45	under	under	ADP
ihlr-18967	463	46	paragraph	paragraph	NOUN
ihlr-18967	463	47	iv	iv	NOUN
ihlr-18967	463	48	as	as	ADP
ihlr-18967	463	49	“	"	PUNCT
ihlr-18967	463	50	[	[	X
ihlr-18967	463	51	p]atent	p]atent	ADJ
ihlr-18967	463	52	litigation	litigation	NOUN
ihlr-18967	463	53	is	be	AUX
ihlr-18967	463	54	costly	costly	ADJ
ihlr-18967	463	55	,	,	PUNCT
ihlr-18967	463	56	time	time	NOUN
ihlr-18967	463	57	consuming	consuming	NOUN
ihlr-18967	463	58	,	,	PUNCT
ihlr-18967	463	59	and	and	CCONJ
ihlr-18967	463	60	uncertain	uncertain	ADJ
ihlr-18967	463	61	.	.	PUNCT
ihlr-18967	463	62	”154	”154	PROPN
ihlr-18967	463	63	as	as	ADP
ihlr-18967	463	64	a	a	DET
ihlr-18967	463	65	result	result	NOUN
ihlr-18967	463	66	,	,	PUNCT
ihlr-18967	463	67	it	it	PRON
ihlr-18967	463	68	may	may	AUX
ihlr-18967	463	69	only	only	ADV
ihlr-18967	463	70	be	be	AUX
ihlr-18967	463	71	economically	economically	ADV
ihlr-18967	463	72	feasible	feasible	ADJ
ihlr-18967	463	73	for	for	SCONJ
ihlr-18967	463	74	generic	generic	ADJ
ihlr-18967	463	75	manufacturers	manufacturer	NOUN
ihlr-18967	463	76	to	to	PART
ihlr-18967	463	77	challenge	challenge	VERB
ihlr-18967	463	78	certain	certain	ADJ
ihlr-18967	463	79	patents	patent	NOUN
ihlr-18967	463	80	and	and	CCONJ
ihlr-18967	463	81	not	not	PART
ihlr-18967	463	82	challenge	challenge	VERB
ihlr-18967	463	83	other	other	ADJ
ihlr-18967	463	84	patents	patent	NOUN
ihlr-18967	463	85	it	it	PRON
ihlr-18967	463	86	would	would	AUX
ihlr-18967	463	87	have	have	VERB
ihlr-18967	463	88	pre	pre	ADJ
ihlr-18967	463	89	-	-	ADJ
ihlr-18967	463	90	actavis	actavis	ADJ
ihlr-18967	463	91	.	.	PUNCT
ihlr-18967	464	1	therefore	therefore	ADV
ihlr-18967	464	2	,	,	PUNCT
ihlr-18967	464	3	generic	generic	ADJ
ihlr-18967	464	4	manufactures	manufacture	NOUN
ihlr-18967	464	5	may	may	AUX
ihlr-18967	464	6	choose	choose	VERB
ihlr-18967	464	7	to	to	PART
ihlr-18967	464	8	only	only	ADV
ihlr-18967	464	9	target	target	VERB
ihlr-18967	464	10	weak	weak	ADJ
ihlr-18967	464	11	patents	patent	NOUN
ihlr-18967	464	12	,	,	PUNCT
ihlr-18967	464	13	ones	one	NOUN
ihlr-18967	464	14	that	that	PRON
ihlr-18967	464	15	have	have	VERB
ihlr-18967	464	16	a	a	DET
ihlr-18967	464	17	high	high	ADJ
ihlr-18967	464	18	likelihood	likelihood	NOUN
ihlr-18967	464	19	of	of	ADP
ihlr-18967	464	20	invalidity.155	invalidity.155	NOUN
ihlr-18967	464	21	149	149	NUM
ihlr-18967	464	22	see	see	NOUN
ihlr-18967	464	23	ariz	ariz	PROPN
ihlr-18967	464	24	.	.	PUNCT
ihlr-18967	465	1	v.	v.	PROPN
ihlr-18967	465	2	maricopa	maricopa	PROPN
ihlr-18967	465	3	cnty	cnty	PROPN
ihlr-18967	465	4	.	.	PUNCT
ihlr-18967	466	1	med	med	PROPN
ihlr-18967	466	2	.	.	PUNCT
ihlr-18967	466	3	soc’y	soc’y	PROPN
ihlr-18967	466	4	,	,	PUNCT
ihlr-18967	466	5	457	457	NUM
ihlr-18967	466	6	u.s	u.s	PROPN
ihlr-18967	466	7	.	.	PROPN
ihlr-18967	466	8	332	332	NUM
ihlr-18967	466	9	,	,	PUNCT
ihlr-18967	466	10	343	343	NUM
ihlr-18967	466	11	(	(	PUNCT
ihlr-18967	466	12	1982	1982	NUM
ihlr-18967	466	13	)	)	PUNCT
ihlr-18967	466	14	(	(	PUNCT
ihlr-18967	466	15	“	"	PUNCT
ihlr-18967	466	16	the	the	DET
ihlr-18967	466	17	elaborate	elaborate	ADJ
ihlr-18967	466	18	inquiry	inquiry	NOUN
ihlr-18967	466	19	into	into	ADP
ihlr-18967	466	20	the	the	DET
ihlr-18967	466	21	reasonableness	reasonableness	NOUN
ihlr-18967	466	22	of	of	ADP
ihlr-18967	466	23	a	a	DET
ihlr-18967	466	24	challenged	challenge	VERB
ihlr-18967	466	25	business	business	NOUN
ihlr-18967	466	26	practice	practice	NOUN
ihlr-18967	466	27	entails	entail	VERB
ihlr-18967	466	28	significant	significant	ADJ
ihlr-18967	466	29	costs	cost	NOUN
ihlr-18967	466	30	.	.	PUNCT
ihlr-18967	466	31	”	"	PUNCT
ihlr-18967	466	32	)	)	PUNCT
ihlr-18967	466	33	;	;	PUNCT
ihlr-18967	466	34	kenneth	kenneth	PROPN
ihlr-18967	466	35	r.	r.	PROPN
ihlr-18967	466	36	o’rourke	o’rourke	PROPN
ihlr-18967	466	37	et	et	PROPN
ihlr-18967	466	38	al	al	PROPN
ihlr-18967	466	39	.	.	PROPN
ihlr-18967	466	40	,	,	PUNCT
ihlr-18967	466	41	ftc	ftc	PROPN
ihlr-18967	466	42	v.	v.	ADP
ihlr-18967	466	43	actavis	actavis	PROPN
ihlr-18967	466	44	:	:	PUNCT
ihlr-18967	466	45	reconciling	reconcile	VERB
ihlr-18967	466	46	conflicts	conflict	NOUN
ihlr-18967	466	47	in	in	ADP
ihlr-18967	466	48	rule	rule	NOUN
ihlr-18967	466	49	of	of	ADP
ihlr-18967	466	50	reason	reason	NOUN
ihlr-18967	466	51	,	,	PUNCT
ihlr-18967	466	52	law	law	NOUN
ihlr-18967	466	53	360	360	NUM
ihlr-18967	466	54	(	(	PUNCT
ihlr-18967	466	55	july	july	PROPN
ihlr-18967	466	56	2	2	NUM
ihlr-18967	466	57	,	,	PUNCT
ihlr-18967	466	58	2013	2013	NUM
ihlr-18967	466	59	,	,	PUNCT
ihlr-18967	466	60	5:55	5:55	NUM
ihlr-18967	466	61	pm	pm	NOUN
ihlr-18967	466	62	)	)	PUNCT
ihlr-18967	466	63	,	,	PUNCT
ihlr-18967	466	64	http://www.law360.com/articles/453428/ftc-v-actavisreconciling-conflicts-in-rule-of-reason	http://www.law360.com/articles/453428/ftc-v-actavisreconciling-conflicts-in-rule-of-reason	X
ihlr-18967	466	65	.	.	PROPN
ihlr-18967	466	66	150	150	NUM
ihlr-18967	466	67	ftc	ftc	PROPN
ihlr-18967	466	68	v.	v.	ADP
ihlr-18967	466	69	actavis	actavis	PROPN
ihlr-18967	466	70	,	,	PUNCT
ihlr-18967	466	71	inc	inc	PROPN
ihlr-18967	466	72	.	.	PROPN
ihlr-18967	466	73	,	,	PUNCT
ihlr-18967	466	74	133	133	NUM
ihlr-18967	466	75	s.	s.	PROPN
ihlr-18967	466	76	ct	ct	PROPN
ihlr-18967	466	77	.	.	PROPN
ihlr-18967	466	78	2223	2223	NUM
ihlr-18967	466	79	,	,	PUNCT
ihlr-18967	466	80	2237	2237	NUM
ihlr-18967	466	81	(	(	PUNCT
ihlr-18967	466	82	2013	2013	NUM
ihlr-18967	466	83	)	)	PUNCT
ihlr-18967	466	84	.	.	PUNCT
ihlr-18967	467	1	151	151	NUM
ihlr-18967	467	2	i	i	PRON
ihlr-18967	467	3	d.	d.	NOUN
ihlr-18967	467	4	at	at	ADP
ihlr-18967	467	5	2236	2236	NUM
ihlr-18967	467	6	-	-	SYM
ihlr-18967	467	7	37	37	NUM
ihlr-18967	467	8	(	(	PUNCT
ihlr-18967	467	9	suggesting	suggest	VERB
ihlr-18967	467	10	that	that	SCONJ
ihlr-18967	467	11	a	a	DET
ihlr-18967	467	12	large	large	ADJ
ihlr-18967	467	13	,	,	PUNCT
ihlr-18967	467	14	unexplainable	unexplainable	ADJ
ihlr-18967	467	15	reverse	reverse	ADJ
ihlr-18967	467	16	payment	payment	NOUN
ihlr-18967	467	17	implies	imply	VERB
ihlr-18967	467	18	a	a	DET
ihlr-18967	467	19	patent	patent	NOUN
ihlr-18967	467	20	is	be	AUX
ihlr-18967	467	21	weak	weak	ADJ
ihlr-18967	467	22	and	and	CCONJ
ihlr-18967	467	23	precludes	preclude	VERB
ihlr-18967	467	24	a	a	DET
ihlr-18967	467	25	court	court	NOUN
ihlr-18967	467	26	from	from	ADP
ihlr-18967	467	27	“	"	PUNCT
ihlr-18967	467	28	conduct[ing	conduct[e	VERB
ihlr-18967	467	29	]	]	PUNCT
ihlr-18967	467	30	a	a	DET
ihlr-18967	467	31	detailed	detailed	ADJ
ihlr-18967	467	32	exploration	exploration	NOUN
ihlr-18967	467	33	[	[	X
ihlr-18967	467	34	into	into	ADP
ihlr-18967	467	35	]	]	X
ihlr-18967	467	36	the	the	DET
ihlr-18967	467	37	validity	validity	NOUN
ihlr-18967	467	38	of	of	ADP
ihlr-18967	467	39	the	the	DET
ihlr-18967	467	40	patent	patent	NOUN
ihlr-18967	467	41	”	"	PUNCT
ihlr-18967	467	42	)	)	PUNCT
ihlr-18967	467	43	.	.	PUNCT
ihlr-18967	468	1	152	152	NUM
ihlr-18967	469	1	i	i	PRON
ihlr-18967	469	2	d.	d.	PROPN
ihlr-18967	469	3	at	at	ADP
ihlr-18967	469	4	2236	2236	NUM
ihlr-18967	469	5	.	.	PUNCT
ihlr-18967	470	1	153	153	NUM
ihlr-18967	470	2	bret	bret	PROPN
ihlr-18967	470	3	dickey	dickey	PROPN
ihlr-18967	470	4	&	&	CCONJ
ihlr-18967	470	5	jonathan	jonathan	PROPN
ihlr-18967	470	6	orszag	orszag	PROPN
ihlr-18967	470	7	,	,	PUNCT
ihlr-18967	470	8	the	the	DET
ihlr-18967	470	9	benefits	benefit	NOUN
ihlr-18967	470	10	of	of	ADP
ihlr-18967	470	11	patent	patent	NOUN
ihlr-18967	470	12	settlements	settlement	NOUN
ihlr-18967	470	13	:	:	PUNCT
ihlr-18967	470	14	new	new	ADJ
ihlr-18967	470	15	survey	survey	NOUN
ihlr-18967	470	16	evidence	evidence	NOUN
ihlr-18967	470	17	on	on	ADP
ihlr-18967	470	18	factors	factor	NOUN
ihlr-18967	470	19	affecting	affect	VERB
ihlr-18967	470	20	generic	generic	ADJ
ihlr-18967	470	21	drug	drug	NOUN
ihlr-18967	470	22	investment	investment	NOUN
ihlr-18967	470	23	,	,	PUNCT
ihlr-18967	470	24	generic	generic	ADJ
ihlr-18967	470	25	pharm	pharm	NOUN
ihlr-18967	470	26	.	.	PUNCT
ihlr-18967	471	1	ass’n	ass’n	PROPN
ihlr-18967	471	2	(	(	PUNCT
ihlr-18967	471	3	july	july	PROPN
ihlr-18967	471	4	23	23	NUM
ihlr-18967	471	5	,	,	PUNCT
ihlr-18967	471	6	2013	2013	NUM
ihlr-18967	471	7	)	)	PUNCT
ihlr-18967	471	8	,	,	PUNCT
ihlr-18967	471	9	http://www.gphaonline.org/media/cms/dickey_orszag_benefits_of_pate	http://www.gphaonline.org/media/cms/dickey_orszag_benefits_of_pate	NOUN
ihlr-18967	471	10	nt_settlements_2012-07-21_final.pdf	nt_settlements_2012-07-21_final.pdf	PROPN
ihlr-18967	471	11	(	(	PUNCT
ihlr-18967	471	12	finding	find	VERB
ihlr-18967	471	13	when	when	SCONJ
ihlr-18967	471	14	patent	patent	NOUN
ihlr-18967	471	15	litigation	litigation	NOUN
ihlr-18967	471	16	goes	go	VERB
ihlr-18967	471	17	to	to	ADP
ihlr-18967	471	18	a	a	DET
ihlr-18967	471	19	judgment	judgment	NOUN
ihlr-18967	471	20	generic	generic	ADJ
ihlr-18967	471	21	manufacturers	manufacturer	NOUN
ihlr-18967	471	22	loose	loose	VERB
ihlr-18967	471	23	two	two	NUM
ihlr-18967	471	24	out	out	ADP
ihlr-18967	471	25	of	of	ADP
ihlr-18967	471	26	three	three	NUM
ihlr-18967	471	27	times	time	NOUN
ihlr-18967	471	28	)	)	PUNCT
ihlr-18967	471	29	.	.	PUNCT
ihlr-18967	472	1	154	154	NUM
ihlr-18967	472	2	actavis	actavi	NOUN
ihlr-18967	472	3	,	,	PUNCT
ihlr-18967	472	4	133	133	NUM
ihlr-18967	472	5	s.	s.	PROPN
ihlr-18967	472	6	ct	ct	PROPN
ihlr-18967	472	7	.	.	PUNCT
ihlr-18967	473	1	at	at	ADP
ihlr-18967	473	2	2247	2247	NUM
ihlr-18967	473	3	(	(	PUNCT
ihlr-18967	473	4	roberts	roberts	PROPN
ihlr-18967	473	5	,	,	PUNCT
ihlr-18967	473	6	c.j	c.j	PROPN
ihlr-18967	473	7	.	.	PROPN
ihlr-18967	473	8	,	,	PUNCT
ihlr-18967	473	9	dissenting	dissent	VERB
ihlr-18967	473	10	)	)	PUNCT
ihlr-18967	473	11	.	.	PUNCT
ihlr-18967	474	1	155	155	NUM
ihlr-18967	474	2	see	see	VERB
ihlr-18967	474	3	hemphill	hemphill	PROPN
ihlr-18967	474	4	&	&	CCONJ
ihlr-18967	474	5	sampat	sampat	PROPN
ihlr-18967	474	6	,	,	PUNCT
ihlr-18967	474	7	supra	supra	PROPN
ihlr-18967	474	8	note	note	NOUN
ihlr-18967	474	9	136	136	NUM
ihlr-18967	474	10	,	,	PUNCT
ihlr-18967	474	11	at	at	ADP
ihlr-18967	474	12	635	635	NUM
ihlr-18967	474	13	-	-	SYM
ihlr-18967	474	14	36	36	NUM
ihlr-18967	474	15	(	(	PUNCT
ihlr-18967	474	16	finding	find	VERB
ihlr-18967	474	17	a	a	DET
ihlr-18967	474	18	correlation	correlation	NOUN
ihlr-18967	474	19	between	between	ADP
ihlr-18967	474	20	patent	patent	NOUN
ihlr-18967	474	21	strength	strength	NOUN
ihlr-18967	474	22	and	and	CCONJ
ihlr-18967	474	23	likelihood	likelihood	NOUN
ihlr-18967	474	24	of	of	ADP
ihlr-18967	474	25	a	a	DET
ihlr-18967	474	26	challenge	challenge	NOUN
ihlr-18967	474	27	to	to	ADP
ihlr-18967	474	28	validity	validity	NOUN
ihlr-18967	474	29	)	)	PUNCT
ihlr-18967	474	30	.	.	PUNCT
ihlr-18967	475	1	2015	2015	NUM
ihlr-18967	475	2	rationale	rationale	NOUN
ihlr-18967	475	3	behind	behind	ADP
ihlr-18967	475	4	hatch	hatch	NOUN
ihlr-18967	475	5	-	-	PUNCT
ihlr-18967	475	6	waxman	waxman	PROPN
ihlr-18967	475	7	act	act	PROPN
ihlr-18967	475	8	and	and	CCONJ
ihlr-18967	475	9	patent	patent	NOUN
ihlr-18967	475	10	law	law	NOUN
ihlr-18967	475	11	451	451	NUM
ihlr-18967	475	12	second	second	ADJ
ihlr-18967	475	13	,	,	PUNCT
ihlr-18967	475	14	pioneer	pioneer	NOUN
ihlr-18967	475	15	manufacturers	manufacturer	NOUN
ihlr-18967	475	16	will	will	AUX
ihlr-18967	475	17	lose	lose	VERB
ihlr-18967	475	18	revenue	revenue	NOUN
ihlr-18967	475	19	and	and	CCONJ
ihlr-18967	475	20	profits	profit	NOUN
ihlr-18967	475	21	by	by	ADP
ihlr-18967	475	22	not	not	PART
ihlr-18967	475	23	being	be	AUX
ihlr-18967	475	24	able	able	ADJ
ihlr-18967	475	25	to	to	PART
ihlr-18967	475	26	delay	delay	VERB
ihlr-18967	475	27	generic	generic	ADJ
ihlr-18967	475	28	manufacturers	manufacturer	NOUN
ihlr-18967	475	29	from	from	ADP
ihlr-18967	475	30	entering	enter	VERB
ihlr-18967	475	31	the	the	DET
ihlr-18967	475	32	market	market	NOUN
ihlr-18967	475	33	.	.	PUNCT
ihlr-18967	476	1	this	this	PRON
ihlr-18967	476	2	will	will	AUX
ihlr-18967	476	3	result	result	VERB
ihlr-18967	476	4	from	from	ADP
ihlr-18967	476	5	more	more	ADJ
ihlr-18967	476	6	consumers	consumer	NOUN
ihlr-18967	476	7	purchasing	purchase	VERB
ihlr-18967	476	8	the	the	DET
ihlr-18967	476	9	less	less	ADV
ihlr-18967	476	10	expensive	expensive	ADJ
ihlr-18967	476	11	generic	generic	ADJ
ihlr-18967	476	12	drug	drug	NOUN
ihlr-18967	476	13	.	.	PUNCT
ihlr-18967	477	1	for	for	ADP
ihlr-18967	477	2	example	example	NOUN
ihlr-18967	477	3	,	,	PUNCT
ihlr-18967	477	4	solvay	solvay	NOUN
ihlr-18967	477	5	pharmaceuticals	pharmaceutical	NOUN
ihlr-18967	477	6	,	,	PUNCT
ihlr-18967	477	7	the	the	DET
ihlr-18967	477	8	pioneer	pioneer	NOUN
ihlr-18967	477	9	manufacturer	manufacturer	NOUN
ihlr-18967	477	10	in	in	ADP
ihlr-18967	477	11	actavis	actavis	PROPN
ihlr-18967	477	12	,	,	PUNCT
ihlr-18967	477	13	estimated	estimate	VERB
ihlr-18967	477	14	the	the	DET
ihlr-18967	477	15	generic	generic	ADJ
ihlr-18967	477	16	version	version	NOUN
ihlr-18967	477	17	of	of	ADP
ihlr-18967	477	18	androgel	androgel	NOUN
ihlr-18967	477	19	could	could	AUX
ihlr-18967	477	20	decrease	decrease	VERB
ihlr-18967	477	21	the	the	DET
ihlr-18967	477	22	sales	sale	NOUN
ihlr-18967	477	23	of	of	ADP
ihlr-18967	477	24	branded	brand	VERB
ihlr-18967	477	25	androgel	androgel	NOUN
ihlr-18967	477	26	by	by	ADP
ihlr-18967	477	27	90	90	NUM
ihlr-18967	477	28	%	%	NOUN
ihlr-18967	477	29	and	and	CCONJ
ihlr-18967	477	30	cut	cut	PROPN
ihlr-18967	477	31	solvay	solvay	NOUN
ihlr-18967	477	32	’s	’s	PART
ihlr-18967	477	33	profits	profit	NOUN
ihlr-18967	477	34	by	by	ADP
ihlr-18967	477	35	$	$	SYM
ihlr-18967	477	36	125	125	NUM
ihlr-18967	477	37	million	million	NUM
ihlr-18967	477	38	per	per	ADP
ihlr-18967	477	39	year.156	year.156	PROPN
ihlr-18967	477	40	additionally	additionally	ADV
ihlr-18967	477	41	,	,	PUNCT
ihlr-18967	477	42	in	in	ADP
ihlr-18967	477	43	2013	2013	NUM
ihlr-18967	477	44	,	,	PUNCT
ihlr-18967	477	45	pfizer	pfizer	NOUN
ihlr-18967	477	46	reported	report	VERB
ihlr-18967	477	47	that	that	SCONJ
ihlr-18967	477	48	the	the	DET
ihlr-18967	477	49	loss	loss	NOUN
ihlr-18967	477	50	of	of	ADP
ihlr-18967	477	51	patent	patent	NOUN
ihlr-18967	477	52	protection	protection	NOUN
ihlr-18967	477	53	in	in	ADP
ihlr-18967	477	54	november	november	PROPN
ihlr-18967	477	55	2011	2011	NUM
ihlr-18967	477	56	on	on	ADP
ihlr-18967	477	57	lipitor	lipitor	NOUN
ihlr-18967	477	58	and	and	CCONJ
ihlr-18967	477	59	other	other	ADJ
ihlr-18967	477	60	patents	patent	NOUN
ihlr-18967	477	61	expiring	expire	VERB
ihlr-18967	477	62	around	around	ADP
ihlr-18967	477	63	that	that	DET
ihlr-18967	477	64	time	time	NOUN
ihlr-18967	477	65	resulted	result	VERB
ihlr-18967	477	66	in	in	ADP
ihlr-18967	477	67	a	a	DET
ihlr-18967	477	68	reduction	reduction	NOUN
ihlr-18967	477	69	in	in	ADP
ihlr-18967	477	70	net	net	ADJ
ihlr-18967	477	71	income	income	NOUN
ihlr-18967	477	72	by	by	ADP
ihlr-18967	477	73	“	"	PUNCT
ihlr-18967	477	74	$	$	SYM
ihlr-18967	477	75	3	3	NUM
ihlr-18967	477	76	billion	billion	NUM
ihlr-18967	477	77	to	to	PART
ihlr-18967	477	78	$	$	SYM
ihlr-18967	477	79	4	4	NUM
ihlr-18967	477	80	billion	billion	NUM
ihlr-18967	477	81	a	a	DET
ihlr-18967	477	82	year	year	NOUN
ihlr-18967	477	83	.	.	PUNCT
ihlr-18967	478	1	”157	”157	NOUN
ihlr-18967	478	2	contrary	contrary	ADJ
ihlr-18967	478	3	to	to	ADP
ihlr-18967	478	4	the	the	DET
ihlr-18967	478	5	hatch	hatch	NOUN
ihlr-18967	478	6	-	-	PUNCT
ihlr-18967	478	7	waxman	waxman	PROPN
ihlr-18967	478	8	act	act	PROPN
ihlr-18967	478	9	and	and	CCONJ
ihlr-18967	478	10	patent	patent	NOUN
ihlr-18967	478	11	law	law	NOUN
ihlr-18967	478	12	,	,	PUNCT
ihlr-18967	478	13	which	which	PRON
ihlr-18967	478	14	attempt	attempt	VERB
ihlr-18967	478	15	to	to	PART
ihlr-18967	478	16	incentivize	incentivize	VERB
ihlr-18967	478	17	pioneer	pioneer	NOUN
ihlr-18967	478	18	manufacturers	manufacturer	NOUN
ihlr-18967	478	19	to	to	PART
ihlr-18967	478	20	develop	develop	VERB
ihlr-18967	478	21	new	new	ADJ
ihlr-18967	478	22	drugs	drug	NOUN
ihlr-18967	478	23	,	,	PUNCT
ihlr-18967	478	24	losing	lose	VERB
ihlr-18967	478	25	such	such	DET
ihlr-18967	478	26	a	a	DET
ihlr-18967	478	27	large	large	ADJ
ihlr-18967	478	28	amount	amount	NOUN
ihlr-18967	478	29	of	of	ADP
ihlr-18967	478	30	revenue	revenue	NOUN
ihlr-18967	478	31	will	will	AUX
ihlr-18967	478	32	disincentivize	disincentivize	VERB
ihlr-18967	478	33	pioneer	pioneer	NOUN
ihlr-18967	478	34	manufacturers	manufacturer	NOUN
ihlr-18967	478	35	from	from	ADP
ihlr-18967	478	36	developing	develop	VERB
ihlr-18967	478	37	new	new	ADJ
ihlr-18967	478	38	drugs	drug	NOUN
ihlr-18967	478	39	in	in	ADP
ihlr-18967	478	40	the	the	DET
ihlr-18967	478	41	future	future	NOUN
ihlr-18967	478	42	.	.	PUNCT
ihlr-18967	479	1	on	on	ADP
ihlr-18967	479	2	the	the	DET
ihlr-18967	479	3	other	other	ADJ
ihlr-18967	479	4	hand	hand	NOUN
ihlr-18967	479	5	,	,	PUNCT
ihlr-18967	479	6	pioneer	pioneer	NOUN
ihlr-18967	479	7	manufacturers	manufacturer	NOUN
ihlr-18967	479	8	may	may	AUX
ihlr-18967	479	9	not	not	PART
ihlr-18967	479	10	suffer	suffer	VERB
ihlr-18967	479	11	any	any	DET
ihlr-18967	479	12	substantial	substantial	ADJ
ihlr-18967	479	13	loss	loss	NOUN
ihlr-18967	479	14	of	of	ADP
ihlr-18967	479	15	revenue	revenue	NOUN
ihlr-18967	479	16	.	.	PUNCT
ihlr-18967	480	1	generic	generic	ADJ
ihlr-18967	480	2	manufacturers	manufacturer	NOUN
ihlr-18967	480	3	take	take	VERB
ihlr-18967	480	4	into	into	ADP
ihlr-18967	480	5	account	account	NOUN
ihlr-18967	480	6	many	many	ADJ
ihlr-18967	480	7	factors	factor	NOUN
ihlr-18967	480	8	,	,	PUNCT
ihlr-18967	480	9	like	like	ADP
ihlr-18967	480	10	most	most	ADJ
ihlr-18967	480	11	other	other	ADJ
ihlr-18967	480	12	businesses	business	NOUN
ihlr-18967	480	13	,	,	PUNCT
ihlr-18967	480	14	before	before	ADP
ihlr-18967	480	15	choosing	choose	VERB
ihlr-18967	480	16	to	to	PART
ihlr-18967	480	17	invest	invest	VERB
ihlr-18967	480	18	in	in	ADP
ihlr-18967	480	19	a	a	DET
ihlr-18967	480	20	product	product	NOUN
ihlr-18967	480	21	.	.	PUNCT
ihlr-18967	481	1	one	one	NUM
ihlr-18967	481	2	report	report	NOUN
ihlr-18967	481	3	which	which	PRON
ihlr-18967	481	4	polled	poll	VERB
ihlr-18967	481	5	generic	generic	ADJ
ihlr-18967	481	6	manufacturers	manufacturer	NOUN
ihlr-18967	481	7	,	,	PUNCT
ihlr-18967	481	8	and	and	CCONJ
ihlr-18967	481	9	had	have	AUX
ihlr-18967	481	10	it	it	PRON
ihlr-18967	481	11	rank	rank	VERB
ihlr-18967	481	12	its	its	PRON
ihlr-18967	481	13	most	most	ADV
ihlr-18967	481	14	important	important	ADJ
ihlr-18967	481	15	factors	factor	NOUN
ihlr-18967	481	16	affecting	affect	VERB
ihlr-18967	481	17	investment	investment	NOUN
ihlr-18967	481	18	decisions	decision	NOUN
ihlr-18967	481	19	,	,	PUNCT
ihlr-18967	481	20	found	find	VERB
ihlr-18967	481	21	that	that	SCONJ
ihlr-18967	481	22	ability	ability	NOUN
ihlr-18967	481	23	to	to	PART
ihlr-18967	481	24	settle	settle	VERB
ihlr-18967	481	25	litigation	litigation	NOUN
ihlr-18967	481	26	was	be	AUX
ihlr-18967	481	27	more	more	ADV
ihlr-18967	481	28	important	important	ADJ
ihlr-18967	481	29	than	than	ADP
ihlr-18967	481	30	items	item	NOUN
ihlr-18967	481	31	such	such	ADJ
ihlr-18967	481	32	as	as	ADP
ihlr-18967	481	33	number	number	NOUN
ihlr-18967	481	34	of	of	ADP
ihlr-18967	481	35	patents	patent	NOUN
ihlr-18967	481	36	or	or	CCONJ
ihlr-18967	481	37	market	market	NOUN
ihlr-18967	481	38	size.158	size.158	VERB
ihlr-18967	481	39	this	this	DET
ihlr-18967	481	40	finding	finding	NOUN
ihlr-18967	481	41	shows	show	VERB
ihlr-18967	481	42	that	that	SCONJ
ihlr-18967	481	43	in	in	ADP
ihlr-18967	481	44	some	some	DET
ihlr-18967	481	45	circumstances	circumstance	NOUN
ihlr-18967	481	46	,	,	PUNCT
ihlr-18967	481	47	a	a	DET
ihlr-18967	481	48	generic	generic	ADJ
ihlr-18967	481	49	manufacturer	manufacturer	NOUN
ihlr-18967	481	50	may	may	AUX
ihlr-18967	481	51	be	be	AUX
ihlr-18967	481	52	influenced	influence	VERB
ihlr-18967	481	53	by	by	ADP
ihlr-18967	481	54	a	a	DET
ihlr-18967	481	55	decreased	decrease	VERB
ihlr-18967	481	56	likelihood	likelihood	NOUN
ihlr-18967	481	57	of	of	ADP
ihlr-18967	481	58	ability	ability	NOUN
ihlr-18967	481	59	to	to	PART
ihlr-18967	481	60	settle	settle	VERB
ihlr-18967	481	61	.	.	PUNCT
ihlr-18967	482	1	as	as	ADP
ihlr-18967	482	2	a	a	DET
ihlr-18967	482	3	result	result	NOUN
ihlr-18967	482	4	,	,	PUNCT
ihlr-18967	482	5	generic	generic	ADJ
ihlr-18967	482	6	manufacturers	manufacturer	NOUN
ihlr-18967	482	7	in	in	ADP
ihlr-18967	482	8	the	the	DET
ihlr-18967	482	9	future	future	NOUN
ihlr-18967	482	10	may	may	AUX
ihlr-18967	482	11	not	not	PART
ihlr-18967	482	12	invest	invest	VERB
ihlr-18967	482	13	in	in	ADP
ihlr-18967	482	14	as	as	ADV
ihlr-18967	482	15	many	many	ADJ
ihlr-18967	482	16	products	product	NOUN
ihlr-18967	482	17	and	and	CCONJ
ihlr-18967	482	18	subsequently	subsequently	ADV
ihlr-18967	482	19	,	,	PUNCT
ihlr-18967	482	20	file	file	VERB
ihlr-18967	482	21	fewer	few	ADJ
ihlr-18967	482	22	andas	anda	NOUN
ihlr-18967	482	23	under	under	ADP
ihlr-18967	482	24	the	the	DET
ihlr-18967	482	25	paragraph	paragraph	NOUN
ihlr-18967	482	26	iv	iv	NUM
ihlr-18967	482	27	route	route	NOUN
ihlr-18967	482	28	.	.	PUNCT
ihlr-18967	483	1	third	third	ADV
ihlr-18967	483	2	,	,	PUNCT
ihlr-18967	483	3	reverse	reverse	ADJ
ihlr-18967	483	4	payment	payment	NOUN
ihlr-18967	483	5	settlements	settlement	NOUN
ihlr-18967	483	6	may	may	AUX
ihlr-18967	483	7	be	be	AUX
ihlr-18967	483	8	uncertain	uncertain	ADJ
ihlr-18967	483	9	and	and	CCONJ
ihlr-18967	483	10	dangerous	dangerous	ADJ
ihlr-18967	483	11	to	to	PART
ihlr-18967	483	12	enter	enter	VERB
ihlr-18967	483	13	into	into	ADP
ihlr-18967	483	14	,	,	PUNCT
ihlr-18967	483	15	and	and	CCONJ
ihlr-18967	483	16	as	as	ADP
ihlr-18967	483	17	a	a	DET
ihlr-18967	483	18	result	result	NOUN
ihlr-18967	483	19	manufacturers	manufacturer	NOUN
ihlr-18967	483	20	156	156	NUM
ihlr-18967	483	21	ftc	ftc	PROPN
ihlr-18967	483	22	v.	v.	PROPN
ihlr-18967	483	23	watson	watson	PROPN
ihlr-18967	483	24	pharms	pharms	PROPN
ihlr-18967	483	25	.	.	PUNCT
ihlr-18967	483	26	,	,	PUNCT
ihlr-18967	483	27	inc	inc	PROPN
ihlr-18967	483	28	.	.	PROPN
ihlr-18967	483	29	677	677	NUM
ihlr-18967	483	30	f.3d	f.3d	NUM
ihlr-18967	483	31	1298	1298	NUM
ihlr-18967	483	32	,	,	PUNCT
ihlr-18967	483	33	1305	1305	NUM
ihlr-18967	483	34	(	(	PUNCT
ihlr-18967	483	35	11th	11th	ADJ
ihlr-18967	483	36	cir	cir	NOUN
ihlr-18967	483	37	.	.	PROPN
ihlr-18967	483	38	2012	2012	NUM
ihlr-18967	483	39	)	)	PUNCT
ihlr-18967	483	40	.	.	PUNCT
ihlr-18967	484	1	157	157	NUM
ihlr-18967	484	2	pressure	pressure	NOUN
ihlr-18967	484	3	from	from	ADP
ihlr-18967	484	4	generic	generic	ADJ
ihlr-18967	484	5	drugs	drug	NOUN
ihlr-18967	484	6	shrinks	shrink	VERB
ihlr-18967	484	7	profit	profit	NOUN
ihlr-18967	484	8	at	at	ADP
ihlr-18967	484	9	pfizer	pfizer	PROPN
ihlr-18967	484	10	,	,	PUNCT
ihlr-18967	484	11	n.y	n.y	PROPN
ihlr-18967	484	12	.	.	PROPN
ihlr-18967	484	13	times	times	PROPN
ihlr-18967	484	14	(	(	PUNCT
ihlr-18967	484	15	oct	oct	PROPN
ihlr-18967	484	16	.	.	PROPN
ihlr-18967	484	17	29	29	NUM
ihlr-18967	484	18	,	,	PUNCT
ihlr-18967	484	19	2013	2013	NUM
ihlr-18967	484	20	)	)	PUNCT
ihlr-18967	484	21	,	,	PUNCT
ihlr-18967	484	22	http://www.nytimes.com/2013/10/30/business/	http://www.nytimes.com/2013/10/30/business/	ADP
ihlr-18967	484	23	pressurefrom-generic-drugs-shrinks-profit-at-pfizer.html?_r=0	pressurefrom-generic-drugs-shrinks-profit-at-pfizer.html?_r=0	PROPN
ihlr-18967	484	24	.	.	PUNCT
ihlr-18967	485	1	158	158	NUM
ihlr-18967	485	2	dickey	dickey	PROPN
ihlr-18967	485	3	&	&	CCONJ
ihlr-18967	485	4	orszag	orszag	PROPN
ihlr-18967	485	5	,	,	PUNCT
ihlr-18967	485	6	supra	supra	PROPN
ihlr-18967	485	7	note	note	PROPN
ihlr-18967	485	8	153	153	NUM
ihlr-18967	485	9	(	(	PUNCT
ihlr-18967	485	10	finding	find	VERB
ihlr-18967	485	11	that	that	DET
ihlr-18967	485	12	ability	ability	NOUN
ihlr-18967	485	13	to	to	PART
ihlr-18967	485	14	settle	settle	VERB
ihlr-18967	485	15	litigation	litigation	NOUN
ihlr-18967	485	16	had	have	VERB
ihlr-18967	485	17	an	an	DET
ihlr-18967	485	18	average	average	ADJ
ihlr-18967	485	19	importance	importance	NOUN
ihlr-18967	485	20	of	of	ADP
ihlr-18967	485	21	2.93/5	2.93/5	NUM
ihlr-18967	485	22	)	)	PUNCT
ihlr-18967	485	23	.	.	PUNCT
ihlr-18967	486	1	452	452	NUM
ihlr-18967	486	2	indiana	indiana	PROPN
ihlr-18967	486	3	health	health	PROPN
ihlr-18967	486	4	law	law	PROPN
ihlr-18967	486	5	review	review	NOUN
ihlr-18967	486	6	vol	vol	NOUN
ihlr-18967	486	7	.	.	PUNCT
ihlr-18967	487	1	12:1	12:1	NUM
ihlr-18967	487	2	may	may	AUX
ihlr-18967	487	3	risk	risk	VERB
ihlr-18967	487	4	millions	million	NOUN
ihlr-18967	487	5	of	of	ADP
ihlr-18967	487	6	dollars	dollar	NOUN
ihlr-18967	487	7	on	on	ADP
ihlr-18967	487	8	the	the	DET
ihlr-18967	487	9	outcome	outcome	NOUN
ihlr-18967	487	10	of	of	ADP
ihlr-18967	487	11	litigation.159	litigation.159	PROPN
ihlr-18967	487	12	this	this	PRON
ihlr-18967	487	13	may	may	AUX
ihlr-18967	487	14	be	be	AUX
ihlr-18967	487	15	seen	see	VERB
ihlr-18967	487	16	as	as	ADP
ihlr-18967	487	17	a	a	DET
ihlr-18967	487	18	large	large	ADJ
ihlr-18967	487	19	burden	burden	NOUN
ihlr-18967	487	20	placed	place	VERB
ihlr-18967	487	21	on	on	ADP
ihlr-18967	487	22	manufacturers	manufacturer	NOUN
ihlr-18967	487	23	because	because	SCONJ
ihlr-18967	487	24	“	"	PUNCT
ihlr-18967	487	25	[	[	X
ihlr-18967	487	26	m]ost	m]ost	X
ihlr-18967	487	27	patent	patent	NOUN
ihlr-18967	487	28	litigation	litigation	NOUN
ihlr-18967	487	29	is	be	AUX
ihlr-18967	487	30	resolved	resolve	VERB
ihlr-18967	487	31	through	through	ADP
ihlr-18967	487	32	a	a	DET
ihlr-18967	487	33	settlement	settlement	NOUN
ihlr-18967	487	34	between	between	ADP
ihlr-18967	487	35	the	the	DET
ihlr-18967	487	36	parties	party	NOUN
ihlr-18967	487	37	.	.	PUNCT
ihlr-18967	488	1	”160	”160	PROPN
ihlr-18967	489	1	moreover	moreover	ADV
ihlr-18967	489	2	,	,	PUNCT
ihlr-18967	489	3	this	this	DET
ihlr-18967	489	4	uncertainty	uncertainty	NOUN
ihlr-18967	489	5	and	and	CCONJ
ihlr-18967	489	6	influence	influence	NOUN
ihlr-18967	489	7	on	on	ADP
ihlr-18967	489	8	reverse	reverse	ADJ
ihlr-18967	489	9	payment	payment	NOUN
ihlr-18967	489	10	settlements	settlement	NOUN
ihlr-18967	489	11	will	will	AUX
ihlr-18967	489	12	vary	vary	VERB
ihlr-18967	489	13	as	as	SCONJ
ihlr-18967	489	14	some	some	DET
ihlr-18967	489	15	companies	company	NOUN
ihlr-18967	489	16	may	may	AUX
ihlr-18967	489	17	be	be	AUX
ihlr-18967	489	18	more	more	ADJ
ihlr-18967	489	19	risk	risk	NOUN
ihlr-18967	489	20	averse	averse	ADJ
ihlr-18967	489	21	than	than	ADP
ihlr-18967	489	22	others	other	NOUN
ihlr-18967	489	23	.	.	PUNCT
ihlr-18967	490	1	the	the	DET
ihlr-18967	490	2	supreme	supreme	PROPN
ihlr-18967	490	3	court	court	PROPN
ihlr-18967	490	4	in	in	ADP
ihlr-18967	490	5	actavis	actavis	PROPN
ihlr-18967	490	6	chose	choose	VERB
ihlr-18967	490	7	not	not	PART
ihlr-18967	490	8	to	to	PART
ihlr-18967	490	9	establish	establish	VERB
ihlr-18967	490	10	a	a	DET
ihlr-18967	490	11	bright	bright	ADJ
ihlr-18967	490	12	line	line	NOUN
ihlr-18967	490	13	rule	rule	NOUN
ihlr-18967	490	14	and	and	CCONJ
ihlr-18967	490	15	instead	instead	ADV
ihlr-18967	490	16	laid	lay	VERB
ihlr-18967	490	17	out	out	ADP
ihlr-18967	490	18	five	five	NUM
ihlr-18967	490	19	general	general	ADJ
ihlr-18967	490	20	considerations	consideration	NOUN
ihlr-18967	490	21	for	for	ADP
ihlr-18967	490	22	lower	low	ADJ
ihlr-18967	490	23	courts.161	courts.161	NOUN
ihlr-18967	490	24	in	in	ADP
ihlr-18967	490	25	doing	do	VERB
ihlr-18967	490	26	so	so	ADV
ihlr-18967	490	27	,	,	PUNCT
ihlr-18967	490	28	until	until	SCONJ
ihlr-18967	490	29	precedent	precedent	NOUN
ihlr-18967	490	30	is	be	AUX
ihlr-18967	490	31	established	establish	VERB
ihlr-18967	490	32	,	,	PUNCT
ihlr-18967	490	33	there	there	PRON
ihlr-18967	490	34	will	will	AUX
ihlr-18967	490	35	be	be	AUX
ihlr-18967	490	36	uncertainty	uncertainty	NOUN
ihlr-18967	490	37	on	on	ADP
ihlr-18967	490	38	whether	whether	SCONJ
ihlr-18967	490	39	or	or	CCONJ
ihlr-18967	490	40	not	not	PART
ihlr-18967	490	41	a	a	DET
ihlr-18967	490	42	reverse	reverse	ADJ
ihlr-18967	490	43	payment	payment	NOUN
ihlr-18967	490	44	settlement	settlement	NOUN
ihlr-18967	490	45	is	be	AUX
ihlr-18967	490	46	anticompetitive	anticompetitive	ADJ
ihlr-18967	490	47	.	.	PUNCT
ihlr-18967	491	1	even	even	ADV
ihlr-18967	491	2	after	after	ADP
ihlr-18967	491	3	the	the	DET
ihlr-18967	491	4	advent	advent	NOUN
ihlr-18967	491	5	of	of	ADP
ihlr-18967	491	6	precedent	precedent	NOUN
ihlr-18967	491	7	,	,	PUNCT
ihlr-18967	491	8	there	there	PRON
ihlr-18967	491	9	will	will	AUX
ihlr-18967	491	10	still	still	ADV
ihlr-18967	491	11	be	be	AUX
ihlr-18967	491	12	uncertainty	uncertainty	NOUN
ihlr-18967	491	13	between	between	ADP
ihlr-18967	491	14	the	the	DET
ihlr-18967	491	15	different	different	ADJ
ihlr-18967	491	16	circuits	circuit	NOUN
ihlr-18967	491	17	.	.	PUNCT
ihlr-18967	492	1	this	this	DET
ihlr-18967	492	2	uncertainty	uncertainty	NOUN
ihlr-18967	492	3	will	will	AUX
ihlr-18967	492	4	lead	lead	VERB
ihlr-18967	492	5	manufacturers	manufacturer	NOUN
ihlr-18967	492	6	to	to	PART
ihlr-18967	492	7	avoid	avoid	VERB
ihlr-18967	492	8	settlements	settlement	NOUN
ihlr-18967	492	9	and	and	CCONJ
ihlr-18967	492	10	litigate	litigate	VERB
ihlr-18967	492	11	to	to	ADP
ihlr-18967	492	12	judgment	judgment	NOUN
ihlr-18967	492	13	.	.	PUNCT
ihlr-18967	493	1	in	in	ADP
ihlr-18967	493	2	doing	do	VERB
ihlr-18967	493	3	so	so	ADV
ihlr-18967	493	4	,	,	PUNCT
ihlr-18967	493	5	funds	fund	NOUN
ihlr-18967	493	6	that	that	PRON
ihlr-18967	493	7	could	could	AUX
ihlr-18967	493	8	be	be	AUX
ihlr-18967	493	9	spent	spend	VERB
ihlr-18967	493	10	on	on	ADP
ihlr-18967	493	11	research	research	NOUN
ihlr-18967	493	12	and	and	CCONJ
ihlr-18967	493	13	development	development	NOUN
ihlr-18967	493	14	will	will	AUX
ihlr-18967	493	15	be	be	AUX
ihlr-18967	493	16	funneled	funnel	VERB
ihlr-18967	493	17	into	into	ADP
ihlr-18967	493	18	costly	costly	ADJ
ihlr-18967	493	19	litigation	litigation	NOUN
ihlr-18967	493	20	.	.	PUNCT
ihlr-18967	494	1	for	for	ADP
ihlr-18967	494	2	instance	instance	NOUN
ihlr-18967	494	3	,	,	PUNCT
ihlr-18967	494	4	in	in	ADP
ihlr-18967	494	5	the	the	DET
ihlr-18967	494	6	case	case	NOUN
ihlr-18967	494	7	of	of	ADP
ihlr-18967	494	8	a	a	DET
ihlr-18967	494	9	pioneer	pioneer	NOUN
ihlr-18967	494	10	manufacturer	manufacturer	NOUN
ihlr-18967	494	11	,	,	PUNCT
ihlr-18967	494	12	it	it	PRON
ihlr-18967	494	13	will	will	AUX
ihlr-18967	494	14	be	be	AUX
ihlr-18967	494	15	risking	risk	VERB
ihlr-18967	494	16	billions	billion	NOUN
ihlr-18967	494	17	of	of	ADP
ihlr-18967	494	18	dollars	dollar	NOUN
ihlr-18967	494	19	on	on	ADP
ihlr-18967	494	20	a	a	DET
ihlr-18967	494	21	district	district	NOUN
ihlr-18967	494	22	court	court	NOUN
ihlr-18967	494	23	’s	’s	PART
ihlr-18967	494	24	interpretation	interpretation	NOUN
ihlr-18967	494	25	of	of	ADP
ihlr-18967	494	26	actavis	actavis	PROPN
ihlr-18967	494	27	.	.	PUNCT
ihlr-18967	495	1	while	while	SCONJ
ihlr-18967	495	2	the	the	DET
ihlr-18967	495	3	rule	rule	NOUN
ihlr-18967	495	4	of	of	ADP
ihlr-18967	495	5	reason	reason	NOUN
ihlr-18967	495	6	will	will	AUX
ihlr-18967	495	7	place	place	VERB
ihlr-18967	495	8	small	small	ADJ
ihlr-18967	495	9	burdens	burden	NOUN
ihlr-18967	495	10	on	on	ADP
ihlr-18967	495	11	manufacturers	manufacturer	NOUN
ihlr-18967	495	12	,	,	PUNCT
ihlr-18967	495	13	any	any	DET
ihlr-18967	495	14	presumption	presumption	NOUN
ihlr-18967	495	15	of	of	ADP
ihlr-18967	495	16	anticompetitiveness	anticompetitiveness	NOUN
ihlr-18967	495	17	established	establish	VERB
ihlr-18967	495	18	by	by	ADP
ihlr-18967	495	19	congress	congress	PROPN
ihlr-18967	495	20	will	will	AUX
ihlr-18967	495	21	cause	cause	VERB
ihlr-18967	495	22	more	more	ADV
ihlr-18967	495	23	severe	severe	ADJ
ihlr-18967	495	24	burdens	burden	NOUN
ihlr-18967	495	25	on	on	ADP
ihlr-18967	495	26	manufacturers	manufacturer	NOUN
ihlr-18967	495	27	.	.	PUNCT
ihlr-18967	496	1	b.	b.	PROPN
ihlr-18967	496	2	complying	comply	VERB
ihlr-18967	496	3	with	with	ADP
ihlr-18967	496	4	the	the	DET
ihlr-18967	496	5	actavis	actavis	ADJ
ihlr-18967	496	6	framework	framework	NOUN
ihlr-18967	496	7	:	:	PUNCT
ihlr-18967	496	8	crafting	craft	VERB
ihlr-18967	496	9	procompetitive	procompetitive	ADJ
ihlr-18967	496	10	reverse	reverse	ADJ
ihlr-18967	496	11	payment	payment	NOUN
ihlr-18967	496	12	settlements	settlement	NOUN
ihlr-18967	496	13	in	in	ADP
ihlr-18967	496	14	actavis	actavi	NOUN
ihlr-18967	496	15	,	,	PUNCT
ihlr-18967	496	16	the	the	DET
ihlr-18967	496	17	court	court	NOUN
ihlr-18967	496	18	held	hold	VERB
ihlr-18967	496	19	that	that	SCONJ
ihlr-18967	496	20	“	"	PUNCT
ihlr-18967	496	21	the	the	DET
ihlr-18967	496	22	likelihood	likelihood	NOUN
ihlr-18967	496	23	of	of	ADP
ihlr-18967	496	24	a	a	DET
ihlr-18967	496	25	reverse	reverse	ADJ
ihlr-18967	496	26	payment	payment	NOUN
ihlr-18967	496	27	bringing	bring	VERB
ihlr-18967	496	28	about	about	ADP
ihlr-18967	496	29	anticompetitive	anticompetitive	ADJ
ihlr-18967	496	30	effects	effect	NOUN
ihlr-18967	496	31	[	[	X
ihlr-18967	496	32	(	(	PUNCT
ihlr-18967	496	33	a	a	NOUN
ihlr-18967	496	34	)	)	PUNCT
ihlr-18967	496	35	]	]	PUNCT
ihlr-18967	496	36	depends	depend	VERB
ihlr-18967	496	37	upon	upon	SCONJ
ihlr-18967	496	38	its	its	PRON
ihlr-18967	496	39	size	size	NOUN
ihlr-18967	496	40	,	,	PUNCT
ihlr-18967	496	41	[	[	X
ihlr-18967	496	42	(	(	PUNCT
ihlr-18967	496	43	b	b	NOUN
ihlr-18967	496	44	)	)	PUNCT
ihlr-18967	496	45	]	]	PUNCT
ihlr-18967	496	46	its	its	PRON
ihlr-18967	496	47	scale	scale	NOUN
ihlr-18967	496	48	in	in	ADP
ihlr-18967	496	49	relation	relation	NOUN
ihlr-18967	496	50	to	to	ADP
ihlr-18967	496	51	the	the	DET
ihlr-18967	496	52	payor	payor	NOUN
ihlr-18967	496	53	’s	’s	PART
ihlr-18967	496	54	anticipated	anticipate	VERB
ihlr-18967	496	55	future	future	ADJ
ihlr-18967	496	56	litigation	litigation	NOUN
ihlr-18967	496	57	costs	cost	NOUN
ihlr-18967	496	58	,	,	PUNCT
ihlr-18967	496	59	[	[	X
ihlr-18967	496	60	(	(	PUNCT
ihlr-18967	496	61	c	c	NOUN
ihlr-18967	496	62	)	)	PUNCT
ihlr-18967	496	63	]	]	PUNCT
ihlr-18967	497	1	its	its	PRON
ihlr-18967	497	2	independence	independence	NOUN
ihlr-18967	497	3	from	from	ADP
ihlr-18967	497	4	other	other	ADJ
ihlr-18967	497	5	services	service	NOUN
ihlr-18967	497	6	for	for	ADP
ihlr-18967	497	7	which	which	PRON
ihlr-18967	497	8	it	it	PRON
ihlr-18967	497	9	might	might	AUX
ihlr-18967	497	10	represent	represent	VERB
ihlr-18967	497	11	payment	payment	NOUN
ihlr-18967	497	12	,	,	PUNCT
ihlr-18967	497	13	159	159	NUM
ihlr-18967	497	14	jennifer	jennifer	PROPN
ihlr-18967	497	15	driscoll	driscoll	PROPN
ihlr-18967	497	16	-	-	PUNCT
ihlr-18967	497	17	chippendale	chippendale	PROPN
ihlr-18967	497	18	&	&	CCONJ
ihlr-18967	497	19	bradley	bradley	PROPN
ihlr-18967	497	20	graveline	graveline	PROPN
ihlr-18967	497	21	,	,	PUNCT
ihlr-18967	497	22	ftc	ftc	PROPN
ihlr-18967	497	23	v.	v.	ADP
ihlr-18967	497	24	actavis	actavis	PROPN
ihlr-18967	497	25	:	:	PUNCT
ihlr-18967	497	26	what	what	PRON
ihlr-18967	497	27	does	do	AUX
ihlr-18967	497	28	it	it	PRON
ihlr-18967	497	29	mean	mean	VERB
ihlr-18967	497	30	for	for	ADP
ihlr-18967	497	31	reverse	reverse	NOUN
ihlr-18967	497	32	-	-	PUNCT
ihlr-18967	497	33	payment	payment	NOUN
ihlr-18967	497	34	settlement	settlement	NOUN
ihlr-18967	497	35	?	?	PUNCT
ihlr-18967	497	36	,	,	PUNCT
ihlr-18967	497	37	jdsupra	jdsupra	PROPN
ihlr-18967	497	38	business	business	PROPN
ihlr-18967	497	39	advisor	advisor	PROPN
ihlr-18967	497	40	(	(	PUNCT
ihlr-18967	497	41	june	june	PROPN
ihlr-18967	497	42	24	24	NUM
ihlr-18967	497	43	,	,	PUNCT
ihlr-18967	497	44	2013	2013	NUM
ihlr-18967	497	45	)	)	PUNCT
ihlr-18967	497	46	,	,	PUNCT
ihlr-18967	497	47	http://www.jdsupra.com/legalnews/ftc-v-actavis-what-does-it-mean-forre-68321/.	http://www.jdsupra.com/legalnews/ftc-v-actavis-what-does-it-mean-forre-68321/.	PROPN
ihlr-18967	497	48	160	160	NUM
ihlr-18967	497	49	dickey	dickey	PROPN
ihlr-18967	497	50	,	,	PUNCT
ihlr-18967	497	51	supra	supra	PROPN
ihlr-18967	497	52	note	note	PROPN
ihlr-18967	497	53	142	142	NUM
ihlr-18967	497	54	,	,	PUNCT
ihlr-18967	497	55	at	at	ADP
ihlr-18967	497	56	373	373	NUM
ihlr-18967	497	57	-	-	SYM
ihlr-18967	497	58	74	74	NUM
ihlr-18967	497	59	(	(	PUNCT
ihlr-18967	497	60	citing	cite	VERB
ihlr-18967	497	61	carl	carl	PROPN
ihlr-18967	497	62	shapiro	shapiro	PROPN
ihlr-18967	497	63	,	,	PUNCT
ihlr-18967	497	64	antitrust	antitrust	ADJ
ihlr-18967	497	65	limits	limit	NOUN
ihlr-18967	497	66	to	to	ADP
ihlr-18967	497	67	patent	patent	NOUN
ihlr-18967	497	68	settlements	settlement	NOUN
ihlr-18967	497	69	,	,	PUNCT
ihlr-18967	497	70	43	43	NUM
ihlr-18967	497	71	rand	rand	NOUN
ihlr-18967	497	72	j.	j.	PROPN
ihlr-18967	497	73	of	of	ADP
ihlr-18967	497	74	econ	econ	PROPN
ihlr-18967	497	75	.	.	PUNCT
ihlr-18967	497	76	,	,	PUNCT
ihlr-18967	497	77	391	391	NUM
ihlr-18967	497	78	,	,	PUNCT
ihlr-18967	497	79	392	392	NUM
ihlr-18967	497	80	(	(	PUNCT
ihlr-18967	497	81	2003	2003	NUM
ihlr-18967	497	82	)	)	PUNCT
ihlr-18967	497	83	)	)	PUNCT
ihlr-18967	497	84	.	.	PUNCT
ihlr-18967	498	1	161	161	NUM
ihlr-18967	498	2	ftc	ftc	PROPN
ihlr-18967	498	3	v.	v.	ADP
ihlr-18967	498	4	actavis	actavis	PROPN
ihlr-18967	498	5	,	,	PUNCT
ihlr-18967	498	6	inc	inc	PROPN
ihlr-18967	498	7	.	.	PROPN
ihlr-18967	498	8	,	,	PUNCT
ihlr-18967	498	9	133	133	NUM
ihlr-18967	498	10	s.	s.	PROPN
ihlr-18967	498	11	ct	ct	PROPN
ihlr-18967	498	12	.	.	PROPN
ihlr-18967	498	13	2223	2223	NUM
ihlr-18967	498	14	,	,	PUNCT
ihlr-18967	498	15	2234	2234	NUM
ihlr-18967	498	16	-	-	SYM
ihlr-18967	498	17	37	37	NUM
ihlr-18967	498	18	(	(	PUNCT
ihlr-18967	498	19	2013	2013	NUM
ihlr-18967	498	20	)	)	PUNCT
ihlr-18967	498	21	.	.	PUNCT
ihlr-18967	499	1	http://dx.doi.org/10.2139/ssrn.273552	http://dx.doi.org/10.2139/ssrn.273552	X
ihlr-18967	499	2	2015	2015	NUM
ihlr-18967	499	3	rationale	rationale	NOUN
ihlr-18967	499	4	behind	behind	ADP
ihlr-18967	499	5	hatch	hatch	NOUN
ihlr-18967	499	6	-	-	PUNCT
ihlr-18967	499	7	waxman	waxman	PROPN
ihlr-18967	499	8	act	act	PROPN
ihlr-18967	499	9	and	and	CCONJ
ihlr-18967	499	10	patent	patent	NOUN
ihlr-18967	499	11	law	law	NOUN
ihlr-18967	499	12	453	453	NUM
ihlr-18967	499	13	and	and	CCONJ
ihlr-18967	499	14	[	[	X
ihlr-18967	499	15	(	(	PUNCT
ihlr-18967	499	16	d	d	NOUN
ihlr-18967	499	17	)	)	PUNCT
ihlr-18967	499	18	]	]	PUNCT
ihlr-18967	500	1	the	the	DET
ihlr-18967	500	2	lack	lack	NOUN
ihlr-18967	500	3	of	of	ADP
ihlr-18967	500	4	any	any	DET
ihlr-18967	500	5	other	other	ADJ
ihlr-18967	500	6	convincing	convincing	ADJ
ihlr-18967	500	7	justification	justification	NOUN
ihlr-18967	500	8	.	.	PUNCT
ihlr-18967	500	9	”162	”162	PUNCT
ihlr-18967	501	1	although	although	ADV
ihlr-18967	501	2	,	,	PUNCT
ihlr-18967	501	3	“	"	PUNCT
ihlr-18967	501	4	there	there	PRON
ihlr-18967	501	5	is	be	VERB
ihlr-18967	501	6	always	always	ADV
ihlr-18967	501	7	something	something	PRON
ihlr-18967	501	8	of	of	ADP
ihlr-18967	501	9	a	a	DET
ihlr-18967	501	10	sliding	slide	VERB
ihlr-18967	501	11	scale	scale	NOUN
ihlr-18967	501	12	in	in	ADP
ihlr-18967	501	13	appraising	appraise	VERB
ihlr-18967	501	14	reasonableness	reasonableness	NOUN
ihlr-18967	501	15	.	.	PUNCT
ihlr-18967	501	16	.	.	PUNCT
ihlr-18967	501	17	.	.	PUNCT
ihlr-18967	502	1	.”163	.”163	PUNCT
ihlr-18967	503	1	actavis	actavis	PROPN
ihlr-18967	503	2	correctly	correctly	ADV
ihlr-18967	503	3	held	hold	VERB
ihlr-18967	503	4	that	that	SCONJ
ihlr-18967	503	5	the	the	DET
ihlr-18967	503	6	rule	rule	NOUN
ihlr-18967	503	7	of	of	ADP
ihlr-18967	503	8	reason	reason	NOUN
ihlr-18967	503	9	is	be	AUX
ihlr-18967	503	10	appropriate	appropriate	ADJ
ihlr-18967	503	11	for	for	ADP
ihlr-18967	503	12	analyzing	analyze	VERB
ihlr-18967	503	13	reverse	reverse	ADJ
ihlr-18967	503	14	payment	payment	NOUN
ihlr-18967	503	15	settlements	settlement	NOUN
ihlr-18967	503	16	.	.	PUNCT
ihlr-18967	504	1	allowing	allow	VERB
ihlr-18967	504	2	pioneer	pioneer	NOUN
ihlr-18967	504	3	manufacturers	manufacturer	NOUN
ihlr-18967	504	4	to	to	PART
ihlr-18967	504	5	create	create	VERB
ihlr-18967	504	6	procompetitive	procompetitive	ADJ
ihlr-18967	504	7	reverse	reverse	ADJ
ihlr-18967	504	8	payment	payment	NOUN
ihlr-18967	504	9	settlements	settlement	NOUN
ihlr-18967	504	10	furthers	further	VERB
ihlr-18967	504	11	the	the	DET
ihlr-18967	504	12	intent	intent	NOUN
ihlr-18967	504	13	behind	behind	ADP
ihlr-18967	504	14	the	the	DET
ihlr-18967	504	15	hatch	hatch	NOUN
ihlr-18967	504	16	-	-	PUNCT
ihlr-18967	504	17	waxman	waxman	PROPN
ihlr-18967	504	18	act	act	NOUN
ihlr-18967	504	19	by	by	ADP
ihlr-18967	504	20	benefiting	benefit	VERB
ihlr-18967	504	21	both	both	PRON
ihlr-18967	504	22	consumers	consumer	NOUN
ihlr-18967	504	23	and	and	CCONJ
ihlr-18967	504	24	drug	drug	NOUN
ihlr-18967	504	25	manufacturers	manufacturer	NOUN
ihlr-18967	504	26	.	.	PUNCT
ihlr-18967	505	1	additionally	additionally	ADV
ihlr-18967	505	2	,	,	PUNCT
ihlr-18967	505	3	the	the	DET
ihlr-18967	505	4	motivation	motivation	NOUN
ihlr-18967	505	5	created	create	VERB
ihlr-18967	505	6	by	by	ADP
ihlr-18967	505	7	patent	patent	NOUN
ihlr-18967	505	8	law	law	NOUN
ihlr-18967	505	9	to	to	PART
ihlr-18967	505	10	develop	develop	VERB
ihlr-18967	505	11	new	new	ADJ
ihlr-18967	505	12	drugs	drug	NOUN
ihlr-18967	505	13	will	will	AUX
ihlr-18967	505	14	not	not	PART
ihlr-18967	505	15	be	be	AUX
ihlr-18967	505	16	at	at	ADP
ihlr-18967	505	17	risk	risk	NOUN
ihlr-18967	505	18	because	because	SCONJ
ihlr-18967	505	19	settlements	settlement	NOUN
ihlr-18967	505	20	protect	protect	VERB
ihlr-18967	505	21	a	a	DET
ihlr-18967	505	22	manufacturer	manufacturer	NOUN
ihlr-18967	505	23	’s	’s	PART
ihlr-18967	505	24	rights	right	NOUN
ihlr-18967	505	25	under	under	ADP
ihlr-18967	505	26	its	its	PRON
ihlr-18967	505	27	patent	patent	NOUN
ihlr-18967	505	28	.	.	PUNCT
ihlr-18967	506	1	conversely	conversely	ADV
ihlr-18967	506	2	,	,	PUNCT
ihlr-18967	506	3	any	any	DET
ihlr-18967	506	4	act	act	NOUN
ihlr-18967	506	5	by	by	ADP
ihlr-18967	506	6	congress	congress	PROPN
ihlr-18967	506	7	to	to	PART
ihlr-18967	506	8	create	create	VERB
ihlr-18967	506	9	a	a	DET
ihlr-18967	506	10	presumption	presumption	NOUN
ihlr-18967	506	11	that	that	SCONJ
ihlr-18967	506	12	reverse	reverse	ADJ
ihlr-18967	506	13	payment	payment	NOUN
ihlr-18967	506	14	settlements	settlement	NOUN
ihlr-18967	506	15	are	be	AUX
ihlr-18967	506	16	anticompetitive164	anticompetitive164	PROPN
ihlr-18967	506	17	will	will	AUX
ihlr-18967	506	18	adversely	adversely	ADV
ihlr-18967	506	19	affect	affect	VERB
ihlr-18967	506	20	the	the	DET
ihlr-18967	506	21	rationale	rationale	NOUN
ihlr-18967	506	22	behind	behind	ADP
ihlr-18967	506	23	the	the	DET
ihlr-18967	506	24	hatch	hatch	NOUN
ihlr-18967	506	25	-	-	PUNCT
ihlr-18967	506	26	waxman	waxman	PROPN
ihlr-18967	506	27	act	act	PROPN
ihlr-18967	506	28	and	and	CCONJ
ihlr-18967	506	29	patent	patent	NOUN
ihlr-18967	506	30	law	law	NOUN
ihlr-18967	506	31	.	.	PUNCT
ihlr-18967	507	1	the	the	DET
ihlr-18967	507	2	following	follow	VERB
ihlr-18967	507	3	is	be	AUX
ihlr-18967	507	4	an	an	DET
ihlr-18967	507	5	analysis	analysis	NOUN
ihlr-18967	507	6	of	of	ADP
ihlr-18967	507	7	relevant	relevant	ADJ
ihlr-18967	507	8	antitrust	antitrust	ADJ
ihlr-18967	507	9	factors	factor	NOUN
ihlr-18967	507	10	,	,	PUNCT
ihlr-18967	507	11	the	the	DET
ihlr-18967	507	12	court	court	NOUN
ihlr-18967	507	13	’s	’s	PART
ihlr-18967	507	14	considerations	consideration	NOUN
ihlr-18967	507	15	in	in	ADP
ihlr-18967	507	16	actavis	actavis	NOUN
ihlr-18967	507	17	,	,	PUNCT
ihlr-18967	507	18	and	and	CCONJ
ihlr-18967	507	19	other	other	ADJ
ihlr-18967	507	20	relevant	relevant	ADJ
ihlr-18967	507	21	considerations	consideration	NOUN
ihlr-18967	507	22	which	which	PRON
ihlr-18967	507	23	support	support	VERB
ihlr-18967	507	24	the	the	DET
ihlr-18967	507	25	rationale	rationale	NOUN
ihlr-18967	507	26	behind	behind	ADP
ihlr-18967	507	27	the	the	DET
ihlr-18967	507	28	hatch	hatch	NOUN
ihlr-18967	507	29	-	-	PUNCT
ihlr-18967	507	30	waxman	waxman	PROPN
ihlr-18967	507	31	act	act	PROPN
ihlr-18967	507	32	and	and	CCONJ
ihlr-18967	507	33	patent	patent	NOUN
ihlr-18967	507	34	law	law	NOUN
ihlr-18967	507	35	.	.	PUNCT
ihlr-18967	508	1	1	1	X
ihlr-18967	508	2	.	.	X
ihlr-18967	508	3	what	what	DET
ihlr-18967	508	4	type	type	NOUN
ihlr-18967	508	5	of	of	ADP
ihlr-18967	508	6	payments	payment	NOUN
ihlr-18967	508	7	implicate	implicate	VERB
ihlr-18967	508	8	the	the	DET
ihlr-18967	508	9	actavis	actavis	ADJ
ihlr-18967	508	10	analysis	analysis	NOUN
ihlr-18967	508	11	?	?	PUNCT
ihlr-18967	509	1	when	when	SCONJ
ihlr-18967	509	2	does	do	AUX
ihlr-18967	509	3	actavis	actavis	NOUN
ihlr-18967	509	4	apply	apply	VERB
ihlr-18967	509	5	?	?	PUNCT
ihlr-18967	510	1	does	do	AUX
ihlr-18967	510	2	it	it	PRON
ihlr-18967	510	3	apply	apply	VERB
ihlr-18967	510	4	to	to	ADP
ihlr-18967	510	5	only	only	ADJ
ihlr-18967	510	6	monetary	monetary	ADJ
ihlr-18967	510	7	payments	payment	NOUN
ihlr-18967	510	8	?	?	PUNCT
ihlr-18967	511	1	the	the	DET
ihlr-18967	511	2	supreme	supreme	PROPN
ihlr-18967	511	3	court	court	PROPN
ihlr-18967	511	4	has	have	AUX
ihlr-18967	511	5	stated	state	VERB
ihlr-18967	511	6	“	"	PUNCT
ihlr-18967	511	7	the	the	DET
ihlr-18967	511	8	rule	rule	NOUN
ihlr-18967	511	9	of	of	ADP
ihlr-18967	511	10	reason	reason	NOUN
ihlr-18967	511	11	requires	require	VERB
ihlr-18967	511	12	the	the	DET
ihlr-18967	511	13	factfinder	factfinder	NOUN
ihlr-18967	511	14	to	to	PART
ihlr-18967	511	15	decide	decide	VERB
ihlr-18967	511	16	whether	whether	SCONJ
ihlr-18967	511	17	under	under	ADP
ihlr-18967	511	18	all	all	DET
ihlr-18967	511	19	the	the	DET
ihlr-18967	511	20	circumstances	circumstance	NOUN
ihlr-18967	511	21	of	of	ADP
ihlr-18967	511	22	the	the	DET
ihlr-18967	511	23	case	case	NOUN
ihlr-18967	511	24	the	the	DET
ihlr-18967	511	25	restrictive	restrictive	ADJ
ihlr-18967	511	26	practice	practice	NOUN
ihlr-18967	511	27	imposes	impose	VERB
ihlr-18967	511	28	an	an	DET
ihlr-18967	511	29	unreasonable	unreasonable	ADJ
ihlr-18967	511	30	restraint	restraint	NOUN
ihlr-18967	511	31	on	on	ADP
ihlr-18967	511	32	competition	competition	NOUN
ihlr-18967	511	33	.	.	PUNCT
ihlr-18967	512	1	”165	”165	PUNCT
ihlr-18967	512	2	a	a	DET
ihlr-18967	512	3	straightforward	straightforward	ADJ
ihlr-18967	512	4	reading	reading	NOUN
ihlr-18967	512	5	of	of	ADP
ihlr-18967	512	6	this	this	DET
ihlr-18967	512	7	statement	statement	NOUN
ihlr-18967	512	8	would	would	AUX
ihlr-18967	512	9	lead	lead	VERB
ihlr-18967	512	10	one	one	NUM
ihlr-18967	512	11	to	to	PART
ihlr-18967	512	12	believe	believe	VERB
ihlr-18967	512	13	actavis	actavis	PROPN
ihlr-18967	512	14	applies	apply	VERB
ihlr-18967	512	15	in	in	ADP
ihlr-18967	512	16	all	all	DET
ihlr-18967	512	17	cases	case	NOUN
ihlr-18967	512	18	where	where	SCONJ
ihlr-18967	512	19	a	a	DET
ihlr-18967	512	20	reverse	reverse	ADJ
ihlr-18967	512	21	payment	payment	NOUN
ihlr-18967	512	22	settlement	settlement	NOUN
ihlr-18967	512	23	creates	create	VERB
ihlr-18967	512	24	unreasonable	unreasonable	ADJ
ihlr-18967	512	25	restraints	restraint	NOUN
ihlr-18967	512	26	on	on	ADP
ihlr-18967	512	27	trade	trade	NOUN
ihlr-18967	512	28	.	.	PUNCT
ihlr-18967	513	1	this	this	PRON
ihlr-18967	513	2	is	be	AUX
ihlr-18967	513	3	supported	support	VERB
ihlr-18967	513	4	by	by	ADP
ihlr-18967	513	5	antitrust	antitrust	ADJ
ihlr-18967	513	6	common	common	ADJ
ihlr-18967	513	7	law	law	NOUN
ihlr-18967	513	8	which	which	PRON
ihlr-18967	513	9	generally	generally	ADV
ihlr-18967	513	10	focuses	focus	VERB
ihlr-18967	513	11	on	on	ADP
ihlr-18967	513	12	unreasonable	unreasonable	ADJ
ihlr-18967	513	13	restraints	restraint	NOUN
ihlr-18967	513	14	caused	cause	VERB
ihlr-18967	513	15	by	by	ADP
ihlr-18967	513	16	the	the	DET
ihlr-18967	513	17	restrict	restrict	NOUN
ihlr-18967	513	18	practice.166	practice.166	NOUN
ihlr-18967	513	19	162	162	NUM
ihlr-18967	513	20	i	i	PRON
ihlr-18967	513	21	d.	d.	PROPN
ihlr-18967	513	22	at	at	ADP
ihlr-18967	513	23	2237	2237	NUM
ihlr-18967	513	24	.	.	PUNCT
ihlr-18967	514	1	163	163	NUM
ihlr-18967	514	2	i	i	NOUN
ihlr-18967	514	3	d.	d.	PROPN
ihlr-18967	514	4	(	(	PUNCT
ihlr-18967	514	5	quoting	quote	VERB
ihlr-18967	514	6	cal	cal	PROPN
ihlr-18967	514	7	.	.	PUNCT
ihlr-18967	515	1	dental	dental	ADJ
ihlr-18967	515	2	ass’n	ass’n	PROPN
ihlr-18967	515	3	v.	v.	ADP
ihlr-18967	515	4	ftc	ftc	PROPN
ihlr-18967	515	5	,	,	PUNCT
ihlr-18967	515	6	526	526	NUM
ihlr-18967	515	7	u.s	u.s	PROPN
ihlr-18967	515	8	.	.	PROPN
ihlr-18967	515	9	756	756	NUM
ihlr-18967	515	10	,	,	PUNCT
ihlr-18967	515	11	780	780	NUM
ihlr-18967	515	12	(	(	PUNCT
ihlr-18967	515	13	1999	1999	NUM
ihlr-18967	515	14	)	)	PUNCT
ihlr-18967	515	15	)	)	PUNCT
ihlr-18967	515	16	.	.	PUNCT
ihlr-18967	516	1	164	164	NUM
ihlr-18967	516	2	preserve	preserve	NOUN
ihlr-18967	516	3	access	access	NOUN
ihlr-18967	516	4	to	to	ADP
ihlr-18967	516	5	affordable	affordable	ADJ
ihlr-18967	516	6	generics	generic	NOUN
ihlr-18967	516	7	act	act	PROPN
ihlr-18967	516	8	,	,	PUNCT
ihlr-18967	516	9	s.	s.	PROPN
ihlr-18967	516	10	214	214	NUM
ihlr-18967	516	11	,	,	PUNCT
ihlr-18967	516	12	113th	113th	PROPN
ihlr-18967	516	13	cong	cong	NOUN
ihlr-18967	516	14	.	.	PUNCT
ihlr-18967	517	1	(	(	PUNCT
ihlr-18967	517	2	2013	2013	NUM
ihlr-18967	517	3	)	)	PUNCT
ihlr-18967	517	4	.	.	PUNCT
ihlr-18967	518	1	165	165	NUM
ihlr-18967	518	2	ariz	ariz	NOUN
ihlr-18967	518	3	.	.	PUNCT
ihlr-18967	519	1	v.	v.	PROPN
ihlr-18967	519	2	maricopa	maricopa	PROPN
ihlr-18967	519	3	cnty	cnty	PROPN
ihlr-18967	519	4	.	.	PUNCT
ihlr-18967	520	1	med	med	PROPN
ihlr-18967	520	2	.	.	PUNCT
ihlr-18967	520	3	soc’y	soc’y	PROPN
ihlr-18967	520	4	,	,	PUNCT
ihlr-18967	520	5	457	457	NUM
ihlr-18967	520	6	u.s	u.s	PROPN
ihlr-18967	520	7	.	.	PROPN
ihlr-18967	520	8	332	332	NUM
ihlr-18967	520	9	,	,	PUNCT
ihlr-18967	520	10	343	343	NUM
ihlr-18967	520	11	(	(	PUNCT
ihlr-18967	520	12	1982	1982	NUM
ihlr-18967	520	13	)	)	PUNCT
ihlr-18967	520	14	.	.	PUNCT
ihlr-18967	521	1	166	166	NUM
ihlr-18967	521	2	see	see	VERB
ihlr-18967	521	3	cont’l	cont’l	PROPN
ihlr-18967	521	4	t.v	t.v	PROPN
ihlr-18967	521	5	.	.	PROPN
ihlr-18967	521	6	,	,	PUNCT
ihlr-18967	521	7	inc	inc	PROPN
ihlr-18967	521	8	.	.	PROPN
ihlr-18967	522	1	v.	v.	PROPN
ihlr-18967	522	2	gte	gte	PROPN
ihlr-18967	522	3	sylvania	sylvania	PROPN
ihlr-18967	522	4	inc	inc	PROPN
ihlr-18967	522	5	.	.	PROPN
ihlr-18967	522	6	,	,	PUNCT
ihlr-18967	522	7	433	433	NUM
ihlr-18967	522	8	u.s	u.s	PROPN
ihlr-18967	522	9	.	.	PROPN
ihlr-18967	522	10	36	36	NUM
ihlr-18967	522	11	,	,	PUNCT
ihlr-18967	522	12	49	49	NUM
ihlr-18967	522	13	(	(	PUNCT
ihlr-18967	522	14	1977	1977	NUM
ihlr-18967	522	15	)	)	PUNCT
ihlr-18967	522	16	;	;	PUNCT
ihlr-18967	522	17	bd	bd	PROPN
ihlr-18967	522	18	.	.	PROPN
ihlr-18967	522	19	of	of	ADP
ihlr-18967	522	20	trade	trade	NOUN
ihlr-18967	522	21	of	of	ADP
ihlr-18967	522	22	city	city	NOUN
ihlr-18967	522	23	of	of	ADP
ihlr-18967	522	24	chi	chi	PROPN
ihlr-18967	522	25	.	.	PUNCT
ihlr-18967	523	1	v.	v.	PROPN
ihlr-18967	523	2	united	united	PROPN
ihlr-18967	523	3	states	states	PROPN
ihlr-18967	523	4	,	,	PUNCT
ihlr-18967	523	5	246	246	NUM
ihlr-18967	523	6	u.s	u.s	PROPN
ihlr-18967	523	7	.	.	PROPN
ihlr-18967	523	8	231	231	NUM
ihlr-18967	523	9	,	,	PUNCT
ihlr-18967	523	10	238	238	NUM
ihlr-18967	523	11	(	(	PUNCT
ihlr-18967	523	12	1918	1918	NUM
ihlr-18967	523	13	)	)	PUNCT
ihlr-18967	523	14	;	;	PUNCT
ihlr-18967	523	15	454	454	NUM
ihlr-18967	523	16	indiana	indiana	PROPN
ihlr-18967	523	17	health	health	PROPN
ihlr-18967	523	18	law	law	PROPN
ihlr-18967	523	19	review	review	NOUN
ihlr-18967	523	20	vol	vol	NOUN
ihlr-18967	523	21	.	.	PUNCT
ihlr-18967	524	1	12:1	12:1	NUM
ihlr-18967	524	2	although	although	SCONJ
ihlr-18967	524	3	,	,	PUNCT
ihlr-18967	524	4	the	the	DET
ihlr-18967	524	5	language	language	NOUN
ihlr-18967	524	6	of	of	ADP
ihlr-18967	524	7	actavis	actavis	PROPN
ihlr-18967	524	8	does	do	AUX
ihlr-18967	524	9	not	not	PART
ihlr-18967	524	10	speak	speak	VERB
ihlr-18967	524	11	broadly	broadly	ADV
ihlr-18967	524	12	,	,	PUNCT
ihlr-18967	524	13	it	it	PRON
ihlr-18967	524	14	speaks	speak	VERB
ihlr-18967	524	15	narrowly	narrowly	ADV
ihlr-18967	524	16	,	,	PUNCT
ihlr-18967	524	17	in	in	ADP
ihlr-18967	524	18	reference	reference	NOUN
ihlr-18967	524	19	to	to	ADP
ihlr-18967	524	20	monetary	monetary	ADJ
ihlr-18967	524	21	payments	payment	NOUN
ihlr-18967	524	22	.	.	PUNCT
ihlr-18967	525	1	as	as	SCONJ
ihlr-18967	525	2	judge	judge	NOUN
ihlr-18967	525	3	walls	wall	NOUN
ihlr-18967	525	4	stated	state	VERB
ihlr-18967	525	5	:	:	PUNCT
ihlr-18967	525	6	“	"	PUNCT
ihlr-18967	525	7	[	[	X
ihlr-18967	525	8	b]oth	b]oth	VERB
ihlr-18967	525	9	the	the	DET
ihlr-18967	525	10	majority	majority	NOUN
ihlr-18967	525	11	and	and	CCONJ
ihlr-18967	525	12	dissenting	dissent	VERB
ihlr-18967	525	13	opinions	opinion	NOUN
ihlr-18967	525	14	reek	reek	ADJ
ihlr-18967	525	15	with	with	ADP
ihlr-18967	525	16	the	the	DET
ihlr-18967	525	17	discussion	discussion	NOUN
ihlr-18967	525	18	of	of	ADP
ihlr-18967	525	19	payment	payment	NOUN
ihlr-18967	525	20	of	of	ADP
ihlr-18967	525	21	money	money	NOUN
ihlr-18967	525	22	.	.	PUNCT
ihlr-18967	526	1	”167	”167	PROPN
ihlr-18967	526	2	throughout	throughout	ADP
ihlr-18967	526	3	the	the	DET
ihlr-18967	526	4	opinion	opinion	NOUN
ihlr-18967	526	5	,	,	PUNCT
ihlr-18967	526	6	the	the	DET
ihlr-18967	526	7	court	court	NOUN
ihlr-18967	526	8	continuously	continuously	ADV
ihlr-18967	526	9	discusses	discuss	VERB
ihlr-18967	526	10	reverse	reverse	ADJ
ihlr-18967	526	11	payments	payment	NOUN
ihlr-18967	526	12	in	in	ADP
ihlr-18967	526	13	terms	term	NOUN
ihlr-18967	526	14	of	of	ADP
ihlr-18967	526	15	a	a	DET
ihlr-18967	526	16	monetary	monetary	ADJ
ihlr-18967	526	17	payment	payment	NOUN
ihlr-18967	526	18	,	,	PUNCT
ihlr-18967	526	19	as	as	SCONJ
ihlr-18967	526	20	opposed	oppose	VERB
ihlr-18967	526	21	to	to	ADP
ihlr-18967	526	22	a	a	DET
ihlr-18967	526	23	reverse	reverse	ADJ
ihlr-18967	526	24	payment	payment	NOUN
ihlr-18967	526	25	for	for	ADP
ihlr-18967	526	26	any	any	DET
ihlr-18967	526	27	financial	financial	ADJ
ihlr-18967	526	28	benefit.168	benefit.168	NOUN
ihlr-18967	526	29	therefore	therefore	ADV
ihlr-18967	526	30	,	,	PUNCT
ihlr-18967	526	31	this	this	DET
ihlr-18967	526	32	language	language	NOUN
ihlr-18967	526	33	implies	imply	VERB
ihlr-18967	526	34	that	that	SCONJ
ihlr-18967	526	35	actavis	actavis	PROPN
ihlr-18967	526	36	only	only	ADV
ihlr-18967	526	37	applies	apply	VERB
ihlr-18967	526	38	to	to	ADP
ihlr-18967	526	39	those	those	DET
ihlr-18967	526	40	reverse	reverse	ADJ
ihlr-18967	526	41	payment	payment	NOUN
ihlr-18967	526	42	settlements	settlement	NOUN
ihlr-18967	526	43	involving	involve	VERB
ihlr-18967	526	44	monetary	monetary	ADJ
ihlr-18967	526	45	payments	payment	NOUN
ihlr-18967	526	46	.	.	PUNCT
ihlr-18967	527	1	2	2	X
ihlr-18967	527	2	.	.	X
ihlr-18967	527	3	market	market	NOUN
ihlr-18967	527	4	power	power	NOUN
ihlr-18967	527	5	according	accord	VERB
ihlr-18967	527	6	to	to	ADP
ihlr-18967	527	7	the	the	DET
ihlr-18967	527	8	supreme	supreme	PROPN
ihlr-18967	527	9	court	court	PROPN
ihlr-18967	527	10	,	,	PUNCT
ihlr-18967	527	11	the	the	DET
ihlr-18967	527	12	market	market	NOUN
ihlr-18967	527	13	power	power	NOUN
ihlr-18967	527	14	possessed	possess	VERB
ihlr-18967	527	15	by	by	ADP
ihlr-18967	527	16	the	the	DET
ihlr-18967	527	17	pioneer	pioneer	NOUN
ihlr-18967	527	18	manufacturer	manufacturer	NOUN
ihlr-18967	527	19	may	may	AUX
ihlr-18967	527	20	indicate	indicate	VERB
ihlr-18967	527	21	anticompetitive	anticompetitive	ADJ
ihlr-18967	527	22	harm.169	harm.169	NOUN
ihlr-18967	527	23	under	under	ADP
ihlr-18967	527	24	rule	rule	NOUN
ihlr-18967	527	25	of	of	ADP
ihlr-18967	527	26	reason	reason	NOUN
ihlr-18967	527	27	analysis	analysis	NOUN
ihlr-18967	527	28	,	,	PUNCT
ihlr-18967	527	29	“	"	PUNCT
ihlr-18967	527	30	a	a	DET
ihlr-18967	527	31	plaintiff	plaintiff	NOUN
ihlr-18967	527	32	must	must	AUX
ihlr-18967	527	33	show	show	VERB
ihlr-18967	527	34	that	that	SCONJ
ihlr-18967	527	35	the	the	DET
ihlr-18967	527	36	defendant	defendant	NOUN
ihlr-18967	527	37	has	have	VERB
ihlr-18967	527	38	market	market	NOUN
ihlr-18967	527	39	power	power	NOUN
ihlr-18967	527	40	—	—	PUNCT
ihlr-18967	527	41	that	that	ADV
ihlr-18967	527	42	is	is	ADV
ihlr-18967	527	43	,	,	PUNCT
ihlr-18967	527	44	the	the	DET
ihlr-18967	527	45	ability	ability	NOUN
ihlr-18967	527	46	to	to	PART
ihlr-18967	527	47	raise	raise	VERB
ihlr-18967	527	48	prices	price	NOUN
ihlr-18967	527	49	significantly	significantly	ADV
ihlr-18967	527	50	without	without	ADP
ihlr-18967	527	51	going	go	VERB
ihlr-18967	527	52	out	out	ADP
ihlr-18967	527	53	of	of	ADP
ihlr-18967	527	54	business	business	NOUN
ihlr-18967	527	55	—	—	PUNCT
ihlr-18967	527	56	without	without	ADP
ihlr-18967	527	57	which	which	PRON
ihlr-18967	527	58	the	the	DET
ihlr-18967	527	59	defendant	defendant	NOUN
ihlr-18967	527	60	could	could	AUX
ihlr-18967	527	61	not	not	PART
ihlr-18967	527	62	cause	cause	VERB
ihlr-18967	527	63	anticompetitive	anticompetitive	ADJ
ihlr-18967	527	64	effects	effect	NOUN
ihlr-18967	527	65	on	on	ADP
ihlr-18967	527	66	market	market	NOUN
ihlr-18967	527	67	pricing	pricing	NOUN
ihlr-18967	527	68	.	.	PUNCT
ihlr-18967	527	69	”170	”170	PUNCT
ihlr-18967	528	1	also	also	ADV
ihlr-18967	528	2	,	,	PUNCT
ihlr-18967	528	3	a	a	DET
ihlr-18967	528	4	plaintiff	plaintiff	NOUN
ihlr-18967	528	5	may	may	AUX
ihlr-18967	528	6	“	"	PUNCT
ihlr-18967	528	7	establish	establish	VERB
ihlr-18967	528	8	anticompetitive	anticompetitive	ADJ
ihlr-18967	528	9	effect	effect	NOUN
ihlr-18967	528	10	indirectly	indirectly	ADV
ihlr-18967	528	11	by	by	ADP
ihlr-18967	528	12	proving	prove	VERB
ihlr-18967	528	13	the	the	DET
ihlr-18967	528	14	defendant	defendant	NOUN
ihlr-18967	528	15	possessed	possess	VERB
ihlr-18967	528	16	the	the	DET
ihlr-18967	528	17	requisite	requisite	ADJ
ihlr-18967	528	18	market	market	NOUN
ihlr-18967	528	19	power	power	NOUN
ihlr-18967	528	20	within	within	ADP
ihlr-18967	528	21	a	a	DET
ihlr-18967	528	22	defined	define	VERB
ihlr-18967	528	23	market	market	NOUN
ihlr-18967	528	24	.	.	PUNCT
ihlr-18967	529	1	”171	”171	PROPN
ihlr-18967	530	1	congress	congress	PROPN
ihlr-18967	530	2	’	'	PUNCT
ihlr-18967	530	3	approach	approach	NOUN
ihlr-18967	530	4	,	,	PUNCT
ihlr-18967	530	5	applying	apply	VERB
ihlr-18967	530	6	a	a	DET
ihlr-18967	530	7	presumption	presumption	NOUN
ihlr-18967	530	8	of	of	ADP
ihlr-18967	530	9	anticompetitive	anticompetitive	ADJ
ihlr-18967	530	10	harm,172	harm,172	NOUN
ihlr-18967	530	11	is	be	AUX
ihlr-18967	530	12	erroneous	erroneous	ADJ
ihlr-18967	530	13	as	as	ADP
ihlr-18967	530	14	it	it	PRON
ihlr-18967	530	15	major	major	ADJ
ihlr-18967	530	16	league	league	NOUN
ihlr-18967	530	17	baseball	baseball	NOUN
ihlr-18967	530	18	props	prop	NOUN
ihlr-18967	530	19	.	.	PUNCT
ihlr-18967	531	1	,	,	PUNCT
ihlr-18967	531	2	inc	inc	PROPN
ihlr-18967	531	3	.	.	PROPN
ihlr-18967	532	1	v.	v.	PROPN
ihlr-18967	532	2	salvino	salvino	PROPN
ihlr-18967	532	3	,	,	PUNCT
ihlr-18967	532	4	inc	inc	PROPN
ihlr-18967	532	5	.	.	PROPN
ihlr-18967	532	6	542	542	NUM
ihlr-18967	532	7	f.3d	f.3d	NUM
ihlr-18967	532	8	290	290	NUM
ihlr-18967	532	9	,	,	PUNCT
ihlr-18967	532	10	316	316	NUM
ihlr-18967	532	11	(	(	PUNCT
ihlr-18967	532	12	2d	2d	NUM
ihlr-18967	532	13	cir	cir	NOUN
ihlr-18967	532	14	.	.	PROPN
ihlr-18967	532	15	2008	2008	NUM
ihlr-18967	532	16	)	)	PUNCT
ihlr-18967	532	17	.	.	PUNCT
ihlr-18967	533	1	167	167	NUM
ihlr-18967	533	2	in	in	ADP
ihlr-18967	533	3	re	re	PROPN
ihlr-18967	533	4	lamictal	lamictal	ADJ
ihlr-18967	533	5	direct	direct	ADJ
ihlr-18967	533	6	purchaser	purchaser	NOUN
ihlr-18967	533	7	antitrust	antitrust	ADJ
ihlr-18967	533	8	litig	litig	NOUN
ihlr-18967	533	9	.	.	PUNCT
ihlr-18967	534	1	,	,	PUNCT
ihlr-18967	534	2	18	18	NUM
ihlr-18967	534	3	f.supp.3d	f.supp.3d	NOUN
ihlr-18967	534	4	560	560	NUM
ihlr-18967	534	5	,	,	PUNCT
ihlr-18967	534	6	567	567	NUM
ihlr-18967	534	7	(	(	PUNCT
ihlr-18967	534	8	d.	d.	PROPN
ihlr-18967	534	9	n.j	n.j	PROPN
ihlr-18967	534	10	.	.	PROPN
ihlr-18967	534	11	2014	2014	NUM
ihlr-18967	534	12	)	)	PUNCT
ihlr-18967	534	13	.	.	PUNCT
ihlr-18967	535	1	168	168	NUM
ihlr-18967	535	2	ftc	ftc	PROPN
ihlr-18967	535	3	v.	v.	ADP
ihlr-18967	535	4	actavis	actavis	PROPN
ihlr-18967	535	5	,	,	PUNCT
ihlr-18967	535	6	inc	inc	PROPN
ihlr-18967	535	7	.	.	PROPN
ihlr-18967	535	8	,	,	PUNCT
ihlr-18967	535	9	133	133	NUM
ihlr-18967	535	10	s.	s.	PROPN
ihlr-18967	535	11	ct	ct	PROPN
ihlr-18967	535	12	.	.	PROPN
ihlr-18967	535	13	2223	2223	NUM
ihlr-18967	535	14	,	,	PUNCT
ihlr-18967	535	15	2227	2227	NUM
ihlr-18967	535	16	(	(	PUNCT
ihlr-18967	535	17	2013	2013	NUM
ihlr-18967	535	18	)	)	PUNCT
ihlr-18967	535	19	(	(	PUNCT
ihlr-18967	535	20	“	"	PUNCT
ihlr-18967	535	21	company	company	NOUN
ihlr-18967	535	22	a	a	NOUN
ihlr-18967	535	23	,	,	PUNCT
ihlr-18967	535	24	the	the	DET
ihlr-18967	535	25	patentee	patentee	NOUN
ihlr-18967	535	26	,	,	PUNCT
ihlr-18967	535	27	to	to	PART
ihlr-18967	535	28	pay	pay	VERB
ihlr-18967	535	29	b	b	NUM
ihlr-18967	535	30	many	many	ADJ
ihlr-18967	535	31	millions	million	NOUN
ihlr-18967	535	32	of	of	ADP
ihlr-18967	535	33	dollars	dollar	NOUN
ihlr-18967	535	34	.	.	PUNCT
ihlr-18967	535	35	”	"	PUNCT
ihlr-18967	535	36	)	)	PUNCT
ihlr-18967	536	1	(	(	PUNCT
ihlr-18967	536	2	emphasis	emphasis	NOUN
ihlr-18967	536	3	added	add	VERB
ihlr-18967	536	4	)	)	PUNCT
ihlr-18967	536	5	;	;	PUNCT
ihlr-18967	536	6	i	i	PRON
ihlr-18967	536	7	d.	d.	PROPN
ihlr-18967	536	8	at	at	ADP
ihlr-18967	536	9	2233	2233	NUM
ihlr-18967	536	10	(	(	PUNCT
ihlr-18967	536	11	“	"	PUNCT
ihlr-18967	536	12	in	in	ADP
ihlr-18967	536	13	reverse	reverse	ADJ
ihlr-18967	536	14	payment	payment	NOUN
ihlr-18967	536	15	settlements	settlement	NOUN
ihlr-18967	536	16	.	.	PUNCT
ihlr-18967	536	17	.	.	PUNCT
ihlr-18967	536	18	.	.	PUNCT
ihlr-18967	537	1	a	a	DET
ihlr-18967	537	2	party	party	NOUN
ihlr-18967	537	3	with	with	ADP
ihlr-18967	537	4	no	no	DET
ihlr-18967	537	5	claim	claim	NOUN
ihlr-18967	537	6	for	for	ADP
ihlr-18967	537	7	damages	damage	NOUN
ihlr-18967	537	8	.	.	PUNCT
ihlr-18967	537	9	.	.	PUNCT
ihlr-18967	537	10	.	.	PUNCT
ihlr-18967	537	11	walks	walk	VERB
ihlr-18967	537	12	away	away	ADV
ihlr-18967	537	13	with	with	ADP
ihlr-18967	537	14	money	money	NOUN
ihlr-18967	537	15	.	.	PUNCT
ihlr-18967	537	16	”	"	PUNCT
ihlr-18967	537	17	)	)	PUNCT
ihlr-18967	538	1	(	(	PUNCT
ihlr-18967	538	2	emphasis	emphasis	NOUN
ihlr-18967	538	3	added	add	VERB
ihlr-18967	538	4	)	)	PUNCT
ihlr-18967	538	5	;	;	PUNCT
ihlr-18967	538	6	i	i	PRON
ihlr-18967	538	7	d.	d.	PROPN
ihlr-18967	538	8	at	at	ADP
ihlr-18967	538	9	2235	2235	NUM
ihlr-18967	538	10	(	(	PUNCT
ihlr-18967	538	11	“	"	PUNCT
ihlr-18967	538	12	[	[	X
ihlr-18967	538	13	p]atentees	p]atentees	PROPN
ihlr-18967	538	14	sometimes	sometimes	ADV
ihlr-18967	538	15	pay	pay	VERB
ihlr-18967	538	16	a	a	DET
ihlr-18967	538	17	generic	generic	ADJ
ihlr-18967	538	18	challenger	challenger	NOUN
ihlr-18967	538	19	a	a	DET
ihlr-18967	538	20	sum	sum	NOUN
ihlr-18967	538	21	even	even	ADV
ihlr-18967	538	22	larger	large	ADJ
ihlr-18967	538	23	than	than	ADP
ihlr-18967	538	24	what	what	PRON
ihlr-18967	538	25	the	the	DET
ihlr-18967	538	26	generic	generic	ADJ
ihlr-18967	538	27	would	would	AUX
ihlr-18967	538	28	gain	gain	VERB
ihlr-18967	538	29	in	in	ADP
ihlr-18967	538	30	profits	profit	NOUN
ihlr-18967	538	31	.	.	PUNCT
ihlr-18967	538	32	”	"	PUNCT
ihlr-18967	538	33	)	)	PUNCT
ihlr-18967	538	34	.	.	PUNCT
ihlr-18967	539	1	169	169	NUM
ihlr-18967	540	1	i	i	PRON
ihlr-18967	540	2	d.	d.	NOUN
ihlr-18967	540	3	at	at	ADP
ihlr-18967	540	4	2236	2236	NUM
ihlr-18967	540	5	.	.	PUNCT
ihlr-18967	541	1	170	170	NUM
ihlr-18967	541	2	agnew	agnew	PROPN
ihlr-18967	541	3	v.	v.	PROPN
ihlr-18967	541	4	nat’l	nat’l	PROPN
ihlr-18967	541	5	collegiate	collegiate	VERB
ihlr-18967	541	6	athletic	athletic	ADJ
ihlr-18967	541	7	ass’n	ass’n	NOUN
ihlr-18967	541	8	,	,	PUNCT
ihlr-18967	541	9	683	683	NUM
ihlr-18967	541	10	f.3d	f.3d	NUM
ihlr-18967	541	11	328	328	NUM
ihlr-18967	541	12	,	,	PUNCT
ihlr-18967	541	13	335	335	NUM
ihlr-18967	541	14	(	(	PUNCT
ihlr-18967	541	15	7th	7th	ADJ
ihlr-18967	541	16	cir	cir	NOUN
ihlr-18967	541	17	.	.	PROPN
ihlr-18967	541	18	2012	2012	NUM
ihlr-18967	541	19	)	)	PUNCT
ihlr-18967	541	20	(	(	PUNCT
ihlr-18967	541	21	citing	cite	VERB
ihlr-18967	541	22	valley	valley	NOUN
ihlr-18967	541	23	liquors	liquor	NOUN
ihlr-18967	541	24	,	,	PUNCT
ihlr-18967	541	25	inc	inc	PROPN
ihlr-18967	541	26	.	.	PROPN
ihlr-18967	542	1	v.	v.	PROPN
ihlr-18967	542	2	renfield	renfield	PROPN
ihlr-18967	542	3	importers	importers	PROPN
ihlr-18967	542	4	,	,	PUNCT
ihlr-18967	542	5	ltd	ltd	PROPN
ihlr-18967	542	6	.	.	PROPN
ihlr-18967	542	7	,	,	PUNCT
ihlr-18967	542	8	822	822	NUM
ihlr-18967	542	9	f.2d	f.2d	ADP
ihlr-18967	542	10	656	656	NUM
ihlr-18967	542	11	,	,	PUNCT
ihlr-18967	542	12	666	666	NUM
ihlr-18967	542	13	(	(	PUNCT
ihlr-18967	542	14	7th	7th	ADJ
ihlr-18967	542	15	cir	cir	NOUN
ihlr-18967	542	16	.	.	PUNCT
ihlr-18967	542	17	1987	1987	NUM
ihlr-18967	542	18	)	)	PUNCT
ihlr-18967	542	19	)	)	PUNCT
ihlr-18967	542	20	.	.	PUNCT
ihlr-18967	543	1	171	171	NUM
ihlr-18967	543	2	law	law	NOUN
ihlr-18967	543	3	v.	v.	ADP
ihlr-18967	543	4	nat’l	nat’l	NOUN
ihlr-18967	543	5	collegiate	collegiate	VERB
ihlr-18967	543	6	athletic	athletic	ADJ
ihlr-18967	543	7	ass’n	ass’n	NOUN
ihlr-18967	543	8	,	,	PUNCT
ihlr-18967	543	9	134	134	NUM
ihlr-18967	543	10	f.3d	f.3d	NUM
ihlr-18967	543	11	1010	1010	NUM
ihlr-18967	543	12	,	,	PUNCT
ihlr-18967	543	13	1019	1019	NUM
ihlr-18967	543	14	(	(	PUNCT
ihlr-18967	543	15	10th	10th	ADJ
ihlr-18967	543	16	cir	cir	NOUN
ihlr-18967	543	17	.	.	PUNCT
ihlr-18967	543	18	1998	1998	NUM
ihlr-18967	543	19	)	)	PUNCT
ihlr-18967	543	20	.	.	PUNCT
ihlr-18967	544	1	172	172	NUM
ihlr-18967	544	2	preserve	preserve	VERB
ihlr-18967	544	3	access	access	NOUN
ihlr-18967	544	4	to	to	ADP
ihlr-18967	544	5	affordable	affordable	ADJ
ihlr-18967	544	6	generics	generic	NOUN
ihlr-18967	544	7	act	act	PROPN
ihlr-18967	544	8	,	,	PUNCT
ihlr-18967	544	9	s.	s.	PROPN
ihlr-18967	544	10	214	214	NUM
ihlr-18967	544	11	,	,	PUNCT
ihlr-18967	544	12	113th	113th	PROPN
ihlr-18967	544	13	cong	cong	NOUN
ihlr-18967	544	14	.	.	PUNCT
ihlr-18967	545	1	§	§	PROPN
ihlr-18967	545	2	28(a)(2	28(a)(2	NUM
ihlr-18967	545	3	)	)	PUNCT
ihlr-18967	545	4	(	(	PUNCT
ihlr-18967	545	5	2013	2013	NUM
ihlr-18967	545	6	)	)	PUNCT
ihlr-18967	545	7	.	.	PUNCT
ihlr-18967	546	1	2015	2015	NUM
ihlr-18967	546	2	rationale	rationale	NOUN
ihlr-18967	546	3	behind	behind	ADP
ihlr-18967	546	4	hatch	hatch	NOUN
ihlr-18967	546	5	-	-	PUNCT
ihlr-18967	546	6	waxman	waxman	PROPN
ihlr-18967	546	7	act	act	PROPN
ihlr-18967	546	8	and	and	CCONJ
ihlr-18967	546	9	patent	patent	NOUN
ihlr-18967	546	10	law	law	NOUN
ihlr-18967	546	11	455	455	NUM
ihlr-18967	546	12	presumes	presume	VERB
ihlr-18967	546	13	the	the	DET
ihlr-18967	546	14	pioneer	pioneer	NOUN
ihlr-18967	546	15	manufacturer	manufacturer	NOUN
ihlr-18967	546	16	has	have	VERB
ihlr-18967	546	17	market	market	NOUN
ihlr-18967	546	18	power	power	NOUN
ihlr-18967	546	19	when	when	SCONJ
ihlr-18967	546	20	that	that	PRON
ihlr-18967	546	21	may	may	AUX
ihlr-18967	546	22	not	not	PART
ihlr-18967	546	23	be	be	AUX
ihlr-18967	546	24	accurate	accurate	ADJ
ihlr-18967	546	25	in	in	ADP
ihlr-18967	546	26	one	one	NUM
ihlr-18967	546	27	-	-	PUNCT
ihlr-18967	546	28	hundred	hundred	NUM
ihlr-18967	546	29	percent	percent	NOUN
ihlr-18967	546	30	of	of	ADP
ihlr-18967	546	31	cases	case	NOUN
ihlr-18967	546	32	.	.	PUNCT
ihlr-18967	547	1	in	in	ADP
ihlr-18967	547	2	actavis	actavis	PROPN
ihlr-18967	547	3	,	,	PUNCT
ihlr-18967	547	4	the	the	DET
ihlr-18967	547	5	court	court	NOUN
ihlr-18967	547	6	was	be	AUX
ihlr-18967	547	7	concerned	concern	VERB
ihlr-18967	547	8	with	with	ADP
ihlr-18967	547	9	a	a	DET
ihlr-18967	547	10	pioneer	pioneer	NOUN
ihlr-18967	547	11	manufacturer	manufacturer	NOUN
ihlr-18967	547	12	using	use	VERB
ihlr-18967	547	13	monopolistic	monopolistic	ADJ
ihlr-18967	547	14	power	power	NOUN
ihlr-18967	547	15	to	to	PART
ihlr-18967	547	16	receive	receive	VERB
ihlr-18967	547	17	“	"	PUNCT
ihlr-18967	547	18	higherthan	higherthan	ADJ
ihlr-18967	547	19	-	-	PUNCT
ihlr-18967	547	20	competitive	competitive	ADJ
ihlr-18967	547	21	profits	profit	NOUN
ihlr-18967	547	22	.	.	PUNCT
ihlr-18967	548	1	”173	”173	ADP
ihlr-18967	548	2	a	a	DET
ihlr-18967	548	3	pioneer	pioneer	NOUN
ihlr-18967	548	4	manufacturer	manufacturer	NOUN
ihlr-18967	548	5	who	who	PRON
ihlr-18967	548	6	is	be	AUX
ihlr-18967	548	7	receiving	receive	VERB
ihlr-18967	548	8	monopolistic	monopolistic	ADJ
ihlr-18967	548	9	profits	profit	NOUN
ihlr-18967	548	10	may	may	AUX
ihlr-18967	548	11	use	use	VERB
ihlr-18967	548	12	this	this	DET
ihlr-18967	548	13	power	power	NOUN
ihlr-18967	548	14	to	to	PART
ihlr-18967	548	15	leverage	leverage	VERB
ihlr-18967	548	16	and	and	CCONJ
ihlr-18967	548	17	finance	finance	VERB
ihlr-18967	548	18	a	a	DET
ihlr-18967	548	19	deal	deal	NOUN
ihlr-18967	548	20	to	to	PART
ihlr-18967	548	21	provide	provide	VERB
ihlr-18967	548	22	the	the	DET
ihlr-18967	548	23	generic	generic	ADJ
ihlr-18967	548	24	manufacturer	manufacturer	NOUN
ihlr-18967	548	25	with	with	ADP
ihlr-18967	548	26	an	an	DET
ihlr-18967	548	27	otherwise	otherwise	ADV
ihlr-18967	548	28	unexplainably	unexplainably	ADV
ihlr-18967	548	29	large	large	ADJ
ihlr-18967	548	30	settlement	settlement	NOUN
ihlr-18967	548	31	payment	payment	NOUN
ihlr-18967	548	32	.	.	PUNCT
ihlr-18967	549	1	due	due	ADP
ihlr-18967	549	2	to	to	ADP
ihlr-18967	549	3	the	the	DET
ihlr-18967	549	4	monopolistic	monopolistic	ADJ
ihlr-18967	549	5	power	power	NOUN
ihlr-18967	549	6	of	of	ADP
ihlr-18967	549	7	said	say	VERB
ihlr-18967	549	8	manufacturer	manufacturer	NOUN
ihlr-18967	549	9	,	,	PUNCT
ihlr-18967	549	10	a	a	DET
ihlr-18967	549	11	pioneer	pioneer	NOUN
ihlr-18967	549	12	manufacturer	manufacturer	NOUN
ihlr-18967	549	13	could	could	AUX
ihlr-18967	549	14	pay	pay	VERB
ihlr-18967	549	15	the	the	DET
ihlr-18967	549	16	generic	generic	ADJ
ihlr-18967	549	17	manufacturer	manufacturer	NOUN
ihlr-18967	549	18	an	an	DET
ihlr-18967	549	19	exorbitant	exorbitant	ADJ
ihlr-18967	549	20	amount	amount	NOUN
ihlr-18967	549	21	and	and	CCONJ
ihlr-18967	549	22	recoup	recoup	VERB
ihlr-18967	549	23	those	those	DET
ihlr-18967	549	24	losses	loss	NOUN
ihlr-18967	549	25	in	in	ADP
ihlr-18967	549	26	the	the	DET
ihlr-18967	549	27	form	form	NOUN
ihlr-18967	549	28	of	of	ADP
ihlr-18967	549	29	higher	high	ADJ
ihlr-18967	549	30	prices	price	NOUN
ihlr-18967	549	31	or	or	CCONJ
ihlr-18967	549	32	by	by	ADP
ihlr-18967	549	33	keeping	keep	VERB
ihlr-18967	549	34	the	the	DET
ihlr-18967	549	35	product	product	NOUN
ihlr-18967	549	36	at	at	ADP
ihlr-18967	549	37	the	the	DET
ihlr-18967	549	38	monopolistic	monopolistic	ADJ
ihlr-18967	549	39	price	price	NOUN
ihlr-18967	549	40	for	for	ADP
ihlr-18967	549	41	more	more	ADJ
ihlr-18967	549	42	years	year	NOUN
ihlr-18967	549	43	,	,	PUNCT
ihlr-18967	549	44	which	which	PRON
ihlr-18967	549	45	in	in	ADP
ihlr-18967	549	46	turn	turn	NOUN
ihlr-18967	549	47	harms	harm	VERB
ihlr-18967	549	48	consumers	consumer	NOUN
ihlr-18967	549	49	.	.	PUNCT
ihlr-18967	550	1	moreover	moreover	ADV
ihlr-18967	550	2	,	,	PUNCT
ihlr-18967	550	3	this	this	DET
ihlr-18967	550	4	“	"	PUNCT
ihlr-18967	550	5	market	market	NOUN
ihlr-18967	550	6	power	power	NOUN
ihlr-18967	550	7	”	"	PUNCT
ihlr-18967	550	8	factor	factor	NOUN
ihlr-18967	550	9	will	will	AUX
ihlr-18967	550	10	be	be	AUX
ihlr-18967	550	11	product	product	NOUN
ihlr-18967	550	12	specific	specific	ADJ
ihlr-18967	550	13	.	.	PUNCT
ihlr-18967	551	1	market	market	NOUN
ihlr-18967	551	2	power	power	NOUN
ihlr-18967	551	3	will	will	AUX
ihlr-18967	551	4	be	be	AUX
ihlr-18967	551	5	less	less	ADV
ihlr-18967	551	6	relevant	relevant	ADJ
ihlr-18967	551	7	in	in	ADP
ihlr-18967	551	8	markets	market	NOUN
ihlr-18967	551	9	where	where	SCONJ
ihlr-18967	551	10	competition	competition	NOUN
ihlr-18967	551	11	is	be	AUX
ihlr-18967	551	12	greater	great	ADJ
ihlr-18967	551	13	and	and	CCONJ
ihlr-18967	551	14	other	other	ADJ
ihlr-18967	551	15	alternatives	alternative	NOUN
ihlr-18967	551	16	to	to	ADP
ihlr-18967	551	17	the	the	DET
ihlr-18967	551	18	pioneer	pioneer	NOUN
ihlr-18967	551	19	manufacturer	manufacturer	NOUN
ihlr-18967	551	20	’s	’s	PART
ihlr-18967	551	21	drug	drug	NOUN
ihlr-18967	551	22	exist	exist	NOUN
ihlr-18967	551	23	.	.	PUNCT
ihlr-18967	552	1	subsequently	subsequently	ADV
ihlr-18967	552	2	,	,	PUNCT
ihlr-18967	552	3	in	in	ADP
ihlr-18967	552	4	a	a	DET
ihlr-18967	552	5	market	market	NOUN
ihlr-18967	552	6	with	with	ADP
ihlr-18967	552	7	minimal	minimal	ADJ
ihlr-18967	552	8	competition	competition	NOUN
ihlr-18967	552	9	,	,	PUNCT
ihlr-18967	552	10	a	a	DET
ihlr-18967	552	11	large	large	ADJ
ihlr-18967	552	12	reverse	reverse	ADJ
ihlr-18967	552	13	payment	payment	NOUN
ihlr-18967	552	14	may	may	AUX
ihlr-18967	552	15	look	look	VERB
ihlr-18967	552	16	more	more	ADV
ihlr-18967	552	17	like	like	ADP
ihlr-18967	552	18	an	an	DET
ihlr-18967	552	19	attempt	attempt	NOUN
ihlr-18967	552	20	by	by	ADP
ihlr-18967	552	21	the	the	DET
ihlr-18967	552	22	pioneer	pioneer	NOUN
ihlr-18967	552	23	manufacture	manufacture	VERB
ihlr-18967	552	24	to	to	PART
ihlr-18967	552	25	keep	keep	VERB
ihlr-18967	552	26	their	their	PRON
ihlr-18967	552	27	monopoly	monopoly	NOUN
ihlr-18967	552	28	and	and	CCONJ
ihlr-18967	552	29	continue	continue	VERB
ihlr-18967	552	30	to	to	PART
ihlr-18967	552	31	charge	charge	VERB
ihlr-18967	552	32	a	a	DET
ihlr-18967	552	33	monopolistic	monopolistic	ADJ
ihlr-18967	552	34	price	price	NOUN
ihlr-18967	552	35	to	to	ADP
ihlr-18967	552	36	consumers	consumer	NOUN
ihlr-18967	552	37	.	.	PUNCT
ihlr-18967	553	1	3	3	X
ihlr-18967	553	2	.	.	X
ihlr-18967	553	3	relevant	relevant	ADJ
ihlr-18967	553	4	market	market	NOUN
ihlr-18967	553	5	under	under	ADP
ihlr-18967	553	6	the	the	DET
ihlr-18967	553	7	rule	rule	NOUN
ihlr-18967	553	8	of	of	ADP
ihlr-18967	553	9	reason	reason	NOUN
ihlr-18967	553	10	,	,	PUNCT
ihlr-18967	553	11	a	a	DET
ihlr-18967	553	12	plaintiff	plaintiff	NOUN
ihlr-18967	553	13	’s	’s	PART
ihlr-18967	553	14	initial	initial	ADJ
ihlr-18967	553	15	burden	burden	NOUN
ihlr-18967	553	16	is	be	AUX
ihlr-18967	553	17	to	to	PART
ihlr-18967	553	18	establish	establish	VERB
ihlr-18967	553	19	the	the	DET
ihlr-18967	553	20	anticompetitive	anticompetitive	ADJ
ihlr-18967	553	21	effect	effect	NOUN
ihlr-18967	553	22	on	on	ADP
ihlr-18967	553	23	a	a	DET
ihlr-18967	553	24	given	give	VERB
ihlr-18967	553	25	market.174	market.174	VERB
ihlr-18967	553	26	“	"	PUNCT
ihlr-18967	553	27	antitrust	antitrust	ADJ
ihlr-18967	553	28	claims	claim	NOUN
ihlr-18967	553	29	often	often	ADV
ihlr-18967	553	30	rise	rise	VERB
ihlr-18967	553	31	or	or	CCONJ
ihlr-18967	553	32	fall	fall	VERB
ihlr-18967	553	33	on	on	ADP
ihlr-18967	553	34	the	the	DET
ihlr-18967	553	35	definition	definition	NOUN
ihlr-18967	553	36	of	of	ADP
ihlr-18967	553	37	the	the	DET
ihlr-18967	553	38	relevant	relevant	ADJ
ihlr-18967	553	39	market	market	NOUN
ihlr-18967	553	40	.	.	PUNCT
ihlr-18967	553	41	”175	”175	PUNCT
ihlr-18967	554	1	the	the	DET
ihlr-18967	554	2	supreme	supreme	PROPN
ihlr-18967	554	3	court	court	PROPN
ihlr-18967	554	4	has	have	AUX
ihlr-18967	554	5	held	hold	VERB
ihlr-18967	554	6	that	that	SCONJ
ihlr-18967	554	7	the	the	DET
ihlr-18967	554	8	relevant	relevant	ADJ
ihlr-18967	554	9	market	market	NOUN
ihlr-18967	554	10	consists	consist	VERB
ihlr-18967	554	11	of	of	ADP
ihlr-18967	554	12	“	"	PUNCT
ihlr-18967	554	13	commodities	commodity	NOUN
ihlr-18967	554	14	reasonably	reasonably	ADV
ihlr-18967	554	15	173	173	NUM
ihlr-18967	554	16	actavis	actavi	NOUN
ihlr-18967	554	17	,	,	PUNCT
ihlr-18967	554	18	133	133	NUM
ihlr-18967	554	19	s.	s.	PROPN
ihlr-18967	554	20	ct	ct	PROPN
ihlr-18967	554	21	.	.	PUNCT
ihlr-18967	555	1	at	at	ADP
ihlr-18967	555	2	2236	2236	NUM
ihlr-18967	555	3	;	;	PUNCT
ihlr-18967	555	4	see	see	VERB
ihlr-18967	555	5	also	also	ADV
ihlr-18967	555	6	in	in	ADP
ihlr-18967	555	7	re	re	PROPN
ihlr-18967	555	8	nexium	nexium	NOUN
ihlr-18967	555	9	(	(	PUNCT
ihlr-18967	555	10	esomeprazole	esomeprazole	PROPN
ihlr-18967	555	11	)	)	PUNCT
ihlr-18967	555	12	antitrust	antitrust	ADJ
ihlr-18967	555	13	litig	litig	NOUN
ihlr-18967	555	14	.	.	PUNCT
ihlr-18967	556	1	,	,	PUNCT
ihlr-18967	556	2	968	968	NUM
ihlr-18967	556	3	f.	f.	PROPN
ihlr-18967	556	4	supp	supp	PROPN
ihlr-18967	556	5	.	.	PUNCT
ihlr-18967	557	1	2d	2d	PROPN
ihlr-18967	557	2	367	367	NUM
ihlr-18967	557	3	,	,	PUNCT
ihlr-18967	557	4	389	389	NUM
ihlr-18967	557	5	(	(	PUNCT
ihlr-18967	557	6	d.	d.	PROPN
ihlr-18967	557	7	mass	mass	PROPN
ihlr-18967	557	8	.	.	PROPN
ihlr-18967	557	9	2013	2013	NUM
ihlr-18967	557	10	)	)	PUNCT
ihlr-18967	558	1	(	(	PUNCT
ihlr-18967	558	2	noting	note	VERB
ihlr-18967	558	3	that	that	SCONJ
ihlr-18967	558	4	astrazeneca	astrazeneca	PROPN
ihlr-18967	558	5	exercised	exercise	VERB
ihlr-18967	558	6	market	market	NOUN
ihlr-18967	558	7	power	power	NOUN
ihlr-18967	558	8	by	by	ADP
ihlr-18967	558	9	using	use	VERB
ihlr-18967	558	10	its	its	PRON
ihlr-18967	558	11	monopolistic	monopolistic	ADJ
ihlr-18967	558	12	position	position	NOUN
ihlr-18967	558	13	to	to	PART
ihlr-18967	558	14	“	"	PUNCT
ihlr-18967	558	15	charge	charge	VERB
ihlr-18967	558	16	supracompetitive	supracompetitive	ADJ
ihlr-18967	558	17	prices	price	NOUN
ihlr-18967	558	18	for	for	ADP
ihlr-18967	558	19	brand	brand	NOUN
ihlr-18967	558	20	nexium	nexium	NOUN
ihlr-18967	558	21	”	"	PUNCT
ihlr-18967	558	22	)	)	PUNCT
ihlr-18967	558	23	.	.	PUNCT
ihlr-18967	559	1	174	174	NUM
ihlr-18967	559	2	agnew	agnew	PROPN
ihlr-18967	559	3	,	,	PUNCT
ihlr-18967	559	4	683	683	NUM
ihlr-18967	559	5	f.3d	f.3d	NUM
ihlr-18967	559	6	at	at	ADP
ihlr-18967	559	7	335	335	NUM
ihlr-18967	559	8	(	(	PUNCT
ihlr-18967	559	9	citing	cite	VERB
ihlr-18967	559	10	reifert	reifert	PROPN
ihlr-18967	559	11	v.	v.	PROPN
ihlr-18967	559	12	s.	s.	PROPN
ihlr-18967	559	13	cent	cent	PROPN
ihlr-18967	559	14	.	.	PUNCT
ihlr-18967	560	1	wis	wis	PROPN
ihlr-18967	560	2	.	.	PUNCT
ihlr-18967	561	1	mls	mls	PROPN
ihlr-18967	561	2	corp	corp	PROPN
ihlr-18967	561	3	.	.	PROPN
ihlr-18967	561	4	,	,	PUNCT
ihlr-18967	561	5	450	450	NUM
ihlr-18967	561	6	f.3d	f.3d	NUM
ihlr-18967	561	7	312	312	NUM
ihlr-18967	561	8	,	,	PUNCT
ihlr-18967	561	9	321	321	NUM
ihlr-18967	561	10	(	(	PUNCT
ihlr-18967	561	11	7th	7th	ADJ
ihlr-18967	561	12	cir	cir	NOUN
ihlr-18967	561	13	.	.	PUNCT
ihlr-18967	561	14	2006	2006	NUM
ihlr-18967	561	15	)	)	PUNCT
ihlr-18967	561	16	)	)	PUNCT
ihlr-18967	561	17	;	;	PUNCT
ihlr-18967	561	18	major	major	ADJ
ihlr-18967	561	19	league	league	NOUN
ihlr-18967	561	20	baseball	baseball	NOUN
ihlr-18967	561	21	props	prop	NOUN
ihlr-18967	561	22	.	.	PUNCT
ihlr-18967	561	23	,	,	PUNCT
ihlr-18967	561	24	inc	inc	PROPN
ihlr-18967	561	25	.	.	PROPN
ihlr-18967	562	1	v.	v.	PROPN
ihlr-18967	562	2	salvino	salvino	PROPN
ihlr-18967	562	3	,	,	PUNCT
ihlr-18967	562	4	inc	inc	PROPN
ihlr-18967	562	5	.	.	PROPN
ihlr-18967	562	6	542	542	NUM
ihlr-18967	562	7	f.3d	f.3d	NUM
ihlr-18967	562	8	290	290	NUM
ihlr-18967	562	9	,	,	PUNCT
ihlr-18967	562	10	317	317	NUM
ihlr-18967	562	11	(	(	PUNCT
ihlr-18967	562	12	2d	2d	NUM
ihlr-18967	562	13	cir	cir	NOUN
ihlr-18967	562	14	.	.	PROPN
ihlr-18967	562	15	2008	2008	NUM
ihlr-18967	562	16	)	)	PUNCT
ihlr-18967	562	17	;	;	PUNCT
ihlr-18967	562	18	law	law	NOUN
ihlr-18967	562	19	,	,	PUNCT
ihlr-18967	562	20	134	134	NUM
ihlr-18967	562	21	f.3d	f.3d	NUM
ihlr-18967	562	22	at	at	ADP
ihlr-18967	562	23	1019	1019	NUM
ihlr-18967	562	24	.	.	PUNCT
ihlr-18967	563	1	175	175	NUM
ihlr-18967	563	2	se	se	X
ihlr-18967	563	3	.	.	PROPN
ihlr-18967	563	4	mo	mo	PROPN
ihlr-18967	563	5	.	.	PROPN
ihlr-18967	563	6	hosp	hosp	PROPN
ihlr-18967	563	7	.	.	PUNCT
ihlr-18967	564	1	v.	v.	ADP
ihlr-18967	564	2	c.r	c.r	PROPN
ihlr-18967	564	3	.	.	PROPN
ihlr-18967	564	4	bard	bard	PROPN
ihlr-18967	564	5	,	,	PUNCT
ihlr-18967	564	6	inc	inc	PROPN
ihlr-18967	564	7	.	.	PROPN
ihlr-18967	564	8	,	,	PUNCT
ihlr-18967	564	9	642	642	NUM
ihlr-18967	564	10	f.3d	f.3d	NUM
ihlr-18967	564	11	608	608	NUM
ihlr-18967	564	12	,	,	PUNCT
ihlr-18967	564	13	613	613	NUM
ihlr-18967	564	14	(	(	PUNCT
ihlr-18967	564	15	8th	8th	ADJ
ihlr-18967	564	16	cir	cir	NOUN
ihlr-18967	564	17	.	.	PUNCT
ihlr-18967	564	18	2011	2011	NUM
ihlr-18967	564	19	)	)	PUNCT
ihlr-18967	565	1	(	(	PUNCT
ihlr-18967	565	2	quoting	quote	VERB
ihlr-18967	565	3	bathke	bathke	PROPN
ihlr-18967	565	4	v.	v.	PROPN
ihlr-18967	565	5	casey	casey	PROPN
ihlr-18967	565	6	’s	’s	PART
ihlr-18967	565	7	gen	gen	PROPN
ihlr-18967	565	8	.	.	PROPN
ihlr-18967	565	9	stores	stores	PROPN
ihlr-18967	565	10	,	,	PUNCT
ihlr-18967	565	11	inc	inc	PROPN
ihlr-18967	565	12	.	.	PROPN
ihlr-18967	565	13	,	,	PUNCT
ihlr-18967	565	14	64	64	NUM
ihlr-18967	565	15	f.3d	f.3d	NUM
ihlr-18967	565	16	340	340	NUM
ihlr-18967	565	17	,	,	PUNCT
ihlr-18967	565	18	345	345	NUM
ihlr-18967	565	19	(	(	PUNCT
ihlr-18967	565	20	8th	8th	ADJ
ihlr-18967	565	21	cir	cir	NOUN
ihlr-18967	565	22	.	.	PUNCT
ihlr-18967	565	23	2009	2009	NUM
ihlr-18967	565	24	)	)	PUNCT
ihlr-18967	565	25	)	)	PUNCT
ihlr-18967	565	26	.	.	PUNCT
ihlr-18967	566	1	456	456	NUM
ihlr-18967	566	2	indiana	indiana	PROPN
ihlr-18967	566	3	health	health	PROPN
ihlr-18967	566	4	law	law	PROPN
ihlr-18967	566	5	review	review	NOUN
ihlr-18967	566	6	vol	vol	NOUN
ihlr-18967	566	7	.	.	PUNCT
ihlr-18967	567	1	12:1	12:1	NUM
ihlr-18967	567	2	interchangeable	interchangeable	ADJ
ihlr-18967	567	3	by	by	ADP
ihlr-18967	567	4	consumers	consumer	NOUN
ihlr-18967	567	5	for	for	ADP
ihlr-18967	567	6	the	the	DET
ihlr-18967	567	7	same	same	ADJ
ihlr-18967	567	8	purposes	purpose	NOUN
ihlr-18967	567	9	.	.	PUNCT
ihlr-18967	567	10	.	.	PUNCT
ihlr-18967	567	11	.	.	PUNCT
ihlr-18967	568	1	.”176	.”176	PROPN
ihlr-18967	569	1	for	for	ADP
ihlr-18967	569	2	instance	instance	NOUN
ihlr-18967	569	3	,	,	PUNCT
ihlr-18967	569	4	the	the	DET
ihlr-18967	569	5	district	district	NOUN
ihlr-18967	569	6	court	court	NOUN
ihlr-18967	569	7	in	in	ADP
ihlr-18967	569	8	in	in	ADP
ihlr-18967	569	9	re	re	PROPN
ihlr-18967	569	10	nexium	nexium	PROPN
ihlr-18967	569	11	said	say	VERB
ihlr-18967	569	12	the	the	DET
ihlr-18967	569	13	“	"	PUNCT
ihlr-18967	569	14	relevant	relevant	ADJ
ihlr-18967	569	15	market	market	NOUN
ihlr-18967	569	16	[	[	X
ihlr-18967	569	17	was	be	AUX
ihlr-18967	569	18	]	]	PUNCT
ihlr-18967	569	19	comprised	comprise	VERB
ihlr-18967	569	20	of	of	ADP
ihlr-18967	569	21	brand	brand	NOUN
ihlr-18967	569	22	and	and	CCONJ
ihlr-18967	569	23	generic	generic	ADJ
ihlr-18967	569	24	nexium	nexium	NOUN
ihlr-18967	569	25	.	.	PUNCT
ihlr-18967	569	26	.	.	PUNCT
ihlr-18967	569	27	.	.	PUNCT
ihlr-18967	570	1	.”177	.”177	PUNCT
ihlr-18967	571	1	notwithstanding	notwithstanding	ADP
ihlr-18967	571	2	the	the	DET
ihlr-18967	571	3	fact	fact	NOUN
ihlr-18967	571	4	that	that	SCONJ
ihlr-18967	571	5	generics	generic	NOUN
ihlr-18967	571	6	are	be	AUX
ihlr-18967	571	7	intended	intend	VERB
ihlr-18967	571	8	to	to	PART
ihlr-18967	571	9	be	be	AUX
ihlr-18967	571	10	substitutes	substitute	NOUN
ihlr-18967	571	11	,	,	PUNCT
ihlr-18967	571	12	an	an	DET
ihlr-18967	571	13	argument	argument	NOUN
ihlr-18967	571	14	could	could	AUX
ihlr-18967	571	15	be	be	AUX
ihlr-18967	571	16	made	make	VERB
ihlr-18967	571	17	that	that	SCONJ
ihlr-18967	571	18	pioneer	pioneer	NOUN
ihlr-18967	571	19	and	and	CCONJ
ihlr-18967	571	20	generic	generic	ADJ
ihlr-18967	571	21	drugs	drug	NOUN
ihlr-18967	571	22	are	be	AUX
ihlr-18967	571	23	in	in	ADP
ihlr-18967	571	24	different	different	ADJ
ihlr-18967	571	25	markets	market	NOUN
ihlr-18967	571	26	because	because	SCONJ
ihlr-18967	571	27	a	a	DET
ihlr-18967	571	28	consumer	consumer	NOUN
ihlr-18967	571	29	,	,	PUNCT
ihlr-18967	571	30	based	base	VERB
ihlr-18967	571	31	on	on	ADP
ihlr-18967	571	32	personal	personal	ADJ
ihlr-18967	571	33	preference	preference	NOUN
ihlr-18967	571	34	,	,	PUNCT
ihlr-18967	571	35	would	would	AUX
ihlr-18967	571	36	not	not	PART
ihlr-18967	571	37	substitute	substitute	VERB
ihlr-18967	571	38	one	one	NUM
ihlr-18967	571	39	product	product	NOUN
ihlr-18967	571	40	for	for	ADP
ihlr-18967	571	41	another	another	PRON
ihlr-18967	571	42	despite	despite	SCONJ
ihlr-18967	571	43	a	a	DET
ihlr-18967	571	44	decrease	decrease	NOUN
ihlr-18967	571	45	in	in	ADP
ihlr-18967	571	46	price	price	NOUN
ihlr-18967	571	47	by	by	ADP
ihlr-18967	571	48	one	one	NUM
ihlr-18967	571	49	of	of	ADP
ihlr-18967	571	50	the	the	DET
ihlr-18967	571	51	drugs.178	drugs.178	NOUN
ihlr-18967	571	52	for	for	ADP
ihlr-18967	571	53	example	example	NOUN
ihlr-18967	571	54	,	,	PUNCT
ihlr-18967	571	55	if	if	SCONJ
ihlr-18967	571	56	an	an	DET
ihlr-18967	571	57	inactive	inactive	ADJ
ihlr-18967	571	58	ingredient179	ingredient179	PROPN
ihlr-18967	571	59	in	in	ADP
ihlr-18967	571	60	the	the	DET
ihlr-18967	571	61	generic	generic	ADJ
ihlr-18967	571	62	drug	drug	NOUN
ihlr-18967	571	63	adversely	adversely	ADV
ihlr-18967	571	64	affects	affect	VERB
ihlr-18967	571	65	consumers	consumer	NOUN
ihlr-18967	571	66	to	to	ADP
ihlr-18967	571	67	the	the	DET
ihlr-18967	571	68	point	point	NOUN
ihlr-18967	571	69	that	that	SCONJ
ihlr-18967	571	70	consumers	consumer	NOUN
ihlr-18967	571	71	will	will	AUX
ihlr-18967	571	72	only	only	ADV
ihlr-18967	571	73	purchase	purchase	VERB
ihlr-18967	571	74	the	the	DET
ihlr-18967	571	75	branded	brand	VERB
ihlr-18967	571	76	drug	drug	NOUN
ihlr-18967	571	77	.	.	PUNCT
ihlr-18967	572	1	however	however	ADV
ihlr-18967	572	2	,	,	PUNCT
ihlr-18967	572	3	this	this	PRON
ihlr-18967	572	4	would	would	AUX
ihlr-18967	572	5	likely	likely	ADV
ihlr-18967	572	6	require	require	VERB
ihlr-18967	572	7	a	a	DET
ihlr-18967	572	8	drug	drug	NOUN
ihlr-18967	572	9	being	be	AUX
ihlr-18967	572	10	used	use	VERB
ihlr-18967	572	11	by	by	ADP
ihlr-18967	572	12	a	a	DET
ihlr-18967	572	13	small	small	ADJ
ihlr-18967	572	14	number	number	NOUN
ihlr-18967	572	15	of	of	ADP
ihlr-18967	572	16	consumers	consumer	NOUN
ihlr-18967	572	17	who	who	PRON
ihlr-18967	572	18	all	all	PRON
ihlr-18967	572	19	,	,	PUNCT
ihlr-18967	572	20	or	or	CCONJ
ihlr-18967	572	21	at	at	ADP
ihlr-18967	572	22	least	least	ADJ
ihlr-18967	572	23	a	a	DET
ihlr-18967	572	24	large	large	ADJ
ihlr-18967	572	25	majority	majority	NOUN
ihlr-18967	572	26	,	,	PUNCT
ihlr-18967	572	27	are	be	AUX
ihlr-18967	572	28	adversely	adversely	ADV
ihlr-18967	572	29	affected	affect	VERB
ihlr-18967	572	30	by	by	ADP
ihlr-18967	572	31	the	the	DET
ihlr-18967	572	32	same	same	ADJ
ihlr-18967	572	33	inactive	inactive	ADJ
ihlr-18967	572	34	ingredient	ingredient	NOUN
ihlr-18967	572	35	in	in	ADP
ihlr-18967	572	36	the	the	DET
ihlr-18967	572	37	generic	generic	ADJ
ihlr-18967	572	38	drug	drug	NOUN
ihlr-18967	572	39	.	.	PUNCT
ihlr-18967	573	1	4	4	X
ihlr-18967	573	2	.	.	X
ihlr-18967	573	3	redeeming	redeem	VERB
ihlr-18967	573	4	virtues	virtue	NOUN
ihlr-18967	573	5	in	in	ADP
ihlr-18967	573	6	the	the	DET
ihlr-18967	573	7	context	context	NOUN
ihlr-18967	573	8	of	of	ADP
ihlr-18967	573	9	reverse	reverse	ADJ
ihlr-18967	573	10	payment	payment	NOUN
ihlr-18967	573	11	settlements	settlement	NOUN
ihlr-18967	573	12	,	,	PUNCT
ihlr-18967	573	13	even	even	ADV
ihlr-18967	573	14	the	the	DET
ihlr-18967	573	15	ftc	ftc	PROPN
ihlr-18967	573	16	has	have	AUX
ihlr-18967	573	17	admitted	admit	VERB
ihlr-18967	573	18	“	"	PUNCT
ihlr-18967	573	19	offsetting	offset	VERB
ihlr-18967	573	20	or	or	CCONJ
ihlr-18967	573	21	redeeming	redeem	VERB
ihlr-18967	573	22	virtues	virtue	NOUN
ihlr-18967	573	23	are	be	AUX
ihlr-18967	573	24	sometimes	sometimes	ADV
ihlr-18967	573	25	present	present	ADJ
ihlr-18967	573	26	.	.	PUNCT
ihlr-18967	573	27	”180	”180	PUNCT
ihlr-18967	574	1	a	a	DET
ihlr-18967	574	2	defendant	defendant	NOUN
ihlr-18967	574	3	under	under	ADP
ihlr-18967	574	4	the	the	DET
ihlr-18967	574	5	rule	rule	NOUN
ihlr-18967	574	6	of	of	ADP
ihlr-18967	574	7	reason	reason	NOUN
ihlr-18967	574	8	can	can	AUX
ihlr-18967	574	9	rebut	rebut	VERB
ihlr-18967	574	10	the	the	DET
ihlr-18967	574	11	plaintiff	plaintiff	NOUN
ihlr-18967	574	12	’s	’s	PART
ihlr-18967	574	13	initial	initial	ADJ
ihlr-18967	574	14	burden	burden	NOUN
ihlr-18967	574	15	by	by	ADP
ihlr-18967	574	16	showing	show	VERB
ihlr-18967	574	17	procompetitive	procompetitive	ADJ
ihlr-18967	574	18	effects	effect	NOUN
ihlr-18967	574	19	from	from	ADP
ihlr-18967	574	20	the	the	DET
ihlr-18967	574	21	restraint.181	restraint.181	NOUN
ihlr-18967	574	22	payments	payment	NOUN
ihlr-18967	574	23	may	may	AUX
ihlr-18967	574	24	be	be	AUX
ihlr-18967	574	25	justified	justify	VERB
ihlr-18967	574	26	if	if	SCONJ
ihlr-18967	574	27	they	they	PRON
ihlr-18967	574	28	are	be	AUX
ihlr-18967	574	29	intended	intend	VERB
ihlr-18967	574	30	to	to	PART
ihlr-18967	574	31	allow	allow	VERB
ihlr-18967	574	32	the	the	DET
ihlr-18967	574	33	generic	generic	ADJ
ihlr-18967	574	34	manufacturer	manufacturer	NOUN
ihlr-18967	574	35	to	to	PART
ihlr-18967	574	36	develop	develop	VERB
ihlr-18967	574	37	other	other	ADJ
ihlr-18967	574	38	(	(	PUNCT
ihlr-18967	574	39	additional	additional	ADJ
ihlr-18967	574	40	)	)	PUNCT
ihlr-18967	574	41	generic	generic	ADJ
ihlr-18967	574	42	drugs	drug	NOUN
ihlr-18967	574	43	for	for	ADP
ihlr-18967	574	44	the	the	DET
ihlr-18967	574	45	consumer	consumer	NOUN
ihlr-18967	574	46	’s	’s	PART
ihlr-18967	574	47	benefit.182	benefit.182	NOUN
ihlr-18967	574	48	moreover	moreover	ADV
ihlr-18967	574	49	,	,	PUNCT
ihlr-18967	574	50	any	any	DET
ihlr-18967	574	51	redeeming	redeem	VERB
ihlr-18967	574	52	virtue	virtue	NOUN
ihlr-18967	574	53	176	176	NUM
ihlr-18967	574	54	united	united	PROPN
ihlr-18967	574	55	states	states	PROPN
ihlr-18967	574	56	v.	v.	PROPN
ihlr-18967	574	57	e.i	e.i	PROPN
ihlr-18967	574	58	.	.	PROPN
ihlr-18967	574	59	du	du	PROPN
ihlr-18967	574	60	pont	pont	PROPN
ihlr-18967	574	61	de	de	PROPN
ihlr-18967	574	62	nemours	nemours	PROPN
ihlr-18967	574	63	&	&	CCONJ
ihlr-18967	574	64	co.	co.	PROPN
ihlr-18967	574	65	,	,	PUNCT
ihlr-18967	574	66	351	351	NUM
ihlr-18967	574	67	u.s	u.s	PROPN
ihlr-18967	574	68	.	.	PROPN
ihlr-18967	574	69	377	377	NUM
ihlr-18967	574	70	,	,	PUNCT
ihlr-18967	574	71	395	395	NUM
ihlr-18967	574	72	(	(	PUNCT
ihlr-18967	574	73	1956	1956	NUM
ihlr-18967	574	74	)	)	PUNCT
ihlr-18967	574	75	.	.	PUNCT
ihlr-18967	575	1	177	177	NUM
ihlr-18967	575	2	in	in	ADP
ihlr-18967	575	3	re	re	NOUN
ihlr-18967	575	4	nexium	nexium	NOUN
ihlr-18967	575	5	,	,	PUNCT
ihlr-18967	575	6	968	968	NUM
ihlr-18967	575	7	f.	f.	PROPN
ihlr-18967	575	8	supp	supp	PROPN
ihlr-18967	575	9	.	.	PUNCT
ihlr-18967	576	1	2d	2d	PROPN
ihlr-18967	576	2	at	at	ADP
ihlr-18967	576	3	389	389	NUM
ihlr-18967	576	4	.	.	NOUN
ihlr-18967	576	5	178	178	NUM
ihlr-18967	576	6	see	see	VERB
ihlr-18967	576	7	e.i	e.i	PROPN
ihlr-18967	576	8	.	.	PROPN
ihlr-18967	576	9	du	du	PROPN
ihlr-18967	576	10	pont	pont	PROPN
ihlr-18967	576	11	de	de	PROPN
ihlr-18967	576	12	nemours	nemours	PROPN
ihlr-18967	576	13	&	&	CCONJ
ihlr-18967	576	14	co.	co.	PROPN
ihlr-18967	576	15	,	,	PUNCT
ihlr-18967	576	16	351	351	NUM
ihlr-18967	576	17	u.s	u.s	PROPN
ihlr-18967	576	18	.	.	PROPN
ihlr-18967	576	19	at	at	ADP
ihlr-18967	576	20	400	400	NUM
ihlr-18967	576	21	.	.	PUNCT
ihlr-18967	576	22	179	179	NUM
ihlr-18967	576	23	generic	generic	ADJ
ihlr-18967	576	24	drugs	drug	NOUN
ihlr-18967	576	25	:	:	PUNCT
ihlr-18967	576	26	answers	answer	NOUN
ihlr-18967	576	27	to	to	ADP
ihlr-18967	576	28	common	common	ADJ
ihlr-18967	576	29	questions	question	NOUN
ihlr-18967	576	30	,	,	PUNCT
ihlr-18967	576	31	webmd	webmd	NOUN
ihlr-18967	576	32	,	,	PUNCT
ihlr-18967	576	33	http://www.webmd.com/healthy-aging/guide/generic-drugs-answers-tocommon-questions	http://www.webmd.com/healthy-aging/guide/generic-drugs-answers-tocommon-question	NOUN
ihlr-18967	576	34	(	(	PUNCT
ihlr-18967	576	35	last	last	ADV
ihlr-18967	576	36	visited	visit	VERB
ihlr-18967	576	37	aug	aug	PROPN
ihlr-18967	576	38	.	.	PROPN
ihlr-18967	576	39	27	27	NUM
ihlr-18967	576	40	,	,	PUNCT
ihlr-18967	576	41	2014	2014	NUM
ihlr-18967	576	42	)	)	PUNCT
ihlr-18967	576	43	(	(	PUNCT
ihlr-18967	576	44	discussing	discuss	VERB
ihlr-18967	576	45	how	how	SCONJ
ihlr-18967	576	46	generic	generic	ADJ
ihlr-18967	576	47	drugs	drug	NOUN
ihlr-18967	576	48	can	can	AUX
ihlr-18967	576	49	have	have	VERB
ihlr-18967	576	50	different	different	ADJ
ihlr-18967	576	51	inactive	inactive	ADJ
ihlr-18967	576	52	ingredients	ingredient	NOUN
ihlr-18967	576	53	)	)	PUNCT
ihlr-18967	576	54	.	.	PUNCT
ihlr-18967	577	1	180	180	NUM
ihlr-18967	577	2	ftc	ftc	PROPN
ihlr-18967	577	3	v.	v.	ADP
ihlr-18967	577	4	actavis	actavis	PROPN
ihlr-18967	577	5	,	,	PUNCT
ihlr-18967	577	6	inc	inc	PROPN
ihlr-18967	577	7	.	.	PROPN
ihlr-18967	577	8	,	,	PUNCT
ihlr-18967	577	9	133	133	NUM
ihlr-18967	577	10	s.	s.	PROPN
ihlr-18967	577	11	ct	ct	PROPN
ihlr-18967	577	12	.	.	PROPN
ihlr-18967	577	13	2223	2223	NUM
ihlr-18967	577	14	,	,	PUNCT
ihlr-18967	577	15	2236	2236	NUM
ihlr-18967	577	16	(	(	PUNCT
ihlr-18967	577	17	2013	2013	NUM
ihlr-18967	577	18	)	)	PUNCT
ihlr-18967	577	19	.	.	PUNCT
ihlr-18967	578	1	181	181	NUM
ihlr-18967	579	1	agnew	agnew	PROPN
ihlr-18967	579	2	v.	v.	PROPN
ihlr-18967	579	3	nat’l	nat’l	PROPN
ihlr-18967	579	4	collegiate	collegiate	VERB
ihlr-18967	579	5	athletic	athletic	ADJ
ihlr-18967	579	6	ass’n	ass’n	NOUN
ihlr-18967	579	7	,	,	PUNCT
ihlr-18967	579	8	683	683	NUM
ihlr-18967	579	9	f.3d	f.3d	NUM
ihlr-18967	579	10	328	328	NUM
ihlr-18967	579	11	,	,	PUNCT
ihlr-18967	579	12	335	335	NUM
ihlr-18967	579	13	-	-	SYM
ihlr-18967	579	14	36	36	NUM
ihlr-18967	579	15	(	(	PUNCT
ihlr-18967	579	16	7th	7th	ADJ
ihlr-18967	579	17	cir	cir	NOUN
ihlr-18967	579	18	.	.	PROPN
ihlr-18967	579	19	2012	2012	NUM
ihlr-18967	579	20	)	)	PUNCT
ihlr-18967	579	21	;	;	PUNCT
ihlr-18967	579	22	major	major	ADJ
ihlr-18967	579	23	league	league	NOUN
ihlr-18967	579	24	baseball	baseball	NOUN
ihlr-18967	579	25	props	prop	NOUN
ihlr-18967	579	26	.	.	PUNCT
ihlr-18967	579	27	,	,	PUNCT
ihlr-18967	579	28	inc	inc	PROPN
ihlr-18967	579	29	.	.	PROPN
ihlr-18967	580	1	v.	v.	PROPN
ihlr-18967	580	2	salvino	salvino	PROPN
ihlr-18967	580	3	,	,	PUNCT
ihlr-18967	580	4	inc	inc	PROPN
ihlr-18967	580	5	.	.	PROPN
ihlr-18967	580	6	542	542	NUM
ihlr-18967	580	7	f.3d	f.3d	NUM
ihlr-18967	580	8	290	290	NUM
ihlr-18967	580	9	,	,	PUNCT
ihlr-18967	580	10	317	317	NUM
ihlr-18967	580	11	(	(	PUNCT
ihlr-18967	580	12	2d	2d	NUM
ihlr-18967	580	13	cir	cir	NOUN
ihlr-18967	580	14	.	.	PROPN
ihlr-18967	580	15	2008	2008	NUM
ihlr-18967	580	16	)	)	PUNCT
ihlr-18967	580	17	;	;	PUNCT
ihlr-18967	580	18	law	law	NOUN
ihlr-18967	580	19	v.	v.	CCONJ
ihlr-18967	580	20	nat’l	nat’l	NOUN
ihlr-18967	580	21	collegiate	collegiate	VERB
ihlr-18967	580	22	athletic	athletic	ADJ
ihlr-18967	580	23	ass’n	ass’n	NOUN
ihlr-18967	580	24	,	,	PUNCT
ihlr-18967	580	25	134	134	NUM
ihlr-18967	580	26	f.3d	f.3d	NUM
ihlr-18967	580	27	1010	1010	NUM
ihlr-18967	580	28	,	,	PUNCT
ihlr-18967	580	29	1019	1019	NUM
ihlr-18967	580	30	(	(	PUNCT
ihlr-18967	580	31	10th	10th	ADJ
ihlr-18967	580	32	cir	cir	NOUN
ihlr-18967	580	33	.	.	PUNCT
ihlr-18967	580	34	1998	1998	NUM
ihlr-18967	580	35	)	)	PUNCT
ihlr-18967	580	36	.	.	PUNCT
ihlr-18967	581	1	182	182	NUM
ihlr-18967	581	2	jeff	jeff	PROPN
ihlr-18967	581	3	overley	overley	PROPN
ihlr-18967	581	4	,	,	PUNCT
ihlr-18967	581	5	big	big	ADJ
ihlr-18967	581	6	pharma	pharma	PROPN
ihlr-18967	581	7	’s	’s	PART
ihlr-18967	581	8	legal	legal	ADJ
ihlr-18967	581	9	bill	bill	NOUN
ihlr-18967	581	10	to	to	PART
ihlr-18967	581	11	take	take	VERB
ihlr-18967	581	12	hit	hit	VERB
ihlr-18967	581	13	from	from	ADP
ihlr-18967	581	14	pay	pay	NOUN
ihlr-18967	581	15	-	-	PUNCT
ihlr-18967	581	16	fordelay	fordelay	NOUN
ihlr-18967	581	17	ruling	ruling	NOUN
ihlr-18967	581	18	,	,	PUNCT
ihlr-18967	581	19	law	law	NOUN
ihlr-18967	581	20	360	360	NUM
ihlr-18967	581	21	(	(	PUNCT
ihlr-18967	581	22	june	june	PROPN
ihlr-18967	581	23	17	17	NUM
ihlr-18967	581	24	,	,	PUNCT
ihlr-18967	581	25	2013	2013	NUM
ihlr-18967	581	26	,	,	PUNCT
ihlr-18967	581	27	8:08	8:08	NUM
ihlr-18967	581	28	pm	pm	NOUN
ihlr-18967	581	29	)	)	PUNCT
ihlr-18967	581	30	,	,	PUNCT
ihlr-18967	581	31	2015	2015	NUM
ihlr-18967	581	32	rationale	rationale	NOUN
ihlr-18967	581	33	behind	behind	ADP
ihlr-18967	581	34	hatch	hatch	NOUN
ihlr-18967	581	35	-	-	PUNCT
ihlr-18967	581	36	waxman	waxman	PROPN
ihlr-18967	581	37	act	act	PROPN
ihlr-18967	581	38	and	and	CCONJ
ihlr-18967	581	39	patent	patent	NOUN
ihlr-18967	581	40	law	law	NOUN
ihlr-18967	581	41	457	457	NUM
ihlr-18967	581	42	or	or	CCONJ
ihlr-18967	581	43	benefit	benefit	NOUN
ihlr-18967	581	44	provided	provide	VERB
ihlr-18967	581	45	must	must	AUX
ihlr-18967	581	46	be	be	AUX
ihlr-18967	581	47	more	more	ADV
ihlr-18967	581	48	compelling	compelling	ADJ
ihlr-18967	581	49	than	than	ADP
ihlr-18967	581	50	the	the	DET
ihlr-18967	581	51	policy	policy	NOUN
ihlr-18967	581	52	favoring	favor	VERB
ihlr-18967	581	53	settlements;183	settlements;183	ADP
ihlr-18967	581	54	the	the	DET
ihlr-18967	581	55	court	court	NOUN
ihlr-18967	581	56	has	have	AUX
ihlr-18967	581	57	held	hold	VERB
ihlr-18967	581	58	that	that	SCONJ
ihlr-18967	581	59	this	this	DET
ihlr-18967	581	60	factor	factor	NOUN
ihlr-18967	581	61	alone	alone	ADV
ihlr-18967	581	62	is	be	AUX
ihlr-18967	581	63	not	not	PART
ihlr-18967	581	64	sufficient	sufficient	ADJ
ihlr-18967	581	65	to	to	PART
ihlr-18967	581	66	overcome	overcome	VERB
ihlr-18967	581	67	anticompetitive	anticompetitive	ADJ
ihlr-18967	581	68	consequences.184	consequences.184	NOUN
ihlr-18967	581	69	for	for	ADP
ihlr-18967	581	70	example	example	NOUN
ihlr-18967	581	71	,	,	PUNCT
ihlr-18967	581	72	based	base	VERB
ihlr-18967	581	73	on	on	ADP
ihlr-18967	581	74	the	the	DET
ihlr-18967	581	75	example	example	NOUN
ihlr-18967	581	76	in	in	ADP
ihlr-18967	581	77	the	the	DET
ihlr-18967	581	78	introduction	introduction	NOUN
ihlr-18967	581	79	,	,	PUNCT
ihlr-18967	581	80	xyz	xyz	PROPN
ihlr-18967	581	81	agrees	agree	VERB
ihlr-18967	581	82	not	not	PART
ihlr-18967	581	83	to	to	PART
ihlr-18967	581	84	enter	enter	VERB
ihlr-18967	581	85	into	into	ADP
ihlr-18967	581	86	the	the	DET
ihlr-18967	581	87	market	market	NOUN
ihlr-18967	581	88	for	for	ADP
ihlr-18967	581	89	abc	abc	PROPN
ihlr-18967	581	90	’s	’s	PART
ihlr-18967	581	91	drug	drug	NOUN
ihlr-18967	581	92	23.185	23.185	NUM
ihlr-18967	581	93	as	as	ADP
ihlr-18967	581	94	consideration	consideration	NOUN
ihlr-18967	581	95	,	,	PUNCT
ihlr-18967	581	96	abc	abc	PROPN
ihlr-18967	581	97	provides	provide	VERB
ihlr-18967	581	98	some	some	DET
ihlr-18967	581	99	form	form	NOUN
ihlr-18967	581	100	of	of	ADP
ihlr-18967	581	101	compensation	compensation	NOUN
ihlr-18967	581	102	to	to	ADP
ihlr-18967	581	103	xyz	xyz	PROPN
ihlr-18967	581	104	which	which	PRON
ihlr-18967	581	105	in	in	ADP
ihlr-18967	581	106	turn	turn	NOUN
ihlr-18967	581	107	lets	let	VERB
ihlr-18967	581	108	xyz	xyz	PRON
ihlr-18967	581	109	introduce	introduce	VERB
ihlr-18967	581	110	one	one	NUM
ihlr-18967	581	111	or	or	CCONJ
ihlr-18967	581	112	more	more	ADJ
ihlr-18967	581	113	other	other	ADJ
ihlr-18967	581	114	generic	generic	ADJ
ihlr-18967	581	115	drugs	drug	NOUN
ihlr-18967	581	116	into	into	ADP
ihlr-18967	581	117	the	the	DET
ihlr-18967	581	118	market	market	NOUN
ihlr-18967	581	119	.	.	PUNCT
ihlr-18967	582	1	while	while	SCONJ
ihlr-18967	582	2	the	the	DET
ihlr-18967	582	3	consumers	consumer	NOUN
ihlr-18967	582	4	may	may	AUX
ihlr-18967	582	5	be	be	AUX
ihlr-18967	582	6	hurt	hurt	VERB
ihlr-18967	582	7	by	by	ADP
ihlr-18967	582	8	the	the	DET
ihlr-18967	582	9	anticompetitive	anticompetitive	ADJ
ihlr-18967	582	10	effect	effect	NOUN
ihlr-18967	582	11	of	of	ADP
ihlr-18967	582	12	not	not	PART
ihlr-18967	582	13	allowing	allow	VERB
ihlr-18967	582	14	xyz	xyz	NOUN
ihlr-18967	582	15	to	to	PART
ihlr-18967	582	16	sell	sell	VERB
ihlr-18967	582	17	generic	generic	ADJ
ihlr-18967	582	18	drug	drug	NOUN
ihlr-18967	582	19	70	70	NUM
ihlr-18967	582	20	,	,	PUNCT
ihlr-18967	582	21	the	the	DET
ihlr-18967	582	22	consumers	consumer	NOUN
ihlr-18967	582	23	may	may	AUX
ihlr-18967	582	24	benefit	benefit	VERB
ihlr-18967	582	25	overall	overall	ADV
ihlr-18967	582	26	due	due	ADP
ihlr-18967	582	27	to	to	ADP
ihlr-18967	582	28	other	other	ADJ
ihlr-18967	582	29	generic	generic	ADJ
ihlr-18967	582	30	drugs	drug	NOUN
ihlr-18967	582	31	xyz	xyz	PRON
ihlr-18967	582	32	will	will	AUX
ihlr-18967	582	33	introduce	introduce	VERB
ihlr-18967	582	34	into	into	ADP
ihlr-18967	582	35	the	the	DET
ihlr-18967	582	36	market.186	market.186	NOUN
ihlr-18967	582	37	this	this	DET
ihlr-18967	582	38	hypothetical	hypothetical	ADJ
ihlr-18967	582	39	situation	situation	NOUN
ihlr-18967	582	40	would	would	AUX
ihlr-18967	582	41	require	require	VERB
ihlr-18967	582	42	the	the	DET
ihlr-18967	582	43	drug	drug	NOUN
ihlr-18967	582	44	manufacturers	manufacturer	NOUN
ihlr-18967	582	45	to	to	PART
ihlr-18967	582	46	show	show	VERB
ihlr-18967	582	47	there	there	PRON
ihlr-18967	582	48	are	be	VERB
ihlr-18967	582	49	procompetitive	procompetitive	ADJ
ihlr-18967	582	50	effects	effect	NOUN
ihlr-18967	582	51	caused	cause	VERB
ihlr-18967	582	52	by	by	ADP
ihlr-18967	582	53	not	not	PART
ihlr-18967	582	54	allowing	allow	VERB
ihlr-18967	582	55	one	one	NUM
ihlr-18967	582	56	generic	generic	ADJ
ihlr-18967	582	57	drug	drug	NOUN
ihlr-18967	582	58	to	to	PART
ihlr-18967	582	59	enter	enter	VERB
ihlr-18967	582	60	the	the	DET
ihlr-18967	582	61	market	market	NOUN
ihlr-18967	582	62	.	.	PUNCT
ihlr-18967	583	1	as	as	ADP
ihlr-18967	583	2	a	a	DET
ihlr-18967	583	3	result	result	NOUN
ihlr-18967	583	4	,	,	PUNCT
ihlr-18967	583	5	the	the	DET
ihlr-18967	583	6	consumer	consumer	NOUN
ihlr-18967	583	7	benefit	benefit	NOUN
ihlr-18967	583	8	would	would	AUX
ihlr-18967	583	9	outweigh	outweigh	VERB
ihlr-18967	583	10	harm	harm	NOUN
ihlr-18967	583	11	through	through	ADP
ihlr-18967	583	12	development	development	NOUN
ihlr-18967	583	13	and	and	CCONJ
ihlr-18967	583	14	production	production	NOUN
ihlr-18967	583	15	of	of	ADP
ihlr-18967	583	16	other	other	ADJ
ihlr-18967	583	17	generic	generic	ADJ
ihlr-18967	583	18	drugs	drug	NOUN
ihlr-18967	583	19	.	.	PUNCT
ihlr-18967	584	1	moreover	moreover	ADV
ihlr-18967	584	2	,	,	PUNCT
ihlr-18967	584	3	it	it	PRON
ihlr-18967	584	4	would	would	AUX
ihlr-18967	584	5	be	be	AUX
ihlr-18967	584	6	necessary	necessary	ADJ
ihlr-18967	584	7	for	for	SCONJ
ihlr-18967	584	8	the	the	DET
ihlr-18967	584	9	drug	drug	NOUN
ihlr-18967	584	10	manufacturers	manufacturer	NOUN
ihlr-18967	584	11	to	to	PART
ihlr-18967	584	12	show	show	VERB
ihlr-18967	584	13	the	the	DET
ihlr-18967	584	14	restraint	restraint	NOUN
ihlr-18967	584	15	caused	cause	VERB
ihlr-18967	584	16	by	by	ADP
ihlr-18967	584	17	the	the	DET
ihlr-18967	584	18	reverse	reverse	ADJ
ihlr-18967	584	19	payment	payment	NOUN
ihlr-18967	584	20	settlement	settlement	NOUN
ihlr-18967	584	21	is	be	AUX
ihlr-18967	584	22	reasonably	reasonably	ADV
ihlr-18967	584	23	necessary	necessary	ADJ
ihlr-18967	584	24	to	to	PART
ihlr-18967	584	25	achieve	achieve	VERB
ihlr-18967	584	26	the	the	DET
ihlr-18967	584	27	procompetitive	procompetitive	ADJ
ihlr-18967	584	28	effect.187	effect.187	NOUN
ihlr-18967	584	29	subsequently	subsequently	ADV
ihlr-18967	584	30	,	,	PUNCT
ihlr-18967	584	31	in	in	ADP
ihlr-18967	584	32	the	the	DET
ihlr-18967	584	33	antitrust	antitrust	ADJ
ihlr-18967	584	34	http://www.law360.com/articles/450706/big-pharma-s-legal-bill-to-takehit-from-pay-for-delay-ruling	http://www.law360.com/articles/450706/big-pharma-s-legal-bill-to-takehit-from-pay-for-delay-ruling	NOUN
ihlr-18967	584	35	.	.	PUNCT
ihlr-18967	584	36	183	183	NUM
ihlr-18967	584	37	in	in	ADP
ihlr-18967	584	38	re	re	PROPN
ihlr-18967	584	39	nexium	nexium	NOUN
ihlr-18967	584	40	(	(	PUNCT
ihlr-18967	584	41	esomeprazole	esomeprazole	PROPN
ihlr-18967	584	42	)	)	PUNCT
ihlr-18967	584	43	antitrust	antitrust	ADJ
ihlr-18967	584	44	litig	litig	NOUN
ihlr-18967	584	45	.	.	PUNCT
ihlr-18967	585	1	,	,	PUNCT
ihlr-18967	585	2	968	968	NUM
ihlr-18967	585	3	f.	f.	PROPN
ihlr-18967	585	4	supp	supp	PROPN
ihlr-18967	585	5	.	.	PUNCT
ihlr-18967	586	1	2d	2d	PROPN
ihlr-18967	586	2	367	367	NUM
ihlr-18967	586	3	,	,	PUNCT
ihlr-18967	586	4	410	410	NUM
ihlr-18967	586	5	(	(	PUNCT
ihlr-18967	586	6	d.	d.	PROPN
ihlr-18967	586	7	mass	mass	PROPN
ihlr-18967	586	8	.	.	PROPN
ihlr-18967	586	9	2013	2013	NUM
ihlr-18967	586	10	)	)	PUNCT
ihlr-18967	587	1	(	(	PUNCT
ihlr-18967	587	2	holding	hold	VERB
ihlr-18967	587	3	that	that	DET
ihlr-18967	587	4	settlement	settlement	NOUN
ihlr-18967	587	5	of	of	ADP
ihlr-18967	587	6	patent	patent	NOUN
ihlr-18967	587	7	disputes	dispute	NOUN
ihlr-18967	587	8	does	do	AUX
ihlr-18967	587	9	not	not	PART
ihlr-18967	587	10	overcome	overcome	VERB
ihlr-18967	587	11	anticompetitive	anticompetitive	ADJ
ihlr-18967	587	12	consequences	consequence	NOUN
ihlr-18967	587	13	)	)	PUNCT
ihlr-18967	587	14	.	.	PUNCT
ihlr-18967	588	1	184	184	NUM
ihlr-18967	588	2	actavis	actavi	NOUN
ihlr-18967	588	3	,	,	PUNCT
ihlr-18967	588	4	133	133	NUM
ihlr-18967	588	5	s.	s.	PROPN
ihlr-18967	588	6	ct	ct	PROPN
ihlr-18967	588	7	.	.	PUNCT
ihlr-18967	589	1	at	at	ADP
ihlr-18967	589	2	2234	2234	NUM
ihlr-18967	589	3	(	(	PUNCT
ihlr-18967	589	4	discussing	discuss	VERB
ihlr-18967	589	5	how	how	SCONJ
ihlr-18967	589	6	the	the	DET
ihlr-18967	589	7	eleventh	eleventh	ADJ
ihlr-18967	589	8	circuit	circuit	NOUN
ihlr-18967	589	9	’s	’s	PART
ihlr-18967	589	10	justification	justification	NOUN
ihlr-18967	589	11	based	base	VERB
ihlr-18967	589	12	on	on	ADP
ihlr-18967	589	13	policy	policy	NOUN
ihlr-18967	589	14	favoring	favor	VERB
ihlr-18967	589	15	settlements	settlement	NOUN
ihlr-18967	589	16	is	be	AUX
ihlr-18967	589	17	not	not	PART
ihlr-18967	589	18	determinative	determinative	ADJ
ihlr-18967	589	19	)	)	PUNCT
ihlr-18967	589	20	.	.	PUNCT
ihlr-18967	590	1	185	185	NUM
ihlr-18967	590	2	see	see	VERB
ihlr-18967	590	3	supra	supra	PROPN
ihlr-18967	590	4	section	section	PROPN
ihlr-18967	590	5	i.	i.	PROPN
ihlr-18967	590	6	186	186	NUM
ihlr-18967	590	7	contra	contra	PROPN
ihlr-18967	590	8	in	in	ADP
ihlr-18967	590	9	re	re	PROPN
ihlr-18967	590	10	nexium	nexium	NOUN
ihlr-18967	590	11	,	,	PUNCT
ihlr-18967	590	12	968	968	NUM
ihlr-18967	590	13	f.	f.	PROPN
ihlr-18967	590	14	supp	supp	PROPN
ihlr-18967	590	15	.	.	PUNCT
ihlr-18967	591	1	2d	2d	PROPN
ihlr-18967	591	2	at	at	ADP
ihlr-18967	591	3	391	391	NUM
ihlr-18967	591	4	(	(	PUNCT
ihlr-18967	591	5	finding	find	VERB
ihlr-18967	591	6	that	that	SCONJ
ihlr-18967	591	7	anticompetitive	anticompetitive	ADJ
ihlr-18967	591	8	consequences	consequence	NOUN
ihlr-18967	591	9	resulted	result	VERB
ihlr-18967	591	10	from	from	ADP
ihlr-18967	591	11	pioneer	pioneer	NOUN
ihlr-18967	591	12	manufacture	manufacture	NOUN
ihlr-18967	591	13	forgiving	forgive	VERB
ihlr-18967	591	14	contingent	contingent	ADJ
ihlr-18967	591	15	liabilities	liability	NOUN
ihlr-18967	591	16	owed	owe	VERB
ihlr-18967	591	17	to	to	ADP
ihlr-18967	591	18	them	they	PRON
ihlr-18967	591	19	by	by	ADP
ihlr-18967	591	20	generic	generic	ADJ
ihlr-18967	591	21	manufacturers	manufacturer	NOUN
ihlr-18967	591	22	,	,	PUNCT
ihlr-18967	591	23	for	for	ADP
ihlr-18967	591	24	infringement	infringement	NOUN
ihlr-18967	591	25	of	of	ADP
ihlr-18967	591	26	unrelated	unrelated	ADJ
ihlr-18967	591	27	patents	patent	NOUN
ihlr-18967	591	28	,	,	PUNCT
ihlr-18967	591	29	in	in	ADP
ihlr-18967	591	30	exchange	exchange	NOUN
ihlr-18967	591	31	for	for	ADP
ihlr-18967	591	32	generic	generic	ADJ
ihlr-18967	591	33	manufacturers	manufacturer	NOUN
ihlr-18967	591	34	agreeing	agree	VERB
ihlr-18967	591	35	that	that	SCONJ
ihlr-18967	591	36	the	the	DET
ihlr-18967	591	37	pioneer	pioneer	NOUN
ihlr-18967	591	38	manufacturer	manufacturer	NOUN
ihlr-18967	591	39	’s	’s	PART
ihlr-18967	591	40	patents	patent	NOUN
ihlr-18967	591	41	were	be	AUX
ihlr-18967	591	42	valid	valid	ADJ
ihlr-18967	591	43	,	,	PUNCT
ihlr-18967	591	44	being	be	AUX
ihlr-18967	591	45	infringed	infringe	VERB
ihlr-18967	591	46	by	by	ADP
ihlr-18967	591	47	them	they	PRON
ihlr-18967	591	48	,	,	PUNCT
ihlr-18967	591	49	and	and	CCONJ
ihlr-18967	591	50	they	they	PRON
ihlr-18967	591	51	would	would	AUX
ihlr-18967	591	52	delay	delay	VERB
ihlr-18967	591	53	the	the	DET
ihlr-18967	591	54	sale	sale	NOUN
ihlr-18967	591	55	of	of	ADP
ihlr-18967	591	56	generic	generic	ADJ
ihlr-18967	591	57	nexium	nexium	NOUN
ihlr-18967	591	58	)	)	PUNCT
ihlr-18967	591	59	.	.	PUNCT
ihlr-18967	592	1	187	187	NUM
ihlr-18967	592	2	see	see	VERB
ihlr-18967	592	3	agnew	agnew	PROPN
ihlr-18967	592	4	v.	v.	PROPN
ihlr-18967	592	5	nat’l	nat’l	PROPN
ihlr-18967	592	6	collegiate	collegiate	VERB
ihlr-18967	592	7	athletic	athletic	ADJ
ihlr-18967	592	8	ass’n	ass’n	NOUN
ihlr-18967	592	9	,	,	PUNCT
ihlr-18967	592	10	683	683	NUM
ihlr-18967	592	11	f.3d	f.3d	NUM
ihlr-18967	592	12	328	328	NUM
ihlr-18967	592	13	,	,	PUNCT
ihlr-18967	592	14	336	336	NUM
ihlr-18967	592	15	(	(	PUNCT
ihlr-18967	592	16	7th	7th	ADJ
ihlr-18967	592	17	cir	cir	NOUN
ihlr-18967	592	18	.	.	PROPN
ihlr-18967	592	19	2012	2012	NUM
ihlr-18967	592	20	)	)	PUNCT
ihlr-18967	592	21	(	(	PUNCT
ihlr-18967	592	22	plaintiff	plaintiff	NOUN
ihlr-18967	592	23	can	can	AUX
ihlr-18967	592	24	rebut	rebut	VERB
ihlr-18967	592	25	defendant	defendant	NOUN
ihlr-18967	592	26	assertion	assertion	NOUN
ihlr-18967	592	27	of	of	ADP
ihlr-18967	592	28	a	a	DET
ihlr-18967	592	29	procompetitive	procompetitive	ADJ
ihlr-18967	592	30	effect	effect	NOUN
ihlr-18967	592	31	by	by	ADP
ihlr-18967	592	32	showing	show	VERB
ihlr-18967	592	33	it	it	PRON
ihlr-18967	592	34	is	be	AUX
ihlr-18967	592	35	not	not	PART
ihlr-18967	592	36	reasonably	reasonably	ADV
ihlr-18967	592	37	necessary	necessary	ADJ
ihlr-18967	592	38	to	to	PART
ihlr-18967	592	39	achieve	achieve	VERB
ihlr-18967	592	40	the	the	DET
ihlr-18967	592	41	objective	objective	NOUN
ihlr-18967	592	42	)	)	PUNCT
ihlr-18967	592	43	;	;	PUNCT
ihlr-18967	592	44	see	see	VERB
ihlr-18967	592	45	also	also	ADV
ihlr-18967	592	46	major	major	ADJ
ihlr-18967	592	47	league	league	NOUN
ihlr-18967	592	48	baseball	baseball	NOUN
ihlr-18967	592	49	props	prop	NOUN
ihlr-18967	592	50	.	.	PUNCT
ihlr-18967	592	51	,	,	PUNCT
ihlr-18967	592	52	inc	inc	PROPN
ihlr-18967	592	53	.	.	PROPN
ihlr-18967	593	1	v.	v.	ADP
ihlr-18967	593	2	458	458	NUM
ihlr-18967	593	3	indiana	indiana	PROPN
ihlr-18967	593	4	health	health	PROPN
ihlr-18967	593	5	law	law	PROPN
ihlr-18967	593	6	review	review	NOUN
ihlr-18967	593	7	vol	vol	NOUN
ihlr-18967	593	8	.	.	PUNCT
ihlr-18967	594	1	12:1	12:1	NUM
ihlr-18967	594	2	context	context	NOUN
ihlr-18967	594	3	,	,	PUNCT
ihlr-18967	594	4	creating	create	VERB
ihlr-18967	594	5	an	an	DET
ihlr-18967	594	6	overall	overall	ADJ
ihlr-18967	594	7	benefit	benefit	NOUN
ihlr-18967	594	8	for	for	ADP
ihlr-18967	594	9	consumers	consumer	NOUN
ihlr-18967	594	10	may	may	AUX
ihlr-18967	594	11	be	be	AUX
ihlr-18967	594	12	seen	see	VERB
ihlr-18967	594	13	as	as	ADP
ihlr-18967	594	14	a	a	DET
ihlr-18967	594	15	redeeming	redeem	VERB
ihlr-18967	594	16	virtue	virtue	NOUN
ihlr-18967	594	17	.	.	PUNCT
ihlr-18967	595	1	additionally	additionally	ADV
ihlr-18967	595	2	,	,	PUNCT
ihlr-18967	595	3	a	a	DET
ihlr-18967	595	4	cash	cash	NOUN
ihlr-18967	595	5	payment	payment	NOUN
ihlr-18967	595	6	from	from	ADP
ihlr-18967	595	7	a	a	DET
ihlr-18967	595	8	pioneer	pioneer	NOUN
ihlr-18967	595	9	manufacture	manufacture	NOUN
ihlr-18967	595	10	to	to	ADP
ihlr-18967	595	11	a	a	DET
ihlr-18967	595	12	generic	generic	ADJ
ihlr-18967	595	13	manufacture	manufacture	NOUN
ihlr-18967	595	14	may	may	AUX
ihlr-18967	595	15	be	be	AUX
ihlr-18967	595	16	procompetitive	procompetitive	ADJ
ihlr-18967	595	17	depending	depend	VERB
ihlr-18967	595	18	on	on	ADP
ihlr-18967	595	19	the	the	DET
ihlr-18967	595	20	economic	economic	ADJ
ihlr-18967	595	21	situation	situation	NOUN
ihlr-18967	595	22	of	of	ADP
ihlr-18967	595	23	the	the	DET
ihlr-18967	595	24	generic	generic	ADJ
ihlr-18967	595	25	manufacturer	manufacturer	NOUN
ihlr-18967	595	26	.	.	PUNCT
ihlr-18967	596	1	as	as	SCONJ
ihlr-18967	596	2	the	the	DET
ihlr-18967	596	3	third	third	ADJ
ihlr-18967	596	4	circuit	circuit	NOUN
ihlr-18967	596	5	suggested	suggest	VERB
ihlr-18967	596	6	,	,	PUNCT
ihlr-18967	596	7	“	"	PUNCT
ihlr-18967	596	8	a	a	DET
ihlr-18967	596	9	modest	modest	ADJ
ihlr-18967	596	10	cash	cash	NOUN
ihlr-18967	596	11	payment	payment	NOUN
ihlr-18967	596	12	that	that	PRON
ihlr-18967	596	13	enables	enable	VERB
ihlr-18967	596	14	a	a	DET
ihlr-18967	596	15	cash	cash	NOUN
ihlr-18967	596	16	-	-	PUNCT
ihlr-18967	596	17	starved	starve	VERB
ihlr-18967	596	18	generic	generic	ADJ
ihlr-18967	596	19	manufacturer	manufacturer	NOUN
ihlr-18967	596	20	to	to	PART
ihlr-18967	596	21	avoid	avoid	VERB
ihlr-18967	596	22	bankruptcy	bankruptcy	NOUN
ihlr-18967	596	23	and	and	CCONJ
ihlr-18967	596	24	begin	begin	VERB
ihlr-18967	596	25	marketing	market	VERB
ihlr-18967	596	26	a	a	DET
ihlr-18967	596	27	generic	generic	ADJ
ihlr-18967	596	28	drug	drug	NOUN
ihlr-18967	596	29	might	might	AUX
ihlr-18967	596	30	have	have	VERB
ihlr-18967	596	31	an	an	DET
ihlr-18967	596	32	overall	overall	ADJ
ihlr-18967	596	33	effect	effect	NOUN
ihlr-18967	596	34	of	of	ADP
ihlr-18967	596	35	increasing	increase	VERB
ihlr-18967	596	36	the	the	DET
ihlr-18967	596	37	amount	amount	NOUN
ihlr-18967	596	38	of	of	ADP
ihlr-18967	596	39	competition	competition	NOUN
ihlr-18967	596	40	in	in	ADP
ihlr-18967	596	41	the	the	DET
ihlr-18967	596	42	market	market	NOUN
ihlr-18967	596	43	.	.	PUNCT
ihlr-18967	597	1	”188	”188	PUNCT
ihlr-18967	597	2	this	this	DET
ihlr-18967	597	3	example	example	NOUN
ihlr-18967	597	4	would	would	AUX
ihlr-18967	597	5	provide	provide	VERB
ihlr-18967	597	6	a	a	DET
ihlr-18967	597	7	redeeming	redeem	VERB
ihlr-18967	597	8	virtue	virtue	NOUN
ihlr-18967	597	9	that	that	PRON
ihlr-18967	597	10	would	would	AUX
ihlr-18967	597	11	not	not	PART
ihlr-18967	597	12	otherwise	otherwise	ADV
ihlr-18967	597	13	occur	occur	VERB
ihlr-18967	597	14	absent	absent	ADJ
ihlr-18967	597	15	the	the	DET
ihlr-18967	597	16	reverse	reverse	ADJ
ihlr-18967	597	17	payment	payment	NOUN
ihlr-18967	597	18	settlement	settlement	NOUN
ihlr-18967	597	19	.	.	PUNCT
ihlr-18967	598	1	5	5	NUM
ihlr-18967	598	2	.	.	NUM
ihlr-18967	598	3	size	size	NOUN
ihlr-18967	598	4	of	of	ADP
ihlr-18967	598	5	monetary	monetary	ADJ
ihlr-18967	598	6	payments	payment	NOUN
ihlr-18967	598	7	of	of	ADP
ihlr-18967	598	8	main	main	ADJ
ihlr-18967	598	9	concern	concern	NOUN
ihlr-18967	598	10	for	for	ADP
ihlr-18967	598	11	the	the	DET
ihlr-18967	598	12	court	court	NOUN
ihlr-18967	598	13	was	be	AUX
ihlr-18967	598	14	a	a	DET
ihlr-18967	598	15	pioneer	pioneer	NOUN
ihlr-18967	598	16	manufacturer	manufacturer	NOUN
ihlr-18967	598	17	offering	offer	VERB
ihlr-18967	598	18	a	a	DET
ihlr-18967	598	19	large	large	ADJ
ihlr-18967	598	20	sum	sum	NOUN
ihlr-18967	598	21	of	of	ADP
ihlr-18967	598	22	money	money	NOUN
ihlr-18967	598	23	to	to	ADP
ihlr-18967	598	24	a	a	DET
ihlr-18967	598	25	generic	generic	ADJ
ihlr-18967	598	26	manufacturer	manufacturer	NOUN
ihlr-18967	598	27	in	in	ADP
ihlr-18967	598	28	order	order	NOUN
ihlr-18967	598	29	to	to	PART
ihlr-18967	598	30	keep	keep	VERB
ihlr-18967	598	31	its	its	PRON
ihlr-18967	598	32	product	product	NOUN
ihlr-18967	598	33	out	out	ADP
ihlr-18967	598	34	of	of	ADP
ihlr-18967	598	35	the	the	DET
ihlr-18967	598	36	market	market	NOUN
ihlr-18967	598	37	so	so	SCONJ
ihlr-18967	598	38	the	the	DET
ihlr-18967	598	39	pioneer	pioneer	NOUN
ihlr-18967	598	40	manufacture	manufacture	NOUN
ihlr-18967	598	41	can	can	AUX
ihlr-18967	598	42	maximize	maximize	VERB
ihlr-18967	598	43	revenue	revenue	NOUN
ihlr-18967	598	44	at	at	ADP
ihlr-18967	598	45	the	the	DET
ihlr-18967	598	46	expense	expense	NOUN
ihlr-18967	598	47	of	of	ADP
ihlr-18967	598	48	consumers.189	consumers.189	NOUN
ihlr-18967	598	49	for	for	ADP
ihlr-18967	598	50	example	example	NOUN
ihlr-18967	598	51	,	,	PUNCT
ihlr-18967	598	52	a	a	DET
ihlr-18967	598	53	large	large	ADJ
ihlr-18967	598	54	payment	payment	NOUN
ihlr-18967	598	55	was	be	AUX
ihlr-18967	598	56	clearly	clearly	ADV
ihlr-18967	598	57	made	make	VERB
ihlr-18967	598	58	when	when	SCONJ
ihlr-18967	598	59	a	a	DET
ihlr-18967	598	60	pioneer	pioneer	NOUN
ihlr-18967	598	61	manufacturer	manufacturer	NOUN
ihlr-18967	598	62	agreed	agree	VERB
ihlr-18967	598	63	to	to	PART
ihlr-18967	598	64	pay	pay	VERB
ihlr-18967	598	65	a	a	DET
ihlr-18967	598	66	generic	generic	ADJ
ihlr-18967	598	67	manufacturer	manufacturer	NOUN
ihlr-18967	598	68	over	over	ADP
ihlr-18967	598	69	$	$	SYM
ihlr-18967	598	70	1,000,000,000	1,000,000,000	NUM
ihlr-18967	598	71	in	in	ADP
ihlr-18967	598	72	exchange	exchange	NOUN
ihlr-18967	598	73	for	for	ADP
ihlr-18967	598	74	the	the	DET
ihlr-18967	598	75	generic	generic	ADJ
ihlr-18967	598	76	manufacturer	manufacturer	NOUN
ihlr-18967	598	77	agreeing	agree	VERB
ihlr-18967	598	78	that	that	SCONJ
ihlr-18967	598	79	the	the	DET
ihlr-18967	598	80	pioneer	pioneer	NOUN
ihlr-18967	598	81	manufacturer	manufacturer	NOUN
ihlr-18967	598	82	’s	’s	PART
ihlr-18967	598	83	patents	patent	NOUN
ihlr-18967	598	84	were	be	AUX
ihlr-18967	598	85	valid	valid	ADJ
ihlr-18967	598	86	,	,	PUNCT
ihlr-18967	598	87	being	be	AUX
ihlr-18967	598	88	infringed	infringe	VERB
ihlr-18967	598	89	by	by	ADP
ihlr-18967	598	90	the	the	DET
ihlr-18967	598	91	generic	generic	ADJ
ihlr-18967	598	92	manufacturer	manufacturer	NOUN
ihlr-18967	598	93	,	,	PUNCT
ihlr-18967	598	94	and	and	CCONJ
ihlr-18967	598	95	having	have	VERB
ihlr-18967	598	96	the	the	DET
ihlr-18967	598	97	generic	generic	ADJ
ihlr-18967	598	98	manufacturer	manufacturer	NOUN
ihlr-18967	598	99	delay	delay	VERB
ihlr-18967	598	100	entry.190	entry.190	NOUN
ihlr-18967	598	101	as	as	SCONJ
ihlr-18967	598	102	one	one	NUM
ihlr-18967	598	103	commentator	commentator	NOUN
ihlr-18967	598	104	puts	put	VERB
ihlr-18967	598	105	it	it	PRON
ihlr-18967	598	106	,	,	PUNCT
ihlr-18967	598	107	“	"	PUNCT
ihlr-18967	598	108	the	the	DET
ihlr-18967	598	109	larger	large	ADJ
ihlr-18967	598	110	the	the	DET
ihlr-18967	598	111	reverse	reverse	ADJ
ihlr-18967	598	112	payment	payment	NOUN
ihlr-18967	598	113	,	,	PUNCT
ihlr-18967	598	114	the	the	PRON
ihlr-18967	598	115	riskier	risky	ADJ
ihlr-18967	598	116	the	the	DET
ihlr-18967	598	117	settlement	settlement	NOUN
ihlr-18967	598	118	from	from	ADP
ihlr-18967	598	119	an	an	DET
ihlr-18967	598	120	antitrust	antitrust	ADJ
ihlr-18967	598	121	perspective	perspective	NOUN
ihlr-18967	598	122	.	.	PUNCT
ihlr-18967	599	1	”191	”191	PUNCT
ihlr-18967	600	1	keeping	keep	VERB
ihlr-18967	600	2	the	the	DET
ihlr-18967	600	3	monetary	monetary	ADJ
ihlr-18967	600	4	payment	payment	NOUN
ihlr-18967	600	5	in	in	ADP
ihlr-18967	600	6	the	the	DET
ihlr-18967	600	7	settlement	settlement	NOUN
ihlr-18967	600	8	consistent	consistent	ADJ
ihlr-18967	600	9	with	with	ADP
ihlr-18967	600	10	some	some	PRON
ihlr-18967	600	11	of	of	ADP
ihlr-18967	600	12	the	the	DET
ihlr-18967	600	13	justifications	justification	NOUN
ihlr-18967	600	14	below	below	ADV
ihlr-18967	600	15	will	will	AUX
ihlr-18967	600	16	go	go	VERB
ihlr-18967	600	17	a	a	DET
ihlr-18967	600	18	long	long	ADJ
ihlr-18967	600	19	way	way	NOUN
ihlr-18967	600	20	in	in	ADP
ihlr-18967	600	21	showing	show	VERB
ihlr-18967	600	22	that	that	SCONJ
ihlr-18967	600	23	the	the	DET
ihlr-18967	600	24	reverse	reverse	ADJ
ihlr-18967	600	25	payment	payment	NOUN
ihlr-18967	600	26	settlement	settlement	NOUN
ihlr-18967	600	27	does	do	AUX
ihlr-18967	600	28	not	not	PART
ihlr-18967	600	29	present	present	VERB
ihlr-18967	600	30	anticompetitive	anticompetitive	ADJ
ihlr-18967	600	31	harm	harm	NOUN
ihlr-18967	600	32	salvino	salvino	NOUN
ihlr-18967	600	33	,	,	PUNCT
ihlr-18967	600	34	inc	inc	PROPN
ihlr-18967	600	35	.	.	PROPN
ihlr-18967	600	36	542	542	NUM
ihlr-18967	600	37	f.3d	f.3d	NUM
ihlr-18967	600	38	290	290	NUM
ihlr-18967	600	39	,	,	PUNCT
ihlr-18967	600	40	317	317	NUM
ihlr-18967	600	41	(	(	PUNCT
ihlr-18967	600	42	2d	2d	NUM
ihlr-18967	600	43	cir	cir	NOUN
ihlr-18967	600	44	.	.	PROPN
ihlr-18967	600	45	2008	2008	NUM
ihlr-18967	600	46	)	)	PUNCT
ihlr-18967	600	47	;	;	PUNCT
ihlr-18967	600	48	law	law	NOUN
ihlr-18967	600	49	v.	v.	CCONJ
ihlr-18967	600	50	nat’l	nat’l	NOUN
ihlr-18967	600	51	collegiate	collegiate	VERB
ihlr-18967	600	52	athletic	athletic	ADJ
ihlr-18967	600	53	ass’n	ass’n	NOUN
ihlr-18967	600	54	,	,	PUNCT
ihlr-18967	600	55	134	134	NUM
ihlr-18967	600	56	f.3d	f.3d	NUM
ihlr-18967	600	57	1010	1010	NUM
ihlr-18967	600	58	,	,	PUNCT
ihlr-18967	600	59	1019	1019	NUM
ihlr-18967	600	60	(	(	PUNCT
ihlr-18967	600	61	10th	10th	ADJ
ihlr-18967	600	62	cir	cir	NOUN
ihlr-18967	600	63	.	.	PUNCT
ihlr-18967	600	64	1998	1998	NUM
ihlr-18967	600	65	)	)	PUNCT
ihlr-18967	600	66	.	.	PUNCT
ihlr-18967	601	1	188	188	NUM
ihlr-18967	601	2	in	in	ADP
ihlr-18967	601	3	re	re	NOUN
ihlr-18967	601	4	k	k	X
ihlr-18967	601	5	-	-	ADJ
ihlr-18967	601	6	dur	dur	ADJ
ihlr-18967	601	7	antitrust	antitrust	ADJ
ihlr-18967	601	8	litig	litig	NOUN
ihlr-18967	601	9	.	.	PUNCT
ihlr-18967	602	1	,	,	PUNCT
ihlr-18967	602	2	686	686	NUM
ihlr-18967	602	3	f.	f.	NOUN
ihlr-18967	602	4	3d	3d	PROPN
ihlr-18967	602	5	197	197	NUM
ihlr-18967	602	6	,	,	PUNCT
ihlr-18967	602	7	218	218	NUM
ihlr-18967	602	8	(	(	PUNCT
ihlr-18967	602	9	3d	3d	PROPN
ihlr-18967	602	10	cir	cir	NOUN
ihlr-18967	602	11	.	.	PROPN
ihlr-18967	602	12	2012	2012	NUM
ihlr-18967	602	13	)	)	PUNCT
ihlr-18967	602	14	189	189	NUM
ihlr-18967	602	15	actavis	actavi	NOUN
ihlr-18967	602	16	,	,	PUNCT
ihlr-18967	602	17	133	133	NUM
ihlr-18967	602	18	s.	s.	PROPN
ihlr-18967	602	19	ct	ct	PROPN
ihlr-18967	602	20	.	.	PUNCT
ihlr-18967	603	1	at	at	ADP
ihlr-18967	603	2	2234	2234	NUM
ihlr-18967	603	3	.	.	PUNCT
ihlr-18967	604	1	190	190	NUM
ihlr-18967	604	2	in	in	ADP
ihlr-18967	604	3	re	re	NOUN
ihlr-18967	604	4	nexium	nexium	NOUN
ihlr-18967	604	5	,	,	PUNCT
ihlr-18967	604	6	968	968	NUM
ihlr-18967	604	7	f.	f.	PROPN
ihlr-18967	604	8	supp	supp	PROPN
ihlr-18967	604	9	.	.	PUNCT
ihlr-18967	605	1	2d	2d	PROPN
ihlr-18967	605	2	at	at	ADP
ihlr-18967	605	3	381	381	NUM
ihlr-18967	605	4	-	-	SYM
ihlr-18967	605	5	82	82	NUM
ihlr-18967	605	6	.	.	PUNCT
ihlr-18967	605	7	191	191	NUM
ihlr-18967	606	1	what	what	PRON
ihlr-18967	606	2	does	do	AUX
ihlr-18967	606	3	ftc	ftc	PROPN
ihlr-18967	606	4	v.	v.	ADP
ihlr-18967	606	5	actavis	actavis	PROPN
ihlr-18967	606	6	inc	inc	PROPN
ihlr-18967	606	7	.	.	PROPN
ihlr-18967	606	8	mean	mean	VERB
ihlr-18967	606	9	for	for	ADP
ihlr-18967	606	10	hatch	hatch	NOUN
ihlr-18967	606	11	-	-	PUNCT
ihlr-18967	606	12	waxman	waxman	NOUN
ihlr-18967	606	13	litigation	litigation	NOUN
ihlr-18967	606	14	?	?	PUNCT
ihlr-18967	606	15	,	,	PUNCT
ihlr-18967	606	16	crowell	crowell	NOUN
ihlr-18967	606	17	moring	moring	NOUN
ihlr-18967	606	18	(	(	PUNCT
ihlr-18967	606	19	june	june	PROPN
ihlr-18967	606	20	21	21	NUM
ihlr-18967	606	21	,	,	PUNCT
ihlr-18967	606	22	2013	2013	NUM
ihlr-18967	606	23	)	)	PUNCT
ihlr-18967	606	24	,	,	PUNCT
ihlr-18967	606	25	http://www.crowell.com/newsevents/alertsnewsletters/all/what-doesftc-v-actavis-inc-mean-for-hatch-waxman-litigation#.um6zafmsim5	http://www.crowell.com/newsevents/alertsnewsletters/all/what-doesftc-v-actavis-inc-mean-for-hatch-waxman-litigation#.um6zafmsim5	NOUN
ihlr-18967	607	1	[	[	X
ihlr-18967	607	2	hereinafter	hereinafter	NOUN
ihlr-18967	607	3	crowell	crowell	NOUN
ihlr-18967	607	4	moring	moring	NOUN
ihlr-18967	607	5	article	article	NOUN
ihlr-18967	607	6	]	]	PUNCT
ihlr-18967	607	7	.	.	PUNCT
ihlr-18967	608	1	2015	2015	NUM
ihlr-18967	608	2	rationale	rationale	NOUN
ihlr-18967	608	3	behind	behind	ADP
ihlr-18967	608	4	hatch	hatch	NOUN
ihlr-18967	608	5	-	-	PUNCT
ihlr-18967	608	6	waxman	waxman	PROPN
ihlr-18967	608	7	act	act	PROPN
ihlr-18967	608	8	and	and	CCONJ
ihlr-18967	608	9	patent	patent	NOUN
ihlr-18967	608	10	law	law	NOUN
ihlr-18967	608	11	459	459	NUM
ihlr-18967	608	12	and	and	CCONJ
ihlr-18967	608	13	supports	support	VERB
ihlr-18967	608	14	the	the	DET
ihlr-18967	608	15	rationale	rationale	NOUN
ihlr-18967	608	16	behind	behind	ADP
ihlr-18967	608	17	the	the	DET
ihlr-18967	608	18	hatch	hatch	NOUN
ihlr-18967	608	19	-	-	PUNCT
ihlr-18967	608	20	waxman	waxman	PROPN
ihlr-18967	608	21	act	act	NOUN
ihlr-18967	608	22	and	and	CCONJ
ihlr-18967	608	23	patent	patent	NOUN
ihlr-18967	608	24	law.192	law.192	NOUN
ihlr-18967	608	25	one	one	NUM
ihlr-18967	608	26	clear	clear	ADJ
ihlr-18967	608	27	justification	justification	NOUN
ihlr-18967	608	28	for	for	ADP
ihlr-18967	608	29	reverse	reverse	ADJ
ihlr-18967	608	30	payments	payment	NOUN
ihlr-18967	608	31	given	give	VERB
ihlr-18967	608	32	by	by	ADP
ihlr-18967	608	33	the	the	DET
ihlr-18967	608	34	court	court	NOUN
ihlr-18967	608	35	is	be	AUX
ihlr-18967	608	36	anticipated	anticipate	VERB
ihlr-18967	608	37	future	future	ADJ
ihlr-18967	608	38	litigation	litigation	NOUN
ihlr-18967	608	39	costs	cost	NOUN
ihlr-18967	608	40	saved	save	VERB
ihlr-18967	608	41	as	as	ADP
ihlr-18967	608	42	a	a	DET
ihlr-18967	608	43	result	result	NOUN
ihlr-18967	608	44	of	of	ADP
ihlr-18967	608	45	the	the	DET
ihlr-18967	608	46	settlement.193	settlement.193	ADP
ihlr-18967	608	47	this	this	PRON
ihlr-18967	608	48	indicates	indicate	VERB
ihlr-18967	608	49	that	that	SCONJ
ihlr-18967	608	50	in	in	ADP
ihlr-18967	608	51	a	a	DET
ihlr-18967	608	52	patent	patent	NOUN
ihlr-18967	608	53	infringement	infringement	NOUN
ihlr-18967	608	54	suit	suit	NOUN
ihlr-18967	608	55	,	,	PUNCT
ihlr-18967	608	56	pioneer	pioneer	NOUN
ihlr-18967	608	57	and	and	CCONJ
ihlr-18967	608	58	generic	generic	ADJ
ihlr-18967	608	59	manufacturers	manufacturer	NOUN
ihlr-18967	608	60	should	should	AUX
ihlr-18967	608	61	attempt	attempt	VERB
ihlr-18967	608	62	to	to	PART
ihlr-18967	608	63	settle	settle	VERB
ihlr-18967	608	64	as	as	ADV
ihlr-18967	608	65	early	early	ADV
ihlr-18967	608	66	as	as	ADP
ihlr-18967	608	67	possible	possible	ADJ
ihlr-18967	608	68	.	.	PUNCT
ihlr-18967	609	1	settling	settle	VERB
ihlr-18967	609	2	early	early	ADV
ihlr-18967	609	3	will	will	AUX
ihlr-18967	609	4	ensure	ensure	VERB
ihlr-18967	609	5	a	a	DET
ihlr-18967	609	6	larger	large	ADJ
ihlr-18967	609	7	cost	cost	NOUN
ihlr-18967	609	8	saved	save	VERB
ihlr-18967	609	9	and	and	CCONJ
ihlr-18967	609	10	subsequently	subsequently	ADV
ihlr-18967	609	11	,	,	PUNCT
ihlr-18967	609	12	a	a	DET
ihlr-18967	609	13	larger	large	ADJ
ihlr-18967	609	14	reverse	reverse	ADJ
ihlr-18967	609	15	payment	payment	NOUN
ihlr-18967	609	16	will	will	AUX
ihlr-18967	609	17	be	be	AUX
ihlr-18967	609	18	justified	justify	VERB
ihlr-18967	609	19	.	.	PUNCT
ihlr-18967	610	1	also	also	ADV
ihlr-18967	610	2	,	,	PUNCT
ihlr-18967	610	3	it	it	PRON
ihlr-18967	610	4	may	may	AUX
ihlr-18967	610	5	be	be	AUX
ihlr-18967	610	6	argued	argue	VERB
ihlr-18967	610	7	that	that	SCONJ
ihlr-18967	610	8	indirect	indirect	ADJ
ihlr-18967	610	9	costs	cost	NOUN
ihlr-18967	610	10	and	and	CCONJ
ihlr-18967	610	11	uncertainty	uncertainty	NOUN
ihlr-18967	610	12	of	of	ADP
ihlr-18967	610	13	the	the	DET
ihlr-18967	610	14	litigation	litigation	NOUN
ihlr-18967	610	15	’s	’s	PART
ihlr-18967	610	16	outcome	outcome	NOUN
ihlr-18967	610	17	may	may	AUX
ihlr-18967	610	18	increase	increase	VERB
ihlr-18967	610	19	future	future	ADJ
ihlr-18967	610	20	litigation	litigation	NOUN
ihlr-18967	610	21	costs	cost	NOUN
ihlr-18967	610	22	.	.	PUNCT
ihlr-18967	611	1	lastly	lastly	ADV
ihlr-18967	611	2	,	,	PUNCT
ihlr-18967	611	3	the	the	DET
ihlr-18967	611	4	complexity	complexity	NOUN
ihlr-18967	611	5	of	of	ADP
ihlr-18967	611	6	the	the	DET
ihlr-18967	611	7	issue	issue	NOUN
ihlr-18967	611	8	and	and	CCONJ
ihlr-18967	611	9	the	the	DET
ihlr-18967	611	10	number	number	NOUN
ihlr-18967	611	11	of	of	ADP
ihlr-18967	611	12	parties	party	NOUN
ihlr-18967	611	13	involved	involve	VERB
ihlr-18967	611	14	will	will	AUX
ihlr-18967	611	15	also	also	ADV
ihlr-18967	611	16	increase	increase	VERB
ihlr-18967	611	17	future	future	ADJ
ihlr-18967	611	18	litigation	litigation	NOUN
ihlr-18967	611	19	costs	cost	NOUN
ihlr-18967	611	20	.	.	PUNCT
ihlr-18967	612	1	additionally	additionally	ADV
ihlr-18967	612	2	,	,	PUNCT
ihlr-18967	612	3	the	the	DET
ihlr-18967	612	4	court	court	NOUN
ihlr-18967	612	5	was	be	AUX
ihlr-18967	612	6	concerned	concern	VERB
ihlr-18967	612	7	with	with	ADP
ihlr-18967	612	8	payment	payment	NOUN
ihlr-18967	612	9	sizes	size	NOUN
ihlr-18967	612	10	which	which	PRON
ihlr-18967	612	11	seek	seek	VERB
ihlr-18967	612	12	to	to	PART
ihlr-18967	612	13	“	"	PUNCT
ihlr-18967	612	14	pay	pay	VERB
ihlr-18967	612	15	a	a	DET
ihlr-18967	612	16	generic	generic	ADJ
ihlr-18967	612	17	challenger	challenger	NOUN
ihlr-18967	612	18	a	a	DET
ihlr-18967	612	19	sum	sum	NOUN
ihlr-18967	612	20	even	even	ADV
ihlr-18967	612	21	larger	large	ADJ
ihlr-18967	612	22	than	than	ADP
ihlr-18967	612	23	what	what	PRON
ihlr-18967	612	24	the	the	DET
ihlr-18967	612	25	generic	generic	ADJ
ihlr-18967	612	26	would	would	AUX
ihlr-18967	612	27	gain	gain	VERB
ihlr-18967	612	28	in	in	ADP
ihlr-18967	612	29	profits	profit	NOUN
ihlr-18967	612	30	.	.	PUNCT
ihlr-18967	613	1	”194	”194	ADJ
ihlr-18967	613	2	economic	economic	ADJ
ihlr-18967	613	3	projections	projection	NOUN
ihlr-18967	613	4	showing	show	VERB
ihlr-18967	613	5	a	a	DET
ihlr-18967	613	6	generic	generic	ADJ
ihlr-18967	613	7	manufacturer	manufacturer	NOUN
ihlr-18967	613	8	earning	earn	VERB
ihlr-18967	613	9	more	more	ADJ
ihlr-18967	613	10	revenue	revenue	NOUN
ihlr-18967	613	11	by	by	ADP
ihlr-18967	613	12	entering	enter	VERB
ihlr-18967	613	13	the	the	DET
ihlr-18967	613	14	market	market	NOUN
ihlr-18967	613	15	,	,	PUNCT
ihlr-18967	613	16	as	as	SCONJ
ihlr-18967	613	17	opposed	oppose	VERB
ihlr-18967	613	18	to	to	ADP
ihlr-18967	613	19	a	a	DET
ihlr-18967	613	20	settlement	settlement	NOUN
ihlr-18967	613	21	,	,	PUNCT
ihlr-18967	613	22	will	will	AUX
ihlr-18967	613	23	be	be	AUX
ihlr-18967	613	24	persuasive	persuasive	ADJ
ihlr-18967	613	25	.	.	PUNCT
ihlr-18967	614	1	when	when	SCONJ
ihlr-18967	614	2	the	the	DET
ihlr-18967	614	3	settlement	settlement	NOUN
ihlr-18967	614	4	is	be	AUX
ihlr-18967	614	5	greater	great	ADJ
ihlr-18967	614	6	than	than	ADP
ihlr-18967	614	7	the	the	DET
ihlr-18967	614	8	generic	generic	ADJ
ihlr-18967	614	9	manufacturer	manufacturer	NOUN
ihlr-18967	614	10	’s	’s	PART
ihlr-18967	614	11	expected	expect	VERB
ihlr-18967	614	12	revenue	revenue	NOUN
ihlr-18967	614	13	,	,	PUNCT
ihlr-18967	614	14	it	it	PRON
ihlr-18967	614	15	suggests	suggest	VERB
ihlr-18967	614	16	the	the	DET
ihlr-18967	614	17	pioneer	pioneer	NOUN
ihlr-18967	614	18	and	and	CCONJ
ihlr-18967	614	19	generic	generic	ADJ
ihlr-18967	614	20	manufacturer	manufacturer	NOUN
ihlr-18967	614	21	have	have	VERB
ihlr-18967	614	22	an	an	DET
ihlr-18967	614	23	ulterior	ulterior	ADJ
ihlr-18967	614	24	motive	motive	NOUN
ihlr-18967	614	25	to	to	PART
ihlr-18967	614	26	settle	settle	VERB
ihlr-18967	614	27	.	.	PUNCT
ihlr-18967	615	1	for	for	ADP
ihlr-18967	615	2	example	example	NOUN
ihlr-18967	615	3	,	,	PUNCT
ihlr-18967	615	4	a	a	DET
ihlr-18967	615	5	pioneer	pioneer	NOUN
ihlr-18967	615	6	and	and	CCONJ
ihlr-18967	615	7	generic	generic	ADJ
ihlr-18967	615	8	manufacturer	manufacturer	NOUN
ihlr-18967	615	9	may	may	AUX
ihlr-18967	615	10	earn	earn	VERB
ihlr-18967	615	11	more	more	ADJ
ihlr-18967	615	12	revenue	revenue	NOUN
ihlr-18967	615	13	by	by	ADP
ihlr-18967	615	14	teaming	team	VERB
ihlr-18967	615	15	up	up	ADP
ihlr-18967	615	16	and	and	CCONJ
ihlr-18967	615	17	charging	charge	VERB
ihlr-18967	615	18	monopolistic	monopolistic	ADJ
ihlr-18967	615	19	prices	price	NOUN
ihlr-18967	615	20	to	to	ADP
ihlr-18967	615	21	consumers	consumer	NOUN
ihlr-18967	615	22	instead	instead	ADV
ihlr-18967	615	23	of	of	ADP
ihlr-18967	615	24	competing	compete	VERB
ihlr-18967	615	25	against	against	ADP
ihlr-18967	615	26	each	each	DET
ihlr-18967	615	27	other	other	ADJ
ihlr-18967	615	28	.	.	PUNCT
ihlr-18967	616	1	conversely	conversely	ADV
ihlr-18967	616	2	,	,	PUNCT
ihlr-18967	616	3	a	a	DET
ihlr-18967	616	4	reverse	reverse	ADJ
ihlr-18967	616	5	payment	payment	NOUN
ihlr-18967	616	6	settlement	settlement	NOUN
ihlr-18967	616	7	not	not	PART
ihlr-18967	616	8	seeking	seek	VERB
ihlr-18967	616	9	to	to	PART
ihlr-18967	616	10	solely	solely	ADV
ihlr-18967	616	11	protect	protect	VERB
ihlr-18967	616	12	the	the	DET
ihlr-18967	616	13	pioneer	pioneer	NOUN
ihlr-18967	616	14	manufacturer	manufacturer	NOUN
ihlr-18967	616	15	’s	’s	PART
ihlr-18967	616	16	monopoly	monopoly	NOUN
ihlr-18967	616	17	will	will	AUX
ihlr-18967	616	18	be	be	AUX
ihlr-18967	616	19	viewed	view	VERB
ihlr-18967	616	20	as	as	ADP
ihlr-18967	616	21	pro	pro	ADJ
ihlr-18967	616	22	-	-	ADJ
ihlr-18967	616	23	competitive	competitive	ADJ
ihlr-18967	616	24	.	.	PUNCT
ihlr-18967	617	1	payments	payment	NOUN
ihlr-18967	617	2	may	may	AUX
ihlr-18967	617	3	be	be	AUX
ihlr-18967	617	4	further	far	ADV
ihlr-18967	617	5	justified	justify	VERB
ihlr-18967	617	6	if	if	SCONJ
ihlr-18967	617	7	the	the	DET
ihlr-18967	617	8	generic	generic	ADJ
ihlr-18967	617	9	manufacturer	manufacturer	NOUN
ihlr-18967	617	10	provides	provide	VERB
ihlr-18967	617	11	a	a	DET
ihlr-18967	617	12	service	service	NOUN
ihlr-18967	617	13	to	to	ADP
ihlr-18967	617	14	the	the	DET
ihlr-18967	617	15	pioneer	pioneer	NOUN
ihlr-18967	617	16	manufacturer.195	manufacturer.195	NOUN
ihlr-18967	617	17	such	such	ADJ
ihlr-18967	617	18	services	service	NOUN
ihlr-18967	617	19	may	may	AUX
ihlr-18967	617	20	include	include	VERB
ihlr-18967	617	21	distribution,196	distribution,196	PROPN
ihlr-18967	617	22	192	192	NUM
ihlr-18967	617	23	in	in	ADP
ihlr-18967	617	24	re	re	PROPN
ihlr-18967	617	25	lamictal	lamictal	ADJ
ihlr-18967	617	26	direct	direct	ADJ
ihlr-18967	617	27	purchaser	purchaser	NOUN
ihlr-18967	617	28	antitrust	antitrust	ADJ
ihlr-18967	617	29	litig	litig	NOUN
ihlr-18967	617	30	.	.	PUNCT
ihlr-18967	618	1	,	,	PUNCT
ihlr-18967	618	2	18	18	NUM
ihlr-18967	618	3	f.supp.3d	f.supp.3d	NOUN
ihlr-18967	618	4	560	560	NUM
ihlr-18967	618	5	,	,	PUNCT
ihlr-18967	618	6	570	570	NUM
ihlr-18967	618	7	(	(	PUNCT
ihlr-18967	618	8	d.	d.	PROPN
ihlr-18967	618	9	n.j	n.j	PROPN
ihlr-18967	618	10	.	.	PROPN
ihlr-18967	618	11	2014	2014	NUM
ihlr-18967	618	12	)	)	PUNCT
ihlr-18967	618	13	(	(	PUNCT
ihlr-18967	618	14	finding	find	VERB
ihlr-18967	618	15	that	that	SCONJ
ihlr-18967	618	16	the	the	DET
ihlr-18967	618	17	value	value	NOUN
ihlr-18967	618	18	to	to	ADP
ihlr-18967	618	19	the	the	DET
ihlr-18967	618	20	generic	generic	ADJ
ihlr-18967	618	21	manufacturer	manufacturer	NOUN
ihlr-18967	618	22	“	"	PUNCT
ihlr-18967	618	23	likely	likely	ADV
ihlr-18967	618	24	exceed[ed	exceed[ed	PROPN
ihlr-18967	618	25	]	]	X
ihlr-18967	618	26	what	what	PRON
ihlr-18967	618	27	the	the	DET
ihlr-18967	618	28	parties	party	NOUN
ihlr-18967	618	29	would	would	AUX
ihlr-18967	618	30	have	have	AUX
ihlr-18967	618	31	spent	spend	VERB
ihlr-18967	618	32	litigating	litigate	VERB
ihlr-18967	618	33	the	the	DET
ihlr-18967	618	34	patent	patent	NOUN
ihlr-18967	618	35	dispute	dispute	NOUN
ihlr-18967	618	36	,	,	PUNCT
ihlr-18967	618	37	the	the	DET
ihlr-18967	618	38	consideration	consideration	NOUN
ihlr-18967	618	39	which	which	PRON
ihlr-18967	618	40	the	the	DET
ihlr-18967	618	41	parties	party	NOUN
ihlr-18967	618	42	exchanged	exchange	VERB
ihlr-18967	618	43	in	in	ADP
ihlr-18967	618	44	the	the	DET
ihlr-18967	618	45	settlement	settlement	NOUN
ihlr-18967	618	46	is	be	AUX
ihlr-18967	618	47	reasonably	reasonably	ADV
ihlr-18967	618	48	related	related	ADJ
ihlr-18967	618	49	to	to	ADP
ihlr-18967	618	50	the	the	DET
ihlr-18967	618	51	removal	removal	NOUN
ihlr-18967	618	52	of	of	ADP
ihlr-18967	618	53	the	the	DET
ihlr-18967	618	54	uncertainty	uncertainty	NOUN
ihlr-18967	618	55	created	create	VERB
ihlr-18967	618	56	by	by	ADP
ihlr-18967	618	57	the	the	DET
ihlr-18967	618	58	dispute	dispute	NOUN
ihlr-18967	618	59	”	"	PUNCT
ihlr-18967	618	60	)	)	PUNCT
ihlr-18967	618	61	.	.	PUNCT
ihlr-18967	619	1	193	193	NUM
ihlr-18967	619	2	actavis	actavi	NOUN
ihlr-18967	619	3	,	,	PUNCT
ihlr-18967	619	4	133	133	NUM
ihlr-18967	619	5	s.	s.	PROPN
ihlr-18967	619	6	ct	ct	PROPN
ihlr-18967	619	7	.	.	PUNCT
ihlr-18967	619	8	at	at	ADP
ihlr-18967	619	9	2236	2236	NUM
ihlr-18967	619	10	.	.	PUNCT
ihlr-18967	620	1	194	194	NUM
ihlr-18967	621	1	i	i	PRON
ihlr-18967	621	2	d.	d.	PROPN
ihlr-18967	621	3	at	at	ADP
ihlr-18967	621	4	2235	2235	NUM
ihlr-18967	621	5	(	(	PUNCT
ihlr-18967	621	6	citing	cite	VERB
ihlr-18967	621	7	c.	c.	PROPN
ihlr-18967	621	8	scott	scott	PROPN
ihlr-18967	621	9	hemphill	hemphill	PROPN
ihlr-18967	621	10	,	,	PUNCT
ihlr-18967	621	11	paying	pay	VERB
ihlr-18967	621	12	for	for	ADP
ihlr-18967	621	13	delay	delay	NOUN
ihlr-18967	621	14	:	:	PUNCT
ihlr-18967	621	15	pharmaceutical	pharmaceutical	NOUN
ihlr-18967	621	16	patent	patent	NOUN
ihlr-18967	621	17	settlements	settlement	NOUN
ihlr-18967	621	18	as	as	ADP
ihlr-18967	621	19	a	a	DET
ihlr-18967	621	20	regulatory	regulatory	ADJ
ihlr-18967	621	21	design	design	NOUN
ihlr-18967	621	22	problem	problem	NOUN
ihlr-18967	621	23	,	,	PUNCT
ihlr-18967	621	24	81	81	NUM
ihlr-18967	621	25	n.y	n.y	PROPN
ihlr-18967	621	26	.	.	PROPN
ihlr-18967	621	27	u.	u.	PROPN
ihlr-18967	621	28	l.	l.	PROPN
ihlr-18967	621	29	rev	rev	PROPN
ihlr-18967	621	30	.	.	PROPN
ihlr-18967	621	31	1553	1553	NUM
ihlr-18967	621	32	,	,	PUNCT
ihlr-18967	621	33	1581	1581	NUM
ihlr-18967	621	34	(	(	PUNCT
ihlr-18967	621	35	2006	2006	NUM
ihlr-18967	621	36	)	)	PUNCT
ihlr-18967	621	37	)	)	PUNCT
ihlr-18967	621	38	.	.	PUNCT
ihlr-18967	622	1	195	195	NUM
ihlr-18967	622	2	i	i	PROPN
ihlr-18967	622	3	d.	d.	NOUN
ihlr-18967	622	4	at	at	ADP
ihlr-18967	622	5	2236	2236	NUM
ihlr-18967	622	6	.	.	PUNCT
ihlr-18967	623	1	460	460	NUM
ihlr-18967	623	2	indiana	indiana	PROPN
ihlr-18967	623	3	health	health	PROPN
ihlr-18967	623	4	law	law	PROPN
ihlr-18967	623	5	review	review	NOUN
ihlr-18967	623	6	vol	vol	NOUN
ihlr-18967	623	7	.	.	PUNCT
ihlr-18967	624	1	12:1	12:1	NUM
ihlr-18967	624	2	marketing,197	marketing,197	PROPN
ihlr-18967	624	3	consulting	consulting	NOUN
ihlr-18967	624	4	,	,	PUNCT
ihlr-18967	624	5	administration	administration	NOUN
ihlr-18967	624	6	,	,	PUNCT
ihlr-18967	624	7	research	research	NOUN
ihlr-18967	624	8	,	,	PUNCT
ihlr-18967	624	9	quality	quality	NOUN
ihlr-18967	624	10	control	control	NOUN
ihlr-18967	624	11	,	,	PUNCT
ihlr-18967	624	12	licensing198	licensing198	PROPN
ihlr-18967	624	13	and	and	CCONJ
ihlr-18967	624	14	any	any	DET
ihlr-18967	624	15	other	other	ADJ
ihlr-18967	624	16	business	business	NOUN
ihlr-18967	624	17	arrangement	arrangement	NOUN
ihlr-18967	624	18	which	which	PRON
ihlr-18967	624	19	is	be	AUX
ihlr-18967	624	20	reasonable	reasonable	ADJ
ihlr-18967	624	21	.	.	PUNCT
ihlr-18967	625	1	for	for	ADP
ihlr-18967	625	2	example	example	NOUN
ihlr-18967	625	3	,	,	PUNCT
ihlr-18967	625	4	in	in	ADP
ihlr-18967	625	5	actavis	actavis	NOUN
ihlr-18967	625	6	,	,	PUNCT
ihlr-18967	625	7	actavis	actavi	NOUN
ihlr-18967	625	8	,	,	PUNCT
ihlr-18967	625	9	paddock	paddock	NOUN
ihlr-18967	625	10	,	,	PUNCT
ihlr-18967	625	11	and	and	CCONJ
ihlr-18967	625	12	par	par	NOUN
ihlr-18967	625	13	provided	provide	VERB
ihlr-18967	625	14	consideration	consideration	NOUN
ihlr-18967	625	15	to	to	AUX
ihlr-18967	625	16	solvay	solvay	VERB
ihlr-18967	625	17	by	by	ADP
ihlr-18967	625	18	agreeing	agree	VERB
ihlr-18967	625	19	to	to	PART
ihlr-18967	625	20	promote	promote	VERB
ihlr-18967	625	21	solvay	solvay	PROPN
ihlr-18967	625	22	’s	’s	PART
ihlr-18967	625	23	androgel	androgel	NOUN
ihlr-18967	625	24	to	to	ADP
ihlr-18967	625	25	physicians.199	physicians.199	PROPN
ihlr-18967	625	26	also	also	ADV
ihlr-18967	625	27	,	,	PUNCT
ihlr-18967	625	28	based	base	VERB
ihlr-18967	625	29	on	on	ADP
ihlr-18967	625	30	the	the	DET
ihlr-18967	625	31	court	court	NOUN
ihlr-18967	625	32	’s	’s	PART
ihlr-18967	625	33	concerns	concern	NOUN
ihlr-18967	625	34	with	with	ADP
ihlr-18967	625	35	overpayment	overpayment	NOUN
ihlr-18967	625	36	,	,	PUNCT
ihlr-18967	625	37	it	it	PRON
ihlr-18967	625	38	will	will	AUX
ihlr-18967	625	39	be	be	AUX
ihlr-18967	625	40	important	important	ADJ
ihlr-18967	625	41	to	to	PART
ihlr-18967	625	42	determine	determine	VERB
ihlr-18967	625	43	the	the	DET
ihlr-18967	625	44	fair	fair	ADJ
ihlr-18967	625	45	market	market	NOUN
ihlr-18967	625	46	value	value	NOUN
ihlr-18967	625	47	of	of	ADP
ihlr-18967	625	48	any	any	DET
ihlr-18967	625	49	services	service	NOUN
ihlr-18967	625	50	that	that	PRON
ihlr-18967	625	51	are	be	AUX
ihlr-18967	625	52	provided	provide	VERB
ihlr-18967	625	53	.	.	PUNCT
ihlr-18967	626	1	further	far	ADV
ihlr-18967	626	2	,	,	PUNCT
ihlr-18967	626	3	a	a	DET
ihlr-18967	626	4	reverse	reverse	ADJ
ihlr-18967	626	5	payment	payment	NOUN
ihlr-18967	626	6	which	which	PRON
ihlr-18967	626	7	is	be	AUX
ihlr-18967	626	8	more	more	ADJ
ihlr-18967	626	9	than	than	ADP
ihlr-18967	626	10	the	the	DET
ihlr-18967	626	11	expected	expect	VERB
ihlr-18967	626	12	loss	loss	NOUN
ihlr-18967	626	13	to	to	ADP
ihlr-18967	626	14	the	the	DET
ihlr-18967	626	15	pioneer	pioneer	NOUN
ihlr-18967	626	16	manufacturer	manufacturer	NOUN
ihlr-18967	626	17	,	,	PUNCT
ihlr-18967	626	18	if	if	SCONJ
ihlr-18967	626	19	they	they	PRON
ihlr-18967	626	20	lose	lose	VERB
ihlr-18967	626	21	the	the	DET
ihlr-18967	626	22	litigation	litigation	NOUN
ihlr-18967	626	23	and	and	CCONJ
ihlr-18967	626	24	the	the	DET
ihlr-18967	626	25	generic	generic	ADJ
ihlr-18967	626	26	manufacturer	manufacturer	NOUN
ihlr-18967	626	27	enters	enter	VERB
ihlr-18967	626	28	the	the	DET
ihlr-18967	626	29	market	market	NOUN
ihlr-18967	626	30	,	,	PUNCT
ihlr-18967	626	31	implies	imply	VERB
ihlr-18967	626	32	anticompetitiveness	anticompetitiveness	NOUN
ihlr-18967	626	33	and	and	CCONJ
ihlr-18967	626	34	“	"	PUNCT
ihlr-18967	626	35	pay	pay	VERB
ihlr-18967	626	36	-	-	PUNCT
ihlr-18967	626	37	for	for	ADP
ihlr-18967	626	38	-	-	PUNCT
ihlr-18967	626	39	delay	delay	NOUN
ihlr-18967	626	40	.	.	PUNCT
ihlr-18967	626	41	”	"	PUNCT
ihlr-18967	627	1	this	this	DET
ihlr-18967	627	2	type	type	NOUN
ihlr-18967	627	3	of	of	ADP
ihlr-18967	627	4	payment	payment	NOUN
ihlr-18967	627	5	suggests	suggest	VERB
ihlr-18967	627	6	the	the	DET
ihlr-18967	627	7	pioneer	pioneer	NOUN
ihlr-18967	627	8	manufacturer	manufacturer	NOUN
ihlr-18967	627	9	’s	’s	PART
ihlr-18967	627	10	motive	motive	NOUN
ihlr-18967	627	11	is	be	AUX
ihlr-18967	627	12	to	to	PART
ihlr-18967	627	13	keep	keep	VERB
ihlr-18967	627	14	the	the	DET
ihlr-18967	627	15	generic	generic	ADJ
ihlr-18967	627	16	manufacturer	manufacturer	NOUN
ihlr-18967	627	17	out	out	ADP
ihlr-18967	627	18	of	of	ADP
ihlr-18967	627	19	the	the	DET
ihlr-18967	627	20	market	market	NOUN
ihlr-18967	627	21	.	.	PUNCT
ihlr-18967	628	1	for	for	ADP
ihlr-18967	628	2	example	example	NOUN
ihlr-18967	628	3	,	,	PUNCT
ihlr-18967	628	4	using	use	VERB
ihlr-18967	628	5	the	the	DET
ihlr-18967	628	6	example	example	NOUN
ihlr-18967	628	7	from	from	ADP
ihlr-18967	628	8	the	the	DET
ihlr-18967	628	9	introduction	introduction	NOUN
ihlr-18967	628	10	,	,	PUNCT
ihlr-18967	628	11	if	if	SCONJ
ihlr-18967	628	12	abc	abc	PROPN
ihlr-18967	628	13	is	be	AUX
ihlr-18967	628	14	expected	expect	VERB
ihlr-18967	628	15	to	to	PART
ihlr-18967	628	16	lose	lose	VERB
ihlr-18967	628	17	$	$	SYM
ihlr-18967	628	18	5	5	NUM
ihlr-18967	628	19	million	million	NUM
ihlr-18967	628	20	in	in	ADP
ihlr-18967	628	21	revenue	revenue	NOUN
ihlr-18967	628	22	when	when	SCONJ
ihlr-18967	628	23	xyz	xyz	PROPN
ihlr-18967	628	24	enters	enter	VERB
ihlr-18967	628	25	the	the	DET
ihlr-18967	628	26	market	market	NOUN
ihlr-18967	628	27	,	,	PUNCT
ihlr-18967	628	28	but	but	CCONJ
ihlr-18967	628	29	enters	enter	VERB
ihlr-18967	628	30	into	into	ADP
ihlr-18967	628	31	a	a	DET
ihlr-18967	628	32	reverse	reverse	ADJ
ihlr-18967	628	33	payment	payment	NOUN
ihlr-18967	628	34	for	for	ADP
ihlr-18967	628	35	$	$	SYM
ihlr-18967	628	36	6	6	NUM
ihlr-18967	628	37	million	million	NUM
ihlr-18967	628	38	,	,	PUNCT
ihlr-18967	628	39	abc	abc	PROPN
ihlr-18967	628	40	’s	’s	PART
ihlr-18967	628	41	likely	likely	ADJ
ihlr-18967	628	42	motivation	motivation	NOUN
ihlr-18967	628	43	is	be	AUX
ihlr-18967	628	44	to	to	PART
ihlr-18967	628	45	be	be	AUX
ihlr-18967	628	46	able	able	ADJ
ihlr-18967	628	47	to	to	PART
ihlr-18967	628	48	continue	continue	VERB
ihlr-18967	628	49	to	to	PART
ihlr-18967	628	50	exert	exert	VERB
ihlr-18967	628	51	its	its	PRON
ihlr-18967	628	52	monopolistic	monopolistic	ADJ
ihlr-18967	628	53	power	power	NOUN
ihlr-18967	628	54	.	.	PUNCT
ihlr-18967	629	1	on	on	ADP
ihlr-18967	629	2	the	the	DET
ihlr-18967	629	3	contrary	contrary	NOUN
ihlr-18967	629	4	,	,	PUNCT
ihlr-18967	629	5	a	a	DET
ihlr-18967	629	6	payment	payment	NOUN
ihlr-18967	629	7	which	which	PRON
ihlr-18967	629	8	is	be	AUX
ihlr-18967	629	9	less	less	ADJ
ihlr-18967	629	10	than	than	ADP
ihlr-18967	629	11	the	the	DET
ihlr-18967	629	12	expected	expect	VERB
ihlr-18967	629	13	loss	loss	NOUN
ihlr-18967	629	14	to	to	ADP
ihlr-18967	629	15	the	the	DET
ihlr-18967	629	16	pioneer	pioneer	NOUN
ihlr-18967	629	17	manufacturer	manufacturer	NOUN
ihlr-18967	629	18	suggests	suggest	VERB
ihlr-18967	629	19	its	its	PRON
ihlr-18967	629	20	motive	motive	NOUN
ihlr-18967	629	21	is	be	AUX
ihlr-18967	629	22	not	not	PART
ihlr-18967	629	23	to	to	PART
ihlr-18967	629	24	keep	keep	VERB
ihlr-18967	629	25	the	the	DET
ihlr-18967	629	26	generic	generic	ADJ
ihlr-18967	629	27	manufacturer	manufacturer	NOUN
ihlr-18967	629	28	out	out	ADP
ihlr-18967	629	29	of	of	ADP
ihlr-18967	629	30	the	the	DET
ihlr-18967	629	31	market	market	NOUN
ihlr-18967	629	32	.	.	PUNCT
ihlr-18967	630	1	one	one	NUM
ihlr-18967	630	2	way	way	NOUN
ihlr-18967	630	3	of	of	ADP
ihlr-18967	630	4	determining	determine	VERB
ihlr-18967	630	5	the	the	DET
ihlr-18967	630	6	expected	expect	VERB
ihlr-18967	630	7	cost	cost	NOUN
ihlr-18967	630	8	to	to	ADP
ihlr-18967	630	9	the	the	DET
ihlr-18967	630	10	pioneer	pioneer	NOUN
ihlr-18967	630	11	manufacturer	manufacturer	NOUN
ihlr-18967	630	12	when	when	SCONJ
ihlr-18967	630	13	losing	lose	VERB
ihlr-18967	630	14	the	the	DET
ihlr-18967	630	15	patent	patent	NOUN
ihlr-18967	630	16	litigation	litigation	NOUN
ihlr-18967	630	17	would	would	AUX
ihlr-18967	630	18	be	be	AUX
ihlr-18967	630	19	to	to	PART
ihlr-18967	630	20	take	take	VERB
ihlr-18967	630	21	the	the	DET
ihlr-18967	630	22	potential	potential	ADJ
ihlr-18967	630	23	lost	lose	VERB
ihlr-18967	630	24	profits	profit	NOUN
ihlr-18967	630	25	from	from	ADP
ihlr-18967	630	26	the	the	DET
ihlr-18967	630	27	generic	generic	ADJ
ihlr-18967	630	28	manufacturer	manufacturer	NOUN
ihlr-18967	630	29	entering	enter	VERB
ihlr-18967	630	30	the	the	DET
ihlr-18967	630	31	market	market	NOUN
ihlr-18967	630	32	,	,	PUNCT
ihlr-18967	630	33	mitigated	mitigate	VERB
ihlr-18967	630	34	by	by	ADP
ihlr-18967	630	35	the	the	DET
ihlr-18967	630	36	litigation	litigation	NOUN
ihlr-18967	630	37	odds	odd	NOUN
ihlr-18967	630	38	,	,	PUNCT
ihlr-18967	630	39	and	and	CCONJ
ihlr-18967	630	40	add	add	VERB
ihlr-18967	630	41	in	in	ADP
ihlr-18967	630	42	any	any	DET
ihlr-18967	630	43	costs	cost	NOUN
ihlr-18967	630	44	saved	save	VERB
ihlr-18967	630	45	by	by	ADP
ihlr-18967	630	46	settling.200	settling.200	PROPN
ihlr-18967	630	47	assume	assume	VERB
ihlr-18967	630	48	the	the	DET
ihlr-18967	630	49	following	follow	VERB
ihlr-18967	630	50	:	:	PUNCT
ihlr-18967	630	51	196	196	NUM
ihlr-18967	631	1	i	i	PRON
ihlr-18967	631	2	d.	d.	PROPN
ihlr-18967	631	3	197	197	NUM
ihlr-18967	632	1	i	i	PRON
ihlr-18967	632	2	d.	d.	PROPN
ihlr-18967	632	3	198	198	NUM
ihlr-18967	632	4	client	client	PROPN
ihlr-18967	632	5	memorandum	memorandum	NOUN
ihlr-18967	632	6	from	from	ADP
ihlr-18967	632	7	davis	davis	PROPN
ihlr-18967	632	8	polk	polk	PROPN
ihlr-18967	632	9	&	&	CCONJ
ihlr-18967	632	10	wardwell	wardwell	PROPN
ihlr-18967	632	11	llp	llp	PROPN
ihlr-18967	632	12	(	(	PUNCT
ihlr-18967	632	13	june	june	PROPN
ihlr-18967	632	14	18	18	NUM
ihlr-18967	632	15	,	,	PUNCT
ihlr-18967	632	16	2013	2013	NUM
ihlr-18967	632	17	)	)	PUNCT
ihlr-18967	632	18	(	(	PUNCT
ihlr-18967	632	19	on	on	ADP
ihlr-18967	632	20	file	file	NOUN
ihlr-18967	632	21	with	with	ADP
ihlr-18967	632	22	author	author	NOUN
ihlr-18967	632	23	)	)	PUNCT
ihlr-18967	632	24	,	,	PUNCT
ihlr-18967	632	25	available	available	ADJ
ihlr-18967	632	26	at	at	ADP
ihlr-18967	632	27	http://www.davispolk.com/	http://www.davispolk.com/	PROPN
ihlr-18967	632	28	download.php?file=sites/default/files/files/publication/3c1830cd-3c9241fc-beff-d7b544d7d7d5/preview/publicationattachment/c59b096e-696f4951-abde-d8c44acadeb6/06.18.13.ftcv.actavis.pdf	download.php?file=sites/default/files/files/publication/3c1830cd-3c9241fc-beff-d7b544d7d7d5/preview/publicationattachment/c59b096e-696f4951-abde-d8c44acadeb6/06.18.13.ftcv.actavis.pdf	PROPN
ihlr-18967	632	29	.	.	PUNCT
ihlr-18967	633	1	199	199	NUM
ihlr-18967	633	2	actavis	actavi	NOUN
ihlr-18967	633	3	,	,	PUNCT
ihlr-18967	633	4	133	133	NUM
ihlr-18967	633	5	s.	s.	PROPN
ihlr-18967	633	6	ct	ct	PROPN
ihlr-18967	633	7	.	.	PUNCT
ihlr-18967	634	1	at	at	ADP
ihlr-18967	634	2	2229	2229	NUM
ihlr-18967	634	3	.	.	PUNCT
ihlr-18967	635	1	200	200	NUM
ihlr-18967	635	2	peter	peter	PROPN
ihlr-18967	635	3	todaro	todaro	VERB
ihlr-18967	635	4	et	et	PROPN
ihlr-18967	635	5	al	al	PROPN
ihlr-18967	635	6	.	.	PROPN
ihlr-18967	635	7	,	,	PUNCT
ihlr-18967	635	8	applying	apply	VERB
ihlr-18967	635	9	the	the	DET
ihlr-18967	635	10	supreme	supreme	PROPN
ihlr-18967	635	11	court	court	PROPN
ihlr-18967	635	12	’s	’s	PART
ihlr-18967	635	13	decision	decision	NOUN
ihlr-18967	635	14	in	in	ADP
ihlr-18967	635	15	actavis	actavis	PROPN
ihlr-18967	635	16	,	,	PUNCT
ihlr-18967	635	17	king	king	NOUN
ihlr-18967	635	18	&	&	CCONJ
ihlr-18967	635	19	spalding	spalding	PROPN
ihlr-18967	635	20	(	(	PUNCT
ihlr-18967	635	21	july	july	PROPN
ihlr-18967	635	22	24	24	NUM
ihlr-18967	635	23	,	,	PUNCT
ihlr-18967	635	24	2013	2013	NUM
ihlr-18967	635	25	)	)	PUNCT
ihlr-18967	635	26	,	,	PUNCT
ihlr-18967	635	27	http://www.kslaw.com/	http://www.kslaw.com/	NOUN
ihlr-18967	635	28	imageserver	imageserver	PROPN
ihlr-18967	635	29	/	/	SYM
ihlr-18967	635	30	kspublic	kspublic	ADJ
ihlr-18967	635	31	/	/	SYM
ihlr-18967	635	32	library	library	NOUN
ihlr-18967	635	33	/	/	SYM
ihlr-18967	635	34	publication	publication	NOUN
ihlr-18967	635	35	/	/	SYM
ihlr-18967	635	36	ca072413.pdf	ca072413.pdf	PROPN
ihlr-18967	635	37	.	.	PUNCT
ihlr-18967	636	1	2015	2015	NUM
ihlr-18967	636	2	rationale	rationale	NOUN
ihlr-18967	636	3	behind	behind	ADP
ihlr-18967	636	4	hatch	hatch	NOUN
ihlr-18967	636	5	-	-	PUNCT
ihlr-18967	636	6	waxman	waxman	PROPN
ihlr-18967	636	7	act	act	PROPN
ihlr-18967	636	8	and	and	CCONJ
ihlr-18967	636	9	patent	patent	NOUN
ihlr-18967	636	10	law	law	NOUN
ihlr-18967	636	11	461	461	NUM
ihlr-18967	636	12	(	(	PUNCT
ihlr-18967	636	13	1	1	NUM
ihlr-18967	636	14	)	)	PUNCT
ihlr-18967	636	15	the	the	DET
ihlr-18967	636	16	[	[	X
ihlr-18967	636	17	pioneer	pioneer	NOUN
ihlr-18967	636	18	manufacturer	manufacturer	NOUN
ihlr-18967	636	19	’s	’s	PART
ihlr-18967	636	20	]	]	PUNCT
ihlr-18967	636	21	future	future	ADJ
ihlr-18967	636	22	prepatent	prepatent	NOUN
ihlr-18967	636	23	expiration	expiration	NOUN
ihlr-18967	636	24	revenues	revenue	NOUN
ihlr-18967	636	25	had	have	VERB
ihlr-18967	636	26	a	a	DET
ihlr-18967	636	27	net	net	ADJ
ihlr-18967	636	28	present	present	ADJ
ihlr-18967	636	29	value	value	NOUN
ihlr-18967	636	30	of	of	ADP
ihlr-18967	636	31	$	$	SYM
ihlr-18967	636	32	1	1	NUM
ihlr-18967	636	33	billion	billion	NUM
ihlr-18967	636	34	;	;	PUNCT
ihlr-18967	636	35	(	(	PUNCT
ihlr-18967	636	36	2	2	X
ihlr-18967	636	37	)	)	PUNCT
ihlr-18967	636	38	the	the	DET
ihlr-18967	636	39	[	[	X
ihlr-18967	636	40	pioneer	pioneer	NOUN
ihlr-18967	636	41	manufacturer	manufacturer	NOUN
ihlr-18967	636	42	]	]	PUNCT
ihlr-18967	636	43	would	would	AUX
ihlr-18967	636	44	lose	lose	VERB
ihlr-18967	636	45	90	90	NUM
ihlr-18967	636	46	%	%	NOUN
ihlr-18967	636	47	of	of	ADP
ihlr-18967	636	48	its	its	PRON
ihlr-18967	636	49	sales	sale	NOUN
ihlr-18967	636	50	upon	upon	SCONJ
ihlr-18967	636	51	generic	generic	ADJ
ihlr-18967	636	52	entry	entry	NOUN
ihlr-18967	636	53	;	;	PUNCT
ihlr-18967	636	54	and	and	CCONJ
ihlr-18967	636	55	(	(	PUNCT
ihlr-18967	636	56	3	3	X
ihlr-18967	636	57	)	)	PUNCT
ihlr-18967	636	58	the	the	DET
ihlr-18967	636	59	[	[	X
ihlr-18967	636	60	pioneer	pioneer	NOUN
ihlr-18967	636	61	manufacturer	manufacturer	NOUN
ihlr-18967	636	62	’s	’s	PART
ihlr-18967	636	63	]	]	PUNCT
ihlr-18967	636	64	probability	probability	NOUN
ihlr-18967	636	65	of	of	ADP
ihlr-18967	636	66	litigation	litigation	NOUN
ihlr-18967	636	67	success	success	NOUN
ihlr-18967	636	68	was	be	AUX
ihlr-18967	636	69	60	60	NUM
ihlr-18967	636	70	%	%	NOUN
ihlr-18967	636	71	making	make	VERB
ihlr-18967	636	72	its	its	PRON
ihlr-18967	636	73	chance	chance	NOUN
ihlr-18967	636	74	of	of	ADP
ihlr-18967	636	75	losing	lose	VERB
ihlr-18967	636	76	40	40	NUM
ihlr-18967	636	77	%	%	NOUN
ihlr-18967	636	78	:	:	PUNCT
ihlr-18967	636	79	then	then	ADV
ihlr-18967	636	80	the	the	DET
ihlr-18967	636	81	value	value	NOUN
ihlr-18967	636	82	of	of	ADP
ihlr-18967	636	83	a	a	DET
ihlr-18967	636	84	settlement	settlement	NOUN
ihlr-18967	636	85	to	to	ADP
ihlr-18967	636	86	the	the	DET
ihlr-18967	636	87	[	[	X
ihlr-18967	636	88	pioneer	pioneer	NOUN
ihlr-18967	636	89	manufacturer	manufacturer	NOUN
ihlr-18967	636	90	]	]	PUNCT
ihlr-18967	636	91	would	would	AUX
ihlr-18967	636	92	be	be	AUX
ihlr-18967	636	93	$	$	SYM
ihlr-18967	636	94	360	360	NUM
ihlr-18967	636	95	million	million	NUM
ihlr-18967	636	96	(	(	PUNCT
ihlr-18967	636	97	$	$	SYM
ihlr-18967	636	98	1billion	1billion	NUM
ihlr-18967	636	99	×	×	NOUN
ihlr-18967	636	100	90	90	NUM
ihlr-18967	636	101	%	%	NOUN
ihlr-18967	636	102	×	×	NOUN
ihlr-18967	636	103	40%).201	40%).201	NUM
ihlr-18967	636	104	additionally	additionally	ADV
ihlr-18967	636	105	,	,	PUNCT
ihlr-18967	636	106	litigation	litigation	NOUN
ihlr-18967	636	107	costs	cost	NOUN
ihlr-18967	636	108	or	or	CCONJ
ihlr-18967	636	109	value	value	NOUN
ihlr-18967	636	110	of	of	ADP
ihlr-18967	636	111	services	service	NOUN
ihlr-18967	636	112	provided	provide	VERB
ihlr-18967	636	113	by	by	ADP
ihlr-18967	636	114	the	the	DET
ihlr-18967	636	115	generic	generic	ADJ
ihlr-18967	636	116	manufacturer	manufacturer	NOUN
ihlr-18967	636	117	would	would	AUX
ihlr-18967	636	118	be	be	AUX
ihlr-18967	636	119	in	in	ADP
ihlr-18967	636	120	addition	addition	NOUN
ihlr-18967	636	121	to	to	ADP
ihlr-18967	636	122	the	the	DET
ihlr-18967	636	123	settlement	settlement	NOUN
ihlr-18967	636	124	value	value	NOUN
ihlr-18967	636	125	of	of	ADP
ihlr-18967	636	126	$	$	SYM
ihlr-18967	636	127	360	360	NUM
ihlr-18967	636	128	million	million	NUM
ihlr-18967	636	129	.	.	PUNCT
ihlr-18967	637	1	lastly	lastly	ADV
ihlr-18967	637	2	,	,	PUNCT
ihlr-18967	637	3	“	"	PUNCT
ihlr-18967	637	4	value	value	NOUN
ihlr-18967	637	5	to	to	ADP
ihlr-18967	637	6	the	the	DET
ihlr-18967	637	7	generic	generic	ADJ
ihlr-18967	637	8	[	[	X
ihlr-18967	637	9	manufacturer	manufacturer	NOUN
ihlr-18967	637	10	]	]	PUNCT
ihlr-18967	637	11	would	would	AUX
ihlr-18967	637	12	be	be	AUX
ihlr-18967	637	13	determined	determine	VERB
ihlr-18967	637	14	by	by	ADP
ihlr-18967	637	15	the	the	DET
ihlr-18967	637	16	value	value	NOUN
ihlr-18967	637	17	of	of	ADP
ihlr-18967	637	18	consideration	consideration	NOUN
ihlr-18967	637	19	received	receive	VERB
ihlr-18967	637	20	.	.	PUNCT
ihlr-18967	638	1	”202	”202	NOUN
ihlr-18967	638	2	computing	computing	NOUN
ihlr-18967	638	3	expected	expect	VERB
ihlr-18967	638	4	costs	cost	NOUN
ihlr-18967	638	5	in	in	ADP
ihlr-18967	638	6	this	this	PRON
ihlr-18967	638	7	or	or	CCONJ
ihlr-18967	638	8	a	a	DET
ihlr-18967	638	9	similar	similar	ADJ
ihlr-18967	638	10	manner	manner	NOUN
ihlr-18967	638	11	will	will	AUX
ihlr-18967	638	12	assist	assist	VERB
ihlr-18967	638	13	in	in	ADP
ihlr-18967	638	14	showing	show	VERB
ihlr-18967	638	15	that	that	SCONJ
ihlr-18967	638	16	a	a	DET
ihlr-18967	638	17	reverse	reverse	ADJ
ihlr-18967	638	18	payment	payment	NOUN
ihlr-18967	638	19	settlement	settlement	NOUN
ihlr-18967	638	20	is	be	AUX
ihlr-18967	638	21	not	not	PART
ihlr-18967	638	22	anticompetitive	anticompetitive	ADJ
ihlr-18967	638	23	.	.	PUNCT
ihlr-18967	639	1	6	6	NUM
ihlr-18967	639	2	.	.	NOUN
ihlr-18967	639	3	time	time	NOUN
ihlr-18967	639	4	frame	frame	NOUN
ihlr-18967	639	5	for	for	ADP
ihlr-18967	639	6	generic	generic	ADJ
ihlr-18967	639	7	entry	entry	NOUN
ihlr-18967	639	8	the	the	DET
ihlr-18967	639	9	time	time	NOUN
ihlr-18967	639	10	frame	frame	NOUN
ihlr-18967	639	11	for	for	ADP
ihlr-18967	639	12	the	the	DET
ihlr-18967	639	13	generic	generic	ADJ
ihlr-18967	639	14	manufacturer	manufacturer	NOUN
ihlr-18967	639	15	to	to	PART
ihlr-18967	639	16	enter	enter	VERB
ihlr-18967	639	17	the	the	DET
ihlr-18967	639	18	market	market	NOUN
ihlr-18967	639	19	is	be	AUX
ihlr-18967	639	20	extremely	extremely	ADV
ihlr-18967	639	21	relevant.203	relevant.203	VERB
ihlr-18967	639	22	by	by	ADP
ihlr-18967	639	23	restricting	restrict	VERB
ihlr-18967	639	24	the	the	DET
ihlr-18967	639	25	generic	generic	ADJ
ihlr-18967	639	26	manufacturer	manufacturer	NOUN
ihlr-18967	639	27	from	from	ADP
ihlr-18967	639	28	entering	enter	VERB
ihlr-18967	639	29	the	the	DET
ihlr-18967	639	30	market	market	NOUN
ihlr-18967	639	31	,	,	PUNCT
ihlr-18967	639	32	it	it	PRON
ihlr-18967	639	33	can	can	AUX
ihlr-18967	639	34	be	be	AUX
ihlr-18967	639	35	seen	see	VERB
ihlr-18967	639	36	as	as	ADP
ihlr-18967	639	37	a	a	DET
ihlr-18967	639	38	restraint	restraint	NOUN
ihlr-18967	639	39	on	on	ADP
ihlr-18967	639	40	output	output	NOUN
ihlr-18967	639	41	which	which	PRON
ihlr-18967	639	42	has	have	AUX
ihlr-18967	639	43	generally	generally	ADV
ihlr-18967	639	44	been	be	AUX
ihlr-18967	639	45	seen	see	VERB
ihlr-18967	639	46	as	as	ADP
ihlr-18967	639	47	anticompetitive.204	anticompetitive.204	NOUN
ihlr-18967	639	48	moreover	moreover	ADV
ihlr-18967	639	49	,	,	PUNCT
ihlr-18967	639	50	significantly	significantly	ADV
ihlr-18967	639	51	delaying	delay	VERB
ihlr-18967	639	52	generic	generic	ADJ
ihlr-18967	639	53	entry	entry	NOUN
ihlr-18967	639	54	may	may	AUX
ihlr-18967	639	55	provide	provide	VERB
ihlr-18967	639	56	ammunition	ammunition	NOUN
ihlr-18967	639	57	to	to	ADP
ihlr-18967	639	58	the	the	DET
ihlr-18967	639	59	ftc	ftc	PROPN
ihlr-18967	639	60	to	to	PART
ihlr-18967	639	61	satisfy	satisfy	VERB
ihlr-18967	639	62	its	its	PRON
ihlr-18967	639	63	initial	initial	ADJ
ihlr-18967	639	64	burden	burden	NOUN
ihlr-18967	639	65	under	under	ADP
ihlr-18967	639	66	rule	rule	NOUN
ihlr-18967	639	67	of	of	ADP
ihlr-18967	639	68	reason	reason	NOUN
ihlr-18967	639	69	analysis	analysis	NOUN
ihlr-18967	639	70	.	.	PUNCT
ihlr-18967	640	1	as	as	SCONJ
ihlr-18967	640	2	the	the	DET
ihlr-18967	640	3	court	court	NOUN
ihlr-18967	640	4	stated	state	VERB
ihlr-18967	640	5	in	in	ADP
ihlr-18967	640	6	actavis	actavis	NOUN
ihlr-18967	640	7	,	,	PUNCT
ihlr-18967	640	8	“	"	PUNCT
ihlr-18967	640	9	permitting	permit	VERB
ihlr-18967	640	10	the	the	DET
ihlr-18967	640	11	patent	patent	NOUN
ihlr-18967	640	12	challenger	challenger	NOUN
ihlr-18967	640	13	to	to	PART
ihlr-18967	640	14	enter	enter	VERB
ihlr-18967	640	15	the	the	DET
ihlr-18967	640	16	market	market	NOUN
ihlr-18967	640	17	before	before	SCONJ
ihlr-18967	640	18	the	the	DET
ihlr-18967	640	19	patent	patent	NOUN
ihlr-18967	640	20	expires	expire	VERB
ihlr-18967	640	21	would	would	AUX
ihlr-18967	640	22	also	also	ADV
ihlr-18967	640	23	bring	bring	VERB
ihlr-18967	640	24	about	about	ADP
ihlr-18967	640	25	competition	competition	NOUN
ihlr-18967	640	26	.	.	PUNCT
ihlr-18967	640	27	.	.	PUNCT
ihlr-18967	641	1	.	.	PUNCT
ihlr-18967	642	1	to	to	ADP
ihlr-18967	642	2	the	the	DET
ihlr-18967	642	3	consumer	consumer	NOUN
ihlr-18967	642	4	’s	’s	PART
ihlr-18967	642	5	benefit	benefit	NOUN
ihlr-18967	642	6	.	.	PUNCT
ihlr-18967	642	7	”205	”205	PUNCT
ihlr-18967	643	1	allowing	allow	VERB
ihlr-18967	643	2	generic	generic	ADJ
ihlr-18967	643	3	manufacturers	manufacturer	NOUN
ihlr-18967	643	4	to	to	PART
ihlr-18967	643	5	enter	enter	VERB
ihlr-18967	643	6	the	the	DET
ihlr-18967	643	7	market	market	NOUN
ihlr-18967	643	8	before	before	SCONJ
ihlr-18967	643	9	the	the	DET
ihlr-18967	643	10	pioneer	pioneer	NOUN
ihlr-18967	643	11	manufacturer	manufacturer	NOUN
ihlr-18967	643	12	’s	’s	PART
ihlr-18967	643	13	patent	patent	NOUN
ihlr-18967	643	14	expires	expire	VERB
ihlr-18967	643	15	is	be	AUX
ihlr-18967	643	16	likely	likely	ADJ
ihlr-18967	643	17	to	to	PART
ihlr-18967	643	18	be	be	AUX
ihlr-18967	643	19	seen	see	VERB
ihlr-18967	643	20	as	as	ADP
ihlr-18967	643	21	201	201	NUM
ihlr-18967	643	22	i	i	NOUN
ihlr-18967	643	23	d.	d.	NOUN
ihlr-18967	644	1	202	202	NUM
ihlr-18967	645	1	i	i	PRON
ihlr-18967	645	2	d.	d.	PROPN
ihlr-18967	645	3	203	203	NUM
ihlr-18967	645	4	see	see	VERB
ihlr-18967	645	5	in	in	ADP
ihlr-18967	645	6	re	re	ADJ
ihlr-18967	645	7	lamictal	lamictal	ADJ
ihlr-18967	645	8	direct	direct	ADJ
ihlr-18967	645	9	purchaser	purchaser	NOUN
ihlr-18967	645	10	antitrust	antitrust	ADJ
ihlr-18967	645	11	litig	litig	NOUN
ihlr-18967	645	12	.	.	PUNCT
ihlr-18967	646	1	,	,	PUNCT
ihlr-18967	646	2	18	18	NUM
ihlr-18967	646	3	f.supp.3d	f.supp.3d	NOUN
ihlr-18967	646	4	560	560	NUM
ihlr-18967	646	5	,	,	PUNCT
ihlr-18967	646	6	570	570	NUM
ihlr-18967	646	7	(	(	PUNCT
ihlr-18967	646	8	d.	d.	PROPN
ihlr-18967	646	9	n.j	n.j	PROPN
ihlr-18967	646	10	.	.	PROPN
ihlr-18967	646	11	2014	2014	NUM
ihlr-18967	646	12	)	)	PUNCT
ihlr-18967	646	13	(	(	PUNCT
ihlr-18967	646	14	noting	note	VERB
ihlr-18967	646	15	that	that	SCONJ
ihlr-18967	646	16	the	the	DET
ihlr-18967	646	17	generic	generic	ADJ
ihlr-18967	646	18	manufacturer	manufacturer	NOUN
ihlr-18967	646	19	“	"	PUNCT
ihlr-18967	646	20	was	be	AUX
ihlr-18967	646	21	allowed	allow	VERB
ihlr-18967	646	22	six	six	NUM
ihlr-18967	646	23	months	month	NOUN
ihlr-18967	646	24	of	of	ADP
ihlr-18967	646	25	early	early	ADJ
ihlr-18967	646	26	entry	entry	NOUN
ihlr-18967	646	27	”	"	PUNCT
ihlr-18967	646	28	)	)	PUNCT
ihlr-18967	646	29	.	.	PUNCT
ihlr-18967	647	1	204	204	NUM
ihlr-18967	647	2	see	see	VERB
ihlr-18967	647	3	nat’l	nat’l	NOUN
ihlr-18967	647	4	collegiate	collegiate	VERB
ihlr-18967	647	5	athletic	athletic	ADJ
ihlr-18967	647	6	ass’n	ass’n	NOUN
ihlr-18967	647	7	v.	v.	ADP
ihlr-18967	647	8	bd	bd	PROPN
ihlr-18967	647	9	.	.	PROPN
ihlr-18967	647	10	of	of	ADP
ihlr-18967	647	11	regents	regent	NOUN
ihlr-18967	647	12	of	of	ADP
ihlr-18967	647	13	univ	univ	PROPN
ihlr-18967	647	14	.	.	PROPN
ihlr-18967	647	15	of	of	ADP
ihlr-18967	647	16	okla	okla	PROPN
ihlr-18967	647	17	.	.	PUNCT
ihlr-18967	647	18	,	,	PUNCT
ihlr-18967	647	19	468	468	NUM
ihlr-18967	647	20	u.s	u.s	PROPN
ihlr-18967	647	21	.	.	PROPN
ihlr-18967	647	22	85	85	NUM
ihlr-18967	647	23	,	,	PUNCT
ihlr-18967	647	24	104	104	NUM
ihlr-18967	647	25	(	(	PUNCT
ihlr-18967	647	26	1984	1984	NUM
ihlr-18967	647	27	)	)	PUNCT
ihlr-18967	647	28	.	.	PUNCT
ihlr-18967	648	1	205	205	NUM
ihlr-18967	648	2	ftc	ftc	PROPN
ihlr-18967	648	3	v.	v.	ADP
ihlr-18967	648	4	actavis	actavis	PROPN
ihlr-18967	648	5	,	,	PUNCT
ihlr-18967	648	6	inc	inc	PROPN
ihlr-18967	648	7	.	.	PROPN
ihlr-18967	648	8	,	,	PUNCT
ihlr-18967	648	9	133	133	NUM
ihlr-18967	648	10	s.	s.	PROPN
ihlr-18967	648	11	ct	ct	PROPN
ihlr-18967	648	12	.	.	PROPN
ihlr-18967	648	13	2223	2223	NUM
ihlr-18967	648	14	,	,	PUNCT
ihlr-18967	648	15	2234	2234	NUM
ihlr-18967	648	16	(	(	PUNCT
ihlr-18967	648	17	2013	2013	NUM
ihlr-18967	648	18	)	)	PUNCT
ihlr-18967	648	19	.	.	PUNCT
ihlr-18967	649	1	462	462	NUM
ihlr-18967	649	2	indiana	indiana	PROPN
ihlr-18967	649	3	health	health	PROPN
ihlr-18967	649	4	law	law	PROPN
ihlr-18967	649	5	review	review	NOUN
ihlr-18967	649	6	vol	vol	NOUN
ihlr-18967	649	7	.	.	PUNCT
ihlr-18967	650	1	12:1	12:1	NUM
ihlr-18967	650	2	procompetitive	procompetitive	ADJ
ihlr-18967	650	3	and	and	CCONJ
ihlr-18967	650	4	is	be	AUX
ihlr-18967	650	5	directly	directly	ADV
ihlr-18967	650	6	supported	support	VERB
ihlr-18967	650	7	by	by	ADP
ihlr-18967	650	8	the	the	DET
ihlr-18967	650	9	hatchwaxman	hatchwaxman	PROPN
ihlr-18967	650	10	act	act	NOUN
ihlr-18967	650	11	because	because	SCONJ
ihlr-18967	650	12	consumers	consumer	NOUN
ihlr-18967	650	13	will	will	AUX
ihlr-18967	650	14	receive	receive	VERB
ihlr-18967	650	15	drugs	drug	NOUN
ihlr-18967	650	16	sooner	soon	ADV
ihlr-18967	650	17	than	than	SCONJ
ihlr-18967	650	18	they	they	PRON
ihlr-18967	650	19	would	would	AUX
ihlr-18967	650	20	without	without	ADP
ihlr-18967	650	21	the	the	DET
ihlr-18967	650	22	settlement	settlement	NOUN
ihlr-18967	650	23	.	.	PUNCT
ihlr-18967	651	1	similarly	similarly	ADV
ihlr-18967	651	2	,	,	PUNCT
ihlr-18967	651	3	reaching	reach	VERB
ihlr-18967	651	4	a	a	DET
ihlr-18967	651	5	settlement	settlement	NOUN
ihlr-18967	651	6	not	not	PART
ihlr-18967	651	7	involving	involve	VERB
ihlr-18967	651	8	a	a	DET
ihlr-18967	651	9	monetary	monetary	ADJ
ihlr-18967	651	10	payment	payment	NOUN
ihlr-18967	651	11	and	and	CCONJ
ihlr-18967	651	12	only	only	ADV
ihlr-18967	651	13	allowing	allow	VERB
ihlr-18967	651	14	the	the	DET
ihlr-18967	651	15	generic	generic	ADJ
ihlr-18967	651	16	manufacturer	manufacturer	NOUN
ihlr-18967	651	17	to	to	PART
ihlr-18967	651	18	enter	enter	VERB
ihlr-18967	651	19	the	the	DET
ihlr-18967	651	20	market	market	NOUN
ihlr-18967	651	21	before	before	ADP
ihlr-18967	651	22	expiration	expiration	NOUN
ihlr-18967	651	23	of	of	ADP
ihlr-18967	651	24	the	the	DET
ihlr-18967	651	25	pioneer	pioneer	NOUN
ihlr-18967	651	26	manufacturer	manufacturer	NOUN
ihlr-18967	651	27	’s	’s	PART
ihlr-18967	651	28	patent	patent	NOUN
ihlr-18967	651	29	would	would	AUX
ihlr-18967	651	30	most	most	ADV
ihlr-18967	651	31	likely	likely	ADV
ihlr-18967	651	32	be	be	AUX
ihlr-18967	651	33	procompetitive.206	procompetitive.206	VERB
ihlr-18967	651	34	therefore	therefore	ADV
ihlr-18967	651	35	,	,	PUNCT
ihlr-18967	651	36	allowing	allow	VERB
ihlr-18967	651	37	generic	generic	ADJ
ihlr-18967	651	38	drugs	drug	NOUN
ihlr-18967	651	39	to	to	PART
ihlr-18967	651	40	enter	enter	VERB
ihlr-18967	651	41	the	the	DET
ihlr-18967	651	42	market	market	NOUN
ihlr-18967	651	43	sometime	sometime	ADV
ihlr-18967	651	44	before	before	SCONJ
ihlr-18967	651	45	patent	patent	NOUN
ihlr-18967	651	46	expiration	expiration	NOUN
ihlr-18967	651	47	is	be	AUX
ihlr-18967	651	48	procompetitive	procompetitive	ADJ
ihlr-18967	651	49	.	.	PUNCT
ihlr-18967	652	1	7	7	X
ihlr-18967	652	2	.	.	X
ihlr-18967	652	3	strength	strength	NOUN
ihlr-18967	652	4	of	of	ADP
ihlr-18967	652	5	patent	patent	NOUN
ihlr-18967	652	6	pharmaceutical	pharmaceutical	ADJ
ihlr-18967	652	7	drugs	drug	NOUN
ihlr-18967	652	8	are	be	AUX
ihlr-18967	652	9	patentable	patentable	ADJ
ihlr-18967	652	10	inventions	invention	NOUN
ihlr-18967	652	11	under	under	ADP
ihlr-18967	652	12	patent	patent	NOUN
ihlr-18967	652	13	law.207	law.207	NOUN
ihlr-18967	652	14	while	while	SCONJ
ihlr-18967	652	15	the	the	DET
ihlr-18967	652	16	court	court	NOUN
ihlr-18967	652	17	in	in	ADP
ihlr-18967	652	18	actavis	actavis	PROPN
ihlr-18967	652	19	held	hold	VERB
ihlr-18967	652	20	that	that	SCONJ
ihlr-18967	652	21	district	district	NOUN
ihlr-18967	652	22	courts	court	NOUN
ihlr-18967	652	23	are	be	AUX
ihlr-18967	652	24	not	not	PART
ihlr-18967	652	25	necessarily	necessarily	ADV
ihlr-18967	652	26	required	require	VERB
ihlr-18967	652	27	to	to	PART
ihlr-18967	652	28	litigate	litigate	VERB
ihlr-18967	652	29	the	the	DET
ihlr-18967	652	30	patent	patent	NOUN
ihlr-18967	652	31	’s	’s	PART
ihlr-18967	652	32	validity	validity	NOUN
ihlr-18967	652	33	before	before	ADP
ihlr-18967	652	34	ruling	rule	VERB
ihlr-18967	652	35	on	on	ADP
ihlr-18967	652	36	the	the	DET
ihlr-18967	652	37	reverse	reverse	ADJ
ihlr-18967	652	38	payment	payment	NOUN
ihlr-18967	652	39	settlement,208	settlement,208	NOUN
ihlr-18967	652	40	the	the	DET
ihlr-18967	652	41	strength	strength	NOUN
ihlr-18967	652	42	of	of	ADP
ihlr-18967	652	43	a	a	DET
ihlr-18967	652	44	patent	patent	NOUN
ihlr-18967	652	45	will	will	AUX
ihlr-18967	652	46	still	still	ADV
ihlr-18967	652	47	be	be	AUX
ihlr-18967	652	48	factored	factor	VERB
ihlr-18967	652	49	into	into	ADP
ihlr-18967	652	50	a	a	DET
ihlr-18967	652	51	court	court	NOUN
ihlr-18967	652	52	’s	’s	PART
ihlr-18967	652	53	analysis	analysis	NOUN
ihlr-18967	652	54	and	and	CCONJ
ihlr-18967	652	55	may	may	AUX
ihlr-18967	652	56	indicate	indicate	VERB
ihlr-18967	652	57	anticompetitive	anticompetitive	ADJ
ihlr-18967	652	58	harm.209	harm.209	NOUN
ihlr-18967	652	59	by	by	ADP
ihlr-18967	652	60	factoring	factor	VERB
ihlr-18967	652	61	in	in	ADP
ihlr-18967	652	62	the	the	DET
ihlr-18967	652	63	strength	strength	NOUN
ihlr-18967	652	64	of	of	ADP
ihlr-18967	652	65	a	a	DET
ihlr-18967	652	66	patent	patent	NOUN
ihlr-18967	652	67	,	,	PUNCT
ihlr-18967	652	68	actavis	actavis	PROPN
ihlr-18967	652	69	supports	support	VERB
ihlr-18967	652	70	the	the	DET
ihlr-18967	652	71	hatch	hatch	NOUN
ihlr-18967	652	72	-	-	PUNCT
ihlr-18967	652	73	waxman	waxman	PROPN
ihlr-18967	652	74	act	act	NOUN
ihlr-18967	652	75	and	and	CCONJ
ihlr-18967	652	76	the	the	DET
ihlr-18967	652	77	protections	protection	NOUN
ihlr-18967	652	78	afforded	afford	VERB
ihlr-18967	652	79	through	through	ADP
ihlr-18967	652	80	patent	patent	NOUN
ihlr-18967	652	81	law	law	NOUN
ihlr-18967	652	82	.	.	PUNCT
ihlr-18967	653	1	generally	generally	ADV
ihlr-18967	653	2	speaking	speak	VERB
ihlr-18967	653	3	,	,	PUNCT
ihlr-18967	653	4	a	a	DET
ihlr-18967	653	5	strong	strong	ADJ
ihlr-18967	653	6	patent	patent	NOUN
ihlr-18967	653	7	refers	refer	VERB
ihlr-18967	653	8	to	to	ADP
ihlr-18967	653	9	one	one	NUM
ihlr-18967	653	10	“	"	PUNCT
ihlr-18967	653	11	likely	likely	ADJ
ihlr-18967	653	12	to	to	PART
ihlr-18967	653	13	be	be	AUX
ihlr-18967	653	14	found	find	VERB
ihlr-18967	653	15	valid	valid	ADJ
ihlr-18967	653	16	and	and	CCONJ
ihlr-18967	653	17	infringed	infringe	VERB
ihlr-18967	653	18	.	.	PUNCT
ihlr-18967	654	1	”210	”210	PART
ihlr-18967	654	2	evidence	evidence	NOUN
ihlr-18967	654	3	presented	present	VERB
ihlr-18967	654	4	in	in	ADP
ihlr-18967	654	5	support	support	NOUN
ihlr-18967	654	6	of	of	ADP
ihlr-18967	654	7	a	a	DET
ihlr-18967	654	8	stronger	strong	ADJ
ihlr-18967	654	9	patent	patent	NOUN
ihlr-18967	654	10	is	be	AUX
ihlr-18967	654	11	more	more	ADV
ihlr-18967	654	12	likely	likely	ADJ
ihlr-18967	654	13	to	to	PART
ihlr-18967	654	14	indicate	indicate	VERB
ihlr-18967	654	15	the	the	DET
ihlr-18967	654	16	reverse	reverse	ADJ
ihlr-18967	654	17	payment	payment	NOUN
ihlr-18967	654	18	settlement	settlement	NOUN
ihlr-18967	654	19	is	be	AUX
ihlr-18967	654	20	for	for	ADP
ihlr-18967	654	21	some	some	DET
ihlr-18967	654	22	other	other	ADJ
ihlr-18967	654	23	justifiable	justifiable	ADJ
ihlr-18967	654	24	reason	reason	NOUN
ihlr-18967	654	25	or	or	CCONJ
ihlr-18967	654	26	service	service	NOUN
ihlr-18967	654	27	,	,	PUNCT
ihlr-18967	654	28	as	as	SCONJ
ihlr-18967	654	29	opposed	oppose	VERB
ihlr-18967	654	30	to	to	ADP
ihlr-18967	654	31	the	the	DET
ihlr-18967	654	32	payment	payment	NOUN
ihlr-18967	654	33	being	be	AUX
ihlr-18967	654	34	used	use	VERB
ihlr-18967	654	35	to	to	PART
ihlr-18967	654	36	keep	keep	VERB
ihlr-18967	654	37	the	the	DET
ihlr-18967	654	38	generic	generic	ADJ
ihlr-18967	654	39	manufacturer	manufacturer	NOUN
ihlr-18967	654	40	out	out	ADP
ihlr-18967	654	41	of	of	ADP
ihlr-18967	654	42	the	the	DET
ihlr-18967	654	43	market	market	NOUN
ihlr-18967	654	44	.	.	PUNCT
ihlr-18967	655	1	on	on	ADP
ihlr-18967	655	2	the	the	DET
ihlr-18967	655	3	other	other	ADJ
ihlr-18967	655	4	hand	hand	NOUN
ihlr-18967	655	5	,	,	PUNCT
ihlr-18967	655	6	a	a	DET
ihlr-18967	655	7	weaker	weak	ADJ
ihlr-18967	655	8	patent	patent	NOUN
ihlr-18967	655	9	may	may	AUX
ihlr-18967	655	10	indicate	indicate	VERB
ihlr-18967	655	11	the	the	DET
ihlr-18967	655	12	pioneer	pioneer	NOUN
ihlr-18967	655	13	manufacturer	manufacturer	NOUN
ihlr-18967	655	14	is	be	AUX
ihlr-18967	655	15	using	use	VERB
ihlr-18967	655	16	the	the	DET
ihlr-18967	655	17	reverse	reverse	ADJ
ihlr-18967	655	18	payment	payment	NOUN
ihlr-18967	655	19	in	in	ADP
ihlr-18967	655	20	order	order	NOUN
ihlr-18967	655	21	to	to	PART
ihlr-18967	655	22	avoid	avoid	VERB
ihlr-18967	655	23	206	206	NUM
ihlr-18967	655	24	i	i	PRON
ihlr-18967	655	25	d.	d.	PROPN
ihlr-18967	655	26	at	at	ADP
ihlr-18967	655	27	2237	2237	NUM
ihlr-18967	655	28	.	.	PUNCT
ihlr-18967	656	1	207	207	NUM
ihlr-18967	656	2	patentable	patentable	ADJ
ihlr-18967	656	3	inventions	invention	NOUN
ihlr-18967	656	4	are	be	AUX
ihlr-18967	656	5	defined	define	VERB
ihlr-18967	656	6	as	as	ADP
ihlr-18967	656	7	“	"	PUNCT
ihlr-18967	656	8	any	any	DET
ihlr-18967	656	9	new	new	ADJ
ihlr-18967	656	10	and	and	CCONJ
ihlr-18967	656	11	useful	useful	ADJ
ihlr-18967	656	12	process	process	NOUN
ihlr-18967	656	13	,	,	PUNCT
ihlr-18967	656	14	machine	machine	NOUN
ihlr-18967	656	15	,	,	PUNCT
ihlr-18967	656	16	manufacture	manufacture	NOUN
ihlr-18967	656	17	,	,	PUNCT
ihlr-18967	656	18	or	or	CCONJ
ihlr-18967	656	19	composition	composition	NOUN
ihlr-18967	656	20	of	of	ADP
ihlr-18967	656	21	matter	matter	NOUN
ihlr-18967	656	22	,	,	PUNCT
ihlr-18967	656	23	or	or	CCONJ
ihlr-18967	656	24	any	any	DET
ihlr-18967	656	25	new	new	ADJ
ihlr-18967	656	26	and	and	CCONJ
ihlr-18967	656	27	useful	useful	ADJ
ihlr-18967	656	28	improvement	improvement	NOUN
ihlr-18967	656	29	.	.	PUNCT
ihlr-18967	656	30	”	"	PUNCT
ihlr-18967	657	1	35	35	NUM
ihlr-18967	657	2	u.s.c	u.s.c	NOUN
ihlr-18967	657	3	.	.	PUNCT
ihlr-18967	658	1	§	§	PROPN
ihlr-18967	658	2	101	101	NUM
ihlr-18967	658	3	(	(	PUNCT
ihlr-18967	658	4	2015	2015	NUM
ihlr-18967	658	5	)	)	PUNCT
ihlr-18967	658	6	.	.	PUNCT
ihlr-18967	659	1	recently	recently	ADV
ihlr-18967	659	2	,	,	PUNCT
ihlr-18967	659	3	the	the	DET
ihlr-18967	659	4	supreme	supreme	PROPN
ihlr-18967	659	5	court	court	PROPN
ihlr-18967	659	6	has	have	AUX
ihlr-18967	659	7	addressed	address	VERB
ihlr-18967	659	8	the	the	DET
ihlr-18967	659	9	limitations	limitation	NOUN
ihlr-18967	659	10	of	of	ADP
ihlr-18967	659	11	§	§	PROPN
ihlr-18967	659	12	101	101	NUM
ihlr-18967	659	13	and	and	CCONJ
ihlr-18967	659	14	held	hold	VERB
ihlr-18967	659	15	that	that	SCONJ
ihlr-18967	659	16	items	item	NOUN
ihlr-18967	659	17	naturally	naturally	ADV
ihlr-18967	659	18	occurring	occur	VERB
ihlr-18967	659	19	in	in	ADP
ihlr-18967	659	20	nature	nature	NOUN
ihlr-18967	659	21	are	be	AUX
ihlr-18967	659	22	not	not	PART
ihlr-18967	659	23	patent	patent	NOUN
ihlr-18967	659	24	eligible	eligible	ADJ
ihlr-18967	659	25	.	.	PUNCT
ihlr-18967	660	1	ass’n	ass’n	VERB
ihlr-18967	660	2	for	for	ADP
ihlr-18967	660	3	molecular	molecular	ADJ
ihlr-18967	660	4	pathology	pathology	NOUN
ihlr-18967	660	5	v.	v.	ADP
ihlr-18967	660	6	myriad	myriad	ADJ
ihlr-18967	660	7	genetics	genetic	NOUN
ihlr-18967	660	8	,	,	PUNCT
ihlr-18967	660	9	inc	inc	PROPN
ihlr-18967	660	10	.	.	PROPN
ihlr-18967	660	11	,	,	PUNCT
ihlr-18967	660	12	133	133	NUM
ihlr-18967	660	13	s.	s.	PROPN
ihlr-18967	660	14	ct	ct	PROPN
ihlr-18967	660	15	.	.	PROPN
ihlr-18967	660	16	2107	2107	NUM
ihlr-18967	660	17	,	,	PUNCT
ihlr-18967	660	18	2111	2111	NUM
ihlr-18967	660	19	(	(	PUNCT
ihlr-18967	660	20	2013	2013	NUM
ihlr-18967	660	21	)	)	PUNCT
ihlr-18967	660	22	.	.	PUNCT
ihlr-18967	661	1	furthermore	furthermore	ADV
ihlr-18967	661	2	,	,	PUNCT
ihlr-18967	661	3	to	to	PART
ihlr-18967	661	4	be	be	AUX
ihlr-18967	661	5	patentable	patentable	ADJ
ihlr-18967	661	6	,	,	PUNCT
ihlr-18967	661	7	an	an	DET
ihlr-18967	661	8	invention	invention	NOUN
ihlr-18967	661	9	must	must	AUX
ihlr-18967	661	10	be	be	AUX
ihlr-18967	661	11	novel	novel	ADJ
ihlr-18967	661	12	,	,	PUNCT
ihlr-18967	661	13	35	35	NUM
ihlr-18967	661	14	u.s.c	u.s.c	NOUN
ihlr-18967	661	15	.	.	PUNCT
ihlr-18967	662	1	§	§	PROPN
ihlr-18967	662	2	102	102	NUM
ihlr-18967	662	3	(	(	PUNCT
ihlr-18967	662	4	2015	2015	NUM
ihlr-18967	662	5	)	)	PUNCT
ihlr-18967	662	6	,	,	PUNCT
ihlr-18967	662	7	and	and	CCONJ
ihlr-18967	662	8	not	not	PART
ihlr-18967	662	9	obvious	obvious	ADJ
ihlr-18967	662	10	in	in	ADP
ihlr-18967	662	11	the	the	DET
ihlr-18967	662	12	light	light	NOUN
ihlr-18967	662	13	of	of	ADP
ihlr-18967	662	14	prior	prior	ADJ
ihlr-18967	662	15	art	art	NOUN
ihlr-18967	662	16	,	,	PUNCT
ihlr-18967	662	17	i	i	PROPN
ihlr-18967	662	18	d.	d.	PROPN
ihlr-18967	662	19	§	§	PROPN
ihlr-18967	662	20	103	103	NUM
ihlr-18967	662	21	.	.	PUNCT
ihlr-18967	662	22	208	208	NUM
ihlr-18967	662	23	actavis	actavi	NOUN
ihlr-18967	662	24	,	,	PUNCT
ihlr-18967	662	25	133	133	NUM
ihlr-18967	662	26	s.	s.	PROPN
ihlr-18967	662	27	ct	ct	PROPN
ihlr-18967	662	28	.	.	PUNCT
ihlr-18967	663	1	at	at	ADP
ihlr-18967	663	2	2237	2237	NUM
ihlr-18967	663	3	.	.	PUNCT
ihlr-18967	664	1	209	209	NUM
ihlr-18967	664	2	overley	overley	NOUN
ihlr-18967	664	3	,	,	PUNCT
ihlr-18967	664	4	supra	supra	PROPN
ihlr-18967	664	5	note	note	NOUN
ihlr-18967	664	6	182	182	NUM
ihlr-18967	664	7	.	.	X
ihlr-18967	664	8	210	210	NUM
ihlr-18967	664	9	dickey	dickey	PROPN
ihlr-18967	664	10	&	&	CCONJ
ihlr-18967	664	11	orszag	orszag	PROPN
ihlr-18967	664	12	,	,	PUNCT
ihlr-18967	664	13	supra	supra	PROPN
ihlr-18967	664	14	note	note	PROPN
ihlr-18967	664	15	153	153	NUM
ihlr-18967	664	16	,	,	PUNCT
ihlr-18967	664	17	at	at	ADP
ihlr-18967	664	18	8	8	NUM
ihlr-18967	664	19	.	.	NOUN
ihlr-18967	664	20	2015	2015	NUM
ihlr-18967	664	21	rationale	rationale	NOUN
ihlr-18967	664	22	behind	behind	ADP
ihlr-18967	664	23	hatch	hatch	NOUN
ihlr-18967	664	24	-	-	PUNCT
ihlr-18967	664	25	waxman	waxman	PROPN
ihlr-18967	664	26	act	act	PROPN
ihlr-18967	664	27	and	and	CCONJ
ihlr-18967	664	28	patent	patent	NOUN
ihlr-18967	664	29	law	law	NOUN
ihlr-18967	664	30	463	463	NUM
ihlr-18967	664	31	litigation	litigation	NOUN
ihlr-18967	664	32	regarding	regard	VERB
ihlr-18967	664	33	validity	validity	NOUN
ihlr-18967	664	34	.	.	PUNCT
ihlr-18967	665	1	subsequently	subsequently	ADV
ihlr-18967	665	2	,	,	PUNCT
ihlr-18967	665	3	a	a	DET
ihlr-18967	665	4	settlement	settlement	NOUN
ihlr-18967	665	5	“	"	PUNCT
ihlr-18967	665	6	intended	intend	VERB
ihlr-18967	665	7	to	to	PART
ihlr-18967	665	8	maintain	maintain	VERB
ihlr-18967	665	9	supracompetitive	supracompetitive	ADJ
ihlr-18967	665	10	prices	price	NOUN
ihlr-18967	665	11	and	and	CCONJ
ihlr-18967	665	12	serve	serve	VERB
ihlr-18967	665	13	as	as	ADP
ihlr-18967	665	14	a	a	DET
ihlr-18967	665	15	‘	'	PUNCT
ihlr-18967	665	16	workable	workable	ADJ
ihlr-18967	665	17	surrogate	surrogate	NOUN
ihlr-18967	665	18	for	for	ADP
ihlr-18967	665	19	a	a	DET
ihlr-18967	665	20	patent	patent	NOUN
ihlr-18967	665	21	’s	’	VERB
ihlr-18967	665	22	weakness’”211	weakness’”211	PRON
ihlr-18967	665	23	indicates	indicate	VERB
ihlr-18967	665	24	anti	anti	ADJ
ihlr-18967	665	25	-	-	ADJ
ihlr-18967	665	26	competitive	competitive	ADJ
ihlr-18967	665	27	harm	harm	NOUN
ihlr-18967	665	28	.	.	PUNCT
ihlr-18967	666	1	8	8	X
ihlr-18967	666	2	.	.	X
ihlr-18967	666	3	venue	venue	NOUN
ihlr-18967	666	4	while	while	SCONJ
ihlr-18967	666	5	venue	venue	NOUN
ihlr-18967	666	6	was	be	AUX
ihlr-18967	666	7	extremely	extremely	ADV
ihlr-18967	666	8	important	important	ADJ
ihlr-18967	666	9	before	before	ADP
ihlr-18967	666	10	actavis	actavis	PROPN
ihlr-18967	666	11	due	due	ADP
ihlr-18967	666	12	to	to	PART
ihlr-18967	666	13	stare	stare	VERB
ihlr-18967	666	14	decisis,212	decisis,212	NOUN
ihlr-18967	666	15	venue	venue	NOUN
ihlr-18967	666	16	will	will	AUX
ihlr-18967	666	17	still	still	ADV
ihlr-18967	666	18	be	be	AUX
ihlr-18967	666	19	an	an	DET
ihlr-18967	666	20	important	important	ADJ
ihlr-18967	666	21	factor	factor	NOUN
ihlr-18967	666	22	to	to	PART
ihlr-18967	666	23	consider	consider	VERB
ihlr-18967	666	24	in	in	ADP
ihlr-18967	666	25	the	the	DET
ihlr-18967	666	26	aftermath	aftermath	NOUN
ihlr-18967	666	27	of	of	ADP
ihlr-18967	666	28	actavis	actavis	PROPN
ihlr-18967	666	29	.	.	PUNCT
ihlr-18967	667	1	venue	venue	NOUN
ihlr-18967	667	2	determines	determine	NOUN
ihlr-18967	667	3	which	which	PRON
ihlr-18967	667	4	judicial	judicial	ADJ
ihlr-18967	667	5	district	district	NOUN
ihlr-18967	667	6	a	a	DET
ihlr-18967	667	7	civil	civil	ADJ
ihlr-18967	667	8	action	action	NOUN
ihlr-18967	667	9	may	may	AUX
ihlr-18967	667	10	be	be	AUX
ihlr-18967	667	11	brought	bring	VERB
ihlr-18967	667	12	in.213	in.213	NOUN
ihlr-18967	667	13	in	in	ADP
ihlr-18967	667	14	actavis	actavis	NOUN
ihlr-18967	667	15	,	,	PUNCT
ihlr-18967	667	16	the	the	DET
ihlr-18967	667	17	court	court	NOUN
ihlr-18967	667	18	left	leave	VERB
ihlr-18967	667	19	it	it	PRON
ihlr-18967	667	20	to	to	ADP
ihlr-18967	667	21	the	the	DET
ihlr-18967	667	22	lower	low	ADJ
ihlr-18967	667	23	courts	court	NOUN
ihlr-18967	667	24	to	to	PART
ihlr-18967	667	25	structure	structure	VERB
ihlr-18967	667	26	the	the	DET
ihlr-18967	667	27	rule	rule	NOUN
ihlr-18967	667	28	of	of	ADP
ihlr-18967	667	29	reason	reason	NOUN
ihlr-18967	667	30	for	for	ADP
ihlr-18967	667	31	reverse	reverse	ADJ
ihlr-18967	667	32	payment	payment	NOUN
ihlr-18967	667	33	settlement	settlement	NOUN
ihlr-18967	667	34	cases.214	cases.214	ADJ
ihlr-18967	667	35	for	for	ADP
ihlr-18967	667	36	example	example	NOUN
ihlr-18967	667	37	,	,	PUNCT
ihlr-18967	667	38	the	the	DET
ihlr-18967	667	39	eleventh	eleventh	ADJ
ihlr-18967	667	40	circuit	circuit	NOUN
ihlr-18967	667	41	may	may	AUX
ihlr-18967	667	42	interpret	interpret	VERB
ihlr-18967	667	43	reverse	reverse	ADJ
ihlr-18967	667	44	payments	payment	NOUN
ihlr-18967	667	45	under	under	ADP
ihlr-18967	667	46	the	the	DET
ihlr-18967	667	47	rule	rule	NOUN
ihlr-18967	667	48	of	of	ADP
ihlr-18967	667	49	reason	reason	NOUN
ihlr-18967	667	50	analysis	analysis	NOUN
ihlr-18967	667	51	in	in	ADP
ihlr-18967	667	52	favor	favor	NOUN
ihlr-18967	667	53	of	of	ADP
ihlr-18967	667	54	pharmaceutical	pharmaceutical	ADJ
ihlr-18967	667	55	manufacturers	manufacturer	NOUN
ihlr-18967	667	56	,	,	PUNCT
ihlr-18967	667	57	as	as	SCONJ
ihlr-18967	667	58	it	it	PRON
ihlr-18967	667	59	did	do	VERB
ihlr-18967	667	60	before	before	ADP
ihlr-18967	667	61	actavis	actavis	PROPN
ihlr-18967	667	62	.	.	PUNCT
ihlr-18967	668	1	with	with	ADP
ihlr-18967	668	2	no	no	DET
ihlr-18967	668	3	bright	bright	ADJ
ihlr-18967	668	4	-	-	PUNCT
ihlr-18967	668	5	line	line	NOUN
ihlr-18967	668	6	rules	rule	NOUN
ihlr-18967	668	7	,	,	PUNCT
ihlr-18967	668	8	some	some	DET
ihlr-18967	668	9	circuits	circuit	NOUN
ihlr-18967	668	10	will	will	AUX
ihlr-18967	668	11	be	be	AUX
ihlr-18967	668	12	more	more	ADV
ihlr-18967	668	13	or	or	CCONJ
ihlr-18967	668	14	less	less	ADV
ihlr-18967	668	15	restrictive	restrictive	ADJ
ihlr-18967	668	16	as	as	ADP
ihlr-18967	668	17	to	to	ADP
ihlr-18967	668	18	what	what	PRON
ihlr-18967	668	19	constitutes	constitute	VERB
ihlr-18967	668	20	anticompetitive	anticompetitive	ADJ
ihlr-18967	668	21	harm	harm	NOUN
ihlr-18967	668	22	.	.	PUNCT
ihlr-18967	669	1	also	also	ADV
ihlr-18967	669	2	,	,	PUNCT
ihlr-18967	669	3	most	most	ADJ
ihlr-18967	669	4	pharmaceutical	pharmaceutical	ADJ
ihlr-18967	669	5	companies	company	NOUN
ihlr-18967	669	6	operate	operate	VERB
ihlr-18967	669	7	on	on	ADP
ihlr-18967	669	8	a	a	DET
ihlr-18967	669	9	national	national	ADJ
ihlr-18967	669	10	or	or	CCONJ
ihlr-18967	669	11	international	international	ADJ
ihlr-18967	669	12	level	level	NOUN
ihlr-18967	669	13	.	.	PUNCT
ihlr-18967	670	1	so	so	ADV
ihlr-18967	670	2	,	,	PUNCT
ihlr-18967	670	3	common	common	ADJ
ihlr-18967	670	4	law	law	NOUN
ihlr-18967	670	5	consistency	consistency	NOUN
ihlr-18967	670	6	will	will	AUX
ihlr-18967	670	7	be	be	AUX
ihlr-18967	670	8	an	an	DET
ihlr-18967	670	9	important	important	ADJ
ihlr-18967	670	10	factor	factor	NOUN
ihlr-18967	670	11	for	for	ADP
ihlr-18967	670	12	pharmaceutical	pharmaceutical	ADJ
ihlr-18967	670	13	companies	company	NOUN
ihlr-18967	670	14	in	in	ADP
ihlr-18967	670	15	constructing	construct	VERB
ihlr-18967	670	16	reverse	reverse	ADJ
ihlr-18967	670	17	payment	payment	NOUN
ihlr-18967	670	18	settlements	settlement	NOUN
ihlr-18967	670	19	.	.	PUNCT
ihlr-18967	671	1	moreover	moreover	ADV
ihlr-18967	671	2	,	,	PUNCT
ihlr-18967	671	3	common	common	ADJ
ihlr-18967	671	4	law	law	NOUN
ihlr-18967	671	5	consistency	consistency	NOUN
ihlr-18967	671	6	is	be	AUX
ihlr-18967	671	7	important	important	ADJ
ihlr-18967	671	8	in	in	ADP
ihlr-18967	671	9	deciding	decide	VERB
ihlr-18967	671	10	where	where	SCONJ
ihlr-18967	671	11	to	to	PART
ihlr-18967	671	12	appeal	appeal	VERB
ihlr-18967	671	13	ftc	ftc	PROPN
ihlr-18967	671	14	final	final	ADJ
ihlr-18967	671	15	orders	order	NOUN
ihlr-18967	671	16	since	since	SCONJ
ihlr-18967	671	17	the	the	DET
ihlr-18967	671	18	appellant	appellant	NOUN
ihlr-18967	671	19	can	can	AUX
ihlr-18967	671	20	choose	choose	VERB
ihlr-18967	671	21	the	the	DET
ihlr-18967	671	22	circuit	circuit	NOUN
ihlr-18967	671	23	of	of	ADP
ihlr-18967	671	24	its	its	PRON
ihlr-18967	671	25	choice	choice	NOUN
ihlr-18967	671	26	.	.	PUNCT
ihlr-18967	672	1	finally	finally	ADV
ihlr-18967	672	2	,	,	PUNCT
ihlr-18967	672	3	one	one	NUM
ihlr-18967	672	4	circuit	circuit	NOUN
ihlr-18967	672	5	may	may	AUX
ihlr-18967	672	6	quickly	quickly	ADV
ihlr-18967	672	7	develop	develop	VERB
ihlr-18967	672	8	211	211	NUM
ihlr-18967	672	9	see	see	NOUN
ihlr-18967	672	10	in	in	ADP
ihlr-18967	672	11	re	re	ADJ
ihlr-18967	672	12	lamictal	lamictal	ADJ
ihlr-18967	672	13	direct	direct	ADJ
ihlr-18967	672	14	purchaser	purchaser	NOUN
ihlr-18967	672	15	antitrust	antitrust	ADJ
ihlr-18967	672	16	litig	litig	NOUN
ihlr-18967	672	17	.	.	PUNCT
ihlr-18967	673	1	,	,	PUNCT
ihlr-18967	673	2	18	18	NUM
ihlr-18967	673	3	f.supp.3d	f.supp.3d	NOUN
ihlr-18967	673	4	560	560	NUM
ihlr-18967	673	5	,	,	PUNCT
ihlr-18967	673	6	570	570	NUM
ihlr-18967	673	7	(	(	PUNCT
ihlr-18967	673	8	d.	d.	PROPN
ihlr-18967	673	9	n.j	n.j	PROPN
ihlr-18967	673	10	.	.	PROPN
ihlr-18967	673	11	2014	2014	NUM
ihlr-18967	673	12	)	)	PUNCT
ihlr-18967	673	13	(	(	PUNCT
ihlr-18967	673	14	emphasis	emphasis	NOUN
ihlr-18967	673	15	added	add	VERB
ihlr-18967	673	16	)	)	PUNCT
ihlr-18967	673	17	.	.	PUNCT
ihlr-18967	674	1	212	212	NUM
ihlr-18967	674	2	compare	compare	PROPN
ihlr-18967	674	3	valley	valley	NOUN
ihlr-18967	674	4	drug	drug	PROPN
ihlr-18967	674	5	co.	co.	PROPN
ihlr-18967	674	6	v.	v.	ADP
ihlr-18967	674	7	geneva	geneva	PROPN
ihlr-18967	674	8	pharms	pharms	PROPN
ihlr-18967	674	9	.	.	PUNCT
ihlr-18967	674	10	,	,	PUNCT
ihlr-18967	674	11	inc	inc	PROPN
ihlr-18967	674	12	.	.	PROPN
ihlr-18967	674	13	,	,	PUNCT
ihlr-18967	674	14	344	344	NUM
ihlr-18967	674	15	f.3d	f.3d	NUM
ihlr-18967	674	16	1294	1294	NUM
ihlr-18967	674	17	(	(	PUNCT
ihlr-18967	674	18	11th	11th	ADJ
ihlr-18967	674	19	cir	cir	NOUN
ihlr-18967	674	20	.	.	PROPN
ihlr-18967	674	21	2003	2003	NUM
ihlr-18967	674	22	)	)	PUNCT
ihlr-18967	674	23	with	with	ADP
ihlr-18967	674	24	in	in	ADP
ihlr-18967	674	25	re	re	NOUN
ihlr-18967	674	26	k	k	ADJ
ihlr-18967	674	27	-	-	ADJ
ihlr-18967	674	28	dur	dur	ADJ
ihlr-18967	674	29	antitrust	antitrust	ADJ
ihlr-18967	674	30	litig	litig	NOUN
ihlr-18967	674	31	.	.	PUNCT
ihlr-18967	674	32	,	,	PUNCT
ihlr-18967	674	33	686	686	NUM
ihlr-18967	674	34	f.	f.	NOUN
ihlr-18967	674	35	3d	3d	NUM
ihlr-18967	674	36	197	197	NUM
ihlr-18967	674	37	(	(	PUNCT
ihlr-18967	674	38	3d	3d	NUM
ihlr-18967	674	39	cir	cir	NOUN
ihlr-18967	674	40	.	.	PROPN
ihlr-18967	674	41	2012	2012	NUM
ihlr-18967	674	42	)	)	PUNCT
ihlr-18967	674	43	.	.	PUNCT
ihlr-18967	675	1	213	213	NUM
ihlr-18967	675	2	28	28	NUM
ihlr-18967	675	3	u.s.c	u.s.c	ADJ
ihlr-18967	675	4	.	.	PUNCT
ihlr-18967	676	1	§	§	PROPN
ihlr-18967	676	2	1391(b)(1)-(3	1391(b)(1)-(3	NUM
ihlr-18967	676	3	)	)	PUNCT
ihlr-18967	676	4	(	(	PUNCT
ihlr-18967	676	5	2015	2015	NUM
ihlr-18967	676	6	)	)	PUNCT
ihlr-18967	676	7	(	(	PUNCT
ihlr-18967	676	8	establishing	establish	VERB
ihlr-18967	676	9	venue	venue	NOUN
ihlr-18967	676	10	in	in	ADP
ihlr-18967	676	11	any	any	DET
ihlr-18967	676	12	judicial	judicial	ADJ
ihlr-18967	676	13	district	district	NOUN
ihlr-18967	676	14	where	where	SCONJ
ihlr-18967	676	15	(	(	PUNCT
ihlr-18967	676	16	1	1	NUM
ihlr-18967	676	17	)	)	PUNCT
ihlr-18967	676	18	“	"	PUNCT
ihlr-18967	676	19	any	any	DET
ihlr-18967	676	20	defendant	defendant	NOUN
ihlr-18967	676	21	resides	reside	VERB
ihlr-18967	676	22	,	,	PUNCT
ihlr-18967	676	23	if	if	SCONJ
ihlr-18967	676	24	all	all	DET
ihlr-18967	676	25	defendants	defendant	NOUN
ihlr-18967	676	26	are	be	AUX
ihlr-18967	676	27	residents	resident	NOUN
ihlr-18967	676	28	of	of	ADP
ihlr-18967	676	29	the	the	DET
ihlr-18967	676	30	state	state	NOUN
ihlr-18967	676	31	in	in	ADP
ihlr-18967	676	32	which	which	PRON
ihlr-18967	676	33	the	the	DET
ihlr-18967	676	34	district	district	NOUN
ihlr-18967	676	35	is	be	AUX
ihlr-18967	676	36	located	locate	VERB
ihlr-18967	676	37	”	"	PUNCT
ihlr-18967	676	38	;	;	PUNCT
ihlr-18967	676	39	(	(	PUNCT
ihlr-18967	676	40	2	2	X
ihlr-18967	676	41	)	)	PUNCT
ihlr-18967	676	42	“	"	PUNCT
ihlr-18967	676	43	a	a	DET
ihlr-18967	676	44	substantial	substantial	ADJ
ihlr-18967	676	45	part	part	NOUN
ihlr-18967	676	46	of	of	ADP
ihlr-18967	676	47	the	the	DET
ihlr-18967	676	48	events	event	NOUN
ihlr-18967	676	49	of	of	ADP
ihlr-18967	676	50	omissions	omission	NOUN
ihlr-18967	676	51	giving	give	VERB
ihlr-18967	676	52	rise	rise	NOUN
ihlr-18967	676	53	to	to	ADP
ihlr-18967	676	54	the	the	DET
ihlr-18967	676	55	claim	claim	NOUN
ihlr-18967	676	56	occurred	occur	VERB
ihlr-18967	676	57	,	,	PUNCT
ihlr-18967	676	58	or	or	CCONJ
ihlr-18967	676	59	a	a	DET
ihlr-18967	676	60	substantial	substantial	ADJ
ihlr-18967	676	61	part	part	NOUN
ihlr-18967	676	62	of	of	ADP
ihlr-18967	676	63	property	property	NOUN
ihlr-18967	676	64	that	that	PRON
ihlr-18967	676	65	is	be	AUX
ihlr-18967	676	66	the	the	DET
ihlr-18967	676	67	subject	subject	NOUN
ihlr-18967	676	68	of	of	ADP
ihlr-18967	676	69	the	the	DET
ihlr-18967	676	70	action	action	NOUN
ihlr-18967	676	71	is	be	AUX
ihlr-18967	676	72	situated	situate	VERB
ihlr-18967	676	73	”	"	PUNCT
ihlr-18967	676	74	;	;	PUNCT
ihlr-18967	676	75	or	or	CCONJ
ihlr-18967	676	76	(	(	PUNCT
ihlr-18967	676	77	3	3	X
ihlr-18967	676	78	)	)	PUNCT
ihlr-18967	676	79	“	"	PUNCT
ihlr-18967	676	80	if	if	SCONJ
ihlr-18967	676	81	there	there	PRON
ihlr-18967	676	82	is	be	VERB
ihlr-18967	676	83	no	no	DET
ihlr-18967	676	84	district	district	NOUN
ihlr-18967	676	85	in	in	ADP
ihlr-18967	676	86	which	which	PRON
ihlr-18967	676	87	an	an	DET
ihlr-18967	676	88	action	action	NOUN
ihlr-18967	676	89	may	may	AUX
ihlr-18967	676	90	otherwise	otherwise	ADV
ihlr-18967	676	91	be	be	AUX
ihlr-18967	676	92	brought	bring	VERB
ihlr-18967	676	93	as	as	ADP
ihlr-18967	676	94	provided	provide	VERB
ihlr-18967	676	95	in	in	ADP
ihlr-18967	676	96	this	this	DET
ihlr-18967	676	97	section	section	NOUN
ihlr-18967	676	98	,	,	PUNCT
ihlr-18967	676	99	any	any	DET
ihlr-18967	676	100	judicial	judicial	ADJ
ihlr-18967	676	101	district	district	NOUN
ihlr-18967	676	102	in	in	ADP
ihlr-18967	676	103	which	which	PRON
ihlr-18967	676	104	any	any	DET
ihlr-18967	676	105	defendant	defendant	NOUN
ihlr-18967	676	106	is	be	AUX
ihlr-18967	676	107	subject	subject	ADJ
ihlr-18967	676	108	to	to	ADP
ihlr-18967	676	109	the	the	DET
ihlr-18967	676	110	court	court	NOUN
ihlr-18967	676	111	's	's	PART
ihlr-18967	676	112	personal	personal	ADJ
ihlr-18967	676	113	jurisdiction	jurisdiction	NOUN
ihlr-18967	676	114	with	with	ADP
ihlr-18967	676	115	respect	respect	NOUN
ihlr-18967	676	116	to	to	ADP
ihlr-18967	676	117	such	such	ADJ
ihlr-18967	676	118	action	action	NOUN
ihlr-18967	676	119	”	"	PUNCT
ihlr-18967	676	120	)	)	PUNCT
ihlr-18967	676	121	.	.	PUNCT
ihlr-18967	677	1	214	214	NUM
ihlr-18967	677	2	f.t.c	f.t.c	NOUN
ihlr-18967	677	3	.	.	PUNCT
ihlr-18967	678	1	v.	v.	ADP
ihlr-18967	678	2	actavis	actavis	PROPN
ihlr-18967	678	3	,	,	PUNCT
ihlr-18967	678	4	inc	inc	PROPN
ihlr-18967	678	5	.	.	PROPN
ihlr-18967	678	6	,	,	PUNCT
ihlr-18967	678	7	133	133	NUM
ihlr-18967	678	8	s.	s.	PROPN
ihlr-18967	678	9	ct	ct	PROPN
ihlr-18967	678	10	.	.	PROPN
ihlr-18967	678	11	2223	2223	NUM
ihlr-18967	678	12	,	,	PUNCT
ihlr-18967	678	13	2238	2238	NUM
ihlr-18967	678	14	(	(	PUNCT
ihlr-18967	678	15	2013	2013	NUM
ihlr-18967	678	16	)	)	PUNCT
ihlr-18967	678	17	.	.	PUNCT
ihlr-18967	679	1	464	464	NUM
ihlr-18967	679	2	indiana	indiana	PROPN
ihlr-18967	679	3	health	health	PROPN
ihlr-18967	679	4	law	law	PROPN
ihlr-18967	679	5	review	review	NOUN
ihlr-18967	679	6	vol	vol	NOUN
ihlr-18967	679	7	.	.	PUNCT
ihlr-18967	680	1	12:1	12:1	NUM
ihlr-18967	680	2	a	a	DET
ihlr-18967	680	3	robust	robust	ADJ
ihlr-18967	680	4	common	common	ADJ
ihlr-18967	680	5	law	law	NOUN
ihlr-18967	680	6	which	which	PRON
ihlr-18967	680	7	will	will	AUX
ihlr-18967	680	8	be	be	AUX
ihlr-18967	680	9	favored	favor	VERB
ihlr-18967	680	10	among	among	ADP
ihlr-18967	680	11	pharmaceutical	pharmaceutical	NOUN
ihlr-18967	680	12	manufacturers.215	manufacturers.215	VERB
ihlr-18967	680	13	9	9	NUM
ihlr-18967	680	14	.	.	PUNCT
ihlr-18967	680	15	ability	ability	NOUN
ihlr-18967	680	16	to	to	PART
ihlr-18967	680	17	explain	explain	VERB
ihlr-18967	680	18	all	all	DET
ihlr-18967	680	19	portions	portion	NOUN
ihlr-18967	680	20	of	of	ADP
ihlr-18967	680	21	the	the	DET
ihlr-18967	680	22	reverse	reverse	ADJ
ihlr-18967	680	23	payment	payment	NOUN
ihlr-18967	680	24	settlement	settlement	NOUN
ihlr-18967	680	25	need	need	VERB
ihlr-18967	680	26	to	to	PART
ihlr-18967	680	27	be	be	AUX
ihlr-18967	680	28	explainable.216	explainable.216	VERB
ihlr-18967	680	29	the	the	DET
ihlr-18967	680	30	court	court	NOUN
ihlr-18967	680	31	in	in	ADP
ihlr-18967	680	32	actavis	actavis	PROPN
ihlr-18967	680	33	emphasized	emphasize	VERB
ihlr-18967	680	34	that	that	SCONJ
ihlr-18967	680	35	unjustified	unjustified	ADJ
ihlr-18967	680	36	payments	payment	NOUN
ihlr-18967	680	37	carry	carry	VERB
ihlr-18967	680	38	the	the	DET
ihlr-18967	680	39	risk	risk	NOUN
ihlr-18967	680	40	of	of	ADP
ihlr-18967	680	41	anticompetitive	anticompetitive	ADJ
ihlr-18967	680	42	effects.217	effects.217	ADJ
ihlr-18967	680	43	being	being	NOUN
ihlr-18967	680	44	able	able	ADJ
ihlr-18967	680	45	to	to	PART
ihlr-18967	680	46	explain	explain	VERB
ihlr-18967	680	47	why	why	SCONJ
ihlr-18967	680	48	such	such	ADJ
ihlr-18967	680	49	payment	payment	NOUN
ihlr-18967	680	50	was	be	AUX
ihlr-18967	680	51	made	make	VERB
ihlr-18967	680	52	will	will	AUX
ihlr-18967	680	53	go	go	VERB
ihlr-18967	680	54	a	a	DET
ihlr-18967	680	55	long	long	ADJ
ihlr-18967	680	56	way	way	NOUN
ihlr-18967	680	57	to	to	ADP
ihlr-18967	680	58	rebutting	rebut	VERB
ihlr-18967	680	59	a	a	DET
ihlr-18967	680	60	claim	claim	NOUN
ihlr-18967	680	61	that	that	SCONJ
ihlr-18967	680	62	the	the	DET
ihlr-18967	680	63	payment	payment	NOUN
ihlr-18967	680	64	is	be	AUX
ihlr-18967	680	65	anticompetitive	anticompetitive	ADJ
ihlr-18967	680	66	.	.	PUNCT
ihlr-18967	681	1	as	as	ADP
ihlr-18967	681	2	one	one	NUM
ihlr-18967	681	3	suggestion	suggestion	NOUN
ihlr-18967	681	4	states	state	NOUN
ihlr-18967	681	5	,	,	PUNCT
ihlr-18967	681	6	“	"	PUNCT
ihlr-18967	681	7	parties	party	NOUN
ihlr-18967	681	8	should	should	AUX
ihlr-18967	681	9	from	from	ADP
ihlr-18967	681	10	the	the	DET
ihlr-18967	681	11	outset	outset	NOUN
ihlr-18967	681	12	have	have	VERB
ihlr-18967	681	13	a	a	DET
ihlr-18967	681	14	contemporaneous	contemporaneous	ADJ
ihlr-18967	681	15	documented	document	VERB
ihlr-18967	681	16	explanation	explanation	NOUN
ihlr-18967	681	17	for	for	ADP
ihlr-18967	681	18	every	every	DET
ihlr-18967	681	19	dollar	dollar	NOUN
ihlr-18967	681	20	of	of	ADP
ihlr-18967	681	21	each	each	DET
ihlr-18967	681	22	settlement	settlement	NOUN
ihlr-18967	681	23	.	.	PUNCT
ihlr-18967	682	1	”218	”218	NOUN
ihlr-18967	683	1	iv	iv	NUM
ihlr-18967	683	2	.	.	PUNCT
ihlr-18967	683	3	policy	policy	NOUN
ihlr-18967	683	4	recommendation	recommendation	NOUN
ihlr-18967	683	5	:	:	PUNCT
ihlr-18967	683	6	how	how	SCONJ
ihlr-18967	683	7	reverse	reverse	ADJ
ihlr-18967	683	8	payment	payment	NOUN
ihlr-18967	683	9	settlements	settlement	NOUN
ihlr-18967	683	10	support	support	VERB
ihlr-18967	683	11	the	the	DET
ihlr-18967	683	12	intent	intent	NOUN
ihlr-18967	683	13	of	of	ADP
ihlr-18967	683	14	patent	patent	NOUN
ihlr-18967	683	15	law	law	NOUN
ihlr-18967	683	16	and	and	CCONJ
ihlr-18967	683	17	the	the	DET
ihlr-18967	683	18	hatch	hatch	NOUN
ihlr-18967	683	19	-	-	PUNCT
ihlr-18967	683	20	waxman	waxman	PROPN
ihlr-18967	683	21	act	act	NOUN
ihlr-18967	683	22	while	while	SCONJ
ihlr-18967	683	23	congress	congress	PROPN
ihlr-18967	683	24	can	can	AUX
ihlr-18967	683	25	not	not	PART
ihlr-18967	683	26	“	"	PUNCT
ihlr-18967	683	27	overrule	overrule	VERB
ihlr-18967	683	28	”	"	PUNCT
ihlr-18967	683	29	a	a	DET
ihlr-18967	683	30	united	united	PROPN
ihlr-18967	683	31	states	states	PROPN
ihlr-18967	683	32	supreme	supreme	PROPN
ihlr-18967	683	33	court	court	PROPN
ihlr-18967	683	34	decision,219	decision,219	PROPN
ihlr-18967	683	35	congress	congress	PROPN
ihlr-18967	683	36	can	can	AUX
ihlr-18967	683	37	pass	pass	VERB
ihlr-18967	683	38	new	new	ADJ
ihlr-18967	683	39	laws	law	NOUN
ihlr-18967	683	40	to	to	PART
ihlr-18967	683	41	effectively	effectively	ADV
ihlr-18967	683	42	overturn	overturn	VERB
ihlr-18967	683	43	a	a	DET
ihlr-18967	683	44	united	united	PROPN
ihlr-18967	683	45	states	states	PROPN
ihlr-18967	683	46	supreme	supreme	PROPN
ihlr-18967	683	47	court	court	PROPN
ihlr-18967	683	48	decision.220	decision.220	ADP
ihlr-18967	683	49	presently	presently	ADV
ihlr-18967	683	50	,	,	PUNCT
ihlr-18967	683	51	some	some	DET
ihlr-18967	683	52	critics	critic	NOUN
ihlr-18967	683	53	argue	argue	VERB
ihlr-18967	683	54	that	that	SCONJ
ihlr-18967	683	55	congress	congress	PROPN
ihlr-18967	683	56	215	215	NUM
ihlr-18967	683	57	this	this	PRON
ihlr-18967	683	58	may	may	AUX
ihlr-18967	683	59	be	be	AUX
ihlr-18967	683	60	comparable	comparable	ADJ
ihlr-18967	683	61	to	to	ADP
ihlr-18967	683	62	the	the	DET
ihlr-18967	683	63	robust	robust	ADJ
ihlr-18967	683	64	common	common	ADJ
ihlr-18967	683	65	law	law	NOUN
ihlr-18967	683	66	dealing	deal	VERB
ihlr-18967	683	67	with	with	ADP
ihlr-18967	683	68	corporations	corporation	NOUN
ihlr-18967	683	69	in	in	ADP
ihlr-18967	683	70	delaware	delaware	PROPN
ihlr-18967	683	71	,	,	PUNCT
ihlr-18967	683	72	which	which	PRON
ihlr-18967	683	73	has	have	AUX
ihlr-18967	683	74	led	lead	VERB
ihlr-18967	683	75	many	many	ADJ
ihlr-18967	683	76	corporations	corporation	NOUN
ihlr-18967	683	77	to	to	PART
ihlr-18967	683	78	file	file	VERB
ihlr-18967	683	79	their	their	PRON
ihlr-18967	683	80	articles	article	NOUN
ihlr-18967	683	81	of	of	ADP
ihlr-18967	683	82	incorporation	incorporation	NOUN
ihlr-18967	683	83	in	in	ADP
ihlr-18967	683	84	the	the	DET
ihlr-18967	683	85	state	state	NOUN
ihlr-18967	683	86	.	.	PUNCT
ihlr-18967	684	1	see	see	VERB
ihlr-18967	684	2	generally	generally	ADV
ihlr-18967	684	3	lewis	lewis	PROPN
ihlr-18967	684	4	s.	s.	PROPN
ihlr-18967	684	5	black	black	PROPN
ihlr-18967	684	6	,	,	PUNCT
ihlr-18967	684	7	jr	jr	PROPN
ihlr-18967	684	8	.	.	PROPN
ihlr-18967	684	9	,	,	PUNCT
ihlr-18967	684	10	why	why	SCONJ
ihlr-18967	684	11	corporations	corporation	NOUN
ihlr-18967	684	12	choose	choose	VERB
ihlr-18967	684	13	delaware	delaware	PROPN
ihlr-18967	684	14	(	(	PUNCT
ihlr-18967	684	15	2007	2007	NUM
ihlr-18967	684	16	)	)	PUNCT
ihlr-18967	684	17	,	,	PUNCT
ihlr-18967	684	18	available	available	ADJ
ihlr-18967	684	19	at	at	ADP
ihlr-18967	684	20	http://corp.delaware.gov/whycorporations_web.pdf	http://corp.delaware.gov/whycorporations_web.pdf	NOUN
ihlr-18967	684	21	.	.	PUNCT
ihlr-18967	684	22	216	216	NUM
ihlr-18967	684	23	see	see	VERB
ihlr-18967	684	24	actavis	actavi	NOUN
ihlr-18967	684	25	,	,	PUNCT
ihlr-18967	684	26	133	133	NUM
ihlr-18967	684	27	s.	s.	PROPN
ihlr-18967	684	28	ct	ct	PROPN
ihlr-18967	684	29	.	.	PUNCT
ihlr-18967	685	1	at	at	ADP
ihlr-18967	685	2	2237	2237	NUM
ihlr-18967	685	3	(	(	PUNCT
ihlr-18967	685	4	stating	state	VERB
ihlr-18967	685	5	that	that	SCONJ
ihlr-18967	685	6	a	a	DET
ihlr-18967	685	7	payment	payment	NOUN
ihlr-18967	685	8	which	which	PRON
ihlr-18967	685	9	is	be	AUX
ihlr-18967	685	10	unexplainable	unexplainable	ADJ
ihlr-18967	685	11	or	or	CCONJ
ihlr-18967	685	12	unjustifiable	unjustifiable	ADJ
ihlr-18967	685	13	can	can	AUX
ihlr-18967	685	14	indicate	indicate	VERB
ihlr-18967	685	15	anticompetitive	anticompetitive	ADJ
ihlr-18967	685	16	harm	harm	NOUN
ihlr-18967	685	17	)	)	PUNCT
ihlr-18967	685	18	.	.	PUNCT
ihlr-18967	686	1	217	217	NUM
ihlr-18967	687	1	i	i	PRON
ihlr-18967	687	2	d.	d.	NOUN
ihlr-18967	687	3	218	218	NUM
ihlr-18967	687	4	crowell	crowell	NOUN
ihlr-18967	687	5	moring	moring	NOUN
ihlr-18967	687	6	article	article	NOUN
ihlr-18967	687	7	,	,	PUNCT
ihlr-18967	687	8	supra	supra	PROPN
ihlr-18967	687	9	note	note	NOUN
ihlr-18967	687	10	191	191	NUM
ihlr-18967	687	11	.	.	PUNCT
ihlr-18967	687	12	219	219	NUM
ihlr-18967	687	13	u.s	u.s	PROPN
ihlr-18967	687	14	.	.	PROPN
ihlr-18967	687	15	const	const	PROPN
ihlr-18967	687	16	.	.	PUNCT
ihlr-18967	688	1	art	art	PROPN
ihlr-18967	688	2	iii	iii	PROPN
ihlr-18967	688	3	,	,	PUNCT
ihlr-18967	688	4	§	§	PROPN
ihlr-18967	688	5	1	1	NUM
ihlr-18967	688	6	(	(	PUNCT
ihlr-18967	688	7	“	"	PUNCT
ihlr-18967	688	8	the	the	DET
ihlr-18967	688	9	judicial	judicial	ADJ
ihlr-18967	688	10	power	power	NOUN
ihlr-18967	688	11	of	of	ADP
ihlr-18967	688	12	the	the	DET
ihlr-18967	688	13	united	united	PROPN
ihlr-18967	688	14	states	states	PROPN
ihlr-18967	688	15	,	,	PUNCT
ihlr-18967	688	16	shall	shall	AUX
ihlr-18967	688	17	be	be	AUX
ihlr-18967	688	18	vested	vest	VERB
ihlr-18967	688	19	in	in	ADP
ihlr-18967	688	20	one	one	NUM
ihlr-18967	688	21	supreme	supreme	ADJ
ihlr-18967	688	22	court	court	NOUN
ihlr-18967	688	23	.	.	PUNCT
ihlr-18967	688	24	”	"	PUNCT
ihlr-18967	688	25	)	)	PUNCT
ihlr-18967	688	26	;	;	PUNCT
ihlr-18967	688	27	marbury	marbury	PROPN
ihlr-18967	688	28	v.	v.	ADP
ihlr-18967	688	29	madison	madison	PROPN
ihlr-18967	688	30	,	,	PUNCT
ihlr-18967	688	31	5	5	NUM
ihlr-18967	688	32	u.s	u.s	PROPN
ihlr-18967	688	33	.	.	PROPN
ihlr-18967	688	34	137	137	NUM
ihlr-18967	688	35	,	,	PUNCT
ihlr-18967	688	36	177	177	NUM
ihlr-18967	688	37	(	(	PUNCT
ihlr-18967	688	38	1803	1803	NUM
ihlr-18967	688	39	)	)	PUNCT
ihlr-18967	688	40	(	(	PUNCT
ihlr-18967	688	41	“	"	PUNCT
ihlr-18967	688	42	it	it	PRON
ihlr-18967	688	43	is	be	AUX
ihlr-18967	688	44	emphatically	emphatically	ADV
ihlr-18967	688	45	the	the	DET
ihlr-18967	688	46	province	province	NOUN
ihlr-18967	688	47	and	and	CCONJ
ihlr-18967	688	48	duty	duty	NOUN
ihlr-18967	688	49	of	of	ADP
ihlr-18967	688	50	the	the	DET
ihlr-18967	688	51	judicial	judicial	ADJ
ihlr-18967	688	52	department	department	NOUN
ihlr-18967	688	53	to	to	PART
ihlr-18967	688	54	say	say	VERB
ihlr-18967	688	55	what	what	PRON
ihlr-18967	688	56	the	the	DET
ihlr-18967	688	57	law	law	NOUN
ihlr-18967	688	58	is	be	AUX
ihlr-18967	688	59	.	.	PUNCT
ihlr-18967	688	60	”	"	PUNCT
ihlr-18967	688	61	)	)	PUNCT
ihlr-18967	688	62	.	.	PUNCT
ihlr-18967	689	1	220	220	NUM
ihlr-18967	689	2	see	see	VERB
ihlr-18967	689	3	holmes	holmes	PROPN
ihlr-18967	689	4	grp	grp	PROPN
ihlr-18967	689	5	.	.	PROPN
ihlr-18967	689	6	,	,	PUNCT
ihlr-18967	689	7	inc	inc	PROPN
ihlr-18967	689	8	.	.	PROPN
ihlr-18967	690	1	v.	v.	PROPN
ihlr-18967	690	2	vornado	vornado	PROPN
ihlr-18967	690	3	air	air	PROPN
ihlr-18967	690	4	circulation	circulation	PROPN
ihlr-18967	690	5	sys	sys	PROPN
ihlr-18967	690	6	.	.	PROPN
ihlr-18967	690	7	,	,	PUNCT
ihlr-18967	690	8	inc	inc	PROPN
ihlr-18967	690	9	.	.	PROPN
ihlr-18967	690	10	,	,	PUNCT
ihlr-18967	690	11	535	535	NUM
ihlr-18967	690	12	u.s	u.s	PROPN
ihlr-18967	690	13	.	.	PROPN
ihlr-18967	690	14	826	826	NUM
ihlr-18967	690	15	(	(	PUNCT
ihlr-18967	690	16	2002	2002	NUM
ihlr-18967	690	17	)	)	PUNCT
ihlr-18967	690	18	,	,	PUNCT
ihlr-18967	690	19	superseded	supersede	VERB
ihlr-18967	690	20	by	by	ADP
ihlr-18967	690	21	statute	statute	PROPN
ihlr-18967	690	22	,	,	PUNCT
ihlr-18967	690	23	28	28	NUM
ihlr-18967	690	24	u.s.c	u.s.c	ADJ
ihlr-18967	690	25	.	.	PUNCT
ihlr-18967	691	1	§	§	PROPN
ihlr-18967	691	2	1454(a	1454(a	NUM
ihlr-18967	691	3	)	)	PUNCT
ihlr-18967	691	4	(	(	PUNCT
ihlr-18967	691	5	2015	2015	NUM
ihlr-18967	691	6	)	)	PUNCT
ihlr-18967	691	7	;	;	PUNCT
ihlr-18967	691	8	city	city	NOUN
ihlr-18967	691	9	of	of	ADP
ihlr-18967	691	10	mobile	mobile	NOUN
ihlr-18967	691	11	,	,	PUNCT
ihlr-18967	691	12	ala	ala	PROPN
ihlr-18967	691	13	.	.	PUNCT
ihlr-18967	692	1	v.	v.	PROPN
ihlr-18967	692	2	bolden	bolden	PROPN
ihlr-18967	692	3	,	,	PUNCT
ihlr-18967	692	4	446	446	NUM
ihlr-18967	692	5	u.s	u.s	PROPN
ihlr-18967	692	6	.	.	PROPN
ihlr-18967	692	7	55	55	NUM
ihlr-18967	692	8	(	(	PUNCT
ihlr-18967	692	9	1980	1980	NUM
ihlr-18967	692	10	)	)	PUNCT
ihlr-18967	692	11	,	,	PUNCT
ihlr-18967	692	12	superseded	supersede	VERB
ihlr-18967	692	13	by	by	ADP
ihlr-18967	692	14	statute	statute	PROPN
ihlr-18967	692	15	,	,	PUNCT
ihlr-18967	692	16	voting	voting	NOUN
ihlr-18967	692	17	rights	right	NOUN
ihlr-18967	692	18	act	act	NOUN
ihlr-18967	692	19	of	of	ADP
ihlr-18967	692	20	1965	1965	NUM
ihlr-18967	692	21	,	,	PUNCT
ihlr-18967	692	22	§	§	PROPN
ihlr-18967	692	23	2	2	NUM
ihlr-18967	692	24	,	,	PUNCT
ihlr-18967	692	25	pub	pub	NOUN
ihlr-18967	692	26	.	.	PUNCT
ihlr-18967	693	1	l.	l.	PROPN
ihlr-18967	693	2	no	no	INTJ
ihlr-18967	693	3	.	.	PROPN
ihlr-18967	693	4	89	89	NUM
ihlr-18967	693	5	-	-	SYM
ihlr-18967	693	6	110	110	NUM
ihlr-18967	693	7	,	,	PUNCT
ihlr-18967	693	8	79	79	NUM
ihlr-18967	693	9	stat	stat	NOUN
ihlr-18967	693	10	.	.	PUNCT
ihlr-18967	694	1	437	437	NUM
ihlr-18967	694	2	(	(	PUNCT
ihlr-18967	694	3	amended	amend	VERB
ihlr-18967	694	4	1982	1982	NUM
ihlr-18967	694	5	)	)	PUNCT
ihlr-18967	694	6	,	,	PUNCT
ihlr-18967	694	7	as	as	SCONJ
ihlr-18967	694	8	recognized	recognize	VERB
ihlr-18967	694	9	in	in	ADP
ihlr-18967	694	10	bartlett	bartlett	PROPN
ihlr-18967	694	11	v.	v.	PROPN
ihlr-18967	694	12	strickland	strickland	PROPN
ihlr-18967	694	13	,	,	PUNCT
ihlr-18967	694	14	556	556	NUM
ihlr-18967	694	15	u.s	u.s	PROPN
ihlr-18967	694	16	.	.	PROPN
ihlr-18967	694	17	1	1	NUM
ihlr-18967	694	18	,	,	PUNCT
ihlr-18967	694	19	10	10	NUM
ihlr-18967	694	20	(	(	PUNCT
ihlr-18967	694	21	2009	2009	NUM
ihlr-18967	694	22	)	)	PUNCT
ihlr-18967	694	23	.	.	PUNCT
ihlr-18967	695	1	2015	2015	NUM
ihlr-18967	695	2	rationale	rationale	NOUN
ihlr-18967	695	3	behind	behind	ADP
ihlr-18967	695	4	hatch	hatch	NOUN
ihlr-18967	695	5	-	-	PUNCT
ihlr-18967	695	6	waxman	waxman	PROPN
ihlr-18967	695	7	act	act	PROPN
ihlr-18967	695	8	and	and	CCONJ
ihlr-18967	695	9	patent	patent	NOUN
ihlr-18967	695	10	law	law	NOUN
ihlr-18967	695	11	465	465	NUM
ihlr-18967	695	12	should	should	AUX
ihlr-18967	695	13	outright	outright	ADV
ihlr-18967	695	14	ban	ban	VERB
ihlr-18967	695	15	reverse	reverse	ADJ
ihlr-18967	695	16	payment	payment	NOUN
ihlr-18967	695	17	settlements.221	settlements.221	NOUN
ihlr-18967	695	18	more	more	ADV
ihlr-18967	695	19	importantly	importantly	ADV
ihlr-18967	695	20	,	,	PUNCT
ihlr-18967	695	21	in	in	ADP
ihlr-18967	695	22	2013	2013	NUM
ihlr-18967	695	23	,	,	PUNCT
ihlr-18967	695	24	senator	senator	PROPN
ihlr-18967	695	25	amy	amy	PROPN
ihlr-18967	695	26	klobuchar	klobuchar	PROPN
ihlr-18967	695	27	introduced	introduce	VERB
ihlr-18967	695	28	paaga.222	paaga.222	NOUN
ihlr-18967	695	29	while	while	SCONJ
ihlr-18967	695	30	the	the	DET
ihlr-18967	695	31	present	present	ADJ
ihlr-18967	695	32	state	state	NOUN
ihlr-18967	695	33	of	of	ADP
ihlr-18967	695	34	paaga	paaga	NOUN
ihlr-18967	695	35	does	do	AUX
ihlr-18967	695	36	not	not	PART
ihlr-18967	695	37	create	create	VERB
ihlr-18967	695	38	a	a	DET
ihlr-18967	695	39	per	per	X
ihlr-18967	695	40	se	se	X
ihlr-18967	695	41	ban	ban	NOUN
ihlr-18967	695	42	on	on	ADP
ihlr-18967	695	43	reverse	reverse	ADJ
ihlr-18967	695	44	payment	payment	NOUN
ihlr-18967	695	45	settlements	settlement	NOUN
ihlr-18967	695	46	,	,	PUNCT
ihlr-18967	695	47	paaga	paaga	NOUN
ihlr-18967	695	48	has	have	VERB
ihlr-18967	695	49	an	an	DET
ihlr-18967	695	50	anti	anti	ADJ
ihlr-18967	695	51	-	-	ADJ
ihlr-18967	695	52	reverse	reverse	ADJ
ihlr-18967	695	53	payment	payment	NOUN
ihlr-18967	695	54	settlement	settlement	NOUN
ihlr-18967	695	55	“	"	PUNCT
ihlr-18967	695	56	taste	taste	NOUN
ihlr-18967	695	57	”	"	PUNCT
ihlr-18967	695	58	and	and	CCONJ
ihlr-18967	695	59	is	be	AUX
ihlr-18967	695	60	comparable	comparable	ADJ
ihlr-18967	695	61	to	to	ADP
ihlr-18967	695	62	the	the	DET
ihlr-18967	695	63	“	"	PUNCT
ihlr-18967	695	64	quick	quick	ADJ
ihlr-18967	695	65	look	look	NOUN
ihlr-18967	695	66	”	"	PUNCT
ihlr-18967	695	67	analysis	analysis	NOUN
ihlr-18967	695	68	previously	previously	ADV
ihlr-18967	695	69	used	use	VERB
ihlr-18967	695	70	by	by	ADP
ihlr-18967	695	71	the	the	DET
ihlr-18967	695	72	third	third	ADJ
ihlr-18967	695	73	circuit.223	circuit.223	NOUN
ihlr-18967	695	74	the	the	DET
ihlr-18967	695	75	court	court	NOUN
ihlr-18967	695	76	implicitly	implicitly	ADV
ihlr-18967	695	77	rejected	reject	VERB
ihlr-18967	695	78	the	the	DET
ihlr-18967	695	79	presumption	presumption	NOUN
ihlr-18967	695	80	of	of	ADP
ihlr-18967	695	81	anticompetitive	anticompetitive	ADJ
ihlr-18967	695	82	harm	harm	NOUN
ihlr-18967	695	83	in	in	ADP
ihlr-18967	695	84	paaga	paaga	NOUN
ihlr-18967	695	85	by	by	ADP
ihlr-18967	695	86	explicitly	explicitly	ADV
ihlr-18967	695	87	rejecting	reject	VERB
ihlr-18967	695	88	the	the	DET
ihlr-18967	695	89	quick	quick	ADJ
ihlr-18967	695	90	-	-	PUNCT
ihlr-18967	695	91	look	look	NOUN
ihlr-18967	695	92	analysis.224	analysis.224	NOUN
ihlr-18967	695	93	subsequently	subsequently	ADV
ihlr-18967	695	94	,	,	PUNCT
ihlr-18967	695	95	this	this	DET
ihlr-18967	695	96	presumption	presumption	NOUN
ihlr-18967	695	97	of	of	ADP
ihlr-18967	695	98	anticompetitive	anticompetitive	ADJ
ihlr-18967	695	99	harm	harm	NOUN
ihlr-18967	695	100	under	under	ADP
ihlr-18967	695	101	paaga	paaga	NOUN
ihlr-18967	695	102	is	be	AUX
ihlr-18967	695	103	contrary	contrary	ADJ
ihlr-18967	695	104	to	to	ADP
ihlr-18967	695	105	actavis	actavis	ADJ
ihlr-18967	695	106	’	'	PUNCT
ihlr-18967	695	107	holding	holding	NOUN
ihlr-18967	695	108	.	.	PUNCT
ihlr-18967	696	1	congress	congress	PROPN
ihlr-18967	696	2	should	should	AUX
ihlr-18967	696	3	not	not	PART
ihlr-18967	696	4	ban	ban	VERB
ihlr-18967	696	5	reverse	reverse	ADJ
ihlr-18967	696	6	payment	payment	NOUN
ihlr-18967	696	7	settlements	settlement	NOUN
ihlr-18967	696	8	or	or	CCONJ
ihlr-18967	696	9	invoke	invoke	VERB
ihlr-18967	696	10	analysis	analysis	NOUN
ihlr-18967	696	11	requiring	require	VERB
ihlr-18967	696	12	a	a	DET
ihlr-18967	696	13	standard	standard	NOUN
ihlr-18967	696	14	more	more	ADV
ihlr-18967	696	15	stringent	stringent	ADJ
ihlr-18967	696	16	than	than	ADP
ihlr-18967	696	17	actavis	actavis	ADJ
ihlr-18967	696	18	.	.	PUNCT
ihlr-18967	697	1	instead	instead	ADV
ihlr-18967	697	2	,	,	PUNCT
ihlr-18967	697	3	congress	congress	PROPN
ihlr-18967	697	4	should	should	AUX
ihlr-18967	697	5	endorse	endorse	VERB
ihlr-18967	697	6	the	the	DET
ihlr-18967	697	7	actavis	actavis	ADJ
ihlr-18967	697	8	framework	framework	NOUN
ihlr-18967	697	9	for	for	ADP
ihlr-18967	697	10	analyzing	analyze	VERB
ihlr-18967	697	11	reverse	reverse	ADJ
ihlr-18967	697	12	payment	payment	NOUN
ihlr-18967	697	13	settlements.225	settlements.225	NOUN
ihlr-18967	697	14	actavis	actavis	PROPN
ihlr-18967	697	15	provides	provide	VERB
ihlr-18967	697	16	a	a	DET
ihlr-18967	697	17	middle	middle	ADJ
ihlr-18967	697	18	ground	ground	NOUN
ihlr-18967	697	19	which	which	PRON
ihlr-18967	697	20	supports	support	VERB
ihlr-18967	697	21	both	both	CCONJ
ihlr-18967	697	22	the	the	DET
ihlr-18967	697	23	intent	intent	NOUN
ihlr-18967	697	24	behind	behind	ADP
ihlr-18967	697	25	patent	patent	NOUN
ihlr-18967	697	26	law	law	NOUN
ihlr-18967	697	27	and	and	CCONJ
ihlr-18967	697	28	rationale	rationale	NOUN
ihlr-18967	697	29	of	of	ADP
ihlr-18967	697	30	the	the	DET
ihlr-18967	697	31	hatchwaxman	hatchwaxman	PROPN
ihlr-18967	697	32	act	act	PROPN
ihlr-18967	697	33	.	.	PUNCT
ihlr-18967	698	1	under	under	ADP
ihlr-18967	698	2	actavis	actavis	NOUN
ihlr-18967	698	3	,	,	PUNCT
ihlr-18967	698	4	motivation	motivation	NOUN
ihlr-18967	698	5	for	for	ADP
ihlr-18967	698	6	pioneer	pioneer	NOUN
ihlr-18967	698	7	manufacturers	manufacturer	NOUN
ihlr-18967	698	8	to	to	PART
ihlr-18967	698	9	innovate	innovate	VERB
ihlr-18967	698	10	coexists	coexist	NOUN
ihlr-18967	698	11	with	with	ADP
ihlr-18967	698	12	the	the	DET
ihlr-18967	698	13	elimination	elimination	NOUN
ihlr-18967	698	14	of	of	ADP
ihlr-18967	698	15	frivolous	frivolous	ADJ
ihlr-18967	698	16	patents	patent	NOUN
ihlr-18967	698	17	and	and	CCONJ
ihlr-18967	698	18	allowing	allow	VERB
ihlr-18967	698	19	generic	generic	ADJ
ihlr-18967	698	20	drugs	drug	NOUN
ihlr-18967	698	21	to	to	PART
ihlr-18967	698	22	reach	reach	VERB
ihlr-18967	698	23	the	the	DET
ihlr-18967	698	24	market	market	NOUN
ihlr-18967	698	25	.	.	PUNCT
ihlr-18967	699	1	to	to	PART
ihlr-18967	699	2	begin	begin	VERB
ihlr-18967	699	3	with	with	ADP
ihlr-18967	699	4	,	,	PUNCT
ihlr-18967	699	5	patent	patent	NOUN
ihlr-18967	699	6	law	law	NOUN
ihlr-18967	699	7	was	be	AUX
ihlr-18967	699	8	designed	design	VERB
ihlr-18967	699	9	to	to	PART
ihlr-18967	699	10	“	"	PUNCT
ihlr-18967	699	11	stimulate	stimulate	VERB
ihlr-18967	699	12	the	the	DET
ihlr-18967	699	13	efforts	effort	NOUN
ihlr-18967	699	14	of	of	ADP
ihlr-18967	699	15	genius	genius	NOUN
ihlr-18967	699	16	”	"	PUNCT
ihlr-18967	699	17	to	to	PART
ihlr-18967	699	18	develop	develop	VERB
ihlr-18967	699	19	progress	progress	NOUN
ihlr-18967	699	20	in	in	ADP
ihlr-18967	699	21	science.226	science.226	PROPN
ihlr-18967	699	22	while	while	SCONJ
ihlr-18967	699	23	patent	patent	NOUN
ihlr-18967	699	24	law	law	NOUN
ihlr-18967	699	25	was	be	AUX
ihlr-18967	699	26	not	not	PART
ihlr-18967	699	27	designed	design	VERB
ihlr-18967	699	28	to	to	PART
ihlr-18967	699	29	create	create	VERB
ihlr-18967	699	30	“	"	PUNCT
ihlr-18967	699	31	private	private	ADJ
ihlr-18967	699	32	fortunes	fortune	NOUN
ihlr-18967	699	33	for	for	ADP
ihlr-18967	699	34	the	the	DET
ihlr-18967	699	35	owners	owner	NOUN
ihlr-18967	699	36	of	of	ADP
ihlr-18967	699	37	patents,”227	patents,”227	PROPN
ihlr-18967	699	38	it	it	PRON
ihlr-18967	699	39	is	be	AUX
ihlr-18967	699	40	undeniable	undeniable	ADJ
ihlr-18967	699	41	that	that	SCONJ
ihlr-18967	699	42	most	most	ADJ
ihlr-18967	699	43	people	people	NOUN
ihlr-18967	699	44	,	,	PUNCT
ihlr-18967	699	45	221	221	NUM
ihlr-18967	699	46	ford	ford	NOUN
ihlr-18967	699	47	,	,	PUNCT
ihlr-18967	699	48	supra	supra	PROPN
ihlr-18967	699	49	note	note	PROPN
ihlr-18967	699	50	17	17	NUM
ihlr-18967	699	51	;	;	PUNCT
ihlr-18967	699	52	see	see	VERB
ihlr-18967	699	53	generally	generally	ADV
ihlr-18967	699	54	pay	pay	VERB
ihlr-18967	699	55	-	-	PUNCT
ihlr-18967	699	56	for	for	ADP
ihlr-18967	699	57	-	-	PUNCT
ihlr-18967	699	58	delay	delay	NOUN
ihlr-18967	699	59	,	,	PUNCT
ihlr-18967	699	60	supra	supra	NOUN
ihlr-18967	699	61	note	note	NOUN
ihlr-18967	699	62	9	9	NUM
ihlr-18967	699	63	.	.	NOUN
ihlr-18967	699	64	222	222	NUM
ihlr-18967	699	65	preserve	preserve	VERB
ihlr-18967	699	66	access	access	NOUN
ihlr-18967	699	67	to	to	ADP
ihlr-18967	699	68	affordable	affordable	ADJ
ihlr-18967	699	69	generics	generic	NOUN
ihlr-18967	699	70	act	act	PROPN
ihlr-18967	699	71	,	,	PUNCT
ihlr-18967	699	72	s.	s.	PROPN
ihlr-18967	699	73	214	214	NUM
ihlr-18967	699	74	,	,	PUNCT
ihlr-18967	699	75	113th	113th	PROPN
ihlr-18967	699	76	cong	cong	NOUN
ihlr-18967	699	77	.	.	PUNCT
ihlr-18967	700	1	(	(	PUNCT
ihlr-18967	700	2	2013	2013	NUM
ihlr-18967	700	3	)	)	PUNCT
ihlr-18967	700	4	.	.	PUNCT
ihlr-18967	701	1	223	223	NUM
ihlr-18967	702	1	in	in	ADP
ihlr-18967	702	2	re	re	PROPN
ihlr-18967	702	3	k	k	X
ihlr-18967	702	4	-	-	ADJ
ihlr-18967	702	5	dur	dur	ADJ
ihlr-18967	702	6	antitrust	antitrust	ADJ
ihlr-18967	702	7	litig	litig	NOUN
ihlr-18967	702	8	.	.	PUNCT
ihlr-18967	703	1	,	,	PUNCT
ihlr-18967	703	2	686	686	NUM
ihlr-18967	703	3	f.3d	f.3d	NUM
ihlr-18967	703	4	197	197	NUM
ihlr-18967	703	5	,	,	PUNCT
ihlr-18967	703	6	218	218	NUM
ihlr-18967	703	7	(	(	PUNCT
ihlr-18967	703	8	3d	3d	PROPN
ihlr-18967	703	9	cir	cir	NOUN
ihlr-18967	703	10	.	.	PROPN
ihlr-18967	703	11	2012	2012	NUM
ihlr-18967	703	12	)	)	PUNCT
ihlr-18967	704	1	(	(	PUNCT
ihlr-18967	704	2	holding	hold	VERB
ihlr-18967	704	3	reverse	reverse	ADJ
ihlr-18967	704	4	payment	payment	NOUN
ihlr-18967	704	5	settlements	settlement	NOUN
ihlr-18967	704	6	as	as	ADP
ihlr-18967	704	7	“	"	PUNCT
ihlr-18967	704	8	prima	prima	NOUN
ihlr-18967	704	9	facie	facie	NOUN
ihlr-18967	704	10	evidence	evidence	NOUN
ihlr-18967	704	11	of	of	ADP
ihlr-18967	704	12	an	an	DET
ihlr-18967	704	13	unreasonable	unreasonable	ADJ
ihlr-18967	704	14	restraint	restraint	NOUN
ihlr-18967	704	15	of	of	ADP
ihlr-18967	704	16	trade	trade	NOUN
ihlr-18967	704	17	”	"	PUNCT
ihlr-18967	704	18	)	)	PUNCT
ihlr-18967	704	19	.	.	PUNCT
ihlr-18967	705	1	224	224	NUM
ihlr-18967	705	2	ftc	ftc	PROPN
ihlr-18967	705	3	v.	v.	ADP
ihlr-18967	705	4	actavis	actavis	PROPN
ihlr-18967	705	5	,	,	PUNCT
ihlr-18967	705	6	inc	inc	PROPN
ihlr-18967	705	7	.	.	PROPN
ihlr-18967	705	8	,	,	PUNCT
ihlr-18967	705	9	133	133	NUM
ihlr-18967	705	10	s.	s.	PROPN
ihlr-18967	705	11	ct	ct	PROPN
ihlr-18967	705	12	.	.	PROPN
ihlr-18967	705	13	2223	2223	NUM
ihlr-18967	705	14	,	,	PUNCT
ihlr-18967	705	15	2237	2237	NUM
ihlr-18967	705	16	(	(	PUNCT
ihlr-18967	705	17	2013	2013	NUM
ihlr-18967	705	18	)	)	PUNCT
ihlr-18967	705	19	.	.	PUNCT
ihlr-18967	706	1	225	225	NUM
ihlr-18967	706	2	see	see	VERB
ihlr-18967	706	3	testimony	testimony	NOUN
ihlr-18967	706	4	of	of	ADP
ihlr-18967	706	5	jonathan	jonathan	PROPN
ihlr-18967	706	6	m.	m.	PROPN
ihlr-18967	706	7	orszag	orszag	PROPN
ihlr-18967	706	8	before	before	ADP
ihlr-18967	706	9	the	the	DET
ihlr-18967	706	10	senate	senate	PROPN
ihlr-18967	706	11	judiciary	judiciary	PROPN
ihlr-18967	706	12	subcomm	subcomm	PROPN
ihlr-18967	706	13	.	.	PUNCT
ihlr-18967	707	1	on	on	ADP
ihlr-18967	707	2	antitrust	antitrust	ADJ
ihlr-18967	707	3	,	,	PUNCT
ihlr-18967	707	4	competition	competition	NOUN
ihlr-18967	707	5	policy	policy	NOUN
ihlr-18967	707	6	,	,	PUNCT
ihlr-18967	707	7	and	and	CCONJ
ihlr-18967	707	8	consumer	consumer	NOUN
ihlr-18967	707	9	rights	right	NOUN
ihlr-18967	707	10	,	,	PUNCT
ihlr-18967	707	11	113th	113th	PROPN
ihlr-18967	707	12	cong	cong	NOUN
ihlr-18967	707	13	.	.	PUNCT
ihlr-18967	708	1	9	9	NUM
ihlr-18967	708	2	(	(	PUNCT
ihlr-18967	708	3	2013	2013	NUM
ihlr-18967	708	4	)	)	PUNCT
ihlr-18967	709	1	[	[	X
ihlr-18967	709	2	hereinafter	hereinafter	NOUN
ihlr-18967	709	3	orszag	orszag	NOUN
ihlr-18967	709	4	testimony	testimony	NOUN
ihlr-18967	709	5	]	]	PUNCT
ihlr-18967	709	6	(	(	PUNCT
ihlr-18967	709	7	statement	statement	NOUN
ihlr-18967	709	8	of	of	ADP
ihlr-18967	709	9	jonathan	jonathan	PROPN
ihlr-18967	709	10	m.	m.	PROPN
ihlr-18967	709	11	orszag	orszag	PROPN
ihlr-18967	709	12	,	,	PUNCT
ihlr-18967	709	13	senior	senior	ADJ
ihlr-18967	709	14	managing	managing	NOUN
ihlr-18967	709	15	director	director	NOUN
ihlr-18967	709	16	,	,	PUNCT
ihlr-18967	709	17	compass	compass	NOUN
ihlr-18967	709	18	lexecon	lexecon	NOUN
ihlr-18967	709	19	)	)	PUNCT
ihlr-18967	709	20	(	(	PUNCT
ihlr-18967	709	21	stating	state	VERB
ihlr-18967	709	22	that	that	SCONJ
ihlr-18967	709	23	congressional	congressional	ADJ
ihlr-18967	709	24	action	action	NOUN
ihlr-18967	709	25	making	make	VERB
ihlr-18967	709	26	reverse	reverse	ADJ
ihlr-18967	709	27	payment	payment	NOUN
ihlr-18967	709	28	settlements	settlement	NOUN
ihlr-18967	709	29	per	per	ADP
ihlr-18967	709	30	se	se	X
ihlr-18967	709	31	illegal	illegal	ADJ
ihlr-18967	709	32	or	or	CCONJ
ihlr-18967	709	33	per	per	ADP
ihlr-18967	709	34	se	se	X
ihlr-18967	709	35	immune	immune	ADJ
ihlr-18967	709	36	to	to	ADP
ihlr-18967	709	37	challenges	challenge	NOUN
ihlr-18967	709	38	would	would	AUX
ihlr-18967	709	39	be	be	AUX
ihlr-18967	709	40	counterproductive	counterproductive	ADJ
ihlr-18967	709	41	)	)	PUNCT
ihlr-18967	709	42	.	.	PUNCT
ihlr-18967	710	1	226	226	NUM
ihlr-18967	710	2	motion	motion	NOUN
ihlr-18967	710	3	picture	picture	NOUN
ihlr-18967	710	4	patents	patent	NOUN
ihlr-18967	710	5	co.	co.	PROPN
ihlr-18967	710	6	v.	v.	ADP
ihlr-18967	710	7	universal	universal	ADJ
ihlr-18967	710	8	film	film	PROPN
ihlr-18967	710	9	mfg	mfg	PROPN
ihlr-18967	710	10	.	.	PROPN
ihlr-18967	710	11	co.	co.	PROPN
ihlr-18967	710	12	,	,	PUNCT
ihlr-18967	710	13	243	243	NUM
ihlr-18967	710	14	u.s	u.s	PROPN
ihlr-18967	710	15	.	.	PROPN
ihlr-18967	710	16	502	502	NUM
ihlr-18967	710	17	,	,	PUNCT
ihlr-18967	710	18	511	511	NUM
ihlr-18967	710	19	(	(	PUNCT
ihlr-18967	710	20	1917	1917	NUM
ihlr-18967	710	21	)	)	PUNCT
ihlr-18967	710	22	.	.	PUNCT
ihlr-18967	711	1	227	227	NUM
ihlr-18967	712	1	i	i	PRON
ihlr-18967	712	2	d.	d.	PROPN
ihlr-18967	712	3	466	466	NUM
ihlr-18967	712	4	indiana	indiana	PROPN
ihlr-18967	712	5	health	health	PROPN
ihlr-18967	712	6	law	law	PROPN
ihlr-18967	712	7	review	review	NOUN
ihlr-18967	712	8	vol	vol	NOUN
ihlr-18967	712	9	.	.	PUNCT
ihlr-18967	713	1	12:1	12:1	NUM
ihlr-18967	713	2	especially	especially	ADV
ihlr-18967	713	3	corporations	corporation	NOUN
ihlr-18967	713	4	which	which	PRON
ihlr-18967	713	5	work	work	VERB
ihlr-18967	713	6	to	to	PART
ihlr-18967	713	7	maximize	maximize	VERB
ihlr-18967	713	8	shareholder	shareholder	NOUN
ihlr-18967	713	9	profits	profit	NOUN
ihlr-18967	713	10	,	,	PUNCT
ihlr-18967	713	11	are	be	AUX
ihlr-18967	713	12	motivated	motivate	VERB
ihlr-18967	713	13	by	by	ADP
ihlr-18967	713	14	economic	economic	ADJ
ihlr-18967	713	15	incentives	incentive	NOUN
ihlr-18967	713	16	.	.	PUNCT
ihlr-18967	714	1	this	this	DET
ihlr-18967	714	2	incentive	incentive	NOUN
ihlr-18967	714	3	to	to	PART
ihlr-18967	714	4	invent	invent	VERB
ihlr-18967	714	5	and	and	CCONJ
ihlr-18967	714	6	create	create	VERB
ihlr-18967	714	7	,	,	PUNCT
ihlr-18967	714	8	for	for	ADP
ihlr-18967	714	9	the	the	DET
ihlr-18967	714	10	progress	progress	NOUN
ihlr-18967	714	11	of	of	ADP
ihlr-18967	714	12	science	science	NOUN
ihlr-18967	714	13	,	,	PUNCT
ihlr-18967	714	14	is	be	AUX
ihlr-18967	714	15	so	so	ADV
ihlr-18967	714	16	important	important	ADJ
ihlr-18967	714	17	and	and	CCONJ
ihlr-18967	714	18	widely	widely	ADV
ihlr-18967	714	19	recognized	recognize	VERB
ihlr-18967	714	20	that	that	SCONJ
ihlr-18967	714	21	it	it	PRON
ihlr-18967	714	22	is	be	AUX
ihlr-18967	714	23	ingrained	ingrain	VERB
ihlr-18967	714	24	in	in	ADP
ihlr-18967	714	25	the	the	DET
ihlr-18967	714	26	constitution.228	constitution.228	PROPN
ihlr-18967	714	27	moreover	moreover	ADV
ihlr-18967	714	28	,	,	PUNCT
ihlr-18967	714	29	this	this	PRON
ihlr-18967	714	30	led	lead	VERB
ihlr-18967	714	31	the	the	DET
ihlr-18967	714	32	supreme	supreme	PROPN
ihlr-18967	714	33	court	court	PROPN
ihlr-18967	714	34	to	to	ADP
ihlr-18967	714	35	state	state	VERB
ihlr-18967	714	36	:	:	PUNCT
ihlr-18967	714	37	the	the	DET
ihlr-18967	714	38	economic	economic	ADJ
ihlr-18967	714	39	philosophy	philosophy	NOUN
ihlr-18967	714	40	behind	behind	ADP
ihlr-18967	714	41	the	the	DET
ihlr-18967	714	42	clause	clause	NOUN
ihlr-18967	714	43	empowering	empower	VERB
ihlr-18967	714	44	congress	congress	PROPN
ihlr-18967	714	45	to	to	PART
ihlr-18967	714	46	grant	grant	VERB
ihlr-18967	714	47	patents	patent	NOUN
ihlr-18967	714	48	and	and	CCONJ
ihlr-18967	714	49	copyrights	copyright	NOUN
ihlr-18967	714	50	is	be	AUX
ihlr-18967	714	51	the	the	DET
ihlr-18967	714	52	conviction	conviction	NOUN
ihlr-18967	714	53	that	that	DET
ihlr-18967	714	54	encouragement	encouragement	NOUN
ihlr-18967	714	55	of	of	ADP
ihlr-18967	714	56	individual	individual	ADJ
ihlr-18967	714	57	effort	effort	NOUN
ihlr-18967	714	58	by	by	ADP
ihlr-18967	714	59	personal	personal	ADJ
ihlr-18967	714	60	gain	gain	NOUN
ihlr-18967	714	61	is	be	AUX
ihlr-18967	714	62	the	the	DET
ihlr-18967	714	63	best	good	ADJ
ihlr-18967	714	64	way	way	NOUN
ihlr-18967	714	65	to	to	PART
ihlr-18967	714	66	advance	advance	VERB
ihlr-18967	714	67	public	public	ADJ
ihlr-18967	714	68	welfare	welfare	NOUN
ihlr-18967	714	69	through	through	ADP
ihlr-18967	714	70	the	the	DET
ihlr-18967	714	71	talents	talent	NOUN
ihlr-18967	714	72	of	of	ADP
ihlr-18967	714	73	authors	author	NOUN
ihlr-18967	714	74	and	and	CCONJ
ihlr-18967	714	75	inventors	inventor	NOUN
ihlr-18967	714	76	in	in	ADP
ihlr-18967	714	77	‘	'	PUNCT
ihlr-18967	714	78	science	science	NOUN
ihlr-18967	714	79	and	and	CCONJ
ihlr-18967	714	80	useful	useful	ADJ
ihlr-18967	714	81	arts	art	NOUN
ihlr-18967	714	82	.	.	PUNCT
ihlr-18967	714	83	’	'	PUNCT
ihlr-18967	715	1	sacrificial	sacrificial	ADJ
ihlr-18967	715	2	days	day	NOUN
ihlr-18967	715	3	devoted	devote	VERB
ihlr-18967	715	4	to	to	ADP
ihlr-18967	715	5	such	such	ADJ
ihlr-18967	715	6	creative	creative	ADJ
ihlr-18967	715	7	activities	activity	NOUN
ihlr-18967	715	8	deserve	deserve	VERB
ihlr-18967	715	9	rewards	reward	NOUN
ihlr-18967	715	10	commensurate	commensurate	ADJ
ihlr-18967	715	11	with	with	ADP
ihlr-18967	715	12	the	the	DET
ihlr-18967	715	13	services	service	NOUN
ihlr-18967	715	14	rendered.229	rendered.229	PROPN
ihlr-18967	715	15	actavis	actavis	PROPN
ihlr-18967	715	16	keeps	keep	VERB
ihlr-18967	715	17	this	this	DET
ihlr-18967	715	18	motivation	motivation	NOUN
ihlr-18967	715	19	for	for	ADP
ihlr-18967	715	20	pioneer	pioneer	NOUN
ihlr-18967	715	21	manufacturers	manufacturer	NOUN
ihlr-18967	715	22	alive	alive	ADJ
ihlr-18967	715	23	in	in	ADP
ihlr-18967	715	24	those	those	DET
ihlr-18967	715	25	settlements	settlement	NOUN
ihlr-18967	715	26	not	not	PART
ihlr-18967	715	27	designed	design	VERB
ihlr-18967	715	28	to	to	PART
ihlr-18967	715	29	create	create	VERB
ihlr-18967	715	30	anticompetitive	anticompetitive	ADJ
ihlr-18967	715	31	consequences	consequence	NOUN
ihlr-18967	715	32	.	.	PUNCT
ihlr-18967	716	1	if	if	SCONJ
ihlr-18967	716	2	congress	congress	PROPN
ihlr-18967	716	3	completely	completely	ADV
ihlr-18967	716	4	eliminates	eliminate	VERB
ihlr-18967	716	5	or	or	CCONJ
ihlr-18967	716	6	adversely	adversely	ADV
ihlr-18967	716	7	affects	affect	VERB
ihlr-18967	716	8	the	the	DET
ihlr-18967	716	9	ability	ability	NOUN
ihlr-18967	716	10	of	of	ADP
ihlr-18967	716	11	pioneer	pioneer	NOUN
ihlr-18967	716	12	and	and	CCONJ
ihlr-18967	716	13	generic	generic	ADJ
ihlr-18967	716	14	manufacturers	manufacturer	NOUN
ihlr-18967	716	15	from	from	ADP
ihlr-18967	716	16	entering	enter	VERB
ihlr-18967	716	17	into	into	ADP
ihlr-18967	716	18	such	such	ADJ
ihlr-18967	716	19	agreements	agreement	NOUN
ihlr-18967	716	20	,	,	PUNCT
ihlr-18967	716	21	pioneer	pioneer	NOUN
ihlr-18967	716	22	manufacturers	manufacturer	NOUN
ihlr-18967	716	23	would	would	AUX
ihlr-18967	716	24	be	be	AUX
ihlr-18967	716	25	less	less	ADV
ihlr-18967	716	26	willing	willing	ADJ
ihlr-18967	716	27	to	to	PART
ihlr-18967	716	28	invest	invest	VERB
ihlr-18967	716	29	billions	billion	NOUN
ihlr-18967	716	30	of	of	ADP
ihlr-18967	716	31	dollars	dollar	NOUN
ihlr-18967	716	32	into	into	ADP
ihlr-18967	716	33	a	a	DET
ihlr-18967	716	34	drug	drug	NOUN
ihlr-18967	716	35	because	because	SCONJ
ihlr-18967	716	36	it	it	PRON
ihlr-18967	716	37	would	would	AUX
ihlr-18967	716	38	have	have	VERB
ihlr-18967	716	39	a	a	DET
ihlr-18967	716	40	decreased	decrease	VERB
ihlr-18967	716	41	chance	chance	NOUN
ihlr-18967	716	42	of	of	ADP
ihlr-18967	716	43	protecting	protect	VERB
ihlr-18967	716	44	its	its	PRON
ihlr-18967	716	45	investment	investment	NOUN
ihlr-18967	716	46	.	.	PUNCT
ihlr-18967	717	1	while	while	SCONJ
ihlr-18967	717	2	consumers	consumer	NOUN
ihlr-18967	717	3	would	would	AUX
ihlr-18967	717	4	be	be	AUX
ihlr-18967	717	5	saving	save	VERB
ihlr-18967	717	6	money	money	NOUN
ihlr-18967	717	7	,	,	PUNCT
ihlr-18967	717	8	it	it	PRON
ihlr-18967	717	9	would	would	AUX
ihlr-18967	717	10	be	be	AUX
ihlr-18967	717	11	at	at	ADP
ihlr-18967	717	12	the	the	DET
ihlr-18967	717	13	expense	expense	NOUN
ihlr-18967	717	14	of	of	ADP
ihlr-18967	717	15	losing	lose	VERB
ihlr-18967	717	16	new	new	ADJ
ihlr-18967	717	17	drugs	drug	NOUN
ihlr-18967	717	18	which	which	PRON
ihlr-18967	717	19	may	may	AUX
ihlr-18967	717	20	improve	improve	VERB
ihlr-18967	717	21	health	health	NOUN
ihlr-18967	717	22	and	and	CCONJ
ihlr-18967	717	23	increase	increase	VERB
ihlr-18967	717	24	life	life	NOUN
ihlr-18967	717	25	expectancy.230	expectancy.230	VERB
ihlr-18967	717	26	consumer	consumer	NOUN
ihlr-18967	717	27	health	health	NOUN
ihlr-18967	717	28	and	and	CCONJ
ihlr-18967	717	29	welfare	welfare	NOUN
ihlr-18967	717	30	over	over	ADP
ihlr-18967	717	31	the	the	DET
ihlr-18967	717	32	long	long	ADJ
ihlr-18967	717	33	-	-	PUNCT
ihlr-18967	717	34	term	term	NOUN
ihlr-18967	717	35	is	be	AUX
ihlr-18967	717	36	more	more	ADV
ihlr-18967	717	37	important	important	ADJ
ihlr-18967	717	38	to	to	ADP
ihlr-18967	717	39	our	our	PRON
ihlr-18967	717	40	society	society	NOUN
ihlr-18967	717	41	as	as	ADP
ihlr-18967	717	42	a	a	DET
ihlr-18967	717	43	whole	whole	NOUN
ihlr-18967	717	44	than	than	ADP
ihlr-18967	717	45	short	short	ADJ
ihlr-18967	717	46	-	-	PUNCT
ihlr-18967	717	47	term	term	NOUN
ihlr-18967	717	48	economic	economic	ADJ
ihlr-18967	717	49	savings.231	savings.231	ADJ
ihlr-18967	717	50	as	as	SCONJ
ihlr-18967	717	51	judge	judge	PROPN
ihlr-18967	717	52	easterbrook	easterbrook	PROPN
ihlr-18967	717	53	said	say	VERB
ihlr-18967	717	54	,	,	PUNCT
ihlr-18967	717	55	“	"	PUNCT
ihlr-18967	717	56	[	[	X
ihlr-18967	717	57	a]n	a]n	ADJ
ihlr-18967	717	58	antitrust	antitrust	ADJ
ihlr-18967	717	59	policy	policy	NOUN
ihlr-18967	717	60	that	that	PRON
ihlr-18967	717	61	reduces	reduce	VERB
ihlr-18967	717	62	prices	price	NOUN
ihlr-18967	717	63	by	by	ADP
ihlr-18967	717	64	5	5	NUM
ihlr-18967	717	65	percent	percent	NOUN
ihlr-18967	717	66	today	today	NOUN
ihlr-18967	717	67	at	at	ADP
ihlr-18967	717	68	the	the	DET
ihlr-18967	717	69	expense	expense	NOUN
ihlr-18967	717	70	of	of	ADP
ihlr-18967	717	71	reducing	reduce	VERB
ihlr-18967	717	72	by	by	ADP
ihlr-18967	717	73	1	1	NUM
ihlr-18967	717	74	percent	percent	NOUN
ihlr-18967	717	75	the	the	DET
ihlr-18967	717	76	annual	annual	ADJ
ihlr-18967	717	77	rate	rate	NOUN
ihlr-18967	717	78	at	at	ADP
ihlr-18967	717	79	which	which	PRON
ihlr-18967	717	80	innovations	innovation	NOUN
ihlr-18967	717	81	lower	low	ADJ
ihlr-18967	717	82	the	the	DET
ihlr-18967	717	83	costs	cost	NOUN
ihlr-18967	717	84	of	of	ADP
ihlr-18967	717	85	patent	patent	NOUN
ihlr-18967	717	86	introduction	introduction	NOUN
ihlr-18967	717	87	would	would	AUX
ihlr-18967	717	88	be	be	AUX
ihlr-18967	717	89	a	a	DET
ihlr-18967	717	90	calamity	calamity	NOUN
ihlr-18967	717	91	.	.	PUNCT
ihlr-18967	718	1	in	in	ADP
ihlr-18967	718	2	the	the	DET
ihlr-18967	718	3	long	long	ADJ
ihlr-18967	718	4	run	run	NOUN
ihlr-18967	718	5	a	a	DET
ihlr-18967	718	6	continuous	continuous	ADJ
ihlr-18967	718	7	rate	rate	NOUN
ihlr-18967	718	8	of	of	ADP
ihlr-18967	718	9	change	change	NOUN
ihlr-18967	718	10	,	,	PUNCT
ihlr-18967	718	11	compounded	compound	VERB
ihlr-18967	718	12	,	,	PUNCT
ihlr-18967	718	13	swamps	swamps	PROPN
ihlr-18967	718	14	static	static	VERB
ihlr-18967	718	15	228	228	NUM
ihlr-18967	718	16	u.s	u.s	PROPN
ihlr-18967	718	17	.	.	PROPN
ihlr-18967	718	18	const	const	PROPN
ihlr-18967	718	19	.	.	PUNCT
ihlr-18967	719	1	art	art	NOUN
ihlr-18967	719	2	i	i	PROPN
ihlr-18967	719	3	,	,	PUNCT
ihlr-18967	719	4	§	§	PROPN
ihlr-18967	719	5	8	8	NUM
ihlr-18967	719	6	,	,	PUNCT
ihlr-18967	719	7	cl	cl	NOUN
ihlr-18967	719	8	.	.	NOUN
ihlr-18967	719	9	8	8	NUM
ihlr-18967	719	10	(	(	PUNCT
ihlr-18967	719	11	“	"	PUNCT
ihlr-18967	719	12	to	to	PART
ihlr-18967	719	13	promote	promote	VERB
ihlr-18967	719	14	the	the	DET
ihlr-18967	719	15	progress	progress	NOUN
ihlr-18967	719	16	of	of	ADP
ihlr-18967	719	17	science	science	NOUN
ihlr-18967	719	18	and	and	CCONJ
ihlr-18967	719	19	useful	useful	ADJ
ihlr-18967	719	20	arts	art	NOUN
ihlr-18967	719	21	,	,	PUNCT
ihlr-18967	719	22	by	by	ADP
ihlr-18967	719	23	securing	secure	VERB
ihlr-18967	719	24	for	for	ADP
ihlr-18967	719	25	limited	limited	ADJ
ihlr-18967	719	26	times	time	NOUN
ihlr-18967	719	27	to	to	ADP
ihlr-18967	719	28	authors	author	NOUN
ihlr-18967	719	29	and	and	CCONJ
ihlr-18967	719	30	inventors	inventor	NOUN
ihlr-18967	719	31	the	the	DET
ihlr-18967	719	32	exclusive	exclusive	ADJ
ihlr-18967	719	33	right	right	NOUN
ihlr-18967	719	34	to	to	ADP
ihlr-18967	719	35	their	their	PRON
ihlr-18967	719	36	respective	respective	ADJ
ihlr-18967	719	37	writings	writing	NOUN
ihlr-18967	719	38	and	and	CCONJ
ihlr-18967	719	39	discoveries	discovery	NOUN
ihlr-18967	719	40	.	.	PUNCT
ihlr-18967	719	41	”	"	PUNCT
ihlr-18967	719	42	)	)	PUNCT
ihlr-18967	719	43	.	.	PUNCT
ihlr-18967	720	1	229	229	NUM
ihlr-18967	720	2	mazer	mazer	PROPN
ihlr-18967	720	3	v.	v.	PROPN
ihlr-18967	720	4	stein	stein	PROPN
ihlr-18967	720	5	,	,	PUNCT
ihlr-18967	720	6	347	347	NUM
ihlr-18967	720	7	u.s	u.s	PROPN
ihlr-18967	720	8	.	.	PROPN
ihlr-18967	720	9	201	201	NUM
ihlr-18967	720	10	,	,	PUNCT
ihlr-18967	720	11	219	219	NUM
ihlr-18967	720	12	(	(	PUNCT
ihlr-18967	720	13	1954	1954	NUM
ihlr-18967	720	14	)	)	PUNCT
ihlr-18967	720	15	(	(	PUNCT
ihlr-18967	720	16	emphasis	emphasis	NOUN
ihlr-18967	720	17	added	add	VERB
ihlr-18967	720	18	)	)	PUNCT
ihlr-18967	720	19	.	.	PUNCT
ihlr-18967	721	1	230	230	NUM
ihlr-18967	721	2	see	see	VERB
ihlr-18967	721	3	paul	paul	PROPN
ihlr-18967	721	4	grootendorst	grootendorst	PROPN
ihlr-18967	721	5	et	et	PROPN
ihlr-18967	721	6	al	al	PROPN
ihlr-18967	721	7	.	.	PROPN
ihlr-18967	721	8	,	,	PUNCT
ihlr-18967	721	9	the	the	DET
ihlr-18967	721	10	life	life	NOUN
ihlr-18967	721	11	expectancy	expectancy	NOUN
ihlr-18967	721	12	gain	gain	NOUN
ihlr-18967	721	13	from	from	ADP
ihlr-18967	721	14	pharmaceutical	pharmaceutical	ADJ
ihlr-18967	721	15	drugs	drug	NOUN
ihlr-18967	721	16	:	:	PUNCT
ihlr-18967	721	17	a	a	DET
ihlr-18967	721	18	critical	critical	ADJ
ihlr-18967	721	19	appraisal	appraisal	NOUN
ihlr-18967	721	20	of	of	ADP
ihlr-18967	721	21	the	the	DET
ihlr-18967	721	22	literature	literature	NOUN
ihlr-18967	721	23	11	11	NUM
ihlr-18967	721	24	(	(	PUNCT
ihlr-18967	721	25	2007	2007	NUM
ihlr-18967	721	26	)	)	PUNCT
ihlr-18967	721	27	(	(	PUNCT
ihlr-18967	721	28	discussing	discuss	VERB
ihlr-18967	721	29	how	how	SCONJ
ihlr-18967	721	30	pharmaceutical	pharmaceutical	ADJ
ihlr-18967	721	31	drugs	drug	NOUN
ihlr-18967	721	32	have	have	AUX
ihlr-18967	721	33	contributed	contribute	VERB
ihlr-18967	721	34	to	to	ADP
ihlr-18967	721	35	increased	increase	VERB
ihlr-18967	721	36	life	life	NOUN
ihlr-18967	721	37	expectancy	expectancy	NOUN
ihlr-18967	721	38	over	over	ADP
ihlr-18967	721	39	the	the	DET
ihlr-18967	721	40	past	past	ADJ
ihlr-18967	721	41	50	50	NUM
ihlr-18967	721	42	years	year	NOUN
ihlr-18967	721	43	)	)	PUNCT
ihlr-18967	721	44	.	.	PUNCT
ihlr-18967	722	1	231	231	NUM
ihlr-18967	722	2	orszag	orszag	NOUN
ihlr-18967	722	3	testimony	testimony	NOUN
ihlr-18967	722	4	,	,	PUNCT
ihlr-18967	722	5	supra	supra	PROPN
ihlr-18967	722	6	note	note	NOUN
ihlr-18967	722	7	225	225	NUM
ihlr-18967	722	8	.	.	SYM
ihlr-18967	722	9	2015	2015	NUM
ihlr-18967	722	10	rationale	rationale	NOUN
ihlr-18967	722	11	behind	behind	ADP
ihlr-18967	722	12	hatch	hatch	NOUN
ihlr-18967	722	13	-	-	PUNCT
ihlr-18967	722	14	waxman	waxman	PROPN
ihlr-18967	722	15	act	act	PROPN
ihlr-18967	722	16	and	and	CCONJ
ihlr-18967	722	17	patent	patent	NOUN
ihlr-18967	722	18	law	law	NOUN
ihlr-18967	722	19	467	467	NUM
ihlr-18967	722	20	losses	loss	NOUN
ihlr-18967	722	21	.	.	PUNCT
ihlr-18967	723	1	”232	”232	PROPN
ihlr-18967	723	2	also	also	ADV
ihlr-18967	723	3	,	,	PUNCT
ihlr-18967	723	4	some	some	PRON
ihlr-18967	723	5	of	of	ADP
ihlr-18967	723	6	the	the	DET
ihlr-18967	723	7	brightest	bright	ADJ
ihlr-18967	723	8	scientists	scientist	NOUN
ihlr-18967	723	9	and	and	CCONJ
ihlr-18967	723	10	innovative	innovative	ADJ
ihlr-18967	723	11	corporations	corporation	NOUN
ihlr-18967	723	12	may	may	AUX
ihlr-18967	723	13	not	not	PART
ihlr-18967	723	14	work	work	VERB
ihlr-18967	723	15	in	in	ADP
ihlr-18967	723	16	or	or	CCONJ
ihlr-18967	723	17	invest	invest	VERB
ihlr-18967	723	18	in	in	ADP
ihlr-18967	723	19	pharmaceutical	pharmaceutical	ADJ
ihlr-18967	723	20	drugs	drug	NOUN
ihlr-18967	723	21	,	,	PUNCT
ihlr-18967	723	22	a	a	DET
ihlr-18967	723	23	consequence	consequence	NOUN
ihlr-18967	723	24	which	which	PRON
ihlr-18967	723	25	the	the	DET
ihlr-18967	723	26	constitution	constitution	NOUN
ihlr-18967	723	27	and	and	CCONJ
ihlr-18967	723	28	patent	patent	NOUN
ihlr-18967	723	29	law	law	NOUN
ihlr-18967	723	30	seek	seek	VERB
ihlr-18967	723	31	to	to	PART
ihlr-18967	723	32	avoid	avoid	VERB
ihlr-18967	723	33	.	.	PUNCT
ihlr-18967	724	1	additionally	additionally	ADV
ihlr-18967	724	2	,	,	PUNCT
ihlr-18967	724	3	the	the	DET
ihlr-18967	724	4	hatch	hatch	NOUN
ihlr-18967	724	5	-	-	PUNCT
ihlr-18967	724	6	waxman	waxman	PROPN
ihlr-18967	724	7	act	act	NOUN
ihlr-18967	724	8	attempts	attempt	VERB
ihlr-18967	724	9	to	to	PART
ihlr-18967	724	10	“	"	PUNCT
ihlr-18967	724	11	‘	'	PUNCT
ihlr-18967	724	12	strike	strike	VERB
ihlr-18967	724	13	a	a	DET
ihlr-18967	724	14	balance	balance	NOUN
ihlr-18967	724	15	between	between	ADP
ihlr-18967	724	16	two	two	NUM
ihlr-18967	724	17	competing	compete	VERB
ihlr-18967	724	18	policy	policy	NOUN
ihlr-18967	724	19	interests	interest	NOUN
ihlr-18967	724	20	:	:	PUNCT
ihlr-18967	724	21	(	(	PUNCT
ihlr-18967	724	22	1	1	X
ihlr-18967	724	23	)	)	PUNCT
ihlr-18967	724	24	inducing	induce	VERB
ihlr-18967	724	25	pioneering	pioneer	VERB
ihlr-18967	724	26	research	research	NOUN
ihlr-18967	724	27	and	and	CCONJ
ihlr-18967	724	28	development	development	NOUN
ihlr-18967	724	29	of	of	ADP
ihlr-18967	724	30	new	new	ADJ
ihlr-18967	724	31	drugs	drug	NOUN
ihlr-18967	724	32	and	and	CCONJ
ihlr-18967	724	33	(	(	PUNCT
ihlr-18967	724	34	2	2	X
ihlr-18967	724	35	)	)	PUNCT
ihlr-18967	724	36	enabling	enable	VERB
ihlr-18967	724	37	competitors	competitor	NOUN
ihlr-18967	724	38	to	to	PART
ihlr-18967	724	39	bring	bring	VERB
ihlr-18967	724	40	low	low	ADJ
ihlr-18967	724	41	-	-	PUNCT
ihlr-18967	724	42	cost	cost	NOUN
ihlr-18967	724	43	,	,	PUNCT
ihlr-18967	724	44	generic	generic	ADJ
ihlr-18967	724	45	copies	copy	NOUN
ihlr-18967	724	46	of	of	ADP
ihlr-18967	724	47	those	those	DET
ihlr-18967	724	48	drugs	drug	NOUN
ihlr-18967	724	49	to	to	ADP
ihlr-18967	724	50	market	market	NOUN
ihlr-18967	724	51	.	.	PUNCT
ihlr-18967	725	1	’”233	’”233	PROPN
ihlr-18967	725	2	in	in	ADP
ihlr-18967	725	3	reality	reality	NOUN
ihlr-18967	725	4	,	,	PUNCT
ihlr-18967	725	5	legislation	legislation	NOUN
ihlr-18967	725	6	which	which	PRON
ihlr-18967	725	7	in	in	ADP
ihlr-18967	725	8	effect	effect	NOUN
ihlr-18967	725	9	works	work	VERB
ihlr-18967	725	10	to	to	PART
ihlr-18967	725	11	prohibit	prohibit	VERB
ihlr-18967	725	12	reverse	reverse	ADJ
ihlr-18967	725	13	payment	payment	NOUN
ihlr-18967	725	14	settlements	settlement	NOUN
ihlr-18967	725	15	will	will	AUX
ihlr-18967	725	16	contradict	contradict	VERB
ihlr-18967	725	17	the	the	DET
ihlr-18967	725	18	first	first	ADJ
ihlr-18967	725	19	policy	policy	NOUN
ihlr-18967	725	20	interest	interest	NOUN
ihlr-18967	725	21	behind	behind	ADP
ihlr-18967	725	22	the	the	DET
ihlr-18967	725	23	hatch	hatch	NOUN
ihlr-18967	725	24	-	-	PUNCT
ihlr-18967	725	25	waxman	waxman	PROPN
ihlr-18967	725	26	act	act	PROPN
ihlr-18967	725	27	.	.	PUNCT
ihlr-18967	726	1	further	further	ADJ
ihlr-18967	726	2	prohibition	prohibition	NOUN
ihlr-18967	726	3	“	"	PUNCT
ihlr-18967	726	4	would	would	AUX
ihlr-18967	726	5	narrow	narrow	VERB
ihlr-18967	726	6	the	the	DET
ihlr-18967	726	7	patent	patent	NOUN
ihlr-18967	726	8	protection	protection	NOUN
ihlr-18967	726	9	provided	provide	VERB
ihlr-18967	726	10	to	to	ADP
ihlr-18967	726	11	branded	brand	VERB
ihlr-18967	726	12	manufacturers	manufacturer	NOUN
ihlr-18967	726	13	and	and	CCONJ
ihlr-18967	726	14	,	,	PUNCT
ihlr-18967	726	15	on	on	ADP
ihlr-18967	726	16	the	the	DET
ihlr-18967	726	17	margin	margin	NOUN
ihlr-18967	726	18	,	,	PUNCT
ihlr-18967	726	19	reduce	reduce	VERB
ihlr-18967	726	20	incentives	incentive	NOUN
ihlr-18967	726	21	to	to	PART
ihlr-18967	726	22	invest	invest	VERB
ihlr-18967	726	23	in	in	ADP
ihlr-18967	726	24	new	new	ADJ
ihlr-18967	726	25	medicines	medicine	NOUN
ihlr-18967	726	26	in	in	ADP
ihlr-18967	726	27	the	the	DET
ihlr-18967	726	28	future	future	NOUN
ihlr-18967	726	29	.	.	PUNCT
ihlr-18967	727	1	”234	”234	VERB
ihlr-18967	727	2	the	the	DET
ihlr-18967	727	3	second	second	ADJ
ihlr-18967	727	4	policy	policy	NOUN
ihlr-18967	727	5	interest	interest	NOUN
ihlr-18967	727	6	,	,	PUNCT
ihlr-18967	727	7	bringing	bring	VERB
ihlr-18967	727	8	low	low	ADJ
ihlr-18967	727	9	-	-	PUNCT
ihlr-18967	727	10	cost	cost	NOUN
ihlr-18967	727	11	drugs	drug	NOUN
ihlr-18967	727	12	to	to	ADP
ihlr-18967	727	13	the	the	DET
ihlr-18967	727	14	market	market	NOUN
ihlr-18967	727	15	for	for	ADP
ihlr-18967	727	16	consumers	consumer	NOUN
ihlr-18967	727	17	,	,	PUNCT
ihlr-18967	727	18	was	be	AUX
ihlr-18967	727	19	based	base	VERB
ihlr-18967	727	20	in	in	ADP
ihlr-18967	727	21	the	the	DET
ihlr-18967	727	22	context	context	NOUN
ihlr-18967	727	23	that	that	SCONJ
ihlr-18967	727	24	procedures	procedure	NOUN
ihlr-18967	727	25	for	for	ADP
ihlr-18967	727	26	filing	file	VERB
ihlr-18967	727	27	a	a	DET
ihlr-18967	727	28	nda	nda	NOUN
ihlr-18967	727	29	under	under	ADP
ihlr-18967	727	30	the	the	DET
ihlr-18967	727	31	fdca	fdca	NOUN
ihlr-18967	727	32	needed	need	VERB
ihlr-18967	727	33	to	to	PART
ihlr-18967	727	34	be	be	AUX
ihlr-18967	727	35	revised235	revised235	PROPN
ihlr-18967	727	36	because	because	SCONJ
ihlr-18967	727	37	generic	generic	ADJ
ihlr-18967	727	38	companies	company	NOUN
ihlr-18967	727	39	would	would	AUX
ihlr-18967	727	40	not	not	PART
ihlr-18967	727	41	spend	spend	VERB
ihlr-18967	727	42	time	time	NOUN
ihlr-18967	727	43	or	or	CCONJ
ihlr-18967	727	44	money	money	NOUN
ihlr-18967	727	45	to	to	PART
ihlr-18967	727	46	complete	complete	VERB
ihlr-18967	727	47	the	the	DET
ihlr-18967	727	48	required	require	VERB
ihlr-18967	727	49	clinical	clinical	NOUN
ihlr-18967	727	50	trials.236	trials.236	VERB
ihlr-18967	727	51	nothing	nothing	PRON
ihlr-18967	727	52	in	in	ADP
ihlr-18967	727	53	reverse	reverse	ADJ
ihlr-18967	727	54	payment	payment	NOUN
ihlr-18967	727	55	settlements	settlement	NOUN
ihlr-18967	727	56	adversely	adversely	ADV
ihlr-18967	727	57	affects	affect	VERB
ihlr-18967	727	58	this	this	DET
ihlr-18967	727	59	intent	intent	NOUN
ihlr-18967	727	60	to	to	PART
ihlr-18967	727	61	have	have	AUX
ihlr-18967	727	62	more	more	ADJ
ihlr-18967	727	63	generic	generic	ADJ
ihlr-18967	727	64	drugs	drug	NOUN
ihlr-18967	727	65	in	in	ADP
ihlr-18967	727	66	the	the	DET
ihlr-18967	727	67	market	market	NOUN
ihlr-18967	727	68	by	by	ADP
ihlr-18967	727	69	revising	revise	VERB
ihlr-18967	727	70	procedures	procedure	NOUN
ihlr-18967	727	71	for	for	ADP
ihlr-18967	727	72	filing	file	VERB
ihlr-18967	727	73	a	a	DET
ihlr-18967	727	74	nda	nda	NOUN
ihlr-18967	727	75	.	.	PUNCT
ihlr-18967	728	1	an	an	DET
ihlr-18967	728	2	outright	outright	ADJ
ihlr-18967	728	3	ban	ban	NOUN
ihlr-18967	728	4	on	on	ADP
ihlr-18967	728	5	reverse	reverse	ADJ
ihlr-18967	728	6	payment	payment	NOUN
ihlr-18967	728	7	settlements	settlement	NOUN
ihlr-18967	728	8	would	would	AUX
ihlr-18967	728	9	actually	actually	ADV
ihlr-18967	728	10	increase	increase	VERB
ihlr-18967	728	11	the	the	DET
ihlr-18967	728	12	time	time	NOUN
ihlr-18967	728	13	it	it	PRON
ihlr-18967	728	14	takes	take	VERB
ihlr-18967	728	15	for	for	ADP
ihlr-18967	728	16	low	low	ADJ
ihlr-18967	728	17	-	-	PUNCT
ihlr-18967	728	18	cost	cost	NOUN
ihlr-18967	728	19	drugs	drug	NOUN
ihlr-18967	728	20	to	to	PART
ihlr-18967	728	21	reach	reach	VERB
ihlr-18967	728	22	consumers	consumer	NOUN
ihlr-18967	728	23	.	.	PUNCT
ihlr-18967	729	1	without	without	ADP
ihlr-18967	729	2	the	the	DET
ihlr-18967	729	3	availability	availability	NOUN
ihlr-18967	729	4	of	of	ADP
ihlr-18967	729	5	settlements	settlement	NOUN
ihlr-18967	729	6	,	,	PUNCT
ihlr-18967	729	7	pioneer	pioneer	NOUN
ihlr-18967	729	8	and	and	CCONJ
ihlr-18967	729	9	generic	generic	ADJ
ihlr-18967	729	10	manufacturers	manufacturer	NOUN
ihlr-18967	729	11	will	will	AUX
ihlr-18967	729	12	be	be	AUX
ihlr-18967	729	13	forced	force	VERB
ihlr-18967	729	14	to	to	PART
ihlr-18967	729	15	litigate	litigate	VERB
ihlr-18967	729	16	matters	matter	NOUN
ihlr-18967	729	17	on	on	ADP
ihlr-18967	729	18	the	the	DET
ihlr-18967	729	19	merits	merit	NOUN
ihlr-18967	729	20	and	and	CCONJ
ihlr-18967	729	21	then	then	ADV
ihlr-18967	729	22	wait	wait	VERB
ihlr-18967	729	23	for	for	ADP
ihlr-18967	729	24	the	the	DET
ihlr-18967	729	25	results	result	NOUN
ihlr-18967	729	26	of	of	ADP
ihlr-18967	729	27	any	any	DET
ihlr-18967	729	28	appeals	appeal	NOUN
ihlr-18967	729	29	.	.	PUNCT
ihlr-18967	730	1	for	for	ADP
ihlr-18967	730	2	example	example	NOUN
ihlr-18967	730	3	,	,	PUNCT
ihlr-18967	730	4	the	the	DET
ihlr-18967	730	5	fda	fda	PROPN
ihlr-18967	730	6	blocked	block	VERB
ihlr-18967	730	7	a	a	DET
ihlr-18967	730	8	reverse	reverse	ADJ
ihlr-18967	730	9	payment	payment	NOUN
ihlr-18967	730	10	settlement	settlement	NOUN
ihlr-18967	730	11	232	232	NUM
ihlr-18967	731	1	i	i	PRON
ihlr-18967	731	2	d.	d.	PROPN
ihlr-18967	731	3	(	(	PUNCT
ihlr-18967	731	4	quoting	quote	VERB
ihlr-18967	731	5	frank	frank	PROPN
ihlr-18967	731	6	h.	h.	PROPN
ihlr-18967	731	7	easterbrook	easterbrook	PROPN
ihlr-18967	731	8	,	,	PUNCT
ihlr-18967	731	9	ignorance	ignorance	NOUN
ihlr-18967	731	10	and	and	CCONJ
ihlr-18967	731	11	antitrust	antitrust	ADJ
ihlr-18967	731	12	,	,	PUNCT
ihlr-18967	731	13	in	in	ADP
ihlr-18967	731	14	antitrust	antitrust	ADJ
ihlr-18967	731	15	,	,	PUNCT
ihlr-18967	731	16	innovation	innovation	NOUN
ihlr-18967	731	17	and	and	CCONJ
ihlr-18967	731	18	competitiveness	competitiveness	NOUN
ihlr-18967	731	19	122	122	NUM
ihlr-18967	731	20	-	-	SYM
ihlr-18967	731	21	23	23	NUM
ihlr-18967	731	22	(	(	PUNCT
ihlr-18967	731	23	thomas	thomas	PROPN
ihlr-18967	731	24	m.	m.	PROPN
ihlr-18967	731	25	jorde	jorde	PROPN
ihlr-18967	731	26	&	&	CCONJ
ihlr-18967	731	27	david	david	PROPN
ihlr-18967	731	28	j.	j.	PROPN
ihlr-18967	731	29	teece	teece	PROPN
ihlr-18967	731	30	eds	eds	PROPN
ihlr-18967	731	31	.	.	PROPN
ihlr-18967	731	32	,	,	PUNCT
ihlr-18967	731	33	1992	1992	NUM
ihlr-18967	731	34	)	)	PUNCT
ihlr-18967	731	35	)	)	PUNCT
ihlr-18967	731	36	.	.	PUNCT
ihlr-18967	732	1	233	233	NUM
ihlr-18967	732	2	caraco	caraco	PROPN
ihlr-18967	732	3	pharm	pharm	NOUN
ihlr-18967	732	4	.	.	PUNCT
ihlr-18967	733	1	labs	labs	PROPN
ihlr-18967	733	2	.	.	PUNCT
ihlr-18967	733	3	,	,	PUNCT
ihlr-18967	733	4	ltd	ltd	PROPN
ihlr-18967	733	5	.	.	PROPN
ihlr-18967	733	6	v.	v.	ADP
ihlr-18967	733	7	forest	forest	PROPN
ihlr-18967	733	8	labs	labs	PROPN
ihlr-18967	733	9	.	.	PUNCT
ihlr-18967	733	10	,	,	PUNCT
ihlr-18967	733	11	inc	inc	PROPN
ihlr-18967	733	12	.	.	PROPN
ihlr-18967	733	13	527	527	NUM
ihlr-18967	733	14	f.3d	f.3d	NUM
ihlr-18967	733	15	1278	1278	NUM
ihlr-18967	733	16	,	,	PUNCT
ihlr-18967	733	17	1282	1282	NUM
ihlr-18967	733	18	(	(	PUNCT
ihlr-18967	733	19	fed	fed	PROPN
ihlr-18967	733	20	.	.	PUNCT
ihlr-18967	733	21	cir	cir	PROPN
ihlr-18967	733	22	.	.	PROPN
ihlr-18967	733	23	2008	2008	NUM
ihlr-18967	733	24	)	)	PUNCT
ihlr-18967	734	1	(	(	PUNCT
ihlr-18967	734	2	quoting	quote	VERB
ihlr-18967	734	3	andrx	andrx	NOUN
ihlr-18967	734	4	pharms	pharm	NOUN
ihlr-18967	734	5	.	.	PUNCT
ihlr-18967	734	6	,	,	PUNCT
ihlr-18967	734	7	inc	inc	PROPN
ihlr-18967	734	8	.	.	PROPN
ihlr-18967	734	9	v.	v.	PROPN
ihlr-18967	734	10	biovail	biovail	PROPN
ihlr-18967	734	11	corp	corp	PROPN
ihlr-18967	734	12	.	.	PROPN
ihlr-18967	734	13	,	,	PUNCT
ihlr-18967	734	14	276	276	NUM
ihlr-18967	734	15	f.3d	f.3d	NUM
ihlr-18967	734	16	1368	1368	NUM
ihlr-18967	734	17	,	,	PUNCT
ihlr-18967	734	18	1371	1371	NUM
ihlr-18967	735	1	(	(	PUNCT
ihlr-18967	735	2	fed	fed	PROPN
ihlr-18967	735	3	.	.	PUNCT
ihlr-18967	735	4	cir	cir	PROPN
ihlr-18967	735	5	.	.	PROPN
ihlr-18967	735	6	2002	2002	NUM
ihlr-18967	735	7	)	)	PUNCT
ihlr-18967	735	8	)	)	PUNCT
ihlr-18967	735	9	.	.	PUNCT
ihlr-18967	736	1	234	234	NUM
ihlr-18967	736	2	orszag	orszag	NOUN
ihlr-18967	736	3	testimony	testimony	NOUN
ihlr-18967	736	4	,	,	PUNCT
ihlr-18967	736	5	supra	supra	PROPN
ihlr-18967	736	6	note	note	NOUN
ihlr-18967	736	7	225	225	NUM
ihlr-18967	736	8	.	.	SYM
ihlr-18967	736	9	235	235	NUM
ihlr-18967	736	10	drug	drug	NOUN
ihlr-18967	736	11	price	price	NOUN
ihlr-18967	736	12	competition	competition	NOUN
ihlr-18967	736	13	and	and	CCONJ
ihlr-18967	736	14	patent	patent	NOUN
ihlr-18967	736	15	term	term	NOUN
ihlr-18967	736	16	restoration	restoration	NOUN
ihlr-18967	736	17	act	act	NOUN
ihlr-18967	736	18	of	of	ADP
ihlr-18967	736	19	1984	1984	NUM
ihlr-18967	736	20	,	,	PUNCT
ihlr-18967	736	21	pub	pub	NOUN
ihlr-18967	736	22	.	.	PUNCT
ihlr-18967	737	1	l.	l.	PROPN
ihlr-18967	737	2	no	no	INTJ
ihlr-18967	737	3	.	.	PROPN
ihlr-18967	738	1	98	98	NUM
ihlr-18967	738	2	-	-	SYM
ihlr-18967	738	3	417	417	NUM
ihlr-18967	738	4	,	,	PUNCT
ihlr-18967	738	5	98	98	NUM
ihlr-18967	738	6	stat	stat	NOUN
ihlr-18967	738	7	.	.	PUNCT
ihlr-18967	739	1	1585	1585	NUM
ihlr-18967	739	2	(	(	PUNCT
ihlr-18967	739	3	1984	1984	NUM
ihlr-18967	739	4	)	)	PUNCT
ihlr-18967	739	5	.	.	PUNCT
ihlr-18967	740	1	236	236	NUM
ihlr-18967	740	2	mossinghoff	mossinghoff	NOUN
ihlr-18967	740	3	,	,	PUNCT
ihlr-18967	740	4	supra	supra	PROPN
ihlr-18967	740	5	note	note	NOUN
ihlr-18967	740	6	20	20	NUM
ihlr-18967	740	7	(	(	PUNCT
ihlr-18967	740	8	citing	cite	VERB
ihlr-18967	740	9	h.r	h.r	PROPN
ihlr-18967	740	10	.	.	PROPN
ihlr-18967	740	11	rep	rep	PROPN
ihlr-18967	740	12	.	.	PROPN
ihlr-18967	740	13	no	no	INTJ
ihlr-18967	740	14	.	.	NOUN
ihlr-18967	740	15	98	98	NUM
ihlr-18967	740	16	-	-	SYM
ihlr-18967	740	17	857	857	NUM
ihlr-18967	740	18	,	,	PUNCT
ihlr-18967	740	19	pt	pt	X
ihlr-18967	740	20	.	.	PROPN
ihlr-18967	740	21	1	1	NUM
ihlr-18967	740	22	(	(	PUNCT
ihlr-18967	740	23	1984	1984	NUM
ihlr-18967	740	24	)	)	PUNCT
ihlr-18967	740	25	)	)	PUNCT
ihlr-18967	740	26	.	.	PUNCT
ihlr-18967	741	1	468	468	NUM
ihlr-18967	741	2	indiana	indiana	PROPN
ihlr-18967	741	3	health	health	PROPN
ihlr-18967	741	4	law	law	PROPN
ihlr-18967	741	5	review	review	NOUN
ihlr-18967	741	6	vol	vol	NOUN
ihlr-18967	741	7	.	.	PUNCT
ihlr-18967	742	1	12:1	12:1	NUM
ihlr-18967	742	2	involving	involve	VERB
ihlr-18967	742	3	the	the	DET
ihlr-18967	742	4	drug	drug	NOUN
ihlr-18967	742	5	plavix237	plavix237	PROPN
ihlr-18967	742	6	which	which	PRON
ihlr-18967	742	7	would	would	AUX
ihlr-18967	742	8	have	have	AUX
ihlr-18967	742	9	allowed	allow	VERB
ihlr-18967	742	10	the	the	DET
ihlr-18967	742	11	generic	generic	ADJ
ihlr-18967	742	12	drug	drug	NOUN
ihlr-18967	742	13	to	to	PART
ihlr-18967	742	14	reach	reach	VERB
ihlr-18967	742	15	consumers	consumer	NOUN
ihlr-18967	742	16	10.5	10.5	NUM
ihlr-18967	742	17	months	month	NOUN
ihlr-18967	742	18	earlier	early	ADV
ihlr-18967	742	19	than	than	SCONJ
ihlr-18967	742	20	it	it	PRON
ihlr-18967	742	21	actually	actually	ADV
ihlr-18967	742	22	did.238	did.238	VERB
ihlr-18967	742	23	analogous	analogous	ADJ
ihlr-18967	742	24	to	to	ADP
ihlr-18967	742	25	the	the	DET
ihlr-18967	742	26	hatch	hatch	NOUN
ihlr-18967	742	27	-	-	PUNCT
ihlr-18967	742	28	waxman	waxman	PROPN
ihlr-18967	742	29	act	act	PROPN
ihlr-18967	742	30	,	,	PUNCT
ihlr-18967	742	31	the	the	DET
ihlr-18967	742	32	rule	rule	NOUN
ihlr-18967	742	33	of	of	ADP
ihlr-18967	742	34	reason	reason	NOUN
ihlr-18967	742	35	,	,	PUNCT
ihlr-18967	742	36	as	as	SCONJ
ihlr-18967	742	37	outlined	outline	VERB
ihlr-18967	742	38	in	in	ADP
ihlr-18967	742	39	actavis	actavi	NOUN
ihlr-18967	742	40	,	,	PUNCT
ihlr-18967	742	41	strikes	strike	VERB
ihlr-18967	742	42	a	a	DET
ihlr-18967	742	43	balance	balance	NOUN
ihlr-18967	742	44	between	between	ADP
ihlr-18967	742	45	protecting	protect	VERB
ihlr-18967	742	46	manufacturers	manufacturer	NOUN
ihlr-18967	742	47	rights	right	NOUN
ihlr-18967	742	48	while	while	SCONJ
ihlr-18967	742	49	allowing	allow	VERB
ihlr-18967	742	50	generic	generic	ADJ
ihlr-18967	742	51	drugs	drug	NOUN
ihlr-18967	742	52	to	to	PART
ihlr-18967	742	53	be	be	AUX
ihlr-18967	742	54	brought	bring	VERB
ihlr-18967	742	55	to	to	ADP
ihlr-18967	742	56	the	the	DET
ihlr-18967	742	57	market	market	NOUN
ihlr-18967	742	58	.	.	PUNCT
ihlr-18967	743	1	for	for	ADP
ihlr-18967	743	2	instance	instance	NOUN
ihlr-18967	743	3	,	,	PUNCT
ihlr-18967	743	4	by	by	ADP
ihlr-18967	743	5	subjecting	subject	VERB
ihlr-18967	743	6	reverse	reverse	ADJ
ihlr-18967	743	7	payment	payment	NOUN
ihlr-18967	743	8	settlements	settlement	NOUN
ihlr-18967	743	9	to	to	ADP
ihlr-18967	743	10	the	the	DET
ihlr-18967	743	11	rule	rule	NOUN
ihlr-18967	743	12	of	of	ADP
ihlr-18967	743	13	reason	reason	NOUN
ihlr-18967	743	14	,	,	PUNCT
ihlr-18967	743	15	settlements	settlement	NOUN
ihlr-18967	743	16	which	which	PRON
ihlr-18967	743	17	are	be	AUX
ihlr-18967	743	18	not	not	PART
ihlr-18967	743	19	intended	intend	VERB
ihlr-18967	743	20	to	to	PART
ihlr-18967	743	21	prevent	prevent	VERB
ihlr-18967	743	22	low	low	ADJ
ihlr-18967	743	23	-	-	PUNCT
ihlr-18967	743	24	cost	cost	NOUN
ihlr-18967	743	25	generic	generic	ADJ
ihlr-18967	743	26	drugs	drug	NOUN
ihlr-18967	743	27	from	from	ADP
ihlr-18967	743	28	reaching	reach	VERB
ihlr-18967	743	29	the	the	DET
ihlr-18967	743	30	market	market	NOUN
ihlr-18967	743	31	will	will	AUX
ihlr-18967	743	32	receive	receive	VERB
ihlr-18967	743	33	the	the	DET
ihlr-18967	743	34	protections	protection	NOUN
ihlr-18967	743	35	afforded	afford	VERB
ihlr-18967	743	36	under	under	ADP
ihlr-18967	743	37	patent	patent	NOUN
ihlr-18967	743	38	law	law	NOUN
ihlr-18967	743	39	and	and	CCONJ
ihlr-18967	743	40	those	those	PRON
ihlr-18967	743	41	having	have	VERB
ihlr-18967	743	42	anticompetitive	anticompetitive	ADJ
ihlr-18967	743	43	effects	effect	NOUN
ihlr-18967	743	44	will	will	AUX
ihlr-18967	743	45	be	be	AUX
ihlr-18967	743	46	struck	strike	VERB
ihlr-18967	743	47	down	down	ADP
ihlr-18967	743	48	.	.	PUNCT
ihlr-18967	744	1	as	as	ADP
ihlr-18967	744	2	a	a	DET
ihlr-18967	744	3	result	result	NOUN
ihlr-18967	744	4	,	,	PUNCT
ihlr-18967	744	5	consumers	consumer	NOUN
ihlr-18967	744	6	will	will	AUX
ihlr-18967	744	7	no	no	ADV
ihlr-18967	744	8	longer	long	ADV
ihlr-18967	744	9	be	be	AUX
ihlr-18967	744	10	burdened	burden	VERB
ihlr-18967	744	11	with	with	ADP
ihlr-18967	744	12	the	the	DET
ihlr-18967	744	13	effects	effect	NOUN
ihlr-18967	744	14	from	from	ADP
ihlr-18967	744	15	anticompetitive	anticompetitive	ADJ
ihlr-18967	744	16	settlements	settlement	NOUN
ihlr-18967	744	17	.	.	PUNCT
ihlr-18967	745	1	analyzing	analyze	VERB
ihlr-18967	745	2	reverse	reverse	ADJ
ihlr-18967	745	3	payment	payment	NOUN
ihlr-18967	745	4	settlements	settlement	NOUN
ihlr-18967	745	5	under	under	ADP
ihlr-18967	745	6	actavis	actavis	PROPN
ihlr-18967	745	7	does	do	AUX
ihlr-18967	745	8	not	not	PART
ihlr-18967	745	9	impede	impede	VERB
ihlr-18967	745	10	upon	upon	SCONJ
ihlr-18967	745	11	the	the	DET
ihlr-18967	745	12	rationale	rationale	NOUN
ihlr-18967	745	13	of	of	ADP
ihlr-18967	745	14	patent	patent	NOUN
ihlr-18967	745	15	law	law	NOUN
ihlr-18967	745	16	or	or	CCONJ
ihlr-18967	745	17	the	the	DET
ihlr-18967	745	18	hatch	hatch	NOUN
ihlr-18967	745	19	-	-	PUNCT
ihlr-18967	745	20	waxman	waxman	PROPN
ihlr-18967	745	21	act	act	PROPN
ihlr-18967	745	22	.	.	PUNCT
ihlr-18967	746	1	to	to	ADP
ihlr-18967	746	2	the	the	DET
ihlr-18967	746	3	contrary	contrary	NOUN
ihlr-18967	746	4	,	,	PUNCT
ihlr-18967	746	5	it	it	PRON
ihlr-18967	746	6	supports	support	VERB
ihlr-18967	746	7	these	these	DET
ihlr-18967	746	8	rationales	rationale	NOUN
ihlr-18967	746	9	.	.	PUNCT
ihlr-18967	747	1	therefore	therefore	ADV
ihlr-18967	747	2	,	,	PUNCT
ihlr-18967	747	3	congress	congress	PROPN
ihlr-18967	747	4	should	should	AUX
ihlr-18967	747	5	not	not	PART
ihlr-18967	747	6	act	act	VERB
ihlr-18967	747	7	and	and	CCONJ
ihlr-18967	747	8	allow	allow	VERB
ihlr-18967	747	9	courts	court	NOUN
ihlr-18967	747	10	to	to	PART
ihlr-18967	747	11	continue	continue	VERB
ihlr-18967	747	12	analyzing	analyze	VERB
ihlr-18967	747	13	reverse	reverse	ADJ
ihlr-18967	747	14	payment	payment	NOUN
ihlr-18967	747	15	settlements	settlement	NOUN
ihlr-18967	747	16	under	under	ADP
ihlr-18967	747	17	the	the	DET
ihlr-18967	747	18	actavis	actavis	ADJ
ihlr-18967	747	19	framework	framework	NOUN
ihlr-18967	747	20	.	.	PUNCT
ihlr-18967	748	1	v.	v.	ADP
ihlr-18967	748	2	conclusion	conclusion	NOUN
ihlr-18967	748	3	the	the	DET
ihlr-18967	748	4	supreme	supreme	PROPN
ihlr-18967	748	5	court	court	PROPN
ihlr-18967	748	6	’s	’s	PART
ihlr-18967	748	7	correct	correct	ADJ
ihlr-18967	748	8	analysis	analysis	NOUN
ihlr-18967	748	9	in	in	ADP
ihlr-18967	748	10	actavis	actavis	PROPN
ihlr-18967	748	11	provides	provide	VERB
ihlr-18967	748	12	a	a	DET
ihlr-18967	748	13	useful	useful	ADJ
ihlr-18967	748	14	and	and	CCONJ
ihlr-18967	748	15	workable	workable	ADJ
ihlr-18967	748	16	framework	framework	NOUN
ihlr-18967	748	17	for	for	ADP
ihlr-18967	748	18	practitioners	practitioner	NOUN
ihlr-18967	748	19	to	to	PART
ihlr-18967	748	20	construct	construct	VERB
ihlr-18967	748	21	reverse	reverse	ADJ
ihlr-18967	748	22	payment	payment	NOUN
ihlr-18967	748	23	settlements	settlement	NOUN
ihlr-18967	748	24	and	and	CCONJ
ihlr-18967	748	25	for	for	SCONJ
ihlr-18967	748	26	courts	court	NOUN
ihlr-18967	748	27	to	to	PART
ihlr-18967	748	28	review	review	VERB
ihlr-18967	748	29	such	such	ADJ
ihlr-18967	748	30	settlements	settlement	NOUN
ihlr-18967	748	31	.	.	PUNCT
ihlr-18967	749	1	a	a	DET
ihlr-18967	749	2	per	per	X
ihlr-18967	749	3	se	se	X
ihlr-18967	749	4	ban	ban	NOUN
ihlr-18967	749	5	on	on	ADP
ihlr-18967	749	6	reverse	reverse	ADJ
ihlr-18967	749	7	payment	payment	NOUN
ihlr-18967	749	8	settlements	settlement	NOUN
ihlr-18967	749	9	or	or	CCONJ
ihlr-18967	749	10	a	a	DET
ihlr-18967	749	11	presumption	presumption	NOUN
ihlr-18967	749	12	of	of	ADP
ihlr-18967	749	13	anticompetitive	anticompetitive	ADJ
ihlr-18967	749	14	harm	harm	NOUN
ihlr-18967	749	15	would	would	AUX
ihlr-18967	749	16	be	be	AUX
ihlr-18967	749	17	unsupported	unsupported	ADJ
ihlr-18967	749	18	by	by	ADP
ihlr-18967	749	19	the	the	DET
ihlr-18967	749	20	framers	framer	NOUN
ihlr-18967	749	21	of	of	ADP
ihlr-18967	749	22	the	the	DET
ihlr-18967	749	23	hatch	hatch	NOUN
ihlr-18967	749	24	-	-	PUNCT
ihlr-18967	749	25	waxman	waxman	PROPN
ihlr-18967	749	26	act	act	NOUN
ihlr-18967	749	27	and	and	CCONJ
ihlr-18967	749	28	simultaneously	simultaneously	ADV
ihlr-18967	749	29	undermines	undermine	VERB
ihlr-18967	749	30	the	the	DET
ihlr-18967	749	31	important	important	ADJ
ihlr-18967	749	32	motivations	motivation	NOUN
ihlr-18967	749	33	provided	provide	VERB
ihlr-18967	749	34	through	through	ADP
ihlr-18967	749	35	patent	patent	NOUN
ihlr-18967	749	36	law	law	NOUN
ihlr-18967	749	37	.	.	PUNCT
ihlr-18967	750	1	actavis	actavi	NOUN
ihlr-18967	750	2	,	,	PUNCT
ihlr-18967	750	3	like	like	ADP
ihlr-18967	750	4	the	the	DET
ihlr-18967	750	5	hatch	hatch	NOUN
ihlr-18967	750	6	-	-	PUNCT
ihlr-18967	750	7	waxman	waxman	PROPN
ihlr-18967	750	8	act	act	PROPN
ihlr-18967	750	9	,	,	PUNCT
ihlr-18967	750	10	is	be	AUX
ihlr-18967	750	11	a	a	DET
ihlr-18967	750	12	compromise	compromise	NOUN
ihlr-18967	750	13	between	between	ADP
ihlr-18967	750	14	consumers	consumer	NOUN
ihlr-18967	750	15	and	and	CCONJ
ihlr-18967	750	16	manufacturers	manufacturer	NOUN
ihlr-18967	750	17	by	by	ADP
ihlr-18967	750	18	forcing	force	VERB
ihlr-18967	750	19	each	each	PRON
ihlr-18967	750	20	to	to	PART
ihlr-18967	750	21	give	give	VERB
ihlr-18967	750	22	up	up	ADP
ihlr-18967	750	23	something	something	PRON
ihlr-18967	750	24	in	in	ADP
ihlr-18967	750	25	exchange	exchange	NOUN
ihlr-18967	750	26	for	for	ADP
ihlr-18967	750	27	something	something	PRON
ihlr-18967	750	28	else	else	ADV
ihlr-18967	750	29	.	.	PUNCT
ihlr-18967	751	1	consequently	consequently	ADV
ihlr-18967	751	2	,	,	PUNCT
ihlr-18967	751	3	actavis	actavis	ADJ
ihlr-18967	751	4	237	237	NUM
ihlr-18967	751	5	plavix	plavix	NOUN
ihlr-18967	751	6	is	be	AUX
ihlr-18967	751	7	a	a	DET
ihlr-18967	751	8	branded	brand	VERB
ihlr-18967	751	9	drug	drug	NOUN
ihlr-18967	751	10	,	,	PUNCT
ihlr-18967	751	11	distributed	distribute	VERB
ihlr-18967	751	12	by	by	ADP
ihlr-18967	751	13	bristol	bristol	PROPN
ihlr-18967	751	14	-	-	PUNCT
ihlr-18967	751	15	myers	myers	PROPN
ihlr-18967	751	16	squibb	squibb	PROPN
ihlr-18967	751	17	,	,	PUNCT
ihlr-18967	751	18	prescribed	prescribe	VERB
ihlr-18967	751	19	to	to	PART
ihlr-18967	751	20	treat	treat	VERB
ihlr-18967	751	21	various	various	ADJ
ihlr-18967	751	22	aliments	aliment	NOUN
ihlr-18967	751	23	related	relate	VERB
ihlr-18967	751	24	to	to	ADP
ihlr-18967	751	25	the	the	DET
ihlr-18967	751	26	heart	heart	NOUN
ihlr-18967	751	27	.	.	PUNCT
ihlr-18967	752	1	medication	medication	NOUN
ihlr-18967	752	2	guide	guide	NOUN
ihlr-18967	752	3	plavix	plavix	PROPN
ihlr-18967	752	4	®	®	NOUN
ihlr-18967	752	5	(	(	PUNCT
ihlr-18967	752	6	plav	plav	NOUN
ihlr-18967	752	7	-	-	PUNCT
ihlr-18967	752	8	iks	iks	NOUN
ihlr-18967	752	9	)	)	PUNCT
ihlr-18967	752	10	(	(	PUNCT
ihlr-18967	752	11	clopidogrel	clopidogrel	NOUN
ihlr-18967	752	12	bisulfate	bisulfate	VERB
ihlr-18967	752	13	)	)	PUNCT
ihlr-18967	752	14	tablets	tablet	NOUN
ihlr-18967	752	15	,	,	PUNCT
ihlr-18967	752	16	fda.gov	fda.gov	NUM
ihlr-18967	752	17	,	,	PUNCT
ihlr-18967	752	18	http://www.fda.gov/downloads/drugs/drugsafety/ucm243349.pdf	http://www.fda.gov/downloads/drugs/drugsafety/ucm243349.pdf	NOUN
ihlr-18967	752	19	(	(	PUNCT
ihlr-18967	752	20	last	last	ADV
ihlr-18967	752	21	visited	visit	VERB
ihlr-18967	752	22	nov	nov	PROPN
ihlr-18967	752	23	.	.	PROPN
ihlr-18967	752	24	8	8	NUM
ihlr-18967	752	25	,	,	PUNCT
ihlr-18967	752	26	2014	2014	NUM
ihlr-18967	752	27	)	)	PUNCT
ihlr-18967	752	28	.	.	PUNCT
ihlr-18967	753	1	238	238	NUM
ihlr-18967	753	2	orszag	orszag	NOUN
ihlr-18967	753	3	testimony	testimony	NOUN
ihlr-18967	753	4	,	,	PUNCT
ihlr-18967	753	5	supra	supra	PROPN
ihlr-18967	753	6	note	note	NOUN
ihlr-18967	753	7	225	225	NUM
ihlr-18967	753	8	.	.	SYM
ihlr-18967	753	9	2015	2015	NUM
ihlr-18967	753	10	rationale	rationale	NOUN
ihlr-18967	753	11	behind	behind	ADP
ihlr-18967	753	12	hatch	hatch	NOUN
ihlr-18967	753	13	-	-	PUNCT
ihlr-18967	753	14	waxman	waxman	PROPN
ihlr-18967	753	15	act	act	PROPN
ihlr-18967	753	16	and	and	CCONJ
ihlr-18967	753	17	patent	patent	NOUN
ihlr-18967	753	18	law	law	NOUN
ihlr-18967	753	19	469	469	NUM
ihlr-18967	753	20	provides	provide	VERB
ihlr-18967	753	21	us	we	PRON
ihlr-18967	753	22	with	with	ADP
ihlr-18967	753	23	a	a	DET
ihlr-18967	753	24	sound	sound	ADJ
ihlr-18967	753	25	approach	approach	NOUN
ihlr-18967	753	26	to	to	ADP
ihlr-18967	753	27	analyzing	analyze	VERB
ihlr-18967	753	28	reverse	reverse	ADJ
ihlr-18967	753	29	payment	payment	NOUN
ihlr-18967	753	30	settlements	settlement	NOUN
ihlr-18967	753	31	,	,	PUNCT
ihlr-18967	753	32	which	which	PRON
ihlr-18967	753	33	should	should	AUX
ihlr-18967	753	34	rightly	rightly	ADV
ihlr-18967	753	35	be	be	AUX
ihlr-18967	753	36	left	leave	VERB
ihlr-18967	753	37	undisturbed	undisturbed	ADJ
ihlr-18967	753	38	by	by	ADP
ihlr-18967	753	39	congress	congress	PROPN
ihlr-18967	753	40	.	.	PUNCT